data_1k2n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k2n _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.479 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 8.7 ttm180 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.642 0.258 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.592 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 5.5 t80 -122.43 -57.07 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.471 ' CD1' HG11 ' A' ' 694' ' ' VAL . 20.3 tp -111.04 142.36 43.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.381 . . . . 0.0 111.176 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 3.5 m -121.17 114.34 21.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 592' ' ' LEU . 5.6 mt -103.37 108.38 19.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 7.7 mtmt -113.71 99.81 50.74 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -176.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.6 Cg_exo -47.02 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.692 1.595 . . . . 0.0 109.606 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.59 157.25 86.29 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.421 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 9.4 Cg_endo -51.53 -25.9 20.65 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.775 2.983 . . . . 0.0 112.841 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -61.91 -27.46 68.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.408 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.9 t -95.68 154.11 17.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.797 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.425 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 12.6 pt -55.92 -11.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.704 0.288 . . . . 0.0 111.296 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.436 ' CD1' HG22 ' A' ' 613' ' ' ILE . 43.4 mt -109.58 124.88 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.794 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -112.46 57.1 0.66 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.57 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.628 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 tt0 -124.87 171.53 10.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.012 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.64 128.83 46.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.012 0.434 . . . . 0.0 110.846 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -111.97 141.04 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.931 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -123.93 115.93 22.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.679 0.276 . . . . 0.0 111.611 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.473 HG12 ' CD1' ' A' ' 601' ' ' PHE . 80.2 mt -82.61 108.95 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.395 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.91 118.2 10.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.994 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.36 -28.45 1.33 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.44 -23.13 75.15 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.366 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.02 118.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.775 0.788 . . . . 0.0 111.502 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -139.5 122.58 10.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.929 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.8 Cg_endo -90.44 159.92 31.96 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.723 -0.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -91.95 115.28 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.536 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 32.2 m-85 -92.29 138.0 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.071 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.6 mp -124.73 145.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.625 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.09 -172.23 35.77 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.655 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.456 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -68.47 -52.31 33.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.975 0.417 . . . . 0.0 111.723 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -60.2 126.27 26.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.323 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.71 -20.13 2.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.133 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.87 -31.95 60.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.145 0.498 . . . . 0.0 110.201 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 11.4 m -70.74 130.19 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.8 m120 -44.52 -32.63 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.185 0.517 . . . . 0.0 110.39 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 25.9 t -107.35 142.3 37.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.041 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 104.55 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.48 HD12 HG22 ' A' ' 613' ' ' ILE . 24.1 mm -139.6 109.84 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.329 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -103.61 107.04 17.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.46 0.648 . . . . 0.0 112.42 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.468 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.9 t0 -129.16 107.49 9.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.602 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -40.46 -28.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -69.46 -41.28 76.42 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.514 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -89.22 159.11 17.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.75 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -78.18 173.29 12.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.222 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.511 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -46.7 -52.52 13.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.089 0.471 . . . . 0.0 110.187 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 41.6 t -114.44 70.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.291 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.514 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 11.4 t60 -48.06 -44.23 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.683 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 3.5 p -166.85 159.18 13.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 111.334 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.536 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 52.1 p90 -143.2 149.41 37.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.431 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 37.7 mt -102.14 135.16 40.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.001 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.3 t80 -128.68 134.48 48.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.3 ttmt -98.26 136.59 38.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.9 157.63 46.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.546 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.01 114.74 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.321 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.341 0.115 . . . . 0.0 110.863 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.94 148.9 34.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.309 0.576 . . . . 0.0 112.464 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.19 129.6 34.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.787 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.458 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 2.1 pt -87.16 122.85 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.355 0.598 . . . . 0.0 111.918 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.571 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.8 m95 -105.83 148.98 26.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.159 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 12.0 t80 -108.16 116.61 32.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.511 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.7 m -102.07 137.66 40.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.476 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 62.4 t60 -118.4 131.59 56.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.43 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.9 p -129.04 5.79 5.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.303 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.8 151.6 32.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.637 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 14.6 t -76.78 -44.33 33.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.016 0.436 . . . . 0.0 111.414 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.82 -18.09 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.795 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.42 ' HA ' ' NE2' ' A' ' 651' ' ' HIS . 4.4 t 78.55 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.142 0.496 . . . . 0.0 111.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.476 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 93.2 p -114.52 152.22 32.07 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -124.39 119.79 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.33 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.477 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -94.96 99.86 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.083 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 61.19 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.899 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.3 t30 -135.64 -0.44 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.466 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 1.7 m120 -101.0 135.41 42.49 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.927 0.394 . . . . 0.0 111.287 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 41.6 ttm-85 -75.59 141.17 42.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.401 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 19.5 mmm -126.32 94.61 4.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 665' ' ' ILE . 32.7 pt -87.67 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.578 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -48.8 110.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.201 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 100.96 30.78 5.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.287 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.404 HG23 ' CG1' ' A' ' 665' ' ' ILE . 13.8 p -112.78 162.28 15.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 111.348 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.9 ttpm? -143.81 133.95 24.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.477 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -139.88 143.48 36.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.812 0.339 . . . . 0.0 111.165 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.571 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.64 140.55 53.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.434 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 5.0 mt -109.43 125.98 52.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.68 147.16 31.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -48.53 103.7 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 110.465 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.67 33.62 3.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.81 118.8 30.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.533 -0.334 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -96.18 111.5 23.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 30.6 pt -105.71 137.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 112.064 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.42 116.54 30.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.894 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.449 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -84.96 -38.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 681' ' ' ILE . 3.1 tp -155.18 131.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.696 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -136.84 124.88 22.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.369 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.31 116.66 20.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.792 0.329 . . . . 0.0 110.306 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -67.36 -46.57 72.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.125 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -74.51 -40.49 61.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.917 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -87.64 -7.12 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.535 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tttt 59.13 18.18 6.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.732 0.301 . . . . 0.0 110.948 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.425 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 5.9 t80 -77.54 105.02 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.2 p -124.12 121.65 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 111.917 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.425 ' HB ' ' CG2' ' A' ' 681' ' ' ILE . 2.5 mt -128.79 150.34 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.179 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.61 138.68 3.54 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.478 ' CE2' HG13 ' A' ' 613' ' ' ILE . 7.8 m-30 -113.46 148.71 35.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.788 0.328 . . . . 0.0 110.449 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -101.33 116.95 33.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 578' ' ' LEU . 1.0 OUTLIER -81.55 123.1 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.407 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.28 109.46 9.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.589 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 14.9 mt -78.39 105.53 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.703 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -47.95 11.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.22 139.83 46.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.875 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.445 -0.697 0 CA-C-O 121.117 0.484 . . . . 0.0 109.727 178.283 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.778 0.323 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.31 172.2 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -100.64 150.54 22.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -75.27 153.22 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -119.36 -179.17 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.27 -29.53 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -65.96 -50.28 64.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -51.07 66.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.916 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -56.01 -32.86 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.63 -36.77 83.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.988 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.58 -44.16 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.6 p -76.48 -27.59 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -36.02 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 7.8 t80 -122.66 -48.07 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 696' ' ' ILE . 8.2 tp -119.55 141.98 48.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 695' ' ' GLU . 40.3 m -122.39 114.53 20.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 592' ' ' LEU . 1.7 mp -105.63 108.57 20.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 8.4 ptpt -117.04 100.53 53.36 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 26.7 Cg_exo -44.77 104.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.739 1.626 . . . . 0.0 109.47 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.47 157.17 86.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.491 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 73.2 Cg_exo -49.18 -32.6 25.18 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.617 2.878 . . . . 0.0 112.891 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -21.76 66.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.88 0.371 . . . . 0.0 110.577 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.67 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 22.7 p -96.43 153.46 17.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.998 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.494 HG23 HG13 ' A' ' 588' ' ' ILE . 1.2 tt -52.49 -18.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.871 0.367 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.494 HG13 HG23 ' A' ' 587' ' ' ILE . 10.8 mt -111.25 119.78 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.162 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.67 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -110.37 57.71 0.61 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.295 0.569 . . . . 0.0 110.758 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.0 mt-10 -125.13 172.08 9.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.578 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.54 128.31 46.66 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.144 0.497 . . . . 0.0 111.474 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -113.09 138.81 49.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.831 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -123.92 115.76 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.594 HG12 ' CD2' ' A' ' 601' ' ' PHE . 46.3 mt -80.32 109.75 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.923 0.392 . . . . 0.0 111.033 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.75 113.05 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.522 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.66 -30.68 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.05 -22.61 70.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.376 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 67.9 t -101.3 119.6 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 117.669 0.734 . . . . 0.0 111.538 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -138.66 122.73 11.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.38 160.47 32.53 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.618 -0.992 . . . . 0.0 111.994 0.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -91.6 115.68 28.25 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 51.0 m-85 -92.39 138.28 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.036 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.48 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 3.3 mp -127.15 145.42 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.588 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.09 -178.3 34.42 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.327 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.477 ' CG ' HD22 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -59.58 -52.68 64.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.88 0.372 . . . . 0.0 111.849 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.51 122.9 15.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.455 -178.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -21.04 2.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.734 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -51.9 -30.52 24.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.177 0.513 . . . . 0.0 110.08 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 95.0 m -73.57 129.37 37.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.338 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 13.4 m-80 -45.55 -29.5 1.19 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.128 0.49 . . . . 0.0 110.621 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.48 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 53.4 t -109.22 142.91 39.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.47 106.93 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.458 HG13 ' CE2' ' A' ' 692' ' ' PHE . 30.9 mm -138.14 109.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.916 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.09 107.15 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.458 0.647 . . . . 0.0 112.369 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.474 ' OD2' HG21 ' A' ' 681' ' ' ILE . 10.9 t0 -129.1 107.55 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.123 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -41.74 -31.2 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.433 ' NH1' ' CD2' ' A' ' 688' ' ' PHE . 2.0 mtt180 -77.43 -38.15 50.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.303 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -89.67 147.25 23.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.831 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.45 162.73 12.04 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.491 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -63.15 -17.69 62.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.504 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 29.4 t -137.38 55.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.528 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 6.8 t60 -47.66 -43.06 25.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.421 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.3 p -164.29 158.68 19.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 112.261 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.518 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 50.2 p90 -143.74 146.07 32.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.241 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.472 HD11 HD13 ' A' ' 594' ' ' ILE . 71.2 mt -102.18 128.62 54.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.522 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -119.49 134.68 55.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.504 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 35.4 ttmt -97.42 133.66 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.413 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.457 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.14 159.11 42.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.175 -178.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.3 tpt180 -77.07 112.43 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.282 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.091 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.4 mp . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -114.3 146.44 40.47 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.214 0.531 . . . . 0.0 112.025 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.61 157.65 46.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.137 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 2.7 pt -103.8 118.73 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.462 0.649 . . . . 0.0 111.835 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.514 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 89.0 m95 -100.47 127.97 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.206 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 2.6 t80 -90.21 116.69 28.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.457 ' N ' ' O ' ' A' ' 624' ' ' PHE . 14.3 m -103.36 142.12 34.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.374 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.45 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 29.5 t60 -121.15 133.06 55.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.981 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 5.6 p -131.26 9.81 4.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.15 151.13 29.69 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.832 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.9 t -76.39 -33.91 58.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.156 0.503 . . . . 0.0 111.365 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.86 3.09 7.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.33 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 50.7 142.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.731 0.777 . . . . 0.0 112.423 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 656' ' ' VAL . 95.8 p -112.34 166.38 11.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.286 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -129.38 120.31 25.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 111.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.2 OUTLIER -103.98 99.93 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.021 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.403 ' HB2' HD13 ' A' ' 659' ' ' LEU . 1.1 t-20 63.1 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 9.0 m120 -144.91 -0.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.491 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -103.54 141.28 36.27 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.95 0.405 . . . . 0.0 111.312 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -79.6 141.97 36.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.426 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 23.1 mmm -118.04 97.86 6.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.2 pt -87.44 146.98 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -45.19 98.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.416 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.56 37.94 1.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.523 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 4.5 p -135.66 152.61 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.79 0.329 . . . . 0.0 111.336 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 15.1 pttm -123.68 158.03 32.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.282 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 662' ' ' ASN . 0.2 OUTLIER -142.59 142.49 32.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.514 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -69.81 125.48 26.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.975 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 671' ' ' LEU . 2.8 mt -101.33 136.14 41.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.383 0.611 . . . . 0.0 111.891 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.22 137.33 54.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.251 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -39.8 118.81 0.91 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.955 0.407 . . . . 0.0 110.843 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.24 36.36 5.72 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.334 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.95 116.76 29.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.4 108.77 21.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.122 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 9.0 mt -107.95 130.19 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -93.79 116.07 28.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.828 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -77.96 -35.69 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.462 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.474 HG21 ' OD2' ' A' ' 615' ' ' ASP . 8.9 tt -154.8 134.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.854 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.33 123.31 21.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -120.92 117.0 26.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.552 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -67.55 -46.59 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.134 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -75.91 -40.68 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.862 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.33 -12.23 49.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.464 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.13 15.61 8.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.697 0.284 . . . . 0.0 110.873 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.459 ' CE1' HG21 ' A' ' 587' ' ' ILE . 2.3 t80 -76.86 105.12 7.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -121.46 122.43 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 112.122 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.415 HG12 ' CG2' ' A' ' 587' ' ' ILE . 7.6 mt -116.31 145.25 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.743 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -170.47 131.23 2.18 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.481 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.458 ' CE2' HG13 ' A' ' 613' ' ' ILE . 3.3 m-30 -113.81 147.03 39.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.343 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -101.2 116.91 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.491 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 675' ' ' GLY . 3.5 t -81.74 127.34 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.603 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.28 108.71 8.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 0.0 111.146 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.433 HG12 ' CD1' ' A' ' 578' ' ' LEU . 95.6 mt -73.28 105.42 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.504 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -81.16 -45.91 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 109.941 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.4 t0 -110.74 140.68 44.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.878 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.216 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 40.8 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.797 0.332 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.01 147.21 35.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.81 147.02 30.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.36 160.07 24.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.978 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 14.8 p -126.14 -175.75 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.62 -30.93 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.37 -47.29 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.42 -49.93 69.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -57.25 -32.79 66.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.43 -36.92 82.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 12.6 mt -59.76 -44.22 93.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.088 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.5 p -81.93 -29.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -55.75 -28.9 58.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mttp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.441 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.1 tmm_? . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.539 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -122.02 -64.98 1.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.346 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.9 tt -106.31 125.64 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.843 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 695' ' ' GLU . 24.3 m -104.68 117.2 33.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.3 OUTLIER -105.96 108.08 19.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.66 99.12 46.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.3 Cg_exo -48.25 103.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.482 1.455 . . . . 0.0 109.009 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.51 157.26 88.04 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.449 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 10.3 Cg_endo -50.92 -29.16 26.11 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.613 2.876 . . . . 0.0 112.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.72 -15.23 57.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.913 0.387 . . . . 0.0 110.219 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.53 153.71 17.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.414 HG22 ' CZ ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -50.04 -24.44 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.908 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 582' ' ' PRO . 1.5 tt -112.82 144.1 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.113 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.449 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.25 65.41 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 110.785 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.618 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 37.1 mt-10 -125.65 172.1 10.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.054 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.9 127.44 44.9 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.914 0.388 . . . . 0.0 110.99 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -112.94 143.58 43.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.966 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.441 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.39 118.08 25.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.572 HG12 ' CD2' ' A' ' 601' ' ' PHE . 55.1 mt -82.39 108.6 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.11 0.481 . . . . 0.0 110.156 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.0 mp0 -68.67 105.43 2.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.539 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -33.3 -54.23 0.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.209 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -47.39 -21.94 1.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.526 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 53.0 t -99.38 118.39 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.256 0.528 . . . . 0.0 111.293 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -140.13 123.21 10.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.127 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.4 Cg_endo -90.45 159.77 31.85 Favored 'Cis proline' 0 N--CA 1.461 -0.431 0 C-N-CA 124.411 -1.079 . . . . 0.0 111.832 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.61 115.88 28.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.502 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.7 m-85 -92.42 138.39 31.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.044 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 2.8 mp -126.4 145.79 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.668 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.62 -171.83 38.54 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.134 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.46 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -69.57 -50.2 47.02 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.498 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -60.78 131.46 50.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -59.01 -18.04 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.654 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -55.33 -32.41 62.47 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 121.081 0.467 . . . . 0.0 110.241 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 34.5 m -71.53 132.46 44.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 2.4 m-80 -47.12 -27.09 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 0.0 110.681 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 40.4 t -112.75 142.51 45.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.293 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 105.62 13.87 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.408 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 21.4 mm -138.21 109.28 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.43 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.12 106.24 16.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.556 0.693 . . . . 0.0 112.453 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.45 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.3 t0 -130.19 107.8 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.698 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -40.01 -29.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.43 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -68.93 -41.5 78.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.476 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 1.3 pp -90.12 158.8 17.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 12.8 t -76.91 162.98 27.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.049 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.447 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.7 OUTLIER -52.08 -26.68 11.65 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.441 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 37.6 t -130.71 62.7 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.559 ' CD2' HG23 ' A' ' 680' ' ' ILE . 25.1 t60 -51.8 -47.22 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.381 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.1 p -165.01 162.5 20.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.234 0.54 . . . . 0.0 112.138 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 53.8 p90 -143.59 147.31 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.766 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.35 130.57 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.021 0.438 . . . . 0.0 109.981 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.517 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -122.12 133.62 54.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.607 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 30.9 ttmt -97.72 136.99 37.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.23 158.82 43.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.947 -178.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.2 tpt180 -76.64 112.34 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.1 t60 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.384 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.7 mp . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -118.48 146.62 44.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.15 0.5 . . . . 0.0 111.885 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -129.72 160.07 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.438 HG22 ' CE2' ' A' ' 577' ' ' PHE . 1.4 pt -108.66 120.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.479 0.657 . . . . 0.0 111.724 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.588 ' CH2' HD21 ' A' ' 671' ' ' LEU . 67.5 m95 -106.43 127.3 53.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.065 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -90.54 117.61 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.412 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -101.79 130.09 48.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.162 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.458 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 66.2 t60 -109.3 133.74 52.67 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -131.02 1.27 4.26 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.427 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.95 149.63 36.42 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.72 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.8 t -74.57 -32.37 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.451 . . . . 0.0 111.534 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 656' ' ' VAL . 3.5 m-20 -73.13 1.86 8.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.461 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.82 126.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.28 0.562 . . . . 0.0 111.89 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.458 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 8.7 t -96.43 165.93 11.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.255 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -130.53 121.28 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.866 0.365 . . . . 0.0 111.265 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.51 99.47 11.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.9 m120 60.7 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -129.55 -0.27 4.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.488 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.472 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 10.8 m120 -100.89 141.99 32.99 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.888 0.375 . . . . 0.0 111.107 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.6 141.54 32.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 11.5 mmm -123.89 101.21 7.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.812 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.4 ' O ' ' OG1' ' A' ' 668' ' ' THR . 50.7 pt -89.64 161.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.21 98.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.76 44.8 1.18 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 1.2 p -127.62 162.25 26.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.32 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.47 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -129.92 149.03 51.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.398 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.472 ' CE2' ' CB ' ' A' ' 662' ' ' ASN . 4.3 t80 -147.26 145.34 29.38 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.588 HD21 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 129.05 38.8 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.596 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.408 ' CB ' ' CD1' ' A' ' 647' ' ' ILE . 1.2 mt -108.74 119.94 41.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.291 0.567 . . . . 0.0 111.474 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.15 144.0 39.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.24 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -43.06 123.93 3.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.772 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.15 7.39 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.401 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -95.23 112.85 24.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.372 . . . . 0.0 111.502 -179.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.75 108.66 21.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.053 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 11.2 mt -106.89 136.89 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.0 111.958 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -96.12 116.15 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.478 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.559 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.3 mt -83.71 -34.07 10.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.793 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.431 ' CG2' ' HB ' ' A' ' 690' ' ' ILE . 2.1 tp -154.86 131.58 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.102 0.477 . . . . 0.0 112.097 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.73 130.04 31.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -127.1 117.63 22.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.797 0.332 . . . . 0.0 110.735 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -66.97 -46.61 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.101 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -76.39 -40.52 50.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -88.8 -11.09 45.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.42 16.76 7.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CZ ' HG22 ' A' ' 587' ' ' ILE . 15.5 t80 -76.9 105.44 7.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.31 125.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.908 0.385 . . . . 0.0 111.986 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.431 ' HB ' ' CG2' ' A' ' 681' ' ' ILE . 13.1 mt -123.8 153.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.178 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -176.59 138.2 3.93 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.278 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.436 ' CD1' ' HG3' ' A' ' 582' ' ' PRO . 1.8 m-30 -113.45 147.08 38.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 0.0 110.541 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.27 117.23 34.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.477 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 676' ' ' ASP . 3.9 t -80.29 123.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 579' ' ' THR . 24.3 tt0 -132.64 109.38 9.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.448 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 54.6 mt -78.66 106.08 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.24 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.58 -45.26 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.37 140.93 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 37.7 p . . . . . 0 N--CA 1.446 -0.654 0 CA-C-O 121.184 0.516 . . . . 0.0 109.998 178.654 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 27.7 t . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 111.643 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.92 168.31 12.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.484 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.16 146.29 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.01 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -82.29 151.65 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 71.0 p -126.05 -179.19 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.28 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.86 -30.13 57.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.36 -51.1 70.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.65 -50.71 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.695 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -55.86 -32.71 63.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -66.66 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.348 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.0 mt -58.34 -44.58 88.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 111.112 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.6 -25.04 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -36.25 65.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.057 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.4 mttp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' CB ' ' A' ' 593' ' ' GLU . 5.1 tmm_? . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.924 0.392 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -110.2 -61.89 1.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.247 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.519 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.3 tt -106.93 142.71 36.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 24.5 m -113.04 114.26 26.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.044 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.6 OUTLIER -106.75 108.6 20.2 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 10.9 ptpt -118.74 101.59 50.36 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.6 Cg_exo -45.34 105.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.842 1.695 . . . . 0.0 109.239 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.66 157.31 86.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.461 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.9 Cg_endo -53.65 -27.4 41.72 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.807 3.005 . . . . 0.0 112.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.08 -24.28 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.475 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 1.8 t -96.02 153.96 17.49 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.207 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 690' ' ' ILE . 14.9 pt -55.29 -14.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.312 . . . . 0.0 111.022 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 35.4 mt -107.36 125.2 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.665 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.461 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.32 58.22 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.446 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.551 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.6 mp0 -125.28 168.76 13.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.613 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.23 121.59 25.06 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.381 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.3 mm? -113.34 150.73 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.423 ' CB ' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.72 117.09 23.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.49 HG12 ' CD2' ' A' ' 601' ' ' PHE . 66.2 mt -74.46 108.7 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -69.05 111.12 4.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.291 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.498 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -38.81 -52.12 1.72 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.281 0.563 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -46.94 -24.74 2.09 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.234 -0.893 . . . . 0.0 113.14 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.09 117.89 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.287 0.543 . . . . 0.0 110.916 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -140.18 122.33 9.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.058 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.541 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -89.76 159.93 35.32 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 124.407 -1.08 . . . . 0.0 111.54 -0.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.8 t80 -91.55 114.61 27.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.498 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 6.1 m-85 -92.2 138.08 31.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.574 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.5 mp -124.02 148.34 28.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.47 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.41 -171.54 36.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.347 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.459 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.58 -52.58 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 111.644 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.58 133.54 56.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.319 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -57.95 -19.25 28.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.772 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.51 -31.44 56.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.063 0.459 . . . . 0.0 110.258 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 8.6 m -73.56 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.447 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -43.36 -32.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.235 0.54 . . . . 0.0 110.408 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.574 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 34.8 t -106.48 142.01 36.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.007 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.85 104.71 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.406 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.3 mm -139.14 109.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.194 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.9 106.75 17.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.424 0.631 . . . . 0.0 112.432 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.455 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.5 t0 -129.46 107.59 9.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.55 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -40.68 -28.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 688' ' ' PHE . 9.3 mmt180 -69.38 -41.47 76.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -89.19 158.62 17.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.912 0.387 . . . . 0.0 111.527 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 73.1 m -78.97 170.58 16.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.367 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -46.93 -42.58 17.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.51 69.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.289 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.632 ' O ' ' N ' ' A' ' 653' ' ' GLY . 17.7 t60 -50.49 -47.05 57.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.745 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.2 p -164.6 163.35 21.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.119 0.485 . . . . 0.0 111.986 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.498 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 53.3 p90 -144.18 151.03 38.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.877 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.441 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 3.8 mp -102.71 132.89 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -124.17 132.54 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.872 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.411 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 29.9 ttmt -98.17 136.56 38.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.18 158.75 39.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -76.61 114.49 15.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.235 0.54 . . . . 0.0 110.412 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.9 t60 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.771 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 p-10 -122.15 147.62 45.93 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.013 0.435 . . . . 0.0 112.041 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 155.38 47.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.389 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.47 HG23 ' CE2' ' A' ' 577' ' ' PHE . 1.3 pt -104.26 129.16 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.606 0.717 . . . . 0.0 112.702 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.538 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 96.1 m95 -113.49 128.57 56.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.215 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 4.7 t80 -90.32 117.29 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 63.2 m -102.78 130.24 49.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.873 0.368 . . . . 0.0 111.271 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.462 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -109.48 128.22 55.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.207 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.445 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.7 p -126.95 8.98 6.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.206 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.54 151.82 31.42 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.155 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.5 m -83.97 -17.17 41.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.578 0.227 . . . . 0.0 111.49 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.403 ' CB ' ' CD1' ' A' ' 681' ' ' ILE . 2.1 m120 -87.22 -5.51 58.93 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 664' ' ' MET . 6.6 t 74.8 145.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.122 0.486 . . . . 0.0 112.284 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.462 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 61.8 p -119.2 160.3 22.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 679' ' ' LYS . 21.8 m-85 -138.29 120.4 15.64 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.2 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -94.59 103.72 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.564 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 67.75 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -134.86 -3.68 2.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.52 140.79 29.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.878 0.371 . . . . 0.0 111.099 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -83.88 141.53 31.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.929 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.426 ' O ' ' CG1' ' A' ' 656' ' ' VAL . 27.6 mtp -131.92 107.17 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 26.5 pt -86.72 164.73 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.124 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 652' ' ' THR . 36.1 tt0 -50.58 110.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.06 31.7 4.95 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.952 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 9.4 p -112.7 162.57 15.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.594 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.441 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -137.37 144.35 42.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.493 ' CD2' HD13 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.26 144.14 28.63 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.632 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.538 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.23 136.02 51.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.67 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 1.1 mt -107.48 106.72 17.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.117 0.484 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -93.48 141.08 28.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.492 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.452 ' HB3' HD11 ' A' ' 696' ' ' ILE . 1.6 p30 -41.52 112.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 91.28 37.6 6.19 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 124.39 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.353 -0.424 . . . . 0.0 111.101 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -96.31 109.07 21.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.409 HG23 HD22 ' A' ' 659' ' ' LEU . 12.0 pt -105.41 132.83 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.076 0.465 . . . . 0.0 111.768 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 658' ' ' TYR . 12.3 mttp -93.72 115.88 28.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.633 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.414 ' CG2' HG22 ' A' ' 681' ' ' ILE . 1.3 tt -78.01 -34.79 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.125 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.414 HG22 ' CG2' ' A' ' 680' ' ' ILE . 0.9 OUTLIER -154.33 131.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.029 179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.619 ' CD1' ' CG1' ' A' ' 689' ' ' VAL . 11.7 t90 -136.02 113.25 10.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -128.57 114.07 16.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.834 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.59 -42.26 78.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -58.58 -40.16 82.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.258 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -76.08 -19.31 58.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.71 15.85 9.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.196 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 617' ' ' ARG . 0.2 OUTLIER -117.73 125.27 50.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.566 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.619 ' CG1' ' CD1' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -119.21 136.52 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.2 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 587' ' ' ILE . 7.2 mt -128.73 115.82 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.325 0.583 . . . . 0.0 110.464 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.475 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -139.75 147.01 18.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.883 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.08 145.01 41.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -101.59 116.91 33.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.3 t -82.36 114.99 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.957 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.24 108.99 12.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.995 0.426 . . . . 0.0 110.257 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.452 HD11 ' HB3' ' A' ' 674' ' ' ASP . 25.4 mt -79.4 122.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.294 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -105.1 -42.61 5.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.708 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.52 140.96 44.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.112 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.319 0.581 . . . . 0.0 110.025 179.024 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.87 0.367 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.1 mp -91.8 172.28 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -103.25 148.31 25.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.04 157.71 22.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -178.47 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.51 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.93 -52.33 64.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -65.68 -46.65 78.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.44 -32.75 67.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.13 -36.92 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 9.2 mt -59.55 -44.54 93.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.033 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.9 p -81.64 -23.96 9.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -54.44 -34.93 62.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.801 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.1 tmm_? . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 6.0 t80 -121.46 -52.98 2.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.481 HD12 HG12 ' A' ' 696' ' ' ILE . 11.9 tp -112.22 142.32 44.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.023 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 695' ' ' GLU . 19.4 m -120.3 114.06 21.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' A' ' 694' ' ' VAL . 3.1 mp -107.18 108.94 20.62 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.9 pttt -114.45 100.76 53.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -44.9 102.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.787 1.658 . . . . 0.0 109.518 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.22 159.54 83.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.541 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 6.3 Cg_endo -48.69 -30.56 16.95 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.783 2.988 . . . . 0.0 112.989 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.55 -17.72 63.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.063 0.459 . . . . 0.0 109.89 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.579 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 23.8 t -95.46 153.32 17.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.438 HD11 ' CE1' ' A' ' 688' ' ' PHE . 20.9 pt -59.24 -19.24 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 109.972 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 5.4 mt -112.55 118.54 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.6 OUTLIER -106.04 66.0 0.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.374 0.607 . . . . 0.0 110.462 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.591 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.0 mt-10 -125.57 172.34 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.758 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.44 125.6 40.85 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.175 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -112.41 138.63 48.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.837 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.31 114.44 19.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.611 0.243 . . . . 0.0 111.398 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.63 HG12 ' CD2' ' A' ' 601' ' ' PHE . 46.1 mt -72.36 109.36 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.819 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.14 110.13 2.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.45 -29.64 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.028 0.442 . . . . 0.0 111.022 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.78 -22.51 73.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.378 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 63.4 t -101.28 119.31 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 117.712 0.756 . . . . 0.0 111.465 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -138.94 123.37 11.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.884 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.526 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 46.0 Cg_endo -90.11 160.82 34.04 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 124.672 -0.97 . . . . 0.0 111.99 0.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.63 ' CD2' HG12 ' A' ' 594' ' ' ILE . 2.6 t80 -91.94 114.68 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.541 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 22.2 m-85 -92.29 138.21 31.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.702 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.474 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.7 mp -126.46 145.54 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.69 -175.03 36.6 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.43 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.458 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -65.45 -47.73 75.13 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 111.38 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.82 127.17 30.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.355 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -58.18 -17.35 18.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.92 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.36 -30.77 67.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.027 0.442 . . . . 0.0 110.186 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 62.3 m -70.61 133.44 46.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.63 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.536 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -47.47 -28.32 2.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 43.1 t -111.96 142.16 44.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.28 105.27 13.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.421 HG13 ' CE2' ' A' ' 692' ' ' PHE . 25.0 mm -139.09 109.73 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.027 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -104.4 107.16 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.472 0.653 . . . . 0.0 112.548 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.454 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.4 t0 -129.38 107.56 9.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.766 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -40.0 -29.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.551 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 1.3 pp -89.66 158.85 17.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.549 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.8 164.94 25.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.621 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.428 ' HG2' ' CG2' ' A' ' 621' ' ' VAL . 0.0 OUTLIER -53.06 -25.7 13.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.989 0.423 . . . . 0.0 110.369 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.428 ' CG2' ' HG2' ' A' ' 620' ' ' ARG . 47.1 t -131.67 64.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.551 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 8.0 t60 -49.0 -43.77 40.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.227 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.5 p -167.13 161.42 14.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.0 111.902 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.541 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.2 p90 -143.54 148.3 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.593 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.428 HD11 HD13 ' A' ' 594' ' ' ILE . 75.2 mt -102.25 136.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.6 t80 -127.25 135.08 50.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 1.2 tppp? -97.16 136.82 37.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 158.73 43.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.753 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.8 OUTLIER -77.32 112.75 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.424 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.7 t-160 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.828 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.3 mt . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.43 147.96 35.36 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 0.5 OUTLIER -138.03 131.78 31.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.662 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 578' ' ' LEU . 4.6 pt -87.4 123.82 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.537 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 88.0 m95 -104.84 144.09 32.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.871 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -104.38 117.15 33.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 624' ' ' PHE . 25.4 m -105.47 130.02 53.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.482 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.443 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 60.4 t60 -108.78 133.08 53.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.22 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.6 p -130.08 6.32 4.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.249 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.43 150.69 31.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.692 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.9 t -73.64 -35.81 65.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 111.455 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m-80 -70.7 -1.77 12.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.307 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 53.65 125.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.218 0.532 . . . . 0.0 111.786 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.3 p -90.65 165.71 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 89.4 m-85 -128.17 120.27 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.68 100.53 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.33 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 61.4 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -134.44 3.74 3.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.711 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.416 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.8 m-80 -107.12 141.23 38.7 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -80.72 141.21 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 35.1 mmm -119.12 102.36 8.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.1 pt -87.86 150.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.276 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -44.31 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.445 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.6 43.35 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.655 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.04 162.13 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.417 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -131.41 146.28 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 662' ' ' ASN . 0.2 OUTLIER -147.72 144.88 28.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.537 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.06 134.8 49.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.206 179.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 1.1 mt -109.96 98.11 7.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.155 0.502 . . . . 0.0 111.504 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -83.49 141.73 31.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.508 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -46.54 111.42 0.38 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.972 0.415 . . . . 0.0 110.269 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 102.29 36.5 3.58 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.75 31.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 111.176 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.61 108.7 21.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.002 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 10.4 mt -105.97 133.92 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 111.938 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 7.8 mttt -96.65 116.14 28.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.72 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.454 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -80.3 -38.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.204 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 681' ' ' ILE . 1.5 tp -155.37 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.408 . . . . 0.0 111.615 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -136.09 127.28 28.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.18 117.25 21.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -66.73 -46.58 75.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.068 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -81.33 -40.22 23.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.821 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.69 -10.7 59.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.592 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.99 19.52 8.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.438 ' CE1' HD11 ' A' ' 587' ' ' ILE . 4.6 t80 -83.14 105.03 13.78 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.434 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -125.71 122.48 62.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.163 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.524 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 2.7 mt -128.78 119.32 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.37 137.19 7.42 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.801 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.466 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.25 143.75 43.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.673 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.07 116.7 33.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.753 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.453 ' CG2' ' HG ' ' A' ' 580' ' ' LEU . 2.7 t -84.87 125.79 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 25.7 tt0 -134.03 109.28 8.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.786 0.327 . . . . 0.0 111.404 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 578' ' ' LEU . 84.5 mt -69.85 105.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.031 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -85.58 -48.78 8.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.475 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 11.3 t0 -111.9 142.11 44.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.871 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.25 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 61.3 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.848 0.356 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.6 mp -98.42 165.06 12.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.707 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.88 135.61 43.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -73.36 154.34 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 43.1 p -126.0 -174.62 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.198 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.8 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.8 -51.89 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.757 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.26 -48.79 72.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.796 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -56.25 -32.8 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.84 -37.01 83.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.065 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 11.9 mt -59.93 -44.12 94.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.998 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 1.6 t -77.02 -26.1 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.247 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -55.25 -33.75 63.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.849 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 29.9 mttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.804 179.82 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.437 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 45.5 ttp180 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 11.0 t80 -107.25 -55.64 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.611 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.429 HD12 ' CG1' ' A' ' 694' ' ' VAL . 10.2 tp -111.51 141.99 44.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.781 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 695' ' ' GLU . 18.5 m -124.78 113.97 18.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 592' ' ' LEU . 1.6 mp -105.54 108.81 20.52 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -112.7 99.62 48.28 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.101 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.6 Cg_exo -44.6 99.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.864 1.709 . . . . 0.0 109.612 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -74.77 157.45 85.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.52 -25.66 11.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.832 3.021 . . . . 0.0 113.166 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -28.12 69.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.0 OUTLIER -95.98 154.0 17.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.624 178.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.46 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 5.4 pt -58.57 -10.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.732 0.301 . . . . 0.0 110.91 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.401 ' CD1' HG21 ' A' ' 613' ' ' ILE . 41.1 mt -106.96 118.81 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -109.08 57.44 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.213 0.53 . . . . 0.0 110.106 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.617 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.2 mm-40 -124.49 171.91 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.162 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.26 122.99 33.02 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.041 0.448 . . . . 0.0 111.233 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -112.67 132.68 55.07 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.437 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -123.95 121.8 36.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.52 HG12 ' CD2' ' A' ' 601' ' ' PHE . 86.9 mt -74.09 108.96 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.137 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.5 ' O ' ' C ' ' A' ' 596' ' ' GLN . 1.1 mp0 -70.54 81.5 0.58 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -7.53 -62.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.583 0.753 . . . . 0.0 112.788 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . -44.69 -21.2 0.27 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.838 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.61 118.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 117.432 0.616 . . . . 0.0 111.067 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -139.62 123.63 10.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.558 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 49.3 Cg_endo -90.66 159.85 30.86 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 124.454 -1.061 . . . . 0.0 111.798 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.7 t80 -92.08 114.72 27.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.558 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 49.8 m-85 -92.31 138.02 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.733 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.48 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.7 mp -125.88 144.54 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.739 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.09 -169.44 36.68 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.42 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.486 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -69.81 -52.86 21.44 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.819 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.28 130.0 44.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -56.7 -18.63 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.949 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.96 -31.91 61.01 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.15 0.5 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.425 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 73.1 m -71.82 132.72 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.583 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 14.0 m-80 -47.95 -28.43 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.46 . . . . 0.0 110.558 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 42.8 t -111.07 142.79 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.48 105.23 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.488 HG13 ' CE2' ' A' ' 692' ' ' PHE . 34.1 mm -139.39 109.62 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.961 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.48 106.57 17.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.445 0.641 . . . . 0.0 112.652 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.2 t0 -130.35 107.91 9.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.721 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -39.28 -30.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.7 OUTLIER -68.6 -41.01 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.536 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -89.22 159.05 17.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.802 0.334 . . . . 0.0 111.428 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.3 t -80.57 166.05 21.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.376 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 2.9 mpt_? -47.23 -37.14 9.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.374 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 13.1 t -122.95 63.59 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.536 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 9.4 t60 -48.74 -42.97 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.833 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.6 p -167.79 157.73 10.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.507 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 50.1 p90 -143.14 146.0 33.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.687 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.414 HD11 HD23 ' A' ' 580' ' ' LEU . 60.5 mt -102.14 129.27 53.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.323 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.5 t80 -120.83 135.1 55.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.398 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.438 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 25.1 ttmt -97.66 134.34 40.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.961 0.41 . . . . 0.0 110.394 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.46 158.37 44.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.759 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -77.43 111.9 13.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.935 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.2 t60 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.107 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.1 mp . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.4 OUTLIER -113.14 147.0 38.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.54 153.0 51.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 672' ' ' LEU . 2.9 pt -100.64 119.02 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.304 0.573 . . . . 0.0 111.524 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.533 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 84.8 m95 -100.63 127.84 46.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.453 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -90.29 117.59 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 624' ' ' PHE . 7.9 m -104.13 136.98 42.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.444 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -115.88 127.52 55.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.206 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.8 p -125.86 10.96 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.198 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.29 159.61 41.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.261 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.0 m -88.09 -19.17 27.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.677 0.275 . . . . 0.0 111.46 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 656' ' ' VAL . 3.4 m-80 -87.01 2.7 48.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.8 128.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.35 0.595 . . . . 0.0 112.083 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.444 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 87.5 p -100.28 165.74 11.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.341 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -129.79 120.65 25.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.28 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.477 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -94.42 102.59 14.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 61.57 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -131.56 -5.65 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -97.84 141.37 30.91 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 111.095 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.416 ' O ' HG21 ' A' ' 716' ' ' VAL . 29.1 ttp180 -81.86 141.0 33.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.403 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 13.3 mmm -120.89 99.64 6.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.411 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 42.3 pt -87.59 154.28 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -45.62 107.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.313 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.12 35.88 3.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.61 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.407 ' CG2' HG12 ' A' ' 665' ' ' ILE . 3.4 p -119.89 162.28 19.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.184 0.516 . . . . 0.0 111.686 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.432 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.4 ttpm? -130.4 148.79 52.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.007 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.477 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 2.4 t80 -147.25 143.94 28.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.533 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -74.05 130.57 40.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.193 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 0.7 OUTLIER -97.07 139.64 32.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.28 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -124.9 131.5 53.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.075 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.423 ' N ' HD13 ' A' ' 696' ' ' ILE . 40.3 t0 -42.93 104.0 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 110.581 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 106.19 33.77 3.35 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.51 113.86 25.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.382 . . . . 0.0 111.324 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -95.66 111.91 23.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.42 HG12 HD12 ' A' ' 659' ' ' LEU . 4.3 mt -104.92 137.04 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.062 0.458 . . . . 0.0 111.855 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -93.14 115.98 28.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.803 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.474 HG22 ' CD2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -85.47 -35.48 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 681' ' ' ILE . 2.7 tp -154.97 131.33 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.072 0.463 . . . . 0.0 111.826 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -137.11 125.35 23.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -127.15 116.81 21.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.884 0.373 . . . . 0.0 110.266 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -46.84 71.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.21 -40.68 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.84 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -87.24 -8.7 56.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? 60.71 17.94 8.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.46 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 6.7 t80 -77.08 104.59 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -124.51 122.17 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 111.813 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.404 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 7.0 mt -128.18 151.43 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.517 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.416 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 178.26 137.83 2.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.091 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.526 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 1.8 m-30 -114.5 150.33 35.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.732 0.301 . . . . 0.0 110.738 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . 0.426 ' HB2' HD13 ' A' ' 583' ' ' LEU . 6.5 tttt -101.16 116.62 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.633 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 675' ' ' GLY . 3.6 t -79.56 124.72 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.686 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.05 108.75 8.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.423 HD13 ' N ' ' A' ' 674' ' ' ASP . 58.1 mt -69.67 105.6 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.04 -47.06 16.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.697 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.468 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 80.6 m-20 -111.08 140.98 45.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.362 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 663' ' ' ARG . 12.0 t . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.777 0.323 . . . . 0.0 111.267 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.86 168.37 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.84 146.6 27.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -80.66 154.87 27.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -123.77 -177.26 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.26 -30.76 62.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -64.83 -49.9 68.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -50.62 67.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.0 -32.55 69.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.049 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -62.8 -39.93 95.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.003 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 3.2 mt -61.04 -44.56 97.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.5 p -72.56 -25.51 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -65.11 -34.33 78.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.266 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.946 179.54 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 577' ' ' PHE . 3.1 tmm_? . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.832 0.349 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.713 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -115.31 -57.42 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.371 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.511 HD13 HG12 ' A' ' 696' ' ' ILE . 24.0 tp -106.59 142.21 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.656 0.265 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 695' ' ' GLU . 8.3 m -123.57 113.03 18.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.0 OUTLIER -107.9 107.84 18.74 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.5 mtpt -109.57 99.59 38.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -175.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.636 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.3 Cg_exo -46.67 108.92 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.56 1.507 . . . . 0.0 108.722 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.71 156.77 88.19 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.49 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 13.9 Cg_endo -56.24 -25.89 58.29 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.639 2.893 . . . . 0.0 112.825 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -63.31 -20.51 65.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.191 0.52 . . . . 0.0 109.653 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.439 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.4 t -97.38 153.84 17.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.759 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.489 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 5.2 pt -52.68 -21.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 109.908 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 48.1 mt -106.71 118.74 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.845 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -114.38 63.67 0.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.572 0.701 . . . . 0.0 109.773 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.636 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 17.6 mt-10 -125.24 173.25 8.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.455 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.15 116.52 21.48 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.691 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -113.43 128.03 56.31 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -124.98 131.21 53.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 601' ' ' PHE . 67.0 mt -71.44 109.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.17 105.16 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.417 0.627 . . . . 0.0 111.645 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.713 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 1.3 mm-40 41.63 -125.76 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.908 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -96.95 41.04 2.41 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.972 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 4.7 t -73.05 118.73 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -135.26 127.69 18.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.222 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.576 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 19.9 Cg_endo -92.77 153.23 17.6 Favored 'Cis proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.957 -1.268 . . . . 0.0 112.508 0.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.48 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 3.1 t80 -96.1 112.2 24.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.576 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 72.8 m-85 -93.01 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.46 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.481 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -126.57 145.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.478 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.51 -168.38 35.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.383 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.473 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.08 -54.84 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.48 56.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.0 111.592 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -57.58 -19.47 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.815 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -53.34 -31.27 43.58 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.175 0.512 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 87.0 m -73.18 131.19 41.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.493 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.48 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 7.1 m-80 -46.31 -29.87 1.83 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.223 0.535 . . . . 0.0 110.404 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.481 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 41.4 t -110.76 143.13 41.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.028 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.24 105.44 13.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.427 HG13 ' CE2' ' A' ' 692' ' ' PHE . 32.9 mm -138.99 109.61 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.027 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -104.06 106.96 17.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.466 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.3 t0 -130.0 107.7 9.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.604 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -38.73 -30.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.454 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 0.1 OUTLIER -68.86 -41.6 78.18 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -88.65 159.13 17.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.953 0.406 . . . . 0.0 111.938 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 60.1 p -77.55 173.08 12.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.437 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -49.55 -32.95 13.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.516 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.99 66.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.606 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 13.7 t60 -44.65 -39.53 5.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.96 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.3 p -165.39 158.86 16.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 650' ' ' CYS . 36.3 p90 -143.77 147.74 34.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.44 ' CD1' HD12 ' A' ' 594' ' ' ILE . 55.7 mt -101.92 134.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.019 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 135.76 51.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.422 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -97.15 137.84 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.127 0.489 . . . . 0.0 110.879 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.71 158.92 43.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.877 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -77.17 112.47 13.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.307 0.575 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.5 t60 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.885 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 630' ' ' HIS . 1.2 mt . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.343 0.592 . . . . 0.0 112.526 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.13 137.31 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.605 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.4 ' CD1' HD21 ' A' ' 578' ' ' LEU . 2.5 pt -88.96 120.65 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.334 0.587 . . . . 0.0 112.145 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.541 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 87.4 m95 -101.74 143.82 31.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.726 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -104.24 117.34 33.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.463 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -105.29 138.47 41.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.162 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.44 ' CE1' ' N ' ' A' ' 657' ' ' SER . 49.2 t60 -118.44 130.98 56.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.43 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -127.36 8.76 6.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.139 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.37 148.51 28.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.282 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.3 t -75.78 -31.17 59.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 111.197 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.2 m120 -71.95 -1.17 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.6 126.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.346 0.593 . . . . 0.0 111.57 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 91.8 p -95.54 165.92 12.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -128.09 120.03 26.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 111.403 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.451 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -96.56 99.87 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.94 -81.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.11 3.1 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.806 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.445 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 3.2 m-80 -103.68 141.65 35.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.826 0.345 . . . . 0.0 111.111 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.85 141.56 39.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 31.3 mmm -125.93 97.9 5.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.6 pt -87.83 153.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' A' ' 652' ' ' THR . 52.0 tt0 -48.05 100.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.82 37.25 1.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.37 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.9 p -125.48 158.71 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 111.445 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.446 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -130.26 148.56 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.451 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.9 145.35 28.61 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.541 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 135.21 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.419 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 1.5 mt -111.63 104.99 13.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.05 143.58 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.219 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -45.5 113.91 0.67 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 110.877 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 99.52 35.51 4.64 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 116.32 28.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.993 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.05 108.76 21.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.22 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 11.4 mt -107.69 135.0 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 111.894 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 4.5 mttm -96.79 116.2 28.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.848 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.424 HG23 ' HB ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -76.33 -34.6 25.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.303 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 681' ' ' ILE . 1.2 tp -154.27 131.02 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.67 122.08 19.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.548 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.07 116.32 20.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 110.4 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -46.63 71.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.148 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -69.09 -40.51 78.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.058 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.72 -2.44 53.81 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt 58.11 19.23 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 0.0 110.829 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.489 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 2.6 t80 -76.84 104.46 7.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.431 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -126.19 120.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.808 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.424 ' HB ' HG23 ' A' ' 680' ' ' ILE . 13.6 mt -129.64 124.68 59.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -150.04 141.49 8.85 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.716 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.456 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 3.1 m-30 -113.92 141.85 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 580' ' ' LEU . 2.7 tttt -101.23 115.75 31.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.938 0.399 . . . . 0.0 110.299 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 578' ' ' LEU . 1.9 t -80.5 127.02 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.857 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.2 OUTLIER -134.21 109.03 8.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.511 HG12 HD13 ' A' ' 578' ' ' LEU . 60.1 mt -71.45 105.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.099 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.36 -46.85 8.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.288 0.566 . . . . 0.0 109.565 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.536 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.0 t0 -111.32 142.68 43.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.341 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.483 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.1 t . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.917 0.389 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.437 ' CD1' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -106.19 162.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.618 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.89 145.06 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.853 0.358 . . . . 0.0 111.005 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -79.98 156.61 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 33.9 p -126.06 -174.21 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.71 -29.39 53.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.65 -50.37 65.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -64.0 -45.29 89.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -57.73 -32.94 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.42 -37.02 82.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.43 -44.84 92.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.015 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.2 p -84.75 -24.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.347 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -56.6 -30.27 63.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.998 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.428 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.856 0.36 . . . . 0.0 111.068 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 578' ' ' LEU . 1.0 OUTLIER -128.06 -49.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.927 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.494 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 7.3 tp -118.23 142.51 47.39 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.996 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 24.0 m -115.83 117.19 29.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.428 ' CD2' ' CG2' ' A' ' 694' ' ' VAL . 9.6 mt -105.56 109.11 20.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.73 99.55 52.26 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.604 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 38.2 Cg_exo -46.03 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.884 1.722 . . . . 0.0 109.628 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.87 157.78 85.29 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.412 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 74.4 Cg_exo -49.39 -24.93 9.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.633 2.889 . . . . 0.0 112.785 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.62 -27.38 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 4.7 t -95.56 154.0 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.721 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.465 HG12 ' CD1' ' A' ' 690' ' ' ILE . 1.4 pt -56.5 -13.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 60.8 mt -108.08 130.92 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.412 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -117.32 60.12 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.728 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.604 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.7 mt-10 -124.9 169.58 11.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.103 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.56 121.49 25.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.66 0.267 . . . . 0.0 111.559 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.2 mm? -112.93 149.38 33.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.428 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.95 118.69 26.83 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.554 HG12 ' CD2' ' A' ' 601' ' ' PHE . 63.7 mt -73.97 109.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.321 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -64.55 113.55 3.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.661 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.452 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.24 -30.89 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.226 0.536 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.437 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.57 -20.43 73.84 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.052 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.86 118.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.561 0.681 . . . . 0.0 111.287 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -139.54 121.87 10.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.993 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.6 Cg_endo -90.21 160.13 33.22 Favored 'Cis proline' 0 N--CA 1.462 -0.367 0 C-N-CA 124.499 -1.042 . . . . 0.0 111.811 -0.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.4 t80 -91.27 114.76 27.37 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.505 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 33.6 m-85 -91.89 138.04 31.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.294 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.516 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.5 mp -125.39 143.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.229 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.38 -163.57 35.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.454 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.469 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -77.13 -51.15 11.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.37 127.02 29.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.293 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -53.88 -19.78 5.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.004 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.93 -30.32 61.47 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.002 0.43 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 38.0 m -70.59 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.589 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 15.3 m-80 -47.34 -29.0 2.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.036 0.446 . . . . 0.0 110.482 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 37.1 t -110.87 137.0 49.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.16 104.76 14.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.424 HG13 ' CE2' ' A' ' 692' ' ' PHE . 15.5 mm -139.53 109.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.299 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -104.98 107.17 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.469 ' C ' ' HD3' ' A' ' 605' ' ' ARG . 1.9 t0 -129.17 107.4 9.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.466 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -39.86 -27.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.457 ' CB ' ' CD1' ' A' ' 681' ' ' ILE . 0.3 OUTLIER -73.51 -39.81 64.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.514 ' CB ' ' ND1' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -88.78 158.73 18.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 111.403 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.8 m -76.82 169.07 18.99 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.791 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.434 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -51.15 -35.27 35.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.28 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.67 63.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.52 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 653' ' ' GLY . 26.3 t60 -47.83 -40.38 21.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.825 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.7 p -168.69 156.72 8.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.037 0.446 . . . . 0.0 111.631 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.504 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 27.3 p90 -143.34 148.47 36.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.55 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.459 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 61.4 mt -102.15 135.25 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.891 0.377 . . . . 0.0 110.133 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.535 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -126.87 134.13 50.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.647 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.415 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 7.8 ttpt -98.08 134.97 40.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.506 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.71 158.24 44.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.761 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -77.39 115.93 17.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.473 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.3 t60 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.961 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -116.5 147.42 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.146 0.498 . . . . 0.0 111.876 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.48 147.01 51.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.234 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.442 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 9.3 pt -96.74 126.93 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.231 0.538 . . . . 0.0 111.617 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.486 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 91.7 m95 -110.68 131.65 54.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.202 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 6.9 t80 -92.48 117.64 30.15 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 624' ' ' PHE . 36.6 m -104.2 137.16 42.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.991 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.442 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 31.6 t60 -115.86 131.3 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.086 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 3.1 p -131.86 15.75 4.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.415 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.51 153.42 27.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.212 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 89.8 m -82.13 -25.81 34.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.527 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -81.81 3.41 26.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.021 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.527 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.38 134.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 112.181 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.441 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 73.8 m -106.22 166.27 10.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.406 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 679' ' ' LYS . 6.1 m-85 -127.74 120.31 27.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.821 0.343 . . . . 0.0 111.006 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.481 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -102.09 99.53 9.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.4 m120 58.68 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.2 OUTLIER -130.98 3.19 4.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.474 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 4.9 m-80 -109.08 138.01 46.09 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -75.71 141.32 42.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 49.7 mmm -119.82 87.83 2.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.711 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 42.1 pt -87.48 156.1 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.035 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -48.9 94.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.243 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.77 41.71 0.77 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.579 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.1 p -127.9 162.16 27.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.931 0.396 . . . . 0.0 111.381 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpm? -137.76 141.69 40.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.752 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.481 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.58 144.94 28.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.768 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.486 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.56 140.65 55.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.018 0.437 . . . . 0.0 111.192 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.433 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 2.0 mt -112.15 124.04 51.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -109.97 161.84 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.761 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -59.19 100.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.368 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.22 30.27 3.95 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.55 114.19 23.08 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -96.09 108.6 21.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.093 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 5.4 mt -105.67 120.9 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.637 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 658' ' ' TYR . 4.1 mttp -82.28 115.48 21.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.358 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.456 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.6 mt -75.44 -39.05 40.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.457 ' CD1' ' CB ' ' A' ' 617' ' ' ARG . 5.4 tt -155.78 131.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.916 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.58 121.44 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.07 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -127.13 116.82 21.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 110.544 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -67.46 -46.5 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.919 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -66.05 -40.34 90.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.927 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -93.85 -8.46 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.621 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 62.04 16.52 8.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.63 0.253 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.9 t80 -77.06 105.46 8.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.3 p -119.58 124.62 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.1 0.476 . . . . 0.0 111.922 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 587' ' ' ILE . 27.3 mm -128.1 154.97 39.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.397 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 174.05 134.18 1.81 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 9.6 m-30 -112.89 147.28 37.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 110.331 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.37 116.52 32.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.198 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.464 HG12 ' CD1' ' A' ' 578' ' ' LEU . 2.1 t -80.86 129.7 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.464 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -133.47 109.43 9.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.926 0.394 . . . . 0.0 111.16 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.431 HG12 ' CD1' ' A' ' 578' ' ' LEU . 26.7 mt -78.19 105.69 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.238 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . 0.401 ' HB2' ' NH1' ' A' ' 576' ' ' ARG . 20.2 m120 -93.25 -45.93 7.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.05 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.492 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 2.8 t70 -110.78 139.84 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 699' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 121.291 0.567 . . . . 0.0 109.74 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.853 0.359 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.08 172.46 8.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 157.37 16.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -87.32 155.19 20.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.81 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -126.17 -175.25 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.87 -30.74 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.087 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.49 -52.03 66.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -66.14 -46.0 79.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.795 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.68 -33.68 64.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.693 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.2 -36.94 80.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 22.8 mt -56.91 -44.41 82.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.45 -22.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -37.47 78.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.4 mttt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 179.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.401 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 5.4 tmm_? . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.475 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 6.3 t80 -95.33 -54.0 3.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.864 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.483 ' CD1' ' CD1' ' A' ' 647' ' ' ILE . 10.8 tp -108.79 143.31 38.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.989 0.423 . . . . 0.0 111.773 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.3 m -121.94 115.12 22.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.608 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.46 ' HG ' ' CG2' ' A' ' 694' ' ' VAL . 0.7 OUTLIER -105.21 109.13 21.0 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.485 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 18.1 mtmt -115.17 99.41 52.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.635 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 33.2 Cg_exo -46.27 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.711 1.607 . . . . 0.0 109.126 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.426 ' O ' ' OG ' ' A' ' 586' ' ' SER . 0.2 OUTLIER -75.1 157.61 85.06 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.407 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 76.1 Cg_exo -49.84 -25.59 12.19 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.438 2.759 . . . . 0.0 112.644 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -62.23 -28.82 69.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.429 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.8 OUTLIER -96.05 153.84 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.753 178.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 13.9 pt -54.99 -11.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 111.34 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 42.0 mt -107.16 128.73 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.3 OUTLIER -116.09 54.88 0.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.797 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.635 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 51.3 mm-40 -124.62 169.84 11.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.033 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.36 124.07 31.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.661 0.267 . . . . 0.0 111.659 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.429 ' CD2' ' CD ' ' A' ' 582' ' ' PRO . 1.2 mm? -112.87 148.96 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.401 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.68 122.44 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.565 HG12 ' CD1' ' A' ' 601' ' ' PHE . 33.0 mt -78.9 108.68 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.15 111.52 2.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.47 -34.26 1.29 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.41 0.624 . . . . 0.0 109.972 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -62.9 -24.45 66.74 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.329 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 97.7 t -101.29 119.26 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.659 0.73 . . . . 0.0 111.414 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -138.91 122.91 11.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.704 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.54 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 48.0 Cg_endo -90.17 160.32 33.48 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 124.56 -1.017 . . . . 0.0 112.0 0.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.2 t80 -91.97 115.9 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.505 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 30.7 m-85 -92.38 138.0 31.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.8 mp -125.03 145.76 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.742 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 160.63 -171.43 36.78 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.374 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.427 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -70.72 -46.91 62.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 111.372 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.16 130.56 46.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.381 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -18.32 29.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.783 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.05 -30.9 66.53 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.205 0.526 . . . . 0.0 110.301 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 94.7 m -70.54 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.1 m120 -44.52 -33.21 1.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 35.1 t -106.93 138.67 42.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.815 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.97 104.59 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.463 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.6 mm -139.47 109.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.409 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -104.07 106.09 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.436 0.636 . . . . 0.0 111.994 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.527 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 3.1 t70 -129.68 108.85 10.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.894 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . 0.406 ' ND2' ' HG2' ' A' ' 617' ' ' ARG . 0.9 OUTLIER -40.2 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.406 ' HG2' ' ND2' ' A' ' 616' ' ' ASN . 0.0 OUTLIER -70.65 -42.69 70.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 1.5 pp -89.44 158.21 17.82 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.679 0.276 . . . . 0.0 111.013 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.82 165.82 20.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.0 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.447 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.22 -25.21 21.75 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.075 0.464 . . . . 0.0 110.435 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.75 57.44 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.997 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.494 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 37.0 t60 -48.4 -45.69 36.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.6 p -168.37 161.35 11.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 111.543 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.505 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 52.9 p90 -143.44 147.53 34.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.509 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.469 HD11 HD12 ' A' ' 594' ' ' ILE . 62.1 mt -102.02 134.52 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -125.87 134.36 51.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.737 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.437 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 1.9 ttmm -97.59 136.73 37.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.122 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.457 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.15 159.35 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.764 -178.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.82 113.62 14.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.409 0.623 . . . . 0.0 110.502 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.33 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 630' ' ' HIS . 1.1 mt . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 48.1 m-20 -122.23 148.25 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -133.62 151.21 51.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.701 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 8.9 pt -100.25 122.45 52.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 111.487 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.516 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 77.6 m95 -108.05 134.01 51.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.308 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -95.68 117.53 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 624' ' ' PHE . 26.1 m -101.0 133.49 45.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.45 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 54.5 t60 -112.87 131.64 55.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.4 p -129.67 0.95 4.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.449 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 148.36 34.8 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.712 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.8 t -75.91 -34.49 59.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.114 0.483 . . . . 0.0 111.311 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.53 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.1 m120 -70.16 2.0 4.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.379 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.53 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.17 133.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.435 0.636 . . . . 0.0 112.32 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.45 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 98.2 p -103.86 165.69 10.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.482 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.68 120.24 30.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.225 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.481 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -105.24 109.38 21.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.903 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.43 -82.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.975 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 659' ' ' LEU . 18.5 m-20 -137.49 5.87 2.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.814 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.504 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 3.2 t-20 -108.81 135.57 49.81 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.943 0.402 . . . . 0.0 111.253 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 17.0 ttp-105 -73.65 141.43 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.419 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 39.5 mmm -117.07 98.17 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.053 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 41.1 pt -88.19 149.13 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.114 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.59 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.433 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.26 42.31 1.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.1 p -127.14 162.28 26.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.45 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.439 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -134.07 135.93 43.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.467 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.504 ' CE2' ' CB ' ' A' ' 662' ' ' ASN . 0.3 OUTLIER -140.03 144.19 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.46 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.516 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.78 141.05 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.127 0.489 . . . . 0.0 111.345 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.415 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 2.9 mt -112.27 98.16 7.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.427 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -82.72 131.01 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.946 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -36.01 107.32 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.099 0.476 . . . . 0.0 110.96 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.92 33.94 3.62 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.04 118.37 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.003 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -96.2 108.87 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.757 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 25.8 pt -105.61 136.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.99 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.8 OUTLIER -99.05 115.96 30.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.752 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 622' ' ' HIS . 4.3 mt -84.24 -35.67 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.478 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.494 ' CG2' ' HB ' ' A' ' 690' ' ' ILE . 4.2 tp -154.33 129.05 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.328 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -137.96 123.44 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.302 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -127.51 116.08 19.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.925 0.393 . . . . 0.0 110.607 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -46.57 70.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.956 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.78 -40.83 97.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.135 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -98.06 4.01 49.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.9 mttm 54.24 22.07 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.776 0.322 . . . . 0.0 110.93 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.455 ' CZ ' ' OD1' ' A' ' 615' ' ' ASP . 1.5 t80 -76.4 104.36 6.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.45 124.22 72.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.054 0.454 . . . . 0.0 111.867 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.494 ' HB ' ' CG2' ' A' ' 681' ' ' ILE . 4.9 mm -128.06 154.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.331 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.417 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . 175.68 134.11 1.87 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.52 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.491 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.9 m-30 -113.27 142.89 45.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -100.87 116.34 32.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 109.88 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.483 ' CG1' HD13 ' A' ' 578' ' ' LEU . 2.7 t -85.12 123.24 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 110.02 9.51 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.082 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.49 HD12 HG22 ' A' ' 696' ' ' ILE . 66.3 mt -65.3 105.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.24 -48.08 12.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.934 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.445 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 38.7 t0 -111.69 139.38 47.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.173 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.792 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.879 0.371 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.19 172.33 7.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -99.67 156.97 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.958 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.26 148.49 22.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 22.0 p -126.14 -173.44 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.218 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.47 -29.03 33.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.54 -51.61 67.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.36 -44.72 90.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.617 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -57.59 -32.72 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.74 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.15 -37.23 83.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 40.7 mt -59.48 -44.15 93.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.63 -24.93 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -32.14 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 51.6 mttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.394 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.9 tmm_? . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.594 0.235 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 3.1 t80 -99.83 -45.18 5.81 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 594' ' ' ILE . 10.3 tp -118.59 142.84 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 30.3 m -120.49 115.84 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.837 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.439 ' CD2' HD22 ' A' ' 578' ' ' LEU . 0.7 OUTLIER -105.5 109.32 21.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 19.3 pttt -116.87 98.77 52.38 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 23.4 Cg_exo -46.03 98.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.923 1.748 . . . . 0.0 109.823 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 585' ' ' ASP . 0.3 OUTLIER -74.71 157.86 85.45 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.436 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.49 -29.74 19.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.508 2.806 . . . . 0.0 112.876 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 583' ' ' LEU . 23.2 m-20 -62.33 -24.9 67.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.405 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 5.6 t -95.51 153.27 17.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.468 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 10.6 tt -56.34 -14.48 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.414 ' CD1' HG23 ' A' ' 613' ' ' ILE . 21.0 mt -111.51 128.14 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 111.626 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.436 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.7 OUTLIER -112.64 55.98 0.68 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.64 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.7 mt-10 -124.79 170.28 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.908 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.35 119.7 23.17 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.74 0.305 . . . . 0.0 111.621 178.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.406 ' CD2' ' CD ' ' A' ' 582' ' ' PRO . 0.2 OUTLIER -113.03 146.33 39.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.5 OUTLIER -123.97 121.47 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.559 HG12 ' CD2' ' A' ' 601' ' ' PHE . 70.4 mt -75.86 109.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.148 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 2.9 mm-40 -66.12 114.65 5.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.91 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -42.49 -34.73 0.89 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.353 0.597 . . . . 0.0 110.111 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.474 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.0 -20.24 68.61 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.702 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 99.3 t -101.07 118.79 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 117.912 0.856 . . . . 0.0 111.67 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.908 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.55 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -90.39 160.45 32.47 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.621 -0.991 . . . . 0.0 111.632 -0.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.559 ' CD2' HG12 ' A' ' 594' ' ' ILE . 3.5 t80 -91.26 114.88 27.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 46.4 m-85 -91.84 138.16 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.098 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.5 mp -126.76 145.03 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.787 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.31 -165.48 34.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.46 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.58 ' HG2' HD21 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -71.33 -54.59 10.29 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.34 130.81 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.483 -178.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -19.33 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.63 -30.35 42.39 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.119 0.485 . . . . 0.0 110.056 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 95.8 m -73.41 131.21 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.297 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -46.51 -28.65 1.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 42.2 t -111.44 141.58 44.81 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.19 107.53 16.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.456 HG13 ' CE2' ' A' ' 692' ' ' PHE . 26.6 mm -138.37 110.05 5.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.313 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.58 106.09 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.504 ' HB3' ' CD2' ' A' ' 618' ' ' LEU . 31.0 t0 -130.25 108.24 9.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.898 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.25 -32.74 0.2 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.821 0.343 . . . . 0.0 111.601 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.453 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 2.5 mtm-85 -78.19 -38.03 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.03 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.58 HD21 ' HG2' ' A' ' 605' ' ' ARG . 0.0 OUTLIER -88.91 120.03 29.96 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.13 167.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.524 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.3 mpt_? -56.25 -35.92 67.95 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.12 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.01 57.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.736 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.536 ' CD2' HG22 ' A' ' 680' ' ' ILE . 31.9 t60 -50.28 -48.45 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.931 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.3 p -159.33 156.0 27.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.029 0.442 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.512 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 48.5 p90 -143.66 149.31 37.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.461 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.476 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 79.7 mt -102.61 130.34 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.927 0.394 . . . . 0.0 109.981 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.8 t80 -122.65 133.55 54.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 35.4 ttmt -98.28 136.98 37.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.26 158.74 42.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.288 -179.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -76.44 112.74 13.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.329 0.585 . . . . 0.0 110.299 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.447 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.9 t60 . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.823 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 630' ' ' HIS . 2.4 mt . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.1 m-20 -118.78 148.09 43.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.309 0.576 . . . . 0.0 112.378 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.407 ' HB3' HD22 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -132.3 138.51 47.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.778 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 5.0 pt -96.03 119.06 43.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.554 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 85.8 m95 -103.7 132.63 49.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.972 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 15.9 t80 -90.73 116.23 28.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.3 m -98.13 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.111 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.44 ' CE1' ' N ' ' A' ' 657' ' ' SER . 60.8 t60 -124.58 129.28 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 16.9 p -128.6 4.88 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.325 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.95 149.01 33.92 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.692 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.2 t -75.81 -28.27 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.523 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.454 ' C ' ' CG1' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -73.93 0.01 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.272 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.454 ' CG1' ' C ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 56.77 133.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.345 0.593 . . . . 0.0 111.896 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 14.8 t -105.11 165.58 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.004 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.411 ' CZ ' HG23 ' A' ' 656' ' ' VAL . 10.4 m-85 -134.6 120.19 19.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.1 OUTLIER -99.35 100.49 11.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.9 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 31.0 t30 -132.17 -0.7 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.62 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.405 ' OD1' ' CZ ' ' A' ' 670' ' ' PHE . 21.3 m120 -104.04 122.39 45.16 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.991 0.424 . . . . 0.0 111.245 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -66.63 141.77 57.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.968 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 37.6 mmm -114.8 102.49 10.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.16 147.33 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.802 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.91 95.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.435 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.2 39.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.841 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.3 p -138.16 161.99 35.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.405 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 19.3 pttm -135.62 135.66 40.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 716' ' ' VAL . 18.8 t80 -127.15 143.55 51.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.51 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.554 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.95 136.53 50.63 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.03 0.443 . . . . 0.0 111.597 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 2.7 mt -98.57 143.52 28.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.307 0.575 . . . . 0.0 111.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -119.09 141.85 48.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.529 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -48.07 96.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.22 0.533 . . . . 0.0 110.213 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 107.49 32.6 3.36 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.63 114.35 23.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 110.98 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -96.12 108.73 21.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.2 137.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 111.745 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.24 115.87 28.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.623 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.536 HG22 ' CD2' ' A' ' 622' ' ' HIS . 8.1 mt -82.97 -35.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.236 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.447 ' CD1' ' CB ' ' A' ' 617' ' ' ARG . 1.2 tt -154.9 132.67 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 111.586 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -136.33 124.22 22.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.227 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.77 117.0 27.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.314 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -67.16 -47.08 72.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.803 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.5 p-10 -83.44 -40.33 19.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.533 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.408 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 0.7 OUTLIER -77.75 -15.6 59.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.383 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.83 9.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 0.0 110.952 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.468 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.8 t80 -85.37 105.1 15.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -122.87 121.75 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.287 0.565 . . . . 0.0 112.144 -178.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 2.5 mm -109.77 144.41 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.38 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -169.58 127.35 1.48 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.753 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.473 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 9.3 m-30 -113.95 146.13 40.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.784 0.326 . . . . 0.0 110.42 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -101.36 116.59 33.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.5 t -82.5 124.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.436 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.3 tp10 -133.69 109.23 9.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.898 0.38 . . . . 0.0 111.05 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.402 ' CG1' ' CD1' ' A' ' 578' ' ' LEU . 24.0 mt -72.17 104.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.268 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -88.32 -49.97 6.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 5.5 t70 -112.18 139.52 47.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.032 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 699' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.422 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 8.3 p . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.798 0.333 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.4 ' CD1' ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -98.38 163.21 12.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.62 145.61 29.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.44 151.89 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.2 p -126.0 -173.95 2.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.97 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.99 -28.97 55.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -49.21 64.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -63.78 -50.95 67.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -57.41 -32.83 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.85 -37.25 86.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.79 -44.5 96.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.961 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.4 p -76.17 -28.57 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.08 -33.84 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.4 mttm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.763 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.432 ' O ' ' CB ' ' A' ' 698' ' ' ASP . 19.9 ttp-105 . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.532 0.206 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.502 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -99.44 -58.98 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.447 . . . . 0.0 110.504 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.496 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.4 tt -107.84 141.98 38.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 16.0 m -117.58 115.24 24.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -104.4 108.64 20.15 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 11.6 mtmt -114.86 99.13 51.58 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.664 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -47.26 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.761 1.641 . . . . 0.0 109.394 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.68 157.91 85.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.11 -25.27 8.97 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.688 2.925 . . . . 0.0 112.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.65 -28.16 69.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.439 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 2.0 t -95.94 153.8 17.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.631 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.476 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 16.0 pt -57.14 -13.68 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 110.973 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 23.4 mt -105.48 120.26 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.685 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -108.41 56.79 0.62 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.063 0.459 . . . . 0.0 110.343 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.664 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.0 mt-10 -124.72 170.36 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.215 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.19 120.54 24.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.359 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.403 ' CD2' ' CD ' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -113.15 148.43 35.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.427 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.81 125.51 44.12 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.462 HG12 ' CD2' ' A' ' 601' ' ' PHE . 94.0 mt -83.73 109.05 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -67.05 124.38 22.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.696 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.502 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.66 -29.7 3.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.244 0.545 . . . . 0.0 109.817 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.93 -24.04 77.46 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.86 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.24 117.86 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 118.018 0.909 . . . . 0.0 111.66 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -140.37 121.7 9.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.554 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -89.84 160.49 35.22 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.296 -0.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.4 t80 -91.69 115.62 28.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.48 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 23.6 m-85 -92.35 137.91 31.97 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.952 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.516 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 3.1 mp -126.45 146.03 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.436 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.19 -166.53 37.09 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.887 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.53 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.4 OUTLIER -71.49 -54.15 11.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 111.611 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.48 131.32 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.391 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -56.57 -19.07 14.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.982 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.08 -31.66 52.45 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.85 132.88 46.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.66 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 28.8 m120 -46.03 -31.05 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.236 0.541 . . . . 0.0 110.378 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.516 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 42.5 t -110.16 142.06 42.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.318 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.46 109.04 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.439 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 19.7 mm -138.05 109.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.084 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.53 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 1.0 OUTLIER -95.03 104.32 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.919 -178.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.548 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.67 113.96 14.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.19 177.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.5 -21.12 3.43 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.689 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.439 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 0.2 OUTLIER -74.33 -41.65 60.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.548 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -88.53 158.9 18.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 112.268 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 67.6 p -80.77 177.95 8.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.2 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.452 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -47.36 -45.76 25.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.121 0.486 . . . . 0.0 110.197 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.68 71.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.568 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 9.3 t60 -45.7 -47.93 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.537 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 2.1 p -161.2 160.62 30.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.614 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.48 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 1.7 p90 -143.68 148.7 36.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.666 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.96 130.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.086 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -121.3 132.47 54.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 5.3 ttmt -97.97 137.16 37.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.439 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.474 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.59 159.25 41.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.54 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 0.7 OUTLIER -76.25 112.72 13.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.1 t60 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.577 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 630' ' ' HIS . 25.0 mt . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -116.95 147.61 42.1 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.48 160.17 34.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.518 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.445 ' CD1' HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -110.36 127.58 67.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.568 0.699 . . . . 0.0 112.776 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.529 ' CH2' HD22 ' A' ' 671' ' ' LEU . 81.9 m95 -110.93 125.89 54.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.411 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 11.7 t80 -90.01 116.1 27.8 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.457 ' N ' ' O ' ' A' ' 624' ' ' PHE . 20.1 m -101.65 142.57 32.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.427 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 60.6 t60 -125.88 130.23 50.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 25.1 p -126.69 5.18 6.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.168 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.76 153.17 36.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.582 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.8 t -73.64 -34.8 65.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.159 0.504 . . . . 0.0 111.486 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 617' ' ' ARG . 1.3 m120 -68.26 -4.89 15.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.434 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.83 123.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 111.67 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.427 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 57.9 p -88.68 166.26 14.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.354 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -131.22 120.39 23.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.868 0.366 . . . . 0.0 111.409 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.431 ' HG ' ' CD1' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -94.99 99.84 11.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.383 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 61.2 -81.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -134.45 3.4 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.682 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -104.95 123.6 48.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 111.171 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.35 141.38 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.92 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 21.7 mmm -118.14 111.93 19.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.871 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.4 ' O ' ' OG1' ' A' ' 668' ' ' THR . 32.9 pt -91.03 150.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.102 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 652' ' ' THR . 2.9 tt0 -51.87 100.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.471 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.87 37.26 1.16 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.002 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 1.8 p -139.35 159.19 42.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.0 pttm -123.96 158.19 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.58 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.431 ' CD1' ' HG ' ' A' ' 659' ' ' LEU . 10.6 t80 -144.27 146.46 32.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.529 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.53 128.17 35.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.696 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.42 HD23 ' CB ' ' A' ' 649' ' ' TYR . 0.4 OUTLIER -105.76 121.85 44.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.43 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -109.33 162.83 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.39 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -58.62 110.47 1.0 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.42 . . . . 0.0 110.686 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 95.51 36.92 5.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.214 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -91.63 115.35 27.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.323 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.7 OUTLIER -96.28 110.35 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.053 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.406 ' CG2' ' CD2' ' A' ' 659' ' ' LEU . 26.9 pt -105.62 132.58 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.98 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -91.03 116.62 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.004 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.22 -34.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.45 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 681' ' ' ILE . 2.1 tp -154.43 131.34 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 111.718 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -136.47 126.32 25.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -126.22 116.77 21.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -67.4 -46.77 72.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.989 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -77.74 -40.41 41.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.769 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -7.79 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.602 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp 59.66 17.95 6.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.476 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.3 t80 -76.55 104.82 7.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 2.1 p -120.68 121.98 66.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 112.134 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.43 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 4.2 mt -128.72 155.26 40.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.436 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.439 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.98 135.9 2.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.231 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.481 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 5.0 m-30 -113.08 149.73 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.16 117.47 35.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.008 0.433 . . . . 0.0 110.704 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 676' ' ' ASP . 2.6 t -80.48 114.75 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.1 108.96 12.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 0.0 110.123 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.403 HG23 ' CE1' ' A' ' 577' ' ' PHE . 8.9 mt -80.45 111.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.334 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -96.15 -45.85 6.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 4.1 t70 -111.13 140.34 45.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.014 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.426 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 10.0 p . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.777 0.323 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 169.59 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.985 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -102.9 157.94 16.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.855 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -88.6 158.3 18.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.985 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -178.83 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.12 54.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.01 -52.07 52.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -43.34 96.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.783 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -57.32 -33.82 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.22 -36.78 80.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 23.2 mt -58.18 -44.32 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.75 -27.82 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.813 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.869 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 51.5 ttp85 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.686 0.279 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.525 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -101.1 -50.94 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.909 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 44.6 tp -114.55 142.3 46.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.102 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 32.9 m -118.97 121.8 40.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.531 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 692' ' ' PHE . 6.6 mt -109.03 108.57 19.33 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.23 100.24 50.22 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -176.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.588 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.1 Cg_exo -47.84 105.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.694 1.596 . . . . 0.0 109.271 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.17 156.73 87.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.44 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 77.2 Cg_exo -50.4 -25.83 14.81 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.741 2.961 . . . . 0.0 113.357 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.86 -20.62 65.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.056 0.455 . . . . 0.0 110.039 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 3.7 t -97.24 154.34 17.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.969 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.479 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 4.1 pt -55.11 -19.68 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.115 0.483 . . . . 0.0 109.84 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.13 119.01 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.87 63.7 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.124 0.487 . . . . 0.0 110.701 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.588 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.8 mt-10 -124.97 170.81 10.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.48 121.6 27.58 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.681 0.277 . . . . 0.0 111.427 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.3 mm? -113.21 150.8 31.81 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.3 mt-10 -125.18 131.26 53.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.542 HG12 ' CD2' ' A' ' 601' ' ' PHE . 73.7 mt -90.13 108.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -69.14 124.64 24.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.9 -32.37 3.75 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.506 0.669 . . . . 0.0 109.505 179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.81 -22.55 75.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.664 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 81.9 t -98.36 117.94 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.929 0.864 . . . . 0.0 111.545 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 4.5 t30 -140.38 121.33 9.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.023 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.519 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.7 Cg_endo -90.96 159.72 29.3 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.475 -1.052 . . . . 0.0 111.415 -0.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -92.11 113.27 25.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 5.8 m-85 -91.9 138.28 31.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.083 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.9 mp -123.7 145.49 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.481 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.55 -167.55 35.77 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.427 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.443 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -73.62 -52.22 14.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 128.99 39.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.387 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -54.46 -19.9 6.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.965 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -28.26 51.78 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.018 0.437 . . . . 0.0 110.382 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 81.1 m -75.26 131.33 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.589 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 1.5 m-80 -46.44 -29.68 1.84 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.066 0.46 . . . . 0.0 110.464 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 31.0 t -109.59 137.46 47.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.68 104.94 14.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.442 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 14.2 mm -139.32 109.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.322 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.66 106.05 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.436 0.636 . . . . 0.0 111.998 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.486 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.8 OUTLIER -129.99 108.69 10.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.733 177.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -39.44 -27.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -71.4 -42.09 68.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -88.47 158.63 18.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.261 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.7 t -83.9 171.28 13.19 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.619 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.466 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -49.72 -41.83 44.49 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.143 0.497 . . . . 0.0 110.369 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.4 61.52 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.6 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.506 ' CD2' HG22 ' A' ' 680' ' ' ILE . 38.5 t60 -46.21 -45.22 16.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.59 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.4 p -167.34 159.29 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.597 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 51.7 p90 -143.48 146.52 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.817 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.431 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 16.6 mt -102.1 130.22 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 109.919 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -121.7 135.56 54.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.692 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 647' ' ' ILE . 6.0 tttt -97.77 133.46 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.111 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.451 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.8 OUTLIER -136.07 159.79 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.95 -178.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 6.4 tpt85 -75.79 112.31 12.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.359 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.9 t60 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.336 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 630' ' ' HIS . 2.8 mp . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.595 0.236 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -97.05 147.98 23.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 111.434 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.82 160.03 34.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.049 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.477 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 3.2 pt -107.32 119.09 56.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.552 0.691 . . . . 0.0 111.854 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.534 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 86.8 m95 -104.68 130.87 52.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.152 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -90.99 117.24 29.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 624' ' ' PHE . 10.9 m -103.77 138.07 40.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.829 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.45 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 27.0 t60 -120.84 130.53 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.238 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 15.1 p -128.14 7.33 6.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.213 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.13 151.44 36.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.837 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.6 t -75.37 -36.27 60.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 111.405 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m-20 -72.74 2.09 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.601 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.587 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 49.12 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.587 0.708 . . . . 0.0 112.153 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.406 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 39.2 m -105.63 165.6 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 5.1 m-85 -124.7 120.18 31.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 111.266 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -98.86 100.02 11.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.673 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 61.83 -80.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.859 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.0 m120 -135.83 0.76 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.458 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 2.1 m120 -106.77 141.12 38.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.174 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -75.07 141.76 43.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 12.0 mmm -124.08 85.85 2.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.2 pt -87.53 165.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 111.071 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.7 118.39 3.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.366 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.53 27.66 12.69 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 32.9 p -112.96 162.0 16.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 0.0 111.435 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpm? -141.98 140.62 32.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.447 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.3 OUTLIER -145.22 142.64 29.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.224 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.534 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -70.21 140.02 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 110.699 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.433 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 2.0 mt -109.43 119.09 38.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 111.062 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.24 138.03 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.813 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -42.38 107.15 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.089 0.471 . . . . 0.0 110.807 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 105.93 32.65 3.75 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.17 119.99 32.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.371 . . . . 0.0 110.731 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -96.1 111.33 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.093 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 33.2 pt -105.59 135.42 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 112.016 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 116.74 33.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.607 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.506 HG22 ' CD2' ' A' ' 622' ' ' HIS . 5.6 mt -91.36 -30.76 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.473 HG21 ' HB ' ' A' ' 690' ' ' ILE . 4.0 tp -153.8 130.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 111.674 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -137.46 126.83 24.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.88 117.05 21.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.874 0.369 . . . . 0.0 110.363 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.77 -46.81 74.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.804 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -83.36 -40.37 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.565 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.35 -11.1 59.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.446 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 57.75 22.11 8.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.695 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.479 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 0.6 OUTLIER -81.57 104.38 11.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.5 OUTLIER -126.98 120.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.473 ' HB ' HG21 ' A' ' 681' ' ' ILE . 30.2 mt -129.83 120.53 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.511 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -143.03 140.93 10.11 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.516 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 8.6 m-30 -112.66 146.06 39.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.809 0.338 . . . . 0.0 110.368 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -101.04 116.15 32.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.07 0.462 . . . . 0.0 109.846 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 578' ' ' LEU . 1.0 OUTLIER -82.69 122.34 37.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.306 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -133.09 109.84 9.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.971 0.415 . . . . 0.0 111.033 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 16.3 mt -78.89 106.05 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.728 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.75 -45.04 10.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 9.4 t0 -110.3 140.14 44.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.483 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 699' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 121.297 0.57 . . . . 0.0 109.891 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 96.5 t . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.38 171.37 7.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -103.09 142.57 33.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.965 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -77.4 154.44 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 -179.51 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.236 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.88 -31.97 51.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -61.83 -48.84 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.733 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.76 -49.34 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -61.08 -32.74 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.181 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -38.68 92.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.273 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.18 -44.36 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.21 -27.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.119 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -56.34 -30.93 63.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 110.787 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.9 mttm . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.422 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.2 ttm105 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.734 0.302 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -124.01 -63.25 1.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.221 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.536 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 10.1 tt -108.98 142.69 39.27 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.202 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 695' ' ' GLU . 2.1 m -120.97 113.88 20.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.3 OUTLIER -101.52 107.92 19.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 69.1 mttt -113.16 99.18 48.3 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.623 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.6 Cg_exo -47.28 99.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.767 1.645 . . . . 0.0 109.416 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.5 157.47 86.2 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.64 -25.36 11.02 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.809 3.006 . . . . 0.0 112.961 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -27.84 68.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.442 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.0 OUTLIER -95.73 153.87 17.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.554 178.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 6.5 pt -58.17 -11.46 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.412 ' CD1' HG23 ' A' ' 613' ' ' ILE . 49.6 mt -107.16 119.01 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.76 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.424 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -107.68 58.13 0.62 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.134 0.493 . . . . 0.0 110.252 179.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.623 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.7 mm-40 -124.62 171.58 9.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.351 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.03 128.3 44.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.51 141.1 46.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.017 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.0 mt-10 -124.52 115.78 21.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.495 HG12 ' CD2' ' A' ' 601' ' ' PHE . 77.0 mt -83.24 109.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.294 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.94 120.23 13.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.057 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.529 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.67 -29.84 2.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.176 0.513 . . . . 0.0 110.696 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.449 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -18.44 78.63 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.765 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.2 117.98 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 117.902 0.851 . . . . 0.0 111.983 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -140.27 122.77 9.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.873 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.532 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.1 Cg_endo -90.52 159.81 31.53 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.286 -1.131 . . . . 0.0 111.775 -0.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.31 115.62 28.24 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.53 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 43.3 m-85 -92.33 137.95 31.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.838 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 2.7 mp -126.4 143.31 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.438 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.16 -170.3 38.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.297 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.443 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -70.75 -49.45 46.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 111.614 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.71 130.64 47.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.479 -179.058 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -18.14 23.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.3 -28.65 63.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.086 0.47 . . . . 0.0 110.455 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 84.4 m -74.11 132.5 42.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.632 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 14.2 m-80 -47.44 -29.37 2.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.179 0.514 . . . . 0.0 110.254 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 42.5 t -109.93 142.07 41.79 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 105.38 13.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.462 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 20.5 mm -139.09 109.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.13 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.65 106.57 17.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.463 0.649 . . . . 0.0 112.255 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.46 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 2.2 t0 -129.68 107.53 9.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.633 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.39 -27.24 0.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -69.95 -42.05 73.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.684 0.278 . . . . 0.0 111.382 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.48 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 1.2 pp -90.08 158.75 17.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.73 164.15 26.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.014 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.424 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 1.0 OUTLIER -50.38 -28.33 7.89 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.068 0.461 . . . . 0.0 110.449 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 45.0 t -130.8 64.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.546 ' CD2' HG23 ' A' ' 680' ' ' ILE . 20.8 t60 -50.57 -46.94 57.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.119 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.6 p -165.36 161.5 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.511 . . . . 0.0 111.93 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.8 p90 -143.6 147.67 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.406 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.15 130.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -124.4 134.16 53.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 1.0 OUTLIER -99.56 136.93 38.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.619 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.88 158.94 43.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.584 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.6 tpt180 -75.99 112.44 12.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.356 0.598 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.3 t60 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.233 -179.491 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 3.4 m-20 -100.68 146.27 27.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.37 0.605 . . . . 0.0 112.398 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 4.9 t0 -126.69 160.53 30.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.29 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 3.3 pt -114.88 115.37 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.386 0.612 . . . . 0.0 112.026 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.535 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 63.9 m95 -102.73 136.86 41.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.151 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -93.05 117.52 30.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.013 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 624' ' ' PHE . 14.8 m -101.87 130.67 48.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.087 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.46 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 45.0 t60 -111.19 132.88 53.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.483 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 13.4 p -129.27 2.47 5.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.416 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.86 148.1 32.96 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.4 t -73.28 -33.0 64.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 111.244 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.9 m-20 -72.27 -0.18 11.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.362 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.31 130.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 0.0 112.081 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.447 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 46.7 m -100.94 166.3 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.1 121.39 29.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.538 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.416 ' CD2' HD23 ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.75 99.95 11.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.608 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 60.26 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.0 m-80 -130.02 -1.7 4.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.614 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.471 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.5 m-80 -101.6 142.02 33.59 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.239 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.408 ' O ' HG22 ' A' ' 716' ' ' VAL . 46.8 ttp180 -81.55 141.27 33.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.272 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.403 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 15.3 mmm -121.16 96.92 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 6.7 pt -87.75 164.55 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.86 100.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.57 37.78 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.9 p -119.81 162.44 19.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.099 0.476 . . . . 0.0 111.535 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.528 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -131.3 147.27 52.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.471 ' CE1' ' CB ' ' A' ' 662' ' ' ASN . 2.4 t80 -147.44 144.93 28.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.535 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.22 133.34 47.83 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.607 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 2.5 mt -114.8 124.84 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.677 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.91 151.53 33.87 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.464 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -49.07 119.41 3.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 110.405 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.29 36.4 5.95 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.46 110.09 22.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.737 0.303 . . . . 0.0 111.336 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.75 108.82 21.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.06 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 8.9 mt -105.61 136.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.897 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.15 116.48 28.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.679 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.546 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -84.72 -34.05 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.581 -178.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.45 ' CG2' ' HB ' ' A' ' 690' ' ' ILE . 1.5 tp -154.58 131.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.135 0.493 . . . . 0.0 111.866 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -136.26 126.81 26.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.046 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.03 116.9 21.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.416 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -67.36 -46.71 72.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.873 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.11 -40.42 27.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.622 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -85.07 -10.55 56.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.427 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.9 mttt 59.82 19.2 8.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.38 104.76 8.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.7 p -125.64 123.82 65.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 112.195 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.467 HG22 HD12 ' A' ' 690' ' ' ILE . 19.0 mt -128.32 154.87 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.424 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.442 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.24 135.75 2.76 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.113 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.481 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 5.9 m-30 -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.289 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -100.95 117.06 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.721 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.6 t -78.84 126.45 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.373 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.7 tt0 -133.29 109.33 9.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 110.59 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 47.0 mt -82.89 105.68 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.102 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -87.86 -45.98 9.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.826 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.6 140.95 44.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.407 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.325 0.583 . . . . 0.0 109.669 178.494 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.426 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 12.7 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.933 0.397 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.421 HD11 ' CZ3' ' A' ' 648' ' ' TRP . 0.5 OUTLIER -102.55 168.68 9.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.482 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 144.91 30.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -82.61 158.52 23.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -175.01 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.171 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.79 60.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.37 -46.56 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -66.69 -47.8 71.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.767 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -59.99 -33.11 71.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -63.14 -39.58 95.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.53 -44.02 96.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.0 p -80.62 -27.9 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -54.2 -34.4 60.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.005 0.431 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.544 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -126.9 -62.86 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 6.8 tt -106.42 142.23 36.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 695' ' ' GLU . 7.1 m -124.55 114.62 19.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.8 OUTLIER -104.25 108.42 19.81 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.0 100.22 53.28 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 24.5 Cg_exo -45.43 104.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.565 1.51 . . . . 0.0 109.105 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.39 156.98 86.92 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.487 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -49.88 -31.6 27.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.663 2.909 . . . . 0.0 112.908 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.82 -21.49 66.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.465 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.663 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 24.7 p -96.46 153.23 17.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.201 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 3.9 tt -52.46 -19.47 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.633 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 588' ' ' ILE . 40.4 mt -110.62 118.54 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.299 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -109.7 60.81 0.6 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.298 0.571 . . . . 0.0 110.841 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.558 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 29.3 mt-10 -125.48 171.91 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.668 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.24 127.7 44.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 178.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.6 137.72 50.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.616 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.9 OUTLIER -124.12 119.53 29.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.485 HG12 ' CD1' ' A' ' 601' ' ' PHE . 80.3 mt -86.68 109.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.113 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.99 122.5 18.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.996 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.544 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.6 -29.56 1.88 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.449 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.69 -25.2 74.08 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.823 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.13 118.12 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.002 0.901 . . . . 0.0 111.661 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -140.09 122.63 10.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.844 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.1 Cg_endo -89.93 159.66 34.36 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 124.352 -1.104 . . . . 0.0 111.695 -0.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.4 t80 -91.93 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.571 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 58.9 m-85 -92.77 138.16 31.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.665 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.61 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.1 mp -128.12 144.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.66 -173.21 40.56 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.68 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 9.1 ttp85 -75.88 -18.39 59.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.324 0.249 . . . . 0.0 111.372 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.16 129.96 35.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.36 -23.0 21.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -55.07 -30.37 59.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.085 0.469 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 34.8 m -73.44 127.99 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.829 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 32.8 m120 -44.31 -33.93 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.306 0.574 . . . . 0.0 110.298 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.61 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 54.1 t -104.36 143.04 33.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.172 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.79 113.53 20.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . . . . . . . . . 26.5 mm -137.95 109.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.447 177.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.9 pt-20 -97.28 105.23 17.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.513 0.673 . . . . 0.0 112.291 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.545 ' HB3' ' CD1' ' A' ' 618' ' ' LEU . 38.3 t0 -131.43 123.05 27.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.062 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -47.63 -29.23 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.75 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.76 -39.35 44.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.545 ' CD1' ' HB3' ' A' ' 615' ' ' ASP . 2.2 mp -65.88 159.22 26.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.786 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.0 m -110.61 172.08 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.433 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -47.84 31.76 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 110.174 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.45 56.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.482 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.488 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 49.3 t60 -43.67 -47.63 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.598 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 2.7 p -165.6 151.65 9.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.542 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.0 p90 -143.29 146.9 33.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.829 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.41 ' CD1' HD11 ' A' ' 603' ' ' ILE . 3.4 mp -101.86 127.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -120.37 134.33 55.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.427 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 27.2 ttmt -97.82 136.5 38.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.075 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.59 158.29 44.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.833 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.4 113.98 15.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.334 0.588 . . . . 0.0 110.572 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.132 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.6 mp . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.0 m-20 -122.05 146.43 47.19 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.239 0.543 . . . . 0.0 112.033 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.17 160.56 35.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.439 HG23 ' CE2' ' A' ' 577' ' ' PHE . 0.8 OUTLIER -107.9 121.94 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.482 0.658 . . . . 0.0 112.274 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.537 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 79.4 m95 -106.0 124.65 49.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.168 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 7.3 t80 -90.39 116.92 28.71 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 26.6 m -102.11 144.08 31.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.254 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 18.3 t60 -131.03 124.28 30.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.404 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 1.4 p -121.13 6.69 10.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.06 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.48 148.11 35.11 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.278 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.5 t -69.84 -34.7 73.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.795 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.559 ' O ' ' O ' ' A' ' 656' ' ' VAL . 51.5 m-80 -70.56 -2.51 14.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.608 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.559 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.72 133.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.434 0.635 . . . . 0.0 111.893 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 81.8 p -103.06 165.59 10.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.816 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.5 120.26 30.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.775 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.443 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -100.84 101.33 12.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 59.78 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 65.1 t30 -133.47 -2.2 3.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.521 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 1.3 t-20 -104.98 141.41 36.61 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.197 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.89 141.2 33.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.24 100.11 9.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.691 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.422 HD12 HG21 ' A' ' 665' ' ' ILE . 37.7 pt -87.12 134.9 26.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.963 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' A' ' 652' ' ' THR . 1.2 tt0 -38.49 98.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.988 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 37.38 1.17 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.1 p -139.21 158.37 44.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.703 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 12.6 pttm -123.61 158.2 32.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.521 ' CE2' ' CB ' ' A' ' 662' ' ' ASN . 0.3 OUTLIER -145.08 146.3 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.537 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.95 130.92 44.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.86 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 0.9 OUTLIER -109.81 118.65 37.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 111.625 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -108.52 138.31 45.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.438 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -38.88 116.95 0.62 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.84 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.8 35.28 6.19 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.43 114.89 27.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.86 108.52 20.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 13.0 mt -107.91 131.79 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.898 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 115.65 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.567 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.495 ' CG2' HD12 ' A' ' 618' ' ' LEU . 1.1 mt -78.01 -36.05 21.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.364 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.413 ' O ' HG21 ' A' ' 681' ' ' ILE . 1.0 OUTLIER -155.14 131.91 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 111.73 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -136.21 125.75 25.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -127.11 116.9 21.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.924 0.393 . . . . 0.0 110.318 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -67.22 -46.55 73.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.895 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -74.46 -40.29 61.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.77 -11.97 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.451 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt 61.61 16.94 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.727 0.298 . . . . 0.0 111.019 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 2.3 t80 -82.27 105.49 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -125.95 121.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.214 0.531 . . . . 0.0 111.997 -178.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.436 HG12 ' CG2' ' A' ' 587' ' ' ILE . 31.5 mt -117.73 130.82 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.63 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -154.91 130.85 2.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.421 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.466 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 3.4 m-30 -113.33 143.91 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.863 0.363 . . . . 0.0 110.38 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.47 117.35 34.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.03 0.443 . . . . 0.0 110.682 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.425 HG23 ' CD2' ' A' ' 580' ' ' LEU . 3.0 t -79.97 127.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.515 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -133.39 109.53 9.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 52.2 mt -83.19 105.14 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.36 -46.58 12.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.279 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.08 140.68 45.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.316 0.579 . . . . 0.0 109.568 178.064 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.971 0.415 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.07 172.43 6.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.23 158.05 15.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -95.88 160.27 14.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.1 p -120.2 -174.44 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.91 58.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -60.78 -48.17 82.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -64.12 -48.86 74.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -53.1 -33.47 52.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.21 -36.91 80.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 38.4 mt -56.65 -44.31 81.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.166 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.2 p -80.86 -21.25 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -67.82 -39.2 83.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.752 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.198 179.741 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.443 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.139 0 CA-C-O 120.502 0.192 . . . . 0.0 110.487 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -121.69 -62.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 111.476 -179.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.431 ' N ' ' CG ' ' A' ' 577' ' ' PHE . 5.7 tt -105.93 125.99 51.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 19.4 m -102.46 119.19 38.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.268 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 592' ' ' LEU . 4.7 mt -105.64 108.54 20.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -117.97 100.72 52.09 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.125 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.7 Cg_exo -46.14 101.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.778 1.652 . . . . 0.0 109.451 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 157.97 84.72 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.7 Cg_endo -50.06 -25.75 13.33 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.461 2.774 . . . . 0.0 112.244 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.36 -26.47 68.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.403 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 54.5 p -95.4 153.47 17.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.711 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 1.0 OUTLIER -58.7 -14.16 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.56 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 73.0 mt -106.49 118.67 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.315 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -105.35 57.58 0.68 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 110.524 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.603 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.5 mt-10 -124.76 169.39 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.79 122.28 26.89 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.573 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.7 OUTLIER -113.17 150.31 32.43 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.392 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.44 125.34 44.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.509 HG12 ' CD1' ' A' ' 601' ' ' PHE . 93.9 mt -83.51 108.97 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.608 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -64.16 122.84 17.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.507 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.63 -30.06 3.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.258 0.551 . . . . 0.0 110.021 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.463 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -73.42 -20.94 79.97 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.926 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 61.0 t -98.62 118.04 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 118.108 0.954 . . . . 0.0 111.642 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -140.18 121.6 9.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.002 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.55 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.0 Cg_endo -90.56 159.34 31.11 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.442 -1.066 . . . . 0.0 111.511 -0.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.3 t80 -91.78 115.6 28.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.556 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.6 m-85 -92.54 137.94 31.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.349 -177.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.492 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.2 mp -123.97 145.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.438 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 157.67 -169.85 34.58 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.317 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.573 ' HG2' HD21 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -69.83 -48.74 57.82 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.441 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.21 124.28 19.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -178.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -19.44 5.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.665 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.48 -30.15 66.77 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 98.0 m -68.8 133.04 47.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.446 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 32.6 m120 -45.54 -30.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.19 0.519 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 32.8 t -113.1 142.34 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.373 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 105.92 15.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.425 HG13 ' CE2' ' A' ' 692' ' ' PHE . 24.8 mm -138.39 109.71 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.441 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.22 106.89 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.584 0.707 . . . . 0.0 112.657 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.455 ' C ' ' HD3' ' A' ' 605' ' ' ARG . 27.1 t0 -129.42 107.11 9.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.724 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.48 -30.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.407 ' HB2' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -77.98 -37.56 47.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.498 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.573 HD21 ' HG2' ' A' ' 605' ' ' ARG . 0.0 OUTLIER -89.63 134.09 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.66 165.52 0.41 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.475 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -59.45 -21.64 60.35 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.27 56.58 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.535 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 14.1 t60 -41.86 -37.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.39 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.0 p -170.09 160.05 7.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.248 0.547 . . . . 0.0 112.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.556 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 40.6 p90 -143.37 147.59 34.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.172 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.55 130.83 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.0 t80 -122.96 133.8 54.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.891 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.426 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 3.0 tppp? -98.07 136.66 37.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.465 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.65 159.14 41.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.737 -178.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -76.41 112.45 12.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.355 0.598 . . . . 0.0 110.705 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.4 t60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.698 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.9 mp . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 9.9 m-20 -112.63 146.93 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.59 160.09 34.35 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.275 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.416 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.9 pt -106.53 126.86 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.6 0.714 . . . . 0.0 112.892 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.518 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 82.7 m95 -111.22 128.55 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.687 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.436 ' CD1' HD12 ' A' ' 678' ' ' ILE . 20.2 t80 -90.76 117.8 29.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 624' ' ' PHE . 38.4 m -102.8 131.87 49.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.471 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 47.4 t60 -111.91 130.85 55.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.6 p -131.47 12.42 4.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.342 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.32 154.27 32.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.295 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 55.3 m -83.61 -24.15 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.741 0.305 . . . . 0.0 111.381 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.9 OUTLIER -82.6 4.14 25.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 53.27 133.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 111.981 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.457 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 60.0 m -102.0 166.17 10.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.376 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.407 ' O ' ' N ' ' A' ' 679' ' ' LYS . 34.9 m-85 -130.61 120.01 23.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -100.15 103.54 15.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.872 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 60.56 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.768 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.8 m120 -136.43 6.03 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.508 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.457 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.0 OUTLIER -107.37 142.0 37.86 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.804 0.335 . . . . 0.0 111.001 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 24.8 ttt-85 -78.02 141.39 38.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.402 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 42.7 mmm -121.9 93.02 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.542 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 36.1 pt -87.71 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -47.25 96.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.115 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.26 41.47 0.81 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.0 p -128.94 162.15 28.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.056 0.455 . . . . 0.0 111.86 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.454 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -134.73 146.71 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 662' ' ' ASN . 0.2 OUTLIER -147.54 145.5 29.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.518 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.84 133.22 47.98 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.705 179.341 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.412 HD21 ' CB ' ' A' ' 649' ' ' TYR . 0.4 OUTLIER -108.59 119.15 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.153 0.501 . . . . 0.0 111.443 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -106.67 139.73 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.828 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.411 ' CA ' HD13 ' A' ' 696' ' ' ILE . 41.1 t0 -40.8 114.8 0.51 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 110.732 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.78 36.69 5.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.65 115.38 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.056 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -96.55 108.68 21.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.436 HD12 ' CD1' ' A' ' 649' ' ' TYR . 23.4 pt -108.27 129.1 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 0.0 111.946 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -89.22 116.03 27.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.307 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.477 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 3.0 mt -78.31 -36.0 20.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.566 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.437 HG22 ' CG1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -154.92 131.87 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.35 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -136.1 128.34 30.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 111.501 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -127.14 116.37 20.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.14 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.48 -46.47 72.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.16 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.83 -40.37 65.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -90.55 -10.33 43.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 15.97 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.663 0.268 . . . . 0.0 111.064 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.474 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.7 t80 -76.48 104.78 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.95 125.96 74.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.839 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.459 ' CD1' HG12 ' A' ' 587' ' ' ILE . 33.1 mm -127.93 125.62 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.36 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -160.7 136.74 4.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.136 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 8.1 m-30 -112.99 148.76 34.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.348 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' A' ' 578' ' ' LEU . 3.3 t -79.2 121.17 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.702 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.97 109.37 11.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.867 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.411 HD13 ' CA ' ' A' ' 674' ' ' ASP . 64.1 mt -78.31 110.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.33 -45.45 6.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.426 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 7.5 t70 -111.04 140.64 45.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.457 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 92.1 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.023 0.439 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.72 167.52 11.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.377 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.09 150.42 23.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.209 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.77 149.02 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 31.7 p -126.15 -173.62 2.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.405 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -61.86 -28.69 69.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.159 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.13 -53.2 58.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 720' ' ' THR . 2.5 pp20? -70.6 -37.74 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -58.53 -34.93 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.544 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 728' ' ' LYS . 10.2 t70 -68.14 -39.35 82.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 723' ' ' GLU . 17.0 mt -58.27 -44.17 88.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.03 -23.78 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.576 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 725' ' ' ASP . 0.0 OUTLIER -50.49 -48.82 56.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.066 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.919 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.4 tmm_? . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.866 0.365 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.6 ' CD1' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -122.3 -52.79 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.6 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 1.4 tt -107.04 140.42 39.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.112 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.448 ' N ' HD22 ' A' ' 578' ' ' LEU . 23.8 m -118.52 113.55 21.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.755 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.7 OUTLIER -105.7 108.85 20.57 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.1 ptpt -117.01 99.86 53.11 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.1 Cg_exo -45.98 104.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.893 1.729 . . . . 0.0 109.503 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.18 157.39 85.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -176.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.1 Cg_endo -50.72 -27.73 20.78 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.603 2.869 . . . . 0.0 112.53 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.54 -26.72 68.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.64 153.57 17.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.157 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 8.1 pt -57.14 -12.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.977 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 38.9 mt -108.87 118.82 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.637 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -107.65 59.33 0.62 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.146 179.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.656 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mm-40 -125.57 170.04 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.264 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.2 116.73 18.06 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.304 178.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.8 OUTLIER -113.53 143.56 44.32 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.17 123.92 40.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.561 HG12 ' CD2' ' A' ' 601' ' ' PHE . 78.7 mt -75.23 108.84 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 1.6 mp0 -59.44 116.78 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.939 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.501 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -30.44 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.273 0.559 . . . . 0.0 110.118 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.441 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.88 -16.12 79.54 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.671 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.77 117.77 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 118.009 0.905 . . . . 0.0 111.212 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.46 123.91 10.31 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.166 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 34.6 Cg_endo -91.38 158.85 27.27 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.349 -1.105 . . . . 0.0 112.052 -0.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.0 t80 -93.1 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.135 0.493 . . . . 0.0 109.752 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 1.1 m-85 -93.44 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.492 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.9 mp -127.21 143.99 38.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.3 -163.61 31.6 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.504 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.485 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -73.57 -41.7 62.59 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.331 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 28.6 t -60.69 119.9 9.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.551 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.15 -18.65 10.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -62.45 -30.05 70.96 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.235 0.54 . . . . 0.0 109.614 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 61.5 m -67.1 128.05 34.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.378 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.8 m120 -44.1 -31.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.558 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.507 ' HB3' HG13 ' A' ' 603' ' ' ILE . 42.2 t -108.62 135.53 49.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.03 109.08 20.03 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.434 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 24.0 mm -138.2 109.46 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.97 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -103.26 105.17 15.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.591 0.71 . . . . 0.0 112.22 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.498 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 1.0 OUTLIER -130.92 108.3 9.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.422 177.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -39.34 -29.75 0.05 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.403 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 8.3 mpt_? -70.62 -41.12 72.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.588 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -86.64 158.69 19.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 111.443 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 45.8 t -86.36 176.45 7.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.426 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -52.17 -51.75 56.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.479 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.404 ' O ' ' OG1' ' A' ' 652' ' ' THR . 38.5 t -109.22 57.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.588 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 50.4 t60 -46.26 -38.09 8.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.937 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.12 174.9 10.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.531 0.681 . . . . 0.0 111.773 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.46 136.22 25.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.963 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 62.9 mt -132.37 117.05 30.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -134.4 147.49 50.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 111.552 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.456 ' HB2' HG22 ' A' ' 647' ' ' ILE . 16.3 ttmt -101.23 137.55 39.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.562 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 157.19 44.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.118 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.05 118.07 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.5 t60 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.824 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 630' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.7 OUTLIER -123.0 147.34 46.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.088 0.47 . . . . 0.0 111.932 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.76 137.97 42.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.175 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.471 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -90.26 124.87 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-O 121.331 0.586 . . . . 0.0 111.67 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.504 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 92.7 m95 -110.08 131.22 55.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.651 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -100.34 117.3 34.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.592 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.3 m -111.66 145.12 39.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.549 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.442 ' HB2' ' HG2' ' A' ' 664' ' ' MET . 23.5 t60 -119.55 125.2 48.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.398 . . . . 0.0 111.463 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.483 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 4.2 p -120.27 9.13 10.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.929 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.96 -178.99 47.85 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.74 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 655' ' ' ASN . 11.7 t -105.55 -45.07 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 111.642 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 617' ' ' ARG . 5.8 m-80 -60.04 -16.08 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.854 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 4.2 t 79.06 143.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.786 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.418 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 37.9 m -115.39 165.9 12.47 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -137.58 119.61 15.44 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.119 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.483 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -101.61 107.14 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.308 -179.07 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 56.12 -82.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 659' ' ' LEU . 30.3 m-80 -133.92 4.46 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.644 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.501 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 9.5 m120 -106.84 125.85 51.54 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.915 0.388 . . . . 0.0 111.306 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.0 ttm105 -65.95 141.24 58.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.509 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.448 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -114.7 85.71 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.584 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 38.3 pt -87.05 149.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.682 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 652' ' ' THR . 17.1 tt0 -45.62 100.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.542 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 111.81 37.7 1.52 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.603 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 3.0 p -128.9 162.58 27.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.482 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 717' ' ' LEU . 3.5 ttpm? -138.31 144.93 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.123 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.501 ' CE2' ' HB2' ' A' ' 662' ' ' ASN . 0.8 OUTLIER -147.02 145.53 29.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.109 0.48 . . . . 0.0 111.862 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.504 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.8 140.63 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.646 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 1.2 mt -106.87 123.88 48.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.154 0.502 . . . . 0.0 110.852 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -102.28 133.02 47.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.123 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -44.5 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 109.931 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.48 36.29 3.34 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.87 122.63 33.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.045 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.15 108.16 20.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.51 137.52 34.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.867 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -101.74 116.44 32.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.988 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.5 HG23 ' CD2' ' A' ' 622' ' ' HIS . 6.3 mt -82.8 -35.91 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.133 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.417 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.3 tt -154.7 131.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.714 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -136.37 119.84 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.173 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.22 116.57 20.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.678 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -46.6 71.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.877 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.68 -40.72 93.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.181 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -105.19 2.93 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.94 22.59 3.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.725 0.298 . . . . 0.0 110.973 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.3 OUTLIER -76.82 104.88 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.6 p -122.8 122.79 66.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 111.768 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 3.0 mt -127.9 126.07 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.478 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.91 139.98 6.59 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.78 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.477 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 3.2 m-30 -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 0.0 110.483 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -101.01 116.89 33.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.128 0.489 . . . . 0.0 110.312 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.506 HG22 HD23 ' A' ' 578' ' ' LEU . 2.2 t -81.79 120.0 32.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.5 109.22 9.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 13.8 mt -77.82 104.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.04 -45.02 21.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.24 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.44 141.63 43.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.63 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 121.262 0.553 . . . . 0.0 109.632 178.577 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.744 0.307 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 669' ' ' LYS . 3.2 mt -90.13 172.63 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.844 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.92 156.61 17.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.043 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.4 144.3 25.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.752 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 70.9 p -126.36 -176.81 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.8 37.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.269 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -55.97 -51.51 67.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.598 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.423 ' HA ' ' CD1' ' A' ' 726' ' ' LEU . 0.1 OUTLIER -70.18 -49.8 46.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.631 179.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -58.77 -32.12 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.97 -43.48 92.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.49 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 723' ' ' GLU . 1.4 mt -57.51 -44.49 85.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.112 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.4 p -78.45 -14.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.461 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -25.83 19.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.327 . . . . 0.0 111.179 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.8 mttt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.045 -179.968 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.443 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.7 tmm_? . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.606 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 1.3 t80 -127.94 -52.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.998 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.488 ' CD1' HG11 ' A' ' 694' ' ' VAL . 5.3 tp -115.45 125.6 53.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.444 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 11.5 m -105.2 114.12 28.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.8 OUTLIER -106.09 108.83 20.54 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.0 mtmm -113.84 100.04 51.44 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.623 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_exo -45.01 100.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.923 1.749 . . . . 0.0 109.724 177.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.99 157.33 85.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.02 -25.28 12.26 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.698 2.932 . . . . 0.0 113.075 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -28.23 69.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.436 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.5 t -96.12 154.03 17.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.622 178.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 8.6 pt -58.55 -10.21 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.733 0.301 . . . . 0.0 111.121 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 54.6 mt -108.55 118.85 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.736 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.436 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -108.75 60.27 0.6 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.22 0.533 . . . . 0.0 110.33 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.623 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.8 mt-10 -124.73 171.64 9.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.5 123.7 34.21 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -112.75 139.89 47.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 9.4 mt-10 -124.65 111.45 15.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 601' ' ' PHE . 30.8 mt -72.21 108.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.947 0.403 . . . . 0.0 110.071 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -68.03 116.56 8.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.871 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.606 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.29 -30.44 2.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.228 0.537 . . . . 0.0 110.475 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.453 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.22 -21.59 77.23 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.348 -0.842 . . . . 0.0 113.557 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.07 118.42 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -140.14 124.18 10.75 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.919 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.471 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 42.8 Cg_endo -90.63 159.22 30.73 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.232 0.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 1.9 t80 -92.67 114.27 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.562 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 0.4 OUTLIER -93.38 139.09 31.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.127 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.7 mp -127.07 143.79 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.894 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 156.52 -165.72 33.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.477 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.455 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -70.19 -42.61 72.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.92 -179.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 11.3 t -60.42 121.79 12.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.633 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.55 -18.18 18.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.335 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -64.2 -29.18 70.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.142 0.496 . . . . 0.0 109.665 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.0 m -66.96 128.87 37.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.199 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -44.05 -31.21 0.87 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.079 0.466 . . . . 0.0 110.501 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 43.1 t -110.53 142.06 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 107.5 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.412 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 24.5 mm -138.61 109.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.811 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -104.08 106.22 16.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.536 0.684 . . . . 0.0 112.723 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.485 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 2.0 t0 -130.85 107.73 9.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.685 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -39.25 -28.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.2 OUTLIER -73.7 -38.6 64.81 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.617 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.5 OUTLIER -88.41 158.98 18.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.528 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.6 p -83.56 168.76 16.1 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.498 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 4.4 ptp180 -51.24 -46.13 62.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.017 0.437 . . . . 0.0 110.322 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.55 60.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.617 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 13.9 t60 -52.92 -39.71 63.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.926 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.99 175.26 10.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.595 0.712 . . . . 0.0 111.872 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -144.92 142.21 29.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.183 -178.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.474 HG23 HD11 ' A' ' 625' ' ' ILE . 61.4 mt -133.26 116.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 3.0 t80 -132.88 138.7 47.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.586 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.7 ttmt -98.45 136.71 38.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.437 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.36 158.52 44.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.661 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -76.76 116.12 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.178 0.513 . . . . 0.0 110.627 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.1 t60 . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.602 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -116.13 147.74 41.04 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.402 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -134.83 142.88 46.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 5.1 pt -94.76 120.63 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.374 0.607 . . . . 0.0 111.593 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.511 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 96.2 m95 -104.97 125.89 51.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.867 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -90.93 117.44 29.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.94 144.87 36.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.621 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.471 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -115.0 129.98 56.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 3.3 p -127.53 10.45 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.47 152.17 26.21 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.558 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.2 t -76.07 -30.82 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.72 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -75.08 2.05 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.027 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.08 122.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.471 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.2 p -93.15 165.94 12.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.173 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 57.1 m-85 -131.96 119.64 21.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 0.0 110.697 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -95.06 100.53 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.606 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.9 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 22.7 m120 -132.05 -0.3 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.342 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.445 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.8 m-80 -95.36 141.62 28.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.825 0.345 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 3.5 ttm105 -81.96 141.05 33.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.227 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.401 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 31.6 mmm -129.35 108.93 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 111.047 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 3.1 pt -98.95 165.06 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.71 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.72 90.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.94 0.4 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.08 35.19 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.504 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.33 162.06 18.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.832 0.349 . . . . 0.0 111.127 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.427 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.2 ttpt -139.52 138.88 36.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.49 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.05 143.37 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.511 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -71.3 140.31 50.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.206 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 4.3 mt -108.28 127.37 53.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.783 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -106.67 149.94 26.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.772 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.426 ' HB2' HD12 ' A' ' 696' ' ' ILE . 6.0 t70 -47.66 106.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.038 0.447 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.99 36.3 4.52 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.603 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 7.6 t70 -92.13 113.33 25.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.305 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.58 112.16 24.01 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.22 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 22.4 pt -105.41 128.84 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.96 0.41 . . . . 0.0 111.62 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 10.9 mmtp -87.27 116.54 25.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.988 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.444 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -81.0 -36.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.377 -179.248 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 617' ' ' ARG . 4.7 tt -154.71 131.74 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 111.738 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -136.11 124.91 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.13 116.94 21.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.399 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -67.34 -46.66 72.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -74.06 -40.5 62.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.843 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -89.76 -8.65 51.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.548 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.26 19.11 7.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.721 0.296 . . . . 0.0 110.888 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.89 104.88 7.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.5 p -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.016 0.436 . . . . 0.0 111.858 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.409 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 5.0 mt -128.18 152.49 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.358 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.424 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.58 140.93 3.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.281 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 3.0 m-30 -113.65 153.39 28.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 0.0 110.492 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -100.85 117.12 34.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 676' ' ' ASP . 2.2 t -81.13 125.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.53 108.22 8.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.357 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 674' ' ' ASP . 18.9 mt -78.15 105.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -86.27 -46.95 9.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.893 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 27.5 t70 -110.85 140.45 45.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.434 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.444 -0.755 0 CA-C-O 121.292 0.568 . . . . 0.0 109.53 178.407 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 86.2 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.854 0.359 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.37 166.49 10.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.2 144.86 30.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -88.21 146.52 25.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.16 -176.88 3.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.612 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.17 -28.93 43.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.269 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -55.79 -52.81 62.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.649 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.429 ' HA ' ' CD1' ' A' ' 726' ' ' LEU . 2.7 mp0 -70.6 -48.15 56.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.641 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -57.36 -32.28 66.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.92 -40.85 83.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.429 ' CD1' ' HA ' ' A' ' 723' ' ' GLU . 4.9 mt -56.88 -44.39 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.26 -15.32 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.605 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -52.85 -29.73 29.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.8 mttt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 120.757 0.313 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.476 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -103.6 -52.85 2.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.788 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.0 tt -113.45 140.08 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 695' ' ' GLU . 19.1 m -118.49 114.93 23.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 592' ' ' LEU . 6.4 mt -102.09 107.62 18.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.9 mtpt -113.44 99.43 49.42 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.8 Cg_exo -47.15 97.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.838 1.692 . . . . 0.0 109.541 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -74.68 158.37 84.94 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 81.7 Cg_exo -48.58 -25.05 7.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.941 3.094 . . . . 0.0 113.389 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . 0.403 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.3 m-20 -61.39 -25.5 67.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.431 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 4.6 t -95.97 153.96 17.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.678 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.431 ' CD1' HG12 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -62.01 -8.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.872 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 90.1 mt -110.98 118.72 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 1.5 mp0 -104.95 62.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.106 0.479 . . . . 0.0 110.256 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.613 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -124.91 171.45 10.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.207 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.33 128.85 45.36 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.085 0.469 . . . . 0.0 111.098 178.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.3 OUTLIER -112.25 142.62 44.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.74 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -124.51 113.7 18.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.519 HG12 ' CD2' ' A' ' 601' ' ' PHE . 87.3 mt -81.68 108.44 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -70.45 126.39 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.174 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.476 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.25 -32.12 2.88 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.488 0.661 . . . . 0.0 109.743 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -69.71 -23.85 76.56 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.992 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 99.5 t -99.34 117.36 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.084 0.942 . . . . 0.0 111.857 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -141.22 122.1 8.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.826 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.552 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.86 160.19 34.94 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 124.554 -1.019 . . . . 0.0 111.506 -0.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.3 t80 -92.25 115.67 28.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.537 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 42.3 m-85 -92.48 137.81 32.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.843 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.536 HG13 ' HB3' ' A' ' 611' ' ' CYS . 4.1 mp -124.7 144.89 33.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.3 -166.94 36.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.515 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -73.84 -54.87 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.88 0.371 . . . . 0.0 111.9 -179.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 132.66 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.374 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -56.21 -19.78 15.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -27.22 18.81 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.073 0.463 . . . . 0.0 110.432 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 10.5 m -79.03 132.91 36.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.582 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 19.7 m-80 -47.98 -28.64 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.511 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.536 ' HB3' HG13 ' A' ' 603' ' ' ILE . 25.7 t -110.17 141.23 43.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.58 104.6 12.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.457 HG13 ' CE2' ' A' ' 692' ' ' PHE . 24.6 mm -139.43 109.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.869 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.06 107.16 17.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.46 0.647 . . . . 0.0 112.601 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.449 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.2 t0 -129.47 107.59 9.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.624 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -39.81 -29.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -41.3 76.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.513 ' CB ' ' ND1' ' A' ' 622' ' ' HIS . 1.1 pp -89.22 158.7 17.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.463 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 t -78.57 167.37 21.37 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.385 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -48.64 -37.73 19.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.114 0.483 . . . . 0.0 110.37 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 12.2 t -124.41 65.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.459 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 653' ' ' GLY . 28.5 t60 -49.55 -42.12 43.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.809 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -168.98 159.2 9.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.472 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.537 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.2 p90 -143.23 147.92 35.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.498 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 4.7 mt -102.38 132.58 48.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.251 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.552 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -124.24 133.46 53.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.72 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 20.2 ttmt -98.59 136.5 38.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.557 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.33 158.11 41.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.324 -179.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.15 117.71 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.4 t60 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.83 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.1 mp . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -119.55 146.35 45.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.329 0.585 . . . . 0.0 112.444 -178.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.09 160.53 33.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.525 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.421 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.8 OUTLIER -108.76 131.06 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.662 0.744 . . . . 0.0 112.689 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.55 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 92.5 m95 -115.29 126.9 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.504 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 3.7 t80 -90.52 117.63 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 35.3 m -103.32 133.12 48.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.398 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.4 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 64.7 t60 -110.57 130.61 55.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.3 p -130.27 10.74 5.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.461 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.0 178.91 53.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.276 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.1 t -102.06 -36.53 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.407 ' C ' ' CG1' ' A' ' 656' ' ' VAL . 3.0 m-80 -72.63 -0.16 12.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.942 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.478 HG22 ' CZ ' ' A' ' 658' ' ' TYR . 2.0 m 60.34 135.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 121.09 0.472 . . . . 0.0 111.577 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 4.3 t -97.63 165.65 11.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.672 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.478 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 5.6 m-85 -136.47 120.32 17.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.026 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.481 ' CD1' ' CD2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER -103.99 115.77 31.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.06 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.39 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.7 p-10 -136.31 6.29 3.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.471 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.15 141.01 36.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.825 0.345 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.55 141.43 32.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.416 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 31.4 mmm -119.42 106.01 11.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.035 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 49.9 pt -92.36 153.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.2 tt0 -47.07 99.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.37 41.05 1.29 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.3 p -121.43 162.28 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.619 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.4 ttpm? -133.02 146.6 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.579 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.481 ' CD2' ' CD1' ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.49 144.03 28.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.947 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.55 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.73 133.39 47.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.427 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.03 107.35 18.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 111.35 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -95.11 142.35 27.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.827 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -45.15 114.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.758 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.08 36.75 5.63 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -96.92 119.13 34.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.407 -179.201 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -96.2 114.06 25.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.403 HG12 ' HG ' ' A' ' 659' ' ' LEU . 6.4 mt -105.59 128.54 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 23.8 mtpt -90.37 116.5 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.952 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.472 HG22 ' CD2' ' A' ' 622' ' ' HIS . 35.3 mt -84.84 -38.97 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.348 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.417 ' CG2' ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.54 133.0 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -136.4 128.01 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.744 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -122.82 116.56 23.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.583 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -46.83 71.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.942 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.91 -40.54 46.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -82.26 -16.81 48.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.271 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.66 11.44 8.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.963 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.417 ' CE1' HG13 ' A' ' 690' ' ' ILE . 29.0 t80 -81.19 104.39 11.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.73 133.38 64.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.467 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 4.7 mt -128.24 155.04 39.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 690' ' ' ILE . . . 179.43 132.77 1.83 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.578 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CB ' HD21 ' A' ' 580' ' ' LEU . 9.7 m-30 -113.12 145.82 40.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . 0.444 ' HB2' HD12 ' A' ' 583' ' ' LEU . 3.2 ttmt -101.2 117.66 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.991 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.439 ' CG2' ' CD2' ' A' ' 580' ' ' LEU . 2.3 t -80.1 117.95 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.321 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 579' ' ' THR . 7.0 tt0 -126.09 109.29 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 110.266 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 41.0 mt -80.37 105.88 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -91.06 -45.32 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.118 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -110.37 141.08 43.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.414 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.445 0.641 . . . . 0.0 109.559 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.811 0.339 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 166.37 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 135.28 45.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -85.1 160.0 20.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.57 -174.34 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -29.32 36.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.39 -52.09 67.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.692 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -42.37 80.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.587 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -33.46 72.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.85 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.47 -40.83 93.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.049 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.2 mt -57.73 -44.3 85.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.054 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.41 -27.34 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -57.78 -35.44 70.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.665 179.629 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.41 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -107.78 -52.54 2.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.226 -178.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.3 tt -119.59 142.46 48.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.1 m -119.85 114.42 22.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -102.18 108.46 19.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.1 pttp -118.01 99.76 51.98 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -176.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.9 Cg_exo -46.0 102.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.815 1.677 . . . . 0.0 109.603 176.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -75.01 157.6 85.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.37 -24.75 9.09 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.866 3.044 . . . . 0.0 113.382 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.13 -24.11 66.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 1.5 t -95.95 152.01 18.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.93 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.426 HG13 ' CE1' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -56.33 -15.19 2.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.285 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.444 HG21 ' CB ' ' A' ' 582' ' ' PRO . 3.3 tt -112.58 124.88 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.849 0.357 . . . . 0.0 111.656 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.445 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -107.68 71.25 0.81 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.576 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 48.9 mt-10 -125.55 169.89 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.521 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.27 128.17 42.69 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.154 0.502 . . . . 0.0 110.917 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.48 140.09 47.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.637 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.41 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 20.4 mt-10 -124.06 113.81 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.486 HG12 ' CD1' ' A' ' 601' ' ' PHE . 83.6 mt -86.32 109.75 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.63 128.81 35.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.04 -30.24 2.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.367 0.603 . . . . 0.0 110.085 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.419 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -25.56 74.43 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.035 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.89 117.87 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.991 0.896 . . . . 0.0 111.924 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.25 122.13 9.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.861 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 41.6 Cg_endo -90.77 159.55 30.17 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.395 -1.085 . . . . 0.0 111.649 -0.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.25 115.83 28.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.546 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 42.9 m-85 -92.57 138.05 31.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.05 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.514 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 3.1 mp -126.47 145.15 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.511 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.99 -168.44 39.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.495 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 12.2 ttp85 -82.41 -19.22 39.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.614 0.245 . . . . 0.0 111.343 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.04 132.65 34.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -21.55 45.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.06 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.8 -29.36 64.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.908 0.385 . . . . 0.0 110.644 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 18.8 m -74.92 130.2 38.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.925 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 34.3 m120 -45.24 -31.86 1.7 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.26 0.552 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.514 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 43.8 t -107.87 142.74 37.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.618 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.97 116.29 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.474 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 26.7 mm -137.96 109.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.678 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.4 tt0 -92.43 103.49 15.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.881 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.6 t70 -132.22 117.06 17.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.021 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -46.16 -31.15 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.794 0.331 . . . . 0.0 111.194 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.463 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 1.7 mpt_? -77.73 -35.7 51.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.471 HD11 ' CG2' ' A' ' 680' ' ' ILE . 1.2 mp -66.38 159.69 26.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.3 m -108.61 167.09 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -48.93 22.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.239 0.542 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 10.3 t -119.74 61.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.279 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 653' ' ' GLY . 28.2 t60 -49.13 -45.57 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.995 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -167.65 155.81 9.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.053 0.454 . . . . 0.0 111.339 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.443 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 48.2 p90 -143.22 144.32 32.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.768 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' A' ' 603' ' ' ILE . 3.9 mp -101.39 131.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.9 t80 -126.54 133.3 51.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.027 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 31.0 ttmt -98.44 133.6 42.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.91 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 159.62 40.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.771 -178.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.2 tpt180 -75.6 115.07 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.372 0.606 . . . . 0.0 110.533 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.309 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 630' ' ' HIS . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 4.0 m-20 -107.06 137.78 44.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -116.03 157.39 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.811 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.503 HG23 ' CE1' ' A' ' 577' ' ' PHE . 4.7 pt -109.4 117.08 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.502 0.668 . . . . 0.0 111.851 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.593 ' CH2' HD23 ' A' ' 671' ' ' LEU . 70.9 m95 -102.78 131.23 49.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.623 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -91.16 117.13 29.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 624' ' ' PHE . 23.6 m -103.95 123.98 48.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.298 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.451 ' CE1' ' N ' ' A' ' 657' ' ' SER . 68.8 t60 -102.25 134.51 45.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -134.38 8.65 3.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.33 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.92 151.35 26.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.63 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.6 t -73.67 -29.04 62.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.126 0.489 . . . . 0.0 111.464 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 617' ' ' ARG . 1.1 m120 -72.66 -1.8 17.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.539 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.45 ' CG1' ' C ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 54.74 124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 111.877 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.451 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -98.02 166.41 11.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.257 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.401 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 8.1 m-85 -134.21 126.21 29.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.076 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.433 ' CD2' HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -93.74 99.45 11.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.298 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 61.92 -78.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.689 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 15.4 p-10 -129.08 -8.17 4.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.735 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.446 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 9.9 m120 -92.6 140.62 29.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -83.52 141.67 31.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.629 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' A' ' 670' ' ' PHE . 3.2 mtp -125.4 121.81 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.273 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 665' ' ' ILE . 33.7 pt -103.48 156.54 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.546 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -48.2 104.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.38 . . . . 0.0 111.343 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.4 35.73 2.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.4 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.8 p -117.63 162.03 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.741 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.498 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.0 OUTLIER -131.82 145.03 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.061 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.446 ' CE2' ' CB ' ' A' ' 662' ' ' ASN . 3.4 t80 -147.76 145.89 28.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.593 HD23 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.27 130.27 42.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.3 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.403 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 0.9 OUTLIER -109.76 129.58 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.143 0.497 . . . . 0.0 111.154 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.01 144.66 50.27 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.786 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.402 ' N ' HD13 ' A' ' 696' ' ' ILE . 11.0 t70 -41.88 118.6 1.14 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.854 0.359 . . . . 0.0 110.91 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.02 33.83 7.55 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.25 109.89 21.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 111.126 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -95.63 108.21 20.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.433 HG12 ' CD2' ' A' ' 659' ' ' LEU . 13.7 mt -105.46 122.63 59.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.581 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -78.91 115.9 18.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.71 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.537 HG22 ' NE2' ' A' ' 622' ' ' HIS . 1.1 mt -79.34 -32.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 617' ' ' ARG . 6.9 tt -154.98 131.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.63 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.56 126.7 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -126.23 117.39 22.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.226 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -46.58 73.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.105 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -73.57 -40.51 63.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.3 -14.24 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.603 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp 59.74 18.43 7.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.435 ' CE1' ' NH1' ' A' ' 617' ' ' ARG . 36.8 t80 -82.72 105.18 13.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.2 p -121.87 123.69 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.707 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.415 ' CG2' HG23 ' A' ' 680' ' ' ILE . 3.9 tt -127.57 125.08 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.487 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.76 148.17 16.84 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.18 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.474 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.3 OUTLIER -116.14 151.94 34.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . 0.485 ' HB2' HD13 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.47 117.39 34.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.5 t -75.16 128.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.347 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 579' ' ' THR . 5.6 tt0 -133.14 109.01 9.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 674' ' ' ASP . 39.9 mt -83.32 105.06 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.391 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.91 -45.88 11.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.492 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -110.24 140.77 44.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.331 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.446 -0.673 0 CA-C-O 121.338 0.59 . . . . 0.0 109.715 178.926 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.931 0.396 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.14 172.25 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.68 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 153.06 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.196 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.19 160.09 25.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -125.03 -178.66 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -28.82 37.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -66.11 -46.64 76.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -68.6 -43.17 77.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.812 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -55.97 -37.0 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -67.98 -36.6 80.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.003 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 91.5 mt -55.63 -44.27 76.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.93 -29.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.758 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.9 mttp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.87 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.518 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -126.98 -54.38 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.055 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.1 tt -112.98 138.49 49.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.355 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 6.4 m -118.29 114.2 22.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.992 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.5 OUTLIER -104.09 108.04 19.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.6 OUTLIER -116.89 100.99 53.66 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.43 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.1 Cg_exo -45.61 100.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.824 1.682 . . . . 0.0 109.597 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.33 157.02 86.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.31 -26.09 14.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.981 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.09 -27.22 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.413 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.4 t -95.62 154.2 17.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.704 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 31.2 pt -56.97 -11.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.729 0.299 . . . . 0.0 111.13 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.422 ' CD1' HG23 ' A' ' 613' ' ' ILE . 34.3 mt -108.72 122.33 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.744 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.63 57.04 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 110.404 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.549 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 mt-10 -124.62 171.06 10.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.194 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.06 129.32 46.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.073 0.463 . . . . 0.0 111.126 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.48 142.02 45.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.154 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.3 114.41 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.49 HG12 ' CD2' ' A' ' 601' ' ' PHE . 87.4 mt -83.84 108.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.7 125.49 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.315 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.518 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.01 -26.92 1.97 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.169 0.509 . . . . 0.0 110.413 179.512 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -76.65 -21.85 73.78 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.472 -0.785 . . . . 0.0 114.153 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.38 117.74 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 118.324 1.062 . . . . 0.0 111.534 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -140.72 122.29 9.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.23 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.541 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.9 Cg_endo -90.56 160.09 31.47 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.42 -1.075 . . . . 0.0 111.391 -0.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.29 114.96 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.538 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 43.5 m-85 -91.88 138.18 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.833 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 2.7 mp -126.91 145.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.369 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.49 -172.94 36.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.416 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.447 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -67.41 -52.05 44.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.339 . . . . 0.0 111.859 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.49 126.44 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.25 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.276 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -30.36 62.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.064 0.459 . . . . 0.0 110.299 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 8.3 m -71.32 134.69 46.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.485 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 21.0 m-80 -48.43 -26.59 2.18 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.539 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 35.7 t -113.83 142.45 46.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.07 105.2 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.431 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 25.9 mm -138.98 109.51 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.334 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -104.0 106.4 16.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 112.459 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.474 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.9 t0 -130.43 107.53 9.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.65 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.19 -29.37 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.41 ' HB3' HD12 ' A' ' 681' ' ' ILE . 0.3 OUTLIER -67.2 -41.46 85.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.601 0.238 . . . . 0.0 111.473 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.51 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -89.86 158.99 17.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 0.0 111.711 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 92.2 p -78.41 172.86 13.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.364 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.467 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 3.3 mpt_? -47.72 -46.41 29.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.117 0.484 . . . . 0.0 110.278 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.8 70.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.199 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.51 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 12.8 t60 -49.72 -45.98 49.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.769 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.1 p -164.23 158.7 19.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.602 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.492 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.1 p90 -143.4 147.73 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.561 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 603' ' ' ILE . 3.3 mp -102.64 131.12 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.7 t80 -122.29 133.88 54.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.412 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 1.6 tppp? -97.85 136.58 37.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.043 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.437 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.6 OUTLIER -135.31 159.04 42.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.819 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.6 tpt180 -76.69 112.26 13.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.312 0.577 . . . . 0.0 110.334 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.3 mt . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.5 m-20 -116.47 147.34 41.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.242 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.3 156.93 44.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.877 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.9 OUTLIER -104.18 125.02 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.636 . . . . 0.0 112.29 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.529 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 82.5 m95 -108.79 123.08 48.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.653 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 3.0 t80 -89.82 116.08 27.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 62.4 m -100.68 142.6 31.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.451 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.451 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 74.4 t60 -118.97 130.96 55.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.4 p -125.64 2.73 7.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.014 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 150.68 38.05 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.401 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.0 t -73.3 -32.55 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.495 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 656' ' ' VAL . 17.3 m-20 -75.56 2.24 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.764 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.07 125.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.767 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.446 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 37.3 p -88.78 166.15 14.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.609 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.48 120.42 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.73 99.9 10.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 59.5 -83.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -131.44 4.32 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.454 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -113.66 116.85 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -84.3 141.28 31.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.456 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.78 142.33 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.261 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.443 HD11 HG23 ' A' ' 665' ' ' ILE . 31.2 pt -96.56 163.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -52.77 91.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.46 39.91 0.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 0.8 OUTLIER -137.48 158.5 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 111.266 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 18.9 pttm -128.18 158.5 37.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.456 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 15.3 t80 -145.37 146.75 31.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.529 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.78 129.32 39.48 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.36 -179.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -103.82 130.8 51.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.242 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.94 150.37 42.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.5 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -50.12 105.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.369 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.28 32.7 4.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.48 113.11 25.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.04 108.84 21.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.226 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 6.4 mt -105.91 136.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.795 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 116.5 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.864 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.448 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -79.72 -36.34 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.256 -179.17 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 681' ' ' ILE . 2.2 tp -155.15 131.35 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 112.085 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -136.74 122.76 20.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.914 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -126.6 117.02 21.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.906 0.384 . . . . 0.0 110.687 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -46.37 73.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.867 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.74 -40.59 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.687 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.73 -9.61 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.519 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 15.8 tttt 60.61 17.56 7.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.951 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 7.5 t80 -77.5 104.97 8.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.5 p -121.71 121.77 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.168 0.509 . . . . 0.0 112.143 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.451 ' HB ' ' CG2' ' A' ' 681' ' ' ILE . 8.7 mt -128.72 153.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -179.76 137.14 2.97 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.148 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.467 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 9.0 m-30 -113.24 144.82 42.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.716 0.293 . . . . 0.0 110.422 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -101.07 116.85 33.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.996 0.427 . . . . 0.0 110.256 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 672' ' ' LEU . 3.8 t -79.68 125.37 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.636 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.1 109.16 9.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.408 HG22 ' CD1' ' A' ' 577' ' ' PHE . 17.4 mt -84.24 105.7 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.68 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -88.46 -46.02 9.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -110.96 139.53 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.812 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 699' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.416 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 7.4 p . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.747 0.308 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.428 HD13 ' CZ3' ' A' ' 648' ' ' TRP . 0.5 OUTLIER -97.05 166.99 11.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.23 154.81 18.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -87.35 154.69 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.746 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.22 -177.5 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.3 -30.51 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -47.47 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -66.97 -47.32 71.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -55.73 -32.99 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.95 -37.79 82.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.55 -44.14 84.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.12 -15.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -45.19 83.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 110.616 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.21 179.845 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -89.7 -22.25 22.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 151.92 -46.15 0.6 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.53 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.479 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 8.7 ttm180 -113.53 143.7 44.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.642 0.258 . . . . 0.0 111.203 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.592 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 5.5 t80 -122.43 -57.07 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.471 ' CD1' HG11 ' A' ' 694' ' ' VAL . 20.3 tp -111.04 142.36 43.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.381 . . . . 0.0 111.176 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 3.5 m -121.17 114.34 21.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 592' ' ' LEU . 5.6 mt -103.37 108.38 19.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 7.7 mtmt -113.71 99.81 50.74 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -176.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.6 Cg_exo -47.02 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.692 1.595 . . . . 0.0 109.606 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.59 157.25 86.29 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.421 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 9.4 Cg_endo -51.53 -25.9 20.65 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.775 2.983 . . . . 0.0 112.841 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -61.91 -27.46 68.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.408 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.9 t -95.68 154.11 17.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.797 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.425 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 12.6 pt -55.92 -11.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.704 0.288 . . . . 0.0 111.296 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.436 ' CD1' HG22 ' A' ' 613' ' ' ILE . 43.4 mt -109.58 124.88 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.794 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -112.46 57.1 0.66 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.57 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.628 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 tt0 -124.87 171.53 10.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.012 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.64 128.83 46.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.012 0.434 . . . . 0.0 110.846 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -111.97 141.04 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.931 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -123.93 115.93 22.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.679 0.276 . . . . 0.0 111.611 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.473 HG12 ' CD1' ' A' ' 601' ' ' PHE . 80.2 mt -82.61 108.95 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.395 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.1 OUTLIER -66.91 118.2 10.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.994 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.36 -28.45 1.33 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.44 -23.13 75.15 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.366 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.02 118.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.775 0.788 . . . . 0.0 111.502 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -139.5 122.58 10.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.929 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.8 Cg_endo -90.44 159.92 31.96 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.723 -0.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -91.95 115.28 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.536 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 32.2 m-85 -92.29 138.0 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.071 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.6 mp -124.73 145.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.625 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.09 -172.23 35.77 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.655 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.456 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -68.47 -52.31 33.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.975 0.417 . . . . 0.0 111.723 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -60.2 126.27 26.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.323 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.71 -20.13 2.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.133 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.87 -31.95 60.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.145 0.498 . . . . 0.0 110.201 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 11.4 m -70.74 130.19 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.8 m120 -44.52 -32.63 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.185 0.517 . . . . 0.0 110.39 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 25.9 t -107.35 142.3 37.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.041 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 104.55 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.48 HD12 HG22 ' A' ' 613' ' ' ILE . 24.1 mm -139.6 109.84 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.329 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -103.61 107.04 17.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.46 0.648 . . . . 0.0 112.42 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.468 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.9 t0 -129.16 107.49 9.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.602 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -40.46 -28.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -69.46 -41.28 76.42 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.514 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -89.22 159.11 17.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.75 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -78.18 173.29 12.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.222 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.511 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -46.7 -52.52 13.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.089 0.471 . . . . 0.0 110.187 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 41.6 t -114.44 70.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.291 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.514 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 11.4 t60 -48.06 -44.23 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.683 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 3.5 p -166.85 159.18 13.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 111.334 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.536 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 52.1 p90 -143.2 149.41 37.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.431 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 37.7 mt -102.14 135.16 40.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.001 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.3 t80 -128.68 134.48 48.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.3 ttmt -98.26 136.59 38.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.9 157.63 46.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.546 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.01 114.74 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.321 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 -73.89 125.06 27.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -138.87 128.05 24.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.078 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.07 176.35 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -73.86 -56.63 5.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.493 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.64 156.47 43.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 55.0 p -151.11 55.99 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.8 ttt -98.76 31.37 2.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.66 -66.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.416 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . 0.466 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 1.0 OUTLIER -75.83 144.48 41.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.316 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 2.3 m -102.11 101.35 18.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.146 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 6.0 Cg_exo -78.34 -155.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.891 2.394 . . . . 0.0 111.848 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -94.49 24.01 4.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.281 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.81 177.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 111.017 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -91.06 84.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 703' ' ' PHE . 0.7 OUTLIER -103.59 -150.25 0.41 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.988 -0.124 . . . . 0.0 110.863 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.561 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 1.0 OUTLIER -112.94 148.9 34.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.309 0.576 . . . . 0.0 112.464 -178.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.401 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -135.19 129.6 34.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.787 179.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.458 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 2.1 pt -87.16 122.85 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.355 0.598 . . . . 0.0 111.918 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.571 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.8 m95 -105.83 148.98 26.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.159 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 12.0 t80 -108.16 116.61 32.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.511 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.7 m -102.07 137.66 40.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.476 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 62.4 t60 -118.4 131.59 56.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.43 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.9 p -129.04 5.79 5.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.303 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.8 151.6 32.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.637 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 14.6 t -76.78 -44.33 33.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.016 0.436 . . . . 0.0 111.414 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.82 -18.09 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.795 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.42 ' HA ' ' NE2' ' A' ' 651' ' ' HIS . 4.4 t 78.55 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.142 0.496 . . . . 0.0 111.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.476 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 93.2 p -114.52 152.22 32.07 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -124.39 119.79 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.33 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.477 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -94.96 99.86 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.083 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 61.19 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.899 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.3 t30 -135.64 -0.44 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.466 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 1.7 m120 -101.0 135.41 42.49 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.927 0.394 . . . . 0.0 111.287 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 41.6 ttm-85 -75.59 141.17 42.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.401 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 19.5 mmm -126.32 94.61 4.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 665' ' ' ILE . 32.7 pt -87.67 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.578 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -48.8 110.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.201 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 100.96 30.78 5.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.287 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.404 HG23 ' CG1' ' A' ' 665' ' ' ILE . 13.8 p -112.78 162.28 15.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 111.348 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.9 ttpm? -143.81 133.95 24.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.477 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -139.88 143.48 36.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.812 0.339 . . . . 0.0 111.165 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.571 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.64 140.55 53.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.434 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 5.0 mt -109.43 125.98 52.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 706' ' ' GLY . 1.0 OUTLIER -107.68 147.16 31.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -48.53 103.7 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 110.465 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.67 33.62 3.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.81 118.8 30.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.533 -0.334 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -96.18 111.5 23.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 30.6 pt -105.71 137.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 112.064 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.42 116.54 30.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.894 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.449 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -84.96 -38.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 681' ' ' ILE . 3.1 tp -155.18 131.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.696 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -136.84 124.88 22.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.369 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.31 116.66 20.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.792 0.329 . . . . 0.0 110.306 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -67.36 -46.57 72.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.125 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -74.51 -40.49 61.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.917 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -87.64 -7.12 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.535 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tttt 59.13 18.18 6.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.732 0.301 . . . . 0.0 110.948 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.425 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 5.9 t80 -77.54 105.02 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.2 p -124.12 121.65 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 111.917 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.425 ' HB ' ' CG2' ' A' ' 681' ' ' ILE . 2.5 mt -128.79 150.34 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.179 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.61 138.68 3.54 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.478 ' CE2' HG13 ' A' ' 613' ' ' ILE . 7.8 m-30 -113.46 148.71 35.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.788 0.328 . . . . 0.0 110.449 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -101.33 116.95 33.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 578' ' ' LEU . 1.0 OUTLIER -81.55 123.1 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.407 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.28 109.46 9.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.589 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 705' ' ' GLU . 14.9 mt -78.39 105.53 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.703 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -47.95 11.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.22 139.83 46.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.875 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.2 p -115.68 100.5 8.08 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.117 0.484 . . . . 0.0 109.727 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.1 t -67.25 71.13 0.11 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.669 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.404 ' O ' HD11 ' A' ' 644' ' ' LEU . . . 53.82 53.55 35.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.687 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -93.08 153.57 18.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.144 0.497 . . . . 0.0 112.128 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.467 ' HA ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -55.08 -24.84 27.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.22 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.49 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 4.0 t30 -165.54 -57.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.788 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.457 ' O ' HD12 ' A' ' 696' ' ' ILE . 9.3 pt-20 164.82 -33.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.802 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 142.83 40.75 0.06 OUTLIER Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.147 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.49 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 1.0 OUTLIER -97.29 7.18 47.06 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.423 ' HA2' ' CD1' ' A' ' 671' ' ' LEU . . . 72.2 -103.64 1.35 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.884 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.413 ' HE3' ' CE2' ' A' ' 703' ' ' PHE . 8.6 mtm 65.98 71.68 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 0.0 110.712 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.28 -160.39 1.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.698 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -46.99 -71.89 0.06 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.718 0.294 . . . . 0.0 111.205 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -76.76 139.2 40.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.772 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -88.84 100.81 13.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.123 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.445 ' HD3' ' NE2' ' A' ' 673' ' ' GLN . 8.4 mmm-85 47.75 81.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.56 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.65 142.74 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.641 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 14.4 p -84.57 114.79 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.16 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.31 172.2 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -100.64 150.54 22.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -75.27 153.22 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -119.36 -179.17 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.27 -29.53 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -65.96 -50.28 64.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -51.07 66.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.916 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -56.01 -32.86 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.63 -36.77 83.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.988 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.58 -44.16 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.6 p -76.48 -27.59 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -36.02 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -100.83 33.89 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.768 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.834 0.349 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.68 72.22 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -107.79 84.86 2.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 51.9 tp -164.93 119.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.95 78.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.34 125.49 26.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 30.2 mt -67.08 152.15 96.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.954 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.575 2.184 . . . . 0.0 112.382 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.589 -0.205 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -74.59 -22.43 58.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 111.004 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 140.38 -30.51 2.32 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.263 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -106.38 136.07 46.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 7.8 t80 -122.66 -48.07 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 696' ' ' ILE . 8.2 tp -119.55 141.98 48.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 695' ' ' GLU . 40.3 m -122.39 114.53 20.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 592' ' ' LEU . 1.7 mp -105.63 108.57 20.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 8.4 ptpt -117.04 100.53 53.36 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 26.7 Cg_exo -44.77 104.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.739 1.626 . . . . 0.0 109.47 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.47 157.17 86.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.491 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 73.2 Cg_exo -49.18 -32.6 25.18 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.617 2.878 . . . . 0.0 112.891 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -21.76 66.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.88 0.371 . . . . 0.0 110.577 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.67 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 22.7 p -96.43 153.46 17.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.998 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.494 HG23 HG13 ' A' ' 588' ' ' ILE . 1.2 tt -52.49 -18.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.871 0.367 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.494 HG13 HG23 ' A' ' 587' ' ' ILE . 10.8 mt -111.25 119.78 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.162 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.67 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -110.37 57.71 0.61 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.295 0.569 . . . . 0.0 110.758 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.0 mt-10 -125.13 172.08 9.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.578 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.54 128.31 46.66 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.144 0.497 . . . . 0.0 111.474 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -113.09 138.81 49.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.831 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -123.92 115.76 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.594 HG12 ' CD2' ' A' ' 601' ' ' PHE . 46.3 mt -80.32 109.75 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.923 0.392 . . . . 0.0 111.033 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.2 mp0 -66.75 113.05 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.522 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.66 -30.68 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.05 -22.61 70.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.376 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 67.9 t -101.3 119.6 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 117.669 0.734 . . . . 0.0 111.538 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -138.66 122.73 11.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.38 160.47 32.53 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.618 -0.992 . . . . 0.0 111.994 0.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -91.6 115.68 28.25 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 51.0 m-85 -92.39 138.28 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.036 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.48 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 3.3 mp -127.15 145.42 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.588 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.09 -178.3 34.42 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.327 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.477 ' CG ' HD22 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -59.58 -52.68 64.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.88 0.372 . . . . 0.0 111.849 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.51 122.9 15.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.455 -178.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -21.04 2.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.734 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -51.9 -30.52 24.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.177 0.513 . . . . 0.0 110.08 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 95.0 m -73.57 129.37 37.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.338 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 13.4 m-80 -45.55 -29.5 1.19 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.128 0.49 . . . . 0.0 110.621 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.48 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 53.4 t -109.22 142.91 39.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.47 106.93 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.458 HG13 ' CE2' ' A' ' 692' ' ' PHE . 30.9 mm -138.14 109.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.916 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.09 107.15 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.458 0.647 . . . . 0.0 112.369 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.474 ' OD2' HG21 ' A' ' 681' ' ' ILE . 10.9 t0 -129.1 107.55 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.123 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -41.74 -31.2 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.433 ' NH1' ' CD2' ' A' ' 688' ' ' PHE . 2.0 mtt180 -77.43 -38.15 50.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.303 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -89.67 147.25 23.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.831 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.45 162.73 12.04 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.491 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -63.15 -17.69 62.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.504 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 29.4 t -137.38 55.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.528 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 6.8 t60 -47.66 -43.06 25.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.421 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.3 p -164.29 158.68 19.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 112.261 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.518 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 50.2 p90 -143.74 146.07 32.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.241 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.472 HD11 HD13 ' A' ' 594' ' ' ILE . 71.2 mt -102.18 128.62 54.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.522 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -119.49 134.68 55.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.504 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 35.4 ttmt -97.42 133.66 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.413 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.457 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.14 159.11 42.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.175 -178.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.3 tpt180 -77.07 112.43 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.282 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 -71.07 131.09 43.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.091 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -149.14 133.8 17.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.155 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 4.6 p -107.49 159.06 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.036 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -100.45 123.29 7.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.558 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.3 124.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.864 0.364 . . . . 0.0 110.967 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 50.2 m -144.74 42.62 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 90.2 mtp -59.35 134.51 57.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.036 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.2 t80 75.84 -68.47 0.2 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.231 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -77.03 131.48 38.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.072 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.5 m -106.52 90.73 5.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.73 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.08 -164.56 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.489 2.126 . . . . 0.0 112.25 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 642' ' ' GLN . . . -46.84 -28.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.628 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 18.9 mt-30 84.84 -70.73 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -177.86 95.65 0.1 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.322 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 701' ' ' GLY . 4.4 mp -129.82 -157.57 0.83 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -114.3 146.44 40.47 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.214 0.531 . . . . 0.0 112.025 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.48 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.7 OUTLIER -136.61 157.65 46.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.137 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 2.7 pt -103.8 118.73 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.462 0.649 . . . . 0.0 111.835 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.514 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 89.0 m95 -100.47 127.97 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.206 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 2.6 t80 -90.21 116.69 28.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.457 ' N ' ' O ' ' A' ' 624' ' ' PHE . 14.3 m -103.36 142.12 34.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.374 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.45 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 29.5 t60 -121.15 133.06 55.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.981 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 5.6 p -131.26 9.81 4.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.15 151.13 29.69 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.832 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.9 t -76.39 -33.91 58.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.156 0.503 . . . . 0.0 111.365 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.86 3.09 7.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.33 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 50.7 142.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.731 0.777 . . . . 0.0 112.423 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 656' ' ' VAL . 95.8 p -112.34 166.38 11.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.286 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -129.38 120.31 25.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 111.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.2 OUTLIER -103.98 99.93 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.021 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.403 ' HB2' HD13 ' A' ' 659' ' ' LEU . 1.1 t-20 63.1 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 9.0 m120 -144.91 -0.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.491 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -103.54 141.28 36.27 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.95 0.405 . . . . 0.0 111.312 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -79.6 141.97 36.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.426 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 23.1 mmm -118.04 97.86 6.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.2 pt -87.44 146.98 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -45.19 98.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.416 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.56 37.94 1.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.523 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 4.5 p -135.66 152.61 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.79 0.329 . . . . 0.0 111.336 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 15.1 pttm -123.68 158.03 32.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.282 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 662' ' ' ASN . 0.2 OUTLIER -142.59 142.49 32.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.514 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -69.81 125.48 26.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.975 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 671' ' ' LEU . 2.8 mt -101.33 136.14 41.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.383 0.611 . . . . 0.0 111.891 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.433 ' CB ' ' O ' ' A' ' 706' ' ' GLY . 0.5 OUTLIER -124.22 137.33 54.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.251 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 706' ' ' GLY . 1.8 p30 -39.8 118.81 0.91 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.955 0.407 . . . . 0.0 110.843 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.24 36.36 5.72 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.334 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.95 116.76 29.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.4 108.77 21.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.122 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 9.0 mt -107.95 130.19 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -93.79 116.07 28.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.828 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -77.96 -35.69 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.462 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.474 HG21 ' OD2' ' A' ' 615' ' ' ASP . 8.9 tt -154.8 134.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.854 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.33 123.31 21.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -120.92 117.0 26.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.552 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -67.55 -46.59 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.134 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -75.91 -40.68 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.862 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.33 -12.23 49.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.464 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.13 15.61 8.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.697 0.284 . . . . 0.0 110.873 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.459 ' CE1' HG21 ' A' ' 587' ' ' ILE . 2.3 t80 -76.86 105.12 7.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -121.46 122.43 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 112.122 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.415 HG12 ' CG2' ' A' ' 587' ' ' ILE . 7.6 mt -116.31 145.25 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.743 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -170.47 131.23 2.18 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.481 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.458 ' CE2' HG13 ' A' ' 613' ' ' ILE . 3.3 m-30 -113.81 147.03 39.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.343 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -101.2 116.91 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.491 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 675' ' ' GLY . 3.5 t -81.74 127.34 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.603 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.28 108.71 8.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 0.0 111.146 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.433 HG12 ' CD1' ' A' ' 578' ' ' LEU . 95.6 mt -73.28 105.42 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.504 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -81.16 -45.91 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 109.941 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.4 t0 -110.74 140.68 44.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.878 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 43.5 p -114.52 99.22 7.39 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.6 t -79.71 62.69 4.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.547 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 59.19 46.55 93.63 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.438 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.427 HD23 ' CE2' ' A' ' 577' ' ' PHE . 0.8 OUTLIER -64.01 143.6 57.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.703 0.287 . . . . 0.0 111.157 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 704' ' ' ASN . 2.8 p90 -40.92 -34.19 0.38 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.361 0.601 . . . . 0.0 110.839 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -138.24 -42.59 0.51 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.845 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.545 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 11.3 pt-20 137.29 -37.61 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.003 0.921 . . . . 0.0 109.11 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.585 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 126.6 14.14 2.94 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.405 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.82 -0.51 48.32 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.33 -0.512 . . . . 0.0 111.65 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.424 ' HA3' ' CD ' ' A' ' 673' ' ' GLN . . . 41.4 29.27 0.39 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.468 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.445 ' O ' ' CG ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER 45.68 62.3 2.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.733 0.301 . . . . 0.0 110.639 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.445 ' CG ' ' O ' ' A' ' 709' ' ' MET . 0.2 OUTLIER 79.11 -177.8 0.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.601 -179.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -69.01 66.21 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.992 0.425 . . . . 0.0 110.933 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.55 139.8 38.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.227 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -84.21 136.17 34.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.556 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.434 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -90.95 -145.1 0.19 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.423 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 1.5 m -140.37 142.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.48 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.79 130.12 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.862 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.01 147.21 35.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.81 147.02 30.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.36 160.07 24.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.978 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 14.8 p -126.14 -175.75 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.62 -30.93 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.37 -47.29 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.42 -49.93 69.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -57.25 -32.79 66.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.43 -36.92 82.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 12.6 mt -59.76 -44.22 93.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.088 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.5 p -81.93 -29.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -55.75 -28.9 58.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -121.58 38.24 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 602' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.818 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.735 0.302 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.23 149.21 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.045 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -170.4 100.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.99 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.07 105.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -60.02 -36.54 77.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.741 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.64 108.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.082 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.16 143.12 25.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.628 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.448 2.099 . . . . 0.0 112.397 -179.97 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -82.27 -16.28 50.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.725 0.298 . . . . 0.0 111.13 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -171.82 32.56 0.13 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.567 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.441 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.1 tmm_? -102.6 134.78 45.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.539 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -122.02 -64.98 1.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.346 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.9 tt -106.31 125.64 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.843 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 695' ' ' GLU . 24.3 m -104.68 117.2 33.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.3 OUTLIER -105.96 108.08 19.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.66 99.12 46.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.3 Cg_exo -48.25 103.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.482 1.455 . . . . 0.0 109.009 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.51 157.26 88.04 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.449 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 10.3 Cg_endo -50.92 -29.16 26.11 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.613 2.876 . . . . 0.0 112.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.72 -15.23 57.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.913 0.387 . . . . 0.0 110.219 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.53 153.71 17.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.414 HG22 ' CZ ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -50.04 -24.44 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.908 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 582' ' ' PRO . 1.5 tt -112.82 144.1 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.113 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.449 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.25 65.41 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 110.785 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.618 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 37.1 mt-10 -125.65 172.1 10.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.054 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.9 127.44 44.9 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.914 0.388 . . . . 0.0 110.99 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -112.94 143.58 43.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.966 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.441 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.39 118.08 25.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.572 HG12 ' CD2' ' A' ' 601' ' ' PHE . 55.1 mt -82.39 108.6 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.11 0.481 . . . . 0.0 110.156 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.0 mp0 -68.67 105.43 2.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.539 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -33.3 -54.23 0.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.209 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -47.39 -21.94 1.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.526 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 53.0 t -99.38 118.39 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.256 0.528 . . . . 0.0 111.293 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -140.13 123.21 10.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.127 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.4 Cg_endo -90.45 159.77 31.85 Favored 'Cis proline' 0 N--CA 1.461 -0.431 0 C-N-CA 124.411 -1.079 . . . . 0.0 111.832 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.61 115.88 28.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.502 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.7 m-85 -92.42 138.39 31.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.044 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 2.8 mp -126.4 145.79 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.668 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.62 -171.83 38.54 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.134 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.46 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -69.57 -50.2 47.02 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.498 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -60.78 131.46 50.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -59.01 -18.04 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.654 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -55.33 -32.41 62.47 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 121.081 0.467 . . . . 0.0 110.241 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 34.5 m -71.53 132.46 44.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 2.4 m-80 -47.12 -27.09 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 0.0 110.681 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 40.4 t -112.75 142.51 45.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.293 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 105.62 13.87 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.408 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 21.4 mm -138.21 109.28 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.43 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.12 106.24 16.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.556 0.693 . . . . 0.0 112.453 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.45 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.3 t0 -130.19 107.8 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.698 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -40.01 -29.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.43 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -68.93 -41.5 78.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.476 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 1.3 pp -90.12 158.8 17.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 12.8 t -76.91 162.98 27.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.049 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.447 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.7 OUTLIER -52.08 -26.68 11.65 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.441 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 37.6 t -130.71 62.7 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.559 ' CD2' HG23 ' A' ' 680' ' ' ILE . 25.1 t60 -51.8 -47.22 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.381 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.1 p -165.01 162.5 20.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.234 0.54 . . . . 0.0 112.138 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 53.8 p90 -143.59 147.31 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.766 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.35 130.57 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.021 0.438 . . . . 0.0 109.981 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.517 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -122.12 133.62 54.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.607 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 30.9 ttmt -97.72 136.99 37.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.23 158.82 43.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.947 -178.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.2 tpt180 -76.64 112.34 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.1 t60 -66.79 132.38 47.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.384 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -179.73 148.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.041 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 5.7 m -115.92 -179.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -68.29 74.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.605 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.9 177.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.031 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 2.1 t -145.26 131.23 19.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.731 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 11.1 mtm -143.29 29.96 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 638' ' ' GLU . 10.8 p90 -178.39 -47.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.794 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 637' ' ' TYR . 1.7 tp10 -104.68 144.83 31.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.671 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.89 90.49 1.95 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 61.5 Cg_endo -71.49 -159.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.701 2.267 . . . . 0.0 112.183 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.431 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . -54.57 -20.36 7.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.973 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.424 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 1.7 mt-30 83.36 -66.53 0.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.368 0.267 . . . . 0.0 110.901 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 172.9 65.2 0.05 OUTLIER Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.443 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.493 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.7 mp -118.85 -158.5 0.73 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -118.48 146.62 44.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.15 0.5 . . . . 0.0 111.885 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.403 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 2.2 t0 -129.72 160.07 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.438 HG22 ' CE2' ' A' ' 577' ' ' PHE . 1.4 pt -108.66 120.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.479 0.657 . . . . 0.0 111.724 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.588 ' CH2' HD21 ' A' ' 671' ' ' LEU . 67.5 m95 -106.43 127.3 53.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.065 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -90.54 117.61 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.412 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -101.79 130.09 48.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.162 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.458 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 66.2 t60 -109.3 133.74 52.67 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -131.02 1.27 4.26 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.427 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.95 149.63 36.42 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.72 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.8 t -74.57 -32.37 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.451 . . . . 0.0 111.534 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 656' ' ' VAL . 3.5 m-20 -73.13 1.86 8.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.461 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.82 126.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.28 0.562 . . . . 0.0 111.89 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.458 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 8.7 t -96.43 165.93 11.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.255 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -130.53 121.28 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.866 0.365 . . . . 0.0 111.265 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.51 99.47 11.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.9 m120 60.7 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -129.55 -0.27 4.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.488 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.472 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 10.8 m120 -100.89 141.99 32.99 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.888 0.375 . . . . 0.0 111.107 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.6 141.54 32.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 11.5 mmm -123.89 101.21 7.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.812 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.4 ' O ' ' OG1' ' A' ' 668' ' ' THR . 50.7 pt -89.64 161.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.21 98.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.76 44.8 1.18 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 1.2 p -127.62 162.25 26.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.32 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.47 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -129.92 149.03 51.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.398 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.472 ' CE2' ' CB ' ' A' ' 662' ' ' ASN . 4.3 t80 -147.26 145.34 29.38 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.588 HD21 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 129.05 38.8 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.596 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.408 ' CB ' ' CD1' ' A' ' 647' ' ' ILE . 1.2 mt -108.74 119.94 41.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.291 0.567 . . . . 0.0 111.474 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 0.9 OUTLIER -110.15 144.0 39.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.24 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 706' ' ' GLY . 68.3 t0 -43.06 123.93 3.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.772 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.15 7.39 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.401 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -95.23 112.85 24.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.372 . . . . 0.0 111.502 -179.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.75 108.66 21.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.053 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 11.2 mt -106.89 136.89 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.0 111.958 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -96.12 116.15 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.478 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.559 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.3 mt -83.71 -34.07 10.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.793 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.431 ' CG2' ' HB ' ' A' ' 690' ' ' ILE . 2.1 tp -154.86 131.58 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.102 0.477 . . . . 0.0 112.097 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.73 130.04 31.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -127.1 117.63 22.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.797 0.332 . . . . 0.0 110.735 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -66.97 -46.61 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.101 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -76.39 -40.52 50.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -88.8 -11.09 45.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.42 16.76 7.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CZ ' HG22 ' A' ' 587' ' ' ILE . 15.5 t80 -76.9 105.44 7.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.31 125.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.908 0.385 . . . . 0.0 111.986 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.431 ' HB ' ' CG2' ' A' ' 681' ' ' ILE . 13.1 mt -123.8 153.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.178 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -176.59 138.2 3.93 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.278 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.436 ' CD1' ' HG3' ' A' ' 582' ' ' PRO . 1.8 m-30 -113.45 147.08 38.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 0.0 110.541 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.27 117.23 34.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.477 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 676' ' ' ASP . 3.9 t -80.29 123.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 579' ' ' THR . 24.3 tt0 -132.64 109.38 9.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.448 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.423 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 54.6 mt -78.66 106.08 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.24 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.58 -45.26 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.37 140.93 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 37.7 p -114.58 100.14 8.06 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.184 0.516 . . . . 0.0 109.998 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 6.0 t -78.21 61.01 2.61 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.544 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.63 57.26 20.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.996 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.16 141.72 30.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.976 0.417 . . . . 0.0 111.523 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.52 ' CD2' ' HB3' ' A' ' 704' ' ' ASN . 5.7 p90 -37.79 -48.76 1.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.619 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.52 ' HB3' ' CD2' ' A' ' 703' ' ' PHE . 0.1 OUTLIER -142.6 1.94 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.068 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 704' ' ' ASN . 1.4 pt-20 88.67 -45.06 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.028 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 127.46 28.6 0.89 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.565 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.42 ' CD1' ' O ' ' A' ' 707' ' ' LEU . 0.1 OUTLIER -88.49 8.19 29.23 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 90.86 66.83 1.18 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.134 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.68 141.69 9.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 111.269 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -31.97 133.38 0.1 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.809 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.13 52.66 12.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.2 0.524 . . . . 0.0 110.302 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.04 121.79 14.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.961 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.13 100.54 9.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.817 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -95.37 72.25 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.763 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.0 m -124.2 143.72 36.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.479 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 27.7 t -77.74 120.26 28.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.923 0.392 . . . . 0.0 111.643 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.92 168.31 12.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.484 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.16 146.29 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.01 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -82.29 151.65 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 71.0 p -126.05 -179.19 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.28 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.86 -30.13 57.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.36 -51.1 70.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.65 -50.71 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.695 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -55.86 -32.71 63.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -66.66 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.348 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.0 mt -58.34 -44.58 88.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 111.112 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.6 -25.04 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -36.25 65.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.057 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -97.81 30.22 3.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.413 HD13 ' CG ' ' A' ' 602' ' ' PHE . 5.6 tt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.79 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.819 0.342 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.72 121.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -144.86 31.03 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.818 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.84 176.87 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . 0.411 ' CG2' ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.77 74.9 9.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -59.59 125.89 25.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.772 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 9.9 mt -89.62 154.7 48.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 122.607 2.205 . . . . 0.0 112.271 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -69.94 -22.17 63.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.311 . . . . 0.0 111.057 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 178.01 47.95 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.827 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' CB ' ' A' ' 593' ' ' GLU . 5.1 tmm_? -94.45 124.9 38.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.924 0.392 . . . . 0.0 110.23 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -110.2 -61.89 1.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.247 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.519 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.3 tt -106.93 142.71 36.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 24.5 m -113.04 114.26 26.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.044 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.6 OUTLIER -106.75 108.6 20.2 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 10.9 ptpt -118.74 101.59 50.36 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.6 Cg_exo -45.34 105.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.842 1.695 . . . . 0.0 109.239 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.66 157.31 86.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.461 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.9 Cg_endo -53.65 -27.4 41.72 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.807 3.005 . . . . 0.0 112.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.08 -24.28 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.475 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 1.8 t -96.02 153.96 17.49 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.207 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 690' ' ' ILE . 14.9 pt -55.29 -14.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.312 . . . . 0.0 111.022 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 35.4 mt -107.36 125.2 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.665 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.461 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.32 58.22 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.446 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.551 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.6 mp0 -125.28 168.76 13.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.613 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.23 121.59 25.06 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.381 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.3 mm? -113.34 150.73 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.423 ' CB ' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.72 117.09 23.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.49 HG12 ' CD2' ' A' ' 601' ' ' PHE . 66.2 mt -74.46 108.7 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -69.05 111.12 4.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.291 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.498 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -38.81 -52.12 1.72 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.281 0.563 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -46.94 -24.74 2.09 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.234 -0.893 . . . . 0.0 113.14 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.09 117.89 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.287 0.543 . . . . 0.0 110.916 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -140.18 122.33 9.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.058 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.541 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -89.76 159.93 35.32 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 124.407 -1.08 . . . . 0.0 111.54 -0.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.8 t80 -91.55 114.61 27.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.498 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 6.1 m-85 -92.2 138.08 31.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.574 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.5 mp -124.02 148.34 28.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.47 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.41 -171.54 36.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.347 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.459 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.58 -52.58 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 111.644 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.58 133.54 56.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.319 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -57.95 -19.25 28.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.772 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.51 -31.44 56.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.063 0.459 . . . . 0.0 110.258 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 8.6 m -73.56 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.447 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -43.36 -32.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.235 0.54 . . . . 0.0 110.408 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.574 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 34.8 t -106.48 142.01 36.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.007 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.85 104.71 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.406 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.3 mm -139.14 109.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.194 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.9 106.75 17.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.424 0.631 . . . . 0.0 112.432 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.455 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.5 t0 -129.46 107.59 9.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.55 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -40.68 -28.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 688' ' ' PHE . 9.3 mmt180 -69.38 -41.47 76.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -89.19 158.62 17.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.912 0.387 . . . . 0.0 111.527 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 73.1 m -78.97 170.58 16.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.367 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -46.93 -42.58 17.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.51 69.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.289 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.632 ' O ' ' N ' ' A' ' 653' ' ' GLY . 17.7 t60 -50.49 -47.05 57.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.745 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.2 p -164.6 163.35 21.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.119 0.485 . . . . 0.0 111.986 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.498 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 53.3 p90 -144.18 151.03 38.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.877 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.441 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 3.8 mp -102.71 132.89 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -124.17 132.54 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.872 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.411 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 29.9 ttmt -98.17 136.56 38.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.18 158.75 39.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -76.61 114.49 15.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.235 0.54 . . . . 0.0 110.412 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.9 t60 -81.58 130.02 34.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.771 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -157.29 159.84 37.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.169 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 10.4 m -109.23 169.42 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.04 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -74.64 95.81 0.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.596 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 8.8 pttp 43.13 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.337 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.8 144.61 8.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.192 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.5 131.4 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.793 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 7.6 t80 69.35 -65.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.961 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -76.05 143.93 41.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.944 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 6.8 m -105.66 101.43 32.42 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -87.46 -163.14 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.84 2.36 . . . . 0.0 112.04 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -95.8 28.59 3.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.329 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 58.78 -168.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.019 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.415 ' HA3' ' NE ' ' A' ' 629' ' ' ARG . . . -89.88 91.04 1.66 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.542 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -105.18 -153.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 p-10 -122.15 147.62 45.93 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.013 0.435 . . . . 0.0 112.041 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.433 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -131.64 155.38 47.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.389 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.47 HG23 ' CE2' ' A' ' 577' ' ' PHE . 1.3 pt -104.26 129.16 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.606 0.717 . . . . 0.0 112.702 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.538 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 96.1 m95 -113.49 128.57 56.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.215 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 4.7 t80 -90.32 117.29 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 63.2 m -102.78 130.24 49.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.873 0.368 . . . . 0.0 111.271 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.462 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -109.48 128.22 55.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.207 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.445 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.7 p -126.95 8.98 6.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.206 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.54 151.82 31.42 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.155 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.5 m -83.97 -17.17 41.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.578 0.227 . . . . 0.0 111.49 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.403 ' CB ' ' CD1' ' A' ' 681' ' ' ILE . 2.1 m120 -87.22 -5.51 58.93 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 664' ' ' MET . 6.6 t 74.8 145.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.122 0.486 . . . . 0.0 112.284 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.462 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 61.8 p -119.2 160.3 22.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 679' ' ' LYS . 21.8 m-85 -138.29 120.4 15.64 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.2 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -94.59 103.72 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.564 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 67.75 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -134.86 -3.68 2.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.52 140.79 29.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.878 0.371 . . . . 0.0 111.099 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -83.88 141.53 31.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.929 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.426 ' O ' ' CG1' ' A' ' 656' ' ' VAL . 27.6 mtp -131.92 107.17 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 26.5 pt -86.72 164.73 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.124 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 652' ' ' THR . 36.1 tt0 -50.58 110.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.06 31.7 4.95 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.952 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 9.4 p -112.7 162.57 15.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.594 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.441 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -137.37 144.35 42.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.493 ' CD2' HD13 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.26 144.14 28.63 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.632 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.538 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.23 136.02 51.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.67 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 1.1 mt -107.48 106.72 17.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.117 0.484 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.489 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 16.4 mt-30 -93.48 141.08 28.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.492 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 706' ' ' GLY . 1.6 p30 -41.52 112.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 91.28 37.6 6.19 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 124.39 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.353 -0.424 . . . . 0.0 111.101 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -96.31 109.07 21.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.409 HG23 HD22 ' A' ' 659' ' ' LEU . 12.0 pt -105.41 132.83 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.076 0.465 . . . . 0.0 111.768 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 658' ' ' TYR . 12.3 mttp -93.72 115.88 28.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.633 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.414 ' CG2' HG22 ' A' ' 681' ' ' ILE . 1.3 tt -78.01 -34.79 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.125 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.414 HG22 ' CG2' ' A' ' 680' ' ' ILE . 0.9 OUTLIER -154.33 131.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.029 179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.619 ' CD1' ' CG1' ' A' ' 689' ' ' VAL . 11.7 t90 -136.02 113.25 10.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -128.57 114.07 16.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.834 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.59 -42.26 78.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -58.58 -40.16 82.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.258 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -76.08 -19.31 58.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.71 15.85 9.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.196 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 617' ' ' ARG . 0.2 OUTLIER -117.73 125.27 50.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.566 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.619 ' CG1' ' CD1' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -119.21 136.52 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.2 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 587' ' ' ILE . 7.2 mt -128.73 115.82 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.325 0.583 . . . . 0.0 110.464 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.475 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -139.75 147.01 18.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.883 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.08 145.01 41.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -101.59 116.91 33.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.3 t -82.36 114.99 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.957 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.24 108.99 12.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.995 0.426 . . . . 0.0 110.257 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.452 HD11 ' HB3' ' A' ' 674' ' ' ASP . 25.4 mt -79.4 122.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.294 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -105.1 -42.61 5.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.708 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.52 140.96 44.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.112 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.5 p -114.28 100.26 8.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.319 0.581 . . . . 0.0 110.025 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.3 m -72.29 65.42 0.61 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.798 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 66.15 32.83 83.48 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.142 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -79.06 134.31 36.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.746 0.308 . . . . 0.0 111.434 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.514 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 2.5 p90 -42.76 -33.38 0.73 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.411 0.624 . . . . 0.0 110.563 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.572 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 0.9 OUTLIER -153.6 -49.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.501 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 12.4 pt-20 137.5 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.124 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 141.8 86.76 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.3 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -104.93 -9.73 17.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.368 0.584 . . . . 0.0 111.738 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 81.48 47.55 6.34 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.481 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.28 114.38 28.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.361 . . . . 0.0 110.966 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.73 172.86 2.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.772 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -59.56 -65.04 0.74 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -66.9 140.03 57.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.747 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -90.72 100.18 13.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.144 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.475 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 6.1 mmm-85 39.57 86.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.801 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.78 142.92 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 46.7 t -85.69 118.19 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.138 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.1 mp -91.8 172.28 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -103.25 148.31 25.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.04 157.71 22.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -178.47 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.51 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.93 -52.33 64.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -65.68 -46.65 78.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.44 -32.75 67.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.13 -36.92 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 9.2 mt -59.55 -44.54 93.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.033 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.9 p -81.64 -23.96 9.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -54.44 -34.93 62.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -100.18 31.16 3.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.801 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.426 HD12 ' CD2' ' A' ' 602' ' ' PHE . 3.7 tt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.673 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.884 0.373 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 23.3 t -153.96 93.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.0 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -127.17 32.66 5.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.998 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.76 166.48 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.48 82.75 2.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.764 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -57.35 137.44 56.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.026 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.11 98.45 11.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.405 2.07 . . . . 0.0 112.222 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -74.3 -20.45 60.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.654 0.264 . . . . 0.0 111.05 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 118.23 -29.76 6.32 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.264 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.1 tmm_? -105.24 135.92 45.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 6.0 t80 -121.46 -52.98 2.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.481 HD12 HG12 ' A' ' 696' ' ' ILE . 11.9 tp -112.22 142.32 44.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.023 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 695' ' ' GLU . 19.4 m -120.3 114.06 21.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' A' ' 694' ' ' VAL . 3.1 mp -107.18 108.94 20.62 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.9 pttt -114.45 100.76 53.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -44.9 102.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.787 1.658 . . . . 0.0 109.518 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.22 159.54 83.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.541 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 6.3 Cg_endo -48.69 -30.56 16.95 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.783 2.988 . . . . 0.0 112.989 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.55 -17.72 63.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.063 0.459 . . . . 0.0 109.89 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.579 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 23.8 t -95.46 153.32 17.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.438 HD11 ' CE1' ' A' ' 688' ' ' PHE . 20.9 pt -59.24 -19.24 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 109.972 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 5.4 mt -112.55 118.54 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.6 OUTLIER -106.04 66.0 0.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.374 0.607 . . . . 0.0 110.462 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.591 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.0 mt-10 -125.57 172.34 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.758 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.44 125.6 40.85 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.175 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -112.41 138.63 48.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.837 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.31 114.44 19.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.611 0.243 . . . . 0.0 111.398 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.63 HG12 ' CD2' ' A' ' 601' ' ' PHE . 46.1 mt -72.36 109.36 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.819 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.6 OUTLIER -64.14 110.13 2.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.45 -29.64 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.028 0.442 . . . . 0.0 111.022 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.78 -22.51 73.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.378 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 63.4 t -101.28 119.31 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 117.712 0.756 . . . . 0.0 111.465 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -138.94 123.37 11.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.884 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.526 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 46.0 Cg_endo -90.11 160.82 34.04 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 124.672 -0.97 . . . . 0.0 111.99 0.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.63 ' CD2' HG12 ' A' ' 594' ' ' ILE . 2.6 t80 -91.94 114.68 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.541 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 22.2 m-85 -92.29 138.21 31.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.702 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.474 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.7 mp -126.46 145.54 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.69 -175.03 36.6 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.43 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.458 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -65.45 -47.73 75.13 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 111.38 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.82 127.17 30.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.355 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -58.18 -17.35 18.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.92 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.36 -30.77 67.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.027 0.442 . . . . 0.0 110.186 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 62.3 m -70.61 133.44 46.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.63 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.536 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -47.47 -28.32 2.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 43.1 t -111.96 142.16 44.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.28 105.27 13.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.421 HG13 ' CE2' ' A' ' 692' ' ' PHE . 25.0 mm -139.09 109.73 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.027 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -104.4 107.16 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.472 0.653 . . . . 0.0 112.548 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.454 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.4 t0 -129.38 107.56 9.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.766 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -40.0 -29.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.551 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 1.3 pp -89.66 158.85 17.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.549 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.8 164.94 25.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.621 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.428 ' HG2' ' CG2' ' A' ' 621' ' ' VAL . 0.0 OUTLIER -53.06 -25.7 13.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.989 0.423 . . . . 0.0 110.369 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.428 ' CG2' ' HG2' ' A' ' 620' ' ' ARG . 47.1 t -131.67 64.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.551 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 8.0 t60 -49.0 -43.77 40.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.227 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.5 p -167.13 161.42 14.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.0 111.902 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.541 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.2 p90 -143.54 148.3 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.593 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.428 HD11 HD13 ' A' ' 594' ' ' ILE . 75.2 mt -102.25 136.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.6 t80 -127.25 135.08 50.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 1.2 tppp? -97.16 136.82 37.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 158.73 43.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.753 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.8 OUTLIER -77.32 112.75 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.424 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.7 t-160 -82.87 122.84 28.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.828 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -142.77 160.69 39.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 5.8 m -119.88 165.25 15.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -97.64 107.01 3.4 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.327 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 6.4 tttp 63.24 140.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.9 p -126.68 106.33 9.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.2 mtp -94.38 117.07 29.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.74 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 67.25 -74.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.795 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.25 144.17 38.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 9.0 t -112.38 95.36 30.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.961 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 -154.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.574 2.183 . . . . 0.0 112.165 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -54.45 -23.09 14.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.524 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 71.97 -65.04 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.411 ' CA ' ' NE ' ' A' ' 629' ' ' ARG . . . -179.96 79.41 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.731 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.3 mt -121.87 -155.34 0.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 1.6 m-20 -112.43 147.96 35.36 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.444 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -138.03 131.78 31.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.662 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 578' ' ' LEU . 4.6 pt -87.4 123.82 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.537 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 88.0 m95 -104.84 144.09 32.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.871 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -104.38 117.15 33.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 624' ' ' PHE . 25.4 m -105.47 130.02 53.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.482 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.443 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 60.4 t60 -108.78 133.08 53.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.22 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.6 p -130.08 6.32 4.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.249 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.43 150.69 31.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.692 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.9 t -73.64 -35.81 65.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 111.455 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m-80 -70.7 -1.77 12.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.307 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 53.65 125.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.218 0.532 . . . . 0.0 111.786 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.3 p -90.65 165.71 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 89.4 m-85 -128.17 120.27 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.68 100.53 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.33 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 61.4 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -134.44 3.74 3.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.711 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.416 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.8 m-80 -107.12 141.23 38.7 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -80.72 141.21 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 35.1 mmm -119.12 102.36 8.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.1 pt -87.86 150.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.276 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -44.31 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.445 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.6 43.35 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.655 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.04 162.13 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.417 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -131.41 146.28 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.452 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -147.72 144.88 28.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.537 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.06 134.8 49.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.206 179.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 1.1 mt -109.96 98.11 7.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.155 0.502 . . . . 0.0 111.504 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 12.3 mt-30 -83.49 141.73 31.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.508 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 706' ' ' GLY . 19.5 t0 -46.54 111.42 0.38 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.972 0.415 . . . . 0.0 110.269 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 102.29 36.5 3.58 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.75 31.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 111.176 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.61 108.7 21.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.002 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 10.4 mt -105.97 133.92 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 111.938 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 7.8 mttt -96.65 116.14 28.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.72 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.454 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -80.3 -38.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.204 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 681' ' ' ILE . 1.5 tp -155.37 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.408 . . . . 0.0 111.615 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -136.09 127.28 28.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.18 117.25 21.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -66.73 -46.58 75.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.068 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -81.33 -40.22 23.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.821 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.69 -10.7 59.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.592 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.99 19.52 8.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.438 ' CE1' HD11 ' A' ' 587' ' ' ILE . 4.6 t80 -83.14 105.03 13.78 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.434 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -125.71 122.48 62.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.163 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.524 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 2.7 mt -128.78 119.32 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.37 137.19 7.42 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.801 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.466 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.25 143.75 43.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.673 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.07 116.7 33.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.753 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.453 ' CG2' ' HG ' ' A' ' 580' ' ' LEU . 2.7 t -84.87 125.79 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 25.7 tt0 -134.03 109.28 8.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.786 0.327 . . . . 0.0 111.404 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 578' ' ' LEU . 84.5 mt -69.85 105.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.031 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -85.58 -48.78 8.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.475 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 11.3 t0 -111.9 142.11 44.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.871 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 701' ' ' GLY . 66.9 p -113.82 101.29 9.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 24.3 m -65.81 61.75 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.257 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 49.73 42.13 36.23 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.704 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.607 ' CD1' ' HA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -99.21 -176.91 3.44 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.02 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.512 ' C ' ' H ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -60.6 -143.24 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.729 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.464 ' N ' ' CG ' ' A' ' 703' ' ' PHE . 0.8 OUTLIER -56.49 2.57 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.607 ' HA ' ' CD1' ' A' ' 702' ' ' LEU . 0.5 OUTLIER 82.91 -54.63 0.18 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.841 0.353 . . . . 0.0 110.109 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 162.23 74.01 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.475 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.455 ' H ' ' ND2' ' A' ' 704' ' ' ASN . 3.3 mm? -105.49 -10.0 17.16 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.76 -0.259 . . . . 0.0 111.457 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 97.12 31.95 6.66 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.409 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.19 121.68 28.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.33 . . . . 0.0 110.895 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 178.91 166.09 0.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -68.17 -54.19 19.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.769 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 140.22 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.705 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -82.83 100.12 10.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.102 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.452 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.5 mmm-85 37.42 88.16 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.975 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.68 143.51 37.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.783 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 61.3 t -84.38 129.09 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.206 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.6 mp -98.42 165.06 12.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.707 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.88 135.61 43.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -73.36 154.34 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 43.1 p -126.0 -174.62 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.198 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.8 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.8 -51.89 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.757 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.26 -48.79 72.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.796 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -56.25 -32.8 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.84 -37.01 83.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.065 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 11.9 mt -59.93 -44.12 94.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.998 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 1.6 t -77.02 -26.1 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.247 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -55.25 -33.75 63.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.849 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -99.4 30.83 3.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.804 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.444 HD12 ' CD1' ' A' ' 602' ' ' PHE . 5.5 tt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.787 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.776 0.322 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 17.1 t -117.31 77.72 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.981 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -175.82 37.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.986 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.21 120.7 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -47.83 83.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.853 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 62.12 150.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 8.8 mt -123.02 80.79 50.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 C--O 1.249 1.061 0 C-N-CA 122.581 2.188 . . . . 0.0 112.259 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -87.38 -22.08 25.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.688 0.28 . . . . 0.0 111.108 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 174.89 40.12 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.993 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.437 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 45.5 ttp180 -111.99 124.24 51.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 11.0 t80 -107.25 -55.64 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.611 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.429 HD12 ' CG1' ' A' ' 694' ' ' VAL . 10.2 tp -111.51 141.99 44.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.781 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 695' ' ' GLU . 18.5 m -124.78 113.97 18.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 592' ' ' LEU . 1.6 mp -105.54 108.81 20.52 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -112.7 99.62 48.28 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.101 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.6 Cg_exo -44.6 99.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.864 1.709 . . . . 0.0 109.612 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -74.77 157.45 85.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.52 -25.66 11.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.832 3.021 . . . . 0.0 113.166 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -28.12 69.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.0 OUTLIER -95.98 154.0 17.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.624 178.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.46 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 5.4 pt -58.57 -10.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.732 0.301 . . . . 0.0 110.91 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.401 ' CD1' HG21 ' A' ' 613' ' ' ILE . 41.1 mt -106.96 118.81 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -109.08 57.44 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.213 0.53 . . . . 0.0 110.106 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.617 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.2 mm-40 -124.49 171.91 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.162 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.26 122.99 33.02 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.041 0.448 . . . . 0.0 111.233 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -112.67 132.68 55.07 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.437 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -123.95 121.8 36.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.52 HG12 ' CD2' ' A' ' 601' ' ' PHE . 86.9 mt -74.09 108.96 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.137 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.5 ' O ' ' C ' ' A' ' 596' ' ' GLN . 1.1 mp0 -70.54 81.5 0.58 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -7.53 -62.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.583 0.753 . . . . 0.0 112.788 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . -44.69 -21.2 0.27 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.838 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.61 118.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 117.432 0.616 . . . . 0.0 111.067 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -139.62 123.63 10.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.558 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 49.3 Cg_endo -90.66 159.85 30.86 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 124.454 -1.061 . . . . 0.0 111.798 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.7 t80 -92.08 114.72 27.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.558 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 49.8 m-85 -92.31 138.02 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.733 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.48 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.7 mp -125.88 144.54 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.739 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.09 -169.44 36.68 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.42 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.486 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -69.81 -52.86 21.44 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.819 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.28 130.0 44.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -56.7 -18.63 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.949 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.96 -31.91 61.01 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.15 0.5 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.425 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 73.1 m -71.82 132.72 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.583 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 14.0 m-80 -47.95 -28.43 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.46 . . . . 0.0 110.558 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 42.8 t -111.07 142.79 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.48 105.23 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.488 HG13 ' CE2' ' A' ' 692' ' ' PHE . 34.1 mm -139.39 109.62 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.961 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.48 106.57 17.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.445 0.641 . . . . 0.0 112.652 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.2 t0 -130.35 107.91 9.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.721 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -39.28 -30.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.7 OUTLIER -68.6 -41.01 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.536 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -89.22 159.05 17.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.802 0.334 . . . . 0.0 111.428 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.3 t -80.57 166.05 21.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.376 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 2.9 mpt_? -47.23 -37.14 9.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.374 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 13.1 t -122.95 63.59 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.536 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 9.4 t60 -48.74 -42.97 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.833 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.6 p -167.79 157.73 10.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.507 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 50.1 p90 -143.14 146.0 33.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.687 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.414 HD11 HD23 ' A' ' 580' ' ' LEU . 60.5 mt -102.14 129.27 53.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.323 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.5 t80 -120.83 135.1 55.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.398 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.438 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 25.1 ttmt -97.66 134.34 40.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.961 0.41 . . . . 0.0 110.394 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.46 158.37 44.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.759 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -77.43 111.9 13.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.935 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.2 t60 -67.96 125.73 27.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.107 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . 179.92 114.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.933 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 29.0 m -55.21 156.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.214 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -53.59 -27.91 35.89 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.666 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -169.29 115.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 110.784 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.82 134.47 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.0 tpt -90.01 84.3 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 61.73 -84.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.767 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -114.38 103.47 11.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 5.9 p -138.64 156.09 73.22 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.026 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.86 -162.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.588 2.192 . . . . 0.0 111.839 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 78.76 -56.55 0.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.508 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 69.3 -69.19 0.17 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.883 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 153.96 61.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.794 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.1 mp -115.15 -165.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.4 OUTLIER -113.14 147.0 38.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.433 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -133.54 153.0 51.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 672' ' ' LEU . 2.9 pt -100.64 119.02 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.304 0.573 . . . . 0.0 111.524 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.533 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 84.8 m95 -100.63 127.84 46.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.453 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -90.29 117.59 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 624' ' ' PHE . 7.9 m -104.13 136.98 42.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.444 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -115.88 127.52 55.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.206 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.8 p -125.86 10.96 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.198 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.29 159.61 41.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.261 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.0 m -88.09 -19.17 27.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.677 0.275 . . . . 0.0 111.46 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 656' ' ' VAL . 3.4 m-80 -87.01 2.7 48.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.8 128.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.35 0.595 . . . . 0.0 112.083 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.444 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 87.5 p -100.28 165.74 11.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.341 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -129.79 120.65 25.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.28 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.477 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -94.42 102.59 14.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 61.57 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -131.56 -5.65 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -97.84 141.37 30.91 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 111.095 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.416 ' O ' HG21 ' A' ' 716' ' ' VAL . 29.1 ttp180 -81.86 141.0 33.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.403 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 13.3 mmm -120.89 99.64 6.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.411 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 42.3 pt -87.59 154.28 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -45.62 107.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.313 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.12 35.88 3.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.61 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.407 ' CG2' HG12 ' A' ' 665' ' ' ILE . 3.4 p -119.89 162.28 19.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.184 0.516 . . . . 0.0 111.686 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.432 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.4 ttpm? -130.4 148.79 52.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.007 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.591 ' CZ ' ' HG2' ' A' ' 714' ' ' ARG . 2.4 t80 -147.25 143.94 28.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.533 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -74.05 130.57 40.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.193 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 0.7 OUTLIER -97.07 139.64 32.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.28 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.69 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 7.6 mt-30 -124.9 131.5 53.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.075 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.473 ' HB3' ' HG ' ' A' ' 707' ' ' LEU . 40.3 t0 -42.93 104.0 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 110.581 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 106.19 33.77 3.35 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.51 113.86 25.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.382 . . . . 0.0 111.324 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -95.66 111.91 23.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.42 HG12 HD12 ' A' ' 659' ' ' LEU . 4.3 mt -104.92 137.04 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.062 0.458 . . . . 0.0 111.855 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -93.14 115.98 28.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.803 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.474 HG22 ' CD2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -85.47 -35.48 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 681' ' ' ILE . 2.7 tp -154.97 131.33 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.072 0.463 . . . . 0.0 111.826 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -137.11 125.35 23.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -127.15 116.81 21.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.884 0.373 . . . . 0.0 110.266 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -46.84 71.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.21 -40.68 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.84 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -87.24 -8.7 56.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? 60.71 17.94 8.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.46 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 6.7 t80 -77.08 104.59 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -124.51 122.17 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 111.813 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.404 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 7.0 mt -128.18 151.43 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.517 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.416 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 178.26 137.83 2.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.091 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.526 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 1.8 m-30 -114.5 150.33 35.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.732 0.301 . . . . 0.0 110.738 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . 0.426 ' HB2' HD13 ' A' ' 583' ' ' LEU . 6.5 tttt -101.16 116.62 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.633 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 675' ' ' GLY . 3.6 t -79.56 124.72 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.686 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.05 108.75 8.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.483 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 58.1 mt -69.67 105.6 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.04 -47.06 16.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.697 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.468 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 80.6 m-20 -111.08 140.98 45.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 82.8 p -114.32 99.9 7.94 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.7 t -80.32 59.05 3.28 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.97 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.56 60.78 7.92 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.068 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -80.8 144.91 31.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.594 0.235 . . . . 0.0 110.949 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.451 ' CG ' ' N ' ' A' ' 704' ' ' ASN . 4.1 p90 -39.13 -44.58 1.19 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.254 0.55 . . . . 0.0 111.346 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -120.57 -28.08 5.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.844 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 15.8 pt-20 140.63 -17.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.421 1.088 . . . . 0.0 108.618 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.69 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 110.46 12.28 17.52 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.591 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 674' ' ' ASP . 0.4 OUTLIER -103.28 8.11 38.34 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.429 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 89.84 -113.05 4.12 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.562 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 2.4 ptp -173.57 110.42 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.941 0.4 . . . . 0.0 111.22 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 42.0 50.05 4.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.139 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 49.63 27.95 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.445 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -74.12 141.32 45.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.957 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.23 135.96 35.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.402 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.591 ' HG2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -96.13 -150.65 0.33 Allowed 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 120.954 0.406 . . . . 0.0 110.237 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.47 166.92 3.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.692 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 663' ' ' ARG . 12.0 t -98.44 114.19 35.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.267 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.86 168.37 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.84 146.6 27.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -80.66 154.87 27.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -123.77 -177.26 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.26 -30.76 62.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -64.83 -49.9 68.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -50.62 67.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.0 -32.55 69.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.049 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -62.8 -39.93 95.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.003 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 3.2 mt -61.04 -44.56 97.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.5 p -72.56 -25.51 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -65.11 -34.33 78.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.266 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -79.83 -16.86 54.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.946 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 8.2 tt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.068 -179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.93 0.395 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.01 51.43 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.091 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.3 64.75 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 1.7 pp -159.63 163.7 34.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.764 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -41.23 98.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.939 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 53.75 106.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.023 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . 0.49 ' N ' ' CD ' ' P' ' 607' ' ' PRO . 14.8 mt -76.29 -45.5 3.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.454 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' P' ' 606' ' ' LEU . 77.9 Cg_exo . . . . . 0 C--O 1.248 0.988 0 C-N-CA 122.291 1.994 . . . . 0.0 112.331 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -89.39 9.41 26.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.536 0.208 . . . . 0.0 111.379 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.452 ' C ' ' HG2' ' A' ' 596' ' ' GLN . . . 166.74 36.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.15 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 577' ' ' PHE . 3.1 tmm_? -115.1 129.77 56.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.765 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.713 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -115.31 -57.42 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.371 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.511 HD13 HG12 ' A' ' 696' ' ' ILE . 24.0 tp -106.59 142.21 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.656 0.265 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 695' ' ' GLU . 8.3 m -123.57 113.03 18.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.0 OUTLIER -107.9 107.84 18.74 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.5 mtpt -109.57 99.59 38.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -175.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.636 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.3 Cg_exo -46.67 108.92 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.56 1.507 . . . . 0.0 108.722 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.71 156.77 88.19 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.49 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 13.9 Cg_endo -56.24 -25.89 58.29 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.639 2.893 . . . . 0.0 112.825 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -63.31 -20.51 65.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.191 0.52 . . . . 0.0 109.653 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.439 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.4 t -97.38 153.84 17.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.759 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.489 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 5.2 pt -52.68 -21.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 109.908 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 48.1 mt -106.71 118.74 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.845 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -114.38 63.67 0.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.572 0.701 . . . . 0.0 109.773 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.636 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 17.6 mt-10 -125.24 173.25 8.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.455 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.15 116.52 21.48 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.691 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -113.43 128.03 56.31 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -124.98 131.21 53.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 601' ' ' PHE . 67.0 mt -71.44 109.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.17 105.16 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.417 0.627 . . . . 0.0 111.645 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.713 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 1.3 mm-40 41.63 -125.76 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.908 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -96.95 41.04 2.41 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.972 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 4.7 t -73.05 118.73 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -135.26 127.69 18.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.222 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.576 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 19.9 Cg_endo -92.77 153.23 17.6 Favored 'Cis proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.957 -1.268 . . . . 0.0 112.508 0.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.48 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 3.1 t80 -96.1 112.2 24.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.576 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 72.8 m-85 -93.01 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.46 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.481 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -126.57 145.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.478 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.51 -168.38 35.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.383 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.473 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.08 -54.84 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.48 56.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.0 111.592 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -57.58 -19.47 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.815 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -53.34 -31.27 43.58 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.175 0.512 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 87.0 m -73.18 131.19 41.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.493 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.48 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 7.1 m-80 -46.31 -29.87 1.83 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.223 0.535 . . . . 0.0 110.404 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.481 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 41.4 t -110.76 143.13 41.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.028 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.24 105.44 13.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.427 HG13 ' CE2' ' A' ' 692' ' ' PHE . 32.9 mm -138.99 109.61 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.027 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -104.06 106.96 17.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.466 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.3 t0 -130.0 107.7 9.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.604 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -38.73 -30.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.454 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 0.1 OUTLIER -68.86 -41.6 78.18 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -88.65 159.13 17.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.953 0.406 . . . . 0.0 111.938 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 60.1 p -77.55 173.08 12.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.437 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -49.55 -32.95 13.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.516 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.99 66.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.606 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 13.7 t60 -44.65 -39.53 5.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.96 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.3 p -165.39 158.86 16.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 650' ' ' CYS . 36.3 p90 -143.77 147.74 34.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.44 ' CD1' HD12 ' A' ' 594' ' ' ILE . 55.7 mt -101.92 134.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.019 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 135.76 51.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.422 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -97.15 137.84 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.127 0.489 . . . . 0.0 110.879 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.71 158.92 43.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.877 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -77.17 112.47 13.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.307 0.575 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.5 t60 -80.71 129.8 34.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.885 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -141.02 167.39 22.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 4.5 m -114.83 128.43 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -65.23 -34.41 89.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.637 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -140.99 128.07 20.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.883 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 5.7 p -127.11 132.92 50.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.2 mtt -95.53 75.44 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.828 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.6 -68.0 0.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -112.28 105.08 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.34 144.37 50.86 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.806 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.85 178.55 5.71 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.455 2.103 . . . . 0.0 112.228 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 70.35 -64.49 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.47 -68.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.022 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 179.05 67.56 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.439 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 630' ' ' HIS . 1.2 mt -115.28 -154.53 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 1.1 m-20 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.343 0.592 . . . . 0.0 112.526 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.435 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.8 OUTLIER -132.13 137.31 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.605 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.4 ' CD1' HD21 ' A' ' 578' ' ' LEU . 2.5 pt -88.96 120.65 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.334 0.587 . . . . 0.0 112.145 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.541 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 87.4 m95 -101.74 143.82 31.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.726 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -104.24 117.34 33.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.463 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -105.29 138.47 41.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.162 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.44 ' CE1' ' N ' ' A' ' 657' ' ' SER . 49.2 t60 -118.44 130.98 56.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.43 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -127.36 8.76 6.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.139 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.37 148.51 28.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.282 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.3 t -75.78 -31.17 59.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 111.197 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.2 m120 -71.95 -1.17 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.6 126.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.346 0.593 . . . . 0.0 111.57 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 91.8 p -95.54 165.92 12.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -128.09 120.03 26.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 111.403 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.451 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -96.56 99.87 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.94 -81.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.11 3.1 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.806 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.445 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 3.2 m-80 -103.68 141.65 35.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.826 0.345 . . . . 0.0 111.111 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.85 141.56 39.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 31.3 mmm -125.93 97.9 5.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.6 pt -87.83 153.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' A' ' 652' ' ' THR . 52.0 tt0 -48.05 100.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.82 37.25 1.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.37 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.9 p -125.48 158.71 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 111.445 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.446 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -130.26 148.56 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.451 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.9 145.35 28.61 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.541 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 135.21 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.419 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 1.5 mt -111.63 104.99 13.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.534 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 15.5 mt-30 -92.05 143.58 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.219 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 706' ' ' GLY . 40.5 t0 -45.5 113.91 0.67 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 110.877 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 99.52 35.51 4.64 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 116.32 28.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.993 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.05 108.76 21.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.22 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 11.4 mt -107.69 135.0 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 111.894 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 4.5 mttm -96.79 116.2 28.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.848 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.424 HG23 ' HB ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -76.33 -34.6 25.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.303 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 681' ' ' ILE . 1.2 tp -154.27 131.02 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.67 122.08 19.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.548 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.07 116.32 20.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 110.4 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -46.63 71.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.148 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -69.09 -40.51 78.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.058 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.72 -2.44 53.81 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt 58.11 19.23 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 0.0 110.829 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.489 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 2.6 t80 -76.84 104.46 7.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.431 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -126.19 120.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.808 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.424 ' HB ' HG23 ' A' ' 680' ' ' ILE . 13.6 mt -129.64 124.68 59.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -150.04 141.49 8.85 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.716 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.456 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 3.1 m-30 -113.92 141.85 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 580' ' ' LEU . 2.7 tttt -101.23 115.75 31.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.938 0.399 . . . . 0.0 110.299 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 578' ' ' LEU . 1.9 t -80.5 127.02 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.857 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.2 OUTLIER -134.21 109.03 8.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.511 HG12 HD13 ' A' ' 578' ' ' LEU . 60.1 mt -71.45 105.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.099 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.36 -46.85 8.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.288 0.566 . . . . 0.0 109.565 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.536 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.0 t0 -111.32 142.68 43.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.341 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 34.5 p -113.48 100.75 8.76 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.69 62.06 0.07 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.945 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 51.83 47.21 53.87 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.481 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.523 ' CD2' ' HA ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -105.39 177.67 4.78 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.704 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.57 ' C ' ' H ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -58.24 -141.8 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.953 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.503 ' N ' ' CG ' ' A' ' 703' ' ' PHE . 0.7 OUTLIER -59.24 9.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.57 ' H ' ' C ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER 77.95 -56.89 0.49 Allowed 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.962 0.41 . . . . 0.0 110.105 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 160.06 58.94 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.078 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.54 7.21 35.14 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.779 -0.247 . . . . 0.0 111.567 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 86.91 56.28 2.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.008 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.98 135.64 1.28 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.046 0.451 . . . . 0.0 111.677 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.1 mp 73.71 -172.76 0.13 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.8 -97.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.129 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -114.76 101.25 8.89 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.698 0.285 . . . . 0.0 111.378 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 7.2 mp0 -115.12 100.32 8.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.491 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.467 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 8.4 mmm-85 -160.55 76.06 0.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.434 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 4.6 m -123.99 141.42 44.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.289 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.1 t -81.64 130.04 36.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.253 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.437 ' CD1' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -106.19 162.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.618 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.89 145.06 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.853 0.358 . . . . 0.0 111.005 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -79.98 156.61 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 33.9 p -126.06 -174.21 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.71 -29.39 53.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.65 -50.37 65.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -64.0 -45.29 89.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -57.73 -32.94 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.42 -37.02 82.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.43 -44.84 92.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.015 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.2 p -84.75 -24.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.347 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -56.6 -30.27 63.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -112.45 28.39 8.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.635 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.781 0.324 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 14.8 t -146.26 58.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 64.77 39.33 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.46 168.02 3.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.706 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . 0.402 ' CG2' ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.54 80.45 4.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.742 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -59.86 107.79 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.052 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.43 110.68 3.09 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.415 2.077 . . . . 0.0 112.372 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -83.55 -10.99 57.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.536 0.207 . . . . 0.0 111.427 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.403 ' HA2' ' OE1' ' A' ' 596' ' ' GLN . . . 141.15 -8.47 2.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.508 -0.854 . . . . 0.0 113.078 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.428 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.8 OUTLIER -106.58 141.21 38.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.856 0.36 . . . . 0.0 111.068 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 578' ' ' LEU . 1.0 OUTLIER -128.06 -49.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.927 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.494 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 7.3 tp -118.23 142.51 47.39 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.996 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 24.0 m -115.83 117.19 29.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.428 ' CD2' ' CG2' ' A' ' 694' ' ' VAL . 9.6 mt -105.56 109.11 20.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.73 99.55 52.26 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.604 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 38.2 Cg_exo -46.03 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.884 1.722 . . . . 0.0 109.628 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.87 157.78 85.29 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.412 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 74.4 Cg_exo -49.39 -24.93 9.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.633 2.889 . . . . 0.0 112.785 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.62 -27.38 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 4.7 t -95.56 154.0 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.721 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.465 HG12 ' CD1' ' A' ' 690' ' ' ILE . 1.4 pt -56.5 -13.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 60.8 mt -108.08 130.92 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.412 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -117.32 60.12 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.728 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.604 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.7 mt-10 -124.9 169.58 11.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.103 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.56 121.49 25.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.66 0.267 . . . . 0.0 111.559 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.2 mm? -112.93 149.38 33.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.428 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.95 118.69 26.83 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.554 HG12 ' CD2' ' A' ' 601' ' ' PHE . 63.7 mt -73.97 109.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.321 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -64.55 113.55 3.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.661 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.452 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.24 -30.89 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.226 0.536 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.437 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.57 -20.43 73.84 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.052 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.86 118.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.561 0.681 . . . . 0.0 111.287 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -139.54 121.87 10.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.993 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.6 Cg_endo -90.21 160.13 33.22 Favored 'Cis proline' 0 N--CA 1.462 -0.367 0 C-N-CA 124.499 -1.042 . . . . 0.0 111.811 -0.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.4 t80 -91.27 114.76 27.37 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.505 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 33.6 m-85 -91.89 138.04 31.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.294 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.516 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.5 mp -125.39 143.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.229 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.38 -163.57 35.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.454 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.469 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -77.13 -51.15 11.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.37 127.02 29.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.293 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -53.88 -19.78 5.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.004 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.93 -30.32 61.47 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.002 0.43 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 38.0 m -70.59 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.589 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 15.3 m-80 -47.34 -29.0 2.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.036 0.446 . . . . 0.0 110.482 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 37.1 t -110.87 137.0 49.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.16 104.76 14.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.424 HG13 ' CE2' ' A' ' 692' ' ' PHE . 15.5 mm -139.53 109.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.299 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -104.98 107.17 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.469 ' C ' ' HD3' ' A' ' 605' ' ' ARG . 1.9 t0 -129.17 107.4 9.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.466 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -39.86 -27.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.457 ' CB ' ' CD1' ' A' ' 681' ' ' ILE . 0.3 OUTLIER -73.51 -39.81 64.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.514 ' CB ' ' ND1' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -88.78 158.73 18.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 111.403 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.8 m -76.82 169.07 18.99 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.791 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.434 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -51.15 -35.27 35.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.28 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.67 63.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.52 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 653' ' ' GLY . 26.3 t60 -47.83 -40.38 21.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.825 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.7 p -168.69 156.72 8.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.037 0.446 . . . . 0.0 111.631 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.504 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 27.3 p90 -143.34 148.47 36.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.55 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.459 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 61.4 mt -102.15 135.25 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.891 0.377 . . . . 0.0 110.133 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.535 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -126.87 134.13 50.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.647 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.415 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 7.8 ttpt -98.08 134.97 40.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.506 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.71 158.24 44.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.761 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -77.39 115.93 17.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.473 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.3 t60 -74.66 128.15 34.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.961 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -135.77 153.41 51.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.035 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 6.7 p -127.74 159.99 37.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.404 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -56.63 -71.68 0.7 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.523 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -171.12 98.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.35 . . . . 0.0 110.846 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 2.3 m -67.08 153.95 42.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -133.79 142.89 48.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 71.38 -65.42 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -82.86 142.22 31.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.017 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 52.1 m -102.69 105.75 46.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.722 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.23 -161.21 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.628 2.218 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -74.95 -3.93 35.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.822 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 74.72 -68.9 0.2 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.644 0.259 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -172.98 87.1 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.788 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.5 OUTLIER -103.7 -153.15 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -116.5 147.42 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.146 0.498 . . . . 0.0 111.876 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.423 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -133.48 147.01 51.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.234 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.442 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 9.3 pt -96.74 126.93 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.231 0.538 . . . . 0.0 111.617 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.486 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 91.7 m95 -110.68 131.65 54.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.202 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 6.9 t80 -92.48 117.64 30.15 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 624' ' ' PHE . 36.6 m -104.2 137.16 42.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.991 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.442 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 31.6 t60 -115.86 131.3 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.086 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 3.1 p -131.86 15.75 4.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.415 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.51 153.42 27.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.212 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 89.8 m -82.13 -25.81 34.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.527 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -81.81 3.41 26.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.021 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.527 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.38 134.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 112.181 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.441 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 73.8 m -106.22 166.27 10.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.406 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 679' ' ' LYS . 6.1 m-85 -127.74 120.31 27.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.821 0.343 . . . . 0.0 111.006 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.481 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -102.09 99.53 9.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.4 m120 58.68 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.2 OUTLIER -130.98 3.19 4.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.474 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 4.9 m-80 -109.08 138.01 46.09 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -75.71 141.32 42.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 49.7 mmm -119.82 87.83 2.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.711 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 42.1 pt -87.48 156.1 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.035 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -48.9 94.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.243 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.77 41.71 0.77 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.579 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.1 p -127.9 162.16 27.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.931 0.396 . . . . 0.0 111.381 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpm? -137.76 141.69 40.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.752 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.481 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.58 144.94 28.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.768 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.486 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.56 140.65 55.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.018 0.437 . . . . 0.0 111.192 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.433 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 2.0 mt -112.15 124.04 51.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 2.6 mt-30 -109.97 161.84 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.761 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -59.19 100.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.368 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.22 30.27 3.95 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.55 114.19 23.08 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -96.09 108.6 21.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.093 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 5.4 mt -105.67 120.9 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.637 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 658' ' ' TYR . 4.1 mttp -82.28 115.48 21.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.358 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.456 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.6 mt -75.44 -39.05 40.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.457 ' CD1' ' CB ' ' A' ' 617' ' ' ARG . 5.4 tt -155.78 131.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.916 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.58 121.44 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.07 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -127.13 116.82 21.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 110.544 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -67.46 -46.5 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.919 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -66.05 -40.34 90.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.927 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -93.85 -8.46 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.621 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 62.04 16.52 8.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.63 0.253 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.9 t80 -77.06 105.46 8.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.3 p -119.58 124.62 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.1 0.476 . . . . 0.0 111.922 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 587' ' ' ILE . 27.3 mm -128.1 154.97 39.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.397 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 174.05 134.18 1.81 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 9.6 m-30 -112.89 147.28 37.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 110.331 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.37 116.52 32.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.198 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.464 HG12 ' CD1' ' A' ' 578' ' ' LEU . 2.1 t -80.86 129.7 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.464 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -133.47 109.43 9.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.926 0.394 . . . . 0.0 111.16 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.474 ' CD1' ' HB2' ' A' ' 705' ' ' GLU . 26.7 mt -78.19 105.69 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.238 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . 0.401 ' HB2' ' NH1' ' A' ' 576' ' ' ARG . 20.2 m120 -93.25 -45.93 7.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.05 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.492 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 2.8 t70 -110.78 139.84 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 699' ' ' THR . 0.1 OUTLIER -115.71 100.56 8.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.291 0.567 . . . . 0.0 109.74 178.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 24.7 m -69.01 69.2 0.18 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.566 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.19 51.6 56.49 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.612 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.418 ' CD2' ' HB2' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -93.46 153.11 18.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.201 0.524 . . . . 0.0 111.911 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.461 ' HA ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -56.91 -23.19 43.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.878 178.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 3.9 t30 -164.73 -54.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.564 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.474 ' HB2' ' CD1' ' A' ' 696' ' ' ILE . 6.5 pt-20 160.99 -31.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.725 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 140.38 44.38 0.07 OUTLIER Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.591 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.459 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.6 OUTLIER -83.22 7.52 15.99 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.43 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 109.87 -121.93 6.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.946 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 10.8 ptp -178.32 121.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.845 0.355 . . . . 0.0 110.503 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -39.92 162.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.508 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . 0.426 ' HB2' ' CD2' ' A' ' 710' ' ' LEU . 18.4 tt0 75.24 -62.85 0.44 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.178 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.41 103.45 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.283 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -82.58 100.55 10.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.275 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.452 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.8 mmm-85 38.91 88.27 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.24 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.53 141.8 43.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.147 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.95 118.65 42.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.853 0.359 . . . . 0.0 111.356 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.08 172.46 8.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 157.37 16.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -87.32 155.19 20.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.81 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -126.17 -175.25 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.87 -30.74 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.087 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.49 -52.03 66.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -66.14 -46.0 79.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.795 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.68 -33.68 64.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.693 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.2 -36.94 80.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 22.8 mt -56.91 -44.41 82.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.45 -22.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -37.47 78.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -79.15 -18.55 52.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 8.7 tt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.118 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 5.3 m -141.36 99.89 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.019 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -110.29 40.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.91 123.24 18.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.28 150.47 30.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.36 90.35 3.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 8.3 mt -59.64 148.01 76.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.836 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.519 2.146 . . . . 0.0 112.277 180.0 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -78.85 -22.24 46.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.736 0.303 . . . . 0.0 111.083 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 171.87 60.78 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.021 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.401 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 5.4 tmm_? -110.18 107.49 17.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.475 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 6.3 t80 -95.33 -54.0 3.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.864 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.483 ' CD1' ' CD1' ' A' ' 647' ' ' ILE . 10.8 tp -108.79 143.31 38.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.989 0.423 . . . . 0.0 111.773 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.3 m -121.94 115.12 22.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.608 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.46 ' HG ' ' CG2' ' A' ' 694' ' ' VAL . 0.7 OUTLIER -105.21 109.13 21.0 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.485 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 18.1 mtmt -115.17 99.41 52.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.635 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 33.2 Cg_exo -46.27 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.711 1.607 . . . . 0.0 109.126 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.426 ' O ' ' OG ' ' A' ' 586' ' ' SER . 0.2 OUTLIER -75.1 157.61 85.06 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.407 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 76.1 Cg_exo -49.84 -25.59 12.19 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.438 2.759 . . . . 0.0 112.644 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -62.23 -28.82 69.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.429 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.8 OUTLIER -96.05 153.84 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.753 178.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 13.9 pt -54.99 -11.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 111.34 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 42.0 mt -107.16 128.73 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.3 OUTLIER -116.09 54.88 0.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.797 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.635 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 51.3 mm-40 -124.62 169.84 11.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.033 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.36 124.07 31.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.661 0.267 . . . . 0.0 111.659 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.429 ' CD2' ' CD ' ' A' ' 582' ' ' PRO . 1.2 mm? -112.87 148.96 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.401 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.68 122.44 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.565 HG12 ' CD1' ' A' ' 601' ' ' PHE . 33.0 mt -78.9 108.68 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 0.5 OUTLIER -65.15 111.52 2.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.47 -34.26 1.29 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.41 0.624 . . . . 0.0 109.972 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -62.9 -24.45 66.74 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.329 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 97.7 t -101.29 119.26 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.659 0.73 . . . . 0.0 111.414 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -138.91 122.91 11.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.704 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.54 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 48.0 Cg_endo -90.17 160.32 33.48 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 124.56 -1.017 . . . . 0.0 112.0 0.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.2 t80 -91.97 115.9 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.505 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 30.7 m-85 -92.38 138.0 31.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.8 mp -125.03 145.76 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.742 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 160.63 -171.43 36.78 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.374 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.427 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -70.72 -46.91 62.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 111.372 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.16 130.56 46.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.381 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -18.32 29.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.783 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.05 -30.9 66.53 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.205 0.526 . . . . 0.0 110.301 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 94.7 m -70.54 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.1 m120 -44.52 -33.21 1.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 35.1 t -106.93 138.67 42.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.815 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.97 104.59 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.463 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.6 mm -139.47 109.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.409 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -104.07 106.09 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.436 0.636 . . . . 0.0 111.994 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.527 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 3.1 t70 -129.68 108.85 10.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.894 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . 0.406 ' ND2' ' HG2' ' A' ' 617' ' ' ARG . 0.9 OUTLIER -40.2 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.406 ' HG2' ' ND2' ' A' ' 616' ' ' ASN . 0.0 OUTLIER -70.65 -42.69 70.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 1.5 pp -89.44 158.21 17.82 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.679 0.276 . . . . 0.0 111.013 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.82 165.82 20.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.0 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.447 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.22 -25.21 21.75 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.075 0.464 . . . . 0.0 110.435 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.75 57.44 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.997 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.494 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 37.0 t60 -48.4 -45.69 36.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.6 p -168.37 161.35 11.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 111.543 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.505 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 52.9 p90 -143.44 147.53 34.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.509 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.469 HD11 HD12 ' A' ' 594' ' ' ILE . 62.1 mt -102.02 134.52 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -125.87 134.36 51.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.737 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.437 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 1.9 ttmm -97.59 136.73 37.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.122 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.457 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.15 159.35 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.764 -178.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.82 113.62 14.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.409 0.623 . . . . 0.0 110.502 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 -65.88 130.88 44.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.33 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . 170.97 123.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.02 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.25 155.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -55.58 104.48 0.31 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.646 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 13.6 tptt 60.02 159.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 75.3 p -109.59 58.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.87 113.72 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 69.4 -66.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.07 143.76 35.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.4 108.38 54.62 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.49 -153.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.636 2.224 . . . . 0.0 111.798 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -97.33 34.0 1.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.388 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 66.89 -72.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 176.29 76.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 1.1 mt -118.16 -147.64 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 48.1 m-20 -122.23 148.25 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.432 ' OD1' ' CZ ' ' A' ' 703' ' ' PHE . 3.3 t0 -133.62 151.21 51.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.701 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 8.9 pt -100.25 122.45 52.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 111.487 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.516 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 77.6 m95 -108.05 134.01 51.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.308 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -95.68 117.53 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 624' ' ' PHE . 26.1 m -101.0 133.49 45.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.45 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 54.5 t60 -112.87 131.64 55.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.4 p -129.67 0.95 4.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.449 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 148.36 34.8 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.712 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.8 t -75.91 -34.49 59.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.114 0.483 . . . . 0.0 111.311 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.53 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.1 m120 -70.16 2.0 4.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.379 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.53 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.17 133.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.435 0.636 . . . . 0.0 112.32 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.45 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 98.2 p -103.86 165.69 10.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.482 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.68 120.24 30.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.225 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.481 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -105.24 109.38 21.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.903 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.43 -82.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.975 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 659' ' ' LEU . 18.5 m-20 -137.49 5.87 2.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.814 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.504 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 3.2 t-20 -108.81 135.57 49.81 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.943 0.402 . . . . 0.0 111.253 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 17.0 ttp-105 -73.65 141.43 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.419 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 39.5 mmm -117.07 98.17 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.053 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 41.1 pt -88.19 149.13 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.114 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.59 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.433 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.26 42.31 1.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.1 p -127.14 162.28 26.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.45 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.439 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -134.07 135.93 43.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.467 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.613 ' CZ ' ' HG2' ' A' ' 714' ' ' ARG . 0.3 OUTLIER -140.03 144.19 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.46 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.516 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.78 141.05 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.127 0.489 . . . . 0.0 111.345 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.415 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 2.9 mt -112.27 98.16 7.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.427 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.447 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 30.6 mt-30 -82.72 131.01 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.946 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 706' ' ' GLY . 5.7 t70 -36.01 107.32 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.099 0.476 . . . . 0.0 110.96 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.92 33.94 3.62 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.04 118.37 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.003 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -96.2 108.87 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.757 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 25.8 pt -105.61 136.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.99 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.8 OUTLIER -99.05 115.96 30.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.752 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 622' ' ' HIS . 4.3 mt -84.24 -35.67 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.478 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.494 ' CG2' ' HB ' ' A' ' 690' ' ' ILE . 4.2 tp -154.33 129.05 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.328 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -137.96 123.44 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.302 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -127.51 116.08 19.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.925 0.393 . . . . 0.0 110.607 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -46.57 70.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.956 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.78 -40.83 97.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.135 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -98.06 4.01 49.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.9 mttm 54.24 22.07 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.776 0.322 . . . . 0.0 110.93 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.455 ' CZ ' ' OD1' ' A' ' 615' ' ' ASP . 1.5 t80 -76.4 104.36 6.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.45 124.22 72.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.054 0.454 . . . . 0.0 111.867 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.494 ' HB ' ' CG2' ' A' ' 681' ' ' ILE . 4.9 mm -128.06 154.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.331 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.417 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . 175.68 134.11 1.87 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.52 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.491 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.9 m-30 -113.27 142.89 45.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -100.87 116.34 32.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 109.88 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.483 ' CG1' HD13 ' A' ' 578' ' ' LEU . 2.7 t -85.12 123.24 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 110.02 9.51 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.082 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.49 HD12 HG22 ' A' ' 696' ' ' ILE . 66.3 mt -65.3 105.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.24 -48.08 12.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.934 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.445 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 38.7 t0 -111.69 139.38 47.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.173 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p -115.94 100.09 7.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.3 t -75.46 58.08 0.98 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.307 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 48.97 48.08 31.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.984 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 645' ' ' ASP . 1.8 pt? -91.45 -175.91 4.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.771 0.32 . . . . 0.0 111.117 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.568 ' CG ' ' N ' ' A' ' 704' ' ' ASN . 0.2 OUTLIER -55.92 -149.91 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.981 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.568 ' N ' ' CG ' ' A' ' 703' ' ' PHE . 1.1 t30 -31.52 -34.42 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.125 0.57 . . . . 0.0 111.709 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 4.0 pt-20 105.04 6.14 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.964 0.905 . . . . 0.0 111.32 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.673 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 85.32 18.13 61.2 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.63 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.65 7.65 11.81 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.314 -0.521 . . . . 0.0 111.859 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 712' ' ' GLU . . . 62.6 11.0 33.25 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.267 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 2.9 mtm 46.8 86.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.924 0.362 . . . . 0.0 111.281 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 45.42 48.79 10.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.69 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.16 75.5 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 708' ' ' GLY . 20.7 tt0 -114.49 140.52 48.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.062 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -82.49 135.88 35.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.471 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.613 ' HG2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -100.31 -157.54 0.61 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.161 0.505 . . . . 0.0 109.936 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.503 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 0.6 OUTLIER -148.62 142.2 18.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.614 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 12.7 p -88.85 127.67 41.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.35 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.19 172.33 7.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -99.67 156.97 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.958 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.26 148.49 22.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 22.0 p -126.14 -173.44 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.218 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.47 -29.03 33.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.54 -51.61 67.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.36 -44.72 90.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.617 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -57.59 -32.72 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.74 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.15 -37.23 83.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 40.7 mt -59.48 -44.15 93.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.63 -24.93 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -32.14 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -87.76 -12.07 46.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.394 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.44 HD11 ' CD1' ' A' ' 602' ' ' PHE . 8.3 tt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.799 0.333 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.05 49.68 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 60.17 70.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -166.61 130.46 2.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.807 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -84.91 -26.9 26.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 64.33 156.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 2.2 mt -104.72 150.6 38.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.641 2.227 . . . . 0.0 112.296 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.608 -0.197 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.99 -20.74 63.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.984 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -176.87 44.57 0.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.081 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.9 tmm_? -108.1 112.12 24.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.594 0.235 . . . . 0.0 110.919 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 3.1 t80 -99.83 -45.18 5.81 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 594' ' ' ILE . 10.3 tp -118.59 142.84 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 30.3 m -120.49 115.84 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.837 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.439 ' CD2' HD22 ' A' ' 578' ' ' LEU . 0.7 OUTLIER -105.5 109.32 21.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 19.3 pttt -116.87 98.77 52.38 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 23.4 Cg_exo -46.03 98.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.923 1.748 . . . . 0.0 109.823 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 585' ' ' ASP . 0.3 OUTLIER -74.71 157.86 85.45 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.436 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.49 -29.74 19.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.508 2.806 . . . . 0.0 112.876 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 583' ' ' LEU . 23.2 m-20 -62.33 -24.9 67.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.405 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 5.6 t -95.51 153.27 17.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.468 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 10.6 tt -56.34 -14.48 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.414 ' CD1' HG23 ' A' ' 613' ' ' ILE . 21.0 mt -111.51 128.14 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 111.626 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.436 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.7 OUTLIER -112.64 55.98 0.68 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.64 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.7 mt-10 -124.79 170.28 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.908 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.35 119.7 23.17 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.74 0.305 . . . . 0.0 111.621 178.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.406 ' CD2' ' CD ' ' A' ' 582' ' ' PRO . 0.2 OUTLIER -113.03 146.33 39.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.5 OUTLIER -123.97 121.47 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.559 HG12 ' CD2' ' A' ' 601' ' ' PHE . 70.4 mt -75.86 109.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.148 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.9 mm-40 -66.12 114.65 5.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.91 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -42.49 -34.73 0.89 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.353 0.597 . . . . 0.0 110.111 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.474 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.0 -20.24 68.61 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.702 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 99.3 t -101.07 118.79 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 117.912 0.856 . . . . 0.0 111.67 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.908 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.55 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -90.39 160.45 32.47 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.621 -0.991 . . . . 0.0 111.632 -0.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.559 ' CD2' HG12 ' A' ' 594' ' ' ILE . 3.5 t80 -91.26 114.88 27.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 46.4 m-85 -91.84 138.16 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.098 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.5 mp -126.76 145.03 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.787 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.31 -165.48 34.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.46 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.58 ' HG2' HD21 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -71.33 -54.59 10.29 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.34 130.81 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.483 -178.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -19.33 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.63 -30.35 42.39 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.119 0.485 . . . . 0.0 110.056 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 95.8 m -73.41 131.21 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.297 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -46.51 -28.65 1.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 42.2 t -111.44 141.58 44.81 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.19 107.53 16.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.456 HG13 ' CE2' ' A' ' 692' ' ' PHE . 26.6 mm -138.37 110.05 5.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.313 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.58 106.09 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.504 ' HB3' ' CD2' ' A' ' 618' ' ' LEU . 31.0 t0 -130.25 108.24 9.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.898 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.25 -32.74 0.2 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.821 0.343 . . . . 0.0 111.601 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.453 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 2.5 mtm-85 -78.19 -38.03 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.03 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.58 HD21 ' HG2' ' A' ' 605' ' ' ARG . 0.0 OUTLIER -88.91 120.03 29.96 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.13 167.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.524 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.3 mpt_? -56.25 -35.92 67.95 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.12 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.01 57.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.736 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.536 ' CD2' HG22 ' A' ' 680' ' ' ILE . 31.9 t60 -50.28 -48.45 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.931 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.3 p -159.33 156.0 27.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.029 0.442 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.512 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 48.5 p90 -143.66 149.31 37.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.461 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.476 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 79.7 mt -102.61 130.34 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.927 0.394 . . . . 0.0 109.981 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.8 t80 -122.65 133.55 54.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 35.4 ttmt -98.28 136.98 37.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.26 158.74 42.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.288 -179.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -76.44 112.74 13.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.329 0.585 . . . . 0.0 110.299 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.447 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.9 t60 -80.73 125.32 29.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.823 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -130.45 160.77 33.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 1.9 m -131.81 179.27 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -83.82 -106.99 0.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.374 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.4 142.94 39.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 94.1 p -120.69 150.42 40.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 14.0 tpt -132.78 118.85 19.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.71 -65.98 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -75.94 139.55 41.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.85 101.11 14.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 -165.11 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.498 2.132 . . . . 0.0 112.267 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -50.04 -31.38 12.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.468 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 62.55 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.937 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -159.07 61.72 0.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.577 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 2.4 mt -104.15 -152.92 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.594 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 2.1 m-20 -118.78 148.09 43.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.309 0.576 . . . . 0.0 112.378 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.431 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -132.3 138.51 47.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.778 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 5.0 pt -96.03 119.06 43.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.554 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 85.8 m95 -103.7 132.63 49.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.972 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 15.9 t80 -90.73 116.23 28.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.3 m -98.13 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.111 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.44 ' CE1' ' N ' ' A' ' 657' ' ' SER . 60.8 t60 -124.58 129.28 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 16.9 p -128.6 4.88 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.325 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.95 149.01 33.92 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.692 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.2 t -75.81 -28.27 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.523 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.454 ' C ' ' CG1' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -73.93 0.01 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.272 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.454 ' CG1' ' C ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 56.77 133.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.345 0.593 . . . . 0.0 111.896 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 14.8 t -105.11 165.58 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.004 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.411 ' CZ ' HG23 ' A' ' 656' ' ' VAL . 10.4 m-85 -134.6 120.19 19.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.1 OUTLIER -99.35 100.49 11.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.9 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 31.0 t30 -132.17 -0.7 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.62 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.405 ' OD1' ' CZ ' ' A' ' 670' ' ' PHE . 21.3 m120 -104.04 122.39 45.16 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.991 0.424 . . . . 0.0 111.245 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -66.63 141.77 57.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.968 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 37.6 mmm -114.8 102.49 10.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.16 147.33 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.802 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.91 95.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.435 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.2 39.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.841 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.3 p -138.16 161.99 35.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.405 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 19.3 pttm -135.62 135.66 40.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.448 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 18.8 t80 -127.15 143.55 51.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.51 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.554 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.95 136.53 50.63 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.03 0.443 . . . . 0.0 111.597 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 2.7 mt -98.57 143.52 28.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.307 0.575 . . . . 0.0 111.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.671 ' HB3' ' HA ' ' A' ' 707' ' ' LEU . 26.0 mt-30 -119.09 141.85 48.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.529 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -48.07 96.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.22 0.533 . . . . 0.0 110.213 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 107.49 32.6 3.36 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.63 114.35 23.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 110.98 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -96.12 108.73 21.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.2 137.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 111.745 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.24 115.87 28.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.623 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.536 HG22 ' CD2' ' A' ' 622' ' ' HIS . 8.1 mt -82.97 -35.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.236 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.447 ' CD1' ' CB ' ' A' ' 617' ' ' ARG . 1.2 tt -154.9 132.67 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 111.586 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -136.33 124.22 22.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.227 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.77 117.0 27.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.314 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -67.16 -47.08 72.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.803 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.5 p-10 -83.44 -40.33 19.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.533 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.408 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 0.7 OUTLIER -77.75 -15.6 59.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.383 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.83 9.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 0.0 110.952 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.468 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.8 t80 -85.37 105.1 15.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -122.87 121.75 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.287 0.565 . . . . 0.0 112.144 -178.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 2.5 mm -109.77 144.41 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.38 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -169.58 127.35 1.48 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.753 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.473 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 9.3 m-30 -113.95 146.13 40.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.784 0.326 . . . . 0.0 110.42 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -101.36 116.59 33.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.5 t -82.5 124.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.436 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.3 tp10 -133.69 109.23 9.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.898 0.38 . . . . 0.0 111.05 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.402 ' CG1' ' CD1' ' A' ' 578' ' ' LEU . 24.0 mt -72.17 104.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.268 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -88.32 -49.97 6.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 5.5 t70 -112.18 139.52 47.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.032 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 699' ' ' THR . 0.5 OUTLIER -115.94 99.66 7.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.4 t -69.67 72.39 0.36 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 56.78 36.8 73.98 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.381 -0.914 . . . . 0.0 110.901 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -85.37 156.59 20.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.783 0.325 . . . . 0.0 111.532 -178.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.518 ' CG ' ' N ' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -61.2 -142.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 7.0 t30 -35.81 -36.63 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.549 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 6.0 pt-20 125.42 -22.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.736 1.215 . . . . 0.0 109.278 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 129.11 -8.21 6.34 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.866 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.671 ' HA ' ' HB3' ' A' ' 673' ' ' GLN . 1.7 tm? -81.63 8.45 9.78 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.423 ' N ' ' ND2' ' A' ' 704' ' ' ASN . . . -137.44 173.66 22.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.423 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.93 132.97 22.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.941 0.401 . . . . 0.0 110.979 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -154.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.717 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -36.4 -40.86 0.26 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.814 0.34 . . . . 0.0 111.66 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.69 137.27 42.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.405 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -105.17 100.12 9.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.137 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.448 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 8.1 mmm-85 35.26 77.96 0.04 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.079 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.33 142.65 40.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.295 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.422 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 8.3 p -82.7 129.74 36.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.798 0.333 . . . . 0.0 111.28 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.4 ' CD1' ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -98.38 163.21 12.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.62 145.61 29.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.44 151.89 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.2 p -126.0 -173.95 2.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.97 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.99 -28.97 55.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -49.21 64.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -63.78 -50.95 67.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -57.41 -32.83 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.85 -37.25 86.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.79 -44.5 96.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.961 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.4 p -76.17 -28.57 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.08 -33.84 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -98.0 24.57 6.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 4.2 tt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.774 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.818 0.342 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 24.5 t -132.78 96.9 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.071 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.03 171.16 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.83 138.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . 0.433 ' P ' ' N ' ' P' ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.74 98.71 11.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.92 154.44 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.842 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 6.2 mt -137.77 97.64 10.04 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.46 2.107 . . . . 0.0 112.353 -179.967 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -76.85 -7.6 55.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.565 0.222 . . . . 0.0 111.407 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 131.25 -0.19 5.16 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.102 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.432 ' O ' ' CB ' ' A' ' 698' ' ' ASP . 19.9 ttp-105 -92.35 114.69 27.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.819 0.309 . . . . 0.0 110.582 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.502 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -99.44 -58.98 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.447 . . . . 0.0 110.504 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.496 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.4 tt -107.84 141.98 38.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 16.0 m -117.58 115.24 24.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -104.4 108.64 20.15 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 11.6 mtmt -114.86 99.13 51.58 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.664 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -47.26 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.761 1.641 . . . . 0.0 109.394 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.68 157.91 85.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.11 -25.27 8.97 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.688 2.925 . . . . 0.0 112.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.65 -28.16 69.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.439 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 2.0 t -95.94 153.8 17.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.631 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.476 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 16.0 pt -57.14 -13.68 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 110.973 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 23.4 mt -105.48 120.26 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.685 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -108.41 56.79 0.62 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.063 0.459 . . . . 0.0 110.343 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.664 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.0 mt-10 -124.72 170.36 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.215 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.19 120.54 24.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.359 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.403 ' CD2' ' CD ' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -113.15 148.43 35.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.427 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.81 125.51 44.12 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.462 HG12 ' CD2' ' A' ' 601' ' ' PHE . 94.0 mt -83.73 109.05 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -67.05 124.38 22.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.696 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.502 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.66 -29.7 3.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.244 0.545 . . . . 0.0 109.817 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.93 -24.04 77.46 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.86 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.24 117.86 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 118.018 0.909 . . . . 0.0 111.66 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -140.37 121.7 9.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.554 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -89.84 160.49 35.22 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.296 -0.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.4 t80 -91.69 115.62 28.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.48 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 23.6 m-85 -92.35 137.91 31.97 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.952 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.516 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 3.1 mp -126.45 146.03 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.436 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.19 -166.53 37.09 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.887 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.53 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.4 OUTLIER -71.49 -54.15 11.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 111.611 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.48 131.32 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.391 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -56.57 -19.07 14.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.982 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.08 -31.66 52.45 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.85 132.88 46.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.66 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 28.8 m120 -46.03 -31.05 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.236 0.541 . . . . 0.0 110.378 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.516 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 42.5 t -110.16 142.06 42.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.318 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.46 109.04 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.439 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 19.7 mm -138.05 109.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.084 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.53 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 1.0 OUTLIER -95.03 104.32 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.919 -178.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.548 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.67 113.96 14.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.19 177.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.5 -21.12 3.43 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.689 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.439 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 0.2 OUTLIER -74.33 -41.65 60.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.548 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -88.53 158.9 18.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 112.268 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 67.6 p -80.77 177.95 8.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.2 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.452 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -47.36 -45.76 25.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.121 0.486 . . . . 0.0 110.197 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.68 71.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.568 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 9.3 t60 -45.7 -47.93 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.537 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 2.1 p -161.2 160.62 30.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.614 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.48 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 1.7 p90 -143.68 148.7 36.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.666 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.96 130.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.086 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -121.3 132.47 54.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 5.3 ttmt -97.97 137.16 37.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.439 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.474 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.59 159.25 41.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.54 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 0.7 OUTLIER -76.25 112.72 13.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.1 t60 -80.68 127.01 31.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.577 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -150.91 150.31 30.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.21 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 8.5 m -99.38 171.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -63.35 -68.61 1.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.541 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -148.83 122.51 9.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 110.83 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 84.6 p -79.69 61.29 3.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -119.94 33.97 5.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.75 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -176.74 -43.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.594 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -110.99 144.56 39.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.636 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 82.5 p -107.92 95.73 15.66 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -88.84 -161.53 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.93 2.42 . . . . 0.0 112.15 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -96.48 34.66 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.242 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.64 -174.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.021 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -89.22 96.24 2.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 630' ' ' HIS . 25.0 mt -119.89 -149.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -116.95 147.61 42.1 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.436 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -130.48 160.17 34.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.518 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.445 ' CD1' HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -110.36 127.58 67.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.568 0.699 . . . . 0.0 112.776 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.529 ' CH2' HD22 ' A' ' 671' ' ' LEU . 81.9 m95 -110.93 125.89 54.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.411 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 11.7 t80 -90.01 116.1 27.8 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.457 ' N ' ' O ' ' A' ' 624' ' ' PHE . 20.1 m -101.65 142.57 32.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.427 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 60.6 t60 -125.88 130.23 50.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 25.1 p -126.69 5.18 6.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.168 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.76 153.17 36.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.582 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.8 t -73.64 -34.8 65.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.159 0.504 . . . . 0.0 111.486 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 617' ' ' ARG . 1.3 m120 -68.26 -4.89 15.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.434 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.83 123.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 111.67 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.427 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 57.9 p -88.68 166.26 14.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.354 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -131.22 120.39 23.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.868 0.366 . . . . 0.0 111.409 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.431 ' HG ' ' CD1' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -94.99 99.84 11.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.383 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 61.2 -81.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -134.45 3.4 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.682 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -104.95 123.6 48.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 111.171 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.35 141.38 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.92 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 21.7 mmm -118.14 111.93 19.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.871 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.4 ' O ' ' OG1' ' A' ' 668' ' ' THR . 32.9 pt -91.03 150.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.102 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 652' ' ' THR . 2.9 tt0 -51.87 100.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.471 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.87 37.26 1.16 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.002 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 1.8 p -139.35 159.19 42.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.0 pttm -123.96 158.19 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.58 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.431 ' CD1' ' HG ' ' A' ' 659' ' ' LEU . 10.6 t80 -144.27 146.46 32.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.529 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.53 128.17 35.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.696 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.42 HD23 ' CB ' ' A' ' 649' ' ' TYR . 0.4 OUTLIER -105.76 121.85 44.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.43 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 56.2 mt-30 -109.33 162.83 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.39 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 706' ' ' GLY . 11.7 p30 -58.62 110.47 1.0 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.42 . . . . 0.0 110.686 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 95.51 36.92 5.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.214 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -91.63 115.35 27.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.323 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.7 OUTLIER -96.28 110.35 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.053 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.406 ' CG2' ' CD2' ' A' ' 659' ' ' LEU . 26.9 pt -105.62 132.58 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.98 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -91.03 116.62 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.004 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.22 -34.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.45 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 681' ' ' ILE . 2.1 tp -154.43 131.34 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 111.718 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -136.47 126.32 25.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -126.22 116.77 21.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -67.4 -46.77 72.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.989 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -77.74 -40.41 41.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.769 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -7.79 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.602 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp 59.66 17.95 6.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.476 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.3 t80 -76.55 104.82 7.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 2.1 p -120.68 121.98 66.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 112.134 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.43 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 4.2 mt -128.72 155.26 40.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.436 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.439 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.98 135.9 2.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.231 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.481 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 5.0 m-30 -113.08 149.73 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.16 117.47 35.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.008 0.433 . . . . 0.0 110.704 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 676' ' ' ASP . 2.6 t -80.48 114.75 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.1 108.96 12.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 0.0 110.123 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.448 ' CG2' ' HB2' ' A' ' 705' ' ' GLU . 8.9 mt -80.45 111.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.334 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -96.15 -45.85 6.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 4.1 t70 -111.13 140.34 45.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.014 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.2 OUTLIER -115.0 101.35 8.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 9.9 t -66.62 65.3 0.05 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.881 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 56.41 40.07 85.03 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.574 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -112.25 159.08 18.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.728 0.299 . . . . 0.0 110.842 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.745 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -56.29 119.64 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 7.0 t30 49.7 -74.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.418 0.627 . . . . 0.0 110.552 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.745 ' N ' ' O ' ' A' ' 703' ' ' PHE . 19.4 pt-20 161.82 -36.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.265 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.555 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 156.13 84.97 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.004 -1.453 . . . . 0.0 111.317 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.445 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -104.65 -9.56 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.226 -0.573 . . . . 0.0 111.572 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 117.85 -35.73 3.95 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.239 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.458 ' HG2' ' CE1' ' A' ' 630' ' ' HIS . 0.0 OUTLIER 60.31 109.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.691 0.282 . . . . 0.0 110.988 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.57 110.99 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.063 0.458 . . . . 0.0 111.176 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 178.1 -57.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.752 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -114.25 130.04 56.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.856 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.479 ' O ' ' C ' ' A' ' 714' ' ' ARG . 2.4 mm-40 -81.98 99.84 9.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.716 0.293 . . . . 0.0 111.027 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 713' ' ' GLN . 4.4 mmm-85 17.94 84.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.742 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.57 142.48 41.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.632 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.426 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 10.0 p -86.49 119.82 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.048 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 169.59 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.985 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -102.9 157.94 16.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.855 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -88.6 158.3 18.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.985 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -178.83 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.12 54.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.01 -52.07 52.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -43.34 96.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.783 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -57.32 -33.82 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.22 -36.78 80.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 23.2 mt -58.18 -44.32 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.75 -27.82 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.813 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -101.58 27.56 6.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.403 HD13 ' CG ' ' A' ' 602' ' ' PHE . 3.0 tt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.796 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.913 0.387 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.76 155.76 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.071 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -129.28 88.2 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 5.6 tt -149.58 136.12 19.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 88.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.79 145.47 52.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 8.7 mt -116.36 87.38 20.06 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.85 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.602 2.201 . . . . 0.0 112.353 -179.983 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.5 10.16 26.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.655 0.264 . . . . 0.0 111.421 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -166.87 40.54 0.25 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.401 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 51.5 ttp85 -99.55 112.18 24.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.686 0.279 . . . . 0.0 110.803 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.525 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -101.1 -50.94 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.909 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 44.6 tp -114.55 142.3 46.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.102 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 32.9 m -118.97 121.8 40.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.531 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 692' ' ' PHE . 6.6 mt -109.03 108.57 19.33 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.23 100.24 50.22 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -176.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.588 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.1 Cg_exo -47.84 105.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.694 1.596 . . . . 0.0 109.271 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.17 156.73 87.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.44 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 77.2 Cg_exo -50.4 -25.83 14.81 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.741 2.961 . . . . 0.0 113.357 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.86 -20.62 65.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.056 0.455 . . . . 0.0 110.039 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 3.7 t -97.24 154.34 17.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.969 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.479 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 4.1 pt -55.11 -19.68 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.115 0.483 . . . . 0.0 109.84 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.13 119.01 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.87 63.7 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.124 0.487 . . . . 0.0 110.701 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.588 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.8 mt-10 -124.97 170.81 10.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.48 121.6 27.58 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.681 0.277 . . . . 0.0 111.427 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.3 mm? -113.21 150.8 31.81 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.3 mt-10 -125.18 131.26 53.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.542 HG12 ' CD2' ' A' ' 601' ' ' PHE . 73.7 mt -90.13 108.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.8 mt-30 -69.14 124.64 24.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.9 -32.37 3.75 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.506 0.669 . . . . 0.0 109.505 179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.81 -22.55 75.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.664 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 81.9 t -98.36 117.94 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.929 0.864 . . . . 0.0 111.545 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 4.5 t30 -140.38 121.33 9.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.023 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.519 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.7 Cg_endo -90.96 159.72 29.3 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.475 -1.052 . . . . 0.0 111.415 -0.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -92.11 113.27 25.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 5.8 m-85 -91.9 138.28 31.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.083 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.9 mp -123.7 145.49 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.481 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.55 -167.55 35.77 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.427 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.443 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -73.62 -52.22 14.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 128.99 39.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.387 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -54.46 -19.9 6.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.965 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -28.26 51.78 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.018 0.437 . . . . 0.0 110.382 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 81.1 m -75.26 131.33 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.589 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 1.5 m-80 -46.44 -29.68 1.84 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.066 0.46 . . . . 0.0 110.464 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 31.0 t -109.59 137.46 47.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.68 104.94 14.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.442 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 14.2 mm -139.32 109.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.322 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.66 106.05 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.436 0.636 . . . . 0.0 111.998 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.486 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.8 OUTLIER -129.99 108.69 10.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.733 177.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -39.44 -27.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -71.4 -42.09 68.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -88.47 158.63 18.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.261 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.7 t -83.9 171.28 13.19 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.619 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.466 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -49.72 -41.83 44.49 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.143 0.497 . . . . 0.0 110.369 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.4 61.52 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.6 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.506 ' CD2' HG22 ' A' ' 680' ' ' ILE . 38.5 t60 -46.21 -45.22 16.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.59 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.4 p -167.34 159.29 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.597 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 51.7 p90 -143.48 146.52 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.817 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.431 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 16.6 mt -102.1 130.22 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 109.919 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -121.7 135.56 54.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.692 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 647' ' ' ILE . 6.0 tttt -97.77 133.46 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.111 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.451 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.8 OUTLIER -136.07 159.79 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.95 -178.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 6.4 tpt85 -75.79 112.31 12.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.359 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.9 t60 -63.28 134.33 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.336 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -73.15 -163.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.777 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 7.3 p -163.29 160.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.053 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.411 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -145.25 -143.42 3.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 128.94 39.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 4.9 p -128.15 79.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.6 116.1 28.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.649 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 70.97 -63.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.898 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.34 144.33 32.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.78 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.86 105.39 37.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.05 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.54 -155.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.593 2.195 . . . . 0.0 112.08 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -59.09 -22.31 60.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.417 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 70.11 -67.73 0.23 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.003 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 169.55 56.06 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.722 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.419 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 2.8 mp -111.17 -171.76 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.595 0.236 . . . . 0.0 110.748 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.528 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 0.6 OUTLIER -97.05 147.98 23.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 111.434 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.457 ' OD2' ' CD2' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -129.82 160.03 34.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.049 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.477 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 3.2 pt -107.32 119.09 56.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.552 0.691 . . . . 0.0 111.854 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.534 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 86.8 m95 -104.68 130.87 52.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.152 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -90.99 117.24 29.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 624' ' ' PHE . 10.9 m -103.77 138.07 40.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.829 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.45 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 27.0 t60 -120.84 130.53 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.238 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 15.1 p -128.14 7.33 6.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.213 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.13 151.44 36.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.837 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.6 t -75.37 -36.27 60.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 111.405 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m-20 -72.74 2.09 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.601 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.587 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 49.12 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.587 0.708 . . . . 0.0 112.153 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.406 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 39.2 m -105.63 165.6 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 5.1 m-85 -124.7 120.18 31.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 111.266 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -98.86 100.02 11.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.673 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 61.83 -80.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.859 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.0 m120 -135.83 0.76 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.458 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 2.1 m120 -106.77 141.12 38.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.174 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -75.07 141.76 43.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 12.0 mmm -124.08 85.85 2.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.2 pt -87.53 165.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 111.071 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.7 118.39 3.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.366 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.53 27.66 12.69 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 32.9 p -112.96 162.0 16.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 0.0 111.435 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpm? -141.98 140.62 32.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.447 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.3 OUTLIER -145.22 142.64 29.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.224 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.534 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -70.21 140.02 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 110.699 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.433 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 2.0 mt -109.43 119.09 38.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 111.062 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.488 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 2.8 mt-30 -105.24 138.03 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.813 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 706' ' ' GLY . 35.7 t0 -42.38 107.15 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.089 0.471 . . . . 0.0 110.807 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 105.93 32.65 3.75 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.17 119.99 32.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.371 . . . . 0.0 110.731 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -96.1 111.33 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.093 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 33.2 pt -105.59 135.42 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 112.016 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 116.74 33.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.607 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.506 HG22 ' CD2' ' A' ' 622' ' ' HIS . 5.6 mt -91.36 -30.76 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.473 HG21 ' HB ' ' A' ' 690' ' ' ILE . 4.0 tp -153.8 130.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 111.674 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -137.46 126.83 24.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.88 117.05 21.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.874 0.369 . . . . 0.0 110.363 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.77 -46.81 74.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.804 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -83.36 -40.37 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.565 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.35 -11.1 59.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.446 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 57.75 22.11 8.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.695 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.479 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 0.6 OUTLIER -81.57 104.38 11.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.5 OUTLIER -126.98 120.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.473 ' HB ' HG21 ' A' ' 681' ' ' ILE . 30.2 mt -129.83 120.53 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.511 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -143.03 140.93 10.11 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.516 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 8.6 m-30 -112.66 146.06 39.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.809 0.338 . . . . 0.0 110.368 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -101.04 116.15 32.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.07 0.462 . . . . 0.0 109.846 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 578' ' ' LEU . 1.0 OUTLIER -82.69 122.34 37.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.306 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -133.09 109.84 9.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.971 0.415 . . . . 0.0 111.033 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 16.3 mt -78.89 106.05 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.728 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.75 -45.04 10.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 9.4 t0 -110.3 140.14 44.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.483 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 699' ' ' THR . 0.0 OUTLIER -115.32 100.17 7.92 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.297 0.57 . . . . 0.0 109.891 178.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.3 71.68 4.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.015 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 63.32 36.61 93.64 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.033 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 645' ' ' ASP . 1.7 tp -80.98 154.04 27.14 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 111.444 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.598 ' CG ' ' N ' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -60.28 -142.57 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.478 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.598 ' N ' ' CG ' ' A' ' 703' ' ' PHE . 0.6 OUTLIER -29.89 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.791 0.436 . . . . 0.0 111.085 178.172 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 13.2 pt-20 117.55 -37.07 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.458 1.103 . . . . 0.0 109.929 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 127.52 21.52 1.6 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.525 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.01 8.07 19.11 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.497 -0.414 . . . . 0.0 111.659 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 96.05 60.12 1.03 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.286 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 47.1 ttp -57.78 141.31 49.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.63 44.84 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.471 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -105.01 -75.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.319 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -88.85 135.37 33.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.921 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.495 ' O ' ' C ' ' A' ' 714' ' ' ARG . 11.0 mt-30 -82.87 99.53 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.319 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 713' ' ' GLN . 9.1 mmm-85 -10.63 78.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.794 0.838 . . . . 0.0 112.757 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 713' ' ' GLN . 3.0 m -123.67 142.73 39.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.475 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 96.5 t -77.8 130.22 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.38 171.37 7.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -103.09 142.57 33.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.965 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -77.4 154.44 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 -179.51 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.236 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.88 -31.97 51.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -61.83 -48.84 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.733 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.76 -49.34 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -61.08 -32.74 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.181 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -38.68 92.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.273 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.18 -44.36 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.21 -27.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.119 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -56.34 -30.93 63.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 110.787 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -84.03 -22.44 31.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 8.3 tt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.96 179.901 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.842 0.353 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.01 145.36 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.42 52.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.999 0.428 . . . . 0.0 110.891 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 6.8 mp -131.24 152.37 50.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.99 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -101.5 85.22 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.855 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -63.13 108.27 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 19.5 mt -74.89 147.8 84.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.543 2.162 . . . . 0.0 112.276 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -69.86 -22.32 63.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.606 0.241 . . . . 0.0 111.236 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 145.09 -41.32 1.07 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.523 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.422 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.2 ttm105 -112.22 143.82 42.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.734 0.302 . . . . 0.0 111.112 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -124.01 -63.25 1.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.221 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.536 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 10.1 tt -108.98 142.69 39.27 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.202 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 695' ' ' GLU . 2.1 m -120.97 113.88 20.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.3 OUTLIER -101.52 107.92 19.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 69.1 mttt -113.16 99.18 48.3 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.623 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.6 Cg_exo -47.28 99.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.767 1.645 . . . . 0.0 109.416 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.5 157.47 86.2 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.64 -25.36 11.02 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.809 3.006 . . . . 0.0 112.961 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -27.84 68.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.442 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.0 OUTLIER -95.73 153.87 17.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.554 178.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 6.5 pt -58.17 -11.46 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.412 ' CD1' HG23 ' A' ' 613' ' ' ILE . 49.6 mt -107.16 119.01 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.76 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.424 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -107.68 58.13 0.62 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.134 0.493 . . . . 0.0 110.252 179.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.623 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.7 mm-40 -124.62 171.58 9.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.351 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.03 128.3 44.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.51 141.1 46.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.017 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.0 mt-10 -124.52 115.78 21.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.495 HG12 ' CD2' ' A' ' 601' ' ' PHE . 77.0 mt -83.24 109.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.294 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.3 OUTLIER -66.94 120.23 13.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.057 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.529 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.67 -29.84 2.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.176 0.513 . . . . 0.0 110.696 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.449 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -18.44 78.63 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.765 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.2 117.98 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 117.902 0.851 . . . . 0.0 111.983 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -140.27 122.77 9.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.873 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.532 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.1 Cg_endo -90.52 159.81 31.53 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.286 -1.131 . . . . 0.0 111.775 -0.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.31 115.62 28.24 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.53 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 43.3 m-85 -92.33 137.95 31.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.838 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 2.7 mp -126.4 143.31 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.438 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.16 -170.3 38.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.297 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.443 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -70.75 -49.45 46.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 111.614 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.71 130.64 47.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.479 -179.058 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -18.14 23.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.3 -28.65 63.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.086 0.47 . . . . 0.0 110.455 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 84.4 m -74.11 132.5 42.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.632 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 14.2 m-80 -47.44 -29.37 2.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.179 0.514 . . . . 0.0 110.254 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 42.5 t -109.93 142.07 41.79 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 105.38 13.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.462 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 20.5 mm -139.09 109.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.13 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.65 106.57 17.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.463 0.649 . . . . 0.0 112.255 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.46 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 2.2 t0 -129.68 107.53 9.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.633 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.39 -27.24 0.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -69.95 -42.05 73.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.684 0.278 . . . . 0.0 111.382 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.48 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 1.2 pp -90.08 158.75 17.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.73 164.15 26.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.014 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.424 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 1.0 OUTLIER -50.38 -28.33 7.89 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.068 0.461 . . . . 0.0 110.449 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 45.0 t -130.8 64.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.546 ' CD2' HG23 ' A' ' 680' ' ' ILE . 20.8 t60 -50.57 -46.94 57.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.119 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.6 p -165.36 161.5 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.511 . . . . 0.0 111.93 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.8 p90 -143.6 147.67 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.406 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.15 130.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -124.4 134.16 53.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 1.0 OUTLIER -99.56 136.93 38.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.619 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.88 158.94 43.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.584 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.6 tpt180 -75.99 112.44 12.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.356 0.598 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -65.19 134.79 54.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.233 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -107.12 144.55 33.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.112 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.26 166.16 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.111 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -103.43 -95.73 2.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.386 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -105.32 -174.86 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.799 0.333 . . . . 0.0 110.742 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 27.5 p -153.43 116.0 4.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.095 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.27 113.48 26.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 67.81 -72.24 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -89.8 144.44 25.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.726 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 69.0 m -89.58 112.07 49.54 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.36 -150.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 112.164 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . -47.52 -27.16 1.66 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.567 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 77.37 -74.76 0.07 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.987 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 160.34 76.53 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.074 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 703' ' ' PHE . 0.8 OUTLIER -134.2 -156.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 3.4 m-20 -100.68 146.27 27.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.37 0.605 . . . . 0.0 112.398 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 4.9 t0 -126.69 160.53 30.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.29 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 3.3 pt -114.88 115.37 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.386 0.612 . . . . 0.0 112.026 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.535 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 63.9 m95 -102.73 136.86 41.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.151 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -93.05 117.52 30.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.013 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 624' ' ' PHE . 14.8 m -101.87 130.67 48.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.087 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.46 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 45.0 t60 -111.19 132.88 53.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.483 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 13.4 p -129.27 2.47 5.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.416 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.86 148.1 32.96 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.4 t -73.28 -33.0 64.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 111.244 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.9 m-20 -72.27 -0.18 11.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.362 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.31 130.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 0.0 112.081 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.447 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 46.7 m -100.94 166.3 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.1 121.39 29.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.538 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.416 ' CD2' HD23 ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.75 99.95 11.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.608 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 60.26 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.0 m-80 -130.02 -1.7 4.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.614 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.471 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.5 m-80 -101.6 142.02 33.59 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.239 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.408 ' O ' HG22 ' A' ' 716' ' ' VAL . 46.8 ttp180 -81.55 141.27 33.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.272 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.403 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 15.3 mmm -121.16 96.92 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 6.7 pt -87.75 164.55 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.86 100.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.57 37.78 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.9 p -119.81 162.44 19.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.099 0.476 . . . . 0.0 111.535 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.528 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -131.3 147.27 52.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.471 ' CE1' ' CB ' ' A' ' 662' ' ' ASN . 2.4 t80 -147.44 144.93 28.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.535 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.22 133.34 47.83 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.607 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 2.5 mt -114.8 124.84 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.677 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 0.6 OUTLIER -114.91 151.53 33.87 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.464 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 706' ' ' GLY . 8.2 t70 -49.07 119.41 3.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 110.405 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.29 36.4 5.95 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.46 110.09 22.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.737 0.303 . . . . 0.0 111.336 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.75 108.82 21.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.06 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 8.9 mt -105.61 136.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.897 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.15 116.48 28.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.679 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.546 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -84.72 -34.05 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.581 -178.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.45 ' CG2' ' HB ' ' A' ' 690' ' ' ILE . 1.5 tp -154.58 131.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.135 0.493 . . . . 0.0 111.866 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -136.26 126.81 26.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.046 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.03 116.9 21.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.416 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -67.36 -46.71 72.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.873 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.11 -40.42 27.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.622 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -85.07 -10.55 56.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.427 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.9 mttt 59.82 19.2 8.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.38 104.76 8.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.7 p -125.64 123.82 65.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 112.195 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.467 HG22 HD12 ' A' ' 690' ' ' ILE . 19.0 mt -128.32 154.87 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.424 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.442 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.24 135.75 2.76 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.113 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.481 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 5.9 m-30 -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.289 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -100.95 117.06 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.721 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.6 t -78.84 126.45 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.373 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.7 tt0 -133.29 109.33 9.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 110.59 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 47.0 mt -82.89 105.68 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.102 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -87.86 -45.98 9.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.826 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.6 140.95 44.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.407 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.8 p -113.77 99.49 7.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.325 0.583 . . . . 0.0 109.669 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 8.6 t -81.67 60.15 4.49 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.198 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 69.09 59.01 6.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.613 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 645' ' ' ASP . 1.2 mm? -79.39 143.64 34.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.735 0.302 . . . . 0.0 111.119 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.477 ' HA ' ' HB2' ' A' ' 644' ' ' LEU . 3.5 p90 -44.54 -33.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.495 0.665 . . . . 0.0 110.369 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.559 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -141.13 -42.24 0.38 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.557 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.559 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 16.0 pt-20 135.17 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.242 1.017 . . . . 0.0 109.388 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 115.92 15.35 7.37 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.708 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.99 7.5 24.17 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.519 -0.4 . . . . 0.0 111.968 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 107.65 -50.34 0.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.761 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.421 ' O ' ' C ' ' A' ' 710' ' ' LEU . 9.9 ttp 68.79 117.47 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.751 0.31 . . . . 0.0 110.285 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 709' ' ' MET . 0.2 OUTLIER -28.64 144.82 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.082 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 49.13 44.68 23.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.244 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -62.97 109.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.907 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -82.24 102.04 10.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.707 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -96.24 76.57 3.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.53 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.3 143.17 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.421 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.426 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 12.7 t -80.55 125.09 39.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.629 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.421 HD11 ' CZ3' ' A' ' 648' ' ' TRP . 0.5 OUTLIER -102.55 168.68 9.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.482 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 144.91 30.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -82.61 158.52 23.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -175.01 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.171 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.79 60.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.37 -46.56 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -66.69 -47.8 71.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.767 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -59.99 -33.11 71.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -63.14 -39.58 95.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.53 -44.02 96.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.0 p -80.62 -27.9 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -54.2 -34.4 60.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.09 -24.1 40.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.442 ' CD1' ' CG ' ' A' ' 602' ' ' PHE . 10.2 tt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.834 0.349 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 13.1 m -96.05 80.94 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.08 83.85 0.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.957 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 1.3 pp -155.72 169.37 24.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.57 92.41 4.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.797 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.52 133.15 55.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 6.8 mt -109.3 149.89 40.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.581 2.188 . . . . 0.0 112.228 179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -89.55 10.05 24.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.625 0.25 . . . . 0.0 111.316 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 160.6 -26.86 0.3 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.382 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? -106.63 140.28 39.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.005 0.431 . . . . 0.0 111.241 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.544 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -126.9 -62.86 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 6.8 tt -106.42 142.23 36.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 695' ' ' GLU . 7.1 m -124.55 114.62 19.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.8 OUTLIER -104.25 108.42 19.81 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.0 100.22 53.28 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 24.5 Cg_exo -45.43 104.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.565 1.51 . . . . 0.0 109.105 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.39 156.98 86.92 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.487 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -49.88 -31.6 27.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.663 2.909 . . . . 0.0 112.908 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.82 -21.49 66.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.465 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.663 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 24.7 p -96.46 153.23 17.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.201 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 3.9 tt -52.46 -19.47 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.633 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 588' ' ' ILE . 40.4 mt -110.62 118.54 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.299 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -109.7 60.81 0.6 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.298 0.571 . . . . 0.0 110.841 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.558 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 29.3 mt-10 -125.48 171.91 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.668 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.24 127.7 44.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 178.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.6 137.72 50.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.616 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.9 OUTLIER -124.12 119.53 29.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.485 HG12 ' CD1' ' A' ' 601' ' ' PHE . 80.3 mt -86.68 109.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.113 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -68.99 122.5 18.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.996 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.544 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.6 -29.56 1.88 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.449 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.69 -25.2 74.08 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.823 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.13 118.12 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.002 0.901 . . . . 0.0 111.661 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -140.09 122.63 10.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.844 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.1 Cg_endo -89.93 159.66 34.36 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 124.352 -1.104 . . . . 0.0 111.695 -0.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.4 t80 -91.93 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.571 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 58.9 m-85 -92.77 138.16 31.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.665 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.61 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.1 mp -128.12 144.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.66 -173.21 40.56 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.68 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 9.1 ttp85 -75.88 -18.39 59.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.324 0.249 . . . . 0.0 111.372 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.16 129.96 35.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.36 -23.0 21.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -55.07 -30.37 59.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.085 0.469 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 34.8 m -73.44 127.99 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.829 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 32.8 m120 -44.31 -33.93 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.306 0.574 . . . . 0.0 110.298 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.61 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 54.1 t -104.36 143.04 33.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.172 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.79 113.53 20.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . . . . . . . . . 26.5 mm -137.95 109.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.447 177.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.9 pt-20 -97.28 105.23 17.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.513 0.673 . . . . 0.0 112.291 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.545 ' HB3' ' CD1' ' A' ' 618' ' ' LEU . 38.3 t0 -131.43 123.05 27.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.062 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -47.63 -29.23 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.75 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.76 -39.35 44.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.545 ' CD1' ' HB3' ' A' ' 615' ' ' ASP . 2.2 mp -65.88 159.22 26.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.786 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.0 m -110.61 172.08 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.433 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -47.84 31.76 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 110.174 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.45 56.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.482 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.488 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 49.3 t60 -43.67 -47.63 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.598 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 2.7 p -165.6 151.65 9.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.542 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.0 p90 -143.29 146.9 33.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.829 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.41 ' CD1' HD11 ' A' ' 603' ' ' ILE . 3.4 mp -101.86 127.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -120.37 134.33 55.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.427 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 27.2 ttmt -97.82 136.5 38.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.075 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.59 158.29 44.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.833 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.4 113.98 15.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.334 0.588 . . . . 0.0 110.572 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 -70.86 131.05 43.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.132 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -174.7 168.34 3.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.41 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 6.4 p -147.05 159.59 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.059 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -75.05 110.72 3.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.505 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 2.0 mttm 63.3 142.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.836 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.08 48.09 1.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -59.29 123.48 16.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 11.7 t80 68.34 -68.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -78.02 127.7 32.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.817 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 29.1 t -110.92 99.68 43.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.49 -150.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.65 2.233 . . . . 0.0 111.748 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 642' ' ' GLN . . . -89.35 9.89 24.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.665 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 641' ' ' ALA . 19.6 mt-30 81.23 -72.12 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.285 0.234 . . . . 0.0 111.104 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -179.19 90.88 0.08 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.411 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.493 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.6 mp -122.7 -155.3 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.0 m-20 -122.05 146.43 47.19 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.239 0.543 . . . . 0.0 112.033 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.437 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -132.17 160.56 35.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.439 HG23 ' CE2' ' A' ' 577' ' ' PHE . 0.8 OUTLIER -107.9 121.94 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.482 0.658 . . . . 0.0 112.274 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.537 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 79.4 m95 -106.0 124.65 49.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.168 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 7.3 t80 -90.39 116.92 28.71 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 26.6 m -102.11 144.08 31.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.254 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 18.3 t60 -131.03 124.28 30.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.404 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 1.4 p -121.13 6.69 10.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.06 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.48 148.11 35.11 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.278 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.5 t -69.84 -34.7 73.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.795 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.559 ' O ' ' O ' ' A' ' 656' ' ' VAL . 51.5 m-80 -70.56 -2.51 14.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.608 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.559 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.72 133.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.434 0.635 . . . . 0.0 111.893 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 81.8 p -103.06 165.59 10.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.816 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.5 120.26 30.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.775 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.443 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -100.84 101.33 12.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 59.78 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 65.1 t30 -133.47 -2.2 3.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.521 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 1.3 t-20 -104.98 141.41 36.61 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.197 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.89 141.2 33.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.24 100.11 9.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.691 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.422 HD12 HG21 ' A' ' 665' ' ' ILE . 37.7 pt -87.12 134.9 26.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.963 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' A' ' 652' ' ' THR . 1.2 tt0 -38.49 98.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.988 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 37.38 1.17 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.1 p -139.21 158.37 44.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.703 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 12.6 pttm -123.61 158.2 32.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.683 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.3 OUTLIER -145.08 146.3 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.537 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.95 130.92 44.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.86 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 0.9 OUTLIER -109.81 118.65 37.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 111.625 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 3.0 mt-30 -108.52 138.31 45.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.438 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 706' ' ' GLY . 8.7 t70 -38.88 116.95 0.62 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.84 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.8 35.28 6.19 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.43 114.89 27.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.86 108.52 20.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 13.0 mt -107.91 131.79 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.898 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 115.65 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.567 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.495 ' CG2' HD12 ' A' ' 618' ' ' LEU . 1.1 mt -78.01 -36.05 21.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.364 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.413 ' O ' HG21 ' A' ' 681' ' ' ILE . 1.0 OUTLIER -155.14 131.91 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 111.73 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -136.21 125.75 25.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -127.11 116.9 21.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.924 0.393 . . . . 0.0 110.318 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -67.22 -46.55 73.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.895 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -74.46 -40.29 61.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.77 -11.97 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.451 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt 61.61 16.94 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.727 0.298 . . . . 0.0 111.019 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 2.3 t80 -82.27 105.49 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -125.95 121.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.214 0.531 . . . . 0.0 111.997 -178.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.436 HG12 ' CG2' ' A' ' 587' ' ' ILE . 31.5 mt -117.73 130.82 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.63 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -154.91 130.85 2.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.421 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.466 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 3.4 m-30 -113.33 143.91 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.863 0.363 . . . . 0.0 110.38 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.47 117.35 34.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.03 0.443 . . . . 0.0 110.682 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.425 HG23 ' CD2' ' A' ' 580' ' ' LEU . 3.0 t -79.97 127.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.515 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -133.39 109.53 9.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 52.2 mt -83.19 105.14 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.36 -46.58 12.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.279 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.08 140.68 45.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 7.2 p -114.24 99.4 7.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.316 0.579 . . . . 0.0 109.568 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 88.3 m -76.75 67.91 2.9 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.238 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 61.25 55.63 28.2 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.452 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.6 tp -81.51 141.42 33.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.121 0.486 . . . . 0.0 111.595 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.493 ' CA ' ' HB2' ' A' ' 644' ' ' LEU . 2.9 p90 -44.42 -33.87 1.83 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.07 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -140.42 -47.22 0.42 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.001 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 17.0 pt-20 136.28 -35.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.964 0.906 . . . . 0.0 109.179 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 120.64 18.18 4.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.968 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.62 1.87 36.13 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.473 -0.428 . . . . 0.0 111.684 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 48.69 95.48 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.985 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.65 138.07 47.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 0.0 110.821 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.7 -166.42 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.717 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.85 -106.42 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.661 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -114.94 98.91 7.09 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.83 0.347 . . . . 0.0 110.994 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.1 102.53 9.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.683 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER 167.39 130.37 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.298 0.57 . . . . 0.0 110.526 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.79 146.28 28.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.537 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.11 130.2 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.808 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.07 172.43 6.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.23 158.05 15.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -95.88 160.27 14.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.1 p -120.2 -174.44 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.91 58.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -60.78 -48.17 82.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -64.12 -48.86 74.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -53.1 -33.47 52.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.21 -36.91 80.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 38.4 mt -56.65 -44.31 81.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.166 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.2 p -80.86 -21.25 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -67.82 -39.2 83.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.752 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -79.02 -11.69 60.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.198 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.433 HD11 ' CD1' ' A' ' 602' ' ' PHE . 7.2 tt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.052 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.787 0.327 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.14 73.96 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.17 74.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.942 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.06 159.28 41.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.779 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . 0.406 ' N ' ' P ' ' P' ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -36.14 70.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.859 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 59.92 90.29 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 43.8 mt -59.72 139.3 89.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.465 2.11 . . . . 0.0 112.317 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -83.65 0.18 48.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.549 0.214 . . . . 0.0 111.521 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 131.05 -1.87 5.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.998 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.443 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.9 OUTLIER -100.93 131.71 46.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.762 0.281 . . . . 0.0 110.487 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -121.69 -62.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 111.476 -179.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.431 ' N ' ' CG ' ' A' ' 577' ' ' PHE . 5.7 tt -105.93 125.99 51.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 19.4 m -102.46 119.19 38.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.268 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 592' ' ' LEU . 4.7 mt -105.64 108.54 20.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -117.97 100.72 52.09 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.125 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.7 Cg_exo -46.14 101.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.778 1.652 . . . . 0.0 109.451 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 157.97 84.72 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.7 Cg_endo -50.06 -25.75 13.33 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.461 2.774 . . . . 0.0 112.244 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.36 -26.47 68.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.403 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 54.5 p -95.4 153.47 17.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.711 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 1.0 OUTLIER -58.7 -14.16 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.56 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 73.0 mt -106.49 118.67 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.315 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -105.35 57.58 0.68 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 110.524 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.603 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.5 mt-10 -124.76 169.39 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.79 122.28 26.89 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.573 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.7 OUTLIER -113.17 150.31 32.43 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.392 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.44 125.34 44.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.509 HG12 ' CD1' ' A' ' 601' ' ' PHE . 93.9 mt -83.51 108.97 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.608 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.4 mp0 -64.16 122.84 17.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.507 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.63 -30.06 3.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.258 0.551 . . . . 0.0 110.021 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.463 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -73.42 -20.94 79.97 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.926 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 61.0 t -98.62 118.04 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 118.108 0.954 . . . . 0.0 111.642 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -140.18 121.6 9.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.002 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.55 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.0 Cg_endo -90.56 159.34 31.11 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.442 -1.066 . . . . 0.0 111.511 -0.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.3 t80 -91.78 115.6 28.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.556 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.6 m-85 -92.54 137.94 31.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.349 -177.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.492 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.2 mp -123.97 145.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.438 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 157.67 -169.85 34.58 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.317 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.573 ' HG2' HD21 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -69.83 -48.74 57.82 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.441 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.21 124.28 19.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -178.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -19.44 5.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.665 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.48 -30.15 66.77 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 98.0 m -68.8 133.04 47.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.446 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 32.6 m120 -45.54 -30.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.19 0.519 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 32.8 t -113.1 142.34 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.373 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 105.92 15.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.425 HG13 ' CE2' ' A' ' 692' ' ' PHE . 24.8 mm -138.39 109.71 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.441 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.22 106.89 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.584 0.707 . . . . 0.0 112.657 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.455 ' C ' ' HD3' ' A' ' 605' ' ' ARG . 27.1 t0 -129.42 107.11 9.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.724 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.48 -30.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.407 ' HB2' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -77.98 -37.56 47.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.498 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.573 HD21 ' HG2' ' A' ' 605' ' ' ARG . 0.0 OUTLIER -89.63 134.09 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.66 165.52 0.41 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.475 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -59.45 -21.64 60.35 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.27 56.58 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.535 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 14.1 t60 -41.86 -37.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.39 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.0 p -170.09 160.05 7.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.248 0.547 . . . . 0.0 112.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.556 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 40.6 p90 -143.37 147.59 34.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.172 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.55 130.83 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.0 t80 -122.96 133.8 54.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.891 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.426 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 3.0 tppp? -98.07 136.66 37.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.465 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.65 159.14 41.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.737 -178.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -76.41 112.45 12.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.355 0.598 . . . . 0.0 110.705 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.4 t60 -75.1 124.49 27.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.698 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -164.22 98.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.077 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 7.4 m -60.65 162.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.153 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -59.73 89.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.54 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 59.48 -177.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.23 103.75 4.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.042 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.77 123.19 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.719 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.87 -65.46 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.839 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -75.91 144.3 41.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.675 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 74.6 m -105.01 102.46 36.01 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.096 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.81 -150.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.676 2.251 . . . . 0.0 111.81 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -93.61 32.51 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 0.0 111.339 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.29 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 172.27 84.88 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.656 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.9 mp -120.03 -153.23 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 702' ' ' LEU . 9.9 m-20 -112.63 146.93 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.404 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -129.59 160.09 34.35 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.275 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.416 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.9 pt -106.53 126.86 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.6 0.714 . . . . 0.0 112.892 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.518 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 82.7 m95 -111.22 128.55 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.687 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.436 ' CD1' HD12 ' A' ' 678' ' ' ILE . 20.2 t80 -90.76 117.8 29.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 624' ' ' PHE . 38.4 m -102.8 131.87 49.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.471 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 47.4 t60 -111.91 130.85 55.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.6 p -131.47 12.42 4.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.342 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.32 154.27 32.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.295 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 55.3 m -83.61 -24.15 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.741 0.305 . . . . 0.0 111.381 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.9 OUTLIER -82.6 4.14 25.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 53.27 133.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 111.981 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.457 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 60.0 m -102.0 166.17 10.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.376 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.407 ' O ' ' N ' ' A' ' 679' ' ' LYS . 34.9 m-85 -130.61 120.01 23.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -100.15 103.54 15.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.872 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 60.56 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.768 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.8 m120 -136.43 6.03 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.508 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.457 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.0 OUTLIER -107.37 142.0 37.86 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.804 0.335 . . . . 0.0 111.001 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 24.8 ttt-85 -78.02 141.39 38.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.402 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 42.7 mmm -121.9 93.02 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.542 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 36.1 pt -87.71 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -47.25 96.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.115 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.26 41.47 0.81 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.0 p -128.94 162.15 28.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.056 0.455 . . . . 0.0 111.86 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.454 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -134.73 146.71 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.448 ' HE1' ' N ' ' A' ' 715' ' ' VAL . 0.2 OUTLIER -147.54 145.5 29.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.518 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.84 133.22 47.98 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.705 179.341 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.412 HD21 ' CB ' ' A' ' 649' ' ' TYR . 0.4 OUTLIER -108.59 119.15 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.153 0.501 . . . . 0.0 111.443 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 9.6 mt-30 -106.67 139.73 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.828 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 706' ' ' GLY . 41.1 t0 -40.8 114.8 0.51 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 110.732 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.78 36.69 5.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.65 115.38 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.056 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -96.55 108.68 21.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.436 HD12 ' CD1' ' A' ' 649' ' ' TYR . 23.4 pt -108.27 129.1 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 0.0 111.946 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -89.22 116.03 27.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.307 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.477 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 3.0 mt -78.31 -36.0 20.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.566 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.437 HG22 ' CG1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -154.92 131.87 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.35 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -136.1 128.34 30.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 111.501 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -127.14 116.37 20.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.14 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.48 -46.47 72.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.16 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.83 -40.37 65.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -90.55 -10.33 43.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 15.97 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.663 0.268 . . . . 0.0 111.064 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.474 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.7 t80 -76.48 104.78 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.95 125.96 74.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.839 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.459 ' CD1' HG12 ' A' ' 587' ' ' ILE . 33.1 mm -127.93 125.62 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.36 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -160.7 136.74 4.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.136 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 8.1 m-30 -112.99 148.76 34.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.348 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' A' ' 578' ' ' LEU . 3.3 t -79.2 121.17 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.702 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.97 109.37 11.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.867 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.442 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 64.1 mt -78.31 110.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.33 -45.45 6.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.426 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 7.5 t70 -111.04 140.64 45.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.4 OUTLIER -114.46 100.39 8.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 178.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 10.0 t -77.07 63.71 2.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.743 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 72.69 37.35 57.7 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.044 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -81.81 136.99 35.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.657 0.265 . . . . 0.0 111.209 -179.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 5.5 p90 -47.0 -34.85 6.0 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.452 0.644 . . . . 0.0 110.481 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.611 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 0.7 OUTLIER -148.37 -53.4 0.19 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.383 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 8.5 pt-20 144.23 -50.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.096 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.611 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 159.69 79.87 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.766 -1.107 . . . . 0.0 112.127 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.463 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.14 -9.88 17.48 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.532 -0.393 . . . . 0.0 111.43 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.43 ' CA ' ' NE2' ' A' ' 673' ' ' GLN . . . 103.23 28.62 6.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.837 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.454 ' CE ' ' CE1' ' A' ' 630' ' ' HIS . 18.3 mmm 60.39 -143.26 0.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.704 0.287 . . . . 0.0 110.506 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.4 tp -56.92 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.221 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -41.16 -86.13 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.515 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -114.69 98.46 6.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.89 0.376 . . . . 0.0 111.175 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 100.95 8.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.682 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.475 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 14.3 mmm-85 -154.94 77.27 1.02 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.007 0.432 . . . . 0.0 111.737 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.448 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.5 m -123.77 140.99 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.717 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.457 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 92.1 t -82.69 121.87 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.439 . . . . 0.0 111.482 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.72 167.52 11.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.377 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.09 150.42 23.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.209 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.77 149.02 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 31.7 p -126.15 -173.62 2.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.405 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -61.86 -28.69 69.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.159 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.13 -53.2 58.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 720' ' ' THR . 2.5 pp20? -70.6 -37.74 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -58.53 -34.93 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.544 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 728' ' ' LYS . 10.2 t70 -68.14 -39.35 82.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 723' ' ' GLU . 17.0 mt -58.27 -44.17 88.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.03 -23.78 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.576 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 725' ' ' ASP . 0.0 OUTLIER -50.49 -48.82 56.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.066 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -27.31 67.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.919 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.445 ' CD1' ' CG ' ' A' ' 602' ' ' PHE . 1.6 tt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.806 0.336 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.82 120.72 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 60.38 31.79 20.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 10.6 tp -142.36 157.59 44.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -105.23 83.0 1.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.794 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.25 126.6 15.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.129 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 9.6 mt -90.0 143.03 29.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.838 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.472 2.115 . . . . 0.0 112.3 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -74.56 -22.13 59.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.675 0.274 . . . . 0.0 111.13 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 143.32 -15.8 2.29 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.748 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.4 tmm_? -107.7 134.85 50.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 111.314 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.6 ' CD1' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -122.3 -52.79 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.6 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 1.4 tt -107.04 140.42 39.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.112 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.448 ' N ' HD22 ' A' ' 578' ' ' LEU . 23.8 m -118.52 113.55 21.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.755 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.7 OUTLIER -105.7 108.85 20.57 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.1 ptpt -117.01 99.86 53.11 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.1 Cg_exo -45.98 104.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.893 1.729 . . . . 0.0 109.503 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.18 157.39 85.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -176.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.1 Cg_endo -50.72 -27.73 20.78 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.603 2.869 . . . . 0.0 112.53 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.54 -26.72 68.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.64 153.57 17.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.157 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 8.1 pt -57.14 -12.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.977 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 38.9 mt -108.87 118.82 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.637 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -107.65 59.33 0.62 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.146 179.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.656 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mm-40 -125.57 170.04 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.264 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.2 116.73 18.06 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.304 178.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.8 OUTLIER -113.53 143.56 44.32 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.17 123.92 40.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.561 HG12 ' CD2' ' A' ' 601' ' ' PHE . 78.7 mt -75.23 108.84 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 1.6 mp0 -59.44 116.78 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.939 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.501 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -30.44 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.273 0.559 . . . . 0.0 110.118 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.441 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.88 -16.12 79.54 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.671 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.77 117.77 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 118.009 0.905 . . . . 0.0 111.212 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.46 123.91 10.31 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.166 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 34.6 Cg_endo -91.38 158.85 27.27 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.349 -1.105 . . . . 0.0 112.052 -0.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.0 t80 -93.1 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.135 0.493 . . . . 0.0 109.752 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 1.1 m-85 -93.44 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.492 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.9 mp -127.21 143.99 38.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.3 -163.61 31.6 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.504 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.485 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -73.57 -41.7 62.59 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.331 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 28.6 t -60.69 119.9 9.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.551 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.15 -18.65 10.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -62.45 -30.05 70.96 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.235 0.54 . . . . 0.0 109.614 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 61.5 m -67.1 128.05 34.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.378 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.8 m120 -44.1 -31.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.558 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.507 ' HB3' HG13 ' A' ' 603' ' ' ILE . 42.2 t -108.62 135.53 49.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.03 109.08 20.03 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.434 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 24.0 mm -138.2 109.46 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.97 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -103.26 105.17 15.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.591 0.71 . . . . 0.0 112.22 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.498 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 1.0 OUTLIER -130.92 108.3 9.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.422 177.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -39.34 -29.75 0.05 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.403 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 8.3 mpt_? -70.62 -41.12 72.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.588 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -86.64 158.69 19.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 111.443 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 45.8 t -86.36 176.45 7.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.426 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -52.17 -51.75 56.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.479 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.404 ' O ' ' OG1' ' A' ' 652' ' ' THR . 38.5 t -109.22 57.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.588 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 50.4 t60 -46.26 -38.09 8.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.937 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.12 174.9 10.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.531 0.681 . . . . 0.0 111.773 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.46 136.22 25.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.963 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 62.9 mt -132.37 117.05 30.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -134.4 147.49 50.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 111.552 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.456 ' HB2' HG22 ' A' ' 647' ' ' ILE . 16.3 ttmt -101.23 137.55 39.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.562 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 157.19 44.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.118 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.05 118.07 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.5 t60 -81.41 132.53 35.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.824 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -165.42 103.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.217 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 28.7 m -67.76 173.88 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.035 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -57.87 -101.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.539 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -119.55 143.84 47.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.339 . . . . 0.0 110.735 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.29 142.77 51.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.961 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 21.1 ttp -121.3 129.99 53.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.81 -64.11 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.055 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -75.57 141.56 42.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.778 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.31 91.6 5.9 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.118 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.3 -161.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.523 2.149 . . . . 0.0 112.086 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -45.03 -30.45 1.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.535 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 63.27 -78.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -160.14 51.35 0.37 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.73 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 630' ' ' HIS . 0.3 OUTLIER -93.08 -157.36 0.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.7 OUTLIER -123.0 147.34 46.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.088 0.47 . . . . 0.0 111.932 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.408 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -135.76 137.97 42.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.175 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.471 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -90.26 124.87 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-O 121.331 0.586 . . . . 0.0 111.67 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.504 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 92.7 m95 -110.08 131.22 55.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.651 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -100.34 117.3 34.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.592 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.3 m -111.66 145.12 39.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.549 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.442 ' HB2' ' HG2' ' A' ' 664' ' ' MET . 23.5 t60 -119.55 125.2 48.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.398 . . . . 0.0 111.463 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.483 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 4.2 p -120.27 9.13 10.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.929 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.96 -178.99 47.85 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.74 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 655' ' ' ASN . 11.7 t -105.55 -45.07 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 111.642 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 617' ' ' ARG . 5.8 m-80 -60.04 -16.08 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.854 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 4.2 t 79.06 143.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.786 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.418 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 37.9 m -115.39 165.9 12.47 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -137.58 119.61 15.44 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.119 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.483 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -101.61 107.14 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.308 -179.07 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 56.12 -82.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 659' ' ' LEU . 30.3 m-80 -133.92 4.46 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.644 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.501 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 9.5 m120 -106.84 125.85 51.54 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.915 0.388 . . . . 0.0 111.306 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.0 ttm105 -65.95 141.24 58.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.509 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.448 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -114.7 85.71 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.584 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 38.3 pt -87.05 149.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.682 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 652' ' ' THR . 17.1 tt0 -45.62 100.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.542 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 111.81 37.7 1.52 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.603 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 3.0 p -128.9 162.58 27.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.482 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 717' ' ' LEU . 3.5 ttpm? -138.31 144.93 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.123 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.501 ' CE2' ' HB2' ' A' ' 662' ' ' ASN . 0.8 OUTLIER -147.02 145.53 29.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.109 0.48 . . . . 0.0 111.862 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.504 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.8 140.63 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.646 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 1.2 mt -106.87 123.88 48.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.154 0.502 . . . . 0.0 110.852 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.706 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 10.0 mt-30 -102.28 133.02 47.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.123 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.477 ' H ' ' HA ' ' A' ' 707' ' ' LEU . 12.5 t0 -44.5 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 109.931 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.48 36.29 3.34 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.87 122.63 33.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.045 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.15 108.16 20.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.51 137.52 34.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.867 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -101.74 116.44 32.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.988 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.5 HG23 ' CD2' ' A' ' 622' ' ' HIS . 6.3 mt -82.8 -35.91 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.133 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.417 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.3 tt -154.7 131.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.714 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -136.37 119.84 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.173 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.22 116.57 20.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.678 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -46.6 71.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.877 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.68 -40.72 93.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.181 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -105.19 2.93 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.94 22.59 3.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.725 0.298 . . . . 0.0 110.973 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.3 OUTLIER -76.82 104.88 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.6 p -122.8 122.79 66.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 111.768 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 3.0 mt -127.9 126.07 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.478 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.91 139.98 6.59 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.78 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.477 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 3.2 m-30 -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 0.0 110.483 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -101.01 116.89 33.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.128 0.489 . . . . 0.0 110.312 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.506 HG22 HD23 ' A' ' 578' ' ' LEU . 2.2 t -81.79 120.0 32.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.5 109.22 9.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 13.8 mt -77.82 104.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.04 -45.02 21.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.24 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.44 141.63 43.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.63 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 8.1 p -114.1 99.72 7.85 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.262 0.553 . . . . 0.0 109.632 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 35.1 m -75.07 66.84 1.68 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.409 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 60.19 57.01 21.4 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.645 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -86.87 125.39 33.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.641 0.258 . . . . 0.0 111.441 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 704' ' ' ASN . 8.2 p90 -36.48 -43.74 0.41 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.419 0.628 . . . . 0.0 111.05 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.508 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 1.2 t30 -118.33 -43.35 2.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.409 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 9.8 pt-20 146.6 -19.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.208 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 109.03 24.79 5.87 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.094 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.477 ' HA ' ' H ' ' A' ' 674' ' ' ASP . 0.0 OUTLIER -104.3 7.48 35.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.864 0.466 . . . . 0.0 112.092 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 131.04 179.98 16.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.007 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -143.88 130.32 19.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 110.778 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.75 -166.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.077 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 69.79 -65.64 0.3 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.741 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.92 122.32 42.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.365 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -82.69 99.42 9.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.082 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.488 ' NH1' ' O ' ' A' ' 671' ' ' LEU . 0.0 OUTLIER 32.2 94.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.718 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.58 140.68 47.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.049 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.68 124.19 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.164 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 669' ' ' LYS . 3.2 mt -90.13 172.63 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.844 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.92 156.61 17.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.043 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.4 144.3 25.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.752 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 70.9 p -126.36 -176.81 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.8 37.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.269 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -55.97 -51.51 67.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.598 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.423 ' HA ' ' CD1' ' A' ' 726' ' ' LEU . 0.1 OUTLIER -70.18 -49.8 46.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.631 179.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -58.77 -32.12 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.97 -43.48 92.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.49 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 723' ' ' GLU . 1.4 mt -57.51 -44.49 85.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.112 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.4 p -78.45 -14.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.461 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -25.83 19.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.327 . . . . 0.0 111.179 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -116.05 29.59 7.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.045 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.415 HD11 ' CD2' ' A' ' 602' ' ' PHE . 3.4 tt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.706 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.08 68.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -122.93 71.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 25.1 tp -172.22 135.34 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.755 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . 0.512 ' P ' ' N ' ' P' ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -60.12 -37.25 79.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.563 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 59.87 155.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.033 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 4.0 mt -140.95 87.53 10.92 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.501 2.134 . . . . 0.0 112.324 179.944 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.163 -0.375 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -84.8 -16.25 42.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.423 ' HA2' ' OE1' ' A' ' 596' ' ' GLN . . . 161.55 -22.57 0.22 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.768 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.443 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.7 tmm_? -106.08 139.38 40.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.606 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 1.3 t80 -127.94 -52.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.998 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.488 ' CD1' HG11 ' A' ' 694' ' ' VAL . 5.3 tp -115.45 125.6 53.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.444 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 11.5 m -105.2 114.12 28.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.8 OUTLIER -106.09 108.83 20.54 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.0 mtmm -113.84 100.04 51.44 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.623 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_exo -45.01 100.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.923 1.749 . . . . 0.0 109.724 177.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.99 157.33 85.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.02 -25.28 12.26 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.698 2.932 . . . . 0.0 113.075 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -28.23 69.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.436 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.5 t -96.12 154.03 17.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.622 178.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 8.6 pt -58.55 -10.21 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.733 0.301 . . . . 0.0 111.121 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 54.6 mt -108.55 118.85 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.736 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.436 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -108.75 60.27 0.6 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.22 0.533 . . . . 0.0 110.33 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.623 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.8 mt-10 -124.73 171.64 9.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.5 123.7 34.21 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -112.75 139.89 47.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 9.4 mt-10 -124.65 111.45 15.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 601' ' ' PHE . 30.8 mt -72.21 108.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.947 0.403 . . . . 0.0 110.071 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.2 mp0 -68.03 116.56 8.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.871 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.606 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.29 -30.44 2.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.228 0.537 . . . . 0.0 110.475 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.453 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.22 -21.59 77.23 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.348 -0.842 . . . . 0.0 113.557 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.07 118.42 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -140.14 124.18 10.75 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.919 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.471 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 42.8 Cg_endo -90.63 159.22 30.73 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.232 0.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 1.9 t80 -92.67 114.27 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.562 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 0.4 OUTLIER -93.38 139.09 31.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.127 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.7 mp -127.07 143.79 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.894 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 156.52 -165.72 33.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.477 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.455 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -70.19 -42.61 72.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.92 -179.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 11.3 t -60.42 121.79 12.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.633 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.55 -18.18 18.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.335 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -64.2 -29.18 70.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.142 0.496 . . . . 0.0 109.665 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.0 m -66.96 128.87 37.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.199 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -44.05 -31.21 0.87 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.079 0.466 . . . . 0.0 110.501 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 43.1 t -110.53 142.06 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 107.5 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.412 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 24.5 mm -138.61 109.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.811 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -104.08 106.22 16.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.536 0.684 . . . . 0.0 112.723 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.485 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 2.0 t0 -130.85 107.73 9.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.685 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -39.25 -28.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.2 OUTLIER -73.7 -38.6 64.81 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.617 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.5 OUTLIER -88.41 158.98 18.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.528 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.43 ' HB3' ' P ' ' P' ' 603' ' ' TPO . 1.6 p -83.56 168.76 16.1 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.498 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 4.4 ptp180 -51.24 -46.13 62.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.017 0.437 . . . . 0.0 110.322 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.55 60.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.617 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 13.9 t60 -52.92 -39.71 63.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.926 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.99 175.26 10.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.595 0.712 . . . . 0.0 111.872 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -144.92 142.21 29.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.183 -178.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.474 HG23 HD11 ' A' ' 625' ' ' ILE . 61.4 mt -133.26 116.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 3.0 t80 -132.88 138.7 47.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.586 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.7 ttmt -98.45 136.71 38.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.437 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.36 158.52 44.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.661 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -76.76 116.12 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.178 0.513 . . . . 0.0 110.627 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.1 t60 -82.33 129.56 34.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.602 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -158.71 149.61 20.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.241 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 21.0 m -112.82 -177.5 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -51.87 -85.23 0.02 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.705 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -148.5 40.48 0.93 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.828 0.346 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 25.3 p 49.63 86.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.5 ttp -65.95 100.61 0.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.39 -69.07 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.994 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -81.71 141.45 33.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.31 107.12 52.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.98 -149.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.55 2.167 . . . . 0.0 111.884 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -92.29 38.27 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.531 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 54.89 -167.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 111.046 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -89.07 93.97 1.95 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -105.5 -155.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -116.13 147.74 41.04 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.414 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -134.83 142.88 46.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 5.1 pt -94.76 120.63 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.374 0.607 . . . . 0.0 111.593 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.511 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 96.2 m95 -104.97 125.89 51.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.867 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -90.93 117.44 29.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.94 144.87 36.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.621 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.471 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -115.0 129.98 56.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 3.3 p -127.53 10.45 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.47 152.17 26.21 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.558 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.2 t -76.07 -30.82 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.72 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -75.08 2.05 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.027 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.08 122.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.471 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.2 p -93.15 165.94 12.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.173 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 57.1 m-85 -131.96 119.64 21.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 0.0 110.697 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -95.06 100.53 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.606 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.9 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 22.7 m120 -132.05 -0.3 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.342 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.445 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.8 m-80 -95.36 141.62 28.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.825 0.345 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 3.5 ttm105 -81.96 141.05 33.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.227 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.401 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 31.6 mmm -129.35 108.93 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 111.047 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 3.1 pt -98.95 165.06 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.71 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.72 90.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.94 0.4 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.08 35.19 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.504 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.33 162.06 18.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.832 0.349 . . . . 0.0 111.127 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.427 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.2 ttpt -139.52 138.88 36.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.49 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.05 143.37 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.511 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -71.3 140.31 50.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.206 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 4.3 mt -108.28 127.37 53.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.783 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.541 ' HB3' ' HA ' ' A' ' 707' ' ' LEU . 1.3 mt-30 -106.67 149.94 26.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.772 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.426 ' HB2' HD12 ' A' ' 696' ' ' ILE . 6.0 t70 -47.66 106.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.038 0.447 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.99 36.3 4.52 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.603 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 7.6 t70 -92.13 113.33 25.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.305 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.58 112.16 24.01 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.22 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 22.4 pt -105.41 128.84 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.96 0.41 . . . . 0.0 111.62 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 10.9 mmtp -87.27 116.54 25.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.988 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.444 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -81.0 -36.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.377 -179.248 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 617' ' ' ARG . 4.7 tt -154.71 131.74 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 111.738 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -136.11 124.91 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.13 116.94 21.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.399 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -67.34 -46.66 72.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -74.06 -40.5 62.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.843 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -89.76 -8.65 51.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.548 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.26 19.11 7.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.721 0.296 . . . . 0.0 110.888 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.89 104.88 7.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.5 p -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.016 0.436 . . . . 0.0 111.858 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.409 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 5.0 mt -128.18 152.49 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.358 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.424 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.58 140.93 3.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.281 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 3.0 m-30 -113.65 153.39 28.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 0.0 110.492 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -100.85 117.12 34.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 676' ' ' ASP . 2.2 t -81.13 125.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.53 108.22 8.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.357 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 705' ' ' GLU . 18.9 mt -78.15 105.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -86.27 -46.95 9.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.893 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 27.5 t70 -110.85 140.45 45.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.434 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p -114.63 99.63 7.67 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.292 0.568 . . . . 0.0 109.53 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 74.7 p -70.15 73.87 0.48 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.459 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 55.08 48.43 67.88 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.605 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -86.55 140.12 30.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.899 0.381 . . . . 0.0 111.621 -179.076 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.476 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -50.19 -27.38 5.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.328 0.585 . . . . 0.0 109.902 178.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.433 ' ND2' ' HG3' ' A' ' 705' ' ' GLU . 2.5 t30 -158.08 -57.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.946 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.498 ' HB2' HD11 ' A' ' 696' ' ' ILE . 4.9 pt-20 164.4 -30.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.118 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 141.18 30.7 0.16 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.639 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 673' ' ' GLN . 10.0 mt -90.97 7.54 39.77 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.125 0.463 . . . . 0.0 111.887 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 709' ' ' MET . . . 67.88 -76.34 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.71 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 708' ' ' GLY . 0.0 OUTLIER 41.34 33.3 0.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.605 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.43 -164.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.693 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -51.72 -71.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.92 0.39 . . . . 0.0 110.898 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -71.8 131.75 43.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.654 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.82 100.67 10.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.962 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.413 ' HD3' ' NE2' ' A' ' 673' ' ' GLN . 10.2 mmm-85 46.93 87.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.445 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.62 148.71 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.762 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 86.2 t -80.9 130.44 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.251 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.37 166.49 10.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.2 144.86 30.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -88.21 146.52 25.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.16 -176.88 3.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.612 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.17 -28.93 43.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.269 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -55.79 -52.81 62.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.649 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.429 ' HA ' ' CD1' ' A' ' 726' ' ' LEU . 2.7 mp0 -70.6 -48.15 56.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.641 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -57.36 -32.28 66.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.92 -40.85 83.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.429 ' CD1' ' HA ' ' A' ' 723' ' ' GLU . 4.9 mt -56.88 -44.39 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.26 -15.32 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.605 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -52.85 -29.73 29.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -110.86 31.34 6.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.42 HD13 ' CD2' ' A' ' 602' ' ' PHE . 3.0 tt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.788 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.81 0.338 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.17 63.8 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 54.41 45.52 26.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.105 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.0 110.24 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . 0.43 ' P ' ' HB3' ' A' ' 619' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.08 77.32 9.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.708 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -69.77 119.99 14.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.032 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.18 146.81 46.02 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.571 2.181 . . . . 0.0 112.39 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -69.97 -22.22 63.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.726 0.298 . . . . 0.0 111.092 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 158.91 49.19 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.407 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -93.34 115.71 28.28 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.757 0.313 . . . . 0.0 110.226 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.476 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -103.6 -52.85 2.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.788 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.0 tt -113.45 140.08 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 695' ' ' GLU . 19.1 m -118.49 114.93 23.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 592' ' ' LEU . 6.4 mt -102.09 107.62 18.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.9 mtpt -113.44 99.43 49.42 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.8 Cg_exo -47.15 97.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.838 1.692 . . . . 0.0 109.541 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -74.68 158.37 84.94 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 81.7 Cg_exo -48.58 -25.05 7.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.941 3.094 . . . . 0.0 113.389 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . 0.403 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.3 m-20 -61.39 -25.5 67.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.431 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 4.6 t -95.97 153.96 17.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.678 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.431 ' CD1' HG12 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -62.01 -8.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.872 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 90.1 mt -110.98 118.72 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 1.5 mp0 -104.95 62.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.106 0.479 . . . . 0.0 110.256 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.613 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -124.91 171.45 10.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.207 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.33 128.85 45.36 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.085 0.469 . . . . 0.0 111.098 178.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.3 OUTLIER -112.25 142.62 44.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.74 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -124.51 113.7 18.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.519 HG12 ' CD2' ' A' ' 601' ' ' PHE . 87.3 mt -81.68 108.44 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.4 mm-40 -70.45 126.39 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.174 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.476 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.25 -32.12 2.88 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.488 0.661 . . . . 0.0 109.743 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -69.71 -23.85 76.56 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.992 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 99.5 t -99.34 117.36 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.084 0.942 . . . . 0.0 111.857 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -141.22 122.1 8.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.826 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.552 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.86 160.19 34.94 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 124.554 -1.019 . . . . 0.0 111.506 -0.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.3 t80 -92.25 115.67 28.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.537 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 42.3 m-85 -92.48 137.81 32.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.843 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.536 HG13 ' HB3' ' A' ' 611' ' ' CYS . 4.1 mp -124.7 144.89 33.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.3 -166.94 36.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.515 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -73.84 -54.87 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.88 0.371 . . . . 0.0 111.9 -179.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 132.66 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.374 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -56.21 -19.78 15.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -27.22 18.81 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.073 0.463 . . . . 0.0 110.432 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 10.5 m -79.03 132.91 36.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.582 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 19.7 m-80 -47.98 -28.64 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.511 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.536 ' HB3' HG13 ' A' ' 603' ' ' ILE . 25.7 t -110.17 141.23 43.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.58 104.6 12.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.457 HG13 ' CE2' ' A' ' 692' ' ' PHE . 24.6 mm -139.43 109.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.869 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.06 107.16 17.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.46 0.647 . . . . 0.0 112.601 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.449 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.2 t0 -129.47 107.59 9.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.624 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -39.81 -29.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -41.3 76.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.513 ' CB ' ' ND1' ' A' ' 622' ' ' HIS . 1.1 pp -89.22 158.7 17.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.463 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 t -78.57 167.37 21.37 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.385 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -48.64 -37.73 19.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.114 0.483 . . . . 0.0 110.37 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 12.2 t -124.41 65.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.459 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 653' ' ' GLY . 28.5 t60 -49.55 -42.12 43.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.809 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -168.98 159.2 9.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.472 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.537 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.2 p90 -143.23 147.92 35.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.498 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 4.7 mt -102.38 132.58 48.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.251 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.552 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -124.24 133.46 53.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.72 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 20.2 ttmt -98.59 136.5 38.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.557 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.33 158.11 41.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.324 -179.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.15 117.71 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.442 ' CE1' ' CE ' ' A' ' 709' ' ' MET . 4.4 t60 -80.37 130.58 35.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.83 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -160.1 117.53 2.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.221 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 11.4 m -75.55 175.28 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -113.92 -18.25 6.97 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.652 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -89.51 63.26 6.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.972 0.415 . . . . 0.0 110.922 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 80.0 p -150.38 105.33 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 13.1 mtt -110.74 29.24 7.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.078 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 637' ' ' TYR . 0.0 OUTLIER 177.75 -99.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.33 105.82 13.59 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.722 0.296 . . . . 0.0 110.891 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 62.9 m -135.39 143.61 46.08 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.921 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.98 -168.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.535 2.156 . . . . 0.0 112.194 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 69.96 -63.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.204 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 66.17 -175.68 0.19 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -94.23 67.82 1.43 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.604 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.1 mp -100.69 -160.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -119.55 146.35 45.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.329 0.585 . . . . 0.0 112.444 -178.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.444 ' OD2' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -130.09 160.53 33.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.525 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.421 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.8 OUTLIER -108.76 131.06 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.662 0.744 . . . . 0.0 112.689 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.55 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 92.5 m95 -115.29 126.9 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.504 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 3.7 t80 -90.52 117.63 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 35.3 m -103.32 133.12 48.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.398 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.4 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 64.7 t60 -110.57 130.61 55.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.3 p -130.27 10.74 5.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.461 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.0 178.91 53.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.276 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.1 t -102.06 -36.53 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.407 ' C ' ' CG1' ' A' ' 656' ' ' VAL . 3.0 m-80 -72.63 -0.16 12.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.942 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.478 HG22 ' CZ ' ' A' ' 658' ' ' TYR . 2.0 m 60.34 135.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 121.09 0.472 . . . . 0.0 111.577 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 4.3 t -97.63 165.65 11.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.672 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.478 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 5.6 m-85 -136.47 120.32 17.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.026 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.481 ' CD1' ' CD2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER -103.99 115.77 31.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.06 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.39 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.7 p-10 -136.31 6.29 3.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.471 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.15 141.01 36.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.825 0.345 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.55 141.43 32.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.416 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 31.4 mmm -119.42 106.01 11.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.035 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 49.9 pt -92.36 153.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.2 tt0 -47.07 99.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.37 41.05 1.29 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.3 p -121.43 162.28 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.619 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.4 ttpm? -133.02 146.6 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.579 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.494 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -147.49 144.03 28.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.947 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.55 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.73 133.39 47.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.427 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.03 107.35 18.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 111.35 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 11.7 mt-30 -95.11 142.35 27.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.827 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 706' ' ' GLY . 20.2 t0 -45.15 114.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.758 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.08 36.75 5.63 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -96.92 119.13 34.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.407 -179.201 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -96.2 114.06 25.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.403 HG12 ' HG ' ' A' ' 659' ' ' LEU . 6.4 mt -105.59 128.54 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 23.8 mtpt -90.37 116.5 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.952 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.472 HG22 ' CD2' ' A' ' 622' ' ' HIS . 35.3 mt -84.84 -38.97 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.348 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.417 ' CG2' ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.54 133.0 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -136.4 128.01 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.744 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -122.82 116.56 23.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.583 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -46.83 71.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.942 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.91 -40.54 46.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -82.26 -16.81 48.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.271 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.66 11.44 8.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.963 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.417 ' CE1' HG13 ' A' ' 690' ' ' ILE . 29.0 t80 -81.19 104.39 11.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.73 133.38 64.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.467 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 4.7 mt -128.24 155.04 39.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 690' ' ' ILE . . . 179.43 132.77 1.83 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.578 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CB ' HD21 ' A' ' 580' ' ' LEU . 9.7 m-30 -113.12 145.82 40.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . 0.444 ' HB2' HD12 ' A' ' 583' ' ' LEU . 3.2 ttmt -101.2 117.66 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.991 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.439 ' CG2' ' CD2' ' A' ' 580' ' ' LEU . 2.3 t -80.1 117.95 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.321 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 579' ' ' THR . 7.0 tt0 -126.09 109.29 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 110.266 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.419 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 41.0 mt -80.37 105.88 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -91.06 -45.32 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.118 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -110.37 141.08 43.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.414 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.7 OUTLIER -113.29 100.11 8.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.445 0.641 . . . . 0.0 109.559 178.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.4 ' OG1' ' CB ' ' A' ' 596' ' ' GLN . 31.0 m -84.23 57.23 4.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.966 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 85.28 37.37 9.89 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.02 129.75 35.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.654 0.227 . . . . 0.0 110.433 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 4.8 p90 -42.04 -33.99 0.65 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.627 0.727 . . . . 0.0 110.104 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -146.57 -63.27 0.3 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.857 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 8.3 pt-20 145.52 32.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.891 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 67.22 77.07 0.33 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.484 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.08 -9.82 17.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.989 0.394 . . . . 0.0 111.687 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 79.76 38.16 20.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.521 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.442 ' CE ' ' CE1' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -96.69 116.84 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 0.0 111.099 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -176.89 164.96 2.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.937 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -58.02 -42.52 85.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -88.52 139.27 30.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.49 100.33 13.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.1 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.494 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 4.5 mmm-85 41.06 86.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.785 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.9 m -124.63 142.85 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.604 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 48.4 t -79.63 123.77 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.167 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 166.37 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 135.28 45.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -85.1 160.0 20.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.57 -174.34 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -29.32 36.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.39 -52.09 67.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.692 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -42.37 80.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.587 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -33.46 72.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.85 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.47 -40.83 93.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.049 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.2 mt -57.73 -44.3 85.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.054 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.41 -27.34 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -57.78 -35.44 70.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -97.54 25.85 5.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.665 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.426 HD11 ' CG ' ' A' ' 602' ' ' PHE . 5.6 tt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.826 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.775 0.321 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 17.9 t -71.38 70.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.001 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -122.45 -165.35 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.891 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 64.55 116.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.822 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 72.27 3.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.741 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -60.56 119.46 8.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . 0.499 ' N ' ' CD ' ' P' ' 607' ' ' PRO . 9.3 mt -83.51 -46.05 0.81 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.308 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' P' ' 606' ' ' LEU . 78.5 Cg_exo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 122.326 2.017 . . . . 0.0 112.456 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.71 1.71 57.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.561 0.22 . . . . 0.0 111.439 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.425 ' O ' ' CG ' ' A' ' 595' ' ' GLN . . . 122.76 -27.36 5.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.471 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.41 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.0 OUTLIER -78.36 121.14 24.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -107.78 -52.54 2.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.226 -178.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.3 tt -119.59 142.46 48.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.1 m -119.85 114.42 22.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -102.18 108.46 19.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.1 pttp -118.01 99.76 51.98 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -176.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.9 Cg_exo -46.0 102.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.815 1.677 . . . . 0.0 109.603 176.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -75.01 157.6 85.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.37 -24.75 9.09 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.866 3.044 . . . . 0.0 113.382 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.13 -24.11 66.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 1.5 t -95.95 152.01 18.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.93 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.426 HG13 ' CE1' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -56.33 -15.19 2.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.285 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.444 HG21 ' CB ' ' A' ' 582' ' ' PRO . 3.3 tt -112.58 124.88 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.849 0.357 . . . . 0.0 111.656 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.445 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -107.68 71.25 0.81 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.576 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 48.9 mt-10 -125.55 169.89 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.521 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.27 128.17 42.69 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.154 0.502 . . . . 0.0 110.917 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.48 140.09 47.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.637 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.41 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 20.4 mt-10 -124.06 113.81 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.486 HG12 ' CD1' ' A' ' 601' ' ' PHE . 83.6 mt -86.32 109.75 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -76.63 128.81 35.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.04 -30.24 2.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.367 0.603 . . . . 0.0 110.085 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.419 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -25.56 74.43 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.035 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.89 117.87 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.991 0.896 . . . . 0.0 111.924 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.25 122.13 9.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.861 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 41.6 Cg_endo -90.77 159.55 30.17 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.395 -1.085 . . . . 0.0 111.649 -0.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.25 115.83 28.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.546 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 42.9 m-85 -92.57 138.05 31.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.05 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.514 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 3.1 mp -126.47 145.15 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.511 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.99 -168.44 39.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.495 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 12.2 ttp85 -82.41 -19.22 39.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.614 0.245 . . . . 0.0 111.343 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.04 132.65 34.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -21.55 45.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.06 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.8 -29.36 64.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.908 0.385 . . . . 0.0 110.644 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 18.8 m -74.92 130.2 38.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.925 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 34.3 m120 -45.24 -31.86 1.7 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.26 0.552 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.514 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 43.8 t -107.87 142.74 37.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.618 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.97 116.29 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.474 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 26.7 mm -137.96 109.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.678 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.4 tt0 -92.43 103.49 15.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.881 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.6 t70 -132.22 117.06 17.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.021 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -46.16 -31.15 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.794 0.331 . . . . 0.0 111.194 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.463 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 1.7 mpt_? -77.73 -35.7 51.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.471 HD11 ' CG2' ' A' ' 680' ' ' ILE . 1.2 mp -66.38 159.69 26.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.3 m -108.61 167.09 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -48.93 22.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.239 0.542 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 10.3 t -119.74 61.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.279 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 653' ' ' GLY . 28.2 t60 -49.13 -45.57 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.995 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -167.65 155.81 9.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.053 0.454 . . . . 0.0 111.339 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.443 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 48.2 p90 -143.22 144.32 32.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.768 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' A' ' 603' ' ' ILE . 3.9 mp -101.39 131.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.9 t80 -126.54 133.3 51.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.027 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 31.0 ttmt -98.44 133.6 42.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.91 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 159.62 40.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.771 -178.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.2 tpt180 -75.6 115.07 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.372 0.606 . . . . 0.0 110.533 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 -61.53 135.18 57.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.309 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -70.12 -162.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.869 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 6.8 p -169.11 159.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.962 0.411 . . . . 0.0 111.109 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.411 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -145.95 90.2 0.15 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.478 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt 59.65 175.19 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.713 0.292 . . . . 0.0 110.806 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 1.8 p -163.97 36.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.018 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 25.3 ttp -60.47 113.28 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 2.7 t80 71.94 -62.55 0.46 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -75.86 144.28 41.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.0 89.85 21.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -62.14 -154.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.739 2.293 . . . . 0.0 112.311 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -63.63 -14.17 49.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.61 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 78.44 -66.51 0.2 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.713 0.292 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 154.01 68.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.808 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.513 ' CG ' ' HA ' ' A' ' 703' ' ' PHE . 0.1 OUTLIER -108.8 -154.23 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 702' ' ' LEU . 4.0 m-20 -107.06 137.78 44.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.418 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 2.4 t0 -116.03 157.39 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.811 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.503 HG23 ' CE1' ' A' ' 577' ' ' PHE . 4.7 pt -109.4 117.08 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.502 0.668 . . . . 0.0 111.851 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.593 ' CH2' HD23 ' A' ' 671' ' ' LEU . 70.9 m95 -102.78 131.23 49.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.623 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -91.16 117.13 29.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 624' ' ' PHE . 23.6 m -103.95 123.98 48.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.298 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.451 ' CE1' ' N ' ' A' ' 657' ' ' SER . 68.8 t60 -102.25 134.51 45.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -134.38 8.65 3.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.33 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.92 151.35 26.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.63 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.6 t -73.67 -29.04 62.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.126 0.489 . . . . 0.0 111.464 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 617' ' ' ARG . 1.1 m120 -72.66 -1.8 17.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.539 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.45 ' CG1' ' C ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 54.74 124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 111.877 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.451 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -98.02 166.41 11.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.257 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.401 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 8.1 m-85 -134.21 126.21 29.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.076 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.433 ' CD2' HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -93.74 99.45 11.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.298 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 61.92 -78.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.689 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 15.4 p-10 -129.08 -8.17 4.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.735 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.446 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 9.9 m120 -92.6 140.62 29.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -83.52 141.67 31.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.629 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' A' ' 670' ' ' PHE . 3.2 mtp -125.4 121.81 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.273 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 665' ' ' ILE . 33.7 pt -103.48 156.54 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.546 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -48.2 104.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.38 . . . . 0.0 111.343 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.4 35.73 2.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.4 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.8 p -117.63 162.03 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.741 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.498 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.0 OUTLIER -131.82 145.03 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.061 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.446 ' CE2' ' CB ' ' A' ' 662' ' ' ASN . 3.4 t80 -147.76 145.89 28.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.593 HD23 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.27 130.27 42.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.3 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.403 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 0.9 OUTLIER -109.76 129.58 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.143 0.497 . . . . 0.0 111.154 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 1.0 OUTLIER -125.01 144.66 50.27 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.786 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 706' ' ' GLY . 11.0 t70 -41.88 118.6 1.14 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.854 0.359 . . . . 0.0 110.91 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.02 33.83 7.55 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.25 109.89 21.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 111.126 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -95.63 108.21 20.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.433 HG12 ' CD2' ' A' ' 659' ' ' LEU . 13.7 mt -105.46 122.63 59.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.581 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -78.91 115.9 18.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.71 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.537 HG22 ' NE2' ' A' ' 622' ' ' HIS . 1.1 mt -79.34 -32.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 617' ' ' ARG . 6.9 tt -154.98 131.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.63 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.56 126.7 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -126.23 117.39 22.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.226 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -46.58 73.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.105 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -73.57 -40.51 63.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.3 -14.24 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.603 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp 59.74 18.43 7.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.435 ' CE1' ' NH1' ' A' ' 617' ' ' ARG . 36.8 t80 -82.72 105.18 13.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.2 p -121.87 123.69 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.707 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.415 ' CG2' HG23 ' A' ' 680' ' ' ILE . 3.9 tt -127.57 125.08 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.487 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.76 148.17 16.84 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.18 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.474 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.3 OUTLIER -116.14 151.94 34.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . 0.485 ' HB2' HD13 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.47 117.39 34.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.5 t -75.16 128.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.347 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 579' ' ' THR . 5.6 tt0 -133.14 109.01 9.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 674' ' ' ASP . 39.9 mt -83.32 105.06 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.391 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.91 -45.88 11.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.492 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -110.24 140.77 44.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.331 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.8 p -114.03 99.32 7.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.338 0.59 . . . . 0.0 109.715 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 26.3 m -82.36 69.77 9.18 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.147 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 65.79 40.53 95.69 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.388 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 645' ' ' ASP . 1.8 mm? -62.58 129.82 42.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.455 0.169 . . . . 0.0 110.997 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 704' ' ' ASN . 3.4 p90 -37.32 -33.65 0.07 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.252 0.549 . . . . 0.0 111.162 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.56 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -141.29 -43.14 0.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.717 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.56 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 16.5 pt-20 137.89 -32.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.189 0.931 . . . . 0.0 109.342 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 119.37 15.74 5.39 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.08 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.29 8.96 39.99 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 90.83 -141.58 15.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.874 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.57 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.691 0.245 . . . . 0.0 111.212 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 36.92 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.802 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 77.08 121.16 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.919 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.54 98.89 0.13 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.039 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.54 118.83 34.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.316 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.444 ' HG3' ' CZ ' ' A' ' 670' ' ' PHE . 10.1 ptt180 -176.48 125.29 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.325 0.583 . . . . 0.0 110.788 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.97 146.89 27.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.722 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 5.1 p -76.83 121.01 28.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.931 0.396 . . . . 0.0 111.353 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.14 172.25 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.68 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 153.06 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.196 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.19 160.09 25.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -125.03 -178.66 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -28.82 37.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -66.11 -46.64 76.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -68.6 -43.17 77.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.812 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -55.97 -37.0 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -67.98 -36.6 80.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.003 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 91.5 mt -55.63 -44.27 76.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.93 -29.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.758 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -101.52 27.26 6.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.434 HD11 ' CD1' ' A' ' 602' ' ' PHE . 2.5 tt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.666 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.752 0.311 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.83 96.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.077 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -117.36 83.77 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 3.9 pp -168.66 157.98 8.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.11 -30.63 19.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 60.86 96.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 3.7 mt -111.09 153.41 43.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.947 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.59 2.193 . . . . 0.0 112.393 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.95 -21.76 63.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.735 0.302 . . . . 0.0 111.095 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.545 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 147.1 -52.22 0.56 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.162 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -112.19 143.15 43.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.966 0.413 . . . . 0.0 111.451 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.518 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -126.98 -54.38 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.055 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.1 tt -112.98 138.49 49.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.355 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 6.4 m -118.29 114.2 22.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.992 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.5 OUTLIER -104.09 108.04 19.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.6 OUTLIER -116.89 100.99 53.66 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.43 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.1 Cg_exo -45.61 100.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.824 1.682 . . . . 0.0 109.597 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.33 157.02 86.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.31 -26.09 14.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.981 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.09 -27.22 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.413 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.4 t -95.62 154.2 17.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.704 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 31.2 pt -56.97 -11.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.729 0.299 . . . . 0.0 111.13 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.422 ' CD1' HG23 ' A' ' 613' ' ' ILE . 34.3 mt -108.72 122.33 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.744 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.63 57.04 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 110.404 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.549 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 mt-10 -124.62 171.06 10.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.194 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.06 129.32 46.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.073 0.463 . . . . 0.0 111.126 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.48 142.02 45.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.154 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.3 114.41 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.49 HG12 ' CD2' ' A' ' 601' ' ' PHE . 87.4 mt -83.84 108.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.5 mp0 -65.7 125.49 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.315 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.518 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.01 -26.92 1.97 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.169 0.509 . . . . 0.0 110.413 179.512 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -76.65 -21.85 73.78 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.472 -0.785 . . . . 0.0 114.153 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.38 117.74 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 118.324 1.062 . . . . 0.0 111.534 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -140.72 122.29 9.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.23 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.541 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.9 Cg_endo -90.56 160.09 31.47 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.42 -1.075 . . . . 0.0 111.391 -0.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.29 114.96 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.538 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 43.5 m-85 -91.88 138.18 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.833 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 2.7 mp -126.91 145.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.369 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.49 -172.94 36.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.416 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.447 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -67.41 -52.05 44.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.339 . . . . 0.0 111.859 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.49 126.44 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.25 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.276 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -30.36 62.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.064 0.459 . . . . 0.0 110.299 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 8.3 m -71.32 134.69 46.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.485 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 21.0 m-80 -48.43 -26.59 2.18 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.539 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 35.7 t -113.83 142.45 46.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.07 105.2 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.431 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 25.9 mm -138.98 109.51 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.334 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -104.0 106.4 16.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 112.459 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.474 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.9 t0 -130.43 107.53 9.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.65 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.19 -29.37 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.41 ' HB3' HD12 ' A' ' 681' ' ' ILE . 0.3 OUTLIER -67.2 -41.46 85.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.601 0.238 . . . . 0.0 111.473 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.51 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -89.86 158.99 17.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 0.0 111.711 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 92.2 p -78.41 172.86 13.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.364 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.467 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 3.3 mpt_? -47.72 -46.41 29.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.117 0.484 . . . . 0.0 110.278 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.8 70.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.199 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.51 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 12.8 t60 -49.72 -45.98 49.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.769 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.1 p -164.23 158.7 19.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.602 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.492 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.1 p90 -143.4 147.73 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.561 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 603' ' ' ILE . 3.3 mp -102.64 131.12 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.7 t80 -122.29 133.88 54.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.412 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 1.6 tppp? -97.85 136.58 37.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.043 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.437 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.6 OUTLIER -135.31 159.04 42.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.819 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.6 tpt180 -76.69 112.26 13.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.312 0.577 . . . . 0.0 110.334 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 -80.57 123.96 28.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.745 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -142.74 131.73 23.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.299 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 5.4 m -108.13 119.95 58.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.02 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -87.64 57.05 4.44 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.603 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -176.25 81.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.98 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.66 52.35 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.757 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 22.4 ttt -62.5 120.34 10.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.956 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.4 -62.88 0.42 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.27 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.66 144.3 41.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.128 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 10.6 p -114.63 91.85 26.78 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.704 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.16 -148.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.668 2.245 . . . . 0.0 112.098 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -78.25 4.44 12.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.935 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 69.06 -77.89 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.715 0.293 . . . . 0.0 110.989 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -170.82 97.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.865 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.3 mt -115.45 -155.26 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.494 ' O ' HD13 ' A' ' 702' ' ' LEU . 2.5 m-20 -116.47 147.34 41.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.242 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.405 ' OD1' ' CE2' ' A' ' 703' ' ' PHE . 2.1 m-20 -131.3 156.93 44.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.877 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.9 OUTLIER -104.18 125.02 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.636 . . . . 0.0 112.29 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.529 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 82.5 m95 -108.79 123.08 48.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.653 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 3.0 t80 -89.82 116.08 27.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 62.4 m -100.68 142.6 31.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.451 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.451 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 74.4 t60 -118.97 130.96 55.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.4 p -125.64 2.73 7.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.014 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 150.68 38.05 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.401 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.0 t -73.3 -32.55 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.495 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 656' ' ' VAL . 17.3 m-20 -75.56 2.24 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.764 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.07 125.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.767 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.446 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 37.3 p -88.78 166.15 14.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.609 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.48 120.42 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.73 99.9 10.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 59.5 -83.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -131.44 4.32 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.454 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -113.66 116.85 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -84.3 141.28 31.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.456 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.78 142.33 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.261 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.443 HD11 HG23 ' A' ' 665' ' ' ILE . 31.2 pt -96.56 163.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -52.77 91.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.46 39.91 0.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 0.8 OUTLIER -137.48 158.5 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 111.266 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 18.9 pttm -128.18 158.5 37.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.456 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 15.3 t80 -145.37 146.75 31.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.529 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.78 129.32 39.48 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.36 -179.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -103.82 130.8 51.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.242 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 706' ' ' GLY . 0.7 OUTLIER -121.94 150.37 42.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.5 -179.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -50.12 105.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.369 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.28 32.7 4.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.48 113.11 25.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.04 108.84 21.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.226 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 6.4 mt -105.91 136.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.795 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 116.5 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.864 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.448 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -79.72 -36.34 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.256 -179.17 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 681' ' ' ILE . 2.2 tp -155.15 131.35 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 112.085 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -136.74 122.76 20.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.914 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -126.6 117.02 21.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.906 0.384 . . . . 0.0 110.687 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -46.37 73.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.867 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.74 -40.59 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.687 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.73 -9.61 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.519 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 15.8 tttt 60.61 17.56 7.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.951 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 7.5 t80 -77.5 104.97 8.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.5 p -121.71 121.77 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.168 0.509 . . . . 0.0 112.143 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.451 ' HB ' ' CG2' ' A' ' 681' ' ' ILE . 8.7 mt -128.72 153.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -179.76 137.14 2.97 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.148 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.467 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 9.0 m-30 -113.24 144.82 42.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.716 0.293 . . . . 0.0 110.422 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -101.07 116.85 33.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.996 0.427 . . . . 0.0 110.256 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 672' ' ' LEU . 3.8 t -79.68 125.37 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.636 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.1 109.16 9.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 705' ' ' GLU . 17.4 mt -84.24 105.7 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.68 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -88.46 -46.02 9.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -110.96 139.53 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.812 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.3 OUTLIER -115.21 101.64 9.15 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.9 t -66.08 64.13 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.403 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 51.33 48.71 47.16 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.998 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 645' ' ' ASP . 1.0 OUTLIER -111.62 163.47 14.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.818 0.342 . . . . 0.0 111.122 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -58.08 110.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.381 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.47 ' CG ' ' HG2' ' A' ' 705' ' ' GLU . 12.6 t30 55.12 -76.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 0.0 110.674 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.613 ' N ' ' O ' ' A' ' 703' ' ' PHE . 6.7 pt-20 179.82 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.305 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 148.08 39.67 0.04 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.792 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 1.9 mp -85.75 7.89 21.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.478 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 83.5 -90.32 1.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.411 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.439 ' HE2' ' CE1' ' A' ' 630' ' ' HIS . 0.6 OUTLIER 60.16 91.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.368 . . . . 0.0 110.443 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -171.32 -167.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -69.46 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.853 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -76.6 139.34 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.609 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -95.92 110.71 22.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.223 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.413 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 2.8 mmm-85 53.39 76.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.74 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.77 142.87 41.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.193 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.416 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 7.4 p -85.38 128.94 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 111.378 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.428 HD13 ' CZ3' ' A' ' 648' ' ' TRP . 0.5 OUTLIER -97.05 166.99 11.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.23 154.81 18.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -87.35 154.69 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.746 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.22 -177.5 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.3 -30.51 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -47.47 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -66.97 -47.32 71.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -55.73 -32.99 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.95 -37.79 82.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.55 -44.14 84.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.12 -15.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -45.19 83.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 110.616 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -72.45 -14.43 61.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.21 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 8.7 tt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.053 -179.992 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.798 0.332 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 25.6 t -94.3 47.18 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.098 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -79.5 65.17 4.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.807 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.8 -173.7 4.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 88.2 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -65.67 100.59 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.763 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.89 149.85 95.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.558 2.172 . . . . 0.0 112.362 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.51 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 8.7 ttm180 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.642 0.258 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.773 ' CE1' HG21 ' A' ' 647' ' ' ILE . 5.5 t80 -122.43 -57.07 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.026 HD11 HG13 ' A' ' 694' ' ' VAL . 20.3 tp -111.04 142.36 43.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.381 . . . . 0.0 111.176 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 695' ' ' GLU . 3.5 m -121.17 114.34 21.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.951 ' CD2' HG23 ' A' ' 694' ' ' VAL . 5.6 mt -103.37 108.38 19.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 7.7 mtmt -113.71 99.81 50.74 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -176.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.616 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.6 Cg_exo -47.02 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.692 1.595 . . . . 0.0 109.606 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.654 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.59 157.25 86.29 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.542 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.53 -25.9 20.65 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.775 2.983 . . . . 0.0 112.841 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 583' ' ' LEU . 5.2 t0 -61.91 -27.46 68.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.401 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 1.9 t -95.68 154.11 17.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.797 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.719 HD11 HD11 ' A' ' 690' ' ' ILE . 12.6 pt -55.92 -11.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.704 0.288 . . . . 0.0 111.296 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.477 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.4 mt -109.58 124.88 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.794 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.46 57.1 0.66 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.57 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.616 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 tt0 -124.87 171.53 10.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.012 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.64 128.83 46.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.012 0.434 . . . . 0.0 110.846 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.719 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -111.97 141.04 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.931 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.51 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -123.93 115.93 22.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.679 0.276 . . . . 0.0 111.611 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.922 HD11 HD12 ' A' ' 625' ' ' ILE . 80.2 mt -82.61 108.95 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.395 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.91 118.2 10.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.994 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.648 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 1.2 pm0 -46.36 -28.45 1.33 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.44 -23.13 75.15 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.366 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.02 118.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.775 0.788 . . . . 0.0 111.502 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.5 t30 -139.5 122.58 10.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.929 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.8 Cg_endo -90.44 159.92 31.96 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.723 -0.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.667 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.95 115.28 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.553 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 32.2 m-85 -92.29 138.0 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.071 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.81 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.6 mp -124.73 145.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.625 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.09 -172.23 35.77 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.655 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -68.47 -52.31 33.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.975 0.417 . . . . 0.0 111.723 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -60.2 126.27 26.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.323 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.71 -20.13 2.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.133 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.87 -31.95 60.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.145 0.498 . . . . 0.0 110.201 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.673 ' SG ' HG22 ' A' ' 621' ' ' VAL . 11.4 m -70.74 130.19 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.8 m120 -44.52 -32.63 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.185 0.517 . . . . 0.0 110.39 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.81 ' SG ' HG23 ' A' ' 603' ' ' ILE . 25.9 t -107.35 142.3 37.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.041 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 104.55 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.59 HD11 HD21 ' A' ' 592' ' ' LEU . 24.1 mm -139.6 109.84 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.329 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -103.61 107.04 17.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.46 0.648 . . . . 0.0 112.42 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.574 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -129.16 107.49 9.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.602 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -40.46 -28.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -69.46 -41.28 76.42 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.574 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.22 159.11 17.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.75 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -78.18 173.29 12.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.222 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.522 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -46.7 -52.52 13.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.089 0.471 . . . . 0.0 110.187 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.673 HG22 ' SG ' ' A' ' 609' ' ' CYS . 41.6 t -114.44 70.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.291 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.536 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 11.4 t60 -48.06 -44.23 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.683 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 3.5 p -166.85 159.18 13.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 111.334 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.7 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.1 p90 -143.2 149.41 37.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.922 HD12 HD11 ' A' ' 594' ' ' ILE . 37.7 mt -102.14 135.16 40.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.001 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.3 t80 -128.68 134.48 48.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.3 ttmt -98.26 136.59 38.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.9 157.63 46.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.546 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.01 114.74 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.321 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.341 0.115 . . . . 0.0 110.863 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.0 OUTLIER -112.94 148.9 34.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.309 0.576 . . . . 0.0 112.464 -178.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.568 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -135.19 129.6 34.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.787 179.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.788 HD12 ' HB2' ' A' ' 672' ' ' LEU . 2.1 pt -87.16 122.85 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.355 0.598 . . . . 0.0 111.918 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.599 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.8 m95 -105.83 148.98 26.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.159 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.588 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.0 t80 -108.16 116.61 32.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.7 m -102.07 137.66 40.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 62.4 t60 -118.4 131.59 56.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.43 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.9 p -129.04 5.79 5.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.303 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.8 151.6 32.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.637 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.477 HG23 ' N ' ' A' ' 655' ' ' ASN . 14.6 t -76.78 -44.33 33.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.016 0.436 . . . . 0.0 111.414 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.486 ' C ' HG23 ' A' ' 656' ' ' VAL . 2.1 m-20 -58.82 -18.09 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.795 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 664' ' ' MET . 4.4 t 78.55 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.142 0.496 . . . . 0.0 111.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 93.2 p -114.52 152.22 32.07 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -124.39 119.79 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.33 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.622 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -94.96 99.86 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.083 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 61.19 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.899 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.3 t30 -135.64 -0.44 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.481 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 1.7 m120 -101.0 135.41 42.49 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.927 0.394 . . . . 0.0 111.287 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 41.6 ttm-85 -75.59 141.17 42.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.573 ' O ' HG13 ' A' ' 656' ' ' VAL . 19.5 mmm -126.32 94.61 4.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.411 HG12 ' CG2' ' A' ' 668' ' ' THR . 32.7 pt -87.67 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.578 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -48.8 110.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.201 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 100.96 30.78 5.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.287 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.411 ' CG2' HG12 ' A' ' 665' ' ' ILE . 13.8 p -112.78 162.28 15.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 111.348 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.9 ttpm? -143.81 133.95 24.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.57 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -139.88 143.48 36.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.812 0.339 . . . . 0.0 111.165 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.599 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.64 140.55 53.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.788 ' HB2' HD12 ' A' ' 647' ' ' ILE . 5.0 mt -109.43 125.98 52.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.68 147.16 31.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -48.53 103.7 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 110.465 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.67 33.62 3.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.81 118.8 30.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.533 -0.334 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -96.18 111.5 23.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.622 HG22 HD13 ' A' ' 659' ' ' LEU . 30.6 pt -105.71 137.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 112.064 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.42 116.54 30.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.894 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.536 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -84.96 -38.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 690' ' ' ILE . 3.1 tp -155.18 131.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.696 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -136.84 124.88 22.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.369 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.31 116.66 20.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.792 0.329 . . . . 0.0 110.306 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -67.36 -46.57 72.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.125 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -74.51 -40.49 61.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.917 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -87.64 -7.12 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.535 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tttt 59.13 18.18 6.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.732 0.301 . . . . 0.0 110.948 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -77.54 105.02 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.2 p -124.12 121.65 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 111.917 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.772 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.5 mt -128.79 150.34 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.179 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.61 138.68 3.54 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.626 ' HB2' HD22 ' A' ' 580' ' ' LEU . 7.8 m-30 -113.46 148.71 35.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.788 0.328 . . . . 0.0 110.449 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.452 ' HB2' HD22 ' A' ' 583' ' ' LEU . 3.6 tttm -101.33 116.95 33.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 1.026 HG13 HD11 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -81.55 123.1 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.407 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.6 OUTLIER -133.28 109.46 9.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.589 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.625 HG12 HD13 ' A' ' 578' ' ' LEU . 14.9 mt -78.39 105.53 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.703 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -47.95 11.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.22 139.83 46.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.875 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.445 -0.697 0 CA-C-O 121.117 0.484 . . . . 0.0 109.727 178.283 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.4 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.778 0.323 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.31 172.2 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -100.64 150.54 22.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -75.27 153.22 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -119.36 -179.17 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.27 -29.53 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -65.96 -50.28 64.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -51.07 66.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.916 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -56.01 -32.86 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.63 -36.77 83.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.988 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.58 -44.16 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.6 p -76.48 -27.59 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -36.02 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.96 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.421 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 1.3 ttm-85 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.558 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 7.8 t80 -122.66 -48.07 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.752 HD11 ' CG1' ' A' ' 694' ' ' VAL . 8.2 tp -119.55 141.98 48.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 40.3 m -122.39 114.53 20.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.813 ' HG ' HG22 ' A' ' 694' ' ' VAL . 1.7 mp -105.63 108.57 20.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 8.4 ptpt -117.04 100.53 53.36 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 26.7 Cg_exo -44.77 104.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.739 1.626 . . . . 0.0 109.47 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.737 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.47 157.17 86.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.561 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 73.2 Cg_exo -49.18 -32.6 25.18 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.617 2.878 . . . . 0.0 112.891 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.737 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.5 OUTLIER -63.88 -21.76 66.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.88 0.371 . . . . 0.0 110.577 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.67 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 22.7 p -96.43 153.46 17.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.998 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.823 HG22 HG12 ' A' ' 690' ' ' ILE . 1.2 tt -52.49 -18.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.871 0.367 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 582' ' ' PRO . 10.8 mt -111.25 119.78 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.162 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.67 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -110.37 57.71 0.61 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.295 0.569 . . . . 0.0 110.758 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.553 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.0 mt-10 -125.13 172.08 9.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.578 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.54 128.31 46.66 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.144 0.497 . . . . 0.0 111.474 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.765 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -113.09 138.81 49.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.831 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.421 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 3.6 mp0 -123.92 115.76 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.973 HD11 HD12 ' A' ' 625' ' ' ILE . 46.3 mt -80.32 109.75 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.923 0.392 . . . . 0.0 111.033 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.75 113.05 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.522 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.558 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.66 -30.68 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.456 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.05 -22.61 70.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.376 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.63 HG11 ' OD1' ' A' ' 610' ' ' ASN . 67.9 t -101.3 119.6 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 117.669 0.734 . . . . 0.0 111.538 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.3 t30 -138.66 122.73 11.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.59 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.38 160.47 32.53 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.618 -0.992 . . . . 0.0 111.994 0.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.705 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.6 115.68 28.25 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.562 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 51.0 m-85 -92.39 138.28 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.036 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.3 mp -127.15 145.42 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.588 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.09 -178.3 34.42 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.327 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -59.58 -52.68 64.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.88 0.372 . . . . 0.0 111.849 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.51 122.9 15.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.455 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -21.04 2.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.734 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -51.9 -30.52 24.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.177 0.513 . . . . 0.0 110.08 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.591 ' SG ' HG22 ' A' ' 621' ' ' VAL . 95.0 m -73.57 129.37 37.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.338 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 13.4 m-80 -45.55 -29.5 1.19 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.128 0.49 . . . . 0.0 110.621 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.765 ' SG ' HD13 ' A' ' 592' ' ' LEU . 53.4 t -109.22 142.91 39.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.47 106.93 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.462 HG13 ' CE2' ' A' ' 692' ' ' PHE . 30.9 mm -138.14 109.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.916 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.09 107.15 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.458 0.647 . . . . 0.0 112.369 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.579 ' OD2' HG21 ' A' ' 681' ' ' ILE . 10.9 t0 -129.1 107.55 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.123 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -41.74 -31.2 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.676 ' HB3' HD11 ' A' ' 681' ' ' ILE . 2.0 mtt180 -77.43 -38.15 50.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.303 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.774 HD23 ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -89.67 147.25 23.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.831 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.45 162.73 12.04 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.841 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.1 OUTLIER -63.15 -17.69 62.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.504 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.841 HG23 ' HG2' ' A' ' 620' ' ' ARG . 29.4 t -137.38 55.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.617 ' CG ' HD12 ' A' ' 618' ' ' LEU . 6.8 t60 -47.66 -43.06 25.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.421 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.464 ' SG ' HD11 ' A' ' 680' ' ' ILE . 4.3 p -164.29 158.68 19.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 112.261 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.797 ' HA ' HD12 ' A' ' 603' ' ' ILE . 50.2 p90 -143.74 146.07 32.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.241 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.973 HD12 HD11 ' A' ' 594' ' ' ILE . 71.2 mt -102.18 128.62 54.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.522 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -119.49 134.68 55.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.504 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 35.4 ttmt -97.42 133.66 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.413 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.14 159.11 42.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.175 -178.584 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.3 tpt180 -77.07 112.43 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.282 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.091 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 644' ' ' LEU . 4.4 mp . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -114.3 146.44 40.47 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.214 0.531 . . . . 0.0 112.025 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.61 157.65 46.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.137 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.718 HD13 HD13 ' A' ' 578' ' ' LEU . 2.7 pt -103.8 118.73 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.462 0.649 . . . . 0.0 111.835 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.969 ' CH2' HD22 ' A' ' 671' ' ' LEU . 89.0 m95 -100.47 127.97 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.206 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.572 ' CD2' HD13 ' A' ' 678' ' ' ILE . 2.6 t80 -90.21 116.69 28.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 14.3 m -103.36 142.12 34.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.374 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.468 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 29.5 t60 -121.15 133.06 55.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.981 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 5.6 p -131.26 9.81 4.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.422 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -82.15 151.13 29.69 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.832 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.9 t -76.39 -33.91 58.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.156 0.503 . . . . 0.0 111.365 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.86 3.09 7.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.33 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 664' ' ' MET . 1.5 p 50.7 142.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.731 0.777 . . . . 0.0 112.423 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.427 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 95.8 p -112.34 166.38 11.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.286 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -129.38 120.31 25.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 111.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -103.98 99.93 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.021 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.1 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 9.0 m120 -144.91 -0.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.601 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -103.54 141.28 36.27 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.95 0.405 . . . . 0.0 111.312 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -79.6 141.97 36.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.606 ' O ' HG23 ' A' ' 656' ' ' VAL . 23.1 mmm -118.04 97.86 6.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.2 pt -87.44 146.98 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -45.19 98.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.416 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.56 37.94 1.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.523 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 4.5 p -135.66 152.61 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.79 0.329 . . . . 0.0 111.336 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 15.1 pttm -123.68 158.03 32.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.282 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.527 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 0.2 OUTLIER -142.59 142.49 32.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.969 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -69.81 125.48 26.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.975 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.559 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.8 mt -101.33 136.14 41.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.383 0.611 . . . . 0.0 111.891 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.22 137.33 54.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.251 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.601 ' HB3' HD12 ' A' ' 696' ' ' ILE . 1.8 p30 -39.8 118.81 0.91 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.955 0.407 . . . . 0.0 110.843 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.24 36.36 5.72 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.334 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.513 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -94.95 116.76 29.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.4 108.77 21.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.122 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 9.0 mt -107.95 130.19 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -93.79 116.07 28.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.828 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.464 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.0 OUTLIER -77.96 -35.69 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.462 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 617' ' ' ARG . 8.9 tt -154.8 134.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.854 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.33 123.31 21.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -120.92 117.0 26.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.552 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -67.55 -46.59 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.134 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -75.91 -40.68 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.862 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.33 -12.23 49.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.464 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.13 15.61 8.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.697 0.284 . . . . 0.0 110.873 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.566 ' CE1' HG21 ' A' ' 587' ' ' ILE . 2.3 t80 -76.86 105.12 7.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -121.46 122.43 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 112.122 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.823 HG12 HG22 ' A' ' 587' ' ' ILE . 7.6 mt -116.31 145.25 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.743 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -170.47 131.23 2.18 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.481 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.462 ' CE2' HG13 ' A' ' 613' ' ' ILE . 3.3 m-30 -113.81 147.03 39.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.343 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.601 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.1 tttt -101.2 116.91 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.491 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.813 HG22 ' HG ' ' A' ' 580' ' ' LEU . 3.5 t -81.74 127.34 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.603 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.28 108.71 8.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 0.0 111.146 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 674' ' ' ASP . 95.6 mt -73.28 105.42 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.504 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -81.16 -45.91 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 109.941 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.4 t0 -110.74 140.68 44.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.878 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.216 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.601 HG23 ' CG ' ' A' ' 662' ' ' ASN . 40.8 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.797 0.332 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.01 147.21 35.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.81 147.02 30.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.36 160.07 24.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.978 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 14.8 p -126.14 -175.75 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.62 -30.93 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.37 -47.29 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.732 ' HA ' HD12 ' A' ' 726' ' ' LEU . 29.9 mm-40 -64.42 -49.93 69.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -57.25 -32.79 66.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.43 -36.92 82.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 723' ' ' GLU . 12.6 mt -59.76 -44.22 93.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.088 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.5 p -81.93 -29.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -55.75 -28.9 58.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mttp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.906 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.464 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.1 tmm_? . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.538 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -122.02 -64.98 1.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.346 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.009 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -106.31 125.64 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.843 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.725 HG22 ' HG3' ' A' ' 581' ' ' LYS . 24.3 m -104.68 117.2 33.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.637 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -105.96 108.08 19.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.725 ' HG3' HG22 ' A' ' 579' ' ' THR . 0.0 OUTLIER -112.66 99.12 46.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.128 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.3 Cg_exo -48.25 103.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.482 1.455 . . . . 0.0 109.009 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -73.51 157.26 88.04 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.47 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 10.3 Cg_endo -50.92 -29.16 26.11 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.613 2.876 . . . . 0.0 112.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.558 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -63.72 -15.23 57.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.913 0.387 . . . . 0.0 110.219 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.53 153.71 17.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.543 HG21 ' CZ ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -50.04 -24.44 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.908 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.5 tt -112.82 144.1 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.113 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.47 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.25 65.41 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 110.785 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 37.1 mt-10 -125.65 172.1 10.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.054 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.9 127.44 44.9 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.914 0.388 . . . . 0.0 110.99 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.94 143.58 43.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.966 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.8 OUTLIER -124.39 118.08 25.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.738 HD12 HD22 ' A' ' 578' ' ' LEU . 55.1 mt -82.39 108.6 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.11 0.481 . . . . 0.0 110.156 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 593' ' ' GLU . 2.0 mp0 -68.67 105.43 2.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.538 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -33.3 -54.23 0.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.209 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -47.39 -21.94 1.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.526 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.504 HG11 ' OD1' ' A' ' 610' ' ' ASN . 53.0 t -99.38 118.39 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.256 0.528 . . . . 0.0 111.293 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.5 t30 -140.13 123.21 10.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.127 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.561 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.4 Cg_endo -90.45 159.77 31.85 Favored 'Cis proline' 0 N--CA 1.461 -0.431 0 C-N-CA 124.411 -1.079 . . . . 0.0 111.832 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.698 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.61 115.88 28.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.512 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.7 m-85 -92.42 138.39 31.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.044 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.749 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mp -126.4 145.79 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.668 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.62 -171.83 38.54 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.134 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.484 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -69.57 -50.2 47.02 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.498 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -60.78 131.46 50.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -59.01 -18.04 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.654 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -55.33 -32.41 62.47 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 121.081 0.467 . . . . 0.0 110.241 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.509 ' SG ' HG22 ' A' ' 621' ' ' VAL . 34.5 m -71.53 132.46 44.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 2.4 m-80 -47.12 -27.09 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 0.0 110.681 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.768 ' SG ' HD13 ' A' ' 592' ' ' LEU . 40.4 t -112.75 142.51 45.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.293 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 105.62 13.87 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 592' ' ' LEU . 21.4 mm -138.21 109.28 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.43 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.12 106.24 16.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.556 0.693 . . . . 0.0 112.453 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.622 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.3 t0 -130.19 107.8 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.698 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -40.01 -29.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.436 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -68.93 -41.5 78.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.622 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.3 pp -90.12 158.8 17.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 12.8 t -76.91 162.98 27.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.049 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.6 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.7 OUTLIER -52.08 -26.68 11.65 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.441 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.6 HG23 ' HG2' ' A' ' 620' ' ' ARG . 37.6 t -130.71 62.7 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.838 ' CD2' HG23 ' A' ' 680' ' ' ILE . 25.1 t60 -51.8 -47.22 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.381 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 6.1 p -165.01 162.5 20.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.234 0.54 . . . . 0.0 112.138 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 603' ' ' ILE . 53.8 p90 -143.59 147.31 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.766 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.671 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.35 130.57 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.021 0.438 . . . . 0.0 109.981 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -122.12 133.62 54.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.607 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 30.9 ttmt -97.72 136.99 37.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.455 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.23 158.82 43.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.947 -178.451 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.2 tpt180 -76.64 112.34 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.1 t60 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.384 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.7 mp . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -118.48 146.62 44.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.15 0.5 . . . . 0.0 111.885 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.513 ' OD2' HD11 ' A' ' 671' ' ' LEU . 2.2 t0 -129.72 160.07 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.009 HD13 HD12 ' A' ' 578' ' ' LEU . 1.4 pt -108.66 120.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.479 0.657 . . . . 0.0 111.724 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.895 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 67.5 m95 -106.43 127.3 53.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.065 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.628 ' HB2' HD11 ' A' ' 672' ' ' LEU . 20.9 t80 -90.54 117.61 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.79 130.09 48.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.162 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.484 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 66.2 t60 -109.3 133.74 52.67 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -131.02 1.27 4.26 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.427 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.95 149.63 36.42 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.72 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.8 t -74.57 -32.37 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.451 . . . . 0.0 111.534 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.597 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.5 m-20 -73.13 1.86 8.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.461 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.82 126.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.28 0.562 . . . . 0.0 111.89 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.484 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 8.7 t -96.43 165.93 11.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.255 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -130.53 121.28 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.866 0.365 . . . . 0.0 111.265 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.673 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.51 99.47 11.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.9 m120 60.7 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -129.55 -0.27 4.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.488 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.472 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 10.8 m120 -100.89 141.99 32.99 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.888 0.375 . . . . 0.0 111.107 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.665 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -82.6 141.54 32.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 11.5 mmm -123.89 101.21 7.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.812 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.427 HG12 HG21 ' A' ' 668' ' ' THR . 50.7 pt -89.64 161.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.21 98.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.76 44.8 1.18 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.427 HG21 HG12 ' A' ' 665' ' ' ILE . 1.2 p -127.62 162.25 26.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.32 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -129.92 149.03 51.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.398 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.504 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 4.3 t80 -147.26 145.34 29.38 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.895 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 129.05 38.8 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.596 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.732 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.2 mt -108.74 119.94 41.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.291 0.567 . . . . 0.0 111.474 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.15 144.0 39.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.24 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.742 ' HB2' HD12 ' A' ' 696' ' ' ILE . 68.3 t0 -43.06 123.93 3.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.772 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.15 7.39 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -95.23 112.85 24.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.372 . . . . 0.0 111.502 -179.014 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.75 108.66 21.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.053 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.641 HG12 HD13 ' A' ' 659' ' ' LEU . 11.2 mt -106.89 136.89 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.0 111.958 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -96.12 116.15 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.478 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.838 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.3 mt -83.71 -34.07 10.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.793 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.725 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.1 tp -154.86 131.58 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.102 0.477 . . . . 0.0 112.097 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.73 130.04 31.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -127.1 117.63 22.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.797 0.332 . . . . 0.0 110.735 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -66.97 -46.61 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.101 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -76.39 -40.52 50.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -88.8 -11.09 45.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.42 16.76 7.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.543 ' CZ ' HG21 ' A' ' 587' ' ' ILE . 15.5 t80 -76.9 105.44 7.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.31 125.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.908 0.385 . . . . 0.0 111.986 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.725 ' HB ' HG22 ' A' ' 681' ' ' ILE . 13.1 mt -123.8 153.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.178 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -176.59 138.2 3.93 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.278 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.786 ' CE2' HD12 ' A' ' 680' ' ' ILE . 1.8 m-30 -113.45 147.08 38.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 0.0 110.541 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.537 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -101.27 117.23 34.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.477 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.812 HG22 HD21 ' A' ' 578' ' ' LEU . 3.9 t -80.29 123.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 579' ' ' THR . 24.3 tt0 -132.64 109.38 9.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.448 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 674' ' ' ASP . 54.6 mt -78.66 106.08 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.24 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.58 -45.26 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.37 140.93 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 37.7 p . . . . . 0 N--CA 1.446 -0.654 0 CA-C-O 121.184 0.516 . . . . 0.0 109.998 178.654 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 663' ' ' ARG . 27.7 t . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 111.643 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.92 168.31 12.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.484 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.16 146.29 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.01 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -82.29 151.65 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 71.0 p -126.05 -179.19 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.28 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.86 -30.13 57.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.36 -51.1 70.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.678 ' HA ' HD12 ' A' ' 726' ' ' LEU . 5.3 mm-40 -65.65 -50.71 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.695 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 727' ' ' VAL . 2.4 ttpm? -55.86 -32.71 63.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -66.66 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.348 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.0 mt -58.34 -44.58 88.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 111.112 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 724' ' ' LYS . 13.3 p -73.6 -25.04 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -36.25 65.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.057 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.4 mttp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' CB ' ' A' ' 593' ' ' GLU . 5.1 tmm_? . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.924 0.392 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.574 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -110.2 -61.89 1.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.247 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.864 HD21 HG22 ' A' ' 694' ' ' VAL . 9.3 tt -106.93 142.71 36.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.477 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.5 m -113.04 114.26 26.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.044 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.652 HD12 HD11 ' A' ' 594' ' ' ILE . 0.6 OUTLIER -106.75 108.6 20.2 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 10.9 ptpt -118.74 101.59 50.36 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.6 Cg_exo -45.34 105.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.842 1.695 . . . . 0.0 109.239 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.671 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.66 157.31 86.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.342 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.43 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.9 Cg_endo -53.65 -27.4 41.72 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.807 3.005 . . . . 0.0 112.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.671 ' HB2' HD12 ' A' ' 583' ' ' LEU . 7.4 m-20 -62.08 -24.28 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.487 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 1.8 t -96.02 153.96 17.49 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.207 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 690' ' ' ILE . 14.9 pt -55.29 -14.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.312 . . . . 0.0 111.022 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 35.4 mt -107.36 125.2 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.665 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.43 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -112.32 58.22 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.446 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.535 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.6 mp0 -125.28 168.76 13.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.613 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.23 121.59 25.06 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.381 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.3 mm? -113.34 150.73 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.423 ' CB ' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.72 117.09 23.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.688 HD12 HD22 ' A' ' 578' ' ' LEU . 66.2 mt -74.46 108.7 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -69.05 111.12 4.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.291 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.494 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -38.81 -52.12 1.72 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.281 0.563 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -46.94 -24.74 2.09 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.234 -0.893 . . . . 0.0 113.14 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.09 117.89 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.287 0.543 . . . . 0.0 110.916 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.7 t30 -140.18 122.33 9.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.058 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -89.76 159.93 35.32 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 124.407 -1.08 . . . . 0.0 111.54 -0.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.621 ' CG ' HG23 ' A' ' 594' ' ' ILE . 4.8 t80 -91.55 114.61 27.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.506 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 6.1 m-85 -92.2 138.08 31.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.75 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.5 mp -124.02 148.34 28.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.47 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.41 -171.54 36.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.347 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.486 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.58 -52.58 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 111.644 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.58 133.54 56.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.319 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -57.95 -19.25 28.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.772 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.51 -31.44 56.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.063 0.459 . . . . 0.0 110.258 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.621 ' SG ' HG22 ' A' ' 621' ' ' VAL . 8.6 m -73.56 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.447 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -43.36 -32.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.235 0.54 . . . . 0.0 110.408 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.75 ' SG ' HG23 ' A' ' 603' ' ' ILE . 34.8 t -106.48 142.01 36.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.007 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.85 104.71 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.412 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.3 mm -139.14 109.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.194 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.9 106.75 17.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.424 0.631 . . . . 0.0 112.432 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.59 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.5 t0 -129.46 107.59 9.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.55 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -40.68 -28.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 688' ' ' PHE . 9.3 mmt180 -69.38 -41.47 76.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.59 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -89.19 158.62 17.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.912 0.387 . . . . 0.0 111.527 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 73.1 m -78.97 170.58 16.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.367 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -46.93 -42.58 17.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.621 HG22 ' SG ' ' A' ' 609' ' ' CYS . 41.1 t -122.51 69.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.289 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.632 ' O ' ' N ' ' A' ' 653' ' ' GLY . 17.7 t60 -50.49 -47.05 57.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.745 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 6.2 p -164.6 163.35 21.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.119 0.485 . . . . 0.0 111.986 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.506 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 53.3 p90 -144.18 151.03 38.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.877 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.539 HD13 HD11 ' A' ' 594' ' ' ILE . 3.8 mp -102.71 132.89 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -124.17 132.54 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.872 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 29.9 ttmt -98.17 136.56 38.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.18 158.75 39.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -76.61 114.49 15.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.235 0.54 . . . . 0.0 110.412 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.9 t60 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.771 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 p-10 -122.15 147.62 45.93 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.013 0.435 . . . . 0.0 112.041 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 155.38 47.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.389 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.771 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -104.26 129.16 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.606 0.717 . . . . 0.0 112.702 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.917 ' CH2' HD22 ' A' ' 671' ' ' LEU . 96.1 m95 -113.49 128.57 56.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.215 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.476 ' HB2' HD21 ' A' ' 672' ' ' LEU . 4.7 t80 -90.32 117.29 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 63.2 m -102.78 130.24 49.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.873 0.368 . . . . 0.0 111.271 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.453 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -109.48 128.22 55.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.207 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.445 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.7 p -126.95 8.98 6.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.206 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.54 151.82 31.42 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.155 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.5 m -83.97 -17.17 41.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.578 0.227 . . . . 0.0 111.49 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.485 ' CB ' HD12 ' A' ' 681' ' ' ILE . 2.1 m120 -87.22 -5.51 58.93 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 664' ' ' MET . 6.6 t 74.8 145.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.122 0.486 . . . . 0.0 112.284 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.453 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 61.8 p -119.2 160.3 22.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 679' ' ' LYS . 21.8 m-85 -138.29 120.4 15.64 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.2 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -94.59 103.72 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.564 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 67.75 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -134.86 -3.68 2.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.595 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.8 OUTLIER -94.52 140.79 29.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.878 0.371 . . . . 0.0 111.099 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.658 ' O ' HG21 ' A' ' 716' ' ' VAL . 4.8 ttp180 -83.88 141.53 31.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 27.6 mtp -131.92 107.17 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.449 ' H ' HG21 ' A' ' 668' ' ' THR . 26.5 pt -86.72 164.73 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.124 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 652' ' ' THR . 36.1 tt0 -50.58 110.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.06 31.7 4.95 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.952 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 665' ' ' ILE . 9.4 p -112.7 162.57 15.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.594 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.45 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -137.37 144.35 42.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.608 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.26 144.14 28.63 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.632 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.917 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.23 136.02 51.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.67 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 694' ' ' VAL . 1.1 mt -107.48 106.72 17.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.117 0.484 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -93.48 141.08 28.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.492 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.564 ' HB3' HD12 ' A' ' 696' ' ' ILE . 1.6 p30 -41.52 112.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 91.28 37.6 6.19 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 124.39 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.353 -0.424 . . . . 0.0 111.101 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -96.31 109.07 21.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.766 HG22 ' HG ' ' A' ' 659' ' ' LEU . 12.0 pt -105.41 132.83 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.076 0.465 . . . . 0.0 111.768 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 658' ' ' TYR . 12.3 mttp -93.72 115.88 28.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.633 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.482 HG23 HG22 ' A' ' 681' ' ' ILE . 1.3 tt -78.01 -34.79 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.125 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.485 HD12 ' CB ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER -154.33 131.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.029 179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.619 ' CD1' ' CG1' ' A' ' 689' ' ' VAL . 11.7 t90 -136.02 113.25 10.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -128.57 114.07 16.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.834 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.59 -42.26 78.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -58.58 -40.16 82.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.258 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -76.08 -19.31 58.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.71 15.85 9.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.196 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 617' ' ' ARG . 0.2 OUTLIER -117.73 125.27 50.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.566 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.619 ' CG1' ' CD1' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -119.21 136.52 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.2 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 587' ' ' ILE . 7.2 mt -128.73 115.82 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.325 0.583 . . . . 0.0 110.464 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -139.75 147.01 18.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.883 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.453 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.08 145.01 41.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 10.8 tptm -101.59 116.91 33.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.864 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -82.36 114.99 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.957 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.24 108.99 12.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.995 0.426 . . . . 0.0 110.257 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.564 HD12 ' HB3' ' A' ' 674' ' ' ASP . 25.4 mt -79.4 122.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.294 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -105.1 -42.61 5.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.708 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.52 140.96 44.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.112 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.319 0.581 . . . . 0.0 110.025 179.024 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 663' ' ' ARG . 46.7 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.87 0.367 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.1 mp -91.8 172.28 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -103.25 148.31 25.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.04 157.71 22.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -178.47 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.51 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.93 -52.33 64.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -65.68 -46.65 78.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.44 -32.75 67.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.13 -36.92 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 9.2 mt -59.55 -44.54 93.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.033 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.9 p -81.64 -23.96 9.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -54.44 -34.93 62.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.801 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.452 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.1 tmm_? . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 647' ' ' ILE . 6.0 t80 -121.46 -52.98 2.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 647' ' ' ILE . 11.9 tp -112.22 142.32 44.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.023 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 695' ' ' GLU . 19.4 m -120.3 114.06 21.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.831 ' HG ' HG22 ' A' ' 694' ' ' VAL . 3.1 mp -107.18 108.94 20.62 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.9 pttt -114.45 100.76 53.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -44.9 102.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.787 1.658 . . . . 0.0 109.518 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.22 159.54 83.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.286 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.599 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 6.3 Cg_endo -48.69 -30.56 16.95 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.783 2.988 . . . . 0.0 112.989 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.672 ' HB2' HD12 ' A' ' 583' ' ' LEU . 8.2 m-20 -63.55 -17.72 63.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.063 0.459 . . . . 0.0 109.89 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.579 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 23.8 t -95.46 153.32 17.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.628 HD11 HD11 ' A' ' 690' ' ' ILE . 20.9 pt -59.24 -19.24 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 109.972 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.564 HD13 HG23 ' A' ' 613' ' ' ILE . 5.4 mt -112.55 118.54 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.599 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -106.04 66.0 0.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.374 0.607 . . . . 0.0 110.462 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.578 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.0 mt-10 -125.57 172.34 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.758 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.44 125.6 40.85 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.175 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.772 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.41 138.63 48.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.837 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.452 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.31 114.44 19.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.611 0.243 . . . . 0.0 111.398 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.086 HD11 HD12 ' A' ' 625' ' ' ILE . 46.1 mt -72.36 109.36 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.819 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.14 110.13 2.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.45 -29.64 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.028 0.442 . . . . 0.0 111.022 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.78 -22.51 73.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.378 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.671 HG11 ' OD1' ' A' ' 610' ' ' ASN . 63.4 t -101.28 119.31 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 117.712 0.756 . . . . 0.0 111.465 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 15.5 t30 -138.94 123.37 11.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.884 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 46.0 Cg_endo -90.11 160.82 34.04 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 124.672 -0.97 . . . . 0.0 111.99 0.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.693 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.6 t80 -91.94 114.68 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.552 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 22.2 m-85 -92.29 138.21 31.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.702 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.7 mp -126.46 145.54 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.69 -175.03 36.6 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.43 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -65.45 -47.73 75.13 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 111.38 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.82 127.17 30.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.355 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -58.18 -17.35 18.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.92 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.36 -30.77 67.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.027 0.442 . . . . 0.0 110.186 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.723 ' SG ' HG22 ' A' ' 621' ' ' VAL . 62.3 m -70.61 133.44 46.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.63 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.671 ' OD1' HG11 ' A' ' 598' ' ' VAL . 0.7 OUTLIER -47.47 -28.32 2.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.767 ' SG ' HG23 ' A' ' 603' ' ' ILE . 43.1 t -111.96 142.16 44.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.514 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.28 105.27 13.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.772 HD11 HD21 ' A' ' 592' ' ' LEU . 25.0 mm -139.09 109.73 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.027 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -104.4 107.16 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.472 0.653 . . . . 0.0 112.548 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.616 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.4 t0 -129.38 107.56 9.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.766 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -40.0 -29.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.465 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.616 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.3 pp -89.66 158.85 17.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.549 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.8 164.94 25.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.621 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.911 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -53.06 -25.7 13.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.989 0.423 . . . . 0.0 110.369 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.911 HG23 ' HG2' ' A' ' 620' ' ' ARG . 47.1 t -131.67 64.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 8.0 t60 -49.0 -43.77 40.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.227 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.5 p -167.13 161.42 14.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.0 111.902 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.2 p90 -143.54 148.3 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.593 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.086 HD12 HD11 ' A' ' 594' ' ' ILE . 75.2 mt -102.25 136.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.6 t80 -127.25 135.08 50.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.588 ' CE ' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -97.16 136.82 37.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 158.73 43.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.753 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.8 OUTLIER -77.32 112.75 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.424 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.7 t-160 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.828 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.3 mt . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.43 147.96 35.36 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 0.5 OUTLIER -138.03 131.78 31.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.662 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 578' ' ' LEU . 4.6 pt -87.4 123.82 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.876 ' CH2' HD22 ' A' ' 671' ' ' LEU . 88.0 m95 -104.84 144.09 32.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.871 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.717 ' CD2' HD13 ' A' ' 678' ' ' ILE . 7.4 t80 -104.38 117.15 33.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 25.4 m -105.47 130.02 53.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.482 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 60.4 t60 -108.78 133.08 53.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.22 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.6 p -130.08 6.32 4.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.249 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.43 150.69 31.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.692 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.9 t -73.64 -35.81 65.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 111.455 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.604 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.3 m-80 -70.7 -1.77 12.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.307 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 53.65 125.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.218 0.532 . . . . 0.0 111.786 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.3 p -90.65 165.71 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 89.4 m-85 -128.17 120.27 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.652 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -97.68 100.53 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.33 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 61.4 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -134.44 3.74 3.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.711 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.563 ' HB3' HG23 ' A' ' 716' ' ' VAL . 5.4 m120 -107.12 141.23 38.7 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.658 ' O ' HG21 ' A' ' 716' ' ' VAL . 12.5 ttm180 -80.72 141.21 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.414 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 35.1 mmm -119.12 102.36 8.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.1 pt -87.86 150.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.276 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -44.31 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.445 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.6 43.35 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.655 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.04 162.13 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -131.41 146.28 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.588 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.72 144.88 28.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.876 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.06 134.8 49.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.206 179.169 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 694' ' ' VAL . 1.1 mt -109.96 98.11 7.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.155 0.502 . . . . 0.0 111.504 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -83.49 141.73 31.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.508 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 696' ' ' ILE . 19.5 t0 -46.54 111.42 0.38 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.972 0.415 . . . . 0.0 110.269 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 102.29 36.5 3.58 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.75 31.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 111.176 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.61 108.7 21.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.002 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.717 HD13 ' CD2' ' A' ' 649' ' ' TYR . 10.4 mt -105.97 133.92 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 111.938 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 7.8 mttt -96.65 116.14 28.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.72 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.543 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -80.3 -38.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.204 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.84 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.5 tp -155.37 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.408 . . . . 0.0 111.615 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -136.09 127.28 28.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 688' ' ' PHE . 0.4 OUTLIER -127.18 117.25 21.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 179.102 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -66.73 -46.58 75.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.068 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -81.33 -40.22 23.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.821 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.69 -10.7 59.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.592 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.99 19.52 8.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.522 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 4.6 t80 -83.14 105.03 13.78 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.434 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -125.71 122.48 62.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.163 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.84 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.7 mt -128.78 119.32 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.37 137.19 7.42 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.801 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.46 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.25 143.75 43.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.673 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.8 OUTLIER -101.07 116.7 33.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.753 179.353 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.831 HG22 ' HG ' ' A' ' 580' ' ' LEU . 2.7 t -84.87 125.79 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 25.7 tt0 -134.03 109.28 8.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.786 0.327 . . . . 0.0 111.404 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 674' ' ' ASP . 84.5 mt -69.85 105.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.031 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -85.58 -48.78 8.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.475 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 11.3 t0 -111.9 142.11 44.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.871 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.25 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 663' ' ' ARG . 61.3 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.848 0.356 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.6 mp -98.42 165.06 12.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.707 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.88 135.61 43.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -73.36 154.34 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 43.1 p -126.0 -174.62 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.198 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.8 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.8 -51.89 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.757 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.655 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.7 mp0 -65.26 -48.79 72.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.796 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -56.25 -32.8 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.84 -37.01 83.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.065 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 723' ' ' GLU . 11.9 mt -59.93 -44.12 94.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.998 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 1.6 t -77.02 -26.1 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.247 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -55.25 -33.75 63.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.849 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 29.9 mttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.804 179.82 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.46 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 45.5 ttp180 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 647' ' ' ILE . 11.0 t80 -107.25 -55.64 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.611 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.756 HD11 ' CG1' ' A' ' 694' ' ' VAL . 10.2 tp -111.51 141.99 44.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.781 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 695' ' ' GLU . 18.5 m -124.78 113.97 18.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.705 HD21 HD11 ' A' ' 625' ' ' ILE . 1.6 mp -105.54 108.81 20.52 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -112.7 99.62 48.28 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.101 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.6 Cg_exo -44.6 99.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.864 1.709 . . . . 0.0 109.612 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.753 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.77 157.45 85.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.471 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.52 -25.66 11.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.832 3.021 . . . . 0.0 113.166 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -28.12 69.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.427 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.0 OUTLIER -95.98 154.0 17.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.624 178.261 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.46 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 5.4 pt -58.57 -10.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.732 0.301 . . . . 0.0 110.91 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.485 HD13 HG23 ' A' ' 613' ' ' ILE . 41.1 mt -106.96 118.81 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.08 57.44 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.213 0.53 . . . . 0.0 110.106 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.606 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.2 mm-40 -124.49 171.91 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.162 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.26 122.99 33.02 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.041 0.448 . . . . 0.0 111.233 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.987 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.67 132.68 55.07 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.177 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.46 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -123.95 121.8 36.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.106 HD11 HD12 ' A' ' 625' ' ' ILE . 86.9 mt -74.09 108.96 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.137 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.5 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.5 mp0 -70.54 81.5 0.58 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -7.53 -62.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.583 0.753 . . . . 0.0 112.788 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . -44.69 -21.2 0.27 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.838 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.412 HG11 ' CG ' ' A' ' 610' ' ' ASN . 37.6 t -96.61 118.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 117.432 0.616 . . . . 0.0 111.067 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -139.62 123.63 10.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.581 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 49.3 Cg_endo -90.66 159.85 30.86 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 124.454 -1.061 . . . . 0.0 111.798 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.7 t80 -92.08 114.72 27.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.581 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 49.8 m-85 -92.31 138.02 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.733 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.802 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.7 mp -125.88 144.54 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.739 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.09 -169.44 36.68 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.42 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.511 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -69.81 -52.86 21.44 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.819 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.28 130.0 44.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -56.7 -18.63 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.949 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.96 -31.91 61.01 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.15 0.5 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 73.1 m -71.82 132.72 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.583 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 14.0 m-80 -47.95 -28.43 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.46 . . . . 0.0 110.558 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.8 t -111.07 142.79 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.48 105.23 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.987 HD11 HD21 ' A' ' 592' ' ' LEU . 34.1 mm -139.39 109.62 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.961 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.48 106.57 17.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.445 0.641 . . . . 0.0 112.652 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.628 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.2 t0 -130.35 107.91 9.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.721 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -39.28 -30.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.496 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.7 OUTLIER -68.6 -41.01 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.628 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.22 159.05 17.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.802 0.334 . . . . 0.0 111.428 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.3 t -80.57 166.05 21.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.376 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.481 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 2.9 mpt_? -47.23 -37.14 9.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.374 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.453 HG11 HG23 ' A' ' 727' ' ' VAL . 13.1 t -122.95 63.59 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.558 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 9.4 t60 -48.74 -42.97 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.833 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.6 p -167.79 157.73 10.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.802 ' HA ' HD12 ' A' ' 603' ' ' ILE . 50.1 p90 -143.14 146.0 33.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.687 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.106 HD12 HD11 ' A' ' 594' ' ' ILE . 60.5 mt -102.14 129.27 53.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.323 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.5 t80 -120.83 135.1 55.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.398 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 25.1 ttmt -97.66 134.34 40.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.961 0.41 . . . . 0.0 110.394 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.46 158.37 44.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.759 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -77.43 111.9 13.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.935 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.2 t60 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.107 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 644' ' ' LEU . 5.1 mp . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.4 OUTLIER -113.14 147.0 38.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.54 153.0 51.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.714 HD13 HD13 ' A' ' 578' ' ' LEU . 2.9 pt -100.64 119.02 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.304 0.573 . . . . 0.0 111.524 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.918 ' CH2' HD22 ' A' ' 671' ' ' LEU . 84.8 m95 -100.63 127.84 46.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.453 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.462 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.2 t80 -90.29 117.59 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' A' ' 624' ' ' PHE . 7.9 m -104.13 136.98 42.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.444 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -115.88 127.52 55.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.206 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.8 p -125.86 10.96 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.198 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.29 159.61 41.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.261 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.0 m -88.09 -19.17 27.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.677 0.275 . . . . 0.0 111.46 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.584 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.4 m-80 -87.01 2.7 48.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.8 128.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.35 0.595 . . . . 0.0 112.083 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.444 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 87.5 p -100.28 165.74 11.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.341 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -129.79 120.65 25.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.28 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.644 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.42 102.59 14.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 61.57 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -131.56 -5.65 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.537 ' ND2' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -97.84 141.37 30.91 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 111.095 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.675 ' O ' HG21 ' A' ' 716' ' ' VAL . 29.1 ttp180 -81.86 141.0 33.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.773 ' HE1' HG13 ' A' ' 716' ' ' VAL . 13.3 mmm -120.89 99.64 6.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.431 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 42.3 pt -87.59 154.28 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -45.62 107.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.313 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.12 35.88 3.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.61 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.43 ' CG2' HG12 ' A' ' 665' ' ' ILE . 3.4 p -119.89 162.28 19.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.184 0.516 . . . . 0.0 111.686 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.48 ' HE2' HD13 ' A' ' 717' ' ' LEU . 5.4 ttpm? -130.4 148.79 52.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.007 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.535 ' CE1' HG22 ' A' ' 716' ' ' VAL . 2.4 t80 -147.25 143.94 28.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.918 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -74.05 130.57 40.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.193 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.696 HD13 HG21 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -97.07 139.64 32.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.28 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -124.9 131.5 53.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.075 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.852 ' HB2' HD12 ' A' ' 696' ' ' ILE . 40.3 t0 -42.93 104.0 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 110.581 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 106.19 33.77 3.35 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.506 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -94.51 113.86 25.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.382 . . . . 0.0 111.324 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -95.66 111.91 23.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.642 HG12 HD13 ' A' ' 659' ' ' LEU . 4.3 mt -104.92 137.04 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.062 0.458 . . . . 0.0 111.855 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -93.14 115.98 28.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.803 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.549 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -85.47 -35.48 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.744 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.7 tp -154.97 131.33 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.072 0.463 . . . . 0.0 111.826 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -137.11 125.35 23.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -127.15 116.81 21.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.884 0.373 . . . . 0.0 110.266 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -46.84 71.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.21 -40.68 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.84 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -87.24 -8.7 56.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? 60.71 17.94 8.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.46 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 6.7 t80 -77.08 104.59 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -124.51 122.17 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 111.813 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.744 ' HB ' HG22 ' A' ' 681' ' ' ILE . 7.0 mt -128.18 151.43 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.517 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.428 ' O ' HD22 ' A' ' 583' ' ' LEU . . . 178.26 137.83 2.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.091 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.579 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 1.8 m-30 -114.5 150.33 35.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.732 0.301 . . . . 0.0 110.738 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.753 ' HB2' HD12 ' A' ' 583' ' ' LEU . 6.5 tttt -101.16 116.62 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.633 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.756 ' CG1' HD11 ' A' ' 578' ' ' LEU . 3.6 t -79.56 124.72 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.686 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.05 108.75 8.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.852 HD12 ' HB2' ' A' ' 674' ' ' ASP . 58.1 mt -69.67 105.6 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.04 -47.06 16.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.697 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.468 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 80.6 m-20 -111.08 140.98 45.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.362 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.773 HG13 ' HE1' ' A' ' 664' ' ' MET . 12.0 t . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.777 0.323 . . . . 0.0 111.267 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.48 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.8 OUTLIER -89.86 168.37 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.84 146.6 27.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -80.66 154.87 27.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -123.77 -177.26 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.26 -30.76 62.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -64.83 -49.9 68.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.722 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -64.34 -50.62 67.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.498 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.6 OUTLIER -59.0 -32.55 69.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.049 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -62.8 -39.93 95.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.003 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 723' ' ' GLU . 3.2 mt -61.04 -44.56 97.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 724' ' ' LYS . 10.5 p -72.56 -25.51 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -65.11 -34.33 78.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.266 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.946 179.54 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 577' ' ' PHE . 3.1 tmm_? . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.832 0.349 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.761 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -115.31 -57.42 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.371 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.976 HD23 HD12 ' A' ' 594' ' ' ILE . 24.0 tp -106.59 142.21 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.656 0.265 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.896 HG23 ' HG3' ' A' ' 593' ' ' GLU . 8.3 m -123.57 113.03 18.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 1.11 HD22 HG22 ' A' ' 694' ' ' VAL . 0.0 OUTLIER -107.9 107.84 18.74 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.573 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.533 ' HG3' HG22 ' A' ' 579' ' ' THR . 12.5 mtpt -109.57 99.59 38.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -175.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.3 Cg_exo -46.67 108.92 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.56 1.507 . . . . 0.0 108.722 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.71 156.77 88.19 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.49 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 13.9 Cg_endo -56.24 -25.89 58.29 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.639 2.893 . . . . 0.0 112.825 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -63.31 -20.51 65.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.191 0.52 . . . . 0.0 109.653 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.439 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.4 t -97.38 153.84 17.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.759 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 690' ' ' ILE . 5.2 pt -52.68 -21.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 109.908 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.837 HD13 HG23 ' A' ' 613' ' ' ILE . 48.1 mt -106.71 118.74 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.845 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -114.38 63.67 0.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.572 0.701 . . . . 0.0 109.773 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 17.6 mt-10 -125.24 173.25 8.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.455 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.15 116.52 21.48 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.691 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.43 128.03 56.31 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.896 ' HG3' HG23 ' A' ' 579' ' ' THR . 2.8 mp0 -124.98 131.21 53.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.976 HD12 HD23 ' A' ' 578' ' ' LEU . 67.0 mt -71.44 109.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 598' ' ' VAL . 2.2 mp0 -51.17 105.16 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.417 0.627 . . . . 0.0 111.645 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.761 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 1.3 mm-40 41.63 -125.76 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.908 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -96.95 41.04 2.41 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.972 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 595' ' ' GLN . 4.7 t -73.05 118.73 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -135.26 127.69 18.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.222 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.618 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 19.9 Cg_endo -92.77 153.23 17.6 Favored 'Cis proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.957 -1.268 . . . . 0.0 112.508 0.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.749 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.1 t80 -96.1 112.2 24.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.618 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 72.8 m-85 -93.01 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.46 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.772 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mt -126.57 145.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.478 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.51 -168.38 35.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.383 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.497 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.08 -54.84 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.48 56.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.0 111.592 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -57.58 -19.47 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.815 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -53.34 -31.27 43.58 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.175 0.512 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 87.0 m -73.18 131.19 41.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.493 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 7.1 m-80 -46.31 -29.87 1.83 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.223 0.535 . . . . 0.0 110.404 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.82 ' SG ' HD13 ' A' ' 592' ' ' LEU . 41.4 t -110.76 143.13 41.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.028 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.24 105.44 13.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 592' ' ' LEU . 32.9 mm -138.99 109.61 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.027 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -104.06 106.96 17.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.627 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.3 t0 -130.0 107.7 9.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.604 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -38.73 -30.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.499 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -68.86 -41.6 78.18 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.627 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -88.65 159.13 17.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.953 0.406 . . . . 0.0 111.938 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 60.1 p -77.55 173.08 12.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -49.55 -32.95 13.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.516 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 621' ' ' VAL . 8.9 p -134.99 66.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.606 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 13.7 t60 -44.65 -39.53 5.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.96 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.454 ' SG ' HD11 ' A' ' 680' ' ' ILE . 4.3 p -165.39 158.86 16.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.47 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 36.3 p90 -143.77 147.74 34.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.972 HD12 HD11 ' A' ' 594' ' ' ILE . 55.7 mt -101.92 134.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.019 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 626' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 135.76 51.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.422 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 627' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -97.15 137.84 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.127 0.489 . . . . 0.0 110.879 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.71 158.92 43.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.877 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -77.17 112.47 13.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.307 0.575 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.5 t60 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.885 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 630' ' ' HIS . 1.2 mt . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.343 0.592 . . . . 0.0 112.526 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.13 137.31 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.605 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.859 HD13 HD22 ' A' ' 578' ' ' LEU . 2.5 pt -88.96 120.65 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.334 0.587 . . . . 0.0 112.145 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.923 ' CH2' HD22 ' A' ' 671' ' ' LEU . 87.4 m95 -101.74 143.82 31.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.726 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.585 ' HB2' HD11 ' A' ' 672' ' ' LEU . 16.7 t80 -104.24 117.34 33.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -105.29 138.47 41.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.162 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.44 ' CE1' ' N ' ' A' ' 657' ' ' SER . 49.2 t60 -118.44 130.98 56.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.43 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -127.36 8.76 6.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.139 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.37 148.51 28.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.282 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.3 t -75.78 -31.17 59.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 111.197 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.616 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.2 m120 -71.95 -1.17 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.6 126.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.346 0.593 . . . . 0.0 111.57 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 91.8 p -95.54 165.92 12.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -128.09 120.03 26.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 111.403 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -96.56 99.87 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.94 -81.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.11 3.1 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.806 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.469 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 8.0 m120 -103.68 141.65 35.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.826 0.345 . . . . 0.0 111.111 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -77.85 141.56 39.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.425 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 31.3 mmm -125.93 97.9 5.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.6 pt -87.83 153.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' A' ' 652' ' ' THR . 52.0 tt0 -48.05 100.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.82 37.25 1.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.37 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.9 p -125.48 158.71 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 111.445 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.458 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -130.26 148.56 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.458 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.9 145.35 28.61 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.923 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 135.21 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.419 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.5 mt -111.63 104.99 13.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.05 143.58 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.219 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.616 ' HB2' HD12 ' A' ' 696' ' ' ILE . 40.5 t0 -45.5 113.91 0.67 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 110.877 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 99.52 35.51 4.64 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 116.32 28.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.993 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.05 108.76 21.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.22 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.68 HG12 HD13 ' A' ' 659' ' ' LEU . 11.4 mt -107.69 135.0 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 111.894 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.439 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 4.5 mttm -96.79 116.2 28.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.848 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.561 HG23 HD23 ' A' ' 618' ' ' LEU . 0.0 OUTLIER -76.33 -34.6 25.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.303 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.779 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.2 tp -154.27 131.02 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.67 122.08 19.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.548 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.07 116.32 20.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 110.4 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -46.63 71.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.148 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -69.09 -40.51 78.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.058 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.72 -2.44 53.81 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt 58.11 19.23 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 0.0 110.829 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.502 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 2.6 t80 -76.84 104.46 7.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.431 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -126.19 120.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.808 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 587' ' ' ILE . 13.6 mt -129.64 124.68 59.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -150.04 141.49 8.85 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.716 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.616 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 3.1 m-30 -113.92 141.85 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 580' ' ' LEU . 2.7 tttt -101.23 115.75 31.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.938 0.399 . . . . 0.0 110.299 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 1.11 HG22 HD22 ' A' ' 580' ' ' LEU . 1.9 t -80.5 127.02 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.857 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.2 OUTLIER -134.21 109.03 8.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 674' ' ' ASP . 60.1 mt -71.45 105.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.099 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.36 -46.85 8.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.288 0.566 . . . . 0.0 109.565 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.536 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.0 t0 -111.32 142.68 43.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.341 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.483 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.1 t . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.917 0.389 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.477 HD11 ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -106.19 162.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.618 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.89 145.06 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.853 0.358 . . . . 0.0 111.005 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -79.98 156.61 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 33.9 p -126.06 -174.21 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.71 -29.39 53.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.65 -50.37 65.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.668 ' HA ' HD12 ' A' ' 726' ' ' LEU . 41.1 mp0 -64.0 -45.29 89.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -57.73 -32.94 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.42 -37.02 82.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 723' ' ' GLU . 12.2 mt -59.43 -44.84 92.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.015 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.2 p -84.75 -24.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.347 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -56.6 -30.27 63.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.998 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.451 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.856 0.36 . . . . 0.0 111.068 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.752 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -128.06 -49.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.927 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 694' ' ' VAL . 7.3 tp -118.23 142.51 47.39 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.996 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 24.0 m -115.83 117.19 29.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.782 HD11 HD11 ' A' ' 625' ' ' ILE . 9.6 mt -105.56 109.11 20.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.73 99.55 52.26 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 38.2 Cg_exo -46.03 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.884 1.722 . . . . 0.0 109.628 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.798 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.3 OUTLIER -74.87 157.78 85.29 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.39 -24.93 9.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.633 2.889 . . . . 0.0 112.785 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.798 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.5 t0 -61.62 -27.38 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.466 ' OG ' HD13 ' A' ' 690' ' ' ILE . 4.7 t -95.56 154.0 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.721 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 690' ' ' ILE . 1.4 pt -56.5 -13.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.43 ' CD1' HG23 ' A' ' 613' ' ' ILE . 60.8 mt -108.08 130.92 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.32 60.12 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.592 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.7 mt-10 -124.9 169.58 11.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.103 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.56 121.49 25.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.66 0.267 . . . . 0.0 111.559 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.2 mm? -112.93 149.38 33.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.451 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.95 118.69 26.83 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.946 HD11 HD12 ' A' ' 625' ' ' ILE . 63.7 mt -73.97 109.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.321 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -64.55 113.55 3.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.661 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.24 -30.89 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.226 0.536 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.57 -20.43 73.84 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.052 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.488 HG11 ' CG ' ' A' ' 610' ' ' ASN . 48.1 t -99.86 118.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.561 0.681 . . . . 0.0 111.287 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.5 t30 -139.54 121.87 10.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.993 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.6 Cg_endo -90.21 160.13 33.22 Favored 'Cis proline' 0 N--CA 1.462 -0.367 0 C-N-CA 124.499 -1.042 . . . . 0.0 111.811 -0.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.631 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.4 t80 -91.27 114.76 27.37 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 33.6 m-85 -91.89 138.04 31.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.294 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.783 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -125.39 143.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.229 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.38 -163.57 35.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.454 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -77.13 -51.15 11.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.37 127.02 29.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.293 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -53.88 -19.78 5.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.004 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.93 -30.32 61.47 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.002 0.43 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 38.0 m -70.59 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.589 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 15.3 m-80 -47.34 -29.0 2.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.036 0.446 . . . . 0.0 110.482 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.783 ' SG ' HG23 ' A' ' 603' ' ' ILE . 37.1 t -110.87 137.0 49.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.16 104.76 14.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.43 HG23 ' CD1' ' A' ' 588' ' ' ILE . 15.5 mm -139.53 109.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.299 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -104.98 107.17 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.594 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -129.17 107.4 9.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.466 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -39.86 -27.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 681' ' ' ILE . 0.3 OUTLIER -73.51 -39.81 64.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.594 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -88.78 158.73 18.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 111.403 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.8 m -76.82 169.07 18.99 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.791 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.439 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -51.15 -35.27 35.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.28 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.67 63.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.52 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.613 ' HD2' HG23 ' A' ' 680' ' ' ILE . 26.3 t60 -47.83 -40.38 21.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.825 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.7 p -168.69 156.72 8.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.037 0.446 . . . . 0.0 111.631 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.718 ' HA ' HD12 ' A' ' 603' ' ' ILE . 27.3 p90 -143.34 148.47 36.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.55 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.946 HD12 HD11 ' A' ' 594' ' ' ILE . 61.4 mt -102.15 135.25 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.891 0.377 . . . . 0.0 110.133 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -126.87 134.13 50.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.647 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 7.8 ttpt -98.08 134.97 40.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.506 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.71 158.24 44.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.761 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -77.39 115.93 17.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.473 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 644' ' ' LEU . 9.0 t-80 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.961 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -116.5 147.42 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.146 0.498 . . . . 0.0 111.876 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.48 147.01 51.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.234 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.802 HD13 HD13 ' A' ' 578' ' ' LEU . 9.3 pt -96.74 126.93 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.231 0.538 . . . . 0.0 111.617 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.923 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.7 m95 -110.68 131.65 54.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.202 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.601 ' CD2' HD13 ' A' ' 678' ' ' ILE . 6.9 t80 -92.48 117.64 30.15 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.428 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 36.6 m -104.2 137.16 42.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.991 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.454 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 31.6 t60 -115.86 131.3 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.086 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 3.1 p -131.86 15.75 4.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.415 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.51 153.42 27.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.212 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 89.8 m -82.13 -25.81 34.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.555 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.0 OUTLIER -81.81 3.41 26.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.021 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.38 134.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 112.181 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.441 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 73.8 m -106.22 166.27 10.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.406 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 679' ' ' LYS . 6.1 m-85 -127.74 120.31 27.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.821 0.343 . . . . 0.0 111.006 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.603 HD22 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -102.09 99.53 9.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.4 m120 58.68 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.2 OUTLIER -130.98 3.19 4.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.472 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 9.0 m120 -109.08 138.01 46.09 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -75.71 141.32 42.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 656' ' ' VAL . 49.7 mmm -119.82 87.83 2.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.711 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 42.1 pt -87.48 156.1 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.035 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -48.9 94.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.243 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.77 41.71 0.77 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.579 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.1 p -127.9 162.16 27.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.931 0.396 . . . . 0.0 111.381 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpm? -137.76 141.69 40.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.752 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.58 144.94 28.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.768 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.923 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.56 140.65 55.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.018 0.437 . . . . 0.0 111.192 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.815 HD13 HG21 ' A' ' 694' ' ' VAL . 2.0 mt -112.15 124.04 51.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -109.97 161.84 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.761 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.489 ' N ' HD12 ' A' ' 696' ' ' ILE . 35.9 t0 -59.19 100.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.368 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.22 30.27 3.95 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.55 114.19 23.08 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -96.09 108.6 21.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.093 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.603 HG12 HD22 ' A' ' 659' ' ' LEU . 5.4 mt -105.67 120.9 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.637 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 658' ' ' TYR . 4.1 mttp -82.28 115.48 21.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.358 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.613 HG23 ' HD2' ' A' ' 622' ' ' HIS . 1.6 mt -75.44 -39.05 40.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.569 HG22 ' CG1' ' A' ' 690' ' ' ILE . 5.4 tt -155.78 131.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.916 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.58 121.44 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.07 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -127.13 116.82 21.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 110.544 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -67.46 -46.5 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.919 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -66.05 -40.34 90.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.927 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -93.85 -8.46 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.621 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 62.04 16.52 8.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.63 0.253 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.9 t80 -77.06 105.46 8.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.3 p -119.58 124.62 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.1 0.476 . . . . 0.0 111.922 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.569 ' CG1' HG22 ' A' ' 681' ' ' ILE . 27.3 mm -128.1 154.97 39.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.397 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 174.05 134.18 1.81 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.448 ' CZ ' ' HG3' ' A' ' 582' ' ' PRO . 9.6 m-30 -112.89 147.28 37.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 110.331 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -101.37 116.52 32.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.198 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.862 HG13 HD11 ' A' ' 578' ' ' LEU . 2.1 t -80.86 129.7 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.464 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -133.47 109.43 9.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.926 0.394 . . . . 0.0 111.16 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 674' ' ' ASP . 26.7 mt -78.19 105.69 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.238 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 697' ' ' ASN . . . . . 0.42 ' HB2' ' NH1' ' A' ' 576' ' ' ARG . 20.2 m120 -93.25 -45.93 7.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.05 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.492 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 2.8 t70 -110.78 139.84 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 121.291 0.567 . . . . 0.0 109.74 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.5 p . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.853 0.359 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.08 172.46 8.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 157.37 16.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -87.32 155.19 20.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.81 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -126.17 -175.25 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.87 -30.74 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.087 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.49 -52.03 66.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -66.14 -46.0 79.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.795 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.68 -33.68 64.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.693 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.2 -36.94 80.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 22.8 mt -56.91 -44.41 82.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.45 -22.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -37.47 78.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.4 mttt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 179.945 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.425 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 5.4 tmm_? . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.668 ' HE1' HD13 ' A' ' 647' ' ' ILE . 6.3 t80 -95.33 -54.0 3.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.864 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.931 HD13 HD13 ' A' ' 647' ' ' ILE . 10.8 tp -108.79 143.31 38.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.989 0.423 . . . . 0.0 111.773 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.47 HG22 ' CG ' ' A' ' 581' ' ' LYS . 25.3 m -121.94 115.12 22.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.608 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.7 OUTLIER -105.21 109.13 21.0 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.485 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 18.1 mtmt -115.17 99.41 52.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.623 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 33.2 Cg_exo -46.27 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.711 1.607 . . . . 0.0 109.126 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.727 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -75.1 157.61 85.06 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.14 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.84 -25.59 12.19 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.438 2.759 . . . . 0.0 112.644 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.5 t70 -62.23 -28.82 69.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.504 ' HB2' HD13 ' A' ' 690' ' ' ILE . 0.8 OUTLIER -96.05 153.84 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.753 178.321 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.684 HD13 ' CE1' ' A' ' 688' ' ' PHE . 13.9 pt -54.99 -11.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 111.34 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 42.0 mt -107.16 128.73 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.09 54.88 0.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.797 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.623 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 51.3 mm-40 -124.62 169.84 11.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.033 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.36 124.07 31.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.661 0.267 . . . . 0.0 111.659 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.2 mm? -112.87 148.96 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.425 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.68 122.44 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.007 HD11 HD12 ' A' ' 625' ' ' ILE . 33.0 mt -78.9 108.68 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.15 111.52 2.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 1.8 pt20 -43.47 -34.26 1.29 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.41 0.624 . . . . 0.0 109.972 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -62.9 -24.45 66.74 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.329 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.489 HG11 ' ND2' ' A' ' 610' ' ' ASN . 97.7 t -101.29 119.26 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.659 0.73 . . . . 0.0 111.414 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.1 t30 -138.91 122.91 11.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.704 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 48.0 Cg_endo -90.17 160.32 33.48 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 124.56 -1.017 . . . . 0.0 112.0 0.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.2 t80 -91.97 115.9 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.513 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 30.7 m-85 -92.38 138.0 31.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.819 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -125.03 145.76 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.742 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 160.63 -171.43 36.78 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.374 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.442 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -70.72 -46.91 62.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 111.372 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.16 130.56 46.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.381 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -18.32 29.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.783 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.05 -30.9 66.53 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.205 0.526 . . . . 0.0 110.301 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 94.7 m -70.54 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.1 m120 -44.52 -33.21 1.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.819 ' SG ' HG23 ' A' ' 603' ' ' ILE . 35.1 t -106.93 138.67 42.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.815 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.97 104.59 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.466 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.6 mm -139.47 109.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.409 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -104.07 106.09 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.436 0.636 . . . . 0.0 111.994 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.55 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 3.1 t70 -129.68 108.85 10.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.894 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -40.2 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -42.69 70.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 680' ' ' ILE . 1.5 pp -89.44 158.21 17.82 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.679 0.276 . . . . 0.0 111.013 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.82 165.82 20.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.0 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.879 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -54.22 -25.21 21.75 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.075 0.464 . . . . 0.0 110.435 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.879 HG23 ' HG2' ' A' ' 620' ' ' ARG . 57.6 t -130.75 57.44 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.997 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.855 ' CD2' HG23 ' A' ' 680' ' ' ILE . 37.0 t60 -48.4 -45.69 36.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.6 p -168.37 161.35 11.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 111.543 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.73 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.9 p90 -143.44 147.53 34.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.509 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.007 HD12 HD11 ' A' ' 594' ' ' ILE . 62.1 mt -102.02 134.52 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -125.87 134.36 51.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.737 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.529 ' HE2' HG23 ' A' ' 647' ' ' ILE . 1.9 ttmm -97.59 136.73 37.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.122 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.469 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.15 159.35 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.764 -178.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.82 113.62 14.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.409 0.623 . . . . 0.0 110.502 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.33 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 630' ' ' HIS . 1.1 mt . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 48.1 m-20 -122.23 148.25 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.792 ' OD2' HD11 ' A' ' 671' ' ' LEU . 3.3 t0 -133.62 151.21 51.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.701 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.931 HD13 HD13 ' A' ' 578' ' ' LEU . 8.9 pt -100.25 122.45 52.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 111.487 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.55 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 77.6 m95 -108.05 134.01 51.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.308 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.636 ' CE2' HD12 ' A' ' 678' ' ' ILE . 7.9 t80 -95.68 117.53 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 26.1 m -101.0 133.49 45.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 54.5 t60 -112.87 131.64 55.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.4 p -129.67 0.95 4.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.449 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 148.36 34.8 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.712 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.8 t -75.91 -34.49 59.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.114 0.483 . . . . 0.0 111.311 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.586 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.1 m120 -70.16 2.0 4.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.379 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.17 133.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.435 0.636 . . . . 0.0 112.32 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 98.2 p -103.86 165.69 10.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.482 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.68 120.24 30.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.225 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.788 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -105.24 109.38 21.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.903 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.591 ' N ' HD12 ' A' ' 659' ' ' LEU . 1.9 m120 55.43 -82.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.975 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 659' ' ' LEU . 18.5 m-20 -137.49 5.87 2.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.814 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.504 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 3.2 t-20 -108.81 135.57 49.81 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.943 0.402 . . . . 0.0 111.253 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 17.0 ttp-105 -73.65 141.43 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.504 ' O ' HG23 ' A' ' 656' ' ' VAL . 39.5 mmm -117.07 98.17 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.053 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.434 HG12 HG21 ' A' ' 668' ' ' THR . 41.1 pt -88.19 149.13 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.114 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.59 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.433 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.26 42.31 1.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.434 HG21 HG12 ' A' ' 665' ' ' ILE . 1.1 p -127.14 162.28 26.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.45 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.451 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -134.07 135.93 43.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.467 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.518 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -140.03 144.19 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.46 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.792 HD11 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.78 141.05 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.127 0.489 . . . . 0.0 111.345 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.779 HD13 HG21 ' A' ' 694' ' ' VAL . 2.9 mt -112.27 98.16 7.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.427 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -82.72 131.01 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.946 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.478 ' HB2' HD12 ' A' ' 696' ' ' ILE . 5.7 t70 -36.01 107.32 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.099 0.476 . . . . 0.0 110.96 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.92 33.94 3.62 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.537 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -94.04 118.37 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.003 -179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -96.2 108.87 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.757 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.788 HG22 HD13 ' A' ' 659' ' ' LEU . 25.8 pt -105.61 136.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.99 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.8 OUTLIER -99.05 115.96 30.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.752 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.855 HG23 ' CD2' ' A' ' 622' ' ' HIS . 4.3 mt -84.24 -35.67 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.478 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.502 ' CG2' ' HB ' ' A' ' 690' ' ' ILE . 4.2 tp -154.33 129.05 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.328 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -137.96 123.44 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.302 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -127.51 116.08 19.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.925 0.393 . . . . 0.0 110.607 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -46.57 70.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.956 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.78 -40.83 97.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.135 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.06 4.01 49.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.9 mttm 54.24 22.07 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.776 0.322 . . . . 0.0 110.93 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.684 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.5 t80 -76.4 104.36 6.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.7 p -117.45 124.22 72.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.054 0.454 . . . . 0.0 111.867 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.626 HD11 HG12 ' A' ' 587' ' ' ILE . 4.9 mm -128.06 154.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.331 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . 175.68 134.11 1.87 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.52 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.486 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.9 m-30 -113.27 142.89 45.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.727 ' HB2' HD22 ' A' ' 583' ' ' LEU . 7.2 tttp -100.87 116.34 32.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 109.88 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.779 HG21 HD13 ' A' ' 672' ' ' LEU . 2.7 t -85.12 123.24 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 110.02 9.51 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.082 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 674' ' ' ASP . 66.3 mt -65.3 105.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.24 -48.08 12.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.934 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.445 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 38.7 t0 -111.69 139.38 47.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.173 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.792 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.879 0.371 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.19 172.33 7.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -99.67 156.97 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.958 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.26 148.49 22.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 22.0 p -126.14 -173.44 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.218 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.47 -29.03 33.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.54 -51.61 67.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.36 -44.72 90.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.617 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -57.59 -32.72 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.74 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.15 -37.23 83.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 40.7 mt -59.48 -44.15 93.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.63 -24.93 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -32.14 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 51.6 mttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.394 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.9 tmm_? . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.594 0.235 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 3.1 t80 -99.83 -45.18 5.81 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.696 HD22 ' CD1' ' A' ' 647' ' ' ILE . 10.3 tp -118.59 142.84 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 30.3 m -120.49 115.84 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.837 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 1.024 HD22 HG22 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -105.5 109.32 21.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 19.3 pttt -116.87 98.77 52.38 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 23.4 Cg_exo -46.03 98.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.923 1.748 . . . . 0.0 109.823 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.3 OUTLIER -74.71 157.86 85.45 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.49 -29.74 19.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.508 2.806 . . . . 0.0 112.876 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.71 ' HB2' HD12 ' A' ' 583' ' ' LEU . 23.2 m-20 -62.33 -24.9 67.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 5.6 t -95.51 153.27 17.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.644 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 10.6 tt -56.34 -14.48 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 613' ' ' ILE . 21.0 mt -111.51 128.14 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 111.626 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.64 55.98 0.68 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.625 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.7 mt-10 -124.79 170.28 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.908 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.677 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -130.35 119.7 23.17 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.74 0.305 . . . . 0.0 111.621 178.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.677 HD13 ' C ' ' A' ' 591' ' ' SER . 0.2 OUTLIER -113.03 146.33 39.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.5 OUTLIER -123.97 121.47 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.027 HD11 HD12 ' A' ' 625' ' ' ILE . 70.4 mt -75.86 109.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.148 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 2.9 mm-40 -66.12 114.65 5.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.91 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 1.8 pt20 -42.49 -34.73 0.89 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.353 0.597 . . . . 0.0 110.111 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.496 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.0 -20.24 68.61 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.702 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.625 HG11 ' OD1' ' A' ' 610' ' ' ASN . 99.3 t -101.07 118.79 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 117.912 0.856 . . . . 0.0 111.67 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 8.8 t30 -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.908 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.591 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -90.39 160.45 32.47 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.621 -0.991 . . . . 0.0 111.632 -0.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.622 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.5 t80 -91.26 114.88 27.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.548 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 46.4 m-85 -91.84 138.16 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.098 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.79 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -126.76 145.03 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.787 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.31 -165.48 34.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.46 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.427 ' HG2' ' CD2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -71.33 -54.59 10.29 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.34 130.81 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.483 -178.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -19.33 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.63 -30.35 42.39 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.119 0.485 . . . . 0.0 110.056 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 95.8 m -73.41 131.21 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.297 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.625 ' OD1' HG11 ' A' ' 598' ' ' VAL . 0.7 OUTLIER -46.51 -28.65 1.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.79 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.2 t -111.44 141.58 44.81 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.19 107.53 16.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.611 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.6 mm -138.37 110.05 5.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.313 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.58 106.09 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.739 ' CB ' HD22 ' A' ' 618' ' ' LEU . 31.0 t0 -130.25 108.24 9.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.898 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -40.25 -32.74 0.2 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.821 0.343 . . . . 0.0 111.601 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.705 ' HB3' HD11 ' A' ' 681' ' ' ILE . 2.5 mtm-85 -78.19 -38.03 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.03 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.739 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -88.91 120.03 29.96 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.13 167.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.529 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.3 mpt_? -56.25 -35.92 67.95 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.12 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.611 HG11 HG23 ' A' ' 727' ' ' VAL . 17.3 t -124.01 57.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.736 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.775 ' CD2' HG23 ' A' ' 680' ' ' ILE . 31.9 t60 -50.28 -48.45 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.931 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.3 p -159.33 156.0 27.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.029 0.442 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.773 ' HA ' HD12 ' A' ' 603' ' ' ILE . 48.5 p90 -143.66 149.31 37.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.461 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.027 HD12 HD11 ' A' ' 594' ' ' ILE . 79.7 mt -102.61 130.34 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.927 0.394 . . . . 0.0 109.981 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.591 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.8 t80 -122.65 133.55 54.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 647' ' ' ILE . 35.4 ttmt -98.28 136.98 37.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.26 158.74 42.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.288 -179.093 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -76.44 112.74 13.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.329 0.585 . . . . 0.0 110.299 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.447 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.9 t60 . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.823 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 630' ' ' HIS . 2.4 mt . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.1 m-20 -118.78 148.09 43.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.309 0.576 . . . . 0.0 112.378 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.677 ' OD2' HD11 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -132.3 138.51 47.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.778 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.696 ' CD1' HD22 ' A' ' 578' ' ' LEU . 5.0 pt -96.03 119.06 43.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.572 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 85.8 m95 -103.7 132.63 49.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.972 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.561 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.9 t80 -90.73 116.23 28.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 624' ' ' PHE . 1.3 m -98.13 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.111 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 60.8 t60 -124.58 129.28 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 16.9 p -128.6 4.88 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.325 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.95 149.01 33.92 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.692 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.2 t -75.81 -28.27 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.523 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.634 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.7 OUTLIER -73.93 0.01 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.272 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 56.77 133.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.345 0.593 . . . . 0.0 111.896 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 14.8 t -105.11 165.58 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.004 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.408 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 10.4 m-85 -134.6 120.19 19.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.711 ' HA ' HG23 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -99.35 100.49 11.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.9 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 31.0 t30 -132.17 -0.7 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.62 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.405 ' OD1' ' CZ ' ' A' ' 670' ' ' PHE . 21.3 m120 -104.04 122.39 45.16 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.991 0.424 . . . . 0.0 111.245 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -66.63 141.77 57.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.968 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 37.6 mmm -114.8 102.49 10.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.16 147.33 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.802 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.91 95.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.435 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.2 39.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.841 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 718' ' ' LYS . 1.3 p -138.16 161.99 35.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.405 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 19.3 pttm -135.62 135.66 40.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.562 ' HB3' HD23 ' A' ' 659' ' ' LEU . 18.8 t80 -127.15 143.55 51.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.51 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.677 HD11 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.95 136.53 50.63 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.03 0.443 . . . . 0.0 111.597 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 1.011 HD13 HG21 ' A' ' 694' ' ' VAL . 2.7 mt -98.57 143.52 28.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.307 0.575 . . . . 0.0 111.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 26.0 mt-30 -119.09 141.85 48.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.529 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 696' ' ' ILE . 26.8 t70 -48.07 96.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.22 0.533 . . . . 0.0 110.213 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 107.49 32.6 3.36 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.415 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -86.63 114.35 23.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 110.98 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -96.12 108.73 21.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.711 HG23 ' HA ' ' A' ' 659' ' ' LEU . 1.4 mt -105.2 137.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 111.745 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.24 115.87 28.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.623 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.775 HG23 ' CD2' ' A' ' 622' ' ' HIS . 8.1 mt -82.97 -35.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.236 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 617' ' ' ARG . 1.2 tt -154.9 132.67 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 111.586 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -136.33 124.22 22.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.227 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.77 117.0 27.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.314 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -67.16 -47.08 72.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.803 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -83.44 -40.33 19.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.533 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.75 -15.6 59.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.383 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.83 9.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 0.0 110.952 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 1.8 t80 -85.37 105.1 15.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -122.87 121.75 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.287 0.565 . . . . 0.0 112.144 -178.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.667 ' CG1' HG22 ' A' ' 681' ' ' ILE . 2.5 mm -109.77 144.41 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.38 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -169.58 127.35 1.48 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.753 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 9.3 m-30 -113.95 146.13 40.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.784 0.326 . . . . 0.0 110.42 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.736 ' HB2' HD22 ' A' ' 583' ' ' LEU . 26.7 tttt -101.36 116.59 33.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 1.024 HG22 HD22 ' A' ' 580' ' ' LEU . 2.5 t -82.5 124.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.436 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.3 tp10 -133.69 109.23 9.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.898 0.38 . . . . 0.0 111.05 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.683 HD12 ' HB2' ' A' ' 674' ' ' ASP . 24.0 mt -72.17 104.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.268 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -88.32 -49.97 6.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 5.5 t70 -112.18 139.52 47.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.032 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 8.3 p . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.798 0.333 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.557 HD12 ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -98.38 163.21 12.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 718' ' ' LYS . . . . . 0.532 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.1 OUTLIER -102.62 145.61 29.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.44 151.89 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.2 p -126.0 -173.95 2.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.97 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.99 -28.97 55.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -49.21 64.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -63.78 -50.95 67.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -57.41 -32.83 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.85 -37.25 86.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 600' ' ' PRO . 14.4 mt -62.79 -44.5 96.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.961 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.611 HG23 HG11 ' A' ' 621' ' ' VAL . 8.4 p -76.17 -28.57 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.08 -33.84 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.4 mttm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.763 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 19.9 ttp-105 . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.532 0.206 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -99.44 -58.98 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.447 . . . . 0.0 110.504 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.886 HD12 HD13 ' A' ' 647' ' ' ILE . 9.4 tt -107.84 141.98 38.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.633 HG22 ' HG2' ' A' ' 581' ' ' LYS . 16.0 m -117.58 115.24 24.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.587 ' CD1' HD11 ' A' ' 594' ' ' ILE . 0.4 OUTLIER -104.4 108.64 20.15 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.633 ' HG2' HG22 ' A' ' 579' ' ' THR . 11.6 mtmt -114.86 99.13 51.58 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -47.26 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.761 1.641 . . . . 0.0 109.394 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.481 HD21 ' HG3' ' A' ' 677' ' ' GLU . 0.2 OUTLIER -74.68 157.91 85.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.11 -25.27 8.97 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.688 2.925 . . . . 0.0 112.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.65 -28.16 69.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.447 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 2.0 t -95.94 153.8 17.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.631 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.672 HD13 ' CE1' ' A' ' 688' ' ' PHE . 16.0 pt -57.14 -13.68 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 110.973 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 613' ' ' ILE . 23.4 mt -105.48 120.26 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.685 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.41 56.79 0.62 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.063 0.459 . . . . 0.0 110.343 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.652 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.0 mt-10 -124.72 170.36 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.215 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.576 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -130.19 120.54 24.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.359 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 591' ' ' SER . 0.4 OUTLIER -113.15 148.43 35.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.81 125.51 44.12 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.817 HD12 HD22 ' A' ' 578' ' ' LEU . 94.0 mt -83.73 109.05 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 593' ' ' GLU . 2.2 mp0 -67.05 124.38 22.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.696 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.52 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 1.6 pt20 -47.66 -29.7 3.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.244 0.545 . . . . 0.0 109.817 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.93 -24.04 77.46 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.86 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.24 117.86 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 118.018 0.909 . . . . 0.0 111.66 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.5 t30 -140.37 121.7 9.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.596 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -89.84 160.49 35.22 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.296 -0.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.587 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.4 t80 -91.69 115.62 28.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.49 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 23.6 m-85 -92.35 137.91 31.97 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.952 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.777 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.1 mp -126.45 146.03 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.436 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.19 -166.53 37.09 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.887 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.522 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.4 OUTLIER -71.49 -54.15 11.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 111.611 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.48 131.32 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.391 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -56.57 -19.07 14.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.982 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.08 -31.66 52.45 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.85 132.88 46.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.66 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 28.8 m120 -46.03 -31.05 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.236 0.541 . . . . 0.0 110.378 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.777 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.5 t -110.16 142.06 42.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.318 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.46 109.04 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.554 HG23 ' CD1' ' A' ' 588' ' ' ILE . 19.7 mm -138.05 109.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.084 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.522 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 1.0 OUTLIER -95.03 104.32 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.919 -178.741 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.666 ' HB2' HD21 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.67 113.96 14.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.19 177.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -52.5 -21.12 3.43 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.689 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.439 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 0.2 OUTLIER -74.33 -41.65 60.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -88.53 158.9 18.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 112.268 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 67.6 p -80.77 177.95 8.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.2 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.452 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -47.36 -45.76 25.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.121 0.486 . . . . 0.0 110.197 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 621' ' ' VAL . 7.4 p -125.68 71.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.568 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 9.3 t60 -45.7 -47.93 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.537 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 2.1 p -161.2 160.62 30.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.614 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 603' ' ' ILE . 1.7 p90 -143.68 148.7 36.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.666 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.469 HD13 HD11 ' A' ' 603' ' ' ILE . 3.5 mp -101.96 130.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.086 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -121.3 132.47 54.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.519 ' HE3' HG23 ' A' ' 647' ' ' ILE . 5.3 ttmt -97.97 137.16 37.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.439 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.492 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.59 159.25 41.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.54 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.7 OUTLIER -76.25 112.72 13.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.4 t-80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.577 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 630' ' ' HIS . 25.0 mt . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 3.3 m-20 -116.95 147.61 42.1 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.48 160.17 34.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.518 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.886 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -110.36 127.58 67.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.568 0.699 . . . . 0.0 112.776 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.879 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 81.9 m95 -110.93 125.89 54.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.411 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 11.7 t80 -90.01 116.1 27.8 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 20.1 m -101.65 142.57 32.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.432 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 60.6 t60 -125.88 130.23 50.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 25.1 p -126.69 5.18 6.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.168 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.76 153.17 36.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.582 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.8 t -73.64 -34.8 65.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.159 0.504 . . . . 0.0 111.486 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.609 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.3 m120 -68.26 -4.89 15.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.434 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.83 123.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 111.67 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.413 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 57.9 p -88.68 166.26 14.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.354 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -131.22 120.39 23.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.868 0.366 . . . . 0.0 111.409 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.905 HD22 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -94.99 99.84 11.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.383 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 61.2 -81.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -134.45 3.4 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.682 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -104.95 123.6 48.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 111.171 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.35 141.38 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.92 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 21.7 mmm -118.14 111.93 19.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.9 pt -91.03 150.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.102 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 652' ' ' THR . 2.9 tt0 -51.87 100.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.471 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.87 37.26 1.16 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.002 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 718' ' ' LYS . 1.8 p -139.35 159.19 42.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.0 pttm -123.96 158.19 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.58 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 716' ' ' VAL . 10.6 t80 -144.27 146.46 32.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.879 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.53 128.17 35.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.696 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.816 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -105.76 121.85 44.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.43 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -109.33 162.83 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.39 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.574 ' HB3' HD12 ' A' ' 696' ' ' ILE . 11.7 p30 -58.62 110.47 1.0 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.42 . . . . 0.0 110.686 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 95.51 36.92 5.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.214 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -91.63 115.35 27.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.323 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 583' ' ' LEU . 0.7 OUTLIER -96.28 110.35 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.053 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.905 HG22 HD22 ' A' ' 659' ' ' LEU . 26.9 pt -105.62 132.58 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.98 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -91.03 116.62 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.004 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.418 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -81.22 -34.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.45 -179.245 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.651 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.1 tp -154.43 131.34 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 111.718 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.402 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 10.2 t90 -136.47 126.32 25.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -126.22 116.77 21.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -67.4 -46.77 72.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.989 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -77.74 -40.41 41.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.769 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -7.79 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.602 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp 59.66 17.95 6.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.672 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.3 t80 -76.55 104.82 7.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 689' ' ' VAL . 2.1 p -120.68 121.98 66.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 112.134 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.651 ' HB ' HG22 ' A' ' 681' ' ' ILE . 4.2 mt -128.72 155.26 40.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.436 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.447 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.98 135.9 2.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.231 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.478 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 5.0 m-30 -113.08 149.73 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.16 117.47 35.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.008 0.433 . . . . 0.0 110.704 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.774 HG22 HD21 ' A' ' 578' ' ' LEU . 2.6 t -80.48 114.75 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.1 108.96 12.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 0.0 110.123 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.574 HD12 ' HB3' ' A' ' 674' ' ' ASP . 8.9 mt -80.45 111.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.334 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -96.15 -45.85 6.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 4.1 t70 -111.13 140.34 45.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.014 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 716' ' ' VAL . 10.0 p . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.777 0.323 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 169.59 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.985 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 718' ' ' LYS . . . . . 0.691 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.5 OUTLIER -102.9 157.94 16.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.855 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -88.6 158.3 18.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.985 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -178.83 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.12 54.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.01 -52.07 52.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -43.34 96.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.783 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -57.32 -33.82 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.22 -36.78 80.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.483 HD13 ' HG3' ' A' ' 600' ' ' PRO . 23.2 mt -58.18 -44.32 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.75 -27.82 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.813 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.869 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.441 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 51.5 ttp85 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.686 0.279 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.767 ' CE1' HG21 ' A' ' 647' ' ' ILE . 0.5 OUTLIER -101.1 -50.94 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.909 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.011 HD11 HG13 ' A' ' 694' ' ' VAL . 44.6 tp -114.55 142.3 46.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.102 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 32.9 m -118.97 121.8 40.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.531 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.914 ' CD2' HG23 ' A' ' 694' ' ' VAL . 6.6 mt -109.03 108.57 19.33 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.23 100.24 50.22 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -176.314 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.1 Cg_exo -47.84 105.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.694 1.596 . . . . 0.0 109.271 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.535 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.17 156.73 87.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.464 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 77.2 Cg_exo -50.4 -25.83 14.81 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.741 2.961 . . . . 0.0 113.357 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.86 -20.62 65.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.056 0.455 . . . . 0.0 110.039 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.48 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 3.7 t -97.24 154.34 17.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.969 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.767 HD13 ' CE1' ' A' ' 688' ' ' PHE . 4.1 pt -55.11 -19.68 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.115 0.483 . . . . 0.0 109.84 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.13 119.01 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.87 63.7 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.124 0.487 . . . . 0.0 110.701 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.57 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.8 mt-10 -124.97 170.81 10.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.48 121.6 27.58 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.681 0.277 . . . . 0.0 111.427 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.3 mm? -113.21 150.8 31.81 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.441 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.3 mt-10 -125.18 131.26 53.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.826 HD12 HD23 ' A' ' 578' ' ' LEU . 73.7 mt -90.13 108.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -69.14 124.64 24.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 1.5 pt20 -46.9 -32.37 3.75 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.506 0.669 . . . . 0.0 109.505 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.81 -22.55 75.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.664 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.88 HG11 ' OD1' ' A' ' 610' ' ' ASN . 81.9 t -98.36 117.94 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.929 0.864 . . . . 0.0 111.545 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 4.5 t30 -140.38 121.33 9.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.023 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.606 ' HD3' HD22 ' A' ' 726' ' ' LEU . 43.7 Cg_endo -90.96 159.72 29.3 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.475 -1.052 . . . . 0.0 111.415 -0.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.666 ' CG ' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -92.11 113.27 25.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.513 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 5.8 m-85 -91.9 138.28 31.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.083 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.814 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -123.7 145.49 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.481 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.55 -167.55 35.77 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.427 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.456 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -73.62 -52.22 14.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 128.99 39.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.387 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -54.46 -19.9 6.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.965 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -28.26 51.78 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.018 0.437 . . . . 0.0 110.382 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 81.1 m -75.26 131.33 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.589 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.88 ' OD1' HG11 ' A' ' 598' ' ' VAL . 1.5 m-80 -46.44 -29.68 1.84 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.066 0.46 . . . . 0.0 110.464 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.814 ' SG ' HG23 ' A' ' 603' ' ' ILE . 31.0 t -109.59 137.46 47.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.68 104.94 14.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.442 HG13 ' CE2' ' A' ' 692' ' ' PHE . 14.2 mm -139.32 109.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.322 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.66 106.05 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.436 0.636 . . . . 0.0 111.998 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.508 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.8 OUTLIER -129.99 108.69 10.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.733 177.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -39.44 -27.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.554 ' HB3' HD11 ' A' ' 681' ' ' ILE . 32.3 mmt180 -71.4 -42.09 68.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.508 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -88.47 158.63 18.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.261 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.7 t -83.9 171.28 13.19 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.619 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.473 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -49.72 -41.83 44.49 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.143 0.497 . . . . 0.0 110.369 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 727' ' ' VAL . 11.7 t -121.4 61.52 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.6 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.82 ' CD2' HG23 ' A' ' 680' ' ' ILE . 38.5 t60 -46.21 -45.22 16.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.59 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.4 p -167.34 159.29 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.597 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.633 ' HA ' HD12 ' A' ' 603' ' ' ILE . 51.7 p90 -143.48 146.52 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.817 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 580' ' ' LEU . 16.6 mt -102.1 130.22 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 109.919 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -121.7 135.56 54.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.692 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 6.0 tttt -97.77 133.46 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.111 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.8 OUTLIER -136.07 159.79 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.95 -178.523 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 6.4 tpt85 -75.79 112.31 12.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.359 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.9 t60 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.336 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 630' ' ' HIS . 2.8 mp . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.595 0.236 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -97.05 147.98 23.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 111.434 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.452 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -129.82 160.03 34.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.049 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.767 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.2 pt -107.32 119.09 56.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.552 0.691 . . . . 0.0 111.854 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 86.8 m95 -104.68 130.87 52.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.152 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.424 ' CB ' HD21 ' A' ' 672' ' ' LEU . 39.0 t80 -90.99 117.24 29.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 624' ' ' PHE . 10.9 m -103.77 138.07 40.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.829 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.666 ' CE1' ' HA ' ' A' ' 656' ' ' VAL . 52.4 t-80 -120.84 130.53 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.238 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 15.1 p -128.14 7.33 6.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.213 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.13 151.44 36.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.837 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.6 t -75.37 -36.27 60.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 111.405 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m-20 -72.74 2.09 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.601 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.666 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 0.2 OUTLIER 49.12 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.587 0.708 . . . . 0.0 112.153 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.536 ' HB2' ' CD2' ' A' ' 651' ' ' HIS . 39.2 m -105.63 165.6 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 5.1 m-85 -124.7 120.18 31.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 111.266 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -98.86 100.02 11.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.673 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 61.83 -80.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.859 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.0 m120 -135.83 0.76 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.641 ' HB3' HG23 ' A' ' 716' ' ' VAL . 2.1 m120 -106.77 141.12 38.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.174 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.486 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.1 ttm180 -75.07 141.76 43.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.615 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 12.0 mmm -124.08 85.85 2.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.469 HG12 HG21 ' A' ' 668' ' ' THR . 29.2 pt -87.53 165.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 111.071 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.7 118.39 3.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.366 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.53 27.66 12.69 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.469 HG21 HG12 ' A' ' 665' ' ' ILE . 32.9 p -112.96 162.0 16.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 0.0 111.435 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpm? -141.98 140.62 32.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.615 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 0.3 OUTLIER -145.22 142.64 29.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.224 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.55 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -70.21 140.02 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 110.699 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 694' ' ' VAL . 2.0 mt -109.43 119.09 38.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 111.062 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.24 138.03 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.813 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.447 ' HB2' HD12 ' A' ' 696' ' ' ILE . 35.7 t0 -42.38 107.15 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.089 0.471 . . . . 0.0 110.807 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 105.93 32.65 3.75 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.17 119.99 32.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.371 . . . . 0.0 110.731 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.498 ' OE2' HD21 ' A' ' 583' ' ' LEU . 3.4 tm-20 -96.1 111.33 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.093 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.54 HG22 HD13 ' A' ' 659' ' ' LEU . 33.2 pt -105.59 135.42 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 112.016 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 116.74 33.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.607 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.82 HG23 ' CD2' ' A' ' 622' ' ' HIS . 5.6 mt -91.36 -30.76 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.968 HG22 ' HB ' ' A' ' 690' ' ' ILE . 4.0 tp -153.8 130.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 111.674 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -137.46 126.83 24.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -126.88 117.05 21.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.874 0.369 . . . . 0.0 110.363 178.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.77 -46.81 74.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.804 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -83.36 -40.37 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.565 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.35 -11.1 59.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.446 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 57.75 22.11 8.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.695 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.767 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -81.57 104.38 11.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.5 OUTLIER -126.98 120.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.968 ' HB ' HG22 ' A' ' 681' ' ' ILE . 30.2 mt -129.83 120.53 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.511 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -143.03 140.93 10.11 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.516 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.488 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 8.6 m-30 -112.66 146.06 39.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.809 0.338 . . . . 0.0 110.368 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.535 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.1 tptt -101.04 116.15 32.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.07 0.462 . . . . 0.0 109.846 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -82.69 122.34 37.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.306 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -133.09 109.84 9.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.971 0.415 . . . . 0.0 111.033 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.512 HG12 HD13 ' A' ' 578' ' ' LEU . 16.3 mt -78.89 106.05 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.728 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.75 -45.04 10.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 9.4 t0 -110.3 140.14 44.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.483 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 121.297 0.57 . . . . 0.0 109.891 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.641 HG23 ' HB3' ' A' ' 662' ' ' ASN . 96.5 t . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.38 171.37 7.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -103.09 142.57 33.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.965 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -77.4 154.44 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 -179.51 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.236 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.88 -31.97 51.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -61.83 -48.84 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.733 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.707 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.6 mp0 -65.76 -49.34 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -61.08 -32.74 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.181 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -38.68 92.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.273 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 723' ' ' GLU . 2.7 mt -63.18 -44.36 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 621' ' ' VAL . 9.1 p -81.21 -27.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -56.34 -30.93 63.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 110.787 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.9 mttm . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.436 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.2 ttm105 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.734 0.302 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.933 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -124.01 -63.25 1.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.221 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.834 HD21 HG22 ' A' ' 694' ' ' VAL . 10.1 tt -108.98 142.69 39.27 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.202 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.587 HG21 ' CE ' ' A' ' 581' ' ' LYS . 2.1 m -120.97 113.88 20.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.627 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -101.52 107.92 19.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.587 ' CE ' HG21 ' A' ' 579' ' ' THR . 69.1 mttt -113.16 99.18 48.3 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.6 Cg_exo -47.28 99.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.767 1.645 . . . . 0.0 109.416 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -74.5 157.47 86.2 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.59 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.64 -25.36 11.02 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.809 3.006 . . . . 0.0 112.961 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -27.84 68.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.452 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.0 OUTLIER -95.73 153.87 17.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.554 178.241 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 690' ' ' ILE . 6.5 pt -58.17 -11.46 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.629 HD13 HG23 ' A' ' 613' ' ' ILE . 49.6 mt -107.16 119.01 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.76 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.68 58.13 0.62 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.134 0.493 . . . . 0.0 110.252 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.611 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.7 mm-40 -124.62 171.58 9.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.351 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.03 128.3 44.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.775 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.51 141.1 46.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.017 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.436 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.0 mt-10 -124.52 115.78 21.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.801 HD12 HD22 ' A' ' 578' ' ' LEU . 77.0 mt -83.24 109.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.294 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.94 120.23 13.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.057 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.549 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 1.2 pm0 -46.67 -29.84 2.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.176 0.513 . . . . 0.0 110.696 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -18.44 78.63 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.765 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.74 HG11 ' OD1' ' A' ' 610' ' ' ASN . 46.5 t -101.2 117.98 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 117.902 0.851 . . . . 0.0 111.983 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.412 ' ND2' ' HG3' ' A' ' 627' ' ' LYS . 27.9 t30 -140.27 122.77 9.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.873 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.1 Cg_endo -90.52 159.81 31.53 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.286 -1.131 . . . . 0.0 111.775 -0.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.638 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.31 115.62 28.24 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.554 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 43.3 m-85 -92.33 137.95 31.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.838 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.4 143.31 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.438 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.16 -170.3 38.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.297 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.466 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -70.75 -49.45 46.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 111.614 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.71 130.64 47.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.479 -179.058 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -18.14 23.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.3 -28.65 63.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.086 0.47 . . . . 0.0 110.455 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.62 ' SG ' HG22 ' A' ' 621' ' ' VAL . 84.4 m -74.11 132.5 42.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.632 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.74 ' OD1' HG11 ' A' ' 598' ' ' VAL . 14.2 m-80 -47.44 -29.37 2.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.179 0.514 . . . . 0.0 110.254 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.775 ' SG ' HD13 ' A' ' 592' ' ' LEU . 42.5 t -109.93 142.07 41.79 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 105.38 13.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.77 HD11 HD21 ' A' ' 592' ' ' LEU . 20.5 mm -139.09 109.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.13 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.65 106.57 17.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.463 0.649 . . . . 0.0 112.255 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.577 ' H ' HD11 ' A' ' 618' ' ' LEU . 2.2 t0 -129.68 107.53 9.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.633 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -41.39 -27.24 0.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -69.95 -42.05 73.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.684 0.278 . . . . 0.0 111.382 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.577 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.2 pp -90.08 158.75 17.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.73 164.15 26.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.014 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.552 ' HG2' HG23 ' A' ' 621' ' ' VAL . 1.0 OUTLIER -50.38 -28.33 7.89 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.068 0.461 . . . . 0.0 110.449 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.62 HG22 ' SG ' ' A' ' 609' ' ' CYS . 45.0 t -130.8 64.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.694 ' CD2' HG23 ' A' ' 680' ' ' ILE . 20.8 t60 -50.57 -46.94 57.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.119 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.6 p -165.36 161.5 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.511 . . . . 0.0 111.93 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.529 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.8 p90 -143.6 147.67 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.664 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.15 130.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -124.4 134.16 53.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -99.56 136.93 38.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.619 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.4 OUTLIER -135.88 158.94 43.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.584 -178.592 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.6 tpt180 -75.99 112.44 12.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.356 0.598 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.3 t60 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.233 -179.491 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 644' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 3.4 m-20 -100.68 146.27 27.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.37 0.605 . . . . 0.0 112.398 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 4.9 t0 -126.69 160.53 30.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.29 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.933 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 3.3 pt -114.88 115.37 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.386 0.612 . . . . 0.0 112.026 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.929 ' CH2' HD22 ' A' ' 671' ' ' LEU . 63.9 m95 -102.73 136.86 41.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.151 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.667 ' HB2' HD11 ' A' ' 672' ' ' LEU . 17.0 t80 -93.05 117.52 30.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.013 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 14.8 m -101.87 130.67 48.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.087 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.475 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 45.0 t60 -111.19 132.88 53.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.483 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 13.4 p -129.27 2.47 5.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.416 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.86 148.1 32.96 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.4 t -73.28 -33.0 64.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 111.244 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.584 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.1 OUTLIER -72.27 -0.18 11.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.362 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.31 130.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 0.0 112.081 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.447 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 46.7 m -100.94 166.3 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.1 121.39 29.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.538 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.717 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.75 99.95 11.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.608 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 60.26 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.0 m-80 -130.02 -1.7 4.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.614 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.471 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.5 m-80 -101.6 142.02 33.59 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.239 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.585 ' O ' HG21 ' A' ' 716' ' ' VAL . 46.8 ttp180 -81.55 141.27 33.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.272 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.503 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 15.3 mmm -121.16 96.92 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.693 HG13 HG23 ' A' ' 668' ' ' THR . 6.7 pt -87.75 164.55 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.86 100.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.57 37.78 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.693 HG23 HG13 ' A' ' 665' ' ' ILE . 1.9 p -119.81 162.44 19.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.099 0.476 . . . . 0.0 111.535 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.637 ' O ' HD12 ' A' ' 717' ' ' LEU . 1.6 ttpm? -131.3 147.27 52.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.523 ' CD1' HG22 ' A' ' 716' ' ' VAL . 2.4 t80 -147.44 144.93 28.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.929 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.22 133.34 47.83 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.607 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.717 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.5 mt -114.8 124.84 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.677 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.91 151.53 33.87 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.464 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.513 ' HB2' HD12 ' A' ' 696' ' ' ILE . 8.2 t70 -49.07 119.41 3.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 110.405 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.29 36.4 5.95 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.46 110.09 22.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.737 0.303 . . . . 0.0 111.336 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.75 108.82 21.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.06 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.658 HG12 HD13 ' A' ' 659' ' ' LEU . 8.9 mt -105.61 136.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.897 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.15 116.48 28.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.679 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.694 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -84.72 -34.05 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.581 -178.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.843 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.5 tp -154.58 131.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.135 0.493 . . . . 0.0 111.866 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.407 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 13.0 t90 -136.26 126.81 26.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.046 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.03 116.9 21.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.416 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -67.36 -46.71 72.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.873 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.11 -40.42 27.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.622 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -85.07 -10.55 56.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.427 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.9 mttt 59.82 19.2 8.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 682' ' ' TRP . 1.5 t80 -77.38 104.76 8.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.7 p -125.64 123.82 65.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 112.195 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.843 ' HB ' HG22 ' A' ' 681' ' ' ILE . 19.0 mt -128.32 154.87 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.424 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.452 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.24 135.75 2.76 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.113 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.607 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 5.9 m-30 -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.289 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -100.95 117.06 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.721 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.834 HG22 HD21 ' A' ' 578' ' ' LEU . 2.6 t -78.84 126.45 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.373 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.7 tt0 -133.29 109.33 9.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 110.59 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 674' ' ' ASP . 47.0 mt -82.89 105.68 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.102 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -87.86 -45.98 9.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.826 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.6 140.95 44.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.407 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.325 0.583 . . . . 0.0 109.669 178.494 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.585 HG21 ' O ' ' A' ' 663' ' ' ARG . 12.7 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.933 0.397 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.637 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -102.55 168.68 9.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.482 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 144.91 30.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -82.61 158.52 23.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -175.01 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.171 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.79 60.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.37 -46.56 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.694 ' HA ' HD12 ' A' ' 726' ' ' LEU . 3.7 mp0 -66.69 -47.8 71.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.767 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -59.99 -33.11 71.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -63.14 -39.58 95.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.694 HD12 ' HA ' ' A' ' 723' ' ' GLU . 4.7 mt -60.53 -44.02 96.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.0 p -80.62 -27.9 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -54.2 -34.4 60.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.436 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.005 0.431 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -126.9 -62.86 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.087 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -106.42 142.23 36.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.841 ' N ' HD23 ' A' ' 578' ' ' LEU . 7.1 m -124.55 114.62 19.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.713 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.8 OUTLIER -104.25 108.42 19.81 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.0 100.22 53.28 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.506 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 24.5 Cg_exo -45.43 104.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.565 1.51 . . . . 0.0 109.105 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.39 156.98 86.92 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.001 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.56 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -49.88 -31.6 27.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.663 2.909 . . . . 0.0 112.908 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.686 ' HB2' HD12 ' A' ' 583' ' ' LEU . 4.7 m-20 -63.82 -21.49 66.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.465 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.663 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 24.7 p -96.46 153.23 17.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.201 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.655 HG23 HG13 ' A' ' 588' ' ' ILE . 3.9 tt -52.46 -19.47 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.633 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.72 HD13 HG23 ' A' ' 613' ' ' ILE . 40.4 mt -110.62 118.54 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.299 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -109.7 60.81 0.6 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.298 0.571 . . . . 0.0 110.841 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.54 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 29.3 mt-10 -125.48 171.91 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.668 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.24 127.7 44.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 178.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.772 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.6 137.72 50.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.616 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.478 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.9 OUTLIER -124.12 119.53 29.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.587 HD11 HD13 ' A' ' 625' ' ' ILE . 80.3 mt -86.68 109.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.113 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 593' ' ' GLU . 2.1 mp0 -68.99 122.5 18.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.996 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 1.8 pm0 -46.6 -29.56 1.88 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.69 -25.2 74.08 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.823 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.13 118.12 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.002 0.901 . . . . 0.0 111.661 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -140.09 122.63 10.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.844 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.1 Cg_endo -89.93 159.66 34.36 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 124.352 -1.104 . . . . 0.0 111.695 -0.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.4 t80 -91.93 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.595 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 58.9 m-85 -92.77 138.16 31.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.665 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.738 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.1 mp -128.12 144.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.66 -173.21 40.56 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.68 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -75.88 -18.39 59.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.324 0.249 . . . . 0.0 111.372 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.16 129.96 35.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.36 -23.0 21.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -55.07 -30.37 59.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.085 0.469 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 34.8 m -73.44 127.99 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.829 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 32.8 m120 -44.31 -33.93 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.306 0.574 . . . . 0.0 110.298 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.772 ' SG ' HD13 ' A' ' 592' ' ' LEU . 54.1 t -104.36 143.04 33.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.172 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.429 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -119.79 113.53 20.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.753 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.72 HG23 HD13 ' A' ' 588' ' ' ILE . 26.5 mm -137.95 109.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.447 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -97.28 105.23 17.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.513 0.673 . . . . 0.0 112.291 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.666 ' CB ' HD13 ' A' ' 618' ' ' LEU . 38.3 t0 -131.43 123.05 27.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.062 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -47.63 -29.23 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.75 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.616 ' HB3' HD13 ' A' ' 681' ' ' ILE . 3.2 mpt_? -77.76 -39.35 44.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.666 HD13 ' CB ' ' A' ' 615' ' ' ASP . 2.2 mp -65.88 159.22 26.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.786 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.0 m -110.61 172.08 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.433 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -47.84 31.76 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 110.174 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.938 HG11 HG23 ' A' ' 727' ' ' VAL . 4.1 t -121.45 56.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.482 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.572 ' CD2' HG23 ' A' ' 680' ' ' ILE . 49.3 t60 -43.67 -47.63 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.598 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 2.7 p -165.6 151.65 9.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.0 p90 -143.29 146.9 33.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.829 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.721 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.4 mp -101.86 127.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.586 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -120.37 134.33 55.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 27.2 ttmt -97.82 136.5 38.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.075 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.59 158.29 44.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.833 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.4 113.98 15.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.334 0.588 . . . . 0.0 110.572 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.132 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.6 mp . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.0 m-20 -122.05 146.43 47.19 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.239 0.543 . . . . 0.0 112.033 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.17 160.56 35.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.087 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -107.9 121.94 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.482 0.658 . . . . 0.0 112.274 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.933 ' CH2' HD22 ' A' ' 671' ' ' LEU . 79.4 m95 -106.0 124.65 49.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.168 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CD2' HD13 ' A' ' 678' ' ' ILE . 7.3 t80 -90.39 116.92 28.71 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 26.6 m -102.11 144.08 31.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.254 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 18.3 t60 -131.03 124.28 30.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.404 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 1.4 p -121.13 6.69 10.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.06 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.48 148.11 35.11 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.278 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.5 t -69.84 -34.7 73.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.795 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.585 ' O ' HG13 ' A' ' 656' ' ' VAL . 15.9 m120 -70.56 -2.51 14.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.608 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.72 133.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.434 0.635 . . . . 0.0 111.893 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 81.8 p -103.06 165.59 10.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.816 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.5 120.26 30.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.775 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.84 101.33 12.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 59.78 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 65.1 t30 -133.47 -2.2 3.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.521 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 1.3 t-20 -104.98 141.41 36.61 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.197 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.89 141.2 33.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.573 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -109.24 100.11 9.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.691 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.7 pt -87.12 134.9 26.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.963 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' A' ' 652' ' ' THR . 1.2 tt0 -38.49 98.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.988 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 37.38 1.17 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 718' ' ' LYS . 2.1 p -139.21 158.37 44.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.703 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.491 ' HE2' HD13 ' A' ' 717' ' ' LEU . 12.6 pttm -123.61 158.2 32.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.521 ' CE2' ' CB ' ' A' ' 662' ' ' ASN . 0.3 OUTLIER -145.08 146.3 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.622 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.933 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.95 130.92 44.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.86 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.763 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -109.81 118.65 37.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 111.625 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -108.52 138.31 45.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.438 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 696' ' ' ILE . 8.7 t70 -38.88 116.95 0.62 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.84 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.8 35.28 6.19 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.43 114.89 27.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.86 108.52 20.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 13.0 mt -107.91 131.79 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.898 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 115.65 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.567 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.62 HD12 ' CE2' ' A' ' 692' ' ' PHE . 1.1 mt -78.01 -36.05 21.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.364 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.701 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -155.14 131.91 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 111.73 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -136.21 125.75 25.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -127.11 116.9 21.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.924 0.393 . . . . 0.0 110.318 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -67.22 -46.55 73.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.895 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -74.46 -40.29 61.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.77 -11.97 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.451 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt 61.61 16.94 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.727 0.298 . . . . 0.0 111.019 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 2.3 t80 -82.27 105.49 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.613 ' O ' HG22 ' A' ' 587' ' ' ILE . 0.9 OUTLIER -125.95 121.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.214 0.531 . . . . 0.0 111.997 -178.619 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 681' ' ' ILE . 31.5 mt -117.73 130.82 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.63 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -154.91 130.85 2.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.421 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.62 ' CE2' HD12 ' A' ' 680' ' ' ILE . 3.4 m-30 -113.33 143.91 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.863 0.363 . . . . 0.0 110.38 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.627 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -101.47 117.35 34.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.03 0.443 . . . . 0.0 110.682 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.777 HG22 HD21 ' A' ' 578' ' ' LEU . 3.0 t -79.97 127.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.515 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -133.39 109.53 9.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 674' ' ' ASP . 52.2 mt -83.19 105.14 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.36 -46.58 12.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.279 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.08 140.68 45.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.316 0.579 . . . . 0.0 109.568 178.064 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 669' ' ' LYS . 7.2 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.971 0.415 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.491 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.6 OUTLIER -109.07 172.43 6.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.787 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 718' ' ' LYS . . . . . 0.53 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.0 OUTLIER -95.23 158.05 15.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 723' ' ' GLU . 15.1 mt-30 -95.88 160.27 14.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.864 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.1 p -120.2 -174.44 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.91 58.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -60.78 -48.17 82.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 726' ' ' LEU . 5.6 tm-20 -64.12 -48.86 74.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -53.1 -33.47 52.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.21 -36.91 80.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 723' ' ' GLU . 38.4 mt -56.65 -44.31 81.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.938 HG23 HG11 ' A' ' 621' ' ' VAL . 10.2 p -80.86 -21.25 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -67.82 -39.2 83.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.752 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.198 179.741 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.464 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.139 0 CA-C-O 120.502 0.192 . . . . 0.0 110.487 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -121.69 -62.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 111.476 -179.478 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.028 HD12 HD13 ' A' ' 647' ' ' ILE . 5.7 tt -105.93 125.99 51.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.66 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.4 m -102.46 119.19 38.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.268 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.862 HD12 HD11 ' A' ' 594' ' ' ILE . 4.7 mt -105.64 108.54 20.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -117.97 100.72 52.09 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.125 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.59 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.7 Cg_exo -46.14 101.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.778 1.652 . . . . 0.0 109.451 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -75.09 157.97 84.72 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -50.06 -25.75 13.33 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.461 2.774 . . . . 0.0 112.244 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.564 ' CB ' HD12 ' A' ' 583' ' ' LEU . 10.2 t70 -62.36 -26.47 68.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.44 ' HA ' HG13 ' A' ' 689' ' ' VAL . 54.5 p -95.4 153.47 17.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.711 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.801 HD13 ' CE1' ' A' ' 688' ' ' PHE . 1.0 OUTLIER -58.7 -14.16 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.56 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.458 ' CD1' HG23 ' A' ' 613' ' ' ILE . 73.0 mt -106.49 118.67 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.315 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.35 57.58 0.68 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 110.524 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.59 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.5 mt-10 -124.76 169.39 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.79 122.28 26.89 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.573 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.52 HD13 ' C ' ' A' ' 591' ' ' SER . 0.7 OUTLIER -113.17 150.31 32.43 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.392 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.464 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.44 125.34 44.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.862 HD11 HD12 ' A' ' 580' ' ' LEU . 93.9 mt -83.51 108.97 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.608 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -64.16 122.84 17.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 1.4 pt20 -47.63 -30.06 3.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.258 0.551 . . . . 0.0 110.021 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.476 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -73.42 -20.94 79.97 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.926 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.685 HG11 ' ND2' ' A' ' 610' ' ' ASN . 61.0 t -98.62 118.04 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 118.108 0.954 . . . . 0.0 111.642 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.0 t30 -140.18 121.6 9.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.002 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.591 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.0 Cg_endo -90.56 159.34 31.11 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.442 -1.066 . . . . 0.0 111.511 -0.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.62 ' CD2' HG23 ' A' ' 594' ' ' ILE . 4.3 t80 -91.78 115.6 28.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.566 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.6 m-85 -92.54 137.94 31.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.349 -177.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.785 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.2 mp -123.97 145.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.438 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 157.67 -169.85 34.58 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.317 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -69.83 -48.74 57.82 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.21 124.28 19.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -178.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -19.44 5.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.665 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.48 -30.15 66.77 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 98.0 m -68.8 133.04 47.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.446 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.685 ' ND2' HG11 ' A' ' 598' ' ' VAL . 32.6 m120 -45.54 -30.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.19 0.519 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.785 ' SG ' HG23 ' A' ' 603' ' ' ILE . 32.8 t -113.1 142.34 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.373 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 105.92 15.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 588' ' ' ILE . 24.8 mm -138.39 109.71 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.441 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.22 106.89 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.584 0.707 . . . . 0.0 112.657 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.699 ' CB ' HD22 ' A' ' 618' ' ' LEU . 27.1 t0 -129.42 107.11 9.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.724 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -42.48 -30.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.429 ' HB2' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -77.98 -37.56 47.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.498 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.699 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -89.63 134.09 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.255 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.66 165.52 0.41 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -59.45 -21.64 60.35 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 621' ' ' VAL . 14.9 p -140.27 56.58 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.54 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 14.1 t60 -41.86 -37.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.39 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.0 p -170.09 160.05 7.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.248 0.547 . . . . 0.0 112.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.575 ' HA ' HD12 ' A' ' 603' ' ' ILE . 40.6 p90 -143.37 147.59 34.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.172 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 580' ' ' LEU . 3.8 mp -101.55 130.83 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.591 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.0 t80 -122.96 133.8 54.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.891 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.576 ' HD3' HG23 ' A' ' 647' ' ' ILE . 3.0 tppp? -98.07 136.66 37.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.477 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.65 159.14 41.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.737 -178.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -76.41 112.45 12.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.355 0.598 . . . . 0.0 110.705 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.4 t60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.698 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.9 mp . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 9.9 m-20 -112.63 146.93 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.59 160.09 34.35 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.275 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.028 HD13 HD12 ' A' ' 578' ' ' LEU . 1.9 pt -106.53 126.86 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.6 0.714 . . . . 0.0 112.892 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.874 ' CH2' HD22 ' A' ' 671' ' ' LEU . 82.7 m95 -111.22 128.55 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.687 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.734 ' CE1' HD12 ' A' ' 678' ' ' ILE . 20.2 t80 -90.76 117.8 29.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 38.4 m -102.8 131.87 49.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.484 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 47.4 t60 -111.91 130.85 55.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.6 p -131.47 12.42 4.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.342 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.32 154.27 32.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.295 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 55.3 m -83.61 -24.15 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.741 0.305 . . . . 0.0 111.381 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.61 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.9 OUTLIER -82.6 4.14 25.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 53.27 133.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 111.981 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.457 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 60.0 m -102.0 166.17 10.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.376 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.407 ' O ' ' N ' ' A' ' 679' ' ' LYS . 34.9 m-85 -130.61 120.01 23.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.974 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -100.15 103.54 15.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.872 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.468 ' N ' HD12 ' A' ' 659' ' ' LEU . 16.9 t-20 60.56 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.768 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.8 m120 -136.43 6.03 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.508 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.878 ' OD1' HG23 ' A' ' 716' ' ' VAL . 1.0 OUTLIER -107.37 142.0 37.86 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.804 0.335 . . . . 0.0 111.001 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.441 ' NH1' HG22 ' A' ' 665' ' ' ILE . 24.8 ttt-85 -78.02 141.39 38.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.402 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.438 ' O ' HG23 ' A' ' 656' ' ' VAL . 42.7 mmm -121.9 93.02 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.542 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.441 HG22 ' NH1' ' A' ' 663' ' ' ARG . 36.1 pt -87.71 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -47.25 96.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.115 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.26 41.47 0.81 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.0 p -128.94 162.15 28.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.056 0.455 . . . . 0.0 111.86 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.468 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -134.73 146.71 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.468 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.54 145.5 29.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.874 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.84 133.22 47.98 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.705 179.341 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.75 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -108.59 119.15 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.153 0.501 . . . . 0.0 111.443 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -106.67 139.73 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.828 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' A' ' 696' ' ' ILE . 41.1 t0 -40.8 114.8 0.51 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 110.732 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.78 36.69 5.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.65 115.38 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.056 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -96.55 108.68 21.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.974 HG22 HD13 ' A' ' 659' ' ' LEU . 23.4 pt -108.27 129.1 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 0.0 111.946 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -89.22 116.03 27.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.307 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.498 HG23 ' CD2' ' A' ' 622' ' ' HIS . 3.0 mt -78.31 -36.0 20.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.566 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.646 HG22 ' CG1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -154.92 131.87 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.35 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -136.1 128.34 30.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 111.501 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -127.14 116.37 20.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.14 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.48 -46.47 72.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.16 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.83 -40.37 65.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -90.55 -10.33 43.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 15.97 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.663 0.268 . . . . 0.0 111.064 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.801 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.7 t80 -76.48 104.78 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 586' ' ' SER . 2.2 p -118.95 125.96 74.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.839 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.646 ' CG1' HG22 ' A' ' 681' ' ' ILE . 33.1 mm -127.93 125.62 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.36 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -160.7 136.74 4.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.136 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 8.1 m-30 -112.99 148.76 34.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.607 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.348 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.843 HG22 HD21 ' A' ' 578' ' ' LEU . 3.3 t -79.2 121.17 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.702 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.97 109.37 11.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.867 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' A' ' 674' ' ' ASP . 64.1 mt -78.31 110.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.33 -45.45 6.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.426 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 7.5 t70 -111.04 140.64 45.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.878 HG23 ' OD1' ' A' ' 662' ' ' ASN . 92.1 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.023 0.439 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.72 167.52 11.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.377 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.09 150.42 23.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.209 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.77 149.02 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.432 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 31.7 p -126.15 -173.62 2.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.405 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -61.86 -28.69 69.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.159 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.13 -53.2 58.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.7 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.5 pp20? -70.6 -37.74 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -58.53 -34.93 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.544 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 728' ' ' LYS . 10.2 t70 -68.14 -39.35 82.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.7 HD12 ' HA ' ' A' ' 723' ' ' GLU . 17.0 mt -58.27 -44.17 88.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.03 -23.78 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.576 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 728' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 725' ' ' ASP . 0.0 OUTLIER -50.49 -48.82 56.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.066 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.919 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.4 tmm_? . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.866 0.365 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.801 ' CE1' HG21 ' A' ' 647' ' ' ILE . 0.2 OUTLIER -122.3 -52.79 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.059 HD21 HG13 ' A' ' 694' ' ' VAL . 1.4 tt -107.04 140.42 39.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.112 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.732 ' N ' HD23 ' A' ' 578' ' ' LEU . 23.8 m -118.52 113.55 21.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.755 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.848 HD23 HD11 ' A' ' 678' ' ' ILE . 0.7 OUTLIER -105.7 108.85 20.57 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.836 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.1 ptpt -117.01 99.86 53.11 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.1 Cg_exo -45.98 104.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.893 1.729 . . . . 0.0 109.503 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.18 157.39 85.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -176.344 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.1 Cg_endo -50.72 -27.73 20.78 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.603 2.869 . . . . 0.0 112.53 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.578 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.1 t70 -62.54 -26.72 68.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.64 153.57 17.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.157 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 690' ' ' ILE . 8.1 pt -57.14 -12.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.977 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.505 ' CD1' HG23 ' A' ' 613' ' ' ILE . 38.9 mt -108.87 118.82 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.637 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -107.65 59.33 0.62 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.146 179.437 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.645 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mm-40 -125.57 170.04 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.264 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.2 116.73 18.06 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.304 178.644 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.771 HD22 ' SG ' ' A' ' 611' ' ' CYS . 0.8 OUTLIER -113.53 143.56 44.32 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.418 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.7 OUTLIER -125.17 123.92 40.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.252 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.623 HG23 ' CD1' ' A' ' 601' ' ' PHE . 78.7 mt -75.23 108.84 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.511 ' CB ' HG23 ' A' ' 598' ' ' VAL . 2.8 mp0 -59.44 116.78 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.939 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -30.44 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.273 0.559 . . . . 0.0 110.118 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.447 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.88 -16.12 79.54 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.671 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.511 HG23 ' CB ' ' A' ' 595' ' ' GLN . 42.0 t -96.77 117.77 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 118.009 0.905 . . . . 0.0 111.212 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.9 OUTLIER -140.46 123.91 10.31 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.166 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.525 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 34.6 Cg_endo -91.38 158.85 27.27 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.349 -1.105 . . . . 0.0 112.052 -0.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.0 t80 -93.1 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.135 0.493 . . . . 0.0 109.752 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 1.1 m-85 -93.44 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.492 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.78 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -127.21 143.99 38.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.3 -163.61 31.6 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.504 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.558 ' CG ' HD12 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -73.57 -41.7 62.59 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.331 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 28.6 t -60.69 119.9 9.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.551 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.15 -18.65 10.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -62.45 -30.05 70.96 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.235 0.54 . . . . 0.0 109.614 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 61.5 m -67.1 128.05 34.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.378 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.8 m120 -44.1 -31.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.558 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.2 t -108.62 135.53 49.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.03 109.08 20.03 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 588' ' ' ILE . 24.0 mm -138.2 109.46 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.97 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -103.26 105.17 15.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.591 0.71 . . . . 0.0 112.22 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.674 ' HB2' HD21 ' A' ' 618' ' ' LEU . 1.0 OUTLIER -130.92 108.3 9.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.422 177.275 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -39.34 -29.75 0.05 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.57 ' HB3' HD11 ' A' ' 681' ' ' ILE . 8.3 mpt_? -70.62 -41.12 72.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -86.64 158.69 19.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 111.443 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 45.8 t -86.36 176.45 7.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.432 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -52.17 -51.75 56.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.479 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 621' ' ' VAL . 38.5 t -109.22 57.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.766 ' CD2' HG23 ' A' ' 680' ' ' ILE . 50.4 t60 -46.26 -38.09 8.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.937 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.12 174.9 10.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.531 0.681 . . . . 0.0 111.773 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.46 136.22 25.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.963 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.643 HD12 HD11 ' A' ' 603' ' ' ILE . 62.9 mt -132.37 117.05 30.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -134.4 147.49 50.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 111.552 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 16.3 ttmt -101.23 137.55 39.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.562 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 157.19 44.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.118 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.05 118.07 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.5 t60 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.824 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.7 OUTLIER -123.0 147.34 46.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.088 0.47 . . . . 0.0 111.932 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.76 137.97 42.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.175 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.801 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -90.26 124.87 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-O 121.331 0.586 . . . . 0.0 111.67 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.901 ' CH2' HD22 ' A' ' 671' ' ' LEU . 92.7 m95 -110.08 131.22 55.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.651 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.52 ' CB ' HD21 ' A' ' 672' ' ' LEU . 1.6 t80 -100.34 117.3 34.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.592 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.3 m -111.66 145.12 39.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.549 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 664' ' ' MET . 23.5 t60 -119.55 125.2 48.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.398 . . . . 0.0 111.463 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.483 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 4.2 p -120.27 9.13 10.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.929 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.96 -178.99 47.85 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.74 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.471 HG23 ' N ' ' A' ' 655' ' ' ASN . 11.7 t -105.55 -45.07 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 111.642 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.497 ' C ' HG23 ' A' ' 656' ' ' VAL . 1.5 m120 -60.04 -16.08 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.854 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 664' ' ' MET . 4.2 t 79.06 143.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.786 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 664' ' ' MET . 37.9 m -115.39 165.9 12.47 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 679' ' ' LYS . 27.8 m-85 -137.58 119.61 15.44 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.119 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.779 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -101.61 107.14 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.308 -179.07 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 659' ' ' LEU . 44.4 m-20 56.12 -82.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 659' ' ' LEU . 30.3 m-80 -133.92 4.46 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.644 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 9.5 m120 -106.84 125.85 51.54 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.915 0.388 . . . . 0.0 111.306 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.0 ttm105 -65.95 141.24 58.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.509 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.54 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -114.7 85.71 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.584 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.424 HG12 HG21 ' A' ' 668' ' ' THR . 38.3 pt -87.05 149.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 652' ' ' THR . 17.1 tt0 -45.62 100.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.542 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 111.81 37.7 1.52 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.603 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.424 HG21 HG12 ' A' ' 665' ' ' ILE . 3.0 p -128.9 162.58 27.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.482 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 717' ' ' LEU . 3.5 ttpm? -138.31 144.93 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.123 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.505 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.8 OUTLIER -147.02 145.53 29.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.109 0.48 . . . . 0.0 111.862 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.901 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.8 140.63 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.646 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.901 HD13 HG21 ' A' ' 694' ' ' VAL . 1.2 mt -106.87 123.88 48.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.154 0.502 . . . . 0.0 110.852 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -102.28 133.02 47.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.123 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.755 ' HB2' HD12 ' A' ' 696' ' ' ILE . 12.5 t0 -44.5 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 109.931 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.48 36.29 3.34 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.87 122.63 33.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.045 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.15 108.16 20.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.848 HD11 HD23 ' A' ' 580' ' ' LEU . 0.1 OUTLIER -105.51 137.52 34.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.867 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 658' ' ' TYR . 7.9 mmtt -101.74 116.44 32.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.988 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.766 HG23 ' CD2' ' A' ' 622' ' ' HIS . 6.3 mt -82.8 -35.91 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.133 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.616 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.3 tt -154.7 131.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.714 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -136.37 119.84 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.173 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.22 116.57 20.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.678 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -46.6 71.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.877 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.68 -40.72 93.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.181 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -105.19 2.93 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.94 22.59 3.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.725 0.298 . . . . 0.0 110.973 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.3 OUTLIER -76.82 104.88 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.6 p -122.8 122.79 66.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 111.768 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 587' ' ' ILE . 3.0 mt -127.9 126.07 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.478 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.91 139.98 6.59 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.78 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.55 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 3.2 m-30 -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 0.0 110.483 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -101.01 116.89 33.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.128 0.489 . . . . 0.0 110.312 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 1.059 HG13 HD21 ' A' ' 578' ' ' LEU . 2.2 t -81.79 120.0 32.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.0 OUTLIER -133.5 109.22 9.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 179.437 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 674' ' ' ASP . 13.8 mt -77.82 104.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.04 -45.02 21.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.24 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.44 141.63 43.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.63 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 121.262 0.553 . . . . 0.0 109.632 178.577 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.5 p . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.744 0.307 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 669' ' ' LYS . 3.2 mt -90.13 172.63 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.844 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.92 156.61 17.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.043 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.4 144.3 25.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.752 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 70.9 p -126.36 -176.81 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.8 37.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.269 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -55.97 -51.51 67.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.598 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.731 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.1 OUTLIER -70.18 -49.8 46.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.631 179.624 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -58.77 -32.12 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.97 -43.48 92.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.49 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.4 mt -57.51 -44.49 85.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.112 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.4 p -78.45 -14.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.461 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -25.83 19.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.327 . . . . 0.0 111.179 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.8 mttt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.045 -179.968 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.7 tmm_? . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.739 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.3 t80 -127.94 -52.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.998 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.118 HD11 HG13 ' A' ' 694' ' ' VAL . 5.3 tp -115.45 125.6 53.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.444 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.58 ' N ' HD12 ' A' ' 578' ' ' LEU . 11.5 m -105.2 114.12 28.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.689 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.8 OUTLIER -106.09 108.83 20.54 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.0 mtmm -113.84 100.04 51.44 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_exo -45.01 100.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.923 1.749 . . . . 0.0 109.724 177.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 677' ' ' GLU . 0.2 OUTLIER -74.99 157.33 85.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.496 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.02 -25.28 12.26 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.698 2.932 . . . . 0.0 113.075 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -28.23 69.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.435 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.5 t -96.12 154.03 17.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.622 178.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 8.6 pt -58.55 -10.21 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.733 0.301 . . . . 0.0 111.121 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.726 HD13 HG23 ' A' ' 613' ' ' ILE . 54.6 mt -108.55 118.85 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.736 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.75 60.27 0.6 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.22 0.533 . . . . 0.0 110.33 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.613 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.8 mt-10 -124.73 171.64 9.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.5 123.7 34.21 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.75 139.89 47.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 579' ' ' THR . 9.4 mt-10 -124.65 111.45 15.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.895 HD11 HD12 ' A' ' 625' ' ' ILE . 30.8 mt -72.21 108.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.947 0.403 . . . . 0.0 110.071 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.03 116.56 8.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.871 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.29 -30.44 2.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.228 0.537 . . . . 0.0 110.475 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.46 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.22 -21.59 77.23 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.348 -0.842 . . . . 0.0 113.557 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.432 HG11 ' ND2' ' A' ' 610' ' ' ASN . 52.4 t -101.07 118.42 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -140.14 124.18 10.75 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.919 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 42.8 Cg_endo -90.63 159.22 30.73 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.232 0.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 1.9 t80 -92.67 114.27 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.562 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 0.4 OUTLIER -93.38 139.09 31.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.127 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.792 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.7 mp -127.07 143.79 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.894 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 156.52 -165.72 33.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.477 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.468 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -70.19 -42.61 72.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.92 -179.246 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 11.3 t -60.42 121.79 12.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.633 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.55 -18.18 18.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.335 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -64.2 -29.18 70.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.142 0.496 . . . . 0.0 109.665 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.0 m -66.96 128.87 37.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.199 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -44.05 -31.21 0.87 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.079 0.466 . . . . 0.0 110.501 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.792 ' SG ' HG23 ' A' ' 603' ' ' ILE . 43.1 t -110.53 142.06 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 107.5 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.8 HD11 HD21 ' A' ' 592' ' ' LEU . 24.5 mm -138.61 109.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.811 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -104.08 106.22 16.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.536 0.684 . . . . 0.0 112.723 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.643 ' H ' HD11 ' A' ' 618' ' ' LEU . 2.0 t0 -130.85 107.73 9.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.685 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -39.25 -28.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.579 ' HB3' HD11 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -73.7 -38.6 64.81 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.643 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -88.41 158.98 18.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.528 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.6 p -83.56 168.76 16.1 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.504 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 4.4 ptp180 -51.24 -46.13 62.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.017 0.437 . . . . 0.0 110.322 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 727' ' ' VAL . 47.7 t -108.55 60.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.641 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 13.9 t60 -52.92 -39.71 63.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.926 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.773 ' SG ' HD11 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -144.99 175.26 10.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.595 0.712 . . . . 0.0 111.872 -178.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -144.92 142.21 29.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.183 -178.137 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.895 HD12 HD11 ' A' ' 594' ' ' ILE . 61.4 mt -133.26 116.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 3.0 t80 -132.88 138.7 47.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.586 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.7 ttmt -98.45 136.71 38.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.36 158.52 44.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.661 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -76.76 116.12 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.178 0.513 . . . . 0.0 110.627 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.2 t-80 . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.602 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -116.13 147.74 41.04 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.548 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -134.83 142.88 46.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.848 HD13 HD22 ' A' ' 578' ' ' LEU . 5.1 pt -94.76 120.63 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.374 0.607 . . . . 0.0 111.593 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.537 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.2 m95 -104.97 125.89 51.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.867 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.644 ' CB ' HD21 ' A' ' 672' ' ' LEU . 21.4 t80 -90.93 117.44 29.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.94 144.87 36.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.621 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -115.0 129.98 56.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.427 ' OG1' HG12 ' A' ' 621' ' ' VAL . 3.3 p -127.53 10.45 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.47 152.17 26.21 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.558 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.2 t -76.07 -30.82 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.72 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.587 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.1 OUTLIER -75.08 2.05 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.027 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.08 122.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.2 p -93.15 165.94 12.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.173 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 57.1 m-85 -131.96 119.64 21.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 0.0 110.697 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -95.06 100.53 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.606 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.9 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 22.7 m120 -132.05 -0.3 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.342 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.655 ' OD1' HG23 ' A' ' 716' ' ' VAL . 1.8 m-80 -95.36 141.62 28.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.825 0.345 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 3.5 ttm105 -81.96 141.05 33.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.227 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.416 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 31.6 mmm -129.35 108.93 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 111.047 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.528 HG13 HG23 ' A' ' 668' ' ' THR . 3.1 pt -98.95 165.06 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.71 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 653' ' ' GLY . 0.0 OUTLIER -54.72 90.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.94 0.4 . . . . 0.0 110.924 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.08 35.19 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.504 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.528 HG23 HG13 ' A' ' 665' ' ' ILE . 0.8 OUTLIER -116.33 162.06 18.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.832 0.349 . . . . 0.0 111.127 179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.448 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.2 ttpt -139.52 138.88 36.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.555 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.05 143.37 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -71.3 140.31 50.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.206 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 694' ' ' VAL . 4.3 mt -108.28 127.37 53.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.783 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -106.67 149.94 26.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.772 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.478 ' HB2' HD12 ' A' ' 696' ' ' ILE . 6.0 t70 -47.66 106.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.038 0.447 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.99 36.3 4.52 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.602 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 7.6 t70 -92.13 113.33 25.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.305 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.592 ' HG3' HD21 ' A' ' 583' ' ' LEU . 0.5 OUTLIER -96.58 112.16 24.01 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.22 179.462 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.558 HG22 HD13 ' A' ' 659' ' ' LEU . 22.4 pt -105.41 128.84 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.96 0.41 . . . . 0.0 111.62 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 10.9 mmtp -87.27 116.54 25.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.988 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.773 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.1 OUTLIER -81.0 -36.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.377 -179.248 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 617' ' ' ARG . 4.7 tt -154.71 131.74 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 111.738 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -136.11 124.91 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.13 116.94 21.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.399 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -67.34 -46.66 72.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -74.06 -40.5 62.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.843 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -89.76 -8.65 51.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.548 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.26 19.11 7.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.721 0.296 . . . . 0.0 110.888 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.89 104.88 7.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.5 p -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.016 0.436 . . . . 0.0 111.858 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 681' ' ' ILE . 5.0 mt -128.18 152.49 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.358 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.435 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.58 140.93 3.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.281 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.555 ' CD2' HD11 ' A' ' 592' ' ' LEU . 3.0 m-30 -113.65 153.39 28.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 0.0 110.492 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -100.85 117.12 34.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 1.118 HG13 HD11 ' A' ' 578' ' ' LEU . 2.2 t -81.13 125.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.53 108.22 8.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.357 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 674' ' ' ASP . 18.9 mt -78.15 105.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -86.27 -46.95 9.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.893 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 27.5 t70 -110.85 140.45 45.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.434 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.444 -0.755 0 CA-C-O 121.292 0.568 . . . . 0.0 109.53 178.407 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.655 HG23 ' OD1' ' A' ' 662' ' ' ASN . 86.2 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.854 0.359 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.37 166.49 10.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.2 144.86 30.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -88.21 146.52 25.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.16 -176.88 3.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.612 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.17 -28.93 43.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.269 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -55.79 -52.81 62.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.649 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.78 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.7 mp0 -70.6 -48.15 56.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.641 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -57.36 -32.28 66.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.92 -40.85 83.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 723' ' ' GLU . 4.9 mt -56.88 -44.39 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.576 HG21 HG11 ' A' ' 621' ' ' VAL . 10.9 p -86.26 -15.32 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.605 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -52.85 -29.73 29.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.8 mttt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 40.0 ttp180 . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 120.757 0.313 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -103.6 -52.85 2.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.788 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.07 HD12 HD13 ' A' ' 647' ' ' ILE . 7.0 tt -113.45 140.08 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.719 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.1 m -118.49 114.93 23.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.861 HD21 HG23 ' A' ' 694' ' ' VAL . 6.4 mt -102.09 107.62 18.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.9 mtpt -113.44 99.43 49.42 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.8 Cg_exo -47.15 97.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.838 1.692 . . . . 0.0 109.541 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.68 158.37 84.94 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.58 -25.05 7.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.941 3.094 . . . . 0.0 113.389 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.39 -25.5 67.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 4.6 t -95.97 153.96 17.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.678 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -62.01 -8.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.872 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 90.1 mt -110.98 118.72 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.95 62.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.106 0.479 . . . . 0.0 110.256 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.601 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -124.91 171.45 10.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.207 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.33 128.85 45.36 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.085 0.469 . . . . 0.0 111.098 178.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.777 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.3 OUTLIER -112.25 142.62 44.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.74 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -124.51 113.7 18.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.913 HD12 HD22 ' A' ' 578' ' ' LEU . 87.3 mt -81.68 108.44 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 2.4 mm-40 -70.45 126.39 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.174 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.49 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 3.3 pt20 -46.25 -32.12 2.88 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.488 0.661 . . . . 0.0 109.743 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -69.71 -23.85 76.56 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.992 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.523 HG11 ' CG ' ' A' ' 610' ' ' ASN . 99.5 t -99.34 117.36 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.084 0.942 . . . . 0.0 111.857 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.7 t30 -141.22 122.1 8.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.826 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.59 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.86 160.19 34.94 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 124.554 -1.019 . . . . 0.0 111.506 -0.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.601 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.3 t80 -92.25 115.67 28.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.55 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 42.3 m-85 -92.48 137.81 32.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.843 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.796 HG23 ' SG ' ' A' ' 611' ' ' CYS . 4.1 mp -124.7 144.89 33.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.3 -166.94 36.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.515 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.487 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -73.84 -54.87 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.88 0.371 . . . . 0.0 111.9 -179.312 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 132.66 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.374 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -56.21 -19.78 15.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -27.22 18.81 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.073 0.463 . . . . 0.0 110.432 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 10.5 m -79.03 132.91 36.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.582 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 19.7 m-80 -47.98 -28.64 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.511 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.796 ' SG ' HG23 ' A' ' 603' ' ' ILE . 25.7 t -110.17 141.23 43.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.58 104.6 12.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.637 HD11 HD21 ' A' ' 592' ' ' LEU . 24.6 mm -139.43 109.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.869 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.06 107.16 17.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.46 0.647 . . . . 0.0 112.601 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.608 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.2 t0 -129.47 107.59 9.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.624 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -39.81 -29.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -41.3 76.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.608 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.1 pp -89.22 158.7 17.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.463 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 t -78.57 167.37 21.37 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.385 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -48.64 -37.73 19.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.114 0.483 . . . . 0.0 110.37 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 727' ' ' VAL . 12.2 t -124.41 65.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.459 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.856 ' CD2' HG23 ' A' ' 680' ' ' ILE . 28.5 t60 -49.55 -42.12 43.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.809 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -168.98 159.2 9.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.472 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.2 p90 -143.23 147.92 35.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.498 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.728 HD11 HD11 ' A' ' 580' ' ' LEU . 4.7 mt -102.38 132.58 48.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.251 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -124.24 133.46 53.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.72 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 20.2 ttmt -98.59 136.5 38.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.557 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.33 158.11 41.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.324 -179.333 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.15 117.71 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.4 t60 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.83 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.1 mp . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -119.55 146.35 45.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.329 0.585 . . . . 0.0 112.444 -178.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.09 160.53 33.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.525 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.07 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -108.76 131.06 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.662 0.744 . . . . 0.0 112.689 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.911 ' CH2' HD22 ' A' ' 671' ' ' LEU . 92.5 m95 -115.29 126.9 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.504 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.662 ' CD2' HD13 ' A' ' 678' ' ' ILE . 3.7 t80 -90.52 117.63 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 35.3 m -103.32 133.12 48.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.398 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.422 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 64.7 t60 -110.57 130.61 55.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.3 p -130.27 10.74 5.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.461 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.0 178.91 53.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.276 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.1 t -102.06 -36.53 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.585 ' C ' HG13 ' A' ' 656' ' ' VAL . 3.0 m-80 -72.63 -0.16 12.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.942 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.585 HG13 ' C ' ' A' ' 655' ' ' ASN . 2.0 m 60.34 135.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 121.09 0.472 . . . . 0.0 111.577 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.422 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 4.3 t -97.63 165.65 11.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.672 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.488 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 5.6 m-85 -136.47 120.32 17.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.026 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.722 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -103.99 115.77 31.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.06 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.39 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.7 p-10 -136.31 6.29 3.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.471 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.651 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.9 OUTLIER -103.15 141.01 36.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.825 0.345 . . . . 0.0 111.015 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.682 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -82.55 141.43 32.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.424 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 31.4 mmm -119.42 106.01 11.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.035 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.42 ' CG1' HG23 ' A' ' 668' ' ' THR . 49.9 pt -92.36 153.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.2 tt0 -47.07 99.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.37 41.05 1.29 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.42 HG23 ' CG1' ' A' ' 665' ' ' ILE . 1.3 p -121.43 162.28 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.619 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.474 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.4 ttpm? -133.02 146.6 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.579 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.481 ' CD2' ' CD1' ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.49 144.03 28.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.947 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.911 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.73 133.39 47.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.427 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -106.03 107.35 18.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 111.35 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -95.11 142.35 27.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.827 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 696' ' ' ILE . 20.2 t0 -45.15 114.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.758 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.08 36.75 5.63 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.435 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -96.92 119.13 34.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.407 -179.201 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -96.2 114.06 25.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.722 HG23 ' HG ' ' A' ' 659' ' ' LEU . 6.4 mt -105.59 128.54 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 23.8 mtpt -90.37 116.5 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.952 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.856 HG23 ' CD2' ' A' ' 622' ' ' HIS . 35.3 mt -84.84 -38.97 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.348 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.516 HG22 ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.54 133.0 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.672 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -136.4 128.01 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.744 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -122.82 116.56 23.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.583 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -46.83 71.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.942 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.91 -40.54 46.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -82.26 -16.81 48.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.271 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.66 11.44 8.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.963 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.413 ' CE1' HG13 ' A' ' 690' ' ' ILE . 29.0 t80 -81.19 104.39 11.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.7 p -117.73 133.38 64.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.467 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.516 ' HB ' HG22 ' A' ' 681' ' ' ILE . 4.7 mt -128.24 155.04 39.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.481 ' O ' HD22 ' A' ' 583' ' ' LEU . . . 179.43 132.77 1.83 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.578 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.577 ' HB2' HD22 ' A' ' 580' ' ' LEU . 9.7 m-30 -113.12 145.82 40.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.789 ' HB2' HD12 ' A' ' 583' ' ' LEU . 3.2 ttmt -101.2 117.66 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.991 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.861 HG23 HD21 ' A' ' 580' ' ' LEU . 2.3 t -80.1 117.95 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.321 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 579' ' ' THR . 7.0 tt0 -126.09 109.29 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 110.266 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.683 HD12 ' HB2' ' A' ' 674' ' ' ASP . 41.0 mt -80.37 105.88 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -91.06 -45.32 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.118 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 577' ' ' PHE . 9.4 t0 -110.37 141.08 43.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.445 0.641 . . . . 0.0 109.559 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.682 HG21 ' O ' ' A' ' 663' ' ' ARG . 48.4 t . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.811 0.339 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 166.37 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 135.28 45.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -85.1 160.0 20.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.57 -174.34 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -29.32 36.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.39 -52.09 67.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.692 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.742 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.4 OUTLIER -68.08 -42.37 80.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.587 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -33.46 72.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.85 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.47 -40.83 93.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.049 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.2 mt -57.73 -44.3 85.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.054 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.463 HG23 HG11 ' A' ' 621' ' ' VAL . 9.4 p -79.41 -27.34 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -57.78 -35.44 70.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.665 179.629 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.966 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -107.78 -52.54 2.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.226 -178.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 594' ' ' ILE . 9.3 tt -119.59 142.46 48.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.552 ' N ' HD23 ' A' ' 578' ' ' LEU . 6.1 m -119.85 114.42 22.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.669 ' HB3' HD12 ' A' ' 592' ' ' LEU . 0.4 OUTLIER -102.18 108.46 19.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.1 pttp -118.01 99.76 51.98 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -176.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.9 Cg_exo -46.0 102.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.815 1.677 . . . . 0.0 109.603 176.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -75.01 157.6 85.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.418 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.37 -24.75 9.09 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.866 3.044 . . . . 0.0 113.382 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.13 -24.11 66.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 1.5 t -95.95 152.01 18.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.93 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.478 HD13 ' N ' ' A' ' 587' ' ' ILE . 0.2 OUTLIER -56.33 -15.19 2.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.285 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.541 HG23 ' CB ' ' A' ' 582' ' ' PRO . 3.3 tt -112.58 124.88 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.849 0.357 . . . . 0.0 111.656 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.418 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -107.68 71.25 0.81 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.563 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 48.9 mt-10 -125.55 169.89 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.521 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.27 128.17 42.69 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.154 0.502 . . . . 0.0 110.917 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.909 HD21 HD11 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -112.48 140.09 47.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.637 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 20.4 mt-10 -124.06 113.81 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.884 HD12 HD22 ' A' ' 578' ' ' LEU . 83.6 mt -86.32 109.75 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.63 128.81 35.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 2.4 pt20 -47.04 -30.24 2.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.367 0.603 . . . . 0.0 110.085 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.432 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -25.56 74.43 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.035 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.89 117.87 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.991 0.896 . . . . 0.0 111.924 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.25 122.13 9.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.861 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.58 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.6 Cg_endo -90.77 159.55 30.17 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.395 -1.085 . . . . 0.0 111.649 -0.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.25 115.83 28.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 42.9 m-85 -92.57 138.05 31.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.05 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.762 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.1 mp -126.47 145.15 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.511 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.99 -168.44 39.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.495 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.413 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 12.2 ttp85 -82.41 -19.22 39.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.614 0.245 . . . . 0.0 111.343 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.04 132.65 34.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -21.55 45.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.06 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.8 -29.36 64.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.908 0.385 . . . . 0.0 110.644 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.8 m -74.92 130.2 38.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.925 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 34.3 m120 -45.24 -31.86 1.7 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.26 0.552 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.776 ' SG ' HD13 ' A' ' 592' ' ' LEU . 43.8 t -107.87 142.74 37.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.618 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.97 116.29 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.909 HD11 HD21 ' A' ' 592' ' ' LEU . 26.7 mm -137.96 109.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.678 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.4 tt0 -92.43 103.49 15.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.881 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.712 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.6 t70 -132.22 117.06 17.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.021 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -46.16 -31.15 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.794 0.331 . . . . 0.0 111.194 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.482 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 1.7 mpt_? -77.73 -35.7 51.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.712 HD13 ' CB ' ' A' ' 615' ' ' ASP . 1.2 mp -66.38 159.69 26.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.3 m -108.61 167.09 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -48.93 22.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.239 0.542 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.651 HG11 HG23 ' A' ' 727' ' ' VAL . 10.3 t -119.74 61.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.279 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.548 ' NE2' HG23 ' A' ' 680' ' ' ILE . 28.2 t60 -49.13 -45.57 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.995 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -167.65 155.81 9.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.053 0.454 . . . . 0.0 111.339 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 603' ' ' ILE . 48.2 p90 -143.22 144.32 32.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.768 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -101.39 131.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.58 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.9 t80 -126.54 133.3 51.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.027 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.71 ' HB2' HG22 ' A' ' 647' ' ' ILE . 31.0 ttmt -98.44 133.6 42.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.91 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 159.62 40.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.771 -178.47 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.2 tpt180 -75.6 115.07 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.372 0.606 . . . . 0.0 110.533 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.309 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.553 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 4.0 m-20 -107.06 137.78 44.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' A' ' 671' ' ' LEU . 2.4 t0 -116.03 157.39 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.811 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.966 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 4.7 pt -109.4 117.08 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.502 0.668 . . . . 0.0 111.851 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.908 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 70.9 m95 -102.78 131.23 49.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.623 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.701 ' HB2' HD11 ' A' ' 672' ' ' LEU . 27.7 t80 -91.16 117.13 29.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 624' ' ' PHE . 23.6 m -103.95 123.98 48.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.298 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.456 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 68.8 t60 -102.25 134.51 45.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -134.38 8.65 3.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.33 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.92 151.35 26.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.63 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.6 t -73.67 -29.04 62.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.126 0.489 . . . . 0.0 111.464 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.608 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.1 m120 -72.66 -1.8 17.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.539 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 54.74 124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 111.877 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.451 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -98.02 166.41 11.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.257 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -134.21 126.21 29.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.076 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.764 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -93.74 99.45 11.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.298 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 61.92 -78.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.689 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 15.4 p-10 -129.08 -8.17 4.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.735 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.446 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 9.9 m120 -92.6 140.62 29.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -83.52 141.67 31.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.629 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.636 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 3.2 mtp -125.4 121.81 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.273 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.416 HG12 ' CG2' ' A' ' 668' ' ' THR . 33.7 pt -103.48 156.54 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.546 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -48.2 104.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.38 . . . . 0.0 111.343 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.4 35.73 2.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.4 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.416 ' CG2' HG12 ' A' ' 665' ' ' ILE . 2.8 p -117.63 162.03 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.741 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.515 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.0 OUTLIER -131.82 145.03 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.061 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.636 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 3.4 t80 -147.76 145.89 28.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.908 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.27 130.27 42.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.3 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.764 ' CD2' HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -109.76 129.58 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.143 0.497 . . . . 0.0 111.154 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.01 144.66 50.27 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.786 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.473 ' HB2' HD12 ' A' ' 696' ' ' ILE . 11.0 t70 -41.88 118.6 1.14 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.854 0.359 . . . . 0.0 110.91 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.02 33.83 7.55 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.25 109.89 21.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 111.126 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.501 ' HG3' HD11 ' A' ' 583' ' ' LEU . 15.2 tt0 -95.63 108.21 20.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.651 HG12 HD22 ' A' ' 659' ' ' LEU . 13.7 mt -105.46 122.63 59.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.581 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -78.91 115.9 18.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.71 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.734 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 1.1 mt -79.34 -32.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 690' ' ' ILE . 6.9 tt -154.98 131.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.63 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.56 126.7 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -126.23 117.39 22.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.226 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -46.58 73.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.105 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -73.57 -40.51 63.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.3 -14.24 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.603 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp 59.74 18.43 7.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.435 ' CE1' ' NH1' ' A' ' 617' ' ' ARG . 36.8 t80 -82.72 105.18 13.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.2 p -121.87 123.69 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.707 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 681' ' ' ILE . 3.9 tt -127.57 125.08 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.487 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.76 148.17 16.84 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.18 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.734 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 0.3 OUTLIER -116.14 151.94 34.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.666 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.47 117.39 34.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.788 HG22 HD21 ' A' ' 578' ' ' LEU . 2.5 t -75.16 128.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.347 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 579' ' ' THR . 5.6 tt0 -133.14 109.01 9.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 674' ' ' ASP . 39.9 mt -83.32 105.06 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.391 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.91 -45.88 11.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.492 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -110.24 140.77 44.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.331 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.446 -0.673 0 CA-C-O 121.338 0.59 . . . . 0.0 109.715 178.926 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 716' ' ' VAL . 5.1 p . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.931 0.396 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.1 OUTLIER -101.14 172.25 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.68 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 153.06 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.196 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.19 160.09 25.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -125.03 -178.66 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -28.82 37.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -66.11 -46.64 76.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 726' ' ' LEU . 8.3 mp0 -68.6 -43.17 77.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.812 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -55.97 -37.0 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -67.98 -36.6 80.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.003 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 723' ' ' GLU . 91.5 mt -55.63 -44.27 76.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.651 HG23 HG11 ' A' ' 621' ' ' VAL . 8.1 p -77.93 -29.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.758 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.9 mttp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.87 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -126.98 -54.38 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.055 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.049 HD12 HD13 ' A' ' 647' ' ' ILE . 7.1 tt -112.98 138.49 49.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.355 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.757 ' N ' HD23 ' A' ' 578' ' ' LEU . 6.4 m -118.29 114.2 22.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.992 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.769 HD12 HD11 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -104.09 108.04 19.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.6 OUTLIER -116.89 100.99 53.66 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.43 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.1 Cg_exo -45.61 100.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.824 1.682 . . . . 0.0 109.597 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.61 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.33 157.02 86.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.31 -26.09 14.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.981 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.567 ' HB2' HD12 ' A' ' 583' ' ' LEU . 4.0 t0 -62.09 -27.22 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.423 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.4 t -95.62 154.2 17.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.704 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 31.2 pt -56.97 -11.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.729 0.299 . . . . 0.0 111.13 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.607 HD13 HG23 ' A' ' 613' ' ' ILE . 34.3 mt -108.72 122.33 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.744 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.63 57.04 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 110.404 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.533 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 mt-10 -124.62 171.06 10.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.194 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.06 129.32 46.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.073 0.463 . . . . 0.0 111.126 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.48 142.02 45.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.154 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.454 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.7 OUTLIER -124.3 114.41 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.822 HD12 HD22 ' A' ' 578' ' ' LEU . 87.4 mt -83.84 108.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 593' ' ' GLU . 2.1 mp0 -65.7 125.49 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.315 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 2.4 pm0 -48.01 -26.92 1.97 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.169 0.509 . . . . 0.0 110.413 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -76.65 -21.85 73.78 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.472 -0.785 . . . . 0.0 114.153 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.38 117.74 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 118.324 1.062 . . . . 0.0 111.534 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 15.0 t30 -140.72 122.29 9.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.23 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.578 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.9 Cg_endo -90.56 160.09 31.47 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.42 -1.075 . . . . 0.0 111.391 -0.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.627 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.29 114.96 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.561 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 43.5 m-85 -91.88 138.18 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.833 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.78 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.91 145.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.369 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.49 -172.94 36.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.416 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.469 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.6 OUTLIER -67.41 -52.05 44.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.339 . . . . 0.0 111.859 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.49 126.44 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.25 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.276 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -30.36 62.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.064 0.459 . . . . 0.0 110.299 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.642 ' SG ' HG22 ' A' ' 621' ' ' VAL . 8.3 m -71.32 134.69 46.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.485 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 21.0 m-80 -48.43 -26.59 2.18 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.539 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 35.7 t -113.83 142.45 46.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.537 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.07 105.2 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.167 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.785 HD11 HD21 ' A' ' 592' ' ' LEU . 25.9 mm -138.98 109.51 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.334 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -104.0 106.4 16.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 112.459 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.585 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -130.43 107.53 9.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.65 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -41.19 -29.37 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -41.46 85.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.601 0.238 . . . . 0.0 111.473 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.585 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.86 158.99 17.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 0.0 111.711 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 92.2 p -78.41 172.86 13.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.364 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.477 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 3.3 mpt_? -47.72 -46.41 29.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.117 0.484 . . . . 0.0 110.278 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.642 HG22 ' SG ' ' A' ' 609' ' ' CYS . 46.5 t -119.8 70.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.199 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 12.8 t60 -49.72 -45.98 49.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.769 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.1 p -164.23 158.7 19.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.602 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.503 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.1 p90 -143.4 147.73 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.561 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.3 mp -102.64 131.12 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.578 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.7 t80 -122.29 133.88 54.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.63 ' HD3' HG23 ' A' ' 647' ' ' ILE . 1.6 tppp? -97.85 136.58 37.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.043 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.6 OUTLIER -135.31 159.04 42.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.819 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.6 tpt180 -76.69 112.26 13.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.312 0.577 . . . . 0.0 110.334 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.3 mt . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.5 m-20 -116.47 147.34 41.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.242 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.3 156.93 44.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.877 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.049 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -104.18 125.02 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.636 . . . . 0.0 112.29 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.871 ' CH2' HD22 ' A' ' 671' ' ' LEU . 82.5 m95 -108.79 123.08 48.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.653 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.581 ' CD2' HD13 ' A' ' 678' ' ' ILE . 3.0 t80 -89.82 116.08 27.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 62.4 m -100.68 142.6 31.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.451 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.459 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 74.4 t60 -118.97 130.96 55.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.4 p -125.64 2.73 7.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.014 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 150.68 38.05 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.401 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.0 t -73.3 -32.55 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.495 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.588 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.2 m120 -75.56 2.24 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.764 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.07 125.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.767 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 37.3 p -88.78 166.15 14.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.609 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.48 120.42 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.73 99.9 10.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.806 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 59.5 -83.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -131.44 4.32 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.454 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -113.66 116.85 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -84.3 141.28 31.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.485 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.78 142.33 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.261 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.422 ' O ' ' OG1' ' A' ' 668' ' ' THR . 31.2 pt -96.56 163.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -52.77 91.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.46 39.91 0.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.754 HG22 ' HA ' ' A' ' 718' ' ' LYS . 0.8 OUTLIER -137.48 158.5 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 111.266 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.577 ' HE2' HD13 ' A' ' 717' ' ' LEU . 18.9 pttm -128.18 158.5 37.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.621 ' HB3' HD23 ' A' ' 659' ' ' LEU . 15.3 t80 -145.37 146.75 31.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.871 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.78 129.32 39.48 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.36 -179.206 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.774 HD13 HG21 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -103.82 130.8 51.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.242 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.94 150.37 42.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.5 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 696' ' ' ILE . 19.3 t0 -50.12 105.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.369 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.28 32.7 4.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.48 113.11 25.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.04 108.84 21.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.226 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.666 HG12 HD13 ' A' ' 659' ' ' LEU . 6.4 mt -105.91 136.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.795 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 116.5 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.864 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.518 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -79.72 -36.34 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.256 -179.17 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.714 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.2 tp -155.15 131.35 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 112.085 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -136.74 122.76 20.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.914 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -126.6 117.02 21.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.906 0.384 . . . . 0.0 110.687 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -46.37 73.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.867 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.74 -40.59 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.687 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.73 -9.61 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.519 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 15.8 tttt 60.61 17.56 7.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.951 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 7.5 t80 -77.5 104.97 8.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.5 p -121.71 121.77 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.168 0.509 . . . . 0.0 112.143 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' A' ' 681' ' ' ILE . 8.7 mt -128.72 153.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.423 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -179.76 137.14 2.97 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.148 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.487 ' CE2' HD11 ' A' ' 592' ' ' LEU . 9.0 m-30 -113.24 144.82 42.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.716 0.293 . . . . 0.0 110.422 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.61 ' HB2' HD22 ' A' ' 583' ' ' LEU . 13.3 tptm -101.07 116.85 33.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.996 0.427 . . . . 0.0 110.256 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 672' ' ' LEU . 3.8 t -79.68 125.37 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.636 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.1 109.16 9.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.548 HG23 ' CD1' ' A' ' 577' ' ' PHE . 17.4 mt -84.24 105.7 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.68 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -88.46 -46.02 9.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -110.96 139.53 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.812 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.423 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 7.4 p . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.747 0.308 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.577 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -97.05 166.99 11.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 718' ' ' LYS . . . . . 0.754 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.6 OUTLIER -103.23 154.81 18.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -87.35 154.69 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.746 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.22 -177.5 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.3 -30.51 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -47.47 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.695 ' HA ' HD12 ' A' ' 726' ' ' LEU . 57.7 mm-40 -66.97 -47.32 71.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -55.73 -32.99 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.95 -37.79 82.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.695 HD12 ' HA ' ' A' ' 723' ' ' GLU . 15.6 mt -57.55 -44.14 84.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.12 -15.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -45.19 83.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 110.616 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.21 179.845 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -89.7 -22.25 22.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 151.92 -46.15 0.6 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.53 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.51 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 8.7 ttm180 -113.53 143.7 44.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.642 0.258 . . . . 0.0 111.203 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.773 ' CE1' HG21 ' A' ' 647' ' ' ILE . 5.5 t80 -122.43 -57.07 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.026 HD11 HG13 ' A' ' 694' ' ' VAL . 20.3 tp -111.04 142.36 43.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.381 . . . . 0.0 111.176 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 695' ' ' GLU . 3.5 m -121.17 114.34 21.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.951 ' CD2' HG23 ' A' ' 694' ' ' VAL . 5.6 mt -103.37 108.38 19.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 7.7 mtmt -113.71 99.81 50.74 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -176.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.616 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.6 Cg_exo -47.02 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.692 1.595 . . . . 0.0 109.606 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.654 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.59 157.25 86.29 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.53 -25.9 20.65 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.775 2.983 . . . . 0.0 112.841 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 583' ' ' LEU . 5.2 t0 -61.91 -27.46 68.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.401 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 1.9 t -95.68 154.11 17.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.797 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.719 HD11 HD11 ' A' ' 690' ' ' ILE . 12.6 pt -55.92 -11.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.704 0.288 . . . . 0.0 111.296 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.477 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.4 mt -109.58 124.88 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.794 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.46 57.1 0.66 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.57 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.616 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 tt0 -124.87 171.53 10.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.012 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.64 128.83 46.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.012 0.434 . . . . 0.0 110.846 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.719 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -111.97 141.04 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.931 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.51 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -123.93 115.93 22.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.679 0.276 . . . . 0.0 111.611 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.922 HD11 HD12 ' A' ' 625' ' ' ILE . 80.2 mt -82.61 108.95 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.395 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.8 OUTLIER -66.91 118.2 10.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.994 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.648 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.36 -28.45 1.33 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.44 -23.13 75.15 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.366 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.02 118.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.775 0.788 . . . . 0.0 111.502 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.5 t30 -139.5 122.58 10.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.929 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.8 Cg_endo -90.44 159.92 31.96 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.723 -0.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.667 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.95 115.28 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.553 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 32.2 m-85 -92.29 138.0 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.071 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.81 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.6 mp -124.73 145.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.625 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.09 -172.23 35.77 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.655 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -68.47 -52.31 33.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.975 0.417 . . . . 0.0 111.723 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -60.2 126.27 26.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.323 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.71 -20.13 2.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.133 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.87 -31.95 60.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.145 0.498 . . . . 0.0 110.201 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.673 ' SG ' HG22 ' A' ' 621' ' ' VAL . 11.4 m -70.74 130.19 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.8 m120 -44.52 -32.63 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.185 0.517 . . . . 0.0 110.39 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.81 ' SG ' HG23 ' A' ' 603' ' ' ILE . 25.9 t -107.35 142.3 37.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.041 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 104.55 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.59 HD11 HD21 ' A' ' 592' ' ' LEU . 24.1 mm -139.6 109.84 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.329 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -103.61 107.04 17.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.46 0.648 . . . . 0.0 112.42 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.574 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -129.16 107.49 9.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.602 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -40.46 -28.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.695 ' HG2' HD21 ' P' ' 606' ' ' LEU . 3.2 mpt_? -69.46 -41.28 76.42 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.574 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.22 159.11 17.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.75 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -78.18 173.29 12.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.222 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.522 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -46.7 -52.52 13.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.089 0.471 . . . . 0.0 110.187 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.673 HG22 ' SG ' ' A' ' 609' ' ' CYS . 41.6 t -114.44 70.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.291 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.536 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 11.4 t60 -48.06 -44.23 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.683 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 3.5 p -166.85 159.18 13.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 111.334 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.7 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.1 p90 -143.2 149.41 37.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.922 HD12 HD11 ' A' ' 594' ' ' ILE . 37.7 mt -102.14 135.16 40.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.001 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.3 t80 -128.68 134.48 48.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.3 ttmt -98.26 136.59 38.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.9 157.63 46.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.546 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.01 114.74 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.321 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 -73.89 125.06 27.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -138.87 128.05 24.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.078 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.07 176.35 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -73.86 -56.63 5.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.493 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.64 156.47 43.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 55.0 p -151.11 55.99 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.8 ttt -98.76 31.37 2.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.66 -66.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.416 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 638' ' ' GLU . . . . . 0.469 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 1.0 OUTLIER -75.83 144.48 41.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.316 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 2.3 m -102.11 101.35 18.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.146 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 6.0 Cg_exo -78.34 -155.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.891 2.394 . . . . 0.0 111.848 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -94.49 24.01 4.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.281 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.81 177.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 111.017 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.681 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -91.06 84.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.799 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.7 OUTLIER -103.59 -150.25 0.41 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.988 -0.124 . . . . 0.0 110.863 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.568 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 1.0 OUTLIER -112.94 148.9 34.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.309 0.576 . . . . 0.0 112.464 -178.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.568 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -135.19 129.6 34.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.787 179.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.788 HD12 ' HB2' ' A' ' 672' ' ' LEU . 2.1 pt -87.16 122.85 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.355 0.598 . . . . 0.0 111.918 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.599 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.8 m95 -105.83 148.98 26.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.159 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.588 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.0 t80 -108.16 116.61 32.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.7 m -102.07 137.66 40.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 62.4 t60 -118.4 131.59 56.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.43 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.9 p -129.04 5.79 5.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.303 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.8 151.6 32.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.637 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.477 HG23 ' N ' ' A' ' 655' ' ' ASN . 14.6 t -76.78 -44.33 33.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.016 0.436 . . . . 0.0 111.414 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.486 ' C ' HG23 ' A' ' 656' ' ' VAL . 2.1 m-20 -58.82 -18.09 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.795 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 664' ' ' MET . 4.4 t 78.55 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.142 0.496 . . . . 0.0 111.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 93.2 p -114.52 152.22 32.07 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -124.39 119.79 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.33 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.622 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -94.96 99.86 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.083 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 61.19 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.899 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.3 t30 -135.64 -0.44 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.481 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 1.7 m120 -101.0 135.41 42.49 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.927 0.394 . . . . 0.0 111.287 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 41.6 ttm-85 -75.59 141.17 42.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.573 ' O ' HG13 ' A' ' 656' ' ' VAL . 19.5 mmm -126.32 94.61 4.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.411 HG12 ' CG2' ' A' ' 668' ' ' THR . 32.7 pt -87.67 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.578 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -48.8 110.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.201 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 100.96 30.78 5.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.287 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.411 ' CG2' HG12 ' A' ' 665' ' ' ILE . 13.8 p -112.78 162.28 15.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 111.348 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.9 ttpm? -143.81 133.95 24.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.57 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -139.88 143.48 36.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.812 0.339 . . . . 0.0 111.165 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.599 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.64 140.55 53.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.788 ' HB2' HD12 ' A' ' 647' ' ' ILE . 5.0 mt -109.43 125.98 52.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 706' ' ' GLY . 1.0 OUTLIER -107.68 147.16 31.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -48.53 103.7 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 110.465 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.67 33.62 3.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.81 118.8 30.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.533 -0.334 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -96.18 111.5 23.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.622 HG22 HD13 ' A' ' 659' ' ' LEU . 30.6 pt -105.71 137.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 112.064 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.42 116.54 30.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.894 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.536 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -84.96 -38.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 690' ' ' ILE . 3.1 tp -155.18 131.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.696 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -136.84 124.88 22.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.369 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.861 ' OD2' HD22 ' P' ' 606' ' ' LEU . 12.0 t0 -127.31 116.66 20.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.792 0.329 . . . . 0.0 110.306 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -67.36 -46.57 72.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.125 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -74.51 -40.49 61.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.917 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -87.64 -7.12 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.535 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tttt 59.13 18.18 6.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.732 0.301 . . . . 0.0 110.948 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -77.54 105.02 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.2 p -124.12 121.65 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 111.917 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.772 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.5 mt -128.79 150.34 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.179 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.61 138.68 3.54 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.626 ' HB2' HD22 ' A' ' 580' ' ' LEU . 7.8 m-30 -113.46 148.71 35.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.788 0.328 . . . . 0.0 110.449 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.452 ' HB2' HD22 ' A' ' 583' ' ' LEU . 3.6 tttm -101.33 116.95 33.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 1.026 HG13 HD11 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -81.55 123.1 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.407 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.6 OUTLIER -133.28 109.46 9.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.589 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.625 HG12 HD13 ' A' ' 578' ' ' LEU . 14.9 mt -78.39 105.53 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.703 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -47.95 11.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.22 139.83 46.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.875 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 701' ' ' GLY . 3.2 p -115.68 100.5 8.08 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.117 0.484 . . . . 0.0 109.727 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 700' ' ' THR . 5.1 t -67.25 71.13 0.11 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.669 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 53.82 53.55 35.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.687 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.799 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -93.08 153.57 18.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.144 0.497 . . . . 0.0 112.128 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.567 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -55.08 -24.84 27.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.22 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 704' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -165.54 -57.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.788 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.478 ' HA ' HD22 ' A' ' 702' ' ' LEU . 9.3 pt-20 164.82 -33.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.802 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 142.83 40.75 0.06 OUTLIER Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.147 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 673' ' ' GLN . 1.0 OUTLIER -97.29 7.18 47.06 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.481 ' HA2' HD12 ' A' ' 671' ' ' LEU . . . 72.2 -103.64 1.35 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.884 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 8.6 mtm 65.98 71.68 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 0.0 110.712 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 710' ' ' LEU . 2.1 pt? -148.28 -160.39 1.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.698 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -46.99 -71.89 0.06 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.718 0.294 . . . . 0.0 111.205 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -76.76 139.2 40.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.772 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -88.84 100.81 13.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.123 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.45 ' HD3' ' NE2' ' A' ' 673' ' ' GLN . 8.4 mmm-85 47.75 81.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.56 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.65 142.74 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.641 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.4 p -84.57 114.79 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.16 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.31 172.2 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -100.64 150.54 22.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -75.27 153.22 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -119.36 -179.17 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.27 -29.53 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -65.96 -50.28 64.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -51.07 66.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.916 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -56.01 -32.86 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.63 -36.77 83.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.988 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.58 -44.16 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.6 p -76.48 -27.59 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -36.02 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -100.83 33.89 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 621' ' ' VAL . 4.7 tt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.768 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.834 0.349 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.68 72.22 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -107.79 84.86 2.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 51.9 tp -164.93 119.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.42 HG21 HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.95 78.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.34 125.49 26.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.861 HD22 ' OD2' ' A' ' 683' ' ' ASP . 30.2 mt -67.08 152.15 96.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.954 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.575 2.184 . . . . 0.0 112.382 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.589 -0.205 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -74.59 -22.43 58.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 111.004 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 140.38 -30.51 2.32 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.263 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.421 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 1.3 ttm-85 -106.38 136.07 46.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.558 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 7.8 t80 -122.66 -48.07 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.752 HD11 ' CG1' ' A' ' 694' ' ' VAL . 8.2 tp -119.55 141.98 48.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 40.3 m -122.39 114.53 20.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.813 ' HG ' HG22 ' A' ' 694' ' ' VAL . 1.7 mp -105.63 108.57 20.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 8.4 ptpt -117.04 100.53 53.36 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 26.7 Cg_exo -44.77 104.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.739 1.626 . . . . 0.0 109.47 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.737 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.47 157.17 86.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.561 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 73.2 Cg_exo -49.18 -32.6 25.18 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.617 2.878 . . . . 0.0 112.891 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.737 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.5 OUTLIER -63.88 -21.76 66.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.88 0.371 . . . . 0.0 110.577 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.67 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 22.7 p -96.43 153.46 17.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.998 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.823 HG22 HG12 ' A' ' 690' ' ' ILE . 1.2 tt -52.49 -18.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.871 0.367 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 582' ' ' PRO . 10.8 mt -111.25 119.78 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.162 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.67 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -110.37 57.71 0.61 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.295 0.569 . . . . 0.0 110.758 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.553 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.0 mt-10 -125.13 172.08 9.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.578 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.54 128.31 46.66 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.144 0.497 . . . . 0.0 111.474 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.765 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -113.09 138.81 49.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.831 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.421 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 3.6 mp0 -123.92 115.76 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.973 HD11 HD12 ' A' ' 625' ' ' ILE . 46.3 mt -80.32 109.75 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.923 0.392 . . . . 0.0 111.033 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.4 mp0 -66.75 113.05 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.522 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.558 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.66 -30.68 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.456 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.05 -22.61 70.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.376 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.63 HG11 ' OD1' ' A' ' 610' ' ' ASN . 67.9 t -101.3 119.6 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 117.669 0.734 . . . . 0.0 111.538 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.3 t30 -138.66 122.73 11.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.59 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.38 160.47 32.53 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.618 -0.992 . . . . 0.0 111.994 0.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.705 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.6 115.68 28.25 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.562 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 51.0 m-85 -92.39 138.28 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.036 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.3 mp -127.15 145.42 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.588 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.09 -178.3 34.42 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.327 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -59.58 -52.68 64.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.88 0.372 . . . . 0.0 111.849 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.51 122.9 15.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.455 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -21.04 2.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.734 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -51.9 -30.52 24.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.177 0.513 . . . . 0.0 110.08 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.591 ' SG ' HG22 ' A' ' 621' ' ' VAL . 95.0 m -73.57 129.37 37.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.338 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 13.4 m-80 -45.55 -29.5 1.19 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.128 0.49 . . . . 0.0 110.621 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.765 ' SG ' HD13 ' A' ' 592' ' ' LEU . 53.4 t -109.22 142.91 39.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.47 106.93 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.462 HG13 ' CE2' ' A' ' 692' ' ' PHE . 30.9 mm -138.14 109.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.916 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.09 107.15 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.458 0.647 . . . . 0.0 112.369 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.579 ' OD2' HG21 ' A' ' 681' ' ' ILE . 10.9 t0 -129.1 107.55 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.123 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -41.74 -31.2 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.784 ' HG2' HD21 ' P' ' 606' ' ' LEU . 2.0 mtt180 -77.43 -38.15 50.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.303 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.774 HD23 ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -89.67 147.25 23.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.831 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.45 162.73 12.04 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.841 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.1 OUTLIER -63.15 -17.69 62.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.504 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.841 HG23 ' HG2' ' A' ' 620' ' ' ARG . 29.4 t -137.38 55.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.617 ' CG ' HD12 ' A' ' 618' ' ' LEU . 6.8 t60 -47.66 -43.06 25.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.421 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.464 ' SG ' HD11 ' A' ' 680' ' ' ILE . 4.3 p -164.29 158.68 19.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 112.261 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.797 ' HA ' HD12 ' A' ' 603' ' ' ILE . 50.2 p90 -143.74 146.07 32.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.241 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.973 HD12 HD11 ' A' ' 594' ' ' ILE . 71.2 mt -102.18 128.62 54.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.522 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -119.49 134.68 55.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.504 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 35.4 ttmt -97.42 133.66 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.413 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.14 159.11 42.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.175 -178.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.3 tpt180 -77.07 112.43 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.282 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 -71.07 131.09 43.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.091 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -149.14 133.8 17.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.155 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.499 HG22 ' N ' ' A' ' 633' ' ' GLY . 4.6 p -107.49 159.06 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.036 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.499 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -100.45 123.29 7.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.558 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.3 124.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.864 0.364 . . . . 0.0 110.967 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 50.2 m -144.74 42.62 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 90.2 mtp -59.35 134.51 57.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.036 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.2 t80 75.84 -68.47 0.2 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.231 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -77.03 131.48 38.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.072 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.5 m -106.52 90.73 5.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.73 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.08 -164.56 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.489 2.126 . . . . 0.0 112.25 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.617 ' HB1' HD13 ' A' ' 644' ' ' LEU . . . -46.84 -28.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.628 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 18.9 mt-30 84.84 -70.73 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.451 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -177.86 95.65 0.1 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.322 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.769 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.4 mp -129.82 -157.57 0.83 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.831 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -114.3 146.44 40.47 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.214 0.531 . . . . 0.0 112.025 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.48 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.7 OUTLIER -136.61 157.65 46.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.137 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.718 HD13 HD13 ' A' ' 578' ' ' LEU . 2.7 pt -103.8 118.73 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.462 0.649 . . . . 0.0 111.835 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.969 ' CH2' HD22 ' A' ' 671' ' ' LEU . 89.0 m95 -100.47 127.97 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.206 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.572 ' CD2' HD13 ' A' ' 678' ' ' ILE . 2.6 t80 -90.21 116.69 28.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 14.3 m -103.36 142.12 34.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.374 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.468 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 29.5 t60 -121.15 133.06 55.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.981 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 5.6 p -131.26 9.81 4.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.422 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -82.15 151.13 29.69 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.832 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.423 HG22 HG21 ' P' ' 603' ' ' TPO . 3.9 t -76.39 -33.91 58.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.156 0.503 . . . . 0.0 111.365 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.86 3.09 7.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.33 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 664' ' ' MET . 1.5 p 50.7 142.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.731 0.777 . . . . 0.0 112.423 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.427 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 95.8 p -112.34 166.38 11.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.286 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -129.38 120.31 25.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 111.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -103.98 99.93 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.021 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.1 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 9.0 m120 -144.91 -0.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.601 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -103.54 141.28 36.27 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.95 0.405 . . . . 0.0 111.312 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -79.6 141.97 36.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.606 ' O ' HG23 ' A' ' 656' ' ' VAL . 23.1 mmm -118.04 97.86 6.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.2 pt -87.44 146.98 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -45.19 98.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.416 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.56 37.94 1.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.523 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 4.5 p -135.66 152.61 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.79 0.329 . . . . 0.0 111.336 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 15.1 pttm -123.68 158.03 32.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.282 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.527 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 0.2 OUTLIER -142.59 142.49 32.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.969 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -69.81 125.48 26.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.975 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.559 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.8 mt -101.33 136.14 41.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.383 0.611 . . . . 0.0 111.891 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.442 ' CD ' ' HA3' ' A' ' 708' ' ' GLY . 0.5 OUTLIER -124.22 137.33 54.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.251 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.601 ' HB3' HD12 ' A' ' 696' ' ' ILE . 1.8 p30 -39.8 118.81 0.91 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.955 0.407 . . . . 0.0 110.843 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.24 36.36 5.72 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.334 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.513 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -94.95 116.76 29.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.4 108.77 21.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.122 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 9.0 mt -107.95 130.19 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -93.79 116.07 28.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.828 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.464 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.0 OUTLIER -77.96 -35.69 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.462 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 617' ' ' ARG . 8.9 tt -154.8 134.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.854 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.33 123.31 21.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.47 ' OD1' HD13 ' P' ' 606' ' ' LEU . 1.6 t0 -120.92 117.0 26.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.552 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -67.55 -46.59 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.134 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -75.91 -40.68 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.862 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.33 -12.23 49.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.464 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.13 15.61 8.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.697 0.284 . . . . 0.0 110.873 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.566 ' CE1' HG21 ' A' ' 587' ' ' ILE . 2.3 t80 -76.86 105.12 7.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -121.46 122.43 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 112.122 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.823 HG12 HG22 ' A' ' 587' ' ' ILE . 7.6 mt -116.31 145.25 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.743 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -170.47 131.23 2.18 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.481 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.462 ' CE2' HG13 ' A' ' 613' ' ' ILE . 3.3 m-30 -113.81 147.03 39.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.343 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.601 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.1 tttt -101.2 116.91 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.491 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.813 HG22 ' HG ' ' A' ' 580' ' ' LEU . 3.5 t -81.74 127.34 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.603 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.28 108.71 8.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 0.0 111.146 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 674' ' ' ASP . 95.6 mt -73.28 105.42 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.504 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -81.16 -45.91 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 109.941 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.4 t0 -110.74 140.68 44.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.878 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 43.5 p -114.52 99.22 7.39 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.6 t -79.71 62.69 4.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.547 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.717 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 59.19 46.55 93.63 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.438 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.831 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -64.01 143.6 57.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.703 0.287 . . . . 0.0 111.157 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.769 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.8 p90 -40.92 -34.19 0.38 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.361 0.601 . . . . 0.0 110.839 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.59 ' ND2' ' HG2' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -138.24 -42.59 0.51 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.845 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.693 ' OE2' HD23 ' A' ' 707' ' ' LEU . 11.3 pt-20 137.29 -37.61 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.003 0.921 . . . . 0.0 109.11 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.585 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 126.6 14.14 2.94 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.405 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.693 HD23 ' OE2' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -82.82 -0.51 48.32 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.33 -0.512 . . . . 0.0 111.65 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.442 ' HA3' ' CD ' ' A' ' 673' ' ' GLN . . . 41.4 29.27 0.39 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.468 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.445 ' O ' ' CG ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER 45.68 62.3 2.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.733 0.301 . . . . 0.0 110.639 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 711' ' ' GLN . 0.2 OUTLIER 79.11 -177.8 0.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.601 -179.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 711' ' ' GLN . . . . . 0.74 ' N ' HD12 ' A' ' 710' ' ' LEU . 14.5 mt-30 -69.01 66.21 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.992 0.425 . . . . 0.0 110.933 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.55 139.8 38.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.227 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -84.21 136.17 34.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.556 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.435 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -90.95 -145.1 0.19 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.429 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 1.5 m -140.37 142.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.48 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.601 HG23 ' CG ' ' A' ' 662' ' ' ASN . 40.8 t -88.79 130.12 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.01 147.21 35.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.81 147.02 30.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.36 160.07 24.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.978 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 14.8 p -126.14 -175.75 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.62 -30.93 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.37 -47.29 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.732 ' HA ' HD12 ' A' ' 726' ' ' LEU . 29.9 mm-40 -64.42 -49.93 69.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -57.25 -32.79 66.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.43 -36.92 82.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 723' ' ' GLU . 12.6 mt -59.76 -44.22 93.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.088 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.5 p -81.93 -29.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -55.75 -28.9 58.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -121.58 38.24 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.461 ' OXT' HD23 ' A' ' 730' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.818 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.735 0.302 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.23 149.21 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.045 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -170.4 100.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.99 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.07 105.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.423 HG21 HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -60.02 -36.54 77.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.741 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.64 108.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.082 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.784 HD21 ' HG2' ' A' ' 617' ' ' ARG . 11.4 mt -98.16 143.12 25.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.448 2.099 . . . . 0.0 112.397 -179.97 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -82.27 -16.28 50.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.725 0.298 . . . . 0.0 111.13 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -171.82 32.56 0.13 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.567 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.464 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.1 tmm_? -102.6 134.78 45.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.538 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -122.02 -64.98 1.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.346 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.009 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -106.31 125.64 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.843 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.725 HG22 ' HG3' ' A' ' 581' ' ' LYS . 24.3 m -104.68 117.2 33.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.637 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -105.96 108.08 19.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.725 ' HG3' HG22 ' A' ' 579' ' ' THR . 0.0 OUTLIER -112.66 99.12 46.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.3 Cg_exo -48.25 103.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.482 1.455 . . . . 0.0 109.009 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -73.51 157.26 88.04 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.47 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 10.3 Cg_endo -50.92 -29.16 26.11 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.613 2.876 . . . . 0.0 112.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.558 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -63.72 -15.23 57.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.913 0.387 . . . . 0.0 110.219 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.53 153.71 17.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.543 HG21 ' CZ ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -50.04 -24.44 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.908 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.5 tt -112.82 144.1 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.113 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.47 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.25 65.41 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 110.785 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 37.1 mt-10 -125.65 172.1 10.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.054 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.9 127.44 44.9 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.914 0.388 . . . . 0.0 110.99 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.94 143.58 43.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.966 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.8 OUTLIER -124.39 118.08 25.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.738 HD12 HD22 ' A' ' 578' ' ' LEU . 55.1 mt -82.39 108.6 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.11 0.481 . . . . 0.0 110.156 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 593' ' ' GLU . 2.0 mp0 -68.67 105.43 2.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.538 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -33.3 -54.23 0.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.209 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -47.39 -21.94 1.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.526 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.504 HG11 ' OD1' ' A' ' 610' ' ' ASN . 53.0 t -99.38 118.39 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.256 0.528 . . . . 0.0 111.293 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.5 t30 -140.13 123.21 10.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.127 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.561 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.4 Cg_endo -90.45 159.77 31.85 Favored 'Cis proline' 0 N--CA 1.461 -0.431 0 C-N-CA 124.411 -1.079 . . . . 0.0 111.832 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.698 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.61 115.88 28.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.525 ' CG ' HD12 ' A' ' 730' ' ' LEU . 26.7 m-85 -92.42 138.39 31.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.044 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.749 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mp -126.4 145.79 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.668 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.62 -171.83 38.54 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.134 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.484 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -69.57 -50.2 47.02 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.498 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -60.78 131.46 50.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -59.01 -18.04 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.654 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -55.33 -32.41 62.47 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 121.081 0.467 . . . . 0.0 110.241 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.509 ' SG ' HG22 ' A' ' 621' ' ' VAL . 34.5 m -71.53 132.46 44.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 2.4 m-80 -47.12 -27.09 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 0.0 110.681 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.768 ' SG ' HD13 ' A' ' 592' ' ' LEU . 40.4 t -112.75 142.51 45.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.293 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 105.62 13.87 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 592' ' ' LEU . 21.4 mm -138.21 109.28 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.43 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.12 106.24 16.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.556 0.693 . . . . 0.0 112.453 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.622 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.3 t0 -130.19 107.8 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.698 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -40.01 -29.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.625 ' O ' HG23 ' P' ' 603' ' ' TPO . 0.0 OUTLIER -68.93 -41.5 78.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.622 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.3 pp -90.12 158.8 17.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 12.8 t -76.91 162.98 27.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.049 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.6 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.7 OUTLIER -52.08 -26.68 11.65 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.441 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.6 HG23 ' HG2' ' A' ' 620' ' ' ARG . 37.6 t -130.71 62.7 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.838 ' CD2' HG23 ' A' ' 680' ' ' ILE . 25.1 t60 -51.8 -47.22 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.381 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 6.1 p -165.01 162.5 20.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.234 0.54 . . . . 0.0 112.138 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 603' ' ' ILE . 53.8 p90 -143.59 147.31 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.766 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.671 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.35 130.57 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.021 0.438 . . . . 0.0 109.981 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -122.12 133.62 54.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.607 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 30.9 ttmt -97.72 136.99 37.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.455 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.23 158.82 43.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.947 -178.451 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.2 tpt180 -76.64 112.34 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.1 t60 -66.79 132.38 47.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.384 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -179.73 148.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.041 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 5.7 m -115.92 -179.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -68.29 74.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.605 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.9 177.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.031 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 2.1 t -145.26 131.23 19.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.731 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 11.1 mtm -143.29 29.96 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 637' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 638' ' ' GLU . 10.8 p90 -178.39 -47.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.794 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 638' ' ' GLU . . . . . 0.444 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 1.7 tp10 -104.68 144.83 31.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.671 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.89 90.49 1.95 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 61.5 Cg_endo -71.49 -159.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.701 2.267 . . . . 0.0 112.183 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 703' ' ' PHE . . . -54.57 -20.36 7.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.973 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.424 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 1.7 mt-30 83.36 -66.53 0.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.368 0.267 . . . . 0.0 110.901 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.518 ' H ' HD12 ' A' ' 644' ' ' LEU . . . 172.9 65.2 0.05 OUTLIER Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.443 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.681 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.7 mp -118.85 -158.5 0.73 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.799 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.6 OUTLIER -118.48 146.62 44.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.15 0.5 . . . . 0.0 111.885 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.513 ' OD2' HD11 ' A' ' 671' ' ' LEU . 2.2 t0 -129.72 160.07 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.009 HD13 HD12 ' A' ' 578' ' ' LEU . 1.4 pt -108.66 120.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.479 0.657 . . . . 0.0 111.724 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.895 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 67.5 m95 -106.43 127.3 53.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.065 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.628 ' HB2' HD11 ' A' ' 672' ' ' LEU . 20.9 t80 -90.54 117.61 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.79 130.09 48.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.162 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.484 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 66.2 t60 -109.3 133.74 52.67 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -131.02 1.27 4.26 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.427 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.95 149.63 36.42 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.72 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.8 t -74.57 -32.37 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.451 . . . . 0.0 111.534 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.597 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.5 m-20 -73.13 1.86 8.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.461 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.82 126.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.28 0.562 . . . . 0.0 111.89 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.484 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 8.7 t -96.43 165.93 11.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.255 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -130.53 121.28 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.866 0.365 . . . . 0.0 111.265 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.673 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.51 99.47 11.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.9 m120 60.7 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -129.55 -0.27 4.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.488 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.472 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 10.8 m120 -100.89 141.99 32.99 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.888 0.375 . . . . 0.0 111.107 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.665 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -82.6 141.54 32.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 11.5 mmm -123.89 101.21 7.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.812 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.427 HG12 HG21 ' A' ' 668' ' ' THR . 50.7 pt -89.64 161.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.21 98.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.76 44.8 1.18 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.427 HG21 HG12 ' A' ' 665' ' ' ILE . 1.2 p -127.62 162.25 26.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.32 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -129.92 149.03 51.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.398 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.504 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 4.3 t80 -147.26 145.34 29.38 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.895 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 129.05 38.8 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.596 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.732 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.2 mt -108.74 119.94 41.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.291 0.567 . . . . 0.0 111.474 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.498 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 0.9 OUTLIER -110.15 144.0 39.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.24 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.742 ' HB2' HD12 ' A' ' 696' ' ' ILE . 68.3 t0 -43.06 123.93 3.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.772 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.15 7.39 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -95.23 112.85 24.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.372 . . . . 0.0 111.502 -179.014 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.75 108.66 21.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.053 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.641 HG12 HD13 ' A' ' 659' ' ' LEU . 11.2 mt -106.89 136.89 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.0 111.958 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -96.12 116.15 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.478 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.838 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.3 mt -83.71 -34.07 10.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.793 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.725 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.1 tp -154.86 131.58 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.102 0.477 . . . . 0.0 112.097 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.73 130.04 31.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.67 ' OD1' HD22 ' P' ' 606' ' ' LEU . 2.8 t0 -127.1 117.63 22.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.797 0.332 . . . . 0.0 110.735 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -66.97 -46.61 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.101 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -76.39 -40.52 50.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -88.8 -11.09 45.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.42 16.76 7.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.543 ' CZ ' HG21 ' A' ' 587' ' ' ILE . 15.5 t80 -76.9 105.44 7.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.31 125.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.908 0.385 . . . . 0.0 111.986 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.725 ' HB ' HG22 ' A' ' 681' ' ' ILE . 13.1 mt -123.8 153.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.178 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -176.59 138.2 3.93 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.278 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.786 ' CE2' HD12 ' A' ' 680' ' ' ILE . 1.8 m-30 -113.45 147.08 38.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 0.0 110.541 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.537 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -101.27 117.23 34.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.477 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.812 HG22 HD21 ' A' ' 578' ' ' LEU . 3.9 t -80.29 123.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 579' ' ' THR . 24.3 tt0 -132.64 109.38 9.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.448 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 674' ' ' ASP . 54.6 mt -78.66 106.08 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.24 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.58 -45.26 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.37 140.93 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 37.7 p -114.58 100.14 8.06 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.184 0.516 . . . . 0.0 109.998 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 700' ' ' THR . 6.0 t -78.21 61.01 2.61 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.544 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.63 57.26 20.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.996 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -84.16 141.72 30.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.976 0.417 . . . . 0.0 111.523 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.681 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.7 p90 -37.79 -48.76 1.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.619 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -142.6 1.94 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.068 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 704' ' ' ASN . 1.4 pt-20 88.67 -45.06 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.028 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 127.46 28.6 0.89 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.565 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.42 ' CD1' ' O ' ' A' ' 707' ' ' LEU . 0.1 OUTLIER -88.49 8.19 29.23 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 90.86 66.83 1.18 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.134 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.68 141.69 9.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 111.269 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 710' ' ' LEU . 1.2 pt? -31.97 133.38 0.1 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.809 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.13 52.66 12.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.2 0.524 . . . . 0.0 110.302 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.04 121.79 14.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.961 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.13 100.54 9.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.817 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -95.37 72.25 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.763 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.0 m -124.2 143.72 36.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.479 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 663' ' ' ARG . 27.7 t -77.74 120.26 28.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.923 0.392 . . . . 0.0 111.643 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.92 168.31 12.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.484 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.16 146.29 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.01 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -82.29 151.65 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 71.0 p -126.05 -179.19 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.28 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.86 -30.13 57.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.36 -51.1 70.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.678 ' HA ' HD12 ' A' ' 726' ' ' LEU . 5.3 mm-40 -65.65 -50.71 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.695 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 727' ' ' VAL . 2.4 ttpm? -55.86 -32.71 63.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -66.66 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.348 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.0 mt -58.34 -44.58 88.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 111.112 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 724' ' ' LYS . 13.3 p -73.6 -25.04 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -36.25 65.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.057 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -97.81 30.22 3.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.525 HD12 ' CG ' ' A' ' 602' ' ' PHE . 5.6 tt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.79 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.819 0.342 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' P' P ' 600' ' ' VAL . . . . . 0.474 ' O ' HG13 ' P' ' 600' ' ' VAL . 12.1 p -165.72 121.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -144.86 31.03 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.818 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.84 176.87 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.625 HG23 ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.77 74.9 9.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -59.59 125.89 25.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.772 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.67 HD22 ' OD1' ' A' ' 683' ' ' ASP . 9.9 mt -89.62 154.7 48.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 122.607 2.205 . . . . 0.0 112.271 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -69.94 -22.17 63.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.311 . . . . 0.0 111.057 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 178.01 47.95 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.827 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' CB ' ' A' ' 593' ' ' GLU . 5.1 tmm_? -94.45 124.9 38.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.924 0.392 . . . . 0.0 110.23 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.574 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -110.2 -61.89 1.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.247 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.864 HD21 HG22 ' A' ' 694' ' ' VAL . 9.3 tt -106.93 142.71 36.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.477 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.5 m -113.04 114.26 26.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.044 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.652 HD12 HD11 ' A' ' 594' ' ' ILE . 0.6 OUTLIER -106.75 108.6 20.2 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 10.9 ptpt -118.74 101.59 50.36 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.6 Cg_exo -45.34 105.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.842 1.695 . . . . 0.0 109.239 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.671 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.66 157.31 86.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.342 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.43 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.9 Cg_endo -53.65 -27.4 41.72 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.807 3.005 . . . . 0.0 112.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.671 ' HB2' HD12 ' A' ' 583' ' ' LEU . 7.4 m-20 -62.08 -24.28 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.487 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 1.8 t -96.02 153.96 17.49 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.207 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 690' ' ' ILE . 14.9 pt -55.29 -14.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.312 . . . . 0.0 111.022 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 35.4 mt -107.36 125.2 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.665 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.43 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -112.32 58.22 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.446 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.535 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.6 mp0 -125.28 168.76 13.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.613 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.23 121.59 25.06 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.381 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.3 mm? -113.34 150.73 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.423 ' CB ' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.72 117.09 23.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.688 HD12 HD22 ' A' ' 578' ' ' LEU . 66.2 mt -74.46 108.7 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -69.05 111.12 4.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.291 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.523 ' CD ' ' HG1' ' A' ' 700' ' ' THR . 0.0 OUTLIER -38.81 -52.12 1.72 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.281 0.563 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -46.94 -24.74 2.09 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.234 -0.893 . . . . 0.0 113.14 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.09 117.89 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.287 0.543 . . . . 0.0 110.916 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.7 t30 -140.18 122.33 9.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.058 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -89.76 159.93 35.32 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 124.407 -1.08 . . . . 0.0 111.54 -0.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.621 ' CG ' HG23 ' A' ' 594' ' ' ILE . 4.8 t80 -91.55 114.61 27.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.506 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 6.1 m-85 -92.2 138.08 31.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.75 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.5 mp -124.02 148.34 28.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.47 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.41 -171.54 36.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.347 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.486 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.58 -52.58 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 111.644 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.58 133.54 56.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.319 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -57.95 -19.25 28.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.772 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.51 -31.44 56.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.063 0.459 . . . . 0.0 110.258 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.621 ' SG ' HG22 ' A' ' 621' ' ' VAL . 8.6 m -73.56 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.447 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -43.36 -32.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.235 0.54 . . . . 0.0 110.408 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.75 ' SG ' HG23 ' A' ' 603' ' ' ILE . 34.8 t -106.48 142.01 36.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.007 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.85 104.71 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.412 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.3 mm -139.14 109.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.194 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.9 106.75 17.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.424 0.631 . . . . 0.0 112.432 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.59 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.5 t0 -129.46 107.59 9.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.55 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -40.68 -28.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 688' ' ' PHE . 9.3 mmt180 -69.38 -41.47 76.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.59 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -89.19 158.62 17.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.912 0.387 . . . . 0.0 111.527 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 73.1 m -78.97 170.58 16.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.367 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -46.93 -42.58 17.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.621 HG22 ' SG ' ' A' ' 609' ' ' CYS . 41.1 t -122.51 69.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.289 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.632 ' O ' ' N ' ' A' ' 653' ' ' GLY . 17.7 t60 -50.49 -47.05 57.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.745 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 6.2 p -164.6 163.35 21.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.119 0.485 . . . . 0.0 111.986 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.506 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 53.3 p90 -144.18 151.03 38.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.877 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.539 HD13 HD11 ' A' ' 594' ' ' ILE . 3.8 mp -102.71 132.89 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -124.17 132.54 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.872 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 29.9 ttmt -98.17 136.56 38.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.18 158.75 39.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.498 ' HE ' ' HB2' ' A' ' 631' ' ' ALA . 0.8 OUTLIER -76.61 114.49 15.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.235 0.54 . . . . 0.0 110.412 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.562 ' CD2' ' OD2' ' A' ' 646' ' ' ASP . 7.8 t-80 -81.58 130.02 34.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.771 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.498 ' HB2' ' HE ' ' A' ' 629' ' ' ARG . . . -157.29 159.84 37.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.169 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 10.4 m -109.23 169.42 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.04 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -74.64 95.81 0.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.596 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 8.8 pttp 43.13 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.337 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.8 144.61 8.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.192 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.5 131.4 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.793 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 7.6 t80 69.35 -65.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.961 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -76.05 143.93 41.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.944 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 6.8 m -105.66 101.43 32.42 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -87.46 -163.14 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.84 2.36 . . . . 0.0 112.04 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -95.8 28.59 3.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.329 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 58.78 -168.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.019 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.591 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -89.88 91.04 1.66 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.542 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -105.18 -153.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 p-10 -122.15 147.62 45.93 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.013 0.435 . . . . 0.0 112.041 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.562 ' OD2' ' CD2' ' A' ' 630' ' ' HIS . 0.4 OUTLIER -131.64 155.38 47.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.389 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.771 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -104.26 129.16 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.606 0.717 . . . . 0.0 112.702 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.917 ' CH2' HD22 ' A' ' 671' ' ' LEU . 96.1 m95 -113.49 128.57 56.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.215 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.476 ' HB2' HD21 ' A' ' 672' ' ' LEU . 4.7 t80 -90.32 117.29 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 63.2 m -102.78 130.24 49.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.873 0.368 . . . . 0.0 111.271 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.453 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -109.48 128.22 55.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.207 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.445 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.7 p -126.95 8.98 6.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.206 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.54 151.82 31.42 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.155 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.5 m -83.97 -17.17 41.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.578 0.227 . . . . 0.0 111.49 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.485 ' CB ' HD12 ' A' ' 681' ' ' ILE . 2.1 m120 -87.22 -5.51 58.93 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 664' ' ' MET . 6.6 t 74.8 145.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.122 0.486 . . . . 0.0 112.284 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.453 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 61.8 p -119.2 160.3 22.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 679' ' ' LYS . 21.8 m-85 -138.29 120.4 15.64 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.2 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -94.59 103.72 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.564 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 67.75 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -134.86 -3.68 2.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.595 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.8 OUTLIER -94.52 140.79 29.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.878 0.371 . . . . 0.0 111.099 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.658 ' O ' HG21 ' A' ' 716' ' ' VAL . 4.8 ttp180 -83.88 141.53 31.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 27.6 mtp -131.92 107.17 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.449 ' H ' HG21 ' A' ' 668' ' ' THR . 26.5 pt -86.72 164.73 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.124 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 652' ' ' THR . 36.1 tt0 -50.58 110.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.06 31.7 4.95 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.952 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 665' ' ' ILE . 9.4 p -112.7 162.57 15.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.594 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.45 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -137.37 144.35 42.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.608 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.26 144.14 28.63 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.632 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.917 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.23 136.02 51.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.67 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 694' ' ' VAL . 1.1 mt -107.48 106.72 17.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.117 0.484 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.504 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 16.4 mt-30 -93.48 141.08 28.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.492 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 706' ' ' GLY . 1.6 p30 -41.52 112.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 91.28 37.6 6.19 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 124.39 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.353 -0.424 . . . . 0.0 111.101 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -96.31 109.07 21.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.766 HG22 ' HG ' ' A' ' 659' ' ' LEU . 12.0 pt -105.41 132.83 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.076 0.465 . . . . 0.0 111.768 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 658' ' ' TYR . 12.3 mttp -93.72 115.88 28.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.633 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.482 HG23 HG22 ' A' ' 681' ' ' ILE . 1.3 tt -78.01 -34.79 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.125 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.521 HD11 HD21 ' P' ' 606' ' ' LEU . 0.9 OUTLIER -154.33 131.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.029 179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.619 ' CD1' ' CG1' ' A' ' 689' ' ' VAL . 11.7 t90 -136.02 113.25 10.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.768 ' HB2' HD22 ' P' ' 606' ' ' LEU . 16.3 t70 -128.57 114.07 16.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.834 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.59 -42.26 78.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -58.58 -40.16 82.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.258 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -76.08 -19.31 58.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.71 15.85 9.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.196 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 617' ' ' ARG . 0.2 OUTLIER -117.73 125.27 50.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.566 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.619 ' CG1' ' CD1' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -119.21 136.52 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.2 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 587' ' ' ILE . 7.2 mt -128.73 115.82 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.325 0.583 . . . . 0.0 110.464 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -139.75 147.01 18.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.883 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.453 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.08 145.01 41.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 10.8 tptm -101.59 116.91 33.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.864 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -82.36 114.99 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.957 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.24 108.99 12.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.995 0.426 . . . . 0.0 110.257 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.564 HD12 ' HB3' ' A' ' 674' ' ' ASP . 25.4 mt -79.4 122.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.294 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -105.1 -42.61 5.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.708 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.52 140.96 44.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.112 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.5 p -114.28 100.26 8.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.319 0.581 . . . . 0.0 110.025 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.523 ' HG1' ' CD ' ' A' ' 596' ' ' GLN . 3.3 m -72.29 65.42 0.61 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.798 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 66.15 32.83 83.48 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.142 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.772 HD22 ' HA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -79.06 134.31 36.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.746 0.308 . . . . 0.0 111.434 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 2.5 p90 -42.76 -33.38 0.73 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.411 0.624 . . . . 0.0 110.563 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.615 HD22 HD23 ' A' ' 707' ' ' LEU . 0.7 OUTLIER -153.6 -49.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.501 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.772 ' HA ' HD22 ' A' ' 702' ' ' LEU . 12.4 pt-20 137.5 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.124 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 141.8 86.76 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.3 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.615 HD23 HD22 ' A' ' 704' ' ' ASN . 0.1 OUTLIER -104.93 -9.73 17.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.368 0.584 . . . . 0.0 111.738 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 81.48 47.55 6.34 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.481 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.28 114.38 28.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.361 . . . . 0.0 110.966 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.73 172.86 2.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.772 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -59.56 -65.04 0.74 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -66.9 140.03 57.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.747 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -90.72 100.18 13.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.144 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.623 ' NH2' HD22 ' A' ' 659' ' ' LEU . 6.1 mmm-85 39.57 86.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.801 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.78 142.92 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 663' ' ' ARG . 46.7 t -85.69 118.19 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.138 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.1 mp -91.8 172.28 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -103.25 148.31 25.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.04 157.71 22.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -178.47 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.51 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.93 -52.33 64.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -65.68 -46.65 78.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.44 -32.75 67.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.13 -36.92 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 9.2 mt -59.55 -44.54 93.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.033 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.9 p -81.64 -23.96 9.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -54.44 -34.93 62.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -100.18 31.16 3.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.801 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.476 HD12 ' CG ' ' A' ' 602' ' ' PHE . 3.7 tt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.673 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.884 0.373 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 23.3 t -153.96 93.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.0 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -127.17 32.66 5.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.998 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.76 166.48 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.48 82.75 2.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.764 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -57.35 137.44 56.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.026 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.768 HD22 ' HB2' ' A' ' 683' ' ' ASP . 0.5 OUTLIER -136.11 98.45 11.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.405 2.07 . . . . 0.0 112.222 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -74.3 -20.45 60.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.654 0.264 . . . . 0.0 111.05 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 118.23 -29.76 6.32 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.264 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.452 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.1 tmm_? -105.24 135.92 45.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 647' ' ' ILE . 6.0 t80 -121.46 -52.98 2.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 647' ' ' ILE . 11.9 tp -112.22 142.32 44.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.023 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 695' ' ' GLU . 19.4 m -120.3 114.06 21.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.831 ' HG ' HG22 ' A' ' 694' ' ' VAL . 3.1 mp -107.18 108.94 20.62 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.9 pttt -114.45 100.76 53.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -44.9 102.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.787 1.658 . . . . 0.0 109.518 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.22 159.54 83.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.286 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.599 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 6.3 Cg_endo -48.69 -30.56 16.95 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.783 2.988 . . . . 0.0 112.989 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.672 ' HB2' HD12 ' A' ' 583' ' ' LEU . 8.2 m-20 -63.55 -17.72 63.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.063 0.459 . . . . 0.0 109.89 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.579 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 23.8 t -95.46 153.32 17.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.628 HD11 HD11 ' A' ' 690' ' ' ILE . 20.9 pt -59.24 -19.24 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 109.972 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.564 HD13 HG23 ' A' ' 613' ' ' ILE . 5.4 mt -112.55 118.54 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.599 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -106.04 66.0 0.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.374 0.607 . . . . 0.0 110.462 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.578 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.0 mt-10 -125.57 172.34 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.758 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.44 125.6 40.85 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.175 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.772 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.41 138.63 48.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.837 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.452 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.31 114.44 19.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.611 0.243 . . . . 0.0 111.398 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.086 HD11 HD12 ' A' ' 625' ' ' ILE . 46.1 mt -72.36 109.36 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.819 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.6 mp0 -64.14 110.13 2.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.45 -29.64 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.028 0.442 . . . . 0.0 111.022 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.78 -22.51 73.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.378 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.671 HG11 ' OD1' ' A' ' 610' ' ' ASN . 63.4 t -101.28 119.31 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 117.712 0.756 . . . . 0.0 111.465 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 15.5 t30 -138.94 123.37 11.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.884 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 46.0 Cg_endo -90.11 160.82 34.04 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 124.672 -0.97 . . . . 0.0 111.99 0.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.693 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.6 t80 -91.94 114.68 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.699 ' CG ' HD12 ' A' ' 730' ' ' LEU . 22.2 m-85 -92.29 138.21 31.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.702 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.7 mp -126.46 145.54 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.69 -175.03 36.6 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.43 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -65.45 -47.73 75.13 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 111.38 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.82 127.17 30.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.355 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -58.18 -17.35 18.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.92 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.36 -30.77 67.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.027 0.442 . . . . 0.0 110.186 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.723 ' SG ' HG22 ' A' ' 621' ' ' VAL . 62.3 m -70.61 133.44 46.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.63 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.671 ' OD1' HG11 ' A' ' 598' ' ' VAL . 0.7 OUTLIER -47.47 -28.32 2.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.767 ' SG ' HG23 ' A' ' 603' ' ' ILE . 43.1 t -111.96 142.16 44.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.514 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.28 105.27 13.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.772 HD11 HD21 ' A' ' 592' ' ' LEU . 25.0 mm -139.09 109.73 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.027 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -104.4 107.16 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.472 0.653 . . . . 0.0 112.548 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.616 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.4 t0 -129.38 107.56 9.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.766 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -40.0 -29.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.465 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.616 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.3 pp -89.66 158.85 17.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.549 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.8 164.94 25.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.621 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.911 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -53.06 -25.7 13.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.989 0.423 . . . . 0.0 110.369 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.911 HG23 ' HG2' ' A' ' 620' ' ' ARG . 47.1 t -131.67 64.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 8.0 t60 -49.0 -43.77 40.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.227 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.5 p -167.13 161.42 14.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.0 111.902 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.2 p90 -143.54 148.3 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.593 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.086 HD12 HD11 ' A' ' 594' ' ' ILE . 75.2 mt -102.25 136.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.6 t80 -127.25 135.08 50.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.588 ' CE ' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -97.16 136.82 37.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 158.73 43.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.753 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.8 OUTLIER -77.32 112.75 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.424 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.7 t-160 -82.87 122.84 28.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.828 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -142.77 160.69 39.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 5.8 m -119.88 165.25 15.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -97.64 107.01 3.4 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.327 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 6.4 tttp 63.24 140.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.9 p -126.68 106.33 9.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.2 mtp -94.38 117.07 29.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.74 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 67.25 -74.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.795 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.25 144.17 38.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 9.0 t -112.38 95.36 30.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.961 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 -154.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.574 2.183 . . . . 0.0 112.165 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -54.45 -23.09 14.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.524 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 71.97 -65.04 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.411 ' CA ' ' NE ' ' A' ' 629' ' ' ARG . . . -179.96 79.41 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.731 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.949 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.3 mt -121.87 -155.34 0.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 1.6 m-20 -112.43 147.96 35.36 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.444 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -138.03 131.78 31.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.662 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 578' ' ' LEU . 4.6 pt -87.4 123.82 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.876 ' CH2' HD22 ' A' ' 671' ' ' LEU . 88.0 m95 -104.84 144.09 32.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.871 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.717 ' CD2' HD13 ' A' ' 678' ' ' ILE . 7.4 t80 -104.38 117.15 33.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 25.4 m -105.47 130.02 53.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.482 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 60.4 t60 -108.78 133.08 53.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.22 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.6 p -130.08 6.32 4.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.249 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.43 150.69 31.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.692 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.429 HG22 HG21 ' P' ' 603' ' ' TPO . 3.9 t -73.64 -35.81 65.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 111.455 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.604 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.3 m-80 -70.7 -1.77 12.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.307 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 53.65 125.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.218 0.532 . . . . 0.0 111.786 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.3 p -90.65 165.71 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 89.4 m-85 -128.17 120.27 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.652 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -97.68 100.53 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.33 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 61.4 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -134.44 3.74 3.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.711 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.563 ' HB3' HG23 ' A' ' 716' ' ' VAL . 5.4 m120 -107.12 141.23 38.7 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.658 ' O ' HG21 ' A' ' 716' ' ' VAL . 12.5 ttm180 -80.72 141.21 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.414 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 35.1 mmm -119.12 102.36 8.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.1 pt -87.86 150.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.276 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -44.31 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.445 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.6 43.35 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.655 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.04 162.13 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -131.41 146.28 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.588 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.72 144.88 28.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.876 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.06 134.8 49.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.206 179.169 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 694' ' ' VAL . 1.1 mt -109.96 98.11 7.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.155 0.502 . . . . 0.0 111.504 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 12.3 mt-30 -83.49 141.73 31.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.508 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 696' ' ' ILE . 19.5 t0 -46.54 111.42 0.38 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.972 0.415 . . . . 0.0 110.269 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 102.29 36.5 3.58 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.75 31.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 111.176 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.61 108.7 21.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.002 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.717 HD13 ' CD2' ' A' ' 649' ' ' TYR . 10.4 mt -105.97 133.92 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 111.938 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 7.8 mttt -96.65 116.14 28.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.72 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.543 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -80.3 -38.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.204 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.84 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.5 tp -155.37 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.408 . . . . 0.0 111.615 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -136.09 127.28 28.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.452 ' OD2' HD22 ' P' ' 606' ' ' LEU . 0.4 OUTLIER -127.18 117.25 21.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 179.102 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -66.73 -46.58 75.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.068 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -81.33 -40.22 23.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.821 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.69 -10.7 59.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.592 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.99 19.52 8.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.522 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 4.6 t80 -83.14 105.03 13.78 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.434 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -125.71 122.48 62.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.163 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.84 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.7 mt -128.78 119.32 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.37 137.19 7.42 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.801 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.46 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.25 143.75 43.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.673 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.8 OUTLIER -101.07 116.7 33.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.753 179.353 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.831 HG22 ' HG ' ' A' ' 580' ' ' LEU . 2.7 t -84.87 125.79 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 25.7 tt0 -134.03 109.28 8.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.786 0.327 . . . . 0.0 111.404 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.592 HD12 ' HG3' ' A' ' 705' ' ' GLU . 84.5 mt -69.85 105.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.031 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -85.58 -48.78 8.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.475 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 11.3 t0 -111.9 142.11 44.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.871 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.557 HG22 ' HB2' ' A' ' 705' ' ' GLU . 66.9 p -113.82 101.29 9.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 24.3 m -65.81 61.75 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.257 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 49.73 42.13 36.23 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.704 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.618 ' CD1' ' HA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -99.21 -176.91 3.44 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.02 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.949 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -60.6 -143.24 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.729 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.589 ' ND2' ' CD2' ' A' ' 703' ' ' PHE . 7.5 p30 -56.49 2.57 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.618 ' HA ' ' CD1' ' A' ' 702' ' ' LEU . 0.5 OUTLIER 82.91 -54.63 0.18 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.841 0.353 . . . . 0.0 110.109 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 162.23 74.01 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.475 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.49 -10.0 17.16 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.76 -0.259 . . . . 0.0 111.457 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.406 ' HA2' ' NE2' ' A' ' 673' ' ' GLN . . . 97.12 31.95 6.66 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.409 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.453 ' HE2' ' HB3' ' A' ' 709' ' ' MET . 0.6 OUTLIER -85.19 121.68 28.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.33 . . . . 0.0 110.895 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 178.91 166.09 0.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -68.17 -54.19 19.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.769 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 140.22 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.705 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -82.83 100.12 10.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.102 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.5 mmm-85 37.42 88.16 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.975 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.68 143.51 37.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.783 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 663' ' ' ARG . 61.3 t -84.38 129.09 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.206 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.6 mp -98.42 165.06 12.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.707 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.88 135.61 43.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -73.36 154.34 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 43.1 p -126.0 -174.62 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.198 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.8 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.8 -51.89 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.757 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.655 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.7 mp0 -65.26 -48.79 72.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.796 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -56.25 -32.8 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.84 -37.01 83.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.065 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 723' ' ' GLU . 11.9 mt -59.93 -44.12 94.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.998 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 1.6 t -77.02 -26.1 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.247 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -55.25 -33.75 63.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.849 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -99.4 30.83 3.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.804 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.699 HD12 ' CG ' ' A' ' 602' ' ' PHE . 5.5 tt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.787 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.776 0.322 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 17.1 t -117.31 77.72 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.981 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -175.82 37.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.986 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.21 120.7 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.429 HG21 HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -47.83 83.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.853 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 62.12 150.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.485 HD12 ' OD1' ' A' ' 655' ' ' ASN . 8.8 mt -123.02 80.79 50.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 C--O 1.249 1.061 0 C-N-CA 122.581 2.188 . . . . 0.0 112.259 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -87.38 -22.08 25.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.688 0.28 . . . . 0.0 111.108 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 174.89 40.12 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.993 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.46 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 45.5 ttp180 -111.99 124.24 51.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 647' ' ' ILE . 11.0 t80 -107.25 -55.64 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.611 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.756 HD11 ' CG1' ' A' ' 694' ' ' VAL . 10.2 tp -111.51 141.99 44.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.781 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 695' ' ' GLU . 18.5 m -124.78 113.97 18.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.705 HD21 HD11 ' A' ' 625' ' ' ILE . 1.6 mp -105.54 108.81 20.52 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -112.7 99.62 48.28 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.101 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.6 Cg_exo -44.6 99.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.864 1.709 . . . . 0.0 109.612 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.753 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.77 157.45 85.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.52 -25.66 11.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.832 3.021 . . . . 0.0 113.166 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -28.12 69.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.427 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.0 OUTLIER -95.98 154.0 17.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.624 178.261 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.46 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 5.4 pt -58.57 -10.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.732 0.301 . . . . 0.0 110.91 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.485 HD13 HG23 ' A' ' 613' ' ' ILE . 41.1 mt -106.96 118.81 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.08 57.44 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.213 0.53 . . . . 0.0 110.106 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.606 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.2 mm-40 -124.49 171.91 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.162 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.26 122.99 33.02 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.041 0.448 . . . . 0.0 111.233 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.987 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.67 132.68 55.07 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.177 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.46 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -123.95 121.8 36.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.106 HD11 HD12 ' A' ' 625' ' ' ILE . 86.9 mt -74.09 108.96 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.137 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.5 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.5 mp0 -70.54 81.5 0.58 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -7.53 -62.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.583 0.753 . . . . 0.0 112.788 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . -44.69 -21.2 0.27 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.838 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.412 HG11 ' CG ' ' A' ' 610' ' ' ASN . 37.6 t -96.61 118.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 117.432 0.616 . . . . 0.0 111.067 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -139.62 123.63 10.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.581 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 49.3 Cg_endo -90.66 159.85 30.86 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 124.454 -1.061 . . . . 0.0 111.798 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.7 t80 -92.08 114.72 27.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.733 ' CG ' HD12 ' A' ' 730' ' ' LEU . 49.8 m-85 -92.31 138.02 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.733 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.802 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.7 mp -125.88 144.54 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.739 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.09 -169.44 36.68 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.42 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.511 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -69.81 -52.86 21.44 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.819 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.28 130.0 44.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -56.7 -18.63 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.949 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.96 -31.91 61.01 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.15 0.5 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 73.1 m -71.82 132.72 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.583 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 14.0 m-80 -47.95 -28.43 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.46 . . . . 0.0 110.558 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.8 t -111.07 142.79 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.48 105.23 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.987 HD11 HD21 ' A' ' 592' ' ' LEU . 34.1 mm -139.39 109.62 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.961 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.48 106.57 17.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.445 0.641 . . . . 0.0 112.652 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.628 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.2 t0 -130.35 107.91 9.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.721 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -39.28 -30.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.678 ' CD ' HD21 ' P' ' 606' ' ' LEU . 0.7 OUTLIER -68.6 -41.01 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.628 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.22 159.05 17.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.802 0.334 . . . . 0.0 111.428 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.3 t -80.57 166.05 21.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.376 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.481 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 2.9 mpt_? -47.23 -37.14 9.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.374 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.453 HG11 HG23 ' A' ' 727' ' ' VAL . 13.1 t -122.95 63.59 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.558 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 9.4 t60 -48.74 -42.97 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.833 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.6 p -167.79 157.73 10.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.802 ' HA ' HD12 ' A' ' 603' ' ' ILE . 50.1 p90 -143.14 146.0 33.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.687 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.106 HD12 HD11 ' A' ' 594' ' ' ILE . 60.5 mt -102.14 129.27 53.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.323 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.5 t80 -120.83 135.1 55.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.398 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 25.1 ttmt -97.66 134.34 40.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.961 0.41 . . . . 0.0 110.394 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.46 158.37 44.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.759 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -77.43 111.9 13.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.935 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.2 t60 -67.96 125.73 27.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.107 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . 179.92 114.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.933 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 29.0 m -55.21 156.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.214 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -53.59 -27.91 35.89 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.666 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -169.29 115.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 110.784 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.82 134.47 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.0 tpt -90.01 84.3 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 61.73 -84.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.767 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -114.38 103.47 11.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 5.9 p -138.64 156.09 73.22 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.026 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 45.9 Cg_endo -67.86 -162.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.588 2.192 . . . . 0.0 111.839 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 78.76 -56.55 0.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.508 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 69.3 -69.19 0.17 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.883 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.571 ' H ' HD12 ' A' ' 644' ' ' LEU . . . 153.96 61.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.794 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.1 mp -115.15 -165.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.874 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.4 OUTLIER -113.14 147.0 38.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.433 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -133.54 153.0 51.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.714 HD13 HD13 ' A' ' 578' ' ' LEU . 2.9 pt -100.64 119.02 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.304 0.573 . . . . 0.0 111.524 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.918 ' CH2' HD22 ' A' ' 671' ' ' LEU . 84.8 m95 -100.63 127.84 46.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.453 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.462 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.2 t80 -90.29 117.59 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' A' ' 624' ' ' PHE . 7.9 m -104.13 136.98 42.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.444 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -115.88 127.52 55.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.206 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.8 p -125.86 10.96 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.198 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.29 159.61 41.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.261 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.0 m -88.09 -19.17 27.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.677 0.275 . . . . 0.0 111.46 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.584 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.4 m-80 -87.01 2.7 48.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.8 128.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.35 0.595 . . . . 0.0 112.083 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.444 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 87.5 p -100.28 165.74 11.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.341 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -129.79 120.65 25.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.28 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.644 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.42 102.59 14.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 61.57 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -131.56 -5.65 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.537 ' ND2' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -97.84 141.37 30.91 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 111.095 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.675 ' O ' HG21 ' A' ' 716' ' ' VAL . 29.1 ttp180 -81.86 141.0 33.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.773 ' HE1' HG13 ' A' ' 716' ' ' VAL . 13.3 mmm -120.89 99.64 6.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.431 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 42.3 pt -87.59 154.28 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -45.62 107.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.313 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.12 35.88 3.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.61 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.43 ' CG2' HG12 ' A' ' 665' ' ' ILE . 3.4 p -119.89 162.28 19.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.184 0.516 . . . . 0.0 111.686 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.48 ' HE2' HD13 ' A' ' 717' ' ' LEU . 5.4 ttpm? -130.4 148.79 52.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.007 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.625 ' CZ ' ' HG2' ' A' ' 714' ' ' ARG . 2.4 t80 -147.25 143.94 28.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.918 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -74.05 130.57 40.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.193 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.696 HD13 HG21 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -97.07 139.64 32.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.28 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.717 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 2.1 mt-30 -124.9 131.5 53.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.075 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.852 ' HB2' HD12 ' A' ' 696' ' ' ILE . 40.3 t0 -42.93 104.0 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 110.581 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 106.19 33.77 3.35 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.506 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -94.51 113.86 25.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.382 . . . . 0.0 111.324 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -95.66 111.91 23.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.642 HG12 HD13 ' A' ' 659' ' ' LEU . 4.3 mt -104.92 137.04 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.062 0.458 . . . . 0.0 111.855 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -93.14 115.98 28.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.803 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.549 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -85.47 -35.48 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.744 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.7 tp -154.97 131.33 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.072 0.463 . . . . 0.0 111.826 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -137.11 125.35 23.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.843 ' OD2' HD22 ' P' ' 606' ' ' LEU . 7.9 t0 -127.15 116.81 21.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.884 0.373 . . . . 0.0 110.266 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -46.84 71.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.21 -40.68 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.84 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -87.24 -8.7 56.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? 60.71 17.94 8.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.46 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 6.7 t80 -77.08 104.59 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -124.51 122.17 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 111.813 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.744 ' HB ' HG22 ' A' ' 681' ' ' ILE . 7.0 mt -128.18 151.43 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.517 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.428 ' O ' HD22 ' A' ' 583' ' ' LEU . . . 178.26 137.83 2.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.091 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.579 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 1.8 m-30 -114.5 150.33 35.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.732 0.301 . . . . 0.0 110.738 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.753 ' HB2' HD12 ' A' ' 583' ' ' LEU . 6.5 tttt -101.16 116.62 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.633 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.756 ' CG1' HD11 ' A' ' 578' ' ' LEU . 3.6 t -79.56 124.72 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.686 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.05 108.75 8.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.852 HD12 ' HB2' ' A' ' 674' ' ' ASP . 58.1 mt -69.67 105.6 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.04 -47.06 16.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.697 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.468 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 80.6 m-20 -111.08 140.98 45.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 82.8 p -114.32 99.9 7.94 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.7 t -80.32 59.05 3.28 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.97 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.56 60.78 7.92 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.068 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.874 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -80.8 144.91 31.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.594 0.235 . . . . 0.0 110.949 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.709 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.1 p90 -39.13 -44.58 1.19 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.254 0.55 . . . . 0.0 111.346 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -120.57 -28.08 5.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.844 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 15.8 pt-20 140.63 -17.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.421 1.088 . . . . 0.0 108.618 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.717 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 110.46 12.28 17.52 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.591 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' A' ' 674' ' ' ASP . 0.4 OUTLIER -103.28 8.11 38.34 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 89.84 -113.05 4.12 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.562 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.41 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 2.4 ptp -173.57 110.42 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.941 0.4 . . . . 0.0 111.22 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 709' ' ' MET . 0.5 OUTLIER 42.0 50.05 4.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.139 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 49.63 27.95 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.445 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -74.12 141.32 45.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.957 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.23 135.96 35.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.402 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.625 ' HG2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -96.13 -150.65 0.33 Allowed 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 120.954 0.406 . . . . 0.0 110.237 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.47 166.92 3.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.692 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.773 HG13 ' HE1' ' A' ' 664' ' ' MET . 12.0 t -98.44 114.19 35.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.267 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.48 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.8 OUTLIER -89.86 168.37 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.84 146.6 27.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -80.66 154.87 27.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -123.77 -177.26 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.26 -30.76 62.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -64.83 -49.9 68.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.722 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -64.34 -50.62 67.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.498 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.6 OUTLIER -59.0 -32.55 69.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.049 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -62.8 -39.93 95.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.003 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 723' ' ' GLU . 3.2 mt -61.04 -44.56 97.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 724' ' ' LYS . 10.5 p -72.56 -25.51 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -65.11 -34.33 78.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.266 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -79.83 -16.86 54.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.946 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.733 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.2 tt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.068 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.93 0.395 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' P' P ' 600' ' ' VAL . . . . . 0.547 HG22 ' O ' ' P' ' 600' ' ' VAL . 12.3 p -120.01 51.43 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.091 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.3 64.75 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 1.7 pp -159.63 163.7 34.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.764 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.511 HG22 ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -41.23 98.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.939 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 53.75 106.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.023 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.843 HD22 ' OD2' ' A' ' 683' ' ' ASP . 14.8 mt -76.29 -45.5 3.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.454 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 607' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' P' ' 606' ' ' LEU . 77.9 Cg_exo . . . . . 0 C--O 1.248 0.988 0 C-N-CA 122.291 1.994 . . . . 0.0 112.331 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -89.39 9.41 26.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.536 0.208 . . . . 0.0 111.379 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.49 ' C ' ' HG2' ' A' ' 596' ' ' GLN . . . 166.74 36.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.15 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 577' ' ' PHE . 3.1 tmm_? -115.1 129.77 56.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.765 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.761 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -115.31 -57.42 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.371 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.976 HD23 HD12 ' A' ' 594' ' ' ILE . 24.0 tp -106.59 142.21 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.656 0.265 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.896 HG23 ' HG3' ' A' ' 593' ' ' GLU . 8.3 m -123.57 113.03 18.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 1.11 HD22 HG22 ' A' ' 694' ' ' VAL . 0.0 OUTLIER -107.9 107.84 18.74 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.533 ' HG3' HG22 ' A' ' 579' ' ' THR . 12.5 mtpt -109.57 99.59 38.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -175.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.3 Cg_exo -46.67 108.92 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.56 1.507 . . . . 0.0 108.722 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.71 156.77 88.19 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.49 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 13.9 Cg_endo -56.24 -25.89 58.29 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.639 2.893 . . . . 0.0 112.825 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -63.31 -20.51 65.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.191 0.52 . . . . 0.0 109.653 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.439 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.4 t -97.38 153.84 17.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.759 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 690' ' ' ILE . 5.2 pt -52.68 -21.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 109.908 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.837 HD13 HG23 ' A' ' 613' ' ' ILE . 48.1 mt -106.71 118.74 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.845 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -114.38 63.67 0.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.572 0.701 . . . . 0.0 109.773 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 17.6 mt-10 -125.24 173.25 8.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.455 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.15 116.52 21.48 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.691 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.43 128.03 56.31 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.896 ' HG3' HG23 ' A' ' 579' ' ' THR . 2.8 mp0 -124.98 131.21 53.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.976 HD12 HD23 ' A' ' 578' ' ' LEU . 67.0 mt -71.44 109.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 598' ' ' VAL . 0.6 OUTLIER -51.17 105.16 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.417 0.627 . . . . 0.0 111.645 -178.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.761 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 1.3 mm-40 41.63 -125.76 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.908 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -96.95 41.04 2.41 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.972 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 595' ' ' GLN . 4.7 t -73.05 118.73 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -135.26 127.69 18.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.222 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.618 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 19.9 Cg_endo -92.77 153.23 17.6 Favored 'Cis proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.957 -1.268 . . . . 0.0 112.508 0.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.749 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.1 t80 -96.1 112.2 24.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.667 ' CG ' HD12 ' A' ' 730' ' ' LEU . 72.8 m-85 -93.01 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.46 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.772 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mt -126.57 145.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.478 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.51 -168.38 35.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.383 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.497 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.08 -54.84 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.48 56.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.0 111.592 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -57.58 -19.47 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.815 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -53.34 -31.27 43.58 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.175 0.512 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 87.0 m -73.18 131.19 41.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.493 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 7.1 m-80 -46.31 -29.87 1.83 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.223 0.535 . . . . 0.0 110.404 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.82 ' SG ' HD13 ' A' ' 592' ' ' LEU . 41.4 t -110.76 143.13 41.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.028 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.24 105.44 13.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 592' ' ' LEU . 32.9 mm -138.99 109.61 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.027 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -104.06 106.96 17.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.627 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.3 t0 -130.0 107.7 9.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.604 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -38.73 -30.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.499 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -68.86 -41.6 78.18 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.627 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -88.65 159.13 17.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.953 0.406 . . . . 0.0 111.938 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 60.1 p -77.55 173.08 12.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -49.55 -32.95 13.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.516 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 621' ' ' VAL . 8.9 p -134.99 66.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.606 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 13.7 t60 -44.65 -39.53 5.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.96 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.454 ' SG ' HD11 ' A' ' 680' ' ' ILE . 4.3 p -165.39 158.86 16.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.47 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 36.3 p90 -143.77 147.74 34.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.972 HD12 HD11 ' A' ' 594' ' ' ILE . 55.7 mt -101.92 134.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.019 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 626' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 135.76 51.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.422 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 627' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -97.15 137.84 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.127 0.489 . . . . 0.0 110.879 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.71 158.92 43.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.877 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -77.17 112.47 13.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.307 0.575 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.5 t60 -80.71 129.8 34.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.885 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -141.02 167.39 22.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 4.5 m -114.83 128.43 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -65.23 -34.41 89.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.637 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -140.99 128.07 20.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.883 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 5.7 p -127.11 132.92 50.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.2 mtt -95.53 75.44 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.828 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.6 -68.0 0.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -112.28 105.08 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.34 144.37 50.86 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.806 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 58.1 Cg_endo -71.85 178.55 5.71 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.455 2.103 . . . . 0.0 112.228 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.788 ' O ' HD12 ' A' ' 644' ' ' LEU . . . 70.35 -64.49 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.47 -68.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.022 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 179.05 67.56 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.439 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.947 HD13 ' HA ' ' A' ' 703' ' ' PHE . 1.2 mt -115.28 -154.53 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.61 ' O ' HD12 ' A' ' 702' ' ' LEU . 1.1 m-20 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.343 0.592 . . . . 0.0 112.526 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.435 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.8 OUTLIER -132.13 137.31 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.605 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.859 HD13 HD22 ' A' ' 578' ' ' LEU . 2.5 pt -88.96 120.65 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.334 0.587 . . . . 0.0 112.145 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.923 ' CH2' HD22 ' A' ' 671' ' ' LEU . 87.4 m95 -101.74 143.82 31.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.726 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.585 ' HB2' HD11 ' A' ' 672' ' ' LEU . 16.7 t80 -104.24 117.34 33.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -105.29 138.47 41.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.162 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.44 ' CE1' ' N ' ' A' ' 657' ' ' SER . 49.2 t60 -118.44 130.98 56.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.43 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -127.36 8.76 6.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.139 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.37 148.51 28.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.282 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.61 HG21 ' HB3' ' P' ' 605' ' ' GLU . 2.3 t -75.78 -31.17 59.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 111.197 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.616 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.2 m120 -71.95 -1.17 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.6 126.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.346 0.593 . . . . 0.0 111.57 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 91.8 p -95.54 165.92 12.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -128.09 120.03 26.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 111.403 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -96.56 99.87 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.94 -81.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.11 3.1 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.806 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.469 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 8.0 m120 -103.68 141.65 35.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.826 0.345 . . . . 0.0 111.111 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -77.85 141.56 39.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.425 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 31.3 mmm -125.93 97.9 5.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.6 pt -87.83 153.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' A' ' 652' ' ' THR . 52.0 tt0 -48.05 100.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.82 37.25 1.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.37 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.9 p -125.48 158.71 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 111.445 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.458 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -130.26 148.56 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.458 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.9 145.35 28.61 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.923 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 135.21 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.419 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.5 mt -111.63 104.99 13.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.549 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 15.5 mt-30 -92.05 143.58 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.219 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.616 ' HB2' HD12 ' A' ' 696' ' ' ILE . 40.5 t0 -45.5 113.91 0.67 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 110.877 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 99.52 35.51 4.64 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 116.32 28.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.993 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.05 108.76 21.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.22 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.68 HG12 HD13 ' A' ' 659' ' ' LEU . 11.4 mt -107.69 135.0 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 111.894 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.439 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 4.5 mttm -96.79 116.2 28.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.848 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.561 HG23 HD23 ' A' ' 618' ' ' LEU . 0.0 OUTLIER -76.33 -34.6 25.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.303 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.779 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.2 tp -154.27 131.02 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.67 122.08 19.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.548 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.07 116.32 20.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 110.4 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -46.63 71.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.148 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -69.09 -40.51 78.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.058 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.72 -2.44 53.81 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt 58.11 19.23 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 0.0 110.829 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.502 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 2.6 t80 -76.84 104.46 7.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.431 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -126.19 120.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.808 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 587' ' ' ILE . 13.6 mt -129.64 124.68 59.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -150.04 141.49 8.85 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.716 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.616 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 3.1 m-30 -113.92 141.85 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 580' ' ' LEU . 2.7 tttt -101.23 115.75 31.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.938 0.399 . . . . 0.0 110.299 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 1.11 HG22 HD22 ' A' ' 580' ' ' LEU . 1.9 t -80.5 127.02 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.857 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.2 OUTLIER -134.21 109.03 8.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.677 HD12 ' HG3' ' A' ' 705' ' ' GLU . 60.1 mt -71.45 105.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.099 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.36 -46.85 8.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.288 0.566 . . . . 0.0 109.565 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.536 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.0 t0 -111.32 142.68 43.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.341 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.697 ' HB ' HD23 ' A' ' 702' ' ' LEU . 34.5 p -113.48 100.75 8.76 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.69 62.06 0.07 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.945 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 51.83 47.21 53.87 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.481 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.78 HD21 ' HA ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -105.39 177.67 4.78 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.704 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.947 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -58.24 -141.8 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.953 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.503 ' N ' ' CG ' ' A' ' 703' ' ' PHE . 0.7 OUTLIER -59.24 9.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.78 ' HA ' HD21 ' A' ' 702' ' ' LEU . 0.4 OUTLIER 77.95 -56.89 0.49 Allowed 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.962 0.41 . . . . 0.0 110.105 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 160.06 58.94 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.078 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 707' ' ' LEU . 1.0 OUTLIER -104.54 7.21 35.14 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.779 -0.247 . . . . 0.0 111.567 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 86.91 56.28 2.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.008 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.98 135.64 1.28 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.046 0.451 . . . . 0.0 111.677 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.1 mp 73.71 -172.76 0.13 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.8 -97.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.129 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -114.76 101.25 8.89 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.698 0.285 . . . . 0.0 111.378 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 7.2 mp0 -115.12 100.32 8.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.491 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.468 ' HD3' ' NE2' ' A' ' 673' ' ' GLN . 8.4 mmm-85 -160.55 76.06 0.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.438 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 4.6 m -123.99 141.42 44.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.289 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.1 t -81.64 130.04 36.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.253 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.477 HD11 ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -106.19 162.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.618 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.89 145.06 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.853 0.358 . . . . 0.0 111.005 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -79.98 156.61 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 33.9 p -126.06 -174.21 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.71 -29.39 53.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.65 -50.37 65.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.668 ' HA ' HD12 ' A' ' 726' ' ' LEU . 41.1 mp0 -64.0 -45.29 89.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -57.73 -32.94 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.42 -37.02 82.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 723' ' ' GLU . 12.2 mt -59.43 -44.84 92.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.015 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.2 p -84.75 -24.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.347 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -56.6 -30.27 63.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -112.45 28.39 8.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.667 HD12 ' CG ' ' A' ' 602' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.635 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.781 0.324 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 14.8 t -146.26 58.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 64.77 39.33 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.46 168.02 3.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.706 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.402 ' CG2' ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.54 80.45 4.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.742 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 605' ' ' GLU . . . . . 0.61 ' HB3' HG21 ' A' ' 654' ' ' THR . 1.4 pt-20 -59.86 107.79 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.052 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.417 HD21 ' CZ ' ' A' ' 617' ' ' ARG . 93.0 mt -60.43 110.68 3.09 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.415 2.077 . . . . 0.0 112.372 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -83.55 -10.99 57.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.536 0.207 . . . . 0.0 111.427 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.4 ' HA2' ' OE1' ' A' ' 596' ' ' GLN . . . 141.15 -8.47 2.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.508 -0.854 . . . . 0.0 113.078 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.451 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.8 OUTLIER -106.58 141.21 38.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.856 0.36 . . . . 0.0 111.068 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.752 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -128.06 -49.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.927 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 694' ' ' VAL . 7.3 tp -118.23 142.51 47.39 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.996 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 24.0 m -115.83 117.19 29.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.782 HD11 HD11 ' A' ' 625' ' ' ILE . 9.6 mt -105.56 109.11 20.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.73 99.55 52.26 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 38.2 Cg_exo -46.03 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.884 1.722 . . . . 0.0 109.628 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.798 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.3 OUTLIER -74.87 157.78 85.29 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.39 -24.93 9.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.633 2.889 . . . . 0.0 112.785 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.798 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.5 t0 -61.62 -27.38 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.466 ' OG ' HD13 ' A' ' 690' ' ' ILE . 4.7 t -95.56 154.0 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.721 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 690' ' ' ILE . 1.4 pt -56.5 -13.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.43 ' CD1' HG23 ' A' ' 613' ' ' ILE . 60.8 mt -108.08 130.92 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.32 60.12 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.592 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.7 mt-10 -124.9 169.58 11.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.103 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.56 121.49 25.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.66 0.267 . . . . 0.0 111.559 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.2 mm? -112.93 149.38 33.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.451 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.95 118.69 26.83 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.946 HD11 HD12 ' A' ' 625' ' ' ILE . 63.7 mt -73.97 109.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.321 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -64.55 113.55 3.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.661 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.24 -30.89 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.226 0.536 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.57 -20.43 73.84 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.052 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.488 HG11 ' CG ' ' A' ' 610' ' ' ASN . 48.1 t -99.86 118.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.561 0.681 . . . . 0.0 111.287 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.5 t30 -139.54 121.87 10.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.993 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.6 Cg_endo -90.21 160.13 33.22 Favored 'Cis proline' 0 N--CA 1.462 -0.367 0 C-N-CA 124.499 -1.042 . . . . 0.0 111.811 -0.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.631 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.4 t80 -91.27 114.76 27.37 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 33.6 m-85 -91.89 138.04 31.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.294 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.783 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -125.39 143.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.229 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.38 -163.57 35.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.454 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -77.13 -51.15 11.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.37 127.02 29.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.293 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -53.88 -19.78 5.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.004 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.93 -30.32 61.47 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.002 0.43 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 38.0 m -70.59 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.589 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 15.3 m-80 -47.34 -29.0 2.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.036 0.446 . . . . 0.0 110.482 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.783 ' SG ' HG23 ' A' ' 603' ' ' ILE . 37.1 t -110.87 137.0 49.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.16 104.76 14.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.43 HG23 ' CD1' ' A' ' 588' ' ' ILE . 15.5 mm -139.53 109.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.299 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -104.98 107.17 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.594 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -129.17 107.4 9.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.466 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -39.86 -27.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 681' ' ' ILE . 0.3 OUTLIER -73.51 -39.81 64.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.594 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -88.78 158.73 18.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 111.403 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.8 m -76.82 169.07 18.99 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.791 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.439 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -51.15 -35.27 35.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.28 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.67 63.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.52 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.613 ' HD2' HG23 ' A' ' 680' ' ' ILE . 26.3 t60 -47.83 -40.38 21.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.825 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.7 p -168.69 156.72 8.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.037 0.446 . . . . 0.0 111.631 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.718 ' HA ' HD12 ' A' ' 603' ' ' ILE . 27.3 p90 -143.34 148.47 36.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.55 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.946 HD12 HD11 ' A' ' 594' ' ' ILE . 61.4 mt -102.15 135.25 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.891 0.377 . . . . 0.0 110.133 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -126.87 134.13 50.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.647 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 7.8 ttpt -98.08 134.97 40.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.506 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.71 158.24 44.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.761 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -77.39 115.93 17.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.473 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 644' ' ' LEU . 9.0 t-80 -74.66 128.15 34.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.961 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -135.77 153.41 51.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.035 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 633' ' ' GLY . 6.7 p -127.74 159.99 37.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -56.63 -71.68 0.7 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.523 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -171.12 98.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.35 . . . . 0.0 110.846 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 2.3 m -67.08 153.95 42.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -133.79 142.89 48.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 71.38 -65.42 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -82.86 142.22 31.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.017 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 52.1 m -102.69 105.75 46.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.722 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.23 -161.21 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.628 2.218 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.765 ' HB1' ' HG ' ' A' ' 644' ' ' LEU . . . -74.95 -3.93 35.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.822 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 74.72 -68.9 0.2 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.644 0.259 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.645 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -172.98 87.1 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.788 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.809 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.5 OUTLIER -103.7 -153.15 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.805 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -116.5 147.42 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.146 0.498 . . . . 0.0 111.876 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.423 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -133.48 147.01 51.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.234 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.802 HD13 HD13 ' A' ' 578' ' ' LEU . 9.3 pt -96.74 126.93 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.231 0.538 . . . . 0.0 111.617 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.923 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.7 m95 -110.68 131.65 54.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.202 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.601 ' CD2' HD13 ' A' ' 678' ' ' ILE . 6.9 t80 -92.48 117.64 30.15 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.428 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 36.6 m -104.2 137.16 42.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.991 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.454 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 31.6 t60 -115.86 131.3 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.086 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 3.1 p -131.86 15.75 4.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.415 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.51 153.42 27.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.212 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 89.8 m -82.13 -25.81 34.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.619 ' OD1' HD12 ' P' ' 606' ' ' LEU . 1.0 OUTLIER -81.81 3.41 26.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.021 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.38 134.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 112.181 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.441 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 73.8 m -106.22 166.27 10.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.406 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 679' ' ' LYS . 6.1 m-85 -127.74 120.31 27.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.821 0.343 . . . . 0.0 111.006 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.603 HD22 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -102.09 99.53 9.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.4 m120 58.68 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.2 OUTLIER -130.98 3.19 4.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.472 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 9.0 m120 -109.08 138.01 46.09 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -75.71 141.32 42.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 656' ' ' VAL . 49.7 mmm -119.82 87.83 2.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.711 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 42.1 pt -87.48 156.1 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.035 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -48.9 94.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.243 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.77 41.71 0.77 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.579 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.1 p -127.9 162.16 27.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.931 0.396 . . . . 0.0 111.381 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpm? -137.76 141.69 40.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.752 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.58 144.94 28.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.768 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.923 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.56 140.65 55.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.018 0.437 . . . . 0.0 111.192 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.815 HD13 HG21 ' A' ' 694' ' ' VAL . 2.0 mt -112.15 124.04 51.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.899 ' HB3' HD22 ' A' ' 707' ' ' LEU . 2.6 mt-30 -109.97 161.84 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.761 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.489 ' N ' HD12 ' A' ' 696' ' ' ILE . 35.9 t0 -59.19 100.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.368 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.22 30.27 3.95 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.55 114.19 23.08 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -96.09 108.6 21.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.093 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.603 HG12 HD22 ' A' ' 659' ' ' LEU . 5.4 mt -105.67 120.9 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.637 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 658' ' ' TYR . 4.1 mttp -82.28 115.48 21.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.358 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.613 HG23 ' HD2' ' A' ' 622' ' ' HIS . 1.6 mt -75.44 -39.05 40.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.569 HG22 ' CG1' ' A' ' 690' ' ' ILE . 5.4 tt -155.78 131.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.916 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.58 121.44 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.07 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.798 ' OD2' HD22 ' P' ' 606' ' ' LEU . 4.8 t0 -127.13 116.82 21.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 110.544 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -67.46 -46.5 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.919 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -66.05 -40.34 90.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.927 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -93.85 -8.46 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.621 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 62.04 16.52 8.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.63 0.253 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.9 t80 -77.06 105.46 8.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.3 p -119.58 124.62 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.1 0.476 . . . . 0.0 111.922 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.569 ' CG1' HG22 ' A' ' 681' ' ' ILE . 27.3 mm -128.1 154.97 39.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.397 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 174.05 134.18 1.81 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.448 ' CZ ' ' HG3' ' A' ' 582' ' ' PRO . 9.6 m-30 -112.89 147.28 37.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 110.331 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -101.37 116.52 32.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.198 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.862 HG13 HD11 ' A' ' 578' ' ' LEU . 2.1 t -80.86 129.7 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.464 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -133.47 109.43 9.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.926 0.394 . . . . 0.0 111.16 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.821 HD13 ' HB2' ' A' ' 705' ' ' GLU . 26.7 mt -78.19 105.69 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.238 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 697' ' ' ASN . . . . . 0.42 ' HB2' ' NH1' ' A' ' 576' ' ' ARG . 20.2 m120 -93.25 -45.93 7.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.05 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.492 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 2.8 t70 -110.78 139.84 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -115.71 100.56 8.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.291 0.567 . . . . 0.0 109.74 178.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 24.7 m -69.01 69.2 0.18 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.566 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.19 51.6 56.49 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.612 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.809 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -93.46 153.11 18.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.201 0.524 . . . . 0.0 111.911 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.491 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -56.91 -23.19 43.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.878 178.278 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 5.1 t-20 -164.73 -54.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.564 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.821 ' HB2' HD13 ' A' ' 696' ' ' ILE . 6.5 pt-20 160.99 -31.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.725 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 140.38 44.38 0.07 OUTLIER Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.591 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.899 HD22 ' HB3' ' A' ' 673' ' ' GLN . 0.6 OUTLIER -83.22 7.52 15.99 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.423 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 109.87 -121.93 6.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.946 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 10.8 ptp -178.32 121.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.845 0.355 . . . . 0.0 110.503 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.784 HD22 ' HB2' ' A' ' 711' ' ' GLN . 0.0 OUTLIER -39.92 162.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.508 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 711' ' ' GLN . . . . . 0.784 ' HB2' HD22 ' A' ' 710' ' ' LEU . 18.4 tt0 75.24 -62.85 0.44 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.178 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.41 103.45 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.283 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -82.58 100.55 10.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.275 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.8 mmm-85 38.91 88.27 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.24 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.53 141.8 43.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.147 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.5 p -95.95 118.65 42.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.853 0.359 . . . . 0.0 111.356 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.08 172.46 8.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 157.37 16.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -87.32 155.19 20.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.81 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -126.17 -175.25 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.87 -30.74 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.087 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.49 -52.03 66.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -66.14 -46.0 79.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.795 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.68 -33.68 64.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.693 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.2 -36.94 80.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 22.8 mt -56.91 -44.41 82.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 730' ' ' LEU . 8.3 p -80.45 -22.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -37.47 78.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -79.15 -18.55 52.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 730' ' ' LEU . 8.7 tt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.118 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' P' P ' 600' ' ' VAL . . . . . 0.425 HG23 ' O ' ' P' ' 600' ' ' VAL . 5.3 m -141.36 99.89 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.019 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -110.29 40.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.91 123.24 18.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.28 150.47 30.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.36 90.35 3.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.798 HD22 ' OD2' ' A' ' 683' ' ' ASP . 8.3 mt -59.64 148.01 76.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.836 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.519 2.146 . . . . 0.0 112.277 180.0 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -78.85 -22.24 46.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.736 0.303 . . . . 0.0 111.083 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 171.87 60.78 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.021 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.425 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 5.4 tmm_? -110.18 107.49 17.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.668 ' HE1' HD13 ' A' ' 647' ' ' ILE . 6.3 t80 -95.33 -54.0 3.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.864 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.931 HD13 HD13 ' A' ' 647' ' ' ILE . 10.8 tp -108.79 143.31 38.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.989 0.423 . . . . 0.0 111.773 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.47 HG22 ' CG ' ' A' ' 581' ' ' LYS . 25.3 m -121.94 115.12 22.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.608 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.7 OUTLIER -105.21 109.13 21.0 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.485 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 18.1 mtmt -115.17 99.41 52.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.623 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 33.2 Cg_exo -46.27 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.711 1.607 . . . . 0.0 109.126 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.727 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -75.1 157.61 85.06 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.14 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.84 -25.59 12.19 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.438 2.759 . . . . 0.0 112.644 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.5 t70 -62.23 -28.82 69.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.504 ' HB2' HD13 ' A' ' 690' ' ' ILE . 0.8 OUTLIER -96.05 153.84 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.753 178.321 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.684 HD13 ' CE1' ' A' ' 688' ' ' PHE . 13.9 pt -54.99 -11.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 111.34 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 42.0 mt -107.16 128.73 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.09 54.88 0.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.797 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.623 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 51.3 mm-40 -124.62 169.84 11.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.033 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.36 124.07 31.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.661 0.267 . . . . 0.0 111.659 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.2 mm? -112.87 148.96 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.425 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.68 122.44 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.007 HD11 HD12 ' A' ' 625' ' ' ILE . 33.0 mt -78.9 108.68 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -65.15 111.52 2.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 1.8 pt20 -43.47 -34.26 1.29 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.41 0.624 . . . . 0.0 109.972 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -62.9 -24.45 66.74 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.329 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.489 HG11 ' ND2' ' A' ' 610' ' ' ASN . 97.7 t -101.29 119.26 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.659 0.73 . . . . 0.0 111.414 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.1 t30 -138.91 122.91 11.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.704 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 48.0 Cg_endo -90.17 160.32 33.48 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 124.56 -1.017 . . . . 0.0 112.0 0.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.2 t80 -91.97 115.9 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.821 ' CG ' HD12 ' A' ' 730' ' ' LEU . 30.7 m-85 -92.38 138.0 31.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.819 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -125.03 145.76 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.742 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 160.63 -171.43 36.78 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.374 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.442 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -70.72 -46.91 62.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 111.372 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.16 130.56 46.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.381 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -18.32 29.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.783 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.05 -30.9 66.53 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.205 0.526 . . . . 0.0 110.301 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 94.7 m -70.54 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.1 m120 -44.52 -33.21 1.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.819 ' SG ' HG23 ' A' ' 603' ' ' ILE . 35.1 t -106.93 138.67 42.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.815 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.97 104.59 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.466 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.6 mm -139.47 109.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.409 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -104.07 106.09 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.436 0.636 . . . . 0.0 111.994 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.55 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 3.1 t70 -129.68 108.85 10.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.894 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -40.2 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.762 ' HD3' HD21 ' P' ' 606' ' ' LEU . 0.0 OUTLIER -70.65 -42.69 70.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 680' ' ' ILE . 1.5 pp -89.44 158.21 17.82 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.679 0.276 . . . . 0.0 111.013 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.82 165.82 20.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.0 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.879 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -54.22 -25.21 21.75 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.075 0.464 . . . . 0.0 110.435 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.879 HG23 ' HG2' ' A' ' 620' ' ' ARG . 57.6 t -130.75 57.44 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.997 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.855 ' CD2' HG23 ' A' ' 680' ' ' ILE . 37.0 t60 -48.4 -45.69 36.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.6 p -168.37 161.35 11.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 111.543 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.73 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.9 p90 -143.44 147.53 34.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.509 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.007 HD12 HD11 ' A' ' 594' ' ' ILE . 62.1 mt -102.02 134.52 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -125.87 134.36 51.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.737 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.529 ' HE2' HG23 ' A' ' 647' ' ' ILE . 1.9 ttmm -97.59 136.73 37.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.122 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.469 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.15 159.35 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.764 -178.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.82 113.62 14.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.409 0.623 . . . . 0.0 110.502 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 -65.88 130.88 44.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.33 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 630' ' ' HIS . . . 170.97 123.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.02 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.25 155.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -55.58 104.48 0.31 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.646 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 13.6 tptt 60.02 159.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 75.3 p -109.59 58.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.87 113.72 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 69.4 -66.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.07 143.76 35.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.4 108.38 54.62 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.49 -153.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.636 2.224 . . . . 0.0 111.798 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.697 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -97.33 34.0 1.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.388 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 66.89 -72.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 176.29 76.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.843 HD13 ' HA ' ' A' ' 703' ' ' PHE . 1.1 mt -118.16 -147.64 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 48.1 m-20 -122.23 148.25 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.792 ' OD2' HD11 ' A' ' 671' ' ' LEU . 3.3 t0 -133.62 151.21 51.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.701 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.931 HD13 HD13 ' A' ' 578' ' ' LEU . 8.9 pt -100.25 122.45 52.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 111.487 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.55 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 77.6 m95 -108.05 134.01 51.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.308 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.636 ' CE2' HD12 ' A' ' 678' ' ' ILE . 7.9 t80 -95.68 117.53 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 26.1 m -101.0 133.49 45.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 54.5 t60 -112.87 131.64 55.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.4 p -129.67 0.95 4.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.449 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 148.36 34.8 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.712 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.492 HG22 HG21 ' P' ' 603' ' ' TPO . 5.8 t -75.91 -34.49 59.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.114 0.483 . . . . 0.0 111.311 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.586 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.1 m120 -70.16 2.0 4.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.379 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.17 133.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.435 0.636 . . . . 0.0 112.32 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 98.2 p -103.86 165.69 10.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.482 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.68 120.24 30.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.225 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.788 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -105.24 109.38 21.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.903 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.591 ' N ' HD12 ' A' ' 659' ' ' LEU . 1.3 m-80 55.43 -82.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.975 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 659' ' ' LEU . 18.5 m-20 -137.49 5.87 2.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.814 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.504 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 3.2 t-20 -108.81 135.57 49.81 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.943 0.402 . . . . 0.0 111.253 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 17.0 ttp-105 -73.65 141.43 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.504 ' O ' HG23 ' A' ' 656' ' ' VAL . 39.5 mmm -117.07 98.17 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.053 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.434 HG12 HG21 ' A' ' 668' ' ' THR . 41.1 pt -88.19 149.13 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.114 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.59 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.433 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.26 42.31 1.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.434 HG21 HG12 ' A' ' 665' ' ' ILE . 1.1 p -127.14 162.28 26.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.45 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.451 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -134.07 135.93 43.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.467 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.648 ' CZ ' ' HG2' ' A' ' 714' ' ' ARG . 0.3 OUTLIER -140.03 144.19 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.46 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.792 HD11 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.78 141.05 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.127 0.489 . . . . 0.0 111.345 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.779 HD13 HG21 ' A' ' 694' ' ' VAL . 2.9 mt -112.27 98.16 7.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.427 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.457 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 30.6 mt-30 -82.72 131.01 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.946 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 706' ' ' GLY . 5.7 t70 -36.01 107.32 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.099 0.476 . . . . 0.0 110.96 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.92 33.94 3.62 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.537 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -94.04 118.37 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.003 -179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -96.2 108.87 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.757 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.788 HG22 HD13 ' A' ' 659' ' ' LEU . 25.8 pt -105.61 136.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.99 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.8 OUTLIER -99.05 115.96 30.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.752 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.855 HG23 ' CD2' ' A' ' 622' ' ' HIS . 4.3 mt -84.24 -35.67 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.478 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.744 HD11 HD11 ' P' ' 606' ' ' LEU . 4.2 tp -154.33 129.05 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.328 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -137.96 123.44 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.302 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.471 ' CG ' HD22 ' P' ' 606' ' ' LEU . 11.1 t0 -127.51 116.08 19.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.925 0.393 . . . . 0.0 110.607 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -46.57 70.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.956 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.78 -40.83 97.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.135 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.06 4.01 49.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.9 mttm 54.24 22.07 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.776 0.322 . . . . 0.0 110.93 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.684 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.5 t80 -76.4 104.36 6.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.7 p -117.45 124.22 72.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.054 0.454 . . . . 0.0 111.867 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.626 HD11 HG12 ' A' ' 587' ' ' ILE . 4.9 mm -128.06 154.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.331 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . 175.68 134.11 1.87 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.52 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.486 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.9 m-30 -113.27 142.89 45.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.727 ' HB2' HD22 ' A' ' 583' ' ' LEU . 7.2 tttp -100.87 116.34 32.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 109.88 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.779 HG21 HD13 ' A' ' 672' ' ' LEU . 2.7 t -85.12 123.24 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 110.02 9.51 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.082 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 705' ' ' GLU . 66.3 mt -65.3 105.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.24 -48.08 12.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.934 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.445 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 38.7 t0 -111.69 139.38 47.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.173 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p -115.94 100.09 7.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.3 t -75.46 58.08 0.98 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.307 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.452 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 48.97 48.08 31.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.984 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.643 HD21 ' HA ' ' A' ' 705' ' ' GLU . 1.8 pt? -91.45 -175.91 4.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.771 0.32 . . . . 0.0 111.117 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.843 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -55.92 -149.91 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.981 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.568 ' N ' ' CG ' ' A' ' 703' ' ' PHE . 0.7 OUTLIER -31.52 -34.42 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.125 0.57 . . . . 0.0 111.709 178.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.665 ' CD ' HD22 ' A' ' 707' ' ' LEU . 4.0 pt-20 105.04 6.14 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.964 0.905 . . . . 0.0 111.32 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.673 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 85.32 18.13 61.2 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.63 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.665 HD22 ' CD ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -81.65 7.65 11.81 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.314 -0.521 . . . . 0.0 111.859 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 712' ' ' GLU . . . 62.6 11.0 33.25 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.267 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.694 ' C ' HD23 ' A' ' 710' ' ' LEU . 2.9 mtm 46.8 86.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.924 0.362 . . . . 0.0 111.281 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.694 HD23 ' C ' ' A' ' 709' ' ' MET . 1.0 OUTLIER 45.42 48.79 10.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.69 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.16 75.5 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 708' ' ' GLY . 20.7 tt0 -114.49 140.52 48.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.062 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -82.49 135.88 35.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.471 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.648 ' HG2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -100.31 -157.54 0.61 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.161 0.505 . . . . 0.0 109.936 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.511 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 0.6 OUTLIER -148.62 142.2 18.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.614 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 12.7 p -88.85 127.67 41.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.35 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.19 172.33 7.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -99.67 156.97 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.958 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.26 148.49 22.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 22.0 p -126.14 -173.44 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.218 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.47 -29.03 33.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.54 -51.61 67.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.36 -44.72 90.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.617 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -57.59 -32.72 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.74 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.15 -37.23 83.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 40.7 mt -59.48 -44.15 93.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.63 -24.93 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -32.14 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -87.76 -12.07 46.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.394 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.821 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.3 tt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.799 0.333 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.05 49.68 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 60.17 70.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -166.61 130.46 2.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.807 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.492 HG21 HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -84.91 -26.9 26.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 64.33 156.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.762 HD21 ' HD3' ' A' ' 617' ' ' ARG . 2.2 mt -104.72 150.6 38.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.641 2.227 . . . . 0.0 112.296 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.608 -0.197 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.99 -20.74 63.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.984 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -176.87 44.57 0.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.081 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.9 tmm_? -108.1 112.12 24.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.594 0.235 . . . . 0.0 110.919 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.608 ' CZ ' HD22 ' A' ' 702' ' ' LEU . 3.1 t80 -99.83 -45.18 5.81 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.696 HD22 ' CD1' ' A' ' 647' ' ' ILE . 10.3 tp -118.59 142.84 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 30.3 m -120.49 115.84 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.837 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 1.024 HD22 HG22 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -105.5 109.32 21.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 19.3 pttt -116.87 98.77 52.38 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 23.4 Cg_exo -46.03 98.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.923 1.748 . . . . 0.0 109.823 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.3 OUTLIER -74.71 157.86 85.45 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.49 -29.74 19.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.508 2.806 . . . . 0.0 112.876 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.71 ' HB2' HD12 ' A' ' 583' ' ' LEU . 23.2 m-20 -62.33 -24.9 67.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 5.6 t -95.51 153.27 17.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.644 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 10.6 tt -56.34 -14.48 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 613' ' ' ILE . 21.0 mt -111.51 128.14 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 111.626 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.64 55.98 0.68 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.625 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.7 mt-10 -124.79 170.28 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.908 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.677 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -130.35 119.7 23.17 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.74 0.305 . . . . 0.0 111.621 178.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.677 HD13 ' C ' ' A' ' 591' ' ' SER . 0.2 OUTLIER -113.03 146.33 39.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.5 OUTLIER -123.97 121.47 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.027 HD11 HD12 ' A' ' 625' ' ' ILE . 70.4 mt -75.86 109.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.148 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.1 mm100 -66.12 114.65 5.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.91 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 1.8 pt20 -42.49 -34.73 0.89 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.353 0.597 . . . . 0.0 110.111 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.496 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.0 -20.24 68.61 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.702 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.625 HG11 ' OD1' ' A' ' 610' ' ' ASN . 99.3 t -101.07 118.79 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 117.912 0.856 . . . . 0.0 111.67 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 8.8 t30 -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.908 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.591 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -90.39 160.45 32.47 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.621 -0.991 . . . . 0.0 111.632 -0.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.622 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.5 t80 -91.26 114.88 27.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.548 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 46.4 m-85 -91.84 138.16 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.098 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.79 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -126.76 145.03 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.787 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.31 -165.48 34.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.46 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.427 ' HG2' ' CD2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -71.33 -54.59 10.29 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.34 130.81 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.483 -178.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -19.33 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.63 -30.35 42.39 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.119 0.485 . . . . 0.0 110.056 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 95.8 m -73.41 131.21 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.297 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.625 ' OD1' HG11 ' A' ' 598' ' ' VAL . 0.7 OUTLIER -46.51 -28.65 1.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.79 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.2 t -111.44 141.58 44.81 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.19 107.53 16.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.611 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.6 mm -138.37 110.05 5.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.313 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.58 106.09 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.739 ' CB ' HD22 ' A' ' 618' ' ' LEU . 31.0 t0 -130.25 108.24 9.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.898 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -40.25 -32.74 0.2 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.821 0.343 . . . . 0.0 111.601 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.705 ' HB3' HD11 ' A' ' 681' ' ' ILE . 2.5 mtm-85 -78.19 -38.03 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.03 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.739 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -88.91 120.03 29.96 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.13 167.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.529 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.3 mpt_? -56.25 -35.92 67.95 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.12 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.611 HG11 HG23 ' A' ' 727' ' ' VAL . 17.3 t -124.01 57.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.736 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.775 ' CD2' HG23 ' A' ' 680' ' ' ILE . 31.9 t60 -50.28 -48.45 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.931 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.3 p -159.33 156.0 27.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.029 0.442 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.773 ' HA ' HD12 ' A' ' 603' ' ' ILE . 48.5 p90 -143.66 149.31 37.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.461 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.027 HD12 HD11 ' A' ' 594' ' ' ILE . 79.7 mt -102.61 130.34 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.927 0.394 . . . . 0.0 109.981 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.591 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.8 t80 -122.65 133.55 54.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 647' ' ' ILE . 35.4 ttmt -98.28 136.98 37.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.26 158.74 42.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.288 -179.093 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.637 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -76.44 112.74 13.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.329 0.585 . . . . 0.0 110.299 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.447 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.2 t-80 -80.73 125.32 29.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.823 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.637 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -130.45 160.77 33.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 1.9 m -131.81 179.27 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -83.82 -106.99 0.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.374 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.4 142.94 39.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 94.1 p -120.69 150.42 40.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 14.0 tpt -132.78 118.85 19.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.71 -65.98 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -75.94 139.55 41.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.85 101.11 14.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 -165.11 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.498 2.132 . . . . 0.0 112.267 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.549 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -50.04 -31.38 12.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.468 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 62.55 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.937 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -159.07 61.72 0.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.577 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.896 HD13 ' HA ' ' A' ' 703' ' ' PHE . 2.4 mt -104.15 -152.92 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.69 ' HB2' HD12 ' A' ' 702' ' ' LEU . 2.1 m-20 -118.78 148.09 43.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.309 0.576 . . . . 0.0 112.378 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.677 ' OD2' HD11 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -132.3 138.51 47.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.778 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.696 ' CD1' HD22 ' A' ' 578' ' ' LEU . 5.0 pt -96.03 119.06 43.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.572 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 85.8 m95 -103.7 132.63 49.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.972 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.561 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.9 t80 -90.73 116.23 28.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 624' ' ' PHE . 1.3 m -98.13 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.111 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 60.8 t60 -124.58 129.28 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 16.9 p -128.6 4.88 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.325 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.95 149.01 33.92 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.692 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.2 t -75.81 -28.27 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.523 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.634 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.7 OUTLIER -73.93 0.01 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.272 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 56.77 133.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.345 0.593 . . . . 0.0 111.896 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 14.8 t -105.11 165.58 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.004 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.408 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 10.4 m-85 -134.6 120.19 19.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.711 ' HA ' HG23 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -99.35 100.49 11.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.9 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 31.0 t30 -132.17 -0.7 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.62 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.405 ' OD1' ' CZ ' ' A' ' 670' ' ' PHE . 21.3 m120 -104.04 122.39 45.16 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.991 0.424 . . . . 0.0 111.245 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -66.63 141.77 57.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.968 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 37.6 mmm -114.8 102.49 10.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.16 147.33 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.802 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.91 95.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.435 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.2 39.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.841 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 718' ' ' LYS . 1.3 p -138.16 161.99 35.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.405 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 19.3 pttm -135.62 135.66 40.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.562 ' HB3' HD23 ' A' ' 659' ' ' LEU . 18.8 t80 -127.15 143.55 51.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.51 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.677 HD11 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.95 136.53 50.63 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.03 0.443 . . . . 0.0 111.597 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 1.011 HD13 HG21 ' A' ' 694' ' ' VAL . 2.7 mt -98.57 143.52 28.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.307 0.575 . . . . 0.0 111.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.691 ' HB3' ' HA ' ' A' ' 707' ' ' LEU . 26.0 mt-30 -119.09 141.85 48.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.529 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 696' ' ' ILE . 26.8 t70 -48.07 96.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.22 0.533 . . . . 0.0 110.213 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 107.49 32.6 3.36 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.415 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -86.63 114.35 23.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 110.98 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -96.12 108.73 21.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.711 HG23 ' HA ' ' A' ' 659' ' ' LEU . 1.4 mt -105.2 137.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 111.745 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.24 115.87 28.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.623 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.775 HG23 ' CD2' ' A' ' 622' ' ' HIS . 8.1 mt -82.97 -35.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.236 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 617' ' ' ARG . 1.2 tt -154.9 132.67 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 111.586 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -136.33 124.22 22.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.227 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.77 117.0 27.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.314 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -67.16 -47.08 72.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.803 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -83.44 -40.33 19.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.533 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.75 -15.6 59.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.383 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.83 9.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 0.0 110.952 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 1.8 t80 -85.37 105.1 15.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -122.87 121.75 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.287 0.565 . . . . 0.0 112.144 -178.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.667 ' CG1' HG22 ' A' ' 681' ' ' ILE . 2.5 mm -109.77 144.41 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.38 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -169.58 127.35 1.48 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.753 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 9.3 m-30 -113.95 146.13 40.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.784 0.326 . . . . 0.0 110.42 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.736 ' HB2' HD22 ' A' ' 583' ' ' LEU . 26.7 tttt -101.36 116.59 33.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 1.024 HG22 HD22 ' A' ' 580' ' ' LEU . 2.5 t -82.5 124.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.436 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.3 tp10 -133.69 109.23 9.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.898 0.38 . . . . 0.0 111.05 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.683 HD12 ' HB2' ' A' ' 674' ' ' ASP . 24.0 mt -72.17 104.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.268 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -88.32 -49.97 6.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 5.5 t70 -112.18 139.52 47.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.032 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.5 OUTLIER -115.94 99.66 7.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.4 t -69.67 72.39 0.36 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.457 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 56.78 36.8 73.98 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.381 -0.914 . . . . 0.0 110.901 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.695 HD23 ' HA ' ' A' ' 705' ' ' GLU . 0.6 OUTLIER -85.37 156.59 20.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.783 0.325 . . . . 0.0 111.532 -178.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.896 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -61.2 -142.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 7.1 t-20 -35.81 -36.63 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.549 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.695 ' HA ' HD23 ' A' ' 702' ' ' LEU . 6.0 pt-20 125.42 -22.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.736 1.215 . . . . 0.0 109.278 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 129.11 -8.21 6.34 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.866 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.823 HD13 ' O ' ' A' ' 707' ' ' LEU . 1.7 tm? -81.63 8.45 9.78 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -137.44 173.66 22.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.438 ' CE ' HD23 ' A' ' 710' ' ' LEU . 0.0 OUTLIER -143.93 132.97 22.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.941 0.401 . . . . 0.0 110.979 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.438 HD23 ' CE ' ' A' ' 709' ' ' MET . 0.5 OUTLIER -60.23 -154.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.717 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -36.4 -40.86 0.26 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.814 0.34 . . . . 0.0 111.66 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.69 137.27 42.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.405 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -105.17 100.12 9.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.137 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.442 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 8.1 mmm-85 35.26 77.96 0.04 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.079 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.33 142.65 40.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.295 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 8.3 p -82.7 129.74 36.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.798 0.333 . . . . 0.0 111.28 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.557 HD12 ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -98.38 163.21 12.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 718' ' ' LYS . . . . . 0.532 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.1 OUTLIER -102.62 145.61 29.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.44 151.89 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.2 p -126.0 -173.95 2.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.97 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.99 -28.97 55.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -49.21 64.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -63.78 -50.95 67.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -57.41 -32.83 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.85 -37.25 86.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 600' ' ' PRO . 14.4 mt -62.79 -44.5 96.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.961 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.611 HG23 HG11 ' A' ' 621' ' ' VAL . 8.4 p -76.17 -28.57 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.08 -33.84 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -98.0 24.57 6.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.448 HD12 ' CG ' ' A' ' 602' ' ' PHE . 4.2 tt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.774 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.818 0.342 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 24.5 t -132.78 96.9 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.071 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.03 171.16 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.83 138.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.608 ' H ' ' P ' ' P' ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.74 98.71 11.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.92 154.44 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.842 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.586 HD21 ' HG2' ' A' ' 617' ' ' ARG . 6.2 mt -137.77 97.64 10.04 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.46 2.107 . . . . 0.0 112.353 -179.967 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -76.85 -7.6 55.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.565 0.222 . . . . 0.0 111.407 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 131.25 -0.19 5.16 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.102 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 19.9 ttp-105 -92.35 114.69 27.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.819 0.309 . . . . 0.0 110.582 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -99.44 -58.98 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.447 . . . . 0.0 110.504 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.886 HD12 HD13 ' A' ' 647' ' ' ILE . 9.4 tt -107.84 141.98 38.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.633 HG22 ' HG2' ' A' ' 581' ' ' LYS . 16.0 m -117.58 115.24 24.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.587 ' CD1' HD11 ' A' ' 594' ' ' ILE . 0.4 OUTLIER -104.4 108.64 20.15 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.633 ' HG2' HG22 ' A' ' 579' ' ' THR . 11.6 mtmt -114.86 99.13 51.58 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -47.26 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.761 1.641 . . . . 0.0 109.394 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.481 HD21 ' HG3' ' A' ' 677' ' ' GLU . 0.2 OUTLIER -74.68 157.91 85.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.11 -25.27 8.97 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.688 2.925 . . . . 0.0 112.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.65 -28.16 69.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.447 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 2.0 t -95.94 153.8 17.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.631 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.672 HD13 ' CE1' ' A' ' 688' ' ' PHE . 16.0 pt -57.14 -13.68 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 110.973 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 613' ' ' ILE . 23.4 mt -105.48 120.26 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.685 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.41 56.79 0.62 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.063 0.459 . . . . 0.0 110.343 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.652 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.0 mt-10 -124.72 170.36 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.215 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.576 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -130.19 120.54 24.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.359 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 591' ' ' SER . 0.4 OUTLIER -113.15 148.43 35.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.81 125.51 44.12 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.817 HD12 HD22 ' A' ' 578' ' ' LEU . 94.0 mt -83.73 109.05 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.2 mp0 -67.05 124.38 22.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.696 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.52 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 1.6 pt20 -47.66 -29.7 3.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.244 0.545 . . . . 0.0 109.817 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.93 -24.04 77.46 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.86 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.24 117.86 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 118.018 0.909 . . . . 0.0 111.66 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.5 t30 -140.37 121.7 9.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.596 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -89.84 160.49 35.22 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.296 -0.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.587 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.4 t80 -91.69 115.62 28.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.496 ' CG ' HD12 ' A' ' 730' ' ' LEU . 23.6 m-85 -92.35 137.91 31.97 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.952 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.777 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.1 mp -126.45 146.03 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.436 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.19 -166.53 37.09 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.887 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.522 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.4 OUTLIER -71.49 -54.15 11.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 111.611 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.48 131.32 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.391 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -56.57 -19.07 14.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.982 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.08 -31.66 52.45 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.85 132.88 46.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.66 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 28.8 m120 -46.03 -31.05 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.236 0.541 . . . . 0.0 110.378 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.777 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.5 t -110.16 142.06 42.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.318 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.46 109.04 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.554 HG23 ' CD1' ' A' ' 588' ' ' ILE . 19.7 mm -138.05 109.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.084 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.522 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 1.0 OUTLIER -95.03 104.32 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.919 -178.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.666 ' HB2' HD21 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.67 113.96 14.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.19 177.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -52.5 -21.12 3.43 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.689 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.68 ' HD3' HD21 ' P' ' 606' ' ' LEU . 0.2 OUTLIER -74.33 -41.65 60.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -88.53 158.9 18.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 112.268 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 67.6 p -80.77 177.95 8.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.2 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.452 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -47.36 -45.76 25.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.121 0.486 . . . . 0.0 110.197 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 621' ' ' VAL . 7.4 p -125.68 71.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.568 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 9.3 t60 -45.7 -47.93 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.537 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 2.1 p -161.2 160.62 30.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.614 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 603' ' ' ILE . 1.7 p90 -143.68 148.7 36.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.666 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.469 HD13 HD11 ' A' ' 603' ' ' ILE . 3.5 mp -101.96 130.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.086 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -121.3 132.47 54.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.519 ' HE3' HG23 ' A' ' 647' ' ' ILE . 5.3 ttmt -97.97 137.16 37.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.439 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.492 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.59 159.25 41.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.54 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.7 OUTLIER -76.25 112.72 13.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.4 t-80 -80.68 127.01 31.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.577 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -150.91 150.31 30.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.21 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.626 HG21 ' HG3' ' A' ' 640' ' ' PRO . 8.5 m -99.38 171.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -63.35 -68.61 1.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.541 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -148.83 122.51 9.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 110.83 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 84.6 p -79.69 61.29 3.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -119.94 33.97 5.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.75 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -176.74 -43.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.594 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 638' ' ' GLU . . . . . 0.41 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 42.1 mm-40 -110.99 144.56 39.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.636 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 82.5 p -107.92 95.73 15.66 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.626 ' HG3' HG21 ' A' ' 632' ' ' VAL . 69.0 Cg_endo -88.84 -161.53 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.93 2.42 . . . . 0.0 112.15 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -96.48 34.66 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.242 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.64 -174.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.021 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -89.22 96.24 2.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 630' ' ' HIS . 25.0 mt -119.89 -149.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.58 ' O ' HD12 ' A' ' 702' ' ' LEU . 3.3 m-20 -116.95 147.61 42.1 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.436 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -130.48 160.17 34.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.518 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.886 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -110.36 127.58 67.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.568 0.699 . . . . 0.0 112.776 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.879 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 81.9 m95 -110.93 125.89 54.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.411 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 11.7 t80 -90.01 116.1 27.8 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 20.1 m -101.65 142.57 32.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.432 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 60.6 t60 -125.88 130.23 50.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 25.1 p -126.69 5.18 6.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.168 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.76 153.17 36.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.582 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.8 t -73.64 -34.8 65.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.159 0.504 . . . . 0.0 111.486 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.609 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.3 m120 -68.26 -4.89 15.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.434 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.83 123.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 111.67 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.413 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 57.9 p -88.68 166.26 14.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.354 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -131.22 120.39 23.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.868 0.366 . . . . 0.0 111.409 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.905 HD22 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -94.99 99.84 11.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.383 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 61.2 -81.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -134.45 3.4 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.682 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -104.95 123.6 48.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 111.171 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.35 141.38 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.92 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 21.7 mmm -118.14 111.93 19.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.9 pt -91.03 150.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.102 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 652' ' ' THR . 2.9 tt0 -51.87 100.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.471 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.87 37.26 1.16 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.002 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 718' ' ' LYS . 1.8 p -139.35 159.19 42.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.0 pttm -123.96 158.19 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.58 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 716' ' ' VAL . 10.6 t80 -144.27 146.46 32.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.879 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.53 128.17 35.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.696 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.816 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -105.76 121.85 44.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.43 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 14.5 mt-30 -109.33 162.83 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.39 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.574 ' HB3' HD12 ' A' ' 696' ' ' ILE . 11.7 p30 -58.62 110.47 1.0 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.42 . . . . 0.0 110.686 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 95.51 36.92 5.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.214 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -91.63 115.35 27.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.323 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 583' ' ' LEU . 0.7 OUTLIER -96.28 110.35 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.053 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.905 HG22 HD22 ' A' ' 659' ' ' LEU . 26.9 pt -105.62 132.58 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.98 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -91.03 116.62 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.004 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.418 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -81.22 -34.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.45 -179.245 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.651 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.1 tp -154.43 131.34 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 111.718 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.402 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 10.2 t90 -136.47 126.32 25.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.516 ' OD2' HD13 ' P' ' 606' ' ' LEU . 1.9 m-20 -126.22 116.77 21.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -67.4 -46.77 72.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.989 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -77.74 -40.41 41.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.769 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -7.79 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.602 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp 59.66 17.95 6.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.672 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.3 t80 -76.55 104.82 7.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 689' ' ' VAL . 2.1 p -120.68 121.98 66.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 112.134 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.651 ' HB ' HG22 ' A' ' 681' ' ' ILE . 4.2 mt -128.72 155.26 40.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.436 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.447 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.98 135.9 2.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.231 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.478 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 5.0 m-30 -113.08 149.73 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.16 117.47 35.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.008 0.433 . . . . 0.0 110.704 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.774 HG22 HD21 ' A' ' 578' ' ' LEU . 2.6 t -80.48 114.75 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.1 108.96 12.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 0.0 110.123 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.851 HG21 ' HB2' ' A' ' 705' ' ' GLU . 8.9 mt -80.45 111.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.334 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -96.15 -45.85 6.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 4.1 t70 -111.13 140.34 45.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.014 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.2 OUTLIER -115.0 101.35 8.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 700' ' ' THR . 9.9 t -66.62 65.3 0.05 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.881 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 56.41 40.07 85.03 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.574 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -112.25 159.08 18.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.728 0.299 . . . . 0.0 110.842 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.745 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -56.29 119.64 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.47 ' ND2' ' HG2' ' A' ' 705' ' ' GLU . 3.7 t-20 49.7 -74.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.418 0.627 . . . . 0.0 110.552 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.851 ' HB2' HG21 ' A' ' 696' ' ' ILE . 19.4 pt-20 161.82 -36.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.265 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 156.13 84.97 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.004 -1.453 . . . . 0.0 111.317 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -9.56 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.226 -0.573 . . . . 0.0 111.572 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 117.85 -35.73 3.95 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.239 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 703' ' ' PHE . 0.0 OUTLIER 60.31 109.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.691 0.282 . . . . 0.0 110.988 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.57 110.99 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.063 0.458 . . . . 0.0 111.176 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 178.1 -57.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.752 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -114.25 130.04 56.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.856 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.527 ' O ' HG13 ' A' ' 715' ' ' VAL . 2.4 mm-40 -81.98 99.84 9.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.716 0.293 . . . . 0.0 111.027 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 713' ' ' GLN . 4.4 mmm-85 17.94 84.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.742 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 713' ' ' GLN . 3.4 m -124.57 142.48 41.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.632 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 716' ' ' VAL . 10.0 p -86.49 119.82 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.048 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 169.59 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.985 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 718' ' ' LYS . . . . . 0.691 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.5 OUTLIER -102.9 157.94 16.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.855 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -88.6 158.3 18.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.985 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -178.83 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.12 54.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.01 -52.07 52.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -43.34 96.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.783 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -57.32 -33.82 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.22 -36.78 80.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.483 HD13 ' HG3' ' A' ' 600' ' ' PRO . 23.2 mt -58.18 -44.32 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.75 -27.82 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.813 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -101.58 27.56 6.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.496 HD12 ' CG ' ' A' ' 602' ' ' PHE . 3.0 tt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.796 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.913 0.387 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' P' P ' 600' ' ' VAL . . . . . 0.439 HG22 ' N ' ' P' ' 601' ' ' GLU . 10.0 p -58.76 155.76 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.071 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 601' ' ' GLU . . . . . 0.439 ' N ' HG22 ' P' ' 600' ' ' VAL . 49.0 tt0 -129.28 88.2 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 5.6 tt -149.58 136.12 19.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.401 HG22 ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 88.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.79 145.47 52.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.68 HD21 ' HD3' ' A' ' 617' ' ' ARG . 8.7 mt -116.36 87.38 20.06 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.85 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.602 2.201 . . . . 0.0 112.353 -179.983 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.5 10.16 26.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.655 0.264 . . . . 0.0 111.421 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -166.87 40.54 0.25 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.401 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.441 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 51.5 ttp85 -99.55 112.18 24.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.686 0.279 . . . . 0.0 110.803 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.935 ' CE2' HD13 ' A' ' 702' ' ' LEU . 0.5 OUTLIER -101.1 -50.94 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.909 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.011 HD11 HG13 ' A' ' 694' ' ' VAL . 44.6 tp -114.55 142.3 46.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.102 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 32.9 m -118.97 121.8 40.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.531 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.914 ' CD2' HG23 ' A' ' 694' ' ' VAL . 6.6 mt -109.03 108.57 19.33 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.23 100.24 50.22 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -176.314 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.1 Cg_exo -47.84 105.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.694 1.596 . . . . 0.0 109.271 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.535 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.17 156.73 87.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.464 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 77.2 Cg_exo -50.4 -25.83 14.81 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.741 2.961 . . . . 0.0 113.357 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.86 -20.62 65.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.056 0.455 . . . . 0.0 110.039 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.48 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 3.7 t -97.24 154.34 17.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.969 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.767 HD13 ' CE1' ' A' ' 688' ' ' PHE . 4.1 pt -55.11 -19.68 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.115 0.483 . . . . 0.0 109.84 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.13 119.01 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.87 63.7 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.124 0.487 . . . . 0.0 110.701 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.57 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.8 mt-10 -124.97 170.81 10.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.48 121.6 27.58 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.681 0.277 . . . . 0.0 111.427 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.3 mm? -113.21 150.8 31.81 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.441 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.3 mt-10 -125.18 131.26 53.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.826 HD12 HD23 ' A' ' 578' ' ' LEU . 73.7 mt -90.13 108.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.8 mt-30 -69.14 124.64 24.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 1.5 pt20 -46.9 -32.37 3.75 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.506 0.669 . . . . 0.0 109.505 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.81 -22.55 75.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.664 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.88 HG11 ' OD1' ' A' ' 610' ' ' ASN . 81.9 t -98.36 117.94 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.929 0.864 . . . . 0.0 111.545 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 4.5 t30 -140.38 121.33 9.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.023 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.606 ' HD3' HD22 ' A' ' 726' ' ' LEU . 43.7 Cg_endo -90.96 159.72 29.3 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.475 -1.052 . . . . 0.0 111.415 -0.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.666 ' CG ' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -92.11 113.27 25.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.53 ' CG ' HD12 ' A' ' 730' ' ' LEU . 5.8 m-85 -91.9 138.28 31.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.083 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.814 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -123.7 145.49 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.481 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.55 -167.55 35.77 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.427 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.456 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -73.62 -52.22 14.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 128.99 39.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.387 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -54.46 -19.9 6.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.965 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -28.26 51.78 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.018 0.437 . . . . 0.0 110.382 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 81.1 m -75.26 131.33 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.589 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.88 ' OD1' HG11 ' A' ' 598' ' ' VAL . 1.5 m-80 -46.44 -29.68 1.84 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.066 0.46 . . . . 0.0 110.464 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.814 ' SG ' HG23 ' A' ' 603' ' ' ILE . 31.0 t -109.59 137.46 47.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.68 104.94 14.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.442 HG13 ' CE2' ' A' ' 692' ' ' PHE . 14.2 mm -139.32 109.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.322 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.66 106.05 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.436 0.636 . . . . 0.0 111.998 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.508 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.8 OUTLIER -129.99 108.69 10.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.733 177.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -39.44 -27.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.554 ' HB3' HD11 ' A' ' 681' ' ' ILE . 32.3 mmt180 -71.4 -42.09 68.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.508 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -88.47 158.63 18.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.261 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.7 t -83.9 171.28 13.19 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.619 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.473 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -49.72 -41.83 44.49 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.143 0.497 . . . . 0.0 110.369 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 727' ' ' VAL . 11.7 t -121.4 61.52 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.6 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.82 ' CD2' HG23 ' A' ' 680' ' ' ILE . 38.5 t60 -46.21 -45.22 16.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.59 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.4 p -167.34 159.29 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.597 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.633 ' HA ' HD12 ' A' ' 603' ' ' ILE . 51.7 p90 -143.48 146.52 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.817 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 580' ' ' LEU . 16.6 mt -102.1 130.22 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 109.919 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -121.7 135.56 54.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.692 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HE2' HD12 ' A' ' 702' ' ' LEU . 6.0 tttt -97.77 133.46 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.111 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.8 OUTLIER -136.07 159.79 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.95 -178.523 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 6.4 tpt85 -75.79 112.31 12.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.359 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.9 t60 -63.28 134.33 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.336 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -73.15 -163.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.777 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.3 p -163.29 160.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.053 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -145.25 -143.42 3.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 128.94 39.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 635' ' ' SER . . . . . 0.405 ' HB3' ' CD ' ' A' ' 640' ' ' PRO . 4.9 p -128.15 79.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.6 116.1 28.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.649 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 70.97 -63.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.898 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.34 144.33 32.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.78 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.86 105.39 37.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.05 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.405 ' CD ' ' HB3' ' A' ' 635' ' ' SER . 21.0 Cg_exo -65.54 -155.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.593 2.195 . . . . 0.0 112.08 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.742 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -59.09 -22.31 60.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.417 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 70.11 -67.73 0.23 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.003 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.412 ' HA3' ' NH2' ' A' ' 629' ' ' ARG . . . 169.55 56.06 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.722 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 703' ' ' PHE . 2.8 mp -111.17 -171.76 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.595 0.236 . . . . 0.0 110.748 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.538 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 0.6 OUTLIER -97.05 147.98 23.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 111.434 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.457 ' OD2' ' CD2' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -129.82 160.03 34.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.049 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.767 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.2 pt -107.32 119.09 56.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.552 0.691 . . . . 0.0 111.854 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 86.8 m95 -104.68 130.87 52.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.152 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.424 ' CB ' HD21 ' A' ' 672' ' ' LEU . 39.0 t80 -90.99 117.24 29.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 624' ' ' PHE . 10.9 m -103.77 138.07 40.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.829 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.666 ' CE1' ' HA ' ' A' ' 656' ' ' VAL . 52.4 t-80 -120.84 130.53 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.238 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 15.1 p -128.14 7.33 6.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.213 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.13 151.44 36.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.837 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.6 t -75.37 -36.27 60.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 111.405 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m-20 -72.74 2.09 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.601 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.666 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 0.2 OUTLIER 49.12 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.587 0.708 . . . . 0.0 112.153 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.536 ' HB2' ' CD2' ' A' ' 651' ' ' HIS . 39.2 m -105.63 165.6 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 5.1 m-85 -124.7 120.18 31.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 111.266 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -98.86 100.02 11.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.673 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 61.83 -80.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.859 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.0 m120 -135.83 0.76 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.641 ' HB3' HG23 ' A' ' 716' ' ' VAL . 2.1 m120 -106.77 141.12 38.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.174 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.486 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.1 ttm180 -75.07 141.76 43.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.615 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 12.0 mmm -124.08 85.85 2.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.469 HG12 HG21 ' A' ' 668' ' ' THR . 29.2 pt -87.53 165.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 111.071 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.7 118.39 3.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.366 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.53 27.66 12.69 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.469 HG21 HG12 ' A' ' 665' ' ' ILE . 32.9 p -112.96 162.0 16.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 0.0 111.435 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpm? -141.98 140.62 32.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.615 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 0.3 OUTLIER -145.22 142.64 29.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.224 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.55 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -70.21 140.02 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 110.699 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 694' ' ' VAL . 2.0 mt -109.43 119.09 38.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 111.062 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 2.8 mt-30 -105.24 138.03 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.813 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 706' ' ' GLY . 35.7 t0 -42.38 107.15 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.089 0.471 . . . . 0.0 110.807 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 105.93 32.65 3.75 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.17 119.99 32.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.371 . . . . 0.0 110.731 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.498 ' OE2' HD21 ' A' ' 583' ' ' LEU . 3.4 tm-20 -96.1 111.33 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.093 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.54 HG22 HD13 ' A' ' 659' ' ' LEU . 33.2 pt -105.59 135.42 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 112.016 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 116.74 33.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.607 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.82 HG23 ' CD2' ' A' ' 622' ' ' HIS . 5.6 mt -91.36 -30.76 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.968 HG22 ' HB ' ' A' ' 690' ' ' ILE . 4.0 tp -153.8 130.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 111.674 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -137.46 126.83 24.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -126.88 117.05 21.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.874 0.369 . . . . 0.0 110.363 178.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.77 -46.81 74.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.804 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -83.36 -40.37 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.565 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.35 -11.1 59.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.446 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 57.75 22.11 8.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.695 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.767 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -81.57 104.38 11.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.5 OUTLIER -126.98 120.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.968 ' HB ' HG22 ' A' ' 681' ' ' ILE . 30.2 mt -129.83 120.53 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.511 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -143.03 140.93 10.11 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.516 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.488 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 8.6 m-30 -112.66 146.06 39.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.809 0.338 . . . . 0.0 110.368 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.535 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.1 tptt -101.04 116.15 32.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.07 0.462 . . . . 0.0 109.846 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -82.69 122.34 37.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.306 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -133.09 109.84 9.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.971 0.415 . . . . 0.0 111.033 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.628 HD13 ' O ' ' A' ' 705' ' ' GLU . 16.3 mt -78.89 106.05 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.728 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.75 -45.04 10.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 9.4 t0 -110.3 140.14 44.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.483 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.0 OUTLIER -115.32 100.17 7.92 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.297 0.57 . . . . 0.0 109.891 178.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.3 71.68 4.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.015 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.453 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 63.32 36.61 93.64 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.033 -178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.935 HD13 ' CE2' ' A' ' 577' ' ' PHE . 1.7 tp -80.98 154.04 27.14 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 111.444 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.766 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -60.28 -142.57 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.478 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.598 ' N ' ' CG ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -29.89 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.791 0.436 . . . . 0.0 111.085 178.172 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.713 ' HA ' HD23 ' A' ' 702' ' ' LEU . 13.2 pt-20 117.55 -37.07 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.458 1.103 . . . . 0.0 109.929 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 127.52 21.52 1.6 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.525 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.01 8.07 19.11 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.497 -0.414 . . . . 0.0 111.659 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 96.05 60.12 1.03 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.286 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 47.1 ttp -57.78 141.31 49.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.63 44.84 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.471 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -105.01 -75.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.319 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -88.85 135.37 33.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.921 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.763 ' O ' HG13 ' A' ' 715' ' ' VAL . 11.0 mt-30 -82.87 99.53 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.319 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 713' ' ' GLN . 9.1 mmm-85 -10.63 78.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.794 0.838 . . . . 0.0 112.757 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 713' ' ' GLN . 3.0 m -123.67 142.73 39.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.475 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.641 HG23 ' HB3' ' A' ' 662' ' ' ASN . 96.5 t -77.8 130.22 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.38 171.37 7.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -103.09 142.57 33.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.965 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -77.4 154.44 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 -179.51 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.236 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.88 -31.97 51.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -61.83 -48.84 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.733 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.707 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.6 mp0 -65.76 -49.34 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -61.08 -32.74 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.181 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -38.68 92.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.273 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 723' ' ' GLU . 2.7 mt -63.18 -44.36 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 621' ' ' VAL . 9.1 p -81.21 -27.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -56.34 -30.93 63.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 110.787 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -84.03 -22.44 31.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 730' ' ' LEU . 8.3 tt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.96 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.842 0.353 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.01 145.36 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 601' ' ' GLU . . . . . 0.449 ' C ' HD12 ' P' ' 602' ' ' LEU . 0.0 OUTLIER -165.42 52.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.999 0.428 . . . . 0.0 110.891 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 602' ' ' LEU . . . . . 0.449 HD12 ' C ' ' P' ' 601' ' ' GLU . 6.8 mp -131.24 152.37 50.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.99 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -101.5 85.22 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.855 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -63.13 108.27 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 19.5 mt -74.89 147.8 84.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.543 2.162 . . . . 0.0 112.276 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -69.86 -22.32 63.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.606 0.241 . . . . 0.0 111.236 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 145.09 -41.32 1.07 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.523 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.436 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.2 ttm105 -112.22 143.82 42.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.734 0.302 . . . . 0.0 111.112 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.933 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -124.01 -63.25 1.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.221 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.834 HD21 HG22 ' A' ' 694' ' ' VAL . 10.1 tt -108.98 142.69 39.27 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.202 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.587 HG21 ' CE ' ' A' ' 581' ' ' LYS . 2.1 m -120.97 113.88 20.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.627 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -101.52 107.92 19.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.587 ' CE ' HG21 ' A' ' 579' ' ' THR . 69.1 mttt -113.16 99.18 48.3 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.6 Cg_exo -47.28 99.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.767 1.645 . . . . 0.0 109.416 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -74.5 157.47 86.2 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.59 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.64 -25.36 11.02 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.809 3.006 . . . . 0.0 112.961 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -27.84 68.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.452 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.0 OUTLIER -95.73 153.87 17.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.554 178.241 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 690' ' ' ILE . 6.5 pt -58.17 -11.46 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.629 HD13 HG23 ' A' ' 613' ' ' ILE . 49.6 mt -107.16 119.01 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.76 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.68 58.13 0.62 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.134 0.493 . . . . 0.0 110.252 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.611 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.7 mm-40 -124.62 171.58 9.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.351 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.03 128.3 44.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.775 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.51 141.1 46.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.017 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.436 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.0 mt-10 -124.52 115.78 21.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.801 HD12 HD22 ' A' ' 578' ' ' LEU . 77.0 mt -83.24 109.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.294 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.6 tt0 -66.94 120.23 13.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.057 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.549 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.67 -29.84 2.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.176 0.513 . . . . 0.0 110.696 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -18.44 78.63 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.765 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.74 HG11 ' OD1' ' A' ' 610' ' ' ASN . 46.5 t -101.2 117.98 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 117.902 0.851 . . . . 0.0 111.983 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.412 ' ND2' ' HG3' ' A' ' 627' ' ' LYS . 27.9 t30 -140.27 122.77 9.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.873 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.1 Cg_endo -90.52 159.81 31.53 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.286 -1.131 . . . . 0.0 111.775 -0.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.638 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.31 115.62 28.24 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.765 ' CG ' HD12 ' A' ' 730' ' ' LEU . 43.3 m-85 -92.33 137.95 31.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.838 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.4 143.31 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.438 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.16 -170.3 38.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.297 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.466 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -70.75 -49.45 46.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 111.614 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.71 130.64 47.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.479 -179.058 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -18.14 23.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.3 -28.65 63.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.086 0.47 . . . . 0.0 110.455 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.62 ' SG ' HG22 ' A' ' 621' ' ' VAL . 84.4 m -74.11 132.5 42.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.632 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.74 ' OD1' HG11 ' A' ' 598' ' ' VAL . 14.2 m-80 -47.44 -29.37 2.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.179 0.514 . . . . 0.0 110.254 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.775 ' SG ' HD13 ' A' ' 592' ' ' LEU . 42.5 t -109.93 142.07 41.79 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 105.38 13.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.77 HD11 HD21 ' A' ' 592' ' ' LEU . 20.5 mm -139.09 109.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.13 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.65 106.57 17.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.463 0.649 . . . . 0.0 112.255 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.577 ' H ' HD11 ' A' ' 618' ' ' LEU . 2.2 t0 -129.68 107.53 9.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.633 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -41.39 -27.24 0.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.551 ' O ' HG23 ' P' ' 603' ' ' TPO . 2.3 mmt-85 -69.95 -42.05 73.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.684 0.278 . . . . 0.0 111.382 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.577 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.2 pp -90.08 158.75 17.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.73 164.15 26.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.014 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.552 ' HG2' HG23 ' A' ' 621' ' ' VAL . 1.0 OUTLIER -50.38 -28.33 7.89 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.068 0.461 . . . . 0.0 110.449 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.62 HG22 ' SG ' ' A' ' 609' ' ' CYS . 45.0 t -130.8 64.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.694 ' CD2' HG23 ' A' ' 680' ' ' ILE . 20.8 t60 -50.57 -46.94 57.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.119 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.6 p -165.36 161.5 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.511 . . . . 0.0 111.93 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.529 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.8 p90 -143.6 147.67 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.664 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.15 130.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -124.4 134.16 53.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -99.56 136.93 38.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.619 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.4 OUTLIER -135.88 158.94 43.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.584 -178.592 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.6 tpt180 -75.99 112.44 12.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.356 0.598 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -65.19 134.79 54.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.233 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -107.12 144.55 33.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.112 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 641' ' ' ALA . 2.9 m -131.26 166.16 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -103.43 -95.73 2.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.386 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -105.32 -174.86 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.799 0.333 . . . . 0.0 110.742 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 27.5 p -153.43 116.0 4.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.095 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.27 113.48 26.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 67.81 -72.24 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -89.8 144.44 25.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.726 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 69.0 m -89.58 112.07 49.54 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.36 -150.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 112.164 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.553 ' HB3' ' CG1' ' A' ' 632' ' ' VAL . . . -47.52 -27.16 1.66 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.567 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 77.37 -74.76 0.07 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.987 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.435 ' H ' HD12 ' A' ' 644' ' ' LEU . . . 160.34 76.53 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.074 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 703' ' ' PHE . 0.8 OUTLIER -134.2 -156.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.353 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.543 ' O ' HD13 ' A' ' 702' ' ' LEU . 3.4 m-20 -100.68 146.27 27.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.37 0.605 . . . . 0.0 112.398 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 4.9 t0 -126.69 160.53 30.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.29 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.933 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 3.3 pt -114.88 115.37 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.386 0.612 . . . . 0.0 112.026 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.929 ' CH2' HD22 ' A' ' 671' ' ' LEU . 63.9 m95 -102.73 136.86 41.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.151 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.667 ' HB2' HD11 ' A' ' 672' ' ' LEU . 17.0 t80 -93.05 117.52 30.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.013 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 14.8 m -101.87 130.67 48.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.087 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.475 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 45.0 t60 -111.19 132.88 53.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.483 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 13.4 p -129.27 2.47 5.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.416 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.86 148.1 32.96 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.4 t -73.28 -33.0 64.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 111.244 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.584 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.9 m-20 -72.27 -0.18 11.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.362 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.31 130.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 0.0 112.081 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.447 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 46.7 m -100.94 166.3 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.1 121.39 29.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.538 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.717 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.75 99.95 11.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.608 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 60.26 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.0 m-80 -130.02 -1.7 4.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.614 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.471 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.5 m-80 -101.6 142.02 33.59 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.239 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.585 ' O ' HG21 ' A' ' 716' ' ' VAL . 46.8 ttp180 -81.55 141.27 33.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.272 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.503 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 15.3 mmm -121.16 96.92 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.693 HG13 HG23 ' A' ' 668' ' ' THR . 6.7 pt -87.75 164.55 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.86 100.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.57 37.78 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.693 HG23 HG13 ' A' ' 665' ' ' ILE . 1.9 p -119.81 162.44 19.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.099 0.476 . . . . 0.0 111.535 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.637 ' O ' HD12 ' A' ' 717' ' ' LEU . 1.6 ttpm? -131.3 147.27 52.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.523 ' CD1' HG22 ' A' ' 716' ' ' VAL . 2.4 t80 -147.44 144.93 28.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.929 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.22 133.34 47.83 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.607 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.717 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.5 mt -114.8 124.84 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.677 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 0.6 OUTLIER -114.91 151.53 33.87 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.464 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 706' ' ' GLY . 8.2 t70 -49.07 119.41 3.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 110.405 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.29 36.4 5.95 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.46 110.09 22.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.737 0.303 . . . . 0.0 111.336 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.75 108.82 21.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.06 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.658 HG12 HD13 ' A' ' 659' ' ' LEU . 8.9 mt -105.61 136.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.897 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.15 116.48 28.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.679 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.694 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -84.72 -34.05 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.581 -178.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.843 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.5 tp -154.58 131.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.135 0.493 . . . . 0.0 111.866 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.407 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 13.0 t90 -136.26 126.81 26.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.046 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.595 ' OD2' HD22 ' P' ' 606' ' ' LEU . 0.4 OUTLIER -127.03 116.9 21.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.416 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -67.36 -46.71 72.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.873 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.11 -40.42 27.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.622 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -85.07 -10.55 56.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.427 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.9 mttt 59.82 19.2 8.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 682' ' ' TRP . 1.5 t80 -77.38 104.76 8.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.7 p -125.64 123.82 65.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 112.195 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.843 ' HB ' HG22 ' A' ' 681' ' ' ILE . 19.0 mt -128.32 154.87 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.424 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.452 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.24 135.75 2.76 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.113 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.607 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 5.9 m-30 -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.289 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -100.95 117.06 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.721 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.834 HG22 HD21 ' A' ' 578' ' ' LEU . 2.6 t -78.84 126.45 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.373 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.7 tt0 -133.29 109.33 9.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 110.59 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 674' ' ' ASP . 47.0 mt -82.89 105.68 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.102 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -87.86 -45.98 9.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.826 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.6 140.95 44.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.407 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.8 p -113.77 99.49 7.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.325 0.583 . . . . 0.0 109.669 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 700' ' ' THR . 8.6 t -81.67 60.15 4.49 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.198 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 69.09 59.01 6.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.613 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 645' ' ' ASP . 1.2 mm? -79.39 143.64 34.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.735 0.302 . . . . 0.0 111.119 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.492 ' HA ' ' HB2' ' A' ' 644' ' ' LEU . 3.5 p90 -44.54 -33.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.495 0.665 . . . . 0.0 110.369 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.596 ' ND2' ' HG2' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -141.13 -42.24 0.38 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.557 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.596 ' HG2' ' ND2' ' A' ' 704' ' ' ASN . 16.0 pt-20 135.17 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.242 1.017 . . . . 0.0 109.388 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 115.92 15.35 7.37 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.708 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 707' ' ' LEU . 1.0 OUTLIER -85.99 7.5 24.17 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.519 -0.4 . . . . 0.0 111.968 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 107.65 -50.34 0.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.761 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.421 ' O ' ' C ' ' A' ' 710' ' ' LEU . 9.9 ttp 68.79 117.47 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.751 0.31 . . . . 0.0 110.285 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 710' ' ' LEU . 0.2 OUTLIER -28.64 144.82 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.082 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 49.13 44.68 23.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.244 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -62.97 109.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.907 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -82.24 102.04 10.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.707 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -96.24 76.57 3.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.53 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.3 143.17 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.421 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.585 HG21 ' O ' ' A' ' 663' ' ' ARG . 12.7 t -80.55 125.09 39.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.629 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.637 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -102.55 168.68 9.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.482 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 144.91 30.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -82.61 158.52 23.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -175.01 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.171 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.79 60.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.37 -46.56 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.694 ' HA ' HD12 ' A' ' 726' ' ' LEU . 3.7 mp0 -66.69 -47.8 71.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.767 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -59.99 -33.11 71.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -63.14 -39.58 95.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.694 HD12 ' HA ' ' A' ' 723' ' ' GLU . 4.7 mt -60.53 -44.02 96.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.0 p -80.62 -27.9 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -54.2 -34.4 60.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.09 -24.1 40.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.765 HD12 ' CG ' ' A' ' 602' ' ' PHE . 10.2 tt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.834 0.349 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 600' ' ' VAL . . . . . 0.48 HG23 ' O ' ' P' ' 600' ' ' VAL . 13.1 m -96.05 80.94 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.08 83.85 0.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.957 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 602' ' ' LEU . . . . . 0.428 ' O ' HD12 ' P' ' 602' ' ' LEU . 1.3 pp -155.72 169.37 24.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.551 HG23 ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.57 92.41 4.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.797 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.52 133.15 55.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.598 HD11 HD11 ' A' ' 681' ' ' ILE . 6.8 mt -109.3 149.89 40.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.581 2.188 . . . . 0.0 112.228 179.969 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -89.55 10.05 24.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.625 0.25 . . . . 0.0 111.316 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 160.6 -26.86 0.3 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.382 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.436 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? -106.63 140.28 39.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.005 0.431 . . . . 0.0 111.241 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -126.9 -62.86 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.087 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -106.42 142.23 36.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.841 ' N ' HD23 ' A' ' 578' ' ' LEU . 7.1 m -124.55 114.62 19.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.713 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.8 OUTLIER -104.25 108.42 19.81 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.0 100.22 53.28 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.506 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 24.5 Cg_exo -45.43 104.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.565 1.51 . . . . 0.0 109.105 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.39 156.98 86.92 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.001 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.56 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -49.88 -31.6 27.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.663 2.909 . . . . 0.0 112.908 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.686 ' HB2' HD12 ' A' ' 583' ' ' LEU . 4.7 m-20 -63.82 -21.49 66.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.465 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.663 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 24.7 p -96.46 153.23 17.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.201 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.655 HG23 HG13 ' A' ' 588' ' ' ILE . 3.9 tt -52.46 -19.47 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.633 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.72 HD13 HG23 ' A' ' 613' ' ' ILE . 40.4 mt -110.62 118.54 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.299 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -109.7 60.81 0.6 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.298 0.571 . . . . 0.0 110.841 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.54 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 29.3 mt-10 -125.48 171.91 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.668 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.24 127.7 44.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 178.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.772 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.6 137.72 50.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.616 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.478 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.9 OUTLIER -124.12 119.53 29.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.587 HD11 HD13 ' A' ' 625' ' ' ILE . 80.3 mt -86.68 109.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.113 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -68.99 122.5 18.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.996 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.6 -29.56 1.88 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.69 -25.2 74.08 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.823 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.13 118.12 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.002 0.901 . . . . 0.0 111.661 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -140.09 122.63 10.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.844 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.1 Cg_endo -89.93 159.66 34.36 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 124.352 -1.104 . . . . 0.0 111.695 -0.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.4 t80 -91.93 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.86 ' CG ' HD12 ' A' ' 730' ' ' LEU . 58.9 m-85 -92.77 138.16 31.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.665 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.738 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.1 mp -128.12 144.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.66 -173.21 40.56 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.68 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -75.88 -18.39 59.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.324 0.249 . . . . 0.0 111.372 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.16 129.96 35.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.36 -23.0 21.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -55.07 -30.37 59.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.085 0.469 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 34.8 m -73.44 127.99 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.829 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 32.8 m120 -44.31 -33.93 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.306 0.574 . . . . 0.0 110.298 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.772 ' SG ' HD13 ' A' ' 592' ' ' LEU . 54.1 t -104.36 143.04 33.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.172 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.429 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -119.79 113.53 20.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.753 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.72 HG23 HD13 ' A' ' 588' ' ' ILE . 26.5 mm -137.95 109.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.447 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -97.28 105.23 17.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.513 0.673 . . . . 0.0 112.291 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.666 ' CB ' HD13 ' A' ' 618' ' ' LEU . 38.3 t0 -131.43 123.05 27.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.062 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -47.63 -29.23 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.75 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.616 ' HB3' HD13 ' A' ' 681' ' ' ILE . 3.2 mpt_? -77.76 -39.35 44.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.666 HD13 ' CB ' ' A' ' 615' ' ' ASP . 2.2 mp -65.88 159.22 26.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.786 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.0 m -110.61 172.08 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.433 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -47.84 31.76 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 110.174 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.938 HG11 HG23 ' A' ' 727' ' ' VAL . 4.1 t -121.45 56.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.482 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.572 ' CD2' HG23 ' A' ' 680' ' ' ILE . 49.3 t60 -43.67 -47.63 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.598 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 2.7 p -165.6 151.65 9.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.0 p90 -143.29 146.9 33.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.829 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.721 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.4 mp -101.86 127.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.586 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -120.37 134.33 55.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 27.2 ttmt -97.82 136.5 38.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.075 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.59 158.29 44.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.833 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.4 113.98 15.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.334 0.588 . . . . 0.0 110.572 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 -70.86 131.05 43.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.132 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -174.7 168.34 3.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 633' ' ' GLY . 6.4 p -147.05 159.59 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.059 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -75.05 110.72 3.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.505 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 2.0 mttm 63.3 142.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.836 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.08 48.09 1.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -59.29 123.48 16.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 11.7 t80 68.34 -68.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -78.02 127.7 32.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.817 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 29.1 t -110.92 99.68 43.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.49 -150.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.65 2.233 . . . . 0.0 111.748 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.608 ' HB1' HD13 ' A' ' 644' ' ' LEU . . . -89.35 9.89 24.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.665 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 641' ' ' ALA . 19.6 mt-30 81.23 -72.12 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.285 0.234 . . . . 0.0 111.104 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -179.19 90.88 0.08 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.411 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.697 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.6 mp -122.7 -155.3 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.0 m-20 -122.05 146.43 47.19 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.239 0.543 . . . . 0.0 112.033 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.437 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -132.17 160.56 35.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.087 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -107.9 121.94 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.482 0.658 . . . . 0.0 112.274 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.933 ' CH2' HD22 ' A' ' 671' ' ' LEU . 79.4 m95 -106.0 124.65 49.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.168 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CD2' HD13 ' A' ' 678' ' ' ILE . 7.3 t80 -90.39 116.92 28.71 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 26.6 m -102.11 144.08 31.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.254 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 18.3 t60 -131.03 124.28 30.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.404 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 1.4 p -121.13 6.69 10.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.06 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.48 148.11 35.11 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.278 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.466 HG21 ' HG3' ' P' ' 605' ' ' GLU . 3.5 t -69.84 -34.7 73.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.795 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.585 ' O ' HG13 ' A' ' 656' ' ' VAL . 51.5 m-80 -70.56 -2.51 14.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.608 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.72 133.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.434 0.635 . . . . 0.0 111.893 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 81.8 p -103.06 165.59 10.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.816 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.5 120.26 30.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.775 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.84 101.33 12.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 59.78 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 65.1 t30 -133.47 -2.2 3.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.521 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 1.3 t-20 -104.98 141.41 36.61 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.197 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.89 141.2 33.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.573 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -109.24 100.11 9.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.691 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.7 pt -87.12 134.9 26.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.963 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' A' ' 652' ' ' THR . 1.2 tt0 -38.49 98.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.988 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 37.38 1.17 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 718' ' ' LYS . 2.1 p -139.21 158.37 44.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.703 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.491 ' HE2' HD13 ' A' ' 717' ' ' LEU . 12.6 pttm -123.61 158.2 32.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.72 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.3 OUTLIER -145.08 146.3 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.622 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.933 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.95 130.92 44.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.86 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.763 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -109.81 118.65 37.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 111.625 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 3.0 mt-30 -108.52 138.31 45.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.438 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 706' ' ' GLY . 8.7 t70 -38.88 116.95 0.62 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.84 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.8 35.28 6.19 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.43 114.89 27.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.86 108.52 20.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 13.0 mt -107.91 131.79 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.898 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 115.65 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.567 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.62 HD12 ' CE2' ' A' ' 692' ' ' PHE . 1.1 mt -78.01 -36.05 21.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.364 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.701 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -155.14 131.91 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 111.73 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -136.21 125.75 25.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.54 ' OD2' HD22 ' P' ' 606' ' ' LEU . 4.0 t70 -127.11 116.9 21.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.924 0.393 . . . . 0.0 110.318 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -67.22 -46.55 73.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.895 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -74.46 -40.29 61.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.77 -11.97 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.451 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt 61.61 16.94 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.727 0.298 . . . . 0.0 111.019 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 2.3 t80 -82.27 105.49 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.613 ' O ' HG22 ' A' ' 587' ' ' ILE . 0.9 OUTLIER -125.95 121.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.214 0.531 . . . . 0.0 111.997 -178.619 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 681' ' ' ILE . 31.5 mt -117.73 130.82 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.63 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -154.91 130.85 2.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.421 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.62 ' CE2' HD12 ' A' ' 680' ' ' ILE . 3.4 m-30 -113.33 143.91 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.863 0.363 . . . . 0.0 110.38 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.627 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -101.47 117.35 34.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.03 0.443 . . . . 0.0 110.682 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.777 HG22 HD21 ' A' ' 578' ' ' LEU . 3.0 t -79.97 127.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.515 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -133.39 109.53 9.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 674' ' ' ASP . 52.2 mt -83.19 105.14 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.36 -46.58 12.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.279 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.08 140.68 45.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 7.2 p -114.24 99.4 7.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.316 0.579 . . . . 0.0 109.568 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 700' ' ' THR . 88.3 m -76.75 67.91 2.9 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.238 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 61.25 55.63 28.2 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.452 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.683 HD23 ' C ' ' A' ' 705' ' ' GLU . 1.6 tp -81.51 141.42 33.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.121 0.486 . . . . 0.0 111.595 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.697 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.9 p90 -44.42 -33.87 1.83 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.07 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.567 ' ND2' ' HG2' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -140.42 -47.22 0.42 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.001 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.683 ' C ' HD23 ' A' ' 702' ' ' LEU . 17.0 pt-20 136.28 -35.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.964 0.906 . . . . 0.0 109.179 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 120.64 18.18 4.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.968 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.62 1.87 36.13 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.473 -0.428 . . . . 0.0 111.684 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 48.69 95.48 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.985 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.65 138.07 47.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 0.0 110.821 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.7 -166.42 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.717 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.85 -106.42 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.661 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -114.94 98.91 7.09 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.83 0.347 . . . . 0.0 110.994 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.1 102.53 9.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.72 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER 167.39 130.37 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.298 0.57 . . . . 0.0 110.526 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.79 146.28 28.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.537 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 669' ' ' LYS . 7.2 p -77.11 130.2 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.808 -178.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.491 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.6 OUTLIER -109.07 172.43 6.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.787 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 718' ' ' LYS . . . . . 0.53 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.0 OUTLIER -95.23 158.05 15.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 723' ' ' GLU . 15.1 mt-30 -95.88 160.27 14.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.864 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.1 p -120.2 -174.44 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.91 58.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -60.78 -48.17 82.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 726' ' ' LEU . 5.6 tm-20 -64.12 -48.86 74.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -53.1 -33.47 52.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.21 -36.91 80.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 723' ' ' GLU . 38.4 mt -56.65 -44.31 81.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.938 HG23 HG11 ' A' ' 621' ' ' VAL . 10.2 p -80.86 -21.25 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -67.82 -39.2 83.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.752 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -79.02 -11.69 60.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.198 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.86 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.2 tt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.052 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.787 0.327 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.14 73.96 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.17 74.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.942 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.06 159.28 41.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.779 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.548 ' O3P' HG22 ' P' ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -36.14 70.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.859 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 605' ' ' GLU . . . . . 0.466 ' HG3' HG21 ' A' ' 654' ' ' THR . 0.7 OUTLIER 59.92 90.29 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.638 ' CD1' HD11 ' A' ' 681' ' ' ILE . 43.8 mt -59.72 139.3 89.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.465 2.11 . . . . 0.0 112.317 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -83.65 0.18 48.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.549 0.214 . . . . 0.0 111.521 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 131.05 -1.87 5.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.998 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.464 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.9 OUTLIER -100.93 131.71 46.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.762 0.281 . . . . 0.0 110.487 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -121.69 -62.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 111.476 -179.478 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.028 HD12 HD13 ' A' ' 647' ' ' ILE . 5.7 tt -105.93 125.99 51.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.66 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.4 m -102.46 119.19 38.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.268 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.862 HD12 HD11 ' A' ' 594' ' ' ILE . 4.7 mt -105.64 108.54 20.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -117.97 100.72 52.09 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.125 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.59 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.7 Cg_exo -46.14 101.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.778 1.652 . . . . 0.0 109.451 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -75.09 157.97 84.72 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -50.06 -25.75 13.33 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.461 2.774 . . . . 0.0 112.244 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.564 ' CB ' HD12 ' A' ' 583' ' ' LEU . 10.2 t70 -62.36 -26.47 68.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.44 ' HA ' HG13 ' A' ' 689' ' ' VAL . 54.5 p -95.4 153.47 17.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.711 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.801 HD13 ' CE1' ' A' ' 688' ' ' PHE . 1.0 OUTLIER -58.7 -14.16 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.56 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.458 ' CD1' HG23 ' A' ' 613' ' ' ILE . 73.0 mt -106.49 118.67 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.315 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.35 57.58 0.68 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 110.524 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.59 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.5 mt-10 -124.76 169.39 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.79 122.28 26.89 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.573 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.52 HD13 ' C ' ' A' ' 591' ' ' SER . 0.7 OUTLIER -113.17 150.31 32.43 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.392 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.464 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.44 125.34 44.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.862 HD11 HD12 ' A' ' 580' ' ' LEU . 93.9 mt -83.51 108.97 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.608 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.5 mp0 -64.16 122.84 17.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 1.4 pt20 -47.63 -30.06 3.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.258 0.551 . . . . 0.0 110.021 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.476 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -73.42 -20.94 79.97 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.926 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.685 HG11 ' ND2' ' A' ' 610' ' ' ASN . 61.0 t -98.62 118.04 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 118.108 0.954 . . . . 0.0 111.642 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.0 t30 -140.18 121.6 9.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.002 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.591 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.0 Cg_endo -90.56 159.34 31.11 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.442 -1.066 . . . . 0.0 111.511 -0.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.62 ' CD2' HG23 ' A' ' 594' ' ' ILE . 4.3 t80 -91.78 115.6 28.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.566 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.6 m-85 -92.54 137.94 31.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.349 -177.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.785 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.2 mp -123.97 145.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.438 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 157.67 -169.85 34.58 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.317 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -69.83 -48.74 57.82 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.21 124.28 19.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -178.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -19.44 5.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.665 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.48 -30.15 66.77 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 98.0 m -68.8 133.04 47.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.446 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.685 ' ND2' HG11 ' A' ' 598' ' ' VAL . 32.6 m120 -45.54 -30.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.19 0.519 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.785 ' SG ' HG23 ' A' ' 603' ' ' ILE . 32.8 t -113.1 142.34 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.373 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 105.92 15.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 588' ' ' ILE . 24.8 mm -138.39 109.71 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.441 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.22 106.89 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.584 0.707 . . . . 0.0 112.657 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.699 ' CB ' HD22 ' A' ' 618' ' ' LEU . 27.1 t0 -129.42 107.11 9.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.724 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 616' ' ' ASN . . . . . 0.496 ' ND2' ' HG2' ' P' ' 604' ' ' GLN . 0.9 OUTLIER -42.48 -30.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.456 ' HG2' HD21 ' P' ' 606' ' ' LEU . 0.0 OUTLIER -77.98 -37.56 47.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.498 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.699 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -89.63 134.09 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.255 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.66 165.52 0.41 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -59.45 -21.64 60.35 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 621' ' ' VAL . 14.9 p -140.27 56.58 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.54 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 14.1 t60 -41.86 -37.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.39 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.0 p -170.09 160.05 7.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.248 0.547 . . . . 0.0 112.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.575 ' HA ' HD12 ' A' ' 603' ' ' ILE . 40.6 p90 -143.37 147.59 34.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.172 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 580' ' ' LEU . 3.8 mp -101.55 130.83 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.591 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.0 t80 -122.96 133.8 54.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.891 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.576 ' HD3' HG23 ' A' ' 647' ' ' ILE . 3.0 tppp? -98.07 136.66 37.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.477 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.65 159.14 41.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.737 -178.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -76.41 112.45 12.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.355 0.598 . . . . 0.0 110.705 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.1 t-80 -75.1 124.49 27.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.698 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -164.22 98.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.077 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 7.4 m -60.65 162.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.153 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -59.73 89.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.54 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 59.48 -177.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.23 103.75 4.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.042 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.77 123.19 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.719 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.87 -65.46 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.839 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -75.91 144.3 41.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.675 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 74.6 m -105.01 102.46 36.01 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.096 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.81 -150.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.676 2.251 . . . . 0.0 111.81 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 703' ' ' PHE . . . -93.61 32.51 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 0.0 111.339 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.29 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 172.27 84.88 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.656 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.9 mp -120.03 -153.23 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.556 ' O ' HD23 ' A' ' 702' ' ' LEU . 9.9 m-20 -112.63 146.93 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.42 ' OD2' ' CD2' ' A' ' 630' ' ' HIS . 0.4 OUTLIER -129.59 160.09 34.35 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.275 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.028 HD13 HD12 ' A' ' 578' ' ' LEU . 1.9 pt -106.53 126.86 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.6 0.714 . . . . 0.0 112.892 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.874 ' CH2' HD22 ' A' ' 671' ' ' LEU . 82.7 m95 -111.22 128.55 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.687 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.734 ' CE1' HD12 ' A' ' 678' ' ' ILE . 20.2 t80 -90.76 117.8 29.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 38.4 m -102.8 131.87 49.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.484 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 47.4 t60 -111.91 130.85 55.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.6 p -131.47 12.42 4.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.342 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.32 154.27 32.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.295 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.415 HG22 ' HG2' ' P' ' 605' ' ' GLU . 55.3 m -83.61 -24.15 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.741 0.305 . . . . 0.0 111.381 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.61 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.9 OUTLIER -82.6 4.14 25.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 53.27 133.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 111.981 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.457 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 60.0 m -102.0 166.17 10.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.376 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.407 ' O ' ' N ' ' A' ' 679' ' ' LYS . 34.9 m-85 -130.61 120.01 23.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.974 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -100.15 103.54 15.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.872 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.468 ' N ' HD12 ' A' ' 659' ' ' LEU . 16.9 t-20 60.56 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.768 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.8 m120 -136.43 6.03 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.508 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.878 ' OD1' HG23 ' A' ' 716' ' ' VAL . 1.0 OUTLIER -107.37 142.0 37.86 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.804 0.335 . . . . 0.0 111.001 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.441 ' NH1' HG22 ' A' ' 665' ' ' ILE . 24.8 ttt-85 -78.02 141.39 38.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.402 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.438 ' O ' HG23 ' A' ' 656' ' ' VAL . 42.7 mmm -121.9 93.02 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.542 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.441 HG22 ' NH1' ' A' ' 663' ' ' ARG . 36.1 pt -87.71 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -47.25 96.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.115 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.26 41.47 0.81 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.0 p -128.94 162.15 28.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.056 0.455 . . . . 0.0 111.86 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.468 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -134.73 146.71 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.468 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.54 145.5 29.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.874 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.84 133.22 47.98 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.705 179.341 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.75 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -108.59 119.15 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.153 0.501 . . . . 0.0 111.443 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.554 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 2.2 mt-30 -106.67 139.73 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.828 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' A' ' 696' ' ' ILE . 41.1 t0 -40.8 114.8 0.51 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 110.732 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.78 36.69 5.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.65 115.38 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.056 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -96.55 108.68 21.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.974 HG22 HD13 ' A' ' 659' ' ' LEU . 23.4 pt -108.27 129.1 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 0.0 111.946 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -89.22 116.03 27.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.307 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.498 HG23 ' CD2' ' A' ' 622' ' ' HIS . 3.0 mt -78.31 -36.0 20.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.566 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.646 HG22 ' CG1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -154.92 131.87 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.35 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -136.1 128.34 30.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 111.501 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.524 ' OD2' HD22 ' P' ' 606' ' ' LEU . 12.4 t0 -127.14 116.37 20.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.14 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.48 -46.47 72.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.16 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.83 -40.37 65.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -90.55 -10.33 43.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 15.97 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.663 0.268 . . . . 0.0 111.064 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.801 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.7 t80 -76.48 104.78 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 586' ' ' SER . 2.2 p -118.95 125.96 74.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.839 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.646 ' CG1' HG22 ' A' ' 681' ' ' ILE . 33.1 mm -127.93 125.62 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.36 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -160.7 136.74 4.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.136 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 8.1 m-30 -112.99 148.76 34.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.607 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.348 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.843 HG22 HD21 ' A' ' 578' ' ' LEU . 3.3 t -79.2 121.17 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.702 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.97 109.37 11.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.867 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' A' ' 674' ' ' ASP . 64.1 mt -78.31 110.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.33 -45.45 6.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.426 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 7.5 t70 -111.04 140.64 45.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.4 OUTLIER -114.46 100.39 8.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 178.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 700' ' ' THR . 10.0 t -77.07 63.71 2.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.743 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 72.69 37.35 57.7 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.044 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -81.81 136.99 35.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.657 0.265 . . . . 0.0 111.209 -179.686 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.796 ' HB2' ' HB1' ' A' ' 641' ' ' ALA . 5.5 p90 -47.0 -34.85 6.0 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.452 0.644 . . . . 0.0 110.481 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.807 HD22 HD23 ' A' ' 707' ' ' LEU . 0.5 OUTLIER -148.37 -53.4 0.19 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.383 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.539 ' O ' HD13 ' A' ' 696' ' ' ILE . 8.5 pt-20 144.23 -50.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.096 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 159.69 79.87 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.766 -1.107 . . . . 0.0 112.127 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.807 HD23 HD22 ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.14 -9.88 17.48 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.532 -0.393 . . . . 0.0 111.43 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 103.23 28.62 6.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.837 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.449 ' CE ' ' CD2' ' A' ' 630' ' ' HIS . 18.3 mmm 60.39 -143.26 0.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.704 0.287 . . . . 0.0 110.506 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 710' ' ' LEU . 1.4 tp -56.92 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.221 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -41.16 -86.13 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.515 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -114.69 98.46 6.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.89 0.376 . . . . 0.0 111.175 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 100.95 8.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.682 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.468 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 14.3 mmm-85 -154.94 77.27 1.02 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.007 0.432 . . . . 0.0 111.737 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.454 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.5 m -123.77 140.99 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.717 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.878 HG23 ' OD1' ' A' ' 662' ' ' ASN . 92.1 t -82.69 121.87 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.439 . . . . 0.0 111.482 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.72 167.52 11.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.377 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.09 150.42 23.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.209 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.77 149.02 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.432 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 31.7 p -126.15 -173.62 2.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.405 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -61.86 -28.69 69.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.159 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.13 -53.2 58.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.7 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.5 pp20? -70.6 -37.74 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -58.53 -34.93 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.544 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 728' ' ' LYS . 10.2 t70 -68.14 -39.35 82.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.7 HD12 ' HA ' ' A' ' 723' ' ' GLU . 17.0 mt -58.27 -44.17 88.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.03 -23.78 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.576 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 728' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 725' ' ' ASP . 0.0 OUTLIER -50.49 -48.82 56.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.066 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -27.31 67.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.919 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 730' ' ' LEU . 1.6 tt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.806 0.336 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' P' P ' 600' ' ' VAL . . . . . 0.401 ' O ' HG23 ' P' ' 600' ' ' VAL . 16.5 m -143.82 120.72 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 60.38 31.79 20.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 602' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' P' ' 602' ' ' LEU . 10.6 tp -142.36 157.59 44.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' P' P ' 604' ' ' GLN . . . . . 0.496 ' HG2' ' ND2' ' A' ' 616' ' ' ASN . 0.4 OUTLIER -105.23 83.0 1.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.794 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 605' ' ' GLU . . . . . 0.415 ' HG2' HG22 ' A' ' 654' ' ' THR . 1.0 OUTLIER -50.25 126.6 15.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.129 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.524 HD22 ' OD2' ' A' ' 683' ' ' ASP . 9.6 mt -90.0 143.03 29.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.838 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.472 2.115 . . . . 0.0 112.3 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -74.56 -22.13 59.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.675 0.274 . . . . 0.0 111.13 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 143.32 -15.8 2.29 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.748 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.4 tmm_? -107.7 134.85 50.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 111.314 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.801 ' CE1' HG21 ' A' ' 647' ' ' ILE . 0.2 OUTLIER -122.3 -52.79 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.059 HD21 HG13 ' A' ' 694' ' ' VAL . 1.4 tt -107.04 140.42 39.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.112 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.732 ' N ' HD23 ' A' ' 578' ' ' LEU . 23.8 m -118.52 113.55 21.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.755 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.848 HD23 HD11 ' A' ' 678' ' ' ILE . 0.7 OUTLIER -105.7 108.85 20.57 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.1 ptpt -117.01 99.86 53.11 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.1 Cg_exo -45.98 104.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.893 1.729 . . . . 0.0 109.503 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.18 157.39 85.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -176.344 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.1 Cg_endo -50.72 -27.73 20.78 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.603 2.869 . . . . 0.0 112.53 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.578 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.1 t70 -62.54 -26.72 68.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.64 153.57 17.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.157 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 690' ' ' ILE . 8.1 pt -57.14 -12.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.977 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.505 ' CD1' HG23 ' A' ' 613' ' ' ILE . 38.9 mt -108.87 118.82 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.637 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -107.65 59.33 0.62 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.146 179.437 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.645 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mm-40 -125.57 170.04 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.264 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.2 116.73 18.06 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.304 178.644 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.771 HD22 ' SG ' ' A' ' 611' ' ' CYS . 0.8 OUTLIER -113.53 143.56 44.32 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.418 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.7 OUTLIER -125.17 123.92 40.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.252 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.623 HG23 ' CD1' ' A' ' 601' ' ' PHE . 78.7 mt -75.23 108.84 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.511 ' CB ' HG23 ' A' ' 598' ' ' VAL . 2.8 mp0 -59.44 116.78 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.939 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -30.44 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.273 0.559 . . . . 0.0 110.118 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.447 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.88 -16.12 79.54 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.671 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.511 HG23 ' CB ' ' A' ' 595' ' ' GLN . 42.0 t -96.77 117.77 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 118.009 0.905 . . . . 0.0 111.212 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.9 OUTLIER -140.46 123.91 10.31 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.166 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.525 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 34.6 Cg_endo -91.38 158.85 27.27 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.349 -1.105 . . . . 0.0 112.052 -0.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.0 t80 -93.1 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.135 0.493 . . . . 0.0 109.752 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 1.1 m-85 -93.44 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.492 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.78 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -127.21 143.99 38.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.3 -163.61 31.6 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.504 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.558 ' CG ' HD12 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -73.57 -41.7 62.59 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.331 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 28.6 t -60.69 119.9 9.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.551 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.15 -18.65 10.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -62.45 -30.05 70.96 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.235 0.54 . . . . 0.0 109.614 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 61.5 m -67.1 128.05 34.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.378 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.8 m120 -44.1 -31.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.558 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.2 t -108.62 135.53 49.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.03 109.08 20.03 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 588' ' ' ILE . 24.0 mm -138.2 109.46 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.97 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -103.26 105.17 15.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.591 0.71 . . . . 0.0 112.22 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.674 ' HB2' HD21 ' A' ' 618' ' ' LEU . 1.0 OUTLIER -130.92 108.3 9.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.422 177.275 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -39.34 -29.75 0.05 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.744 ' HG2' HD21 ' P' ' 606' ' ' LEU . 8.3 mpt_? -70.62 -41.12 72.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -86.64 158.69 19.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 111.443 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 45.8 t -86.36 176.45 7.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.432 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -52.17 -51.75 56.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.479 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 621' ' ' VAL . 38.5 t -109.22 57.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.766 ' CD2' HG23 ' A' ' 680' ' ' ILE . 50.4 t60 -46.26 -38.09 8.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.937 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.12 174.9 10.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.531 0.681 . . . . 0.0 111.773 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.46 136.22 25.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.963 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.643 HD12 HD11 ' A' ' 603' ' ' ILE . 62.9 mt -132.37 117.05 30.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -134.4 147.49 50.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 111.552 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 16.3 ttmt -101.23 137.55 39.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.562 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 157.19 44.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.118 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.529 ' NH1' ' HB3' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -78.05 118.07 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.5 t60 -81.41 132.53 35.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.824 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.529 ' HB3' ' NH1' ' A' ' 629' ' ' ARG . . . -165.42 103.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.217 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 28.7 m -67.76 173.88 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.035 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -57.87 -101.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.539 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -119.55 143.84 47.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.339 . . . . 0.0 110.735 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.29 142.77 51.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.961 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 21.1 ttp -121.3 129.99 53.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.81 -64.11 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.055 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -75.57 141.56 42.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.778 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.31 91.6 5.9 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.118 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.3 -161.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.523 2.149 . . . . 0.0 112.086 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -45.03 -30.45 1.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.535 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 63.27 -78.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.41 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -160.14 51.35 0.37 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.73 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.666 HD12 ' N ' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -93.08 -157.36 0.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.841 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.7 OUTLIER -123.0 147.34 46.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.088 0.47 . . . . 0.0 111.932 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.408 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -135.76 137.97 42.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.175 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.801 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -90.26 124.87 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-O 121.331 0.586 . . . . 0.0 111.67 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.901 ' CH2' HD22 ' A' ' 671' ' ' LEU . 92.7 m95 -110.08 131.22 55.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.651 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.52 ' CB ' HD21 ' A' ' 672' ' ' LEU . 1.6 t80 -100.34 117.3 34.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.592 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.3 m -111.66 145.12 39.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.549 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 664' ' ' MET . 23.5 t60 -119.55 125.2 48.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.398 . . . . 0.0 111.463 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.483 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 4.2 p -120.27 9.13 10.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.929 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.96 -178.99 47.85 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.74 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.471 HG23 ' N ' ' A' ' 655' ' ' ASN . 11.7 t -105.55 -45.07 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 111.642 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.497 ' C ' HG23 ' A' ' 656' ' ' VAL . 5.8 m-80 -60.04 -16.08 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.854 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 664' ' ' MET . 4.2 t 79.06 143.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.786 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 664' ' ' MET . 37.9 m -115.39 165.9 12.47 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 679' ' ' LYS . 27.8 m-85 -137.58 119.61 15.44 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.119 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.779 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -101.61 107.14 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.308 -179.07 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 659' ' ' LEU . 44.4 m-20 56.12 -82.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 659' ' ' LEU . 30.3 m-80 -133.92 4.46 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.644 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 9.5 m120 -106.84 125.85 51.54 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.915 0.388 . . . . 0.0 111.306 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.0 ttm105 -65.95 141.24 58.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.509 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.54 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -114.7 85.71 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.584 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.424 HG12 HG21 ' A' ' 668' ' ' THR . 38.3 pt -87.05 149.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 652' ' ' THR . 17.1 tt0 -45.62 100.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.542 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 111.81 37.7 1.52 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.603 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.424 HG21 HG12 ' A' ' 665' ' ' ILE . 3.0 p -128.9 162.58 27.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.482 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 717' ' ' LEU . 3.5 ttpm? -138.31 144.93 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.123 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.505 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.8 OUTLIER -147.02 145.53 29.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.109 0.48 . . . . 0.0 111.862 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.901 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.8 140.63 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.646 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.901 HD13 HG21 ' A' ' 694' ' ' VAL . 1.2 mt -106.87 123.88 48.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.154 0.502 . . . . 0.0 110.852 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.74 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 3.0 mt-30 -102.28 133.02 47.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.123 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.755 ' HB2' HD12 ' A' ' 696' ' ' ILE . 12.5 t0 -44.5 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 109.931 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.48 36.29 3.34 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.87 122.63 33.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.045 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.15 108.16 20.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.848 HD11 HD23 ' A' ' 580' ' ' LEU . 0.1 OUTLIER -105.51 137.52 34.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.867 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 658' ' ' TYR . 7.9 mmtt -101.74 116.44 32.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.988 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.766 HG23 ' CD2' ' A' ' 622' ' ' HIS . 6.3 mt -82.8 -35.91 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.133 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.616 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.3 tt -154.7 131.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.714 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -136.37 119.84 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.173 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.22 116.57 20.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.678 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -46.6 71.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.877 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.68 -40.72 93.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.181 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -105.19 2.93 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.94 22.59 3.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.725 0.298 . . . . 0.0 110.973 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.3 OUTLIER -76.82 104.88 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.6 p -122.8 122.79 66.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 111.768 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 587' ' ' ILE . 3.0 mt -127.9 126.07 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.478 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.91 139.98 6.59 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.78 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.55 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 3.2 m-30 -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 0.0 110.483 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -101.01 116.89 33.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.128 0.489 . . . . 0.0 110.312 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 1.059 HG13 HD21 ' A' ' 578' ' ' LEU . 2.2 t -81.79 120.0 32.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.0 OUTLIER -133.5 109.22 9.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 179.437 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 674' ' ' ASP . 13.8 mt -77.82 104.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.04 -45.02 21.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.24 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.44 141.63 43.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.63 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 8.1 p -114.1 99.72 7.85 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.262 0.553 . . . . 0.0 109.632 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 35.1 m -75.07 66.84 1.68 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.409 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 60.19 57.01 21.4 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.645 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.841 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -86.87 125.39 33.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.641 0.258 . . . . 0.0 111.441 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.666 ' N ' HD12 ' A' ' 644' ' ' LEU . 8.2 p90 -36.48 -43.74 0.41 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.419 0.628 . . . . 0.0 111.05 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 1.2 t30 -118.33 -43.35 2.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.409 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 9.8 pt-20 146.6 -19.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.208 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.74 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 109.03 24.79 5.87 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.094 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.0 OUTLIER -104.3 7.48 35.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.864 0.466 . . . . 0.0 112.092 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 131.04 179.98 16.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.007 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -143.88 130.32 19.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 110.778 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.75 -166.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.077 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 69.79 -65.64 0.3 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.741 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.92 122.32 42.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.365 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -82.69 99.42 9.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.082 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.488 ' NH1' ' O ' ' A' ' 671' ' ' LEU . 0.0 OUTLIER 32.2 94.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.718 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.58 140.68 47.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.049 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.5 p -95.68 124.19 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.164 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.432 HD12 ' CZ3' ' A' ' 648' ' ' TRP . 3.2 mt -90.13 172.63 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.844 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.92 156.61 17.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.043 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.4 144.3 25.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.752 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 70.9 p -126.36 -176.81 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.8 37.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.269 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -55.97 -51.51 67.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.598 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.731 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.1 OUTLIER -70.18 -49.8 46.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.631 179.624 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -58.77 -32.12 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.97 -43.48 92.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.49 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.4 mt -57.51 -44.49 85.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.112 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.4 p -78.45 -14.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.461 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -25.83 19.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.327 . . . . 0.0 111.179 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -116.05 29.59 7.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.045 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.605 HD12 ' CD2' ' A' ' 602' ' ' PHE . 3.4 tt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.706 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' P' P ' 600' ' ' VAL . . . . . 0.599 ' O ' HG13 ' P' ' 600' ' ' VAL . 9.6 p -149.08 68.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -122.93 71.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 25.1 tp -172.22 135.34 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.755 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.626 HG22 ' O1P' ' P' ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -60.12 -37.25 79.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.563 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 605' ' ' GLU . . . . . 0.423 ' HG3' HG21 ' A' ' 654' ' ' THR . 13.4 mt-10 59.87 155.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.033 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.744 HD21 ' HG2' ' A' ' 617' ' ' ARG . 4.0 mt -140.95 87.53 10.92 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.501 2.134 . . . . 0.0 112.324 179.944 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.163 -0.375 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -84.8 -16.25 42.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 161.55 -22.57 0.22 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.768 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.7 tmm_? -106.08 139.38 40.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.739 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.3 t80 -127.94 -52.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.998 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.118 HD11 HG13 ' A' ' 694' ' ' VAL . 5.3 tp -115.45 125.6 53.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.444 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.58 ' N ' HD12 ' A' ' 578' ' ' LEU . 11.5 m -105.2 114.12 28.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.689 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.8 OUTLIER -106.09 108.83 20.54 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.0 mtmm -113.84 100.04 51.44 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_exo -45.01 100.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.923 1.749 . . . . 0.0 109.724 177.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 677' ' ' GLU . 0.2 OUTLIER -74.99 157.33 85.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.496 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.02 -25.28 12.26 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.698 2.932 . . . . 0.0 113.075 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -28.23 69.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.435 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.5 t -96.12 154.03 17.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.622 178.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 8.6 pt -58.55 -10.21 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.733 0.301 . . . . 0.0 111.121 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.726 HD13 HG23 ' A' ' 613' ' ' ILE . 54.6 mt -108.55 118.85 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.736 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.75 60.27 0.6 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.22 0.533 . . . . 0.0 110.33 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.613 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.8 mt-10 -124.73 171.64 9.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.5 123.7 34.21 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.75 139.89 47.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 579' ' ' THR . 9.4 mt-10 -124.65 111.45 15.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.895 HD11 HD12 ' A' ' 625' ' ' ILE . 30.8 mt -72.21 108.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.947 0.403 . . . . 0.0 110.071 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.8 mp0 -68.03 116.56 8.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.871 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.29 -30.44 2.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.228 0.537 . . . . 0.0 110.475 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.46 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.22 -21.59 77.23 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.348 -0.842 . . . . 0.0 113.557 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.432 HG11 ' ND2' ' A' ' 610' ' ' ASN . 52.4 t -101.07 118.42 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -140.14 124.18 10.75 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.919 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 42.8 Cg_endo -90.63 159.22 30.73 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.232 0.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 1.9 t80 -92.67 114.27 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.562 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 0.4 OUTLIER -93.38 139.09 31.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.127 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.792 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.7 mp -127.07 143.79 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.894 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 156.52 -165.72 33.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.477 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.468 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -70.19 -42.61 72.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.92 -179.246 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 11.3 t -60.42 121.79 12.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.633 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.55 -18.18 18.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.335 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -64.2 -29.18 70.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.142 0.496 . . . . 0.0 109.665 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.0 m -66.96 128.87 37.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.199 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -44.05 -31.21 0.87 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.079 0.466 . . . . 0.0 110.501 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.792 ' SG ' HG23 ' A' ' 603' ' ' ILE . 43.1 t -110.53 142.06 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 107.5 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.8 HD11 HD21 ' A' ' 592' ' ' LEU . 24.5 mm -138.61 109.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.811 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -104.08 106.22 16.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.536 0.684 . . . . 0.0 112.723 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.643 ' H ' HD11 ' A' ' 618' ' ' LEU . 2.0 t0 -130.85 107.73 9.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.685 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -39.25 -28.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.579 ' HB3' HD11 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -73.7 -38.6 64.81 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.643 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -88.41 158.98 18.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.528 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.446 ' HB3' ' P ' ' P' ' 603' ' ' TPO . 1.6 p -83.56 168.76 16.1 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.504 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 4.4 ptp180 -51.24 -46.13 62.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.017 0.437 . . . . 0.0 110.322 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 727' ' ' VAL . 47.7 t -108.55 60.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.641 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 13.9 t60 -52.92 -39.71 63.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.926 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.773 ' SG ' HD11 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -144.99 175.26 10.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.595 0.712 . . . . 0.0 111.872 -178.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -144.92 142.21 29.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.183 -178.137 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.895 HD12 HD11 ' A' ' 594' ' ' ILE . 61.4 mt -133.26 116.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 3.0 t80 -132.88 138.7 47.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.586 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.7 ttmt -98.45 136.71 38.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.36 158.52 44.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.661 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -76.76 116.12 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.178 0.513 . . . . 0.0 110.627 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.2 t-80 -82.33 129.56 34.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.602 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.427 ' HB2' ' HE ' ' A' ' 629' ' ' ARG . . . -158.71 149.61 20.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.241 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 21.0 m -112.82 -177.5 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -51.87 -85.23 0.02 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.705 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -148.5 40.48 0.93 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.828 0.346 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 25.3 p 49.63 86.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.5 ttp -65.95 100.61 0.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.39 -69.07 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.994 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -81.71 141.45 33.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.31 107.12 52.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.98 -149.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.55 2.167 . . . . 0.0 111.884 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.606 ' HB3' ' HB2' ' A' ' 703' ' ' PHE . . . -92.29 38.27 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.531 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 54.89 -167.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 111.046 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.639 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -89.07 93.97 1.95 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -105.5 -155.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.86 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -116.13 147.74 41.04 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.548 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -134.83 142.88 46.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.848 HD13 HD22 ' A' ' 578' ' ' LEU . 5.1 pt -94.76 120.63 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.374 0.607 . . . . 0.0 111.593 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.537 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.2 m95 -104.97 125.89 51.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.867 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.644 ' CB ' HD21 ' A' ' 672' ' ' LEU . 21.4 t80 -90.93 117.44 29.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.94 144.87 36.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.621 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -115.0 129.98 56.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.427 ' OG1' HG12 ' A' ' 621' ' ' VAL . 3.3 p -127.53 10.45 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.47 152.17 26.21 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.558 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.509 HG21 ' HB3' ' P' ' 605' ' ' GLU . 1.2 t -76.07 -30.82 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.72 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.587 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -75.08 2.05 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.027 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.08 122.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.2 p -93.15 165.94 12.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.173 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 57.1 m-85 -131.96 119.64 21.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 0.0 110.697 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -95.06 100.53 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.606 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.9 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 22.7 m120 -132.05 -0.3 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.342 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.655 ' OD1' HG23 ' A' ' 716' ' ' VAL . 1.8 m-80 -95.36 141.62 28.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.825 0.345 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 3.5 ttm105 -81.96 141.05 33.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.227 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.416 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 31.6 mmm -129.35 108.93 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 111.047 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.528 HG13 HG23 ' A' ' 668' ' ' THR . 3.1 pt -98.95 165.06 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.71 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 653' ' ' GLY . 0.0 OUTLIER -54.72 90.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.94 0.4 . . . . 0.0 110.924 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.08 35.19 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.504 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.528 HG23 HG13 ' A' ' 665' ' ' ILE . 0.8 OUTLIER -116.33 162.06 18.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.832 0.349 . . . . 0.0 111.127 179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.448 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.2 ttpt -139.52 138.88 36.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.555 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.05 143.37 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -71.3 140.31 50.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.206 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 694' ' ' VAL . 4.3 mt -108.28 127.37 53.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.783 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.787 ' OE1' HD23 ' A' ' 707' ' ' LEU . 1.3 mt-30 -106.67 149.94 26.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.772 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.478 ' HB2' HD12 ' A' ' 696' ' ' ILE . 6.0 t70 -47.66 106.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.038 0.447 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.99 36.3 4.52 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.602 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 7.6 t70 -92.13 113.33 25.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.305 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.592 ' HG3' HD21 ' A' ' 583' ' ' LEU . 0.5 OUTLIER -96.58 112.16 24.01 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.22 179.462 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.558 HG22 HD13 ' A' ' 659' ' ' LEU . 22.4 pt -105.41 128.84 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.96 0.41 . . . . 0.0 111.62 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 10.9 mmtp -87.27 116.54 25.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.988 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.773 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.1 OUTLIER -81.0 -36.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.377 -179.248 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 617' ' ' ARG . 4.7 tt -154.71 131.74 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 111.738 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -136.11 124.91 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.537 ' OD2' HD22 ' P' ' 606' ' ' LEU . 1.7 t0 -127.13 116.94 21.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.399 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -67.34 -46.66 72.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -74.06 -40.5 62.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.843 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -89.76 -8.65 51.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.548 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.26 19.11 7.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.721 0.296 . . . . 0.0 110.888 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.89 104.88 7.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.5 p -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.016 0.436 . . . . 0.0 111.858 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 681' ' ' ILE . 5.0 mt -128.18 152.49 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.358 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.435 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.58 140.93 3.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.281 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.555 ' CD2' HD11 ' A' ' 592' ' ' LEU . 3.0 m-30 -113.65 153.39 28.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 0.0 110.492 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -100.85 117.12 34.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 1.118 HG13 HD11 ' A' ' 578' ' ' LEU . 2.2 t -81.13 125.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.53 108.22 8.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.357 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 705' ' ' GLU . 18.9 mt -78.15 105.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -86.27 -46.95 9.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.893 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 27.5 t70 -110.85 140.45 45.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.434 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p -114.63 99.63 7.67 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.292 0.568 . . . . 0.0 109.53 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 74.7 p -70.15 73.87 0.48 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.459 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 55.08 48.43 67.88 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.605 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.86 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -86.55 140.12 30.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.899 0.381 . . . . 0.0 111.621 -179.076 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.606 ' HB2' ' HB3' ' A' ' 641' ' ' ALA . 0.3 OUTLIER -50.19 -27.38 5.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.328 0.585 . . . . 0.0 109.902 178.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 704' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -158.08 -57.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.946 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.577 ' O ' HD13 ' A' ' 696' ' ' ILE . 4.9 pt-20 164.4 -30.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.118 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 141.18 30.7 0.16 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.639 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.787 HD23 ' OE1' ' A' ' 673' ' ' GLN . 10.0 mt -90.97 7.54 39.77 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.125 0.463 . . . . 0.0 111.887 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 671' ' ' LEU . . . 67.88 -76.34 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.71 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 708' ' ' GLY . 0.0 OUTLIER 41.34 33.3 0.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.605 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.43 -164.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.693 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -51.72 -71.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.92 0.39 . . . . 0.0 110.898 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -71.8 131.75 43.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.654 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.82 100.67 10.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.962 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.412 ' HD3' ' NE2' ' A' ' 673' ' ' GLN . 10.2 mmm-85 46.93 87.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.445 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.62 148.71 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.762 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.655 HG23 ' OD1' ' A' ' 662' ' ' ASN . 86.2 t -80.9 130.44 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.251 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.37 166.49 10.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.2 144.86 30.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -88.21 146.52 25.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.16 -176.88 3.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.612 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.17 -28.93 43.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.269 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -55.79 -52.81 62.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.649 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.78 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.7 mp0 -70.6 -48.15 56.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.641 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -57.36 -32.28 66.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.92 -40.85 83.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 723' ' ' GLU . 4.9 mt -56.88 -44.39 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.576 HG21 HG11 ' A' ' 621' ' ' VAL . 10.9 p -86.26 -15.32 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.605 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -52.85 -29.73 29.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -110.86 31.34 6.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.435 HD12 ' CD2' ' A' ' 602' ' ' PHE . 3.0 tt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.788 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.81 0.338 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.17 63.8 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 54.41 45.52 26.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.105 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.0 110.24 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.446 ' P ' ' HB3' ' A' ' 619' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.08 77.32 9.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.708 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 605' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 654' ' ' THR . 8.3 pt-20 -69.77 119.99 14.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.032 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.537 HD22 ' OD2' ' A' ' 683' ' ' ASP . 1.1 mt -85.18 146.81 46.02 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.571 2.181 . . . . 0.0 112.39 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -69.97 -22.22 63.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.726 0.298 . . . . 0.0 111.092 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.492 ' HA2' ' NE2' ' A' ' 596' ' ' GLN . . . 158.91 49.19 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.407 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 40.0 ttp180 -93.34 115.71 28.28 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.757 0.313 . . . . 0.0 110.226 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -103.6 -52.85 2.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.788 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.07 HD12 HD13 ' A' ' 647' ' ' ILE . 7.0 tt -113.45 140.08 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.719 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.1 m -118.49 114.93 23.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.861 HD21 HG23 ' A' ' 694' ' ' VAL . 6.4 mt -102.09 107.62 18.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.9 mtpt -113.44 99.43 49.42 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.8 Cg_exo -47.15 97.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.838 1.692 . . . . 0.0 109.541 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.68 158.37 84.94 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.58 -25.05 7.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.941 3.094 . . . . 0.0 113.389 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.39 -25.5 67.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 4.6 t -95.97 153.96 17.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.678 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -62.01 -8.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.872 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 90.1 mt -110.98 118.72 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.95 62.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.106 0.479 . . . . 0.0 110.256 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.601 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -124.91 171.45 10.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.207 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.33 128.85 45.36 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.085 0.469 . . . . 0.0 111.098 178.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.777 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.3 OUTLIER -112.25 142.62 44.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.74 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -124.51 113.7 18.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.913 HD12 HD22 ' A' ' 578' ' ' LEU . 87.3 mt -81.68 108.44 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.2 mm100 -70.45 126.39 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.174 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.492 ' NE2' ' HA2' ' A' ' 575' ' ' GLY . 3.3 pt20 -46.25 -32.12 2.88 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.488 0.661 . . . . 0.0 109.743 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -69.71 -23.85 76.56 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.992 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.523 HG11 ' CG ' ' A' ' 610' ' ' ASN . 99.5 t -99.34 117.36 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.084 0.942 . . . . 0.0 111.857 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.7 t30 -141.22 122.1 8.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.826 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.59 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.86 160.19 34.94 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 124.554 -1.019 . . . . 0.0 111.506 -0.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.601 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.3 t80 -92.25 115.67 28.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.55 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 42.3 m-85 -92.48 137.81 32.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.843 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.796 HG23 ' SG ' ' A' ' 611' ' ' CYS . 4.1 mp -124.7 144.89 33.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.3 -166.94 36.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.515 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.487 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -73.84 -54.87 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.88 0.371 . . . . 0.0 111.9 -179.312 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 132.66 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.374 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -56.21 -19.78 15.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 608' ' ' ASP . . . . . 0.514 ' HB3' HD21 ' A' ' 730' ' ' LEU . 0.2 OUTLIER -53.05 -27.22 18.81 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.073 0.463 . . . . 0.0 110.432 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 10.5 m -79.03 132.91 36.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.582 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 19.7 m-80 -47.98 -28.64 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.511 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.796 ' SG ' HG23 ' A' ' 603' ' ' ILE . 25.7 t -110.17 141.23 43.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.58 104.6 12.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.637 HD11 HD21 ' A' ' 592' ' ' LEU . 24.6 mm -139.43 109.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.869 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.06 107.16 17.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.46 0.647 . . . . 0.0 112.601 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.608 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.2 t0 -129.47 107.59 9.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.624 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -39.81 -29.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.525 ' HG2' HD21 ' P' ' 606' ' ' LEU . 0.0 OUTLIER -69.58 -41.3 76.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.608 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.1 pp -89.22 158.7 17.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.463 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 t -78.57 167.37 21.37 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.385 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -48.64 -37.73 19.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.114 0.483 . . . . 0.0 110.37 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 727' ' ' VAL . 12.2 t -124.41 65.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.459 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.856 ' CD2' HG23 ' A' ' 680' ' ' ILE . 28.5 t60 -49.55 -42.12 43.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.809 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -168.98 159.2 9.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.472 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.2 p90 -143.23 147.92 35.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.498 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.728 HD11 HD11 ' A' ' 580' ' ' LEU . 4.7 mt -102.38 132.58 48.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.251 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -124.24 133.46 53.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.72 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 20.2 ttmt -98.59 136.5 38.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.557 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.33 158.11 41.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.324 -179.333 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.15 117.71 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.442 ' CE1' ' CE ' ' A' ' 709' ' ' MET . 4.4 t60 -80.37 130.58 35.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.83 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -160.1 117.53 2.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.221 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 11.4 m -75.55 175.28 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -113.92 -18.25 6.97 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.652 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -89.51 63.26 6.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.972 0.415 . . . . 0.0 110.922 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 80.0 p -150.38 105.33 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 13.1 mtt -110.74 29.24 7.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.078 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 637' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 637' ' ' TYR . 0.0 OUTLIER 177.75 -99.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.33 105.82 13.59 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.722 0.296 . . . . 0.0 110.891 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 639' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 640' ' ' PRO . 62.9 m -135.39 143.61 46.08 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.445 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 52.7 Cg_exo -54.98 -168.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.535 2.156 . . . . 0.0 112.194 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 69.96 -63.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.204 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.574 ' HB3' HD12 ' A' ' 644' ' ' LEU . 0.2 OUTLIER 66.17 -175.68 0.19 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -94.23 67.82 1.43 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.604 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 642' ' ' GLN . 4.1 mp -100.69 -160.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.815 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -119.55 146.35 45.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.329 0.585 . . . . 0.0 112.444 -178.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.444 ' OD2' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -130.09 160.53 33.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.525 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.07 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -108.76 131.06 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.662 0.744 . . . . 0.0 112.689 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.911 ' CH2' HD22 ' A' ' 671' ' ' LEU . 92.5 m95 -115.29 126.9 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.504 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.662 ' CD2' HD13 ' A' ' 678' ' ' ILE . 3.7 t80 -90.52 117.63 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 35.3 m -103.32 133.12 48.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.398 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.422 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 64.7 t60 -110.57 130.61 55.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.3 p -130.27 10.74 5.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.461 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.0 178.91 53.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.276 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.1 t -102.06 -36.53 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.585 ' C ' HG13 ' A' ' 656' ' ' VAL . 3.0 m-80 -72.63 -0.16 12.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.942 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.585 HG13 ' C ' ' A' ' 655' ' ' ASN . 2.0 m 60.34 135.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 121.09 0.472 . . . . 0.0 111.577 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.422 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 4.3 t -97.63 165.65 11.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.672 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.488 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 5.6 m-85 -136.47 120.32 17.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.026 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.744 HD22 HH21 ' A' ' 714' ' ' ARG . 0.3 OUTLIER -103.99 115.77 31.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.06 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.39 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.7 p-10 -136.31 6.29 3.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.471 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.651 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -103.15 141.01 36.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.825 0.345 . . . . 0.0 111.015 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.682 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -82.55 141.43 32.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.424 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 31.4 mmm -119.42 106.01 11.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.035 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.42 ' CG1' HG23 ' A' ' 668' ' ' THR . 49.9 pt -92.36 153.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.2 tt0 -47.07 99.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.37 41.05 1.29 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.42 HG23 ' CG1' ' A' ' 665' ' ' ILE . 1.3 p -121.43 162.28 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.619 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.474 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.4 ttpm? -133.02 146.6 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.579 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.499 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -147.49 144.03 28.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.947 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.911 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.73 133.39 47.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.427 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -106.03 107.35 18.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 111.35 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 11.7 mt-30 -95.11 142.35 27.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.827 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 696' ' ' ILE . 20.2 t0 -45.15 114.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.758 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.08 36.75 5.63 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.435 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -96.92 119.13 34.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.407 -179.201 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -96.2 114.06 25.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.722 HG23 ' HG ' ' A' ' 659' ' ' LEU . 6.4 mt -105.59 128.54 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 23.8 mtpt -90.37 116.5 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.952 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.856 HG23 ' CD2' ' A' ' 622' ' ' HIS . 35.3 mt -84.84 -38.97 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.348 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.516 HG22 ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.54 133.0 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.672 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -136.4 128.01 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.744 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.594 ' CG ' HD13 ' P' ' 606' ' ' LEU . 4.1 t0 -122.82 116.56 23.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.583 179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -46.83 71.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.942 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.91 -40.54 46.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -82.26 -16.81 48.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.271 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.66 11.44 8.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.963 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.413 ' CE1' HG13 ' A' ' 690' ' ' ILE . 29.0 t80 -81.19 104.39 11.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.7 p -117.73 133.38 64.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.467 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.516 ' HB ' HG22 ' A' ' 681' ' ' ILE . 4.7 mt -128.24 155.04 39.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.481 ' O ' HD22 ' A' ' 583' ' ' LEU . . . 179.43 132.77 1.83 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.578 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.577 ' HB2' HD22 ' A' ' 580' ' ' LEU . 9.7 m-30 -113.12 145.82 40.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.789 ' HB2' HD12 ' A' ' 583' ' ' LEU . 3.2 ttmt -101.2 117.66 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.991 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.861 HG23 HD21 ' A' ' 580' ' ' LEU . 2.3 t -80.1 117.95 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.321 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 579' ' ' THR . 7.0 tt0 -126.09 109.29 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 110.266 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 705' ' ' GLU . 41.0 mt -80.37 105.88 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -91.06 -45.32 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.118 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 577' ' ' PHE . 9.4 t0 -110.37 141.08 43.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.29 100.11 8.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.445 0.641 . . . . 0.0 109.559 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 700' ' ' THR . 31.0 m -84.23 57.23 4.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.966 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 85.28 37.37 9.89 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -78.02 129.75 35.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.654 0.227 . . . . 0.0 110.433 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.569 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.8 p90 -42.04 -33.99 0.65 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.627 0.727 . . . . 0.0 110.104 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.814 HD22 HD23 ' A' ' 707' ' ' LEU . 0.0 OUTLIER -146.57 -63.27 0.3 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.857 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.687 ' O ' HD12 ' A' ' 696' ' ' ILE . 8.3 pt-20 145.52 32.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.891 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 67.22 77.07 0.33 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.484 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.814 HD23 HD22 ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.08 -9.82 17.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.989 0.394 . . . . 0.0 111.687 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.411 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 79.76 38.16 20.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.521 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.442 ' CE ' ' CE1' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -96.69 116.84 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 0.0 111.099 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -176.89 164.96 2.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.937 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -58.02 -42.52 85.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -88.52 139.27 30.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.49 100.33 13.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.1 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.744 HH21 HD22 ' A' ' 659' ' ' LEU . 4.5 mmm-85 41.06 86.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.785 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.9 m -124.63 142.85 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.604 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.682 HG21 ' O ' ' A' ' 663' ' ' ARG . 48.4 t -79.63 123.77 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.167 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 166.37 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 135.28 45.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -85.1 160.0 20.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.57 -174.34 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -29.32 36.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.39 -52.09 67.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.692 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.742 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.4 OUTLIER -68.08 -42.37 80.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.587 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -33.46 72.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.85 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.47 -40.83 93.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.049 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.2 mt -57.73 -44.3 85.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.054 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.463 HG23 HG11 ' A' ' 621' ' ' VAL . 9.4 p -79.41 -27.34 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -57.78 -35.44 70.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -97.54 25.85 5.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.665 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 730' ' ' LEU . 5.6 tt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.826 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.775 0.321 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 17.9 t -71.38 70.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.001 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -122.45 -165.35 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.891 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 64.55 116.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.822 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 72.27 3.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.741 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -60.56 119.46 8.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.594 HD13 ' CG ' ' A' ' 683' ' ' ASP . 9.3 mt -83.51 -46.05 0.81 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.308 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 607' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' P' ' 606' ' ' LEU . 78.5 Cg_exo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 122.326 2.017 . . . . 0.0 112.456 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.71 1.71 57.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.561 0.22 . . . . 0.0 111.439 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.425 ' O ' ' CG ' ' A' ' 595' ' ' GLN . . . 122.76 -27.36 5.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.471 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.0 OUTLIER -78.36 121.14 24.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.966 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -107.78 -52.54 2.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.226 -178.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 594' ' ' ILE . 9.3 tt -119.59 142.46 48.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.552 ' N ' HD23 ' A' ' 578' ' ' LEU . 6.1 m -119.85 114.42 22.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.669 ' HB3' HD12 ' A' ' 592' ' ' LEU . 0.4 OUTLIER -102.18 108.46 19.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.1 pttp -118.01 99.76 51.98 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -176.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.9 Cg_exo -46.0 102.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.815 1.677 . . . . 0.0 109.603 176.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -75.01 157.6 85.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.418 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.37 -24.75 9.09 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.866 3.044 . . . . 0.0 113.382 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.13 -24.11 66.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 1.5 t -95.95 152.01 18.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.93 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 587' ' ' ILE . 0.2 OUTLIER -56.33 -15.19 2.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.285 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.541 HG23 ' CB ' ' A' ' 582' ' ' PRO . 3.3 tt -112.58 124.88 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.849 0.357 . . . . 0.0 111.656 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.418 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -107.68 71.25 0.81 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.563 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 48.9 mt-10 -125.55 169.89 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.521 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.27 128.17 42.69 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.154 0.502 . . . . 0.0 110.917 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.909 HD21 HD11 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -112.48 140.09 47.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.637 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 20.4 mt-10 -124.06 113.81 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.884 HD12 HD22 ' A' ' 578' ' ' LEU . 83.6 mt -86.32 109.75 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -76.63 128.81 35.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 2.4 pt20 -47.04 -30.24 2.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.367 0.603 . . . . 0.0 110.085 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.432 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -25.56 74.43 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.035 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.89 117.87 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.991 0.896 . . . . 0.0 111.924 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.25 122.13 9.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.861 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.58 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.6 Cg_endo -90.77 159.55 30.17 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.395 -1.085 . . . . 0.0 111.649 -0.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.25 115.83 28.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.795 ' CG ' HD12 ' A' ' 730' ' ' LEU . 42.9 m-85 -92.57 138.05 31.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.05 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.762 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.1 mp -126.47 145.15 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.511 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.99 -168.44 39.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.495 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.413 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 12.2 ttp85 -82.41 -19.22 39.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.614 0.245 . . . . 0.0 111.343 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.04 132.65 34.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -21.55 45.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.06 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.8 -29.36 64.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.908 0.385 . . . . 0.0 110.644 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.8 m -74.92 130.2 38.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.925 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 34.3 m120 -45.24 -31.86 1.7 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.26 0.552 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.776 ' SG ' HD13 ' A' ' 592' ' ' LEU . 43.8 t -107.87 142.74 37.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.618 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.97 116.29 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.909 HD11 HD21 ' A' ' 592' ' ' LEU . 26.7 mm -137.96 109.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.678 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.4 tt0 -92.43 103.49 15.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.881 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.712 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.6 t70 -132.22 117.06 17.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.021 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -46.16 -31.15 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.794 0.331 . . . . 0.0 111.194 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.58 ' HG2' HD11 ' P' ' 606' ' ' LEU . 1.7 mpt_? -77.73 -35.7 51.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.712 HD13 ' CB ' ' A' ' 615' ' ' ASP . 1.2 mp -66.38 159.69 26.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.3 m -108.61 167.09 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -48.93 22.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.239 0.542 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.651 HG11 HG23 ' A' ' 727' ' ' VAL . 10.3 t -119.74 61.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.279 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 653' ' ' GLY . 28.2 t60 -49.13 -45.57 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.995 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -167.65 155.81 9.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.053 0.454 . . . . 0.0 111.339 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 603' ' ' ILE . 48.2 p90 -143.22 144.32 32.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.768 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -101.39 131.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.58 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.9 t80 -126.54 133.3 51.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.027 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.71 ' HB2' HG22 ' A' ' 647' ' ' ILE . 31.0 ttmt -98.44 133.6 42.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.91 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 159.62 40.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.771 -178.47 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.2 tpt180 -75.6 115.07 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.372 0.606 . . . . 0.0 110.533 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 -61.53 135.18 57.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.309 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -70.12 -162.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.869 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 633' ' ' GLY . 6.8 p -169.11 159.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.962 0.411 . . . . 0.0 111.109 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.518 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -145.95 90.2 0.15 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.478 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt 59.65 175.19 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.713 0.292 . . . . 0.0 110.806 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 1.8 p -163.97 36.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.018 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 25.3 ttp -60.47 113.28 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 2.7 t80 71.94 -62.55 0.46 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -75.86 144.28 41.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.0 89.85 21.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -62.14 -154.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.739 2.293 . . . . 0.0 112.311 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -63.63 -14.17 49.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.61 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 78.44 -66.51 0.2 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.713 0.292 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.539 ' C ' HD23 ' A' ' 644' ' ' LEU . . . 154.01 68.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.808 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.933 HD12 ' O ' ' A' ' 702' ' ' LEU . 0.1 OUTLIER -108.8 -154.23 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.668 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 702' ' ' LEU . 4.0 m-20 -107.06 137.78 44.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' A' ' 671' ' ' LEU . 2.4 t0 -116.03 157.39 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.811 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.966 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 4.7 pt -109.4 117.08 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.502 0.668 . . . . 0.0 111.851 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.908 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 70.9 m95 -102.78 131.23 49.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.623 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.701 ' HB2' HD11 ' A' ' 672' ' ' LEU . 27.7 t80 -91.16 117.13 29.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 624' ' ' PHE . 23.6 m -103.95 123.98 48.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.298 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.456 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 68.8 t60 -102.25 134.51 45.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -134.38 8.65 3.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.33 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.92 151.35 26.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.63 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.6 t -73.67 -29.04 62.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.126 0.489 . . . . 0.0 111.464 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.608 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.1 m120 -72.66 -1.8 17.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.539 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 54.74 124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 111.877 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.451 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -98.02 166.41 11.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.257 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -134.21 126.21 29.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.076 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.764 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -93.74 99.45 11.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.298 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 61.92 -78.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.689 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 15.4 p-10 -129.08 -8.17 4.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.735 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.446 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 9.9 m120 -92.6 140.62 29.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -83.52 141.67 31.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.629 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.636 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 3.2 mtp -125.4 121.81 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.273 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.416 HG12 ' CG2' ' A' ' 668' ' ' THR . 33.7 pt -103.48 156.54 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.546 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -48.2 104.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.38 . . . . 0.0 111.343 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.4 35.73 2.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.4 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.416 ' CG2' HG12 ' A' ' 665' ' ' ILE . 2.8 p -117.63 162.03 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.741 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.515 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.0 OUTLIER -131.82 145.03 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.061 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.636 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 3.4 t80 -147.76 145.89 28.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.908 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.27 130.27 42.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.3 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.764 ' CD2' HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -109.76 129.58 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.143 0.497 . . . . 0.0 111.154 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.434 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 1.0 OUTLIER -125.01 144.66 50.27 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.786 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.509 ' H ' ' HA3' ' A' ' 706' ' ' GLY . 11.0 t70 -41.88 118.6 1.14 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.854 0.359 . . . . 0.0 110.91 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.02 33.83 7.55 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.25 109.89 21.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 111.126 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.501 ' HG3' HD11 ' A' ' 583' ' ' LEU . 15.2 tt0 -95.63 108.21 20.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.651 HG12 HD22 ' A' ' 659' ' ' LEU . 13.7 mt -105.46 122.63 59.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.581 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -78.91 115.9 18.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.71 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.734 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 1.1 mt -79.34 -32.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 690' ' ' ILE . 6.9 tt -154.98 131.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.63 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.56 126.7 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.567 ' OD1' HD13 ' P' ' 606' ' ' LEU . 65.0 m-20 -126.23 117.39 22.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.226 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -46.58 73.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.105 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -73.57 -40.51 63.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.3 -14.24 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.603 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp 59.74 18.43 7.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.435 ' CE1' ' NH1' ' A' ' 617' ' ' ARG . 36.8 t80 -82.72 105.18 13.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.2 p -121.87 123.69 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.707 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 681' ' ' ILE . 3.9 tt -127.57 125.08 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.487 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.76 148.17 16.84 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.18 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.734 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 0.3 OUTLIER -116.14 151.94 34.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.666 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.47 117.39 34.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.788 HG22 HD21 ' A' ' 578' ' ' LEU . 2.5 t -75.16 128.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.347 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 579' ' ' THR . 5.6 tt0 -133.14 109.01 9.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 674' ' ' ASP . 39.9 mt -83.32 105.06 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.391 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.91 -45.88 11.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.492 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -110.24 140.77 44.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.331 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.8 p -114.03 99.32 7.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.338 0.59 . . . . 0.0 109.715 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 26.3 m -82.36 69.77 9.18 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.147 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 65.79 40.53 95.69 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.388 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.933 ' O ' HD12 ' A' ' 644' ' ' LEU . 1.8 mm? -62.58 129.82 42.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.455 0.169 . . . . 0.0 110.997 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 704' ' ' ASN . 3.4 p90 -37.32 -33.65 0.07 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.252 0.549 . . . . 0.0 111.162 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.608 ' ND2' ' HG2' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -141.29 -43.14 0.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.717 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.608 ' HG2' ' ND2' ' A' ' 704' ' ' ASN . 16.5 pt-20 137.89 -32.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.189 0.931 . . . . 0.0 109.342 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.509 ' HA3' ' H ' ' A' ' 674' ' ' ASP . . . 119.37 15.74 5.39 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.08 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.29 8.96 39.99 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 90.83 -141.58 15.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.874 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.65 ' C ' HD23 ' A' ' 710' ' ' LEU . 0.0 OUTLIER 172.57 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.691 0.245 . . . . 0.0 111.212 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.65 HD23 ' C ' ' A' ' 709' ' ' MET . 0.7 OUTLIER 36.92 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.802 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 77.08 121.16 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.919 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.54 98.89 0.13 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.039 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.54 118.83 34.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.316 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.446 ' HG3' ' CZ ' ' A' ' 670' ' ' PHE . 10.1 ptt180 -176.48 125.29 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.325 0.583 . . . . 0.0 110.788 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.417 ' O ' HD23 ' A' ' 717' ' ' LEU . 3.2 m -122.97 146.89 27.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.722 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 716' ' ' VAL . 5.1 p -76.83 121.01 28.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.931 0.396 . . . . 0.0 111.353 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.1 OUTLIER -101.14 172.25 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.68 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 153.06 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.196 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.19 160.09 25.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -125.03 -178.66 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -28.82 37.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -66.11 -46.64 76.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 726' ' ' LEU . 8.3 mp0 -68.6 -43.17 77.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.812 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -55.97 -37.0 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -67.98 -36.6 80.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.003 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 723' ' ' GLU . 91.5 mt -55.63 -44.27 76.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.651 HG23 HG11 ' A' ' 621' ' ' VAL . 8.1 p -77.93 -29.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.758 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -101.52 27.26 6.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.795 HD12 ' CG ' ' A' ' 602' ' ' PHE . 2.5 tt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.666 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.752 0.311 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' P' P ' 600' ' ' VAL . . . . . 0.639 ' O ' HG13 ' P' ' 600' ' ' VAL . 7.9 p -153.83 96.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.077 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -117.36 83.77 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 3.9 pp -168.66 157.98 8.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.521 HG22 ' O1P' ' P' ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -88.11 -30.63 19.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 60.86 96.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.924 HD12 HD11 ' A' ' 681' ' ' ILE . 3.7 mt -111.09 153.41 43.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.947 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.59 2.193 . . . . 0.0 112.393 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.95 -21.76 63.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.735 0.302 . . . . 0.0 111.095 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 147.1 -52.22 0.56 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.162 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -112.19 143.15 43.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.966 0.413 . . . . 0.0 111.451 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -126.98 -54.38 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.055 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.049 HD12 HD13 ' A' ' 647' ' ' ILE . 7.1 tt -112.98 138.49 49.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.355 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.757 ' N ' HD23 ' A' ' 578' ' ' LEU . 6.4 m -118.29 114.2 22.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.992 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.769 HD12 HD11 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -104.09 108.04 19.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.6 OUTLIER -116.89 100.99 53.66 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.43 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.1 Cg_exo -45.61 100.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.824 1.682 . . . . 0.0 109.597 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.61 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.33 157.02 86.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.31 -26.09 14.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.981 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.567 ' HB2' HD12 ' A' ' 583' ' ' LEU . 4.0 t0 -62.09 -27.22 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.423 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.4 t -95.62 154.2 17.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.704 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 31.2 pt -56.97 -11.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.729 0.299 . . . . 0.0 111.13 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.607 HD13 HG23 ' A' ' 613' ' ' ILE . 34.3 mt -108.72 122.33 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.744 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.63 57.04 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 110.404 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.533 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 mt-10 -124.62 171.06 10.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.194 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.06 129.32 46.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.073 0.463 . . . . 0.0 111.126 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.48 142.02 45.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.154 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.454 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.7 OUTLIER -124.3 114.41 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.822 HD12 HD22 ' A' ' 578' ' ' LEU . 87.4 mt -83.84 108.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -65.7 125.49 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.315 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.01 -26.92 1.97 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.169 0.509 . . . . 0.0 110.413 179.512 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -76.65 -21.85 73.78 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.472 -0.785 . . . . 0.0 114.153 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.38 117.74 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 118.324 1.062 . . . . 0.0 111.534 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 15.0 t30 -140.72 122.29 9.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.23 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.578 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.9 Cg_endo -90.56 160.09 31.47 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.42 -1.075 . . . . 0.0 111.391 -0.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.627 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.29 114.96 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.561 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 43.5 m-85 -91.88 138.18 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.833 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.78 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.91 145.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.369 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.49 -172.94 36.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.416 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.469 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.6 OUTLIER -67.41 -52.05 44.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.339 . . . . 0.0 111.859 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.49 126.44 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.25 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.276 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -30.36 62.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.064 0.459 . . . . 0.0 110.299 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.642 ' SG ' HG22 ' A' ' 621' ' ' VAL . 8.3 m -71.32 134.69 46.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.485 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 21.0 m-80 -48.43 -26.59 2.18 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.539 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 35.7 t -113.83 142.45 46.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.537 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.07 105.2 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.167 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.785 HD11 HD21 ' A' ' 592' ' ' LEU . 25.9 mm -138.98 109.51 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.334 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -104.0 106.4 16.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 112.459 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.585 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -130.43 107.53 9.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.65 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -41.19 -29.37 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.674 ' CD ' HD21 ' P' ' 606' ' ' LEU . 0.3 OUTLIER -67.2 -41.46 85.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.601 0.238 . . . . 0.0 111.473 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.585 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.86 158.99 17.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 0.0 111.711 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 92.2 p -78.41 172.86 13.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.364 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.477 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 3.3 mpt_? -47.72 -46.41 29.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.117 0.484 . . . . 0.0 110.278 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.642 HG22 ' SG ' ' A' ' 609' ' ' CYS . 46.5 t -119.8 70.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.199 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 12.8 t60 -49.72 -45.98 49.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.769 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.1 p -164.23 158.7 19.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.602 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.503 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.1 p90 -143.4 147.73 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.561 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.3 mp -102.64 131.12 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.578 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.7 t80 -122.29 133.88 54.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.63 ' HD3' HG23 ' A' ' 647' ' ' ILE . 1.6 tppp? -97.85 136.58 37.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.043 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.6 OUTLIER -135.31 159.04 42.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.819 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.6 tpt180 -76.69 112.26 13.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.312 0.577 . . . . 0.0 110.334 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.53 ' CE1' ' HE3' ' A' ' 709' ' ' MET . 4.0 t60 -80.57 123.96 28.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.745 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -142.74 131.73 23.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.299 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 5.4 m -108.13 119.95 58.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.02 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -87.64 57.05 4.44 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.603 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -176.25 81.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.98 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.66 52.35 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.757 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 22.4 ttt -62.5 120.34 10.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.956 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.4 -62.88 0.42 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.27 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.66 144.3 41.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.128 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 10.6 p -114.63 91.85 26.78 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.704 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.16 -148.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.668 2.245 . . . . 0.0 112.098 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.868 ' HB1' HD12 ' A' ' 644' ' ' LEU . . . -78.25 4.44 12.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.935 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 69.06 -77.89 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.715 0.293 . . . . 0.0 110.989 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -170.82 97.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.865 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.868 HD12 ' HB1' ' A' ' 641' ' ' ALA . 5.3 mt -115.45 -155.26 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 2.5 m-20 -116.47 147.34 41.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.242 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.405 ' OD1' ' CE2' ' A' ' 703' ' ' PHE . 2.1 m-20 -131.3 156.93 44.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.877 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.049 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -104.18 125.02 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.636 . . . . 0.0 112.29 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.871 ' CH2' HD22 ' A' ' 671' ' ' LEU . 82.5 m95 -108.79 123.08 48.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.653 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.581 ' CD2' HD13 ' A' ' 678' ' ' ILE . 3.0 t80 -89.82 116.08 27.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 62.4 m -100.68 142.6 31.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.451 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.459 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 74.4 t60 -118.97 130.96 55.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.4 p -125.64 2.73 7.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.014 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 150.68 38.05 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.401 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.408 HG21 ' CG ' ' P' ' 605' ' ' GLU . 2.0 t -73.3 -32.55 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.495 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.588 ' O ' HG13 ' A' ' 656' ' ' VAL . 17.3 m-20 -75.56 2.24 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.764 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.07 125.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.767 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 37.3 p -88.78 166.15 14.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.609 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.48 120.42 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.73 99.9 10.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.806 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.5 -83.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -131.44 4.32 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.454 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -113.66 116.85 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -84.3 141.28 31.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.485 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.78 142.33 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.261 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.422 ' O ' ' OG1' ' A' ' 668' ' ' THR . 31.2 pt -96.56 163.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -52.77 91.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.46 39.91 0.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.754 HG22 ' HA ' ' A' ' 718' ' ' LYS . 0.8 OUTLIER -137.48 158.5 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 111.266 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.577 ' HE2' HD13 ' A' ' 717' ' ' LEU . 18.9 pttm -128.18 158.5 37.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.621 ' HB3' HD23 ' A' ' 659' ' ' LEU . 15.3 t80 -145.37 146.75 31.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.871 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.78 129.32 39.48 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.36 -179.206 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.774 HD13 HG21 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -103.82 130.8 51.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.242 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.939 ' HB3' HD12 ' A' ' 707' ' ' LEU . 0.0 OUTLIER -121.94 150.37 42.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.5 -179.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 696' ' ' ILE . 19.3 t0 -50.12 105.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.369 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.28 32.7 4.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.48 113.11 25.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.04 108.84 21.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.226 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.666 HG12 HD13 ' A' ' 659' ' ' LEU . 6.4 mt -105.91 136.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.795 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 116.5 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.864 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.518 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -79.72 -36.34 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.256 -179.17 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.714 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.2 tp -155.15 131.35 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 112.085 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -136.74 122.76 20.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.914 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.783 ' OD2' HD22 ' P' ' 606' ' ' LEU . 7.7 t0 -126.6 117.02 21.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.906 0.384 . . . . 0.0 110.687 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -46.37 73.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.867 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.74 -40.59 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.687 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.73 -9.61 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.519 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 15.8 tttt 60.61 17.56 7.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.951 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 7.5 t80 -77.5 104.97 8.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.5 p -121.71 121.77 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.168 0.509 . . . . 0.0 112.143 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' A' ' 681' ' ' ILE . 8.7 mt -128.72 153.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.423 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -179.76 137.14 2.97 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.148 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.487 ' CE2' HD11 ' A' ' 592' ' ' LEU . 9.0 m-30 -113.24 144.82 42.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.716 0.293 . . . . 0.0 110.422 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.61 ' HB2' HD22 ' A' ' 583' ' ' LEU . 13.3 tptm -101.07 116.85 33.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.996 0.427 . . . . 0.0 110.256 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 672' ' ' LEU . 3.8 t -79.68 125.37 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.636 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.1 109.16 9.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.548 HG23 ' CD1' ' A' ' 577' ' ' PHE . 17.4 mt -84.24 105.7 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.68 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -88.46 -46.02 9.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -110.96 139.53 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.812 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.3 OUTLIER -115.21 101.64 9.15 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.217 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.9 t -66.08 64.13 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.403 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 51.33 48.71 47.16 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.998 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.826 HD11 ' CA ' ' A' ' 705' ' ' GLU . 1.0 OUTLIER -111.62 163.47 14.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.818 0.342 . . . . 0.0 111.122 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.746 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -58.08 110.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.381 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.496 ' CG ' ' HG2' ' A' ' 705' ' ' GLU . 8.7 t-20 55.12 -76.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 0.0 110.674 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.826 ' CA ' HD11 ' A' ' 702' ' ' LEU . 6.7 pt-20 179.82 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.305 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 148.08 39.67 0.04 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.792 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.939 HD12 ' HB3' ' A' ' 673' ' ' GLN . 1.9 mp -85.75 7.89 21.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.474 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 83.5 -90.32 1.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.411 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.53 ' HE3' ' CE1' ' A' ' 630' ' ' HIS . 0.6 OUTLIER 60.16 91.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.368 . . . . 0.0 110.443 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 710' ' ' LEU . 2.5 pt? -171.32 -167.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -69.46 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.853 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -76.6 139.34 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.609 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -95.92 110.71 22.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.223 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.416 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 2.8 mmm-85 53.39 76.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.74 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.77 142.87 41.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.193 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.423 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 7.4 p -85.38 128.94 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 111.378 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.577 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -97.05 166.99 11.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 718' ' ' LYS . . . . . 0.754 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.6 OUTLIER -103.23 154.81 18.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -87.35 154.69 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.746 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.22 -177.5 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.3 -30.51 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -47.47 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.695 ' HA ' HD12 ' A' ' 726' ' ' LEU . 57.7 mm-40 -66.97 -47.32 71.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -55.73 -32.99 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.95 -37.79 82.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.695 HD12 ' HA ' ' A' ' 723' ' ' GLU . 15.6 mt -57.55 -44.14 84.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.12 -15.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -45.19 83.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 110.616 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -72.45 -14.43 61.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.21 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.463 HD13 HG21 ' A' ' 621' ' ' VAL . 8.7 tt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.053 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.798 0.332 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' P' P ' 600' ' ' VAL . . . . . 0.57 ' O ' HG12 ' P' ' 600' ' ' VAL . 25.6 t -94.3 47.18 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.098 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -79.5 65.17 4.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.807 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.8 -173.7 4.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 603' ' ' TPO . . . . . 0.665 HG23 ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 88.2 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 605' ' ' GLU . . . . . 0.408 ' CG ' HG21 ' A' ' 654' ' ' THR . 17.6 mt-10 -65.67 100.59 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.763 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.783 HD22 ' OD2' ' A' ' 683' ' ' ASP . 25.4 mt -64.89 149.85 95.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.558 2.172 . . . . 0.0 112.362 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.51 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 8.7 ttm180 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.642 0.258 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.773 ' CE1' HG21 ' A' ' 647' ' ' ILE . 5.5 t80 -122.43 -57.07 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.026 HD11 HG13 ' A' ' 694' ' ' VAL . 20.3 tp -111.04 142.36 43.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.381 . . . . 0.0 111.176 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 695' ' ' GLU . 3.5 m -121.17 114.34 21.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.951 ' CD2' HG23 ' A' ' 694' ' ' VAL . 5.6 mt -103.37 108.38 19.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 7.7 mtmt -113.71 99.81 50.74 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -176.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.616 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.6 Cg_exo -47.02 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.692 1.595 . . . . 0.0 109.606 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.654 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.59 157.25 86.29 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.418 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 9.4 Cg_endo -51.53 -25.9 20.65 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.775 2.983 . . . . 0.0 112.841 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 583' ' ' LEU . 5.2 t0 -61.91 -27.46 68.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.408 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.9 t -95.68 154.11 17.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.797 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.719 HD11 HD11 ' A' ' 690' ' ' ILE . 12.6 pt -55.92 -11.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.704 0.288 . . . . 0.0 111.296 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.477 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.4 mt -109.58 124.88 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.794 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -112.46 57.1 0.66 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.57 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.616 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 tt0 -124.87 171.53 10.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.012 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.64 128.83 46.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.012 0.434 . . . . 0.0 110.846 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.719 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -111.97 141.04 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.931 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.51 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -123.93 115.93 22.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.679 0.276 . . . . 0.0 111.611 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.922 HD11 HD12 ' A' ' 625' ' ' ILE . 80.2 mt -82.61 108.95 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.395 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.91 118.2 10.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.994 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.648 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.36 -28.45 1.33 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.44 -23.13 75.15 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.366 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.02 118.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.775 0.788 . . . . 0.0 111.502 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.5 t30 -139.5 122.58 10.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.929 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.8 Cg_endo -90.44 159.92 31.96 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.723 -0.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.667 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.95 115.28 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.553 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 32.2 m-85 -92.29 138.0 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.071 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.81 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.6 mp -124.73 145.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.625 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.09 -172.23 35.77 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.655 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -68.47 -52.31 33.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.975 0.417 . . . . 0.0 111.723 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -60.2 126.27 26.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.323 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.71 -20.13 2.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.133 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.87 -31.95 60.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.145 0.498 . . . . 0.0 110.201 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.673 ' SG ' HG22 ' A' ' 621' ' ' VAL . 11.4 m -70.74 130.19 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.8 m120 -44.52 -32.63 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.185 0.517 . . . . 0.0 110.39 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.81 ' SG ' HG23 ' A' ' 603' ' ' ILE . 25.9 t -107.35 142.3 37.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.041 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 104.55 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.59 HD11 HD21 ' A' ' 592' ' ' LEU . 24.1 mm -139.6 109.84 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.329 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -103.61 107.04 17.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.46 0.648 . . . . 0.0 112.42 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.574 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -129.16 107.49 9.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.602 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -40.46 -28.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -69.46 -41.28 76.42 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.574 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.22 159.11 17.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.75 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -78.18 173.29 12.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.222 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.522 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -46.7 -52.52 13.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.089 0.471 . . . . 0.0 110.187 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.673 HG22 ' SG ' ' A' ' 609' ' ' CYS . 41.6 t -114.44 70.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.291 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.536 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 11.4 t60 -48.06 -44.23 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.683 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 3.5 p -166.85 159.18 13.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 111.334 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.7 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.1 p90 -143.2 149.41 37.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.922 HD12 HD11 ' A' ' 594' ' ' ILE . 37.7 mt -102.14 135.16 40.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.001 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.3 t80 -128.68 134.48 48.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.3 ttmt -98.26 136.59 38.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.9 157.63 46.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.546 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.01 114.74 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.321 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.341 0.115 . . . . 0.0 110.863 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.0 OUTLIER -112.94 148.9 34.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.309 0.576 . . . . 0.0 112.464 -178.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.568 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -135.19 129.6 34.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.787 179.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.788 HD12 ' HB2' ' A' ' 672' ' ' LEU . 2.1 pt -87.16 122.85 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.355 0.598 . . . . 0.0 111.918 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.599 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.8 m95 -105.83 148.98 26.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.159 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.588 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.0 t80 -108.16 116.61 32.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.7 m -102.07 137.66 40.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 62.4 t60 -118.4 131.59 56.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.43 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.9 p -129.04 5.79 5.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.303 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.8 151.6 32.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.637 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.477 HG23 ' N ' ' A' ' 655' ' ' ASN . 14.6 t -76.78 -44.33 33.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.016 0.436 . . . . 0.0 111.414 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.486 ' C ' HG23 ' A' ' 656' ' ' VAL . 2.1 m-20 -58.82 -18.09 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.795 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 664' ' ' MET . 4.4 t 78.55 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.142 0.496 . . . . 0.0 111.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 93.2 p -114.52 152.22 32.07 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -124.39 119.79 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.33 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.622 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -94.96 99.86 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.083 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 61.19 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.899 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.3 t30 -135.64 -0.44 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.481 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 1.7 m120 -101.0 135.41 42.49 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.927 0.394 . . . . 0.0 111.287 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 41.6 ttm-85 -75.59 141.17 42.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.573 ' O ' HG13 ' A' ' 656' ' ' VAL . 19.5 mmm -126.32 94.61 4.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.411 HG12 ' CG2' ' A' ' 668' ' ' THR . 32.7 pt -87.67 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.578 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -48.8 110.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.201 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 100.96 30.78 5.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.287 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.411 ' CG2' HG12 ' A' ' 665' ' ' ILE . 13.8 p -112.78 162.28 15.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 111.348 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.9 ttpm? -143.81 133.95 24.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.57 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -139.88 143.48 36.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.812 0.339 . . . . 0.0 111.165 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.599 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.64 140.55 53.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.788 ' HB2' HD12 ' A' ' 647' ' ' ILE . 5.0 mt -109.43 125.98 52.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.68 147.16 31.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -48.53 103.7 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 110.465 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.67 33.62 3.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.81 118.8 30.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.533 -0.334 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -96.18 111.5 23.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.622 HG22 HD13 ' A' ' 659' ' ' LEU . 30.6 pt -105.71 137.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 112.064 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.42 116.54 30.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.894 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.536 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -84.96 -38.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 690' ' ' ILE . 3.1 tp -155.18 131.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.696 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -136.84 124.88 22.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.369 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.31 116.66 20.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.792 0.329 . . . . 0.0 110.306 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -67.36 -46.57 72.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.125 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -74.51 -40.49 61.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.917 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -87.64 -7.12 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.535 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tttt 59.13 18.18 6.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.732 0.301 . . . . 0.0 110.948 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -77.54 105.02 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.2 p -124.12 121.65 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 111.917 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.772 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.5 mt -128.79 150.34 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.179 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.61 138.68 3.54 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.626 ' HB2' HD22 ' A' ' 580' ' ' LEU . 7.8 m-30 -113.46 148.71 35.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.788 0.328 . . . . 0.0 110.449 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.452 ' HB2' HD22 ' A' ' 583' ' ' LEU . 3.6 tttm -101.33 116.95 33.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 1.026 HG13 HD11 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -81.55 123.1 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.407 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.6 OUTLIER -133.28 109.46 9.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.589 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.625 HG12 HD13 ' A' ' 578' ' ' LEU . 14.9 mt -78.39 105.53 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.703 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -47.95 11.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.22 139.83 46.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.875 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.445 -0.697 0 CA-C-O 121.117 0.484 . . . . 0.0 109.727 178.283 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.4 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.778 0.323 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.31 172.2 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -100.64 150.54 22.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -75.27 153.22 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -119.36 -179.17 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.27 -29.53 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -65.96 -50.28 64.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -51.07 66.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.916 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -56.01 -32.86 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.63 -36.77 83.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.988 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.58 -44.16 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.6 p -76.48 -27.59 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -36.02 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.421 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 1.3 ttm-85 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.558 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 7.8 t80 -122.66 -48.07 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.752 HD11 ' CG1' ' A' ' 694' ' ' VAL . 8.2 tp -119.55 141.98 48.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 40.3 m -122.39 114.53 20.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.813 ' HG ' HG22 ' A' ' 694' ' ' VAL . 1.7 mp -105.63 108.57 20.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 8.4 ptpt -117.04 100.53 53.36 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 26.7 Cg_exo -44.77 104.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.739 1.626 . . . . 0.0 109.47 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.737 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.47 157.17 86.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.561 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 73.2 Cg_exo -49.18 -32.6 25.18 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.617 2.878 . . . . 0.0 112.891 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.737 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.5 OUTLIER -63.88 -21.76 66.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.88 0.371 . . . . 0.0 110.577 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.67 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 22.7 p -96.43 153.46 17.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.998 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.823 HG22 HG12 ' A' ' 690' ' ' ILE . 1.2 tt -52.49 -18.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.871 0.367 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 582' ' ' PRO . 10.8 mt -111.25 119.78 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.162 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.67 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -110.37 57.71 0.61 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.295 0.569 . . . . 0.0 110.758 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.553 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.0 mt-10 -125.13 172.08 9.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.578 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.54 128.31 46.66 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.144 0.497 . . . . 0.0 111.474 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.765 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -113.09 138.81 49.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.831 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.421 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 3.6 mp0 -123.92 115.76 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.973 HD11 HD12 ' A' ' 625' ' ' ILE . 46.3 mt -80.32 109.75 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.923 0.392 . . . . 0.0 111.033 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.75 113.05 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.522 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.558 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.66 -30.68 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.456 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.05 -22.61 70.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.376 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.63 HG11 ' OD1' ' A' ' 610' ' ' ASN . 67.9 t -101.3 119.6 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 117.669 0.734 . . . . 0.0 111.538 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.3 t30 -138.66 122.73 11.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.59 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.38 160.47 32.53 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.618 -0.992 . . . . 0.0 111.994 0.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.705 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.6 115.68 28.25 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.562 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 51.0 m-85 -92.39 138.28 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.036 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.3 mp -127.15 145.42 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.588 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.09 -178.3 34.42 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.327 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -59.58 -52.68 64.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.88 0.372 . . . . 0.0 111.849 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.51 122.9 15.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.455 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -21.04 2.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.734 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -51.9 -30.52 24.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.177 0.513 . . . . 0.0 110.08 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.591 ' SG ' HG22 ' A' ' 621' ' ' VAL . 95.0 m -73.57 129.37 37.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.338 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 13.4 m-80 -45.55 -29.5 1.19 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.128 0.49 . . . . 0.0 110.621 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.765 ' SG ' HD13 ' A' ' 592' ' ' LEU . 53.4 t -109.22 142.91 39.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.47 106.93 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.462 HG13 ' CE2' ' A' ' 692' ' ' PHE . 30.9 mm -138.14 109.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.916 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.09 107.15 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.458 0.647 . . . . 0.0 112.369 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.579 ' OD2' HG21 ' A' ' 681' ' ' ILE . 10.9 t0 -129.1 107.55 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.123 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -41.74 -31.2 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.676 ' HB3' HD11 ' A' ' 681' ' ' ILE . 2.0 mtt180 -77.43 -38.15 50.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.303 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.774 HD23 ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -89.67 147.25 23.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.831 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.45 162.73 12.04 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.841 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.1 OUTLIER -63.15 -17.69 62.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.504 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.841 HG23 ' HG2' ' A' ' 620' ' ' ARG . 29.4 t -137.38 55.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.617 ' CG ' HD12 ' A' ' 618' ' ' LEU . 6.8 t60 -47.66 -43.06 25.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.421 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.464 ' SG ' HD11 ' A' ' 680' ' ' ILE . 4.3 p -164.29 158.68 19.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 112.261 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.797 ' HA ' HD12 ' A' ' 603' ' ' ILE . 50.2 p90 -143.74 146.07 32.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.241 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.973 HD12 HD11 ' A' ' 594' ' ' ILE . 71.2 mt -102.18 128.62 54.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.522 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -119.49 134.68 55.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.504 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 35.4 ttmt -97.42 133.66 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.413 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.14 159.11 42.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.175 -178.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.3 tpt180 -77.07 112.43 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.282 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.091 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 644' ' ' LEU . 4.4 mp . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -114.3 146.44 40.47 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.214 0.531 . . . . 0.0 112.025 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.61 157.65 46.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.137 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.718 HD13 HD13 ' A' ' 578' ' ' LEU . 2.7 pt -103.8 118.73 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.462 0.649 . . . . 0.0 111.835 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.969 ' CH2' HD22 ' A' ' 671' ' ' LEU . 89.0 m95 -100.47 127.97 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.206 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.572 ' CD2' HD13 ' A' ' 678' ' ' ILE . 2.6 t80 -90.21 116.69 28.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 14.3 m -103.36 142.12 34.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.374 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.468 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 29.5 t60 -121.15 133.06 55.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.981 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 5.6 p -131.26 9.81 4.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.422 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -82.15 151.13 29.69 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.832 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.9 t -76.39 -33.91 58.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.156 0.503 . . . . 0.0 111.365 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.86 3.09 7.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.33 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 664' ' ' MET . 1.5 p 50.7 142.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.731 0.777 . . . . 0.0 112.423 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.427 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 95.8 p -112.34 166.38 11.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.286 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -129.38 120.31 25.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 111.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -103.98 99.93 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.021 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.1 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 9.0 m120 -144.91 -0.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.601 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -103.54 141.28 36.27 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.95 0.405 . . . . 0.0 111.312 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -79.6 141.97 36.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.606 ' O ' HG23 ' A' ' 656' ' ' VAL . 23.1 mmm -118.04 97.86 6.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.2 pt -87.44 146.98 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -45.19 98.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.416 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.56 37.94 1.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.523 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 4.5 p -135.66 152.61 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.79 0.329 . . . . 0.0 111.336 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 15.1 pttm -123.68 158.03 32.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.282 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.527 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 0.2 OUTLIER -142.59 142.49 32.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.969 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -69.81 125.48 26.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.975 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.559 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.8 mt -101.33 136.14 41.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.383 0.611 . . . . 0.0 111.891 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.22 137.33 54.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.251 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.601 ' HB3' HD12 ' A' ' 696' ' ' ILE . 1.8 p30 -39.8 118.81 0.91 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.955 0.407 . . . . 0.0 110.843 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.24 36.36 5.72 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.334 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.513 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -94.95 116.76 29.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.4 108.77 21.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.122 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 9.0 mt -107.95 130.19 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -93.79 116.07 28.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.828 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.464 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.0 OUTLIER -77.96 -35.69 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.462 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 617' ' ' ARG . 8.9 tt -154.8 134.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.854 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.33 123.31 21.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -120.92 117.0 26.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.552 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -67.55 -46.59 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.134 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -75.91 -40.68 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.862 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.33 -12.23 49.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.464 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.13 15.61 8.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.697 0.284 . . . . 0.0 110.873 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.566 ' CE1' HG21 ' A' ' 587' ' ' ILE . 2.3 t80 -76.86 105.12 7.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -121.46 122.43 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 112.122 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.823 HG12 HG22 ' A' ' 587' ' ' ILE . 7.6 mt -116.31 145.25 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.743 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -170.47 131.23 2.18 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.481 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.462 ' CE2' HG13 ' A' ' 613' ' ' ILE . 3.3 m-30 -113.81 147.03 39.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.343 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.601 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.1 tttt -101.2 116.91 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.491 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.813 HG22 ' HG ' ' A' ' 580' ' ' LEU . 3.5 t -81.74 127.34 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.603 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.28 108.71 8.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 0.0 111.146 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 674' ' ' ASP . 95.6 mt -73.28 105.42 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.504 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -81.16 -45.91 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 109.941 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.4 t0 -110.74 140.68 44.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.878 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.216 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.601 HG23 ' CG ' ' A' ' 662' ' ' ASN . 40.8 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.797 0.332 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.01 147.21 35.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.81 147.02 30.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.36 160.07 24.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.978 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 14.8 p -126.14 -175.75 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.62 -30.93 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.37 -47.29 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.732 ' HA ' HD12 ' A' ' 726' ' ' LEU . 29.9 mm-40 -64.42 -49.93 69.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -57.25 -32.79 66.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.43 -36.92 82.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 723' ' ' GLU . 12.6 mt -59.76 -44.22 93.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.088 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.5 p -81.93 -29.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -55.75 -28.9 58.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mttp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.906 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.464 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.1 tmm_? . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.538 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -122.02 -64.98 1.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.346 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.009 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -106.31 125.64 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.843 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.725 HG22 ' HG3' ' A' ' 581' ' ' LYS . 24.3 m -104.68 117.2 33.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.637 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -105.96 108.08 19.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.725 ' HG3' HG22 ' A' ' 579' ' ' THR . 0.0 OUTLIER -112.66 99.12 46.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.3 Cg_exo -48.25 103.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.482 1.455 . . . . 0.0 109.009 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -73.51 157.26 88.04 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.47 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 10.3 Cg_endo -50.92 -29.16 26.11 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.613 2.876 . . . . 0.0 112.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.558 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -63.72 -15.23 57.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.913 0.387 . . . . 0.0 110.219 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.53 153.71 17.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.543 HG21 ' CZ ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -50.04 -24.44 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.908 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.5 tt -112.82 144.1 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.113 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.47 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.25 65.41 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 110.785 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 37.1 mt-10 -125.65 172.1 10.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.054 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.9 127.44 44.9 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.914 0.388 . . . . 0.0 110.99 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.94 143.58 43.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.966 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.464 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.39 118.08 25.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.738 HD12 HD22 ' A' ' 578' ' ' LEU . 55.1 mt -82.39 108.6 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.11 0.481 . . . . 0.0 110.156 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.0 mp0 -68.67 105.43 2.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.538 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -33.3 -54.23 0.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.209 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -47.39 -21.94 1.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.526 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.504 HG11 ' OD1' ' A' ' 610' ' ' ASN . 53.0 t -99.38 118.39 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.256 0.528 . . . . 0.0 111.293 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.5 t30 -140.13 123.21 10.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.127 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.561 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.4 Cg_endo -90.45 159.77 31.85 Favored 'Cis proline' 0 N--CA 1.461 -0.431 0 C-N-CA 124.411 -1.079 . . . . 0.0 111.832 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.698 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.61 115.88 28.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.512 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.7 m-85 -92.42 138.39 31.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.044 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.749 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mp -126.4 145.79 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.668 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.62 -171.83 38.54 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.134 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.484 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -69.57 -50.2 47.02 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.498 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -60.78 131.46 50.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -59.01 -18.04 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.654 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -55.33 -32.41 62.47 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 121.081 0.467 . . . . 0.0 110.241 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.509 ' SG ' HG22 ' A' ' 621' ' ' VAL . 34.5 m -71.53 132.46 44.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 2.4 m-80 -47.12 -27.09 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 0.0 110.681 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.768 ' SG ' HD13 ' A' ' 592' ' ' LEU . 40.4 t -112.75 142.51 45.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.293 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 105.62 13.87 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 592' ' ' LEU . 21.4 mm -138.21 109.28 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.43 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.12 106.24 16.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.556 0.693 . . . . 0.0 112.453 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.622 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.3 t0 -130.19 107.8 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.698 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -40.01 -29.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.436 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -68.93 -41.5 78.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.622 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.3 pp -90.12 158.8 17.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 12.8 t -76.91 162.98 27.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.049 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.6 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.7 OUTLIER -52.08 -26.68 11.65 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.441 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.6 HG23 ' HG2' ' A' ' 620' ' ' ARG . 37.6 t -130.71 62.7 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.838 ' CD2' HG23 ' A' ' 680' ' ' ILE . 25.1 t60 -51.8 -47.22 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.381 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 6.1 p -165.01 162.5 20.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.234 0.54 . . . . 0.0 112.138 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 603' ' ' ILE . 53.8 p90 -143.59 147.31 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.766 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.671 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.35 130.57 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.021 0.438 . . . . 0.0 109.981 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -122.12 133.62 54.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.607 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 30.9 ttmt -97.72 136.99 37.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.455 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.23 158.82 43.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.947 -178.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.2 tpt180 -76.64 112.34 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.1 t60 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.384 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.7 mp . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -118.48 146.62 44.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.15 0.5 . . . . 0.0 111.885 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.513 ' OD2' HD11 ' A' ' 671' ' ' LEU . 2.2 t0 -129.72 160.07 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.009 HD13 HD12 ' A' ' 578' ' ' LEU . 1.4 pt -108.66 120.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.479 0.657 . . . . 0.0 111.724 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.895 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 67.5 m95 -106.43 127.3 53.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.065 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.628 ' HB2' HD11 ' A' ' 672' ' ' LEU . 20.9 t80 -90.54 117.61 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.79 130.09 48.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.162 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.484 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 66.2 t60 -109.3 133.74 52.67 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -131.02 1.27 4.26 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.427 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.95 149.63 36.42 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.72 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.8 t -74.57 -32.37 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.451 . . . . 0.0 111.534 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.597 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.5 m-20 -73.13 1.86 8.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.461 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.82 126.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.28 0.562 . . . . 0.0 111.89 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.484 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 8.7 t -96.43 165.93 11.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.255 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -130.53 121.28 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.866 0.365 . . . . 0.0 111.265 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.673 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.51 99.47 11.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.9 m120 60.7 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -129.55 -0.27 4.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.488 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.472 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 10.8 m120 -100.89 141.99 32.99 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.888 0.375 . . . . 0.0 111.107 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.665 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -82.6 141.54 32.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 11.5 mmm -123.89 101.21 7.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.812 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.427 HG12 HG21 ' A' ' 668' ' ' THR . 50.7 pt -89.64 161.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.21 98.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.76 44.8 1.18 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.427 HG21 HG12 ' A' ' 665' ' ' ILE . 1.2 p -127.62 162.25 26.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.32 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -129.92 149.03 51.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.398 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.504 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 4.3 t80 -147.26 145.34 29.38 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.895 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 129.05 38.8 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.596 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.732 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.2 mt -108.74 119.94 41.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.291 0.567 . . . . 0.0 111.474 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.15 144.0 39.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.24 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.742 ' HB2' HD12 ' A' ' 696' ' ' ILE . 68.3 t0 -43.06 123.93 3.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.772 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.15 7.39 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -95.23 112.85 24.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.372 . . . . 0.0 111.502 -179.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.75 108.66 21.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.053 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.641 HG12 HD13 ' A' ' 659' ' ' LEU . 11.2 mt -106.89 136.89 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.0 111.958 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -96.12 116.15 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.478 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.838 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.3 mt -83.71 -34.07 10.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.793 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.725 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.1 tp -154.86 131.58 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.102 0.477 . . . . 0.0 112.097 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.73 130.04 31.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -127.1 117.63 22.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.797 0.332 . . . . 0.0 110.735 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -66.97 -46.61 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.101 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -76.39 -40.52 50.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -88.8 -11.09 45.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.42 16.76 7.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.543 ' CZ ' HG21 ' A' ' 587' ' ' ILE . 15.5 t80 -76.9 105.44 7.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.31 125.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.908 0.385 . . . . 0.0 111.986 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.725 ' HB ' HG22 ' A' ' 681' ' ' ILE . 13.1 mt -123.8 153.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.178 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -176.59 138.2 3.93 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.278 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.786 ' CE2' HD12 ' A' ' 680' ' ' ILE . 1.8 m-30 -113.45 147.08 38.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 0.0 110.541 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.537 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -101.27 117.23 34.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.477 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.812 HG22 HD21 ' A' ' 578' ' ' LEU . 3.9 t -80.29 123.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 579' ' ' THR . 24.3 tt0 -132.64 109.38 9.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.448 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 674' ' ' ASP . 54.6 mt -78.66 106.08 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.24 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.58 -45.26 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.37 140.93 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 37.7 p . . . . . 0 N--CA 1.446 -0.654 0 CA-C-O 121.184 0.516 . . . . 0.0 109.998 178.654 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 663' ' ' ARG . 27.7 t . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 111.643 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.92 168.31 12.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.484 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.16 146.29 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.01 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -82.29 151.65 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 71.0 p -126.05 -179.19 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.28 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.86 -30.13 57.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.36 -51.1 70.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.678 ' HA ' HD12 ' A' ' 726' ' ' LEU . 5.3 mm-40 -65.65 -50.71 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.695 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 727' ' ' VAL . 2.4 ttpm? -55.86 -32.71 63.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -66.66 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.348 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.0 mt -58.34 -44.58 88.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 111.112 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 724' ' ' LYS . 13.3 p -73.6 -25.04 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -36.25 65.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.057 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.4 mttp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' CB ' ' A' ' 593' ' ' GLU . 5.1 tmm_? . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.924 0.392 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.574 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -110.2 -61.89 1.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.247 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.864 HD21 HG22 ' A' ' 694' ' ' VAL . 9.3 tt -106.93 142.71 36.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.477 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.5 m -113.04 114.26 26.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.044 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.652 HD12 HD11 ' A' ' 594' ' ' ILE . 0.6 OUTLIER -106.75 108.6 20.2 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 10.9 ptpt -118.74 101.59 50.36 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.6 Cg_exo -45.34 105.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.842 1.695 . . . . 0.0 109.239 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.671 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.66 157.31 86.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.43 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.9 Cg_endo -53.65 -27.4 41.72 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.807 3.005 . . . . 0.0 112.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.671 ' HB2' HD12 ' A' ' 583' ' ' LEU . 7.4 m-20 -62.08 -24.28 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.487 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 1.8 t -96.02 153.96 17.49 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.207 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 690' ' ' ILE . 14.9 pt -55.29 -14.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.312 . . . . 0.0 111.022 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 35.4 mt -107.36 125.2 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.665 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.43 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.32 58.22 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.446 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.535 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.6 mp0 -125.28 168.76 13.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.613 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.23 121.59 25.06 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.381 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.3 mm? -113.34 150.73 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.423 ' CB ' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.72 117.09 23.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.688 HD12 HD22 ' A' ' 578' ' ' LEU . 66.2 mt -74.46 108.7 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -69.05 111.12 4.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.291 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.494 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -38.81 -52.12 1.72 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.281 0.563 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -46.94 -24.74 2.09 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.234 -0.893 . . . . 0.0 113.14 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.09 117.89 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.287 0.543 . . . . 0.0 110.916 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.7 t30 -140.18 122.33 9.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.058 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -89.76 159.93 35.32 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 124.407 -1.08 . . . . 0.0 111.54 -0.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.621 ' CG ' HG23 ' A' ' 594' ' ' ILE . 4.8 t80 -91.55 114.61 27.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.506 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 6.1 m-85 -92.2 138.08 31.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.75 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.5 mp -124.02 148.34 28.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.47 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.41 -171.54 36.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.347 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.486 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.58 -52.58 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 111.644 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.58 133.54 56.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.319 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -57.95 -19.25 28.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.772 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.51 -31.44 56.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.063 0.459 . . . . 0.0 110.258 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.621 ' SG ' HG22 ' A' ' 621' ' ' VAL . 8.6 m -73.56 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.447 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -43.36 -32.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.235 0.54 . . . . 0.0 110.408 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.75 ' SG ' HG23 ' A' ' 603' ' ' ILE . 34.8 t -106.48 142.01 36.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.007 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.85 104.71 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.412 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.3 mm -139.14 109.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.194 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.9 106.75 17.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.424 0.631 . . . . 0.0 112.432 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.59 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.5 t0 -129.46 107.59 9.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.55 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -40.68 -28.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 688' ' ' PHE . 9.3 mmt180 -69.38 -41.47 76.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.59 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -89.19 158.62 17.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.912 0.387 . . . . 0.0 111.527 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 73.1 m -78.97 170.58 16.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.367 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -46.93 -42.58 17.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.621 HG22 ' SG ' ' A' ' 609' ' ' CYS . 41.1 t -122.51 69.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.289 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.632 ' O ' ' N ' ' A' ' 653' ' ' GLY . 17.7 t60 -50.49 -47.05 57.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.745 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 6.2 p -164.6 163.35 21.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.119 0.485 . . . . 0.0 111.986 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.506 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 53.3 p90 -144.18 151.03 38.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.877 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.539 HD13 HD11 ' A' ' 594' ' ' ILE . 3.8 mp -102.71 132.89 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -124.17 132.54 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.872 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 29.9 ttmt -98.17 136.56 38.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.18 158.75 39.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -76.61 114.49 15.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.235 0.54 . . . . 0.0 110.412 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.9 t60 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.771 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 p-10 -122.15 147.62 45.93 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.013 0.435 . . . . 0.0 112.041 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 155.38 47.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.389 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.771 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -104.26 129.16 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.606 0.717 . . . . 0.0 112.702 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.917 ' CH2' HD22 ' A' ' 671' ' ' LEU . 96.1 m95 -113.49 128.57 56.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.215 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.476 ' HB2' HD21 ' A' ' 672' ' ' LEU . 4.7 t80 -90.32 117.29 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 63.2 m -102.78 130.24 49.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.873 0.368 . . . . 0.0 111.271 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.453 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -109.48 128.22 55.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.207 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.445 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.7 p -126.95 8.98 6.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.206 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.54 151.82 31.42 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.155 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.5 m -83.97 -17.17 41.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.578 0.227 . . . . 0.0 111.49 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.485 ' CB ' HD12 ' A' ' 681' ' ' ILE . 2.1 m120 -87.22 -5.51 58.93 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 664' ' ' MET . 6.6 t 74.8 145.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.122 0.486 . . . . 0.0 112.284 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.453 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 61.8 p -119.2 160.3 22.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 679' ' ' LYS . 21.8 m-85 -138.29 120.4 15.64 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.2 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -94.59 103.72 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.564 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 67.75 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -134.86 -3.68 2.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.595 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.8 OUTLIER -94.52 140.79 29.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.878 0.371 . . . . 0.0 111.099 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.658 ' O ' HG21 ' A' ' 716' ' ' VAL . 4.8 ttp180 -83.88 141.53 31.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 27.6 mtp -131.92 107.17 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.449 ' H ' HG21 ' A' ' 668' ' ' THR . 26.5 pt -86.72 164.73 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.124 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 652' ' ' THR . 36.1 tt0 -50.58 110.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.06 31.7 4.95 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.952 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 665' ' ' ILE . 9.4 p -112.7 162.57 15.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.594 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.45 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -137.37 144.35 42.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.608 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.26 144.14 28.63 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.632 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.917 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.23 136.02 51.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.67 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 694' ' ' VAL . 1.1 mt -107.48 106.72 17.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.117 0.484 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -93.48 141.08 28.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.492 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.564 ' HB3' HD12 ' A' ' 696' ' ' ILE . 1.6 p30 -41.52 112.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 91.28 37.6 6.19 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 124.39 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.353 -0.424 . . . . 0.0 111.101 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -96.31 109.07 21.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.766 HG22 ' HG ' ' A' ' 659' ' ' LEU . 12.0 pt -105.41 132.83 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.076 0.465 . . . . 0.0 111.768 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 658' ' ' TYR . 12.3 mttp -93.72 115.88 28.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.633 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.482 HG23 HG22 ' A' ' 681' ' ' ILE . 1.3 tt -78.01 -34.79 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.125 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.485 HD12 ' CB ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER -154.33 131.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.029 179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.619 ' CD1' ' CG1' ' A' ' 689' ' ' VAL . 11.7 t90 -136.02 113.25 10.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -128.57 114.07 16.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.834 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.59 -42.26 78.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -58.58 -40.16 82.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.258 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -76.08 -19.31 58.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.71 15.85 9.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.196 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 617' ' ' ARG . 0.2 OUTLIER -117.73 125.27 50.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.566 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.619 ' CG1' ' CD1' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -119.21 136.52 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.2 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 587' ' ' ILE . 7.2 mt -128.73 115.82 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.325 0.583 . . . . 0.0 110.464 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -139.75 147.01 18.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.883 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.453 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.08 145.01 41.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 10.8 tptm -101.59 116.91 33.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.864 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -82.36 114.99 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.957 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.24 108.99 12.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.995 0.426 . . . . 0.0 110.257 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.564 HD12 ' HB3' ' A' ' 674' ' ' ASP . 25.4 mt -79.4 122.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.294 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -105.1 -42.61 5.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.708 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.52 140.96 44.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.112 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.319 0.581 . . . . 0.0 110.025 179.024 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 663' ' ' ARG . 46.7 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.87 0.367 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.1 mp -91.8 172.28 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -103.25 148.31 25.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.04 157.71 22.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -178.47 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.51 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.93 -52.33 64.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -65.68 -46.65 78.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.44 -32.75 67.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.13 -36.92 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 9.2 mt -59.55 -44.54 93.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.033 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.9 p -81.64 -23.96 9.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -54.44 -34.93 62.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.801 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.452 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.1 tmm_? . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 647' ' ' ILE . 6.0 t80 -121.46 -52.98 2.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 647' ' ' ILE . 11.9 tp -112.22 142.32 44.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.023 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 695' ' ' GLU . 19.4 m -120.3 114.06 21.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.831 ' HG ' HG22 ' A' ' 694' ' ' VAL . 3.1 mp -107.18 108.94 20.62 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.9 pttt -114.45 100.76 53.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -44.9 102.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.787 1.658 . . . . 0.0 109.518 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.22 159.54 83.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.599 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 6.3 Cg_endo -48.69 -30.56 16.95 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.783 2.988 . . . . 0.0 112.989 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.672 ' HB2' HD12 ' A' ' 583' ' ' LEU . 8.2 m-20 -63.55 -17.72 63.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.063 0.459 . . . . 0.0 109.89 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.579 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 23.8 t -95.46 153.32 17.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.628 HD11 HD11 ' A' ' 690' ' ' ILE . 20.9 pt -59.24 -19.24 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 109.972 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.564 HD13 HG23 ' A' ' 613' ' ' ILE . 5.4 mt -112.55 118.54 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.599 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -106.04 66.0 0.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.374 0.607 . . . . 0.0 110.462 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.578 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.0 mt-10 -125.57 172.34 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.758 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.44 125.6 40.85 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.175 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.772 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.41 138.63 48.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.837 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.452 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.31 114.44 19.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.611 0.243 . . . . 0.0 111.398 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.086 HD11 HD12 ' A' ' 625' ' ' ILE . 46.1 mt -72.36 109.36 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.819 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.14 110.13 2.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.45 -29.64 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.028 0.442 . . . . 0.0 111.022 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.78 -22.51 73.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.378 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.671 HG11 ' OD1' ' A' ' 610' ' ' ASN . 63.4 t -101.28 119.31 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 117.712 0.756 . . . . 0.0 111.465 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 15.5 t30 -138.94 123.37 11.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.884 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 46.0 Cg_endo -90.11 160.82 34.04 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 124.672 -0.97 . . . . 0.0 111.99 0.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.693 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.6 t80 -91.94 114.68 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.552 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 22.2 m-85 -92.29 138.21 31.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.702 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.7 mp -126.46 145.54 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.69 -175.03 36.6 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.43 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -65.45 -47.73 75.13 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 111.38 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.82 127.17 30.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.355 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -58.18 -17.35 18.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.92 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.36 -30.77 67.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.027 0.442 . . . . 0.0 110.186 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.723 ' SG ' HG22 ' A' ' 621' ' ' VAL . 62.3 m -70.61 133.44 46.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.63 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.671 ' OD1' HG11 ' A' ' 598' ' ' VAL . 0.7 OUTLIER -47.47 -28.32 2.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.767 ' SG ' HG23 ' A' ' 603' ' ' ILE . 43.1 t -111.96 142.16 44.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.514 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.28 105.27 13.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.772 HD11 HD21 ' A' ' 592' ' ' LEU . 25.0 mm -139.09 109.73 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.027 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -104.4 107.16 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.472 0.653 . . . . 0.0 112.548 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.616 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.4 t0 -129.38 107.56 9.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.766 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -40.0 -29.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.465 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.616 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.3 pp -89.66 158.85 17.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.549 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.8 164.94 25.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.621 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.911 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -53.06 -25.7 13.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.989 0.423 . . . . 0.0 110.369 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.911 HG23 ' HG2' ' A' ' 620' ' ' ARG . 47.1 t -131.67 64.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 8.0 t60 -49.0 -43.77 40.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.227 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.5 p -167.13 161.42 14.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.0 111.902 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.2 p90 -143.54 148.3 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.593 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.086 HD12 HD11 ' A' ' 594' ' ' ILE . 75.2 mt -102.25 136.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.6 t80 -127.25 135.08 50.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.588 ' CE ' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -97.16 136.82 37.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 158.73 43.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.753 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.8 OUTLIER -77.32 112.75 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.424 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.7 t-160 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.828 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.3 mt . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.43 147.96 35.36 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 0.5 OUTLIER -138.03 131.78 31.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.662 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 578' ' ' LEU . 4.6 pt -87.4 123.82 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.876 ' CH2' HD22 ' A' ' 671' ' ' LEU . 88.0 m95 -104.84 144.09 32.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.871 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.717 ' CD2' HD13 ' A' ' 678' ' ' ILE . 7.4 t80 -104.38 117.15 33.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 25.4 m -105.47 130.02 53.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.482 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 60.4 t60 -108.78 133.08 53.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.22 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.6 p -130.08 6.32 4.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.249 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.43 150.69 31.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.692 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.9 t -73.64 -35.81 65.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 111.455 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.604 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.3 m-80 -70.7 -1.77 12.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.307 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 53.65 125.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.218 0.532 . . . . 0.0 111.786 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.3 p -90.65 165.71 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 89.4 m-85 -128.17 120.27 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.652 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -97.68 100.53 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.33 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 61.4 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -134.44 3.74 3.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.711 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.563 ' HB3' HG23 ' A' ' 716' ' ' VAL . 1.8 m-80 -107.12 141.23 38.7 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.658 ' O ' HG21 ' A' ' 716' ' ' VAL . 12.5 ttm180 -80.72 141.21 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.414 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 35.1 mmm -119.12 102.36 8.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.1 pt -87.86 150.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.276 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -44.31 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.445 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.6 43.35 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.655 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.04 162.13 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -131.41 146.28 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.588 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.72 144.88 28.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.876 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.06 134.8 49.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.206 179.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 694' ' ' VAL . 1.1 mt -109.96 98.11 7.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.155 0.502 . . . . 0.0 111.504 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -83.49 141.73 31.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.508 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 696' ' ' ILE . 19.5 t0 -46.54 111.42 0.38 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.972 0.415 . . . . 0.0 110.269 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 102.29 36.5 3.58 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.75 31.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 111.176 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.61 108.7 21.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.002 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.717 HD13 ' CD2' ' A' ' 649' ' ' TYR . 10.4 mt -105.97 133.92 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 111.938 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 7.8 mttt -96.65 116.14 28.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.72 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.543 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -80.3 -38.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.204 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.84 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.5 tp -155.37 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.408 . . . . 0.0 111.615 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -136.09 127.28 28.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 688' ' ' PHE . 0.4 OUTLIER -127.18 117.25 21.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 179.102 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -66.73 -46.58 75.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.068 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -81.33 -40.22 23.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.821 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.69 -10.7 59.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.592 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.99 19.52 8.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.522 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 4.6 t80 -83.14 105.03 13.78 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.434 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -125.71 122.48 62.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.163 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.84 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.7 mt -128.78 119.32 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.37 137.19 7.42 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.801 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.46 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.25 143.75 43.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.673 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.8 OUTLIER -101.07 116.7 33.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.753 179.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.831 HG22 ' HG ' ' A' ' 580' ' ' LEU . 2.7 t -84.87 125.79 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 25.7 tt0 -134.03 109.28 8.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.786 0.327 . . . . 0.0 111.404 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 674' ' ' ASP . 84.5 mt -69.85 105.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.031 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -85.58 -48.78 8.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.475 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 11.3 t0 -111.9 142.11 44.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.871 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.25 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 663' ' ' ARG . 61.3 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.848 0.356 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.6 mp -98.42 165.06 12.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.707 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.88 135.61 43.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -73.36 154.34 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 43.1 p -126.0 -174.62 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.198 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.8 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.8 -51.89 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.757 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.655 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.7 mp0 -65.26 -48.79 72.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.796 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -56.25 -32.8 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.84 -37.01 83.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.065 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 723' ' ' GLU . 11.9 mt -59.93 -44.12 94.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.998 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 1.6 t -77.02 -26.1 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.247 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -55.25 -33.75 63.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.849 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 29.9 mttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.804 179.82 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.46 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 45.5 ttp180 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 647' ' ' ILE . 11.0 t80 -107.25 -55.64 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.611 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.756 HD11 ' CG1' ' A' ' 694' ' ' VAL . 10.2 tp -111.51 141.99 44.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.781 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 695' ' ' GLU . 18.5 m -124.78 113.97 18.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.705 HD21 HD11 ' A' ' 625' ' ' ILE . 1.6 mp -105.54 108.81 20.52 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -112.7 99.62 48.28 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.101 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.6 Cg_exo -44.6 99.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.864 1.709 . . . . 0.0 109.612 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.753 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.77 157.45 85.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.52 -25.66 11.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.832 3.021 . . . . 0.0 113.166 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -28.12 69.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.0 OUTLIER -95.98 154.0 17.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.624 178.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.46 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 5.4 pt -58.57 -10.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.732 0.301 . . . . 0.0 110.91 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.485 HD13 HG23 ' A' ' 613' ' ' ILE . 41.1 mt -106.96 118.81 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -109.08 57.44 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.213 0.53 . . . . 0.0 110.106 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.606 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.2 mm-40 -124.49 171.91 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.162 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.26 122.99 33.02 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.041 0.448 . . . . 0.0 111.233 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.987 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.67 132.68 55.07 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.46 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -123.95 121.8 36.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.106 HD11 HD12 ' A' ' 625' ' ' ILE . 86.9 mt -74.09 108.96 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.137 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.5 ' O ' ' C ' ' A' ' 596' ' ' GLN . 1.1 mp0 -70.54 81.5 0.58 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -7.53 -62.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.583 0.753 . . . . 0.0 112.788 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . -44.69 -21.2 0.27 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.838 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.412 HG11 ' CG ' ' A' ' 610' ' ' ASN . 37.6 t -96.61 118.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 117.432 0.616 . . . . 0.0 111.067 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -139.62 123.63 10.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.581 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 49.3 Cg_endo -90.66 159.85 30.86 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 124.454 -1.061 . . . . 0.0 111.798 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.7 t80 -92.08 114.72 27.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.581 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 49.8 m-85 -92.31 138.02 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.733 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.802 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.7 mp -125.88 144.54 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.739 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.09 -169.44 36.68 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.42 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.511 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -69.81 -52.86 21.44 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.819 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.28 130.0 44.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -56.7 -18.63 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.949 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.96 -31.91 61.01 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.15 0.5 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 73.1 m -71.82 132.72 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.583 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 14.0 m-80 -47.95 -28.43 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.46 . . . . 0.0 110.558 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.8 t -111.07 142.79 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.48 105.23 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.987 HD11 HD21 ' A' ' 592' ' ' LEU . 34.1 mm -139.39 109.62 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.961 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.48 106.57 17.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.445 0.641 . . . . 0.0 112.652 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.628 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.2 t0 -130.35 107.91 9.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.721 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -39.28 -30.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.496 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.7 OUTLIER -68.6 -41.01 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.628 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.22 159.05 17.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.802 0.334 . . . . 0.0 111.428 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.3 t -80.57 166.05 21.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.376 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.481 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 2.9 mpt_? -47.23 -37.14 9.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.374 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.453 HG11 HG23 ' A' ' 727' ' ' VAL . 13.1 t -122.95 63.59 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.558 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 9.4 t60 -48.74 -42.97 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.833 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.6 p -167.79 157.73 10.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.802 ' HA ' HD12 ' A' ' 603' ' ' ILE . 50.1 p90 -143.14 146.0 33.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.687 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.106 HD12 HD11 ' A' ' 594' ' ' ILE . 60.5 mt -102.14 129.27 53.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.323 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.5 t80 -120.83 135.1 55.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.398 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 25.1 ttmt -97.66 134.34 40.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.961 0.41 . . . . 0.0 110.394 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.46 158.37 44.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.759 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -77.43 111.9 13.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.935 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.2 t60 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.107 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 644' ' ' LEU . 5.1 mp . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.4 OUTLIER -113.14 147.0 38.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.54 153.0 51.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.714 HD13 HD13 ' A' ' 578' ' ' LEU . 2.9 pt -100.64 119.02 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.304 0.573 . . . . 0.0 111.524 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.918 ' CH2' HD22 ' A' ' 671' ' ' LEU . 84.8 m95 -100.63 127.84 46.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.453 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.462 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.2 t80 -90.29 117.59 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' A' ' 624' ' ' PHE . 7.9 m -104.13 136.98 42.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.444 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -115.88 127.52 55.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.206 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.8 p -125.86 10.96 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.198 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.29 159.61 41.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.261 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.0 m -88.09 -19.17 27.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.677 0.275 . . . . 0.0 111.46 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.584 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.4 m-80 -87.01 2.7 48.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.8 128.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.35 0.595 . . . . 0.0 112.083 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.444 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 87.5 p -100.28 165.74 11.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.341 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -129.79 120.65 25.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.28 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.644 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.42 102.59 14.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 61.57 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -131.56 -5.65 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.537 ' ND2' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -97.84 141.37 30.91 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 111.095 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.675 ' O ' HG21 ' A' ' 716' ' ' VAL . 29.1 ttp180 -81.86 141.0 33.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.773 ' HE1' HG13 ' A' ' 716' ' ' VAL . 13.3 mmm -120.89 99.64 6.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.431 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 42.3 pt -87.59 154.28 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -45.62 107.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.313 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.12 35.88 3.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.61 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.43 ' CG2' HG12 ' A' ' 665' ' ' ILE . 3.4 p -119.89 162.28 19.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.184 0.516 . . . . 0.0 111.686 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.48 ' HE2' HD13 ' A' ' 717' ' ' LEU . 5.4 ttpm? -130.4 148.79 52.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.007 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.535 ' CE1' HG22 ' A' ' 716' ' ' VAL . 2.4 t80 -147.25 143.94 28.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.918 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -74.05 130.57 40.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.193 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.696 HD13 HG21 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -97.07 139.64 32.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.28 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -124.9 131.5 53.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.075 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.852 ' HB2' HD12 ' A' ' 696' ' ' ILE . 40.3 t0 -42.93 104.0 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 110.581 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 106.19 33.77 3.35 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.506 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -94.51 113.86 25.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.382 . . . . 0.0 111.324 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -95.66 111.91 23.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.642 HG12 HD13 ' A' ' 659' ' ' LEU . 4.3 mt -104.92 137.04 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.062 0.458 . . . . 0.0 111.855 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -93.14 115.98 28.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.803 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.549 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -85.47 -35.48 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.744 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.7 tp -154.97 131.33 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.072 0.463 . . . . 0.0 111.826 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -137.11 125.35 23.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -127.15 116.81 21.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.884 0.373 . . . . 0.0 110.266 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -46.84 71.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.21 -40.68 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.84 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -87.24 -8.7 56.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? 60.71 17.94 8.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.46 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 6.7 t80 -77.08 104.59 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -124.51 122.17 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 111.813 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.744 ' HB ' HG22 ' A' ' 681' ' ' ILE . 7.0 mt -128.18 151.43 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.517 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.428 ' O ' HD22 ' A' ' 583' ' ' LEU . . . 178.26 137.83 2.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.091 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.579 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 1.8 m-30 -114.5 150.33 35.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.732 0.301 . . . . 0.0 110.738 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.753 ' HB2' HD12 ' A' ' 583' ' ' LEU . 6.5 tttt -101.16 116.62 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.633 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.756 ' CG1' HD11 ' A' ' 578' ' ' LEU . 3.6 t -79.56 124.72 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.686 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.05 108.75 8.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.852 HD12 ' HB2' ' A' ' 674' ' ' ASP . 58.1 mt -69.67 105.6 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.04 -47.06 16.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.697 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.468 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 80.6 m-20 -111.08 140.98 45.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.362 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.773 HG13 ' HE1' ' A' ' 664' ' ' MET . 12.0 t . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.777 0.323 . . . . 0.0 111.267 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.48 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.8 OUTLIER -89.86 168.37 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.84 146.6 27.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -80.66 154.87 27.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -123.77 -177.26 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.26 -30.76 62.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -64.83 -49.9 68.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.722 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -64.34 -50.62 67.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.498 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.6 OUTLIER -59.0 -32.55 69.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.049 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -62.8 -39.93 95.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.003 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 723' ' ' GLU . 3.2 mt -61.04 -44.56 97.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 724' ' ' LYS . 10.5 p -72.56 -25.51 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -65.11 -34.33 78.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.266 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.946 179.54 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 577' ' ' PHE . 3.1 tmm_? . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.832 0.349 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.761 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -115.31 -57.42 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.371 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.976 HD23 HD12 ' A' ' 594' ' ' ILE . 24.0 tp -106.59 142.21 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.656 0.265 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.896 HG23 ' HG3' ' A' ' 593' ' ' GLU . 8.3 m -123.57 113.03 18.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 1.11 HD22 HG22 ' A' ' 694' ' ' VAL . 0.0 OUTLIER -107.9 107.84 18.74 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.5 mtpt -109.57 99.59 38.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -175.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.3 Cg_exo -46.67 108.92 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.56 1.507 . . . . 0.0 108.722 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.71 156.77 88.19 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.49 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 13.9 Cg_endo -56.24 -25.89 58.29 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.639 2.893 . . . . 0.0 112.825 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -63.31 -20.51 65.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.191 0.52 . . . . 0.0 109.653 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.439 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.4 t -97.38 153.84 17.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.759 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 690' ' ' ILE . 5.2 pt -52.68 -21.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 109.908 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.837 HD13 HG23 ' A' ' 613' ' ' ILE . 48.1 mt -106.71 118.74 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.845 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -114.38 63.67 0.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.572 0.701 . . . . 0.0 109.773 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 17.6 mt-10 -125.24 173.25 8.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.455 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.15 116.52 21.48 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.691 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.43 128.03 56.31 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.896 ' HG3' HG23 ' A' ' 579' ' ' THR . 2.8 mp0 -124.98 131.21 53.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.976 HD12 HD23 ' A' ' 578' ' ' LEU . 67.0 mt -71.44 109.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 598' ' ' VAL . 0.6 OUTLIER -51.17 105.16 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.417 0.627 . . . . 0.0 111.645 -178.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.761 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 1.3 mm-40 41.63 -125.76 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.908 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -96.95 41.04 2.41 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.972 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 595' ' ' GLN . 4.7 t -73.05 118.73 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -135.26 127.69 18.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.222 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.618 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 19.9 Cg_endo -92.77 153.23 17.6 Favored 'Cis proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.957 -1.268 . . . . 0.0 112.508 0.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.749 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.1 t80 -96.1 112.2 24.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.618 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 72.8 m-85 -93.01 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.46 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.772 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mt -126.57 145.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.478 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.51 -168.38 35.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.383 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.497 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.08 -54.84 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.48 56.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.0 111.592 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -57.58 -19.47 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.815 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -53.34 -31.27 43.58 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.175 0.512 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 87.0 m -73.18 131.19 41.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.493 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 7.1 m-80 -46.31 -29.87 1.83 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.223 0.535 . . . . 0.0 110.404 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.82 ' SG ' HD13 ' A' ' 592' ' ' LEU . 41.4 t -110.76 143.13 41.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.028 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.24 105.44 13.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 592' ' ' LEU . 32.9 mm -138.99 109.61 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.027 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -104.06 106.96 17.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.627 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.3 t0 -130.0 107.7 9.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.604 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . 0.402 ' ND2' ' HD2' ' A' ' 617' ' ' ARG . 0.3 OUTLIER -38.73 -30.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.499 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -68.86 -41.6 78.18 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.627 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -88.65 159.13 17.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.953 0.406 . . . . 0.0 111.938 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 60.1 p -77.55 173.08 12.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -49.55 -32.95 13.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.516 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 621' ' ' VAL . 8.9 p -134.99 66.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.606 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 13.7 t60 -44.65 -39.53 5.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.96 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.454 ' SG ' HD11 ' A' ' 680' ' ' ILE . 4.3 p -165.39 158.86 16.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.47 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 36.3 p90 -143.77 147.74 34.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.972 HD12 HD11 ' A' ' 594' ' ' ILE . 55.7 mt -101.92 134.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.019 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 135.76 51.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.422 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -97.15 137.84 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.127 0.489 . . . . 0.0 110.879 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.71 158.92 43.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.877 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -77.17 112.47 13.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.307 0.575 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.5 t60 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.885 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 630' ' ' HIS . 1.2 mt . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.343 0.592 . . . . 0.0 112.526 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.13 137.31 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.605 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.859 HD13 HD22 ' A' ' 578' ' ' LEU . 2.5 pt -88.96 120.65 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.334 0.587 . . . . 0.0 112.145 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.923 ' CH2' HD22 ' A' ' 671' ' ' LEU . 87.4 m95 -101.74 143.82 31.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.726 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.585 ' HB2' HD11 ' A' ' 672' ' ' LEU . 16.7 t80 -104.24 117.34 33.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -105.29 138.47 41.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.162 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.44 ' CE1' ' N ' ' A' ' 657' ' ' SER . 49.2 t60 -118.44 130.98 56.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.43 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -127.36 8.76 6.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.139 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.37 148.51 28.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.282 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.3 t -75.78 -31.17 59.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 111.197 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.616 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.2 m120 -71.95 -1.17 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.6 126.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.346 0.593 . . . . 0.0 111.57 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 91.8 p -95.54 165.92 12.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -128.09 120.03 26.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 111.403 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -96.56 99.87 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.94 -81.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.11 3.1 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.806 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.469 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 3.2 m-80 -103.68 141.65 35.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.826 0.345 . . . . 0.0 111.111 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -77.85 141.56 39.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.425 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 31.3 mmm -125.93 97.9 5.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.6 pt -87.83 153.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' A' ' 652' ' ' THR . 52.0 tt0 -48.05 100.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.82 37.25 1.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.37 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.9 p -125.48 158.71 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 111.445 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.458 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -130.26 148.56 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.458 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.9 145.35 28.61 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.923 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 135.21 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.419 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.5 mt -111.63 104.99 13.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.05 143.58 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.219 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.616 ' HB2' HD12 ' A' ' 696' ' ' ILE . 40.5 t0 -45.5 113.91 0.67 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 110.877 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 99.52 35.51 4.64 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 116.32 28.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.993 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.05 108.76 21.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.22 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.68 HG12 HD13 ' A' ' 659' ' ' LEU . 11.4 mt -107.69 135.0 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 111.894 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.439 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 4.5 mttm -96.79 116.2 28.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.848 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.561 HG23 HD23 ' A' ' 618' ' ' LEU . 0.0 OUTLIER -76.33 -34.6 25.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.303 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.779 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.2 tp -154.27 131.02 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.67 122.08 19.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.548 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.07 116.32 20.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 110.4 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -46.63 71.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.148 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -69.09 -40.51 78.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.058 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.72 -2.44 53.81 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt 58.11 19.23 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 0.0 110.829 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.502 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 2.6 t80 -76.84 104.46 7.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.431 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -126.19 120.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.808 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 587' ' ' ILE . 13.6 mt -129.64 124.68 59.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -150.04 141.49 8.85 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.716 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.616 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 3.1 m-30 -113.92 141.85 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 580' ' ' LEU . 2.7 tttt -101.23 115.75 31.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.938 0.399 . . . . 0.0 110.299 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 1.11 HG22 HD22 ' A' ' 580' ' ' LEU . 1.9 t -80.5 127.02 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.857 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.2 OUTLIER -134.21 109.03 8.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 674' ' ' ASP . 60.1 mt -71.45 105.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.099 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.36 -46.85 8.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.288 0.566 . . . . 0.0 109.565 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.536 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.0 t0 -111.32 142.68 43.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.341 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.483 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.1 t . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.917 0.389 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.477 HD11 ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -106.19 162.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.618 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.89 145.06 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.853 0.358 . . . . 0.0 111.005 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -79.98 156.61 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 33.9 p -126.06 -174.21 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.71 -29.39 53.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.65 -50.37 65.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.668 ' HA ' HD12 ' A' ' 726' ' ' LEU . 41.1 mp0 -64.0 -45.29 89.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -57.73 -32.94 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.42 -37.02 82.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 723' ' ' GLU . 12.2 mt -59.43 -44.84 92.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.015 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.2 p -84.75 -24.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.347 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -56.6 -30.27 63.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.998 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.451 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.856 0.36 . . . . 0.0 111.068 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.752 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -128.06 -49.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.927 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 694' ' ' VAL . 7.3 tp -118.23 142.51 47.39 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.996 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 24.0 m -115.83 117.19 29.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.782 HD11 HD11 ' A' ' 625' ' ' ILE . 9.6 mt -105.56 109.11 20.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.73 99.55 52.26 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 38.2 Cg_exo -46.03 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.884 1.722 . . . . 0.0 109.628 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.798 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.3 OUTLIER -74.87 157.78 85.29 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.409 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 74.4 Cg_exo -49.39 -24.93 9.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.633 2.889 . . . . 0.0 112.785 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.798 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.5 t0 -61.62 -27.38 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.466 ' OG ' HD13 ' A' ' 690' ' ' ILE . 4.7 t -95.56 154.0 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.721 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 690' ' ' ILE . 1.4 pt -56.5 -13.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.43 ' CD1' HG23 ' A' ' 613' ' ' ILE . 60.8 mt -108.08 130.92 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -117.32 60.12 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.728 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.592 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.7 mt-10 -124.9 169.58 11.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.103 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.56 121.49 25.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.66 0.267 . . . . 0.0 111.559 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.2 mm? -112.93 149.38 33.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.451 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.95 118.69 26.83 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.946 HD11 HD12 ' A' ' 625' ' ' ILE . 63.7 mt -73.97 109.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.321 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -64.55 113.55 3.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.661 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.24 -30.89 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.226 0.536 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.57 -20.43 73.84 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.052 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.488 HG11 ' CG ' ' A' ' 610' ' ' ASN . 48.1 t -99.86 118.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.561 0.681 . . . . 0.0 111.287 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.5 t30 -139.54 121.87 10.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.993 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.6 Cg_endo -90.21 160.13 33.22 Favored 'Cis proline' 0 N--CA 1.462 -0.367 0 C-N-CA 124.499 -1.042 . . . . 0.0 111.811 -0.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.631 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.4 t80 -91.27 114.76 27.37 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 33.6 m-85 -91.89 138.04 31.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.294 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.783 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -125.39 143.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.229 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.38 -163.57 35.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.454 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -77.13 -51.15 11.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.37 127.02 29.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.293 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -53.88 -19.78 5.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.004 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.93 -30.32 61.47 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.002 0.43 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 38.0 m -70.59 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.589 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 15.3 m-80 -47.34 -29.0 2.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.036 0.446 . . . . 0.0 110.482 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.783 ' SG ' HG23 ' A' ' 603' ' ' ILE . 37.1 t -110.87 137.0 49.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.16 104.76 14.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.43 HG23 ' CD1' ' A' ' 588' ' ' ILE . 15.5 mm -139.53 109.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.299 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -104.98 107.17 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.594 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -129.17 107.4 9.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.466 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -39.86 -27.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 681' ' ' ILE . 0.3 OUTLIER -73.51 -39.81 64.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.594 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -88.78 158.73 18.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 111.403 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.8 m -76.82 169.07 18.99 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.791 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.439 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -51.15 -35.27 35.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.28 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.67 63.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.52 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.613 ' HD2' HG23 ' A' ' 680' ' ' ILE . 26.3 t60 -47.83 -40.38 21.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.825 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.7 p -168.69 156.72 8.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.037 0.446 . . . . 0.0 111.631 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.718 ' HA ' HD12 ' A' ' 603' ' ' ILE . 27.3 p90 -143.34 148.47 36.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.55 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.946 HD12 HD11 ' A' ' 594' ' ' ILE . 61.4 mt -102.15 135.25 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.891 0.377 . . . . 0.0 110.133 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -126.87 134.13 50.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.647 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 7.8 ttpt -98.08 134.97 40.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.506 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.71 158.24 44.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.761 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -77.39 115.93 17.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.473 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.3 t60 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.961 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -116.5 147.42 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.146 0.498 . . . . 0.0 111.876 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.48 147.01 51.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.234 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.802 HD13 HD13 ' A' ' 578' ' ' LEU . 9.3 pt -96.74 126.93 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.231 0.538 . . . . 0.0 111.617 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.923 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.7 m95 -110.68 131.65 54.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.202 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.601 ' CD2' HD13 ' A' ' 678' ' ' ILE . 6.9 t80 -92.48 117.64 30.15 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.428 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 36.6 m -104.2 137.16 42.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.991 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.454 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 31.6 t60 -115.86 131.3 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.086 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 3.1 p -131.86 15.75 4.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.415 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.51 153.42 27.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.212 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 89.8 m -82.13 -25.81 34.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.555 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.0 OUTLIER -81.81 3.41 26.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.021 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.38 134.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 112.181 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.441 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 73.8 m -106.22 166.27 10.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.406 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 679' ' ' LYS . 6.1 m-85 -127.74 120.31 27.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.821 0.343 . . . . 0.0 111.006 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.603 HD22 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -102.09 99.53 9.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.4 m120 58.68 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.2 OUTLIER -130.98 3.19 4.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.472 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 4.9 m-80 -109.08 138.01 46.09 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -75.71 141.32 42.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 656' ' ' VAL . 49.7 mmm -119.82 87.83 2.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.711 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 42.1 pt -87.48 156.1 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.035 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -48.9 94.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.243 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.77 41.71 0.77 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.579 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.1 p -127.9 162.16 27.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.931 0.396 . . . . 0.0 111.381 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpm? -137.76 141.69 40.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.752 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.58 144.94 28.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.768 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.923 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.56 140.65 55.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.018 0.437 . . . . 0.0 111.192 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.815 HD13 HG21 ' A' ' 694' ' ' VAL . 2.0 mt -112.15 124.04 51.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -109.97 161.84 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.761 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.489 ' N ' HD12 ' A' ' 696' ' ' ILE . 35.9 t0 -59.19 100.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.368 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.22 30.27 3.95 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.55 114.19 23.08 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -96.09 108.6 21.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.093 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.603 HG12 HD22 ' A' ' 659' ' ' LEU . 5.4 mt -105.67 120.9 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.637 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 658' ' ' TYR . 4.1 mttp -82.28 115.48 21.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.358 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.613 HG23 ' HD2' ' A' ' 622' ' ' HIS . 1.6 mt -75.44 -39.05 40.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.569 HG22 ' CG1' ' A' ' 690' ' ' ILE . 5.4 tt -155.78 131.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.916 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.58 121.44 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.07 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -127.13 116.82 21.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 110.544 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -67.46 -46.5 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.919 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -66.05 -40.34 90.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.927 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -93.85 -8.46 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.621 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 62.04 16.52 8.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.63 0.253 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.9 t80 -77.06 105.46 8.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.3 p -119.58 124.62 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.1 0.476 . . . . 0.0 111.922 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.569 ' CG1' HG22 ' A' ' 681' ' ' ILE . 27.3 mm -128.1 154.97 39.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.397 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 174.05 134.18 1.81 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.448 ' CZ ' ' HG3' ' A' ' 582' ' ' PRO . 9.6 m-30 -112.89 147.28 37.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 110.331 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -101.37 116.52 32.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.198 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.862 HG13 HD11 ' A' ' 578' ' ' LEU . 2.1 t -80.86 129.7 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.464 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -133.47 109.43 9.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.926 0.394 . . . . 0.0 111.16 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 674' ' ' ASP . 26.7 mt -78.19 105.69 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.238 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . 0.42 ' HB2' ' NH1' ' A' ' 576' ' ' ARG . 20.2 m120 -93.25 -45.93 7.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.05 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.492 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 2.8 t70 -110.78 139.84 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 121.291 0.567 . . . . 0.0 109.74 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.5 p . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.853 0.359 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.08 172.46 8.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 157.37 16.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -87.32 155.19 20.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.81 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -126.17 -175.25 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.87 -30.74 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.087 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.49 -52.03 66.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -66.14 -46.0 79.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.795 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.68 -33.68 64.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.693 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.2 -36.94 80.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 22.8 mt -56.91 -44.41 82.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.45 -22.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -37.47 78.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.4 mttt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 179.945 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.425 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 5.4 tmm_? . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.668 ' HE1' HD13 ' A' ' 647' ' ' ILE . 6.3 t80 -95.33 -54.0 3.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.864 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.931 HD13 HD13 ' A' ' 647' ' ' ILE . 10.8 tp -108.79 143.31 38.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.989 0.423 . . . . 0.0 111.773 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.47 HG22 ' CG ' ' A' ' 581' ' ' LYS . 25.3 m -121.94 115.12 22.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.608 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.7 OUTLIER -105.21 109.13 21.0 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.485 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 18.1 mtmt -115.17 99.41 52.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.623 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 33.2 Cg_exo -46.27 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.711 1.607 . . . . 0.0 109.126 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.727 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -75.1 157.61 85.06 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.437 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 76.1 Cg_exo -49.84 -25.59 12.19 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.438 2.759 . . . . 0.0 112.644 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.5 t70 -62.23 -28.82 69.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.504 ' HB2' HD13 ' A' ' 690' ' ' ILE . 0.8 OUTLIER -96.05 153.84 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.753 178.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.684 HD13 ' CE1' ' A' ' 688' ' ' PHE . 13.9 pt -54.99 -11.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 111.34 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 42.0 mt -107.16 128.73 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.437 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -116.09 54.88 0.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.797 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.623 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 51.3 mm-40 -124.62 169.84 11.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.033 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.36 124.07 31.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.661 0.267 . . . . 0.0 111.659 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.2 mm? -112.87 148.96 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.425 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.68 122.44 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.007 HD11 HD12 ' A' ' 625' ' ' ILE . 33.0 mt -78.9 108.68 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.15 111.52 2.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.47 -34.26 1.29 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.41 0.624 . . . . 0.0 109.972 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -62.9 -24.45 66.74 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.329 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.489 HG11 ' ND2' ' A' ' 610' ' ' ASN . 97.7 t -101.29 119.26 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.659 0.73 . . . . 0.0 111.414 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.1 t30 -138.91 122.91 11.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.704 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 48.0 Cg_endo -90.17 160.32 33.48 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 124.56 -1.017 . . . . 0.0 112.0 0.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.2 t80 -91.97 115.9 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.513 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 30.7 m-85 -92.38 138.0 31.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.819 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -125.03 145.76 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.742 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 160.63 -171.43 36.78 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.374 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.442 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -70.72 -46.91 62.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 111.372 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.16 130.56 46.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.381 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -18.32 29.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.783 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.05 -30.9 66.53 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.205 0.526 . . . . 0.0 110.301 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 94.7 m -70.54 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.1 m120 -44.52 -33.21 1.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.819 ' SG ' HG23 ' A' ' 603' ' ' ILE . 35.1 t -106.93 138.67 42.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.815 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.97 104.59 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.466 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.6 mm -139.47 109.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.409 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -104.07 106.09 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.436 0.636 . . . . 0.0 111.994 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.55 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 3.1 t70 -129.68 108.85 10.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.894 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . 0.419 ' ND2' ' HG2' ' A' ' 617' ' ' ARG . 0.9 OUTLIER -40.2 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.419 ' HG2' ' ND2' ' A' ' 616' ' ' ASN . 0.0 OUTLIER -70.65 -42.69 70.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 680' ' ' ILE . 1.5 pp -89.44 158.21 17.82 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.679 0.276 . . . . 0.0 111.013 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.82 165.82 20.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.0 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.879 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -54.22 -25.21 21.75 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.075 0.464 . . . . 0.0 110.435 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.879 HG23 ' HG2' ' A' ' 620' ' ' ARG . 57.6 t -130.75 57.44 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.997 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.855 ' CD2' HG23 ' A' ' 680' ' ' ILE . 37.0 t60 -48.4 -45.69 36.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.6 p -168.37 161.35 11.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 111.543 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.73 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.9 p90 -143.44 147.53 34.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.509 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.007 HD12 HD11 ' A' ' 594' ' ' ILE . 62.1 mt -102.02 134.52 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -125.87 134.36 51.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.737 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.529 ' HE2' HG23 ' A' ' 647' ' ' ILE . 1.9 ttmm -97.59 136.73 37.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.122 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.469 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.15 159.35 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.764 -178.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.82 113.62 14.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.409 0.623 . . . . 0.0 110.502 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.33 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 630' ' ' HIS . 1.1 mt . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 48.1 m-20 -122.23 148.25 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.792 ' OD2' HD11 ' A' ' 671' ' ' LEU . 3.3 t0 -133.62 151.21 51.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.701 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.931 HD13 HD13 ' A' ' 578' ' ' LEU . 8.9 pt -100.25 122.45 52.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 111.487 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.55 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 77.6 m95 -108.05 134.01 51.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.308 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.636 ' CE2' HD12 ' A' ' 678' ' ' ILE . 7.9 t80 -95.68 117.53 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 26.1 m -101.0 133.49 45.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 54.5 t60 -112.87 131.64 55.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.4 p -129.67 0.95 4.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.449 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 148.36 34.8 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.712 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.8 t -75.91 -34.49 59.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.114 0.483 . . . . 0.0 111.311 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.586 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.1 m120 -70.16 2.0 4.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.379 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.17 133.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.435 0.636 . . . . 0.0 112.32 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 98.2 p -103.86 165.69 10.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.482 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.68 120.24 30.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.225 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.788 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -105.24 109.38 21.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.903 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.591 ' N ' HD12 ' A' ' 659' ' ' LEU . 1.3 m-80 55.43 -82.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.975 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 659' ' ' LEU . 18.5 m-20 -137.49 5.87 2.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.814 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.504 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 3.2 t-20 -108.81 135.57 49.81 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.943 0.402 . . . . 0.0 111.253 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 17.0 ttp-105 -73.65 141.43 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.504 ' O ' HG23 ' A' ' 656' ' ' VAL . 39.5 mmm -117.07 98.17 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.053 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.434 HG12 HG21 ' A' ' 668' ' ' THR . 41.1 pt -88.19 149.13 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.114 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.59 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.433 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.26 42.31 1.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.434 HG21 HG12 ' A' ' 665' ' ' ILE . 1.1 p -127.14 162.28 26.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.45 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.451 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -134.07 135.93 43.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.467 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.518 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -140.03 144.19 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.46 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.792 HD11 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.78 141.05 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.127 0.489 . . . . 0.0 111.345 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.779 HD13 HG21 ' A' ' 694' ' ' VAL . 2.9 mt -112.27 98.16 7.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.427 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -82.72 131.01 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.946 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.478 ' HB2' HD12 ' A' ' 696' ' ' ILE . 5.7 t70 -36.01 107.32 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.099 0.476 . . . . 0.0 110.96 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.92 33.94 3.62 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.537 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -94.04 118.37 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.003 -179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -96.2 108.87 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.757 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.788 HG22 HD13 ' A' ' 659' ' ' LEU . 25.8 pt -105.61 136.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.99 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.8 OUTLIER -99.05 115.96 30.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.752 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.855 HG23 ' CD2' ' A' ' 622' ' ' HIS . 4.3 mt -84.24 -35.67 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.478 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.502 ' CG2' ' HB ' ' A' ' 690' ' ' ILE . 4.2 tp -154.33 129.05 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.328 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -137.96 123.44 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.302 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -127.51 116.08 19.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.925 0.393 . . . . 0.0 110.607 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -46.57 70.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.956 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.78 -40.83 97.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.135 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -98.06 4.01 49.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.9 mttm 54.24 22.07 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.776 0.322 . . . . 0.0 110.93 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.684 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.5 t80 -76.4 104.36 6.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.7 p -117.45 124.22 72.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.054 0.454 . . . . 0.0 111.867 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.626 HD11 HG12 ' A' ' 587' ' ' ILE . 4.9 mm -128.06 154.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.331 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . 175.68 134.11 1.87 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.52 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.486 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.9 m-30 -113.27 142.89 45.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.727 ' HB2' HD22 ' A' ' 583' ' ' LEU . 7.2 tttp -100.87 116.34 32.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 109.88 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.779 HG21 HD13 ' A' ' 672' ' ' LEU . 2.7 t -85.12 123.24 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 110.02 9.51 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.082 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 674' ' ' ASP . 66.3 mt -65.3 105.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.24 -48.08 12.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.934 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.445 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 38.7 t0 -111.69 139.38 47.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.173 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.792 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.879 0.371 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.19 172.33 7.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -99.67 156.97 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.958 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.26 148.49 22.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 22.0 p -126.14 -173.44 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.218 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.47 -29.03 33.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.54 -51.61 67.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.36 -44.72 90.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.617 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -57.59 -32.72 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.74 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.15 -37.23 83.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 40.7 mt -59.48 -44.15 93.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.63 -24.93 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -32.14 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 51.6 mttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.394 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.9 tmm_? . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.594 0.235 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 3.1 t80 -99.83 -45.18 5.81 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.696 HD22 ' CD1' ' A' ' 647' ' ' ILE . 10.3 tp -118.59 142.84 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 30.3 m -120.49 115.84 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.837 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 1.024 HD22 HG22 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -105.5 109.32 21.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 19.3 pttt -116.87 98.77 52.38 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 23.4 Cg_exo -46.03 98.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.923 1.748 . . . . 0.0 109.823 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.3 OUTLIER -74.71 157.86 85.45 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.49 -29.74 19.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.508 2.806 . . . . 0.0 112.876 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.71 ' HB2' HD12 ' A' ' 583' ' ' LEU . 23.2 m-20 -62.33 -24.9 67.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 5.6 t -95.51 153.27 17.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.644 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 10.6 tt -56.34 -14.48 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 613' ' ' ILE . 21.0 mt -111.51 128.14 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 111.626 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.7 OUTLIER -112.64 55.98 0.68 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.625 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.7 mt-10 -124.79 170.28 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.908 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.677 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -130.35 119.7 23.17 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.74 0.305 . . . . 0.0 111.621 178.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.677 HD13 ' C ' ' A' ' 591' ' ' SER . 0.2 OUTLIER -113.03 146.33 39.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.5 OUTLIER -123.97 121.47 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.027 HD11 HD12 ' A' ' 625' ' ' ILE . 70.4 mt -75.86 109.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.148 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 2.9 mm-40 -66.12 114.65 5.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.91 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -42.49 -34.73 0.89 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.353 0.597 . . . . 0.0 110.111 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.496 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.0 -20.24 68.61 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.702 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.625 HG11 ' OD1' ' A' ' 610' ' ' ASN . 99.3 t -101.07 118.79 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 117.912 0.856 . . . . 0.0 111.67 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 8.8 t30 -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.908 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.591 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -90.39 160.45 32.47 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.621 -0.991 . . . . 0.0 111.632 -0.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.622 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.5 t80 -91.26 114.88 27.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.548 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 46.4 m-85 -91.84 138.16 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.098 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.79 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -126.76 145.03 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.787 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.31 -165.48 34.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.46 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.427 ' HG2' ' CD2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -71.33 -54.59 10.29 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.34 130.81 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.483 -178.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -19.33 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.63 -30.35 42.39 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.119 0.485 . . . . 0.0 110.056 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 95.8 m -73.41 131.21 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.297 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.625 ' OD1' HG11 ' A' ' 598' ' ' VAL . 0.7 OUTLIER -46.51 -28.65 1.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.79 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.2 t -111.44 141.58 44.81 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.19 107.53 16.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.611 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.6 mm -138.37 110.05 5.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.313 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.58 106.09 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.739 ' CB ' HD22 ' A' ' 618' ' ' LEU . 31.0 t0 -130.25 108.24 9.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.898 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.25 -32.74 0.2 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.821 0.343 . . . . 0.0 111.601 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.705 ' HB3' HD11 ' A' ' 681' ' ' ILE . 2.5 mtm-85 -78.19 -38.03 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.03 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.739 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -88.91 120.03 29.96 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.13 167.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.529 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.3 mpt_? -56.25 -35.92 67.95 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.12 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.611 HG11 HG23 ' A' ' 727' ' ' VAL . 17.3 t -124.01 57.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.736 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.775 ' CD2' HG23 ' A' ' 680' ' ' ILE . 31.9 t60 -50.28 -48.45 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.931 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.3 p -159.33 156.0 27.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.029 0.442 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.773 ' HA ' HD12 ' A' ' 603' ' ' ILE . 48.5 p90 -143.66 149.31 37.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.461 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.027 HD12 HD11 ' A' ' 594' ' ' ILE . 79.7 mt -102.61 130.34 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.927 0.394 . . . . 0.0 109.981 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.591 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.8 t80 -122.65 133.55 54.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 647' ' ' ILE . 35.4 ttmt -98.28 136.98 37.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.26 158.74 42.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.288 -179.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -76.44 112.74 13.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.329 0.585 . . . . 0.0 110.299 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.447 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.9 t60 . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.823 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 630' ' ' HIS . 2.4 mt . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.1 m-20 -118.78 148.09 43.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.309 0.576 . . . . 0.0 112.378 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.677 ' OD2' HD11 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -132.3 138.51 47.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.778 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.696 ' CD1' HD22 ' A' ' 578' ' ' LEU . 5.0 pt -96.03 119.06 43.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.572 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 85.8 m95 -103.7 132.63 49.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.972 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.561 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.9 t80 -90.73 116.23 28.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 624' ' ' PHE . 1.3 m -98.13 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.111 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 60.8 t60 -124.58 129.28 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 16.9 p -128.6 4.88 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.325 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.95 149.01 33.92 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.692 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.2 t -75.81 -28.27 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.523 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.634 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.7 OUTLIER -73.93 0.01 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.272 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 56.77 133.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.345 0.593 . . . . 0.0 111.896 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 14.8 t -105.11 165.58 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.004 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.408 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 10.4 m-85 -134.6 120.19 19.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.711 ' HA ' HG23 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -99.35 100.49 11.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.9 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 31.0 t30 -132.17 -0.7 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.62 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.405 ' OD1' ' CZ ' ' A' ' 670' ' ' PHE . 21.3 m120 -104.04 122.39 45.16 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.991 0.424 . . . . 0.0 111.245 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -66.63 141.77 57.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.968 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 37.6 mmm -114.8 102.49 10.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.16 147.33 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.802 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.91 95.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.435 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.2 39.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.841 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 718' ' ' LYS . 1.3 p -138.16 161.99 35.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.405 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 19.3 pttm -135.62 135.66 40.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.562 ' HB3' HD23 ' A' ' 659' ' ' LEU . 18.8 t80 -127.15 143.55 51.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.51 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.677 HD11 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.95 136.53 50.63 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.03 0.443 . . . . 0.0 111.597 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 1.011 HD13 HG21 ' A' ' 694' ' ' VAL . 2.7 mt -98.57 143.52 28.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.307 0.575 . . . . 0.0 111.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 26.0 mt-30 -119.09 141.85 48.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.529 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 696' ' ' ILE . 26.8 t70 -48.07 96.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.22 0.533 . . . . 0.0 110.213 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 107.49 32.6 3.36 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.415 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -86.63 114.35 23.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 110.98 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -96.12 108.73 21.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.711 HG23 ' HA ' ' A' ' 659' ' ' LEU . 1.4 mt -105.2 137.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 111.745 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.24 115.87 28.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.623 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.775 HG23 ' CD2' ' A' ' 622' ' ' HIS . 8.1 mt -82.97 -35.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.236 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 617' ' ' ARG . 1.2 tt -154.9 132.67 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 111.586 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -136.33 124.22 22.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.227 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.77 117.0 27.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.314 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -67.16 -47.08 72.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.803 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.5 p-10 -83.44 -40.33 19.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.533 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.408 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 0.7 OUTLIER -77.75 -15.6 59.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.383 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.83 9.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 0.0 110.952 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 1.8 t80 -85.37 105.1 15.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -122.87 121.75 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.287 0.565 . . . . 0.0 112.144 -178.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.667 ' CG1' HG22 ' A' ' 681' ' ' ILE . 2.5 mm -109.77 144.41 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.38 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -169.58 127.35 1.48 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.753 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 9.3 m-30 -113.95 146.13 40.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.784 0.326 . . . . 0.0 110.42 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.736 ' HB2' HD22 ' A' ' 583' ' ' LEU . 26.7 tttt -101.36 116.59 33.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 1.024 HG22 HD22 ' A' ' 580' ' ' LEU . 2.5 t -82.5 124.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.436 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.3 tp10 -133.69 109.23 9.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.898 0.38 . . . . 0.0 111.05 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.683 HD12 ' HB2' ' A' ' 674' ' ' ASP . 24.0 mt -72.17 104.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.268 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -88.32 -49.97 6.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 5.5 t70 -112.18 139.52 47.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.032 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 8.3 p . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.798 0.333 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.557 HD12 ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -98.38 163.21 12.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . 0.532 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.1 OUTLIER -102.62 145.61 29.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.44 151.89 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.2 p -126.0 -173.95 2.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.97 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.99 -28.97 55.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -49.21 64.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -63.78 -50.95 67.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -57.41 -32.83 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.85 -37.25 86.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 600' ' ' PRO . 14.4 mt -62.79 -44.5 96.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.961 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.611 HG23 HG11 ' A' ' 621' ' ' VAL . 8.4 p -76.17 -28.57 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.08 -33.84 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.4 mttm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.763 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 19.9 ttp-105 . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.532 0.206 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -99.44 -58.98 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.447 . . . . 0.0 110.504 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.886 HD12 HD13 ' A' ' 647' ' ' ILE . 9.4 tt -107.84 141.98 38.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.633 HG22 ' HG2' ' A' ' 581' ' ' LYS . 16.0 m -117.58 115.24 24.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.587 ' CD1' HD11 ' A' ' 594' ' ' ILE . 0.4 OUTLIER -104.4 108.64 20.15 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.633 ' HG2' HG22 ' A' ' 579' ' ' THR . 11.6 mtmt -114.86 99.13 51.58 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -47.26 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.761 1.641 . . . . 0.0 109.394 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.481 HD21 ' HG3' ' A' ' 677' ' ' GLU . 0.2 OUTLIER -74.68 157.91 85.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.11 -25.27 8.97 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.688 2.925 . . . . 0.0 112.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.65 -28.16 69.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.447 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 2.0 t -95.94 153.8 17.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.631 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.672 HD13 ' CE1' ' A' ' 688' ' ' PHE . 16.0 pt -57.14 -13.68 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 110.973 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 613' ' ' ILE . 23.4 mt -105.48 120.26 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.685 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -108.41 56.79 0.62 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.063 0.459 . . . . 0.0 110.343 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.652 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.0 mt-10 -124.72 170.36 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.215 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.576 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -130.19 120.54 24.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.359 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 591' ' ' SER . 0.4 OUTLIER -113.15 148.43 35.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.81 125.51 44.12 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.817 HD12 HD22 ' A' ' 578' ' ' LEU . 94.0 mt -83.73 109.05 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -67.05 124.38 22.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.696 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.52 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.66 -29.7 3.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.244 0.545 . . . . 0.0 109.817 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.93 -24.04 77.46 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.86 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.24 117.86 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 118.018 0.909 . . . . 0.0 111.66 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.5 t30 -140.37 121.7 9.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.596 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -89.84 160.49 35.22 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.296 -0.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.587 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.4 t80 -91.69 115.62 28.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.49 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 23.6 m-85 -92.35 137.91 31.97 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.952 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.777 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.1 mp -126.45 146.03 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.436 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.19 -166.53 37.09 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.887 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.522 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.4 OUTLIER -71.49 -54.15 11.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 111.611 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.48 131.32 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.391 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -56.57 -19.07 14.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.982 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.08 -31.66 52.45 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.85 132.88 46.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.66 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 28.8 m120 -46.03 -31.05 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.236 0.541 . . . . 0.0 110.378 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.777 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.5 t -110.16 142.06 42.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.318 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.46 109.04 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.554 HG23 ' CD1' ' A' ' 588' ' ' ILE . 19.7 mm -138.05 109.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.084 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.522 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 1.0 OUTLIER -95.03 104.32 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.919 -178.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.666 ' HB2' HD21 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.67 113.96 14.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.19 177.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.5 -21.12 3.43 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.689 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.439 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 0.2 OUTLIER -74.33 -41.65 60.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -88.53 158.9 18.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 112.268 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 67.6 p -80.77 177.95 8.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.2 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.452 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -47.36 -45.76 25.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.121 0.486 . . . . 0.0 110.197 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 621' ' ' VAL . 7.4 p -125.68 71.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.568 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 9.3 t60 -45.7 -47.93 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.537 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 2.1 p -161.2 160.62 30.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.614 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 603' ' ' ILE . 1.7 p90 -143.68 148.7 36.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.666 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.469 HD13 HD11 ' A' ' 603' ' ' ILE . 3.5 mp -101.96 130.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.086 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -121.3 132.47 54.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.519 ' HE3' HG23 ' A' ' 647' ' ' ILE . 5.3 ttmt -97.97 137.16 37.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.439 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.492 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.59 159.25 41.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.54 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.7 OUTLIER -76.25 112.72 13.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.1 t60 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.577 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 630' ' ' HIS . 25.0 mt . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 3.3 m-20 -116.95 147.61 42.1 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.48 160.17 34.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.518 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.886 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -110.36 127.58 67.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.568 0.699 . . . . 0.0 112.776 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.879 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 81.9 m95 -110.93 125.89 54.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.411 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 11.7 t80 -90.01 116.1 27.8 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 20.1 m -101.65 142.57 32.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.432 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 60.6 t60 -125.88 130.23 50.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 25.1 p -126.69 5.18 6.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.168 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.76 153.17 36.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.582 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.8 t -73.64 -34.8 65.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.159 0.504 . . . . 0.0 111.486 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.609 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.3 m120 -68.26 -4.89 15.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.434 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.83 123.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 111.67 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.413 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 57.9 p -88.68 166.26 14.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.354 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -131.22 120.39 23.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.868 0.366 . . . . 0.0 111.409 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.905 HD22 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -94.99 99.84 11.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.383 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 61.2 -81.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -134.45 3.4 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.682 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -104.95 123.6 48.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 111.171 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.35 141.38 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.92 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 21.7 mmm -118.14 111.93 19.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.9 pt -91.03 150.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.102 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 652' ' ' THR . 2.9 tt0 -51.87 100.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.471 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.87 37.26 1.16 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.002 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 718' ' ' LYS . 1.8 p -139.35 159.19 42.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.0 pttm -123.96 158.19 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.58 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 716' ' ' VAL . 10.6 t80 -144.27 146.46 32.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.879 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.53 128.17 35.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.696 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.816 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -105.76 121.85 44.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.43 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -109.33 162.83 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.39 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.574 ' HB3' HD12 ' A' ' 696' ' ' ILE . 11.7 p30 -58.62 110.47 1.0 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.42 . . . . 0.0 110.686 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 95.51 36.92 5.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.214 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -91.63 115.35 27.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.323 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 583' ' ' LEU . 0.7 OUTLIER -96.28 110.35 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.053 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.905 HG22 HD22 ' A' ' 659' ' ' LEU . 26.9 pt -105.62 132.58 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.98 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -91.03 116.62 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.004 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.418 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -81.22 -34.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.45 -179.245 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.651 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.1 tp -154.43 131.34 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 111.718 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.402 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 10.2 t90 -136.47 126.32 25.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -126.22 116.77 21.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -67.4 -46.77 72.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.989 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -77.74 -40.41 41.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.769 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -7.79 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.602 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp 59.66 17.95 6.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.672 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.3 t80 -76.55 104.82 7.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.1 p -120.68 121.98 66.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 112.134 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.651 ' HB ' HG22 ' A' ' 681' ' ' ILE . 4.2 mt -128.72 155.26 40.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.436 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.447 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.98 135.9 2.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.231 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.478 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 5.0 m-30 -113.08 149.73 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.16 117.47 35.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.008 0.433 . . . . 0.0 110.704 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.774 HG22 HD21 ' A' ' 578' ' ' LEU . 2.6 t -80.48 114.75 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.1 108.96 12.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 0.0 110.123 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.574 HD12 ' HB3' ' A' ' 674' ' ' ASP . 8.9 mt -80.45 111.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.334 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -96.15 -45.85 6.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 4.1 t70 -111.13 140.34 45.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.014 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 716' ' ' VAL . 10.0 p . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.777 0.323 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 169.59 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.985 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . 0.691 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.5 OUTLIER -102.9 157.94 16.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.855 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -88.6 158.3 18.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.985 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -178.83 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.12 54.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.01 -52.07 52.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -43.34 96.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.783 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -57.32 -33.82 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.22 -36.78 80.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.483 HD13 ' HG3' ' A' ' 600' ' ' PRO . 23.2 mt -58.18 -44.32 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.75 -27.82 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.813 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.869 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.441 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 51.5 ttp85 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.686 0.279 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.767 ' CE1' HG21 ' A' ' 647' ' ' ILE . 0.5 OUTLIER -101.1 -50.94 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.909 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.011 HD11 HG13 ' A' ' 694' ' ' VAL . 44.6 tp -114.55 142.3 46.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.102 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 32.9 m -118.97 121.8 40.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.531 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.914 ' CD2' HG23 ' A' ' 694' ' ' VAL . 6.6 mt -109.03 108.57 19.33 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.23 100.24 50.22 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -176.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.1 Cg_exo -47.84 105.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.694 1.596 . . . . 0.0 109.271 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.535 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.17 156.73 87.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.464 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 77.2 Cg_exo -50.4 -25.83 14.81 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.741 2.961 . . . . 0.0 113.357 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.86 -20.62 65.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.056 0.455 . . . . 0.0 110.039 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.48 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 3.7 t -97.24 154.34 17.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.969 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.767 HD13 ' CE1' ' A' ' 688' ' ' PHE . 4.1 pt -55.11 -19.68 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.115 0.483 . . . . 0.0 109.84 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.13 119.01 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.87 63.7 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.124 0.487 . . . . 0.0 110.701 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.57 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.8 mt-10 -124.97 170.81 10.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.48 121.6 27.58 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.681 0.277 . . . . 0.0 111.427 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.3 mm? -113.21 150.8 31.81 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.441 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.3 mt-10 -125.18 131.26 53.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.826 HD12 HD23 ' A' ' 578' ' ' LEU . 73.7 mt -90.13 108.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -69.14 124.64 24.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.9 -32.37 3.75 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.506 0.669 . . . . 0.0 109.505 179.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.81 -22.55 75.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.664 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.88 HG11 ' OD1' ' A' ' 610' ' ' ASN . 81.9 t -98.36 117.94 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.929 0.864 . . . . 0.0 111.545 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 4.5 t30 -140.38 121.33 9.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.023 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.606 ' HD3' HD22 ' A' ' 726' ' ' LEU . 43.7 Cg_endo -90.96 159.72 29.3 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.475 -1.052 . . . . 0.0 111.415 -0.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.666 ' CG ' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -92.11 113.27 25.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.513 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 5.8 m-85 -91.9 138.28 31.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.083 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.814 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -123.7 145.49 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.481 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.55 -167.55 35.77 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.427 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.456 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -73.62 -52.22 14.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 128.99 39.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.387 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -54.46 -19.9 6.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.965 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -28.26 51.78 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.018 0.437 . . . . 0.0 110.382 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 81.1 m -75.26 131.33 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.589 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.88 ' OD1' HG11 ' A' ' 598' ' ' VAL . 1.5 m-80 -46.44 -29.68 1.84 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.066 0.46 . . . . 0.0 110.464 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.814 ' SG ' HG23 ' A' ' 603' ' ' ILE . 31.0 t -109.59 137.46 47.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.68 104.94 14.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.442 HG13 ' CE2' ' A' ' 692' ' ' PHE . 14.2 mm -139.32 109.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.322 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.66 106.05 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.436 0.636 . . . . 0.0 111.998 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.508 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.8 OUTLIER -129.99 108.69 10.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.733 177.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -39.44 -27.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.554 ' HB3' HD11 ' A' ' 681' ' ' ILE . 32.3 mmt180 -71.4 -42.09 68.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.508 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -88.47 158.63 18.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.261 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.7 t -83.9 171.28 13.19 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.619 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.473 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -49.72 -41.83 44.49 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.143 0.497 . . . . 0.0 110.369 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 727' ' ' VAL . 11.7 t -121.4 61.52 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.6 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.82 ' CD2' HG23 ' A' ' 680' ' ' ILE . 38.5 t60 -46.21 -45.22 16.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.59 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.4 p -167.34 159.29 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.597 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.633 ' HA ' HD12 ' A' ' 603' ' ' ILE . 51.7 p90 -143.48 146.52 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.817 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 580' ' ' LEU . 16.6 mt -102.1 130.22 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 109.919 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -121.7 135.56 54.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.692 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 6.0 tttt -97.77 133.46 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.111 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.8 OUTLIER -136.07 159.79 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.95 -178.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 6.4 tpt85 -75.79 112.31 12.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.359 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.9 t60 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.336 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 630' ' ' HIS . 2.8 mp . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.595 0.236 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -97.05 147.98 23.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 111.434 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.452 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -129.82 160.03 34.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.049 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.767 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.2 pt -107.32 119.09 56.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.552 0.691 . . . . 0.0 111.854 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 86.8 m95 -104.68 130.87 52.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.152 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.424 ' CB ' HD21 ' A' ' 672' ' ' LEU . 39.0 t80 -90.99 117.24 29.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 624' ' ' PHE . 10.9 m -103.77 138.07 40.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.829 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.469 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 27.0 t60 -120.84 130.53 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.238 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 15.1 p -128.14 7.33 6.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.213 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.13 151.44 36.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.837 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.6 t -75.37 -36.27 60.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 111.405 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m-20 -72.74 2.09 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.601 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.587 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 49.12 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.587 0.708 . . . . 0.0 112.153 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.406 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 39.2 m -105.63 165.6 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 5.1 m-85 -124.7 120.18 31.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 111.266 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -98.86 100.02 11.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.673 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 61.83 -80.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.859 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.0 m120 -135.83 0.76 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.641 ' HB3' HG23 ' A' ' 716' ' ' VAL . 2.1 m120 -106.77 141.12 38.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.174 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.486 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.1 ttm180 -75.07 141.76 43.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.615 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 12.0 mmm -124.08 85.85 2.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.469 HG12 HG21 ' A' ' 668' ' ' THR . 29.2 pt -87.53 165.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 111.071 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.7 118.39 3.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.366 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.53 27.66 12.69 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.469 HG21 HG12 ' A' ' 665' ' ' ILE . 32.9 p -112.96 162.0 16.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 0.0 111.435 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpm? -141.98 140.62 32.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.615 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 0.3 OUTLIER -145.22 142.64 29.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.224 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.55 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -70.21 140.02 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 110.699 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 694' ' ' VAL . 2.0 mt -109.43 119.09 38.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 111.062 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.24 138.03 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.813 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.447 ' HB2' HD12 ' A' ' 696' ' ' ILE . 35.7 t0 -42.38 107.15 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.089 0.471 . . . . 0.0 110.807 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 105.93 32.65 3.75 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.17 119.99 32.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.371 . . . . 0.0 110.731 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.498 ' OE2' HD21 ' A' ' 583' ' ' LEU . 3.4 tm-20 -96.1 111.33 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.093 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.54 HG22 HD13 ' A' ' 659' ' ' LEU . 33.2 pt -105.59 135.42 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 112.016 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 116.74 33.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.607 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.82 HG23 ' CD2' ' A' ' 622' ' ' HIS . 5.6 mt -91.36 -30.76 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.968 HG22 ' HB ' ' A' ' 690' ' ' ILE . 4.0 tp -153.8 130.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 111.674 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -137.46 126.83 24.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -126.88 117.05 21.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.874 0.369 . . . . 0.0 110.363 178.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.77 -46.81 74.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.804 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -83.36 -40.37 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.565 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.35 -11.1 59.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.446 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 57.75 22.11 8.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.695 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.767 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -81.57 104.38 11.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 689' ' ' VAL . 0.5 OUTLIER -126.98 120.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.968 ' HB ' HG22 ' A' ' 681' ' ' ILE . 30.2 mt -129.83 120.53 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.511 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -143.03 140.93 10.11 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.516 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.488 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 8.6 m-30 -112.66 146.06 39.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.809 0.338 . . . . 0.0 110.368 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.535 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.1 tptt -101.04 116.15 32.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.07 0.462 . . . . 0.0 109.846 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -82.69 122.34 37.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.306 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -133.09 109.84 9.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.971 0.415 . . . . 0.0 111.033 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.512 HG12 HD13 ' A' ' 578' ' ' LEU . 16.3 mt -78.89 106.05 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.728 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.75 -45.04 10.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 9.4 t0 -110.3 140.14 44.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.483 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 121.297 0.57 . . . . 0.0 109.891 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.641 HG23 ' HB3' ' A' ' 662' ' ' ASN . 96.5 t . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.38 171.37 7.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -103.09 142.57 33.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.965 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -77.4 154.44 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 -179.51 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.236 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.88 -31.97 51.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -61.83 -48.84 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.733 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.707 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.6 mp0 -65.76 -49.34 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -61.08 -32.74 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.181 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -38.68 92.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.273 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 723' ' ' GLU . 2.7 mt -63.18 -44.36 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 621' ' ' VAL . 9.1 p -81.21 -27.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -56.34 -30.93 63.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 110.787 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.9 mttm . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.436 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.2 ttm105 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.734 0.302 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.933 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -124.01 -63.25 1.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.221 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.834 HD21 HG22 ' A' ' 694' ' ' VAL . 10.1 tt -108.98 142.69 39.27 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.202 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.587 HG21 ' CE ' ' A' ' 581' ' ' LYS . 2.1 m -120.97 113.88 20.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.627 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -101.52 107.92 19.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.587 ' CE ' HG21 ' A' ' 579' ' ' THR . 69.1 mttt -113.16 99.18 48.3 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.6 Cg_exo -47.28 99.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.767 1.645 . . . . 0.0 109.416 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -74.5 157.47 86.2 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.64 -25.36 11.02 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.809 3.006 . . . . 0.0 112.961 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -27.84 68.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.452 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.0 OUTLIER -95.73 153.87 17.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.554 178.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 690' ' ' ILE . 6.5 pt -58.17 -11.46 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.629 HD13 HG23 ' A' ' 613' ' ' ILE . 49.6 mt -107.16 119.01 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.76 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.424 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -107.68 58.13 0.62 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.134 0.493 . . . . 0.0 110.252 179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.611 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.7 mm-40 -124.62 171.58 9.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.351 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.03 128.3 44.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.775 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.51 141.1 46.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.017 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.436 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.0 mt-10 -124.52 115.78 21.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.801 HD12 HD22 ' A' ' 578' ' ' LEU . 77.0 mt -83.24 109.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.294 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.94 120.23 13.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.057 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.549 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.67 -29.84 2.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.176 0.513 . . . . 0.0 110.696 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -18.44 78.63 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.765 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.74 HG11 ' OD1' ' A' ' 610' ' ' ASN . 46.5 t -101.2 117.98 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 117.902 0.851 . . . . 0.0 111.983 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.412 ' ND2' ' HG3' ' A' ' 627' ' ' LYS . 27.9 t30 -140.27 122.77 9.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.873 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.1 Cg_endo -90.52 159.81 31.53 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.286 -1.131 . . . . 0.0 111.775 -0.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.638 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.31 115.62 28.24 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.554 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 43.3 m-85 -92.33 137.95 31.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.838 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.4 143.31 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.438 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.16 -170.3 38.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.297 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.466 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -70.75 -49.45 46.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 111.614 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.71 130.64 47.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.479 -179.058 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -18.14 23.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.3 -28.65 63.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.086 0.47 . . . . 0.0 110.455 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.62 ' SG ' HG22 ' A' ' 621' ' ' VAL . 84.4 m -74.11 132.5 42.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.632 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.74 ' OD1' HG11 ' A' ' 598' ' ' VAL . 14.2 m-80 -47.44 -29.37 2.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.179 0.514 . . . . 0.0 110.254 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.775 ' SG ' HD13 ' A' ' 592' ' ' LEU . 42.5 t -109.93 142.07 41.79 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 105.38 13.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.77 HD11 HD21 ' A' ' 592' ' ' LEU . 20.5 mm -139.09 109.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.13 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.65 106.57 17.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.463 0.649 . . . . 0.0 112.255 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.577 ' H ' HD11 ' A' ' 618' ' ' LEU . 2.2 t0 -129.68 107.53 9.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.633 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.39 -27.24 0.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -69.95 -42.05 73.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.684 0.278 . . . . 0.0 111.382 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.577 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.2 pp -90.08 158.75 17.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.73 164.15 26.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.014 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.552 ' HG2' HG23 ' A' ' 621' ' ' VAL . 1.0 OUTLIER -50.38 -28.33 7.89 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.068 0.461 . . . . 0.0 110.449 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.62 HG22 ' SG ' ' A' ' 609' ' ' CYS . 45.0 t -130.8 64.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.694 ' CD2' HG23 ' A' ' 680' ' ' ILE . 20.8 t60 -50.57 -46.94 57.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.119 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.6 p -165.36 161.5 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.511 . . . . 0.0 111.93 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.529 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.8 p90 -143.6 147.67 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.664 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.15 130.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -124.4 134.16 53.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -99.56 136.93 38.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.619 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.4 OUTLIER -135.88 158.94 43.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.584 -178.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.6 tpt180 -75.99 112.44 12.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.356 0.598 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.3 t60 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.233 -179.491 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 3.4 m-20 -100.68 146.27 27.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.37 0.605 . . . . 0.0 112.398 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 4.9 t0 -126.69 160.53 30.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.29 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.933 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 3.3 pt -114.88 115.37 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.386 0.612 . . . . 0.0 112.026 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.929 ' CH2' HD22 ' A' ' 671' ' ' LEU . 63.9 m95 -102.73 136.86 41.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.151 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.667 ' HB2' HD11 ' A' ' 672' ' ' LEU . 17.0 t80 -93.05 117.52 30.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.013 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 14.8 m -101.87 130.67 48.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.087 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.475 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 45.0 t60 -111.19 132.88 53.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.483 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 13.4 p -129.27 2.47 5.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.416 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.86 148.1 32.96 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.4 t -73.28 -33.0 64.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 111.244 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.584 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.9 m-20 -72.27 -0.18 11.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.362 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.31 130.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 0.0 112.081 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.447 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 46.7 m -100.94 166.3 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.1 121.39 29.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.538 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.717 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.75 99.95 11.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.608 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 60.26 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.0 m-80 -130.02 -1.7 4.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.614 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.471 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.5 m-80 -101.6 142.02 33.59 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.239 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.585 ' O ' HG21 ' A' ' 716' ' ' VAL . 46.8 ttp180 -81.55 141.27 33.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.272 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.503 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 15.3 mmm -121.16 96.92 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.693 HG13 HG23 ' A' ' 668' ' ' THR . 6.7 pt -87.75 164.55 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.86 100.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.57 37.78 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.693 HG23 HG13 ' A' ' 665' ' ' ILE . 1.9 p -119.81 162.44 19.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.099 0.476 . . . . 0.0 111.535 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.637 ' O ' HD12 ' A' ' 717' ' ' LEU . 1.6 ttpm? -131.3 147.27 52.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.523 ' CD1' HG22 ' A' ' 716' ' ' VAL . 2.4 t80 -147.44 144.93 28.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.929 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.22 133.34 47.83 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.607 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.717 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.5 mt -114.8 124.84 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.677 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.91 151.53 33.87 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.464 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.513 ' HB2' HD12 ' A' ' 696' ' ' ILE . 8.2 t70 -49.07 119.41 3.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 110.405 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.29 36.4 5.95 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.46 110.09 22.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.737 0.303 . . . . 0.0 111.336 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.75 108.82 21.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.06 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.658 HG12 HD13 ' A' ' 659' ' ' LEU . 8.9 mt -105.61 136.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.897 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.15 116.48 28.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.679 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.694 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -84.72 -34.05 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.581 -178.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.843 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.5 tp -154.58 131.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.135 0.493 . . . . 0.0 111.866 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.407 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 13.0 t90 -136.26 126.81 26.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.046 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.03 116.9 21.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.416 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -67.36 -46.71 72.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.873 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.11 -40.42 27.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.622 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -85.07 -10.55 56.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.427 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.9 mttt 59.82 19.2 8.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 682' ' ' TRP . 1.5 t80 -77.38 104.76 8.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.7 p -125.64 123.82 65.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 112.195 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.843 ' HB ' HG22 ' A' ' 681' ' ' ILE . 19.0 mt -128.32 154.87 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.424 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.452 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.24 135.75 2.76 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.113 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.607 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 5.9 m-30 -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.289 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -100.95 117.06 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.721 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.834 HG22 HD21 ' A' ' 578' ' ' LEU . 2.6 t -78.84 126.45 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.373 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.7 tt0 -133.29 109.33 9.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 110.59 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 674' ' ' ASP . 47.0 mt -82.89 105.68 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.102 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -87.86 -45.98 9.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.826 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.6 140.95 44.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.407 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.325 0.583 . . . . 0.0 109.669 178.494 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.585 HG21 ' O ' ' A' ' 663' ' ' ARG . 12.7 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.933 0.397 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.637 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -102.55 168.68 9.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.482 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 144.91 30.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -82.61 158.52 23.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -175.01 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.171 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.79 60.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.37 -46.56 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.694 ' HA ' HD12 ' A' ' 726' ' ' LEU . 3.7 mp0 -66.69 -47.8 71.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.767 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -59.99 -33.11 71.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -63.14 -39.58 95.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.694 HD12 ' HA ' ' A' ' 723' ' ' GLU . 4.7 mt -60.53 -44.02 96.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.0 p -80.62 -27.9 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -54.2 -34.4 60.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.436 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.005 0.431 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -126.9 -62.86 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.087 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -106.42 142.23 36.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.841 ' N ' HD23 ' A' ' 578' ' ' LEU . 7.1 m -124.55 114.62 19.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.713 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.8 OUTLIER -104.25 108.42 19.81 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.0 100.22 53.28 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 24.5 Cg_exo -45.43 104.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.565 1.51 . . . . 0.0 109.105 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.39 156.98 86.92 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.001 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.56 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -49.88 -31.6 27.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.663 2.909 . . . . 0.0 112.908 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.686 ' HB2' HD12 ' A' ' 583' ' ' LEU . 4.7 m-20 -63.82 -21.49 66.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.465 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.663 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 24.7 p -96.46 153.23 17.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.201 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.655 HG23 HG13 ' A' ' 588' ' ' ILE . 3.9 tt -52.46 -19.47 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.633 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.72 HD13 HG23 ' A' ' 613' ' ' ILE . 40.4 mt -110.62 118.54 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.299 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -109.7 60.81 0.6 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.298 0.571 . . . . 0.0 110.841 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.54 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 29.3 mt-10 -125.48 171.91 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.668 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.24 127.7 44.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 178.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.772 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.6 137.72 50.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.616 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.436 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.9 OUTLIER -124.12 119.53 29.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.587 HD11 HD13 ' A' ' 625' ' ' ILE . 80.3 mt -86.68 109.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.113 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.99 122.5 18.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.996 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.6 -29.56 1.88 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.69 -25.2 74.08 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.823 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.13 118.12 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.002 0.901 . . . . 0.0 111.661 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -140.09 122.63 10.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.844 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.1 Cg_endo -89.93 159.66 34.36 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 124.352 -1.104 . . . . 0.0 111.695 -0.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.4 t80 -91.93 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.595 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 58.9 m-85 -92.77 138.16 31.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.665 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.738 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.1 mp -128.12 144.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.66 -173.21 40.56 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.68 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -75.88 -18.39 59.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.324 0.249 . . . . 0.0 111.372 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.16 129.96 35.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.36 -23.0 21.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -55.07 -30.37 59.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.085 0.469 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 34.8 m -73.44 127.99 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.829 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 32.8 m120 -44.31 -33.93 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.306 0.574 . . . . 0.0 110.298 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.772 ' SG ' HD13 ' A' ' 592' ' ' LEU . 54.1 t -104.36 143.04 33.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.172 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.429 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -119.79 113.53 20.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.72 HG23 HD13 ' A' ' 588' ' ' ILE . 26.5 mm -137.95 109.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.447 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -97.28 105.23 17.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.513 0.673 . . . . 0.0 112.291 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.666 ' CB ' HD13 ' A' ' 618' ' ' LEU . 38.3 t0 -131.43 123.05 27.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.062 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -47.63 -29.23 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.75 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.616 ' HB3' HD13 ' A' ' 681' ' ' ILE . 3.2 mpt_? -77.76 -39.35 44.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.666 HD13 ' CB ' ' A' ' 615' ' ' ASP . 2.2 mp -65.88 159.22 26.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.786 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.0 m -110.61 172.08 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.433 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -47.84 31.76 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 110.174 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.938 HG11 HG23 ' A' ' 727' ' ' VAL . 4.1 t -121.45 56.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.482 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.572 ' CD2' HG23 ' A' ' 680' ' ' ILE . 49.3 t60 -43.67 -47.63 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.598 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 2.7 p -165.6 151.65 9.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.0 p90 -143.29 146.9 33.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.829 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.721 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.4 mp -101.86 127.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.586 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -120.37 134.33 55.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 27.2 ttmt -97.82 136.5 38.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.075 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.59 158.29 44.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.833 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.4 113.98 15.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.334 0.588 . . . . 0.0 110.572 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.132 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.6 mp . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.0 m-20 -122.05 146.43 47.19 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.239 0.543 . . . . 0.0 112.033 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.17 160.56 35.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.087 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -107.9 121.94 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.482 0.658 . . . . 0.0 112.274 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.933 ' CH2' HD22 ' A' ' 671' ' ' LEU . 79.4 m95 -106.0 124.65 49.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.168 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CD2' HD13 ' A' ' 678' ' ' ILE . 7.3 t80 -90.39 116.92 28.71 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 26.6 m -102.11 144.08 31.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.254 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 18.3 t60 -131.03 124.28 30.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.404 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 1.4 p -121.13 6.69 10.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.06 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.48 148.11 35.11 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.278 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 3.5 t -69.84 -34.7 73.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.795 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.585 ' O ' HG13 ' A' ' 656' ' ' VAL . 51.5 m-80 -70.56 -2.51 14.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.608 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.72 133.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.434 0.635 . . . . 0.0 111.893 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 81.8 p -103.06 165.59 10.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.816 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.5 120.26 30.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.775 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.84 101.33 12.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 59.78 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 65.1 t30 -133.47 -2.2 3.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.521 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 1.3 t-20 -104.98 141.41 36.61 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.197 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.89 141.2 33.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.573 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -109.24 100.11 9.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.691 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.7 pt -87.12 134.9 26.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.963 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' A' ' 652' ' ' THR . 1.2 tt0 -38.49 98.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.988 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 37.38 1.17 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 718' ' ' LYS . 2.1 p -139.21 158.37 44.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.703 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.491 ' HE2' HD13 ' A' ' 717' ' ' LEU . 12.6 pttm -123.61 158.2 32.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.521 ' CE2' ' CB ' ' A' ' 662' ' ' ASN . 0.3 OUTLIER -145.08 146.3 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.933 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.95 130.92 44.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.86 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.763 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -109.81 118.65 37.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 111.625 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -108.52 138.31 45.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.438 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 696' ' ' ILE . 8.7 t70 -38.88 116.95 0.62 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.84 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.8 35.28 6.19 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.43 114.89 27.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.86 108.52 20.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 13.0 mt -107.91 131.79 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.898 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 115.65 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.567 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.62 HD12 ' CE2' ' A' ' 692' ' ' PHE . 1.1 mt -78.01 -36.05 21.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.364 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.701 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -155.14 131.91 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 111.73 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -136.21 125.75 25.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -127.11 116.9 21.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.924 0.393 . . . . 0.0 110.318 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -67.22 -46.55 73.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.895 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -74.46 -40.29 61.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.77 -11.97 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.451 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt 61.61 16.94 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.727 0.298 . . . . 0.0 111.019 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 2.3 t80 -82.27 105.49 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.613 ' O ' HG22 ' A' ' 587' ' ' ILE . 0.9 OUTLIER -125.95 121.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.214 0.531 . . . . 0.0 111.997 -178.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 681' ' ' ILE . 31.5 mt -117.73 130.82 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.63 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -154.91 130.85 2.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.421 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.62 ' CE2' HD12 ' A' ' 680' ' ' ILE . 3.4 m-30 -113.33 143.91 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.863 0.363 . . . . 0.0 110.38 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.627 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -101.47 117.35 34.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.03 0.443 . . . . 0.0 110.682 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.777 HG22 HD21 ' A' ' 578' ' ' LEU . 3.0 t -79.97 127.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.515 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -133.39 109.53 9.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 674' ' ' ASP . 52.2 mt -83.19 105.14 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.36 -46.58 12.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.279 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.08 140.68 45.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.316 0.579 . . . . 0.0 109.568 178.064 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 669' ' ' LYS . 7.2 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.971 0.415 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.491 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.6 OUTLIER -109.07 172.43 6.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.787 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . 0.53 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.0 OUTLIER -95.23 158.05 15.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 723' ' ' GLU . 15.1 mt-30 -95.88 160.27 14.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.864 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.1 p -120.2 -174.44 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.91 58.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -60.78 -48.17 82.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 726' ' ' LEU . 5.6 tm-20 -64.12 -48.86 74.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -53.1 -33.47 52.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.21 -36.91 80.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 723' ' ' GLU . 38.4 mt -56.65 -44.31 81.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.938 HG23 HG11 ' A' ' 621' ' ' VAL . 10.2 p -80.86 -21.25 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -67.82 -39.2 83.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.752 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.198 179.741 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.464 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.139 0 CA-C-O 120.502 0.192 . . . . 0.0 110.487 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -121.69 -62.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 111.476 -179.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.028 HD12 HD13 ' A' ' 647' ' ' ILE . 5.7 tt -105.93 125.99 51.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.66 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.4 m -102.46 119.19 38.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.268 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.862 HD12 HD11 ' A' ' 594' ' ' ILE . 4.7 mt -105.64 108.54 20.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -117.97 100.72 52.09 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.125 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.59 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.7 Cg_exo -46.14 101.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.778 1.652 . . . . 0.0 109.451 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -75.09 157.97 84.72 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -50.06 -25.75 13.33 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.461 2.774 . . . . 0.0 112.244 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.564 ' CB ' HD12 ' A' ' 583' ' ' LEU . 10.2 t70 -62.36 -26.47 68.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.44 ' HA ' HG13 ' A' ' 689' ' ' VAL . 54.5 p -95.4 153.47 17.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.711 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.801 HD13 ' CE1' ' A' ' 688' ' ' PHE . 1.0 OUTLIER -58.7 -14.16 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.56 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.458 ' CD1' HG23 ' A' ' 613' ' ' ILE . 73.0 mt -106.49 118.67 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.315 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.35 57.58 0.68 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 110.524 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.59 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.5 mt-10 -124.76 169.39 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.79 122.28 26.89 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.573 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.52 HD13 ' C ' ' A' ' 591' ' ' SER . 0.7 OUTLIER -113.17 150.31 32.43 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.392 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.464 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.44 125.34 44.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.862 HD11 HD12 ' A' ' 580' ' ' LEU . 93.9 mt -83.51 108.97 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.608 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -64.16 122.84 17.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.63 -30.06 3.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.258 0.551 . . . . 0.0 110.021 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.476 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -73.42 -20.94 79.97 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.926 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.685 HG11 ' ND2' ' A' ' 610' ' ' ASN . 61.0 t -98.62 118.04 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 118.108 0.954 . . . . 0.0 111.642 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.0 t30 -140.18 121.6 9.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.002 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.591 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.0 Cg_endo -90.56 159.34 31.11 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.442 -1.066 . . . . 0.0 111.511 -0.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.62 ' CD2' HG23 ' A' ' 594' ' ' ILE . 4.3 t80 -91.78 115.6 28.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.566 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.6 m-85 -92.54 137.94 31.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.349 -177.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.785 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.2 mp -123.97 145.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.438 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 157.67 -169.85 34.58 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.317 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -69.83 -48.74 57.82 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.21 124.28 19.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -178.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -19.44 5.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.665 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.48 -30.15 66.77 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 98.0 m -68.8 133.04 47.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.446 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.685 ' ND2' HG11 ' A' ' 598' ' ' VAL . 32.6 m120 -45.54 -30.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.19 0.519 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.785 ' SG ' HG23 ' A' ' 603' ' ' ILE . 32.8 t -113.1 142.34 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.373 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 105.92 15.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 588' ' ' ILE . 24.8 mm -138.39 109.71 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.441 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.22 106.89 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.584 0.707 . . . . 0.0 112.657 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.699 ' CB ' HD22 ' A' ' 618' ' ' LEU . 27.1 t0 -129.42 107.11 9.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.724 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.48 -30.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.429 ' HB2' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -77.98 -37.56 47.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.498 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.699 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -89.63 134.09 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.66 165.52 0.41 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -59.45 -21.64 60.35 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 621' ' ' VAL . 14.9 p -140.27 56.58 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.54 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 14.1 t60 -41.86 -37.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.39 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.0 p -170.09 160.05 7.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.248 0.547 . . . . 0.0 112.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.575 ' HA ' HD12 ' A' ' 603' ' ' ILE . 40.6 p90 -143.37 147.59 34.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.172 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 580' ' ' LEU . 3.8 mp -101.55 130.83 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.591 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.0 t80 -122.96 133.8 54.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.891 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.576 ' HD3' HG23 ' A' ' 647' ' ' ILE . 3.0 tppp? -98.07 136.66 37.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.477 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.65 159.14 41.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.737 -178.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -76.41 112.45 12.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.355 0.598 . . . . 0.0 110.705 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.4 t60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.698 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.9 mp . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 9.9 m-20 -112.63 146.93 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.59 160.09 34.35 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.275 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.028 HD13 HD12 ' A' ' 578' ' ' LEU . 1.9 pt -106.53 126.86 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.6 0.714 . . . . 0.0 112.892 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.874 ' CH2' HD22 ' A' ' 671' ' ' LEU . 82.7 m95 -111.22 128.55 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.687 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.734 ' CE1' HD12 ' A' ' 678' ' ' ILE . 20.2 t80 -90.76 117.8 29.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 38.4 m -102.8 131.87 49.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.484 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 47.4 t60 -111.91 130.85 55.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.6 p -131.47 12.42 4.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.342 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.32 154.27 32.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.295 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 55.3 m -83.61 -24.15 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.741 0.305 . . . . 0.0 111.381 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.61 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.9 OUTLIER -82.6 4.14 25.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 53.27 133.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 111.981 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.457 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 60.0 m -102.0 166.17 10.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.376 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.407 ' O ' ' N ' ' A' ' 679' ' ' LYS . 34.9 m-85 -130.61 120.01 23.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.974 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -100.15 103.54 15.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.872 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.468 ' N ' HD12 ' A' ' 659' ' ' LEU . 16.9 t-20 60.56 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.768 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.8 m120 -136.43 6.03 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.508 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.878 ' OD1' HG23 ' A' ' 716' ' ' VAL . 1.0 OUTLIER -107.37 142.0 37.86 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.804 0.335 . . . . 0.0 111.001 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.441 ' NH1' HG22 ' A' ' 665' ' ' ILE . 24.8 ttt-85 -78.02 141.39 38.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.402 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.438 ' O ' HG23 ' A' ' 656' ' ' VAL . 42.7 mmm -121.9 93.02 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.542 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.441 HG22 ' NH1' ' A' ' 663' ' ' ARG . 36.1 pt -87.71 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -47.25 96.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.115 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.26 41.47 0.81 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.0 p -128.94 162.15 28.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.056 0.455 . . . . 0.0 111.86 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.468 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -134.73 146.71 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.468 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.54 145.5 29.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.874 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.84 133.22 47.98 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.705 179.341 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.75 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -108.59 119.15 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.153 0.501 . . . . 0.0 111.443 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -106.67 139.73 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.828 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' A' ' 696' ' ' ILE . 41.1 t0 -40.8 114.8 0.51 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 110.732 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.78 36.69 5.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.65 115.38 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.056 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -96.55 108.68 21.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.974 HG22 HD13 ' A' ' 659' ' ' LEU . 23.4 pt -108.27 129.1 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 0.0 111.946 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -89.22 116.03 27.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.307 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.498 HG23 ' CD2' ' A' ' 622' ' ' HIS . 3.0 mt -78.31 -36.0 20.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.566 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.646 HG22 ' CG1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -154.92 131.87 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.35 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -136.1 128.34 30.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 111.501 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -127.14 116.37 20.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.14 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.48 -46.47 72.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.16 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.83 -40.37 65.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -90.55 -10.33 43.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 15.97 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.663 0.268 . . . . 0.0 111.064 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.801 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.7 t80 -76.48 104.78 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 586' ' ' SER . 2.2 p -118.95 125.96 74.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.839 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.646 ' CG1' HG22 ' A' ' 681' ' ' ILE . 33.1 mm -127.93 125.62 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.36 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -160.7 136.74 4.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.136 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 8.1 m-30 -112.99 148.76 34.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.607 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.348 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.843 HG22 HD21 ' A' ' 578' ' ' LEU . 3.3 t -79.2 121.17 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.702 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.97 109.37 11.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.867 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' A' ' 674' ' ' ASP . 64.1 mt -78.31 110.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.33 -45.45 6.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.426 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 7.5 t70 -111.04 140.64 45.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.878 HG23 ' OD1' ' A' ' 662' ' ' ASN . 92.1 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.023 0.439 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.72 167.52 11.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.377 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.09 150.42 23.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.209 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.77 149.02 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.432 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 31.7 p -126.15 -173.62 2.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.405 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -61.86 -28.69 69.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.159 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.13 -53.2 58.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.7 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.5 pp20? -70.6 -37.74 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -58.53 -34.93 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.544 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 728' ' ' LYS . 10.2 t70 -68.14 -39.35 82.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.7 HD12 ' HA ' ' A' ' 723' ' ' GLU . 17.0 mt -58.27 -44.17 88.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.03 -23.78 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.576 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 725' ' ' ASP . 0.0 OUTLIER -50.49 -48.82 56.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.066 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.919 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.4 tmm_? . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.866 0.365 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.801 ' CE1' HG21 ' A' ' 647' ' ' ILE . 0.2 OUTLIER -122.3 -52.79 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.059 HD21 HG13 ' A' ' 694' ' ' VAL . 1.4 tt -107.04 140.42 39.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.112 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.732 ' N ' HD23 ' A' ' 578' ' ' LEU . 23.8 m -118.52 113.55 21.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.755 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.848 HD23 HD11 ' A' ' 678' ' ' ILE . 0.7 OUTLIER -105.7 108.85 20.57 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.1 ptpt -117.01 99.86 53.11 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.1 Cg_exo -45.98 104.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.893 1.729 . . . . 0.0 109.503 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.18 157.39 85.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -176.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.1 Cg_endo -50.72 -27.73 20.78 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.603 2.869 . . . . 0.0 112.53 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.578 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.1 t70 -62.54 -26.72 68.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.64 153.57 17.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.157 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 690' ' ' ILE . 8.1 pt -57.14 -12.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.977 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.505 ' CD1' HG23 ' A' ' 613' ' ' ILE . 38.9 mt -108.87 118.82 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.637 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -107.65 59.33 0.62 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.146 179.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.645 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mm-40 -125.57 170.04 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.264 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.2 116.73 18.06 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.304 178.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.771 HD22 ' SG ' ' A' ' 611' ' ' CYS . 0.8 OUTLIER -113.53 143.56 44.32 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.418 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.7 OUTLIER -125.17 123.92 40.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.252 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.623 HG23 ' CD1' ' A' ' 601' ' ' PHE . 78.7 mt -75.23 108.84 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.511 ' CB ' HG23 ' A' ' 598' ' ' VAL . 1.6 mp0 -59.44 116.78 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.939 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -30.44 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.273 0.559 . . . . 0.0 110.118 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.447 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.88 -16.12 79.54 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.671 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.511 HG23 ' CB ' ' A' ' 595' ' ' GLN . 42.0 t -96.77 117.77 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 118.009 0.905 . . . . 0.0 111.212 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.9 OUTLIER -140.46 123.91 10.31 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.166 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.525 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 34.6 Cg_endo -91.38 158.85 27.27 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.349 -1.105 . . . . 0.0 112.052 -0.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.0 t80 -93.1 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.135 0.493 . . . . 0.0 109.752 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 1.1 m-85 -93.44 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.492 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.78 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -127.21 143.99 38.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.3 -163.61 31.6 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.504 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.558 ' CG ' HD12 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -73.57 -41.7 62.59 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 28.6 t -60.69 119.9 9.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.551 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.15 -18.65 10.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -62.45 -30.05 70.96 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.235 0.54 . . . . 0.0 109.614 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 61.5 m -67.1 128.05 34.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.378 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.8 m120 -44.1 -31.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.558 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.2 t -108.62 135.53 49.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.03 109.08 20.03 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 588' ' ' ILE . 24.0 mm -138.2 109.46 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.97 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -103.26 105.17 15.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.591 0.71 . . . . 0.0 112.22 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.674 ' HB2' HD21 ' A' ' 618' ' ' LEU . 1.0 OUTLIER -130.92 108.3 9.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.422 177.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -39.34 -29.75 0.05 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.57 ' HB3' HD11 ' A' ' 681' ' ' ILE . 8.3 mpt_? -70.62 -41.12 72.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -86.64 158.69 19.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 111.443 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 45.8 t -86.36 176.45 7.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.432 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -52.17 -51.75 56.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.479 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 621' ' ' VAL . 38.5 t -109.22 57.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.766 ' CD2' HG23 ' A' ' 680' ' ' ILE . 50.4 t60 -46.26 -38.09 8.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.937 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.12 174.9 10.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.531 0.681 . . . . 0.0 111.773 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.46 136.22 25.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.963 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.643 HD12 HD11 ' A' ' 603' ' ' ILE . 62.9 mt -132.37 117.05 30.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -134.4 147.49 50.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 111.552 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 16.3 ttmt -101.23 137.55 39.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.562 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 157.19 44.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.118 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.05 118.07 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.5 t60 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.824 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.7 OUTLIER -123.0 147.34 46.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.088 0.47 . . . . 0.0 111.932 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.76 137.97 42.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.175 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.801 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -90.26 124.87 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-O 121.331 0.586 . . . . 0.0 111.67 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.901 ' CH2' HD22 ' A' ' 671' ' ' LEU . 92.7 m95 -110.08 131.22 55.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.651 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.52 ' CB ' HD21 ' A' ' 672' ' ' LEU . 1.6 t80 -100.34 117.3 34.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.592 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.3 m -111.66 145.12 39.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.549 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 664' ' ' MET . 23.5 t60 -119.55 125.2 48.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.398 . . . . 0.0 111.463 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.483 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 4.2 p -120.27 9.13 10.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.929 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.96 -178.99 47.85 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.74 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.471 HG23 ' N ' ' A' ' 655' ' ' ASN . 11.7 t -105.55 -45.07 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 111.642 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.497 ' C ' HG23 ' A' ' 656' ' ' VAL . 5.8 m-80 -60.04 -16.08 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.854 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 664' ' ' MET . 4.2 t 79.06 143.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.786 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 664' ' ' MET . 37.9 m -115.39 165.9 12.47 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 679' ' ' LYS . 27.8 m-85 -137.58 119.61 15.44 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.119 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.779 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -101.61 107.14 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.308 -179.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 659' ' ' LEU . 44.4 m-20 56.12 -82.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 659' ' ' LEU . 30.3 m-80 -133.92 4.46 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.644 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 9.5 m120 -106.84 125.85 51.54 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.915 0.388 . . . . 0.0 111.306 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.0 ttm105 -65.95 141.24 58.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.509 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.54 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -114.7 85.71 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.584 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.424 HG12 HG21 ' A' ' 668' ' ' THR . 38.3 pt -87.05 149.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 652' ' ' THR . 17.1 tt0 -45.62 100.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.542 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 111.81 37.7 1.52 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.603 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.424 HG21 HG12 ' A' ' 665' ' ' ILE . 3.0 p -128.9 162.58 27.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.482 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 717' ' ' LEU . 3.5 ttpm? -138.31 144.93 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.123 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.505 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.8 OUTLIER -147.02 145.53 29.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.109 0.48 . . . . 0.0 111.862 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.901 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.8 140.63 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.646 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.901 HD13 HG21 ' A' ' 694' ' ' VAL . 1.2 mt -106.87 123.88 48.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.154 0.502 . . . . 0.0 110.852 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -102.28 133.02 47.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.123 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.755 ' HB2' HD12 ' A' ' 696' ' ' ILE . 12.5 t0 -44.5 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 109.931 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.48 36.29 3.34 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.87 122.63 33.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.045 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.15 108.16 20.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.848 HD11 HD23 ' A' ' 580' ' ' LEU . 0.1 OUTLIER -105.51 137.52 34.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.867 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 658' ' ' TYR . 7.9 mmtt -101.74 116.44 32.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.988 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.766 HG23 ' CD2' ' A' ' 622' ' ' HIS . 6.3 mt -82.8 -35.91 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.133 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.616 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.3 tt -154.7 131.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.714 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -136.37 119.84 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.173 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.22 116.57 20.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.678 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -46.6 71.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.877 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.68 -40.72 93.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.181 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -105.19 2.93 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.94 22.59 3.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.725 0.298 . . . . 0.0 110.973 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.3 OUTLIER -76.82 104.88 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.6 p -122.8 122.79 66.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 111.768 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 587' ' ' ILE . 3.0 mt -127.9 126.07 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.478 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.91 139.98 6.59 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.78 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.55 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 3.2 m-30 -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 0.0 110.483 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -101.01 116.89 33.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.128 0.489 . . . . 0.0 110.312 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 1.059 HG13 HD21 ' A' ' 578' ' ' LEU . 2.2 t -81.79 120.0 32.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.0 OUTLIER -133.5 109.22 9.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 179.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 674' ' ' ASP . 13.8 mt -77.82 104.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.04 -45.02 21.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.24 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.44 141.63 43.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.63 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 121.262 0.553 . . . . 0.0 109.632 178.577 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.5 p . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.744 0.307 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 669' ' ' LYS . 3.2 mt -90.13 172.63 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.844 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.92 156.61 17.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.043 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.4 144.3 25.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.752 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 70.9 p -126.36 -176.81 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.8 37.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.269 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -55.97 -51.51 67.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.598 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.731 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.1 OUTLIER -70.18 -49.8 46.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.631 179.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -58.77 -32.12 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.97 -43.48 92.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.49 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.4 mt -57.51 -44.49 85.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.112 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.4 p -78.45 -14.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.461 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -25.83 19.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.327 . . . . 0.0 111.179 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.8 mttt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.045 -179.968 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.7 tmm_? . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.739 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.3 t80 -127.94 -52.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.998 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.118 HD11 HG13 ' A' ' 694' ' ' VAL . 5.3 tp -115.45 125.6 53.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.444 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.58 ' N ' HD12 ' A' ' 578' ' ' LEU . 11.5 m -105.2 114.12 28.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.689 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.8 OUTLIER -106.09 108.83 20.54 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.0 mtmm -113.84 100.04 51.44 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_exo -45.01 100.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.923 1.749 . . . . 0.0 109.724 177.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 677' ' ' GLU . 0.2 OUTLIER -74.99 157.33 85.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.02 -25.28 12.26 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.698 2.932 . . . . 0.0 113.075 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -28.23 69.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.436 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.5 t -96.12 154.03 17.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.622 178.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 8.6 pt -58.55 -10.21 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.733 0.301 . . . . 0.0 111.121 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.726 HD13 HG23 ' A' ' 613' ' ' ILE . 54.6 mt -108.55 118.85 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.736 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.436 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -108.75 60.27 0.6 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.22 0.533 . . . . 0.0 110.33 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.613 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.8 mt-10 -124.73 171.64 9.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.5 123.7 34.21 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.75 139.89 47.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 579' ' ' THR . 9.4 mt-10 -124.65 111.45 15.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.895 HD11 HD12 ' A' ' 625' ' ' ILE . 30.8 mt -72.21 108.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.947 0.403 . . . . 0.0 110.071 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -68.03 116.56 8.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.871 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.29 -30.44 2.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.228 0.537 . . . . 0.0 110.475 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.46 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.22 -21.59 77.23 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.348 -0.842 . . . . 0.0 113.557 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.432 HG11 ' ND2' ' A' ' 610' ' ' ASN . 52.4 t -101.07 118.42 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -140.14 124.18 10.75 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.919 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 42.8 Cg_endo -90.63 159.22 30.73 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.232 0.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 1.9 t80 -92.67 114.27 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.562 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 0.4 OUTLIER -93.38 139.09 31.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.127 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.792 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.7 mp -127.07 143.79 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.894 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 156.52 -165.72 33.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.477 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.468 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -70.19 -42.61 72.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.92 -179.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 11.3 t -60.42 121.79 12.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.633 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.55 -18.18 18.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.335 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -64.2 -29.18 70.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.142 0.496 . . . . 0.0 109.665 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.0 m -66.96 128.87 37.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.199 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -44.05 -31.21 0.87 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.079 0.466 . . . . 0.0 110.501 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.792 ' SG ' HG23 ' A' ' 603' ' ' ILE . 43.1 t -110.53 142.06 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 107.5 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.8 HD11 HD21 ' A' ' 592' ' ' LEU . 24.5 mm -138.61 109.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.811 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -104.08 106.22 16.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.536 0.684 . . . . 0.0 112.723 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.643 ' H ' HD11 ' A' ' 618' ' ' LEU . 2.0 t0 -130.85 107.73 9.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.685 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -39.25 -28.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.579 ' HB3' HD11 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -73.7 -38.6 64.81 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.643 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -88.41 158.98 18.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.528 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.6 p -83.56 168.76 16.1 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.504 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 4.4 ptp180 -51.24 -46.13 62.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.017 0.437 . . . . 0.0 110.322 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 727' ' ' VAL . 47.7 t -108.55 60.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.641 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 13.9 t60 -52.92 -39.71 63.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.926 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.773 ' SG ' HD11 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -144.99 175.26 10.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.595 0.712 . . . . 0.0 111.872 -178.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -144.92 142.21 29.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.183 -178.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.895 HD12 HD11 ' A' ' 594' ' ' ILE . 61.4 mt -133.26 116.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 3.0 t80 -132.88 138.7 47.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.586 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.7 ttmt -98.45 136.71 38.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.36 158.52 44.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.661 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -76.76 116.12 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.178 0.513 . . . . 0.0 110.627 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.1 t60 . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.602 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -116.13 147.74 41.04 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.548 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -134.83 142.88 46.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.848 HD13 HD22 ' A' ' 578' ' ' LEU . 5.1 pt -94.76 120.63 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.374 0.607 . . . . 0.0 111.593 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.537 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.2 m95 -104.97 125.89 51.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.867 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.644 ' CB ' HD21 ' A' ' 672' ' ' LEU . 21.4 t80 -90.93 117.44 29.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.94 144.87 36.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.621 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -115.0 129.98 56.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.427 ' OG1' HG12 ' A' ' 621' ' ' VAL . 3.3 p -127.53 10.45 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.47 152.17 26.21 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.558 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.2 t -76.07 -30.82 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.72 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.587 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -75.08 2.05 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.027 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.08 122.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.2 p -93.15 165.94 12.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.173 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 57.1 m-85 -131.96 119.64 21.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 0.0 110.697 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -95.06 100.53 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.606 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.9 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 22.7 m120 -132.05 -0.3 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.342 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.655 ' OD1' HG23 ' A' ' 716' ' ' VAL . 1.8 m-80 -95.36 141.62 28.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.825 0.345 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 3.5 ttm105 -81.96 141.05 33.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.227 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.416 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 31.6 mmm -129.35 108.93 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 111.047 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.528 HG13 HG23 ' A' ' 668' ' ' THR . 3.1 pt -98.95 165.06 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.71 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 653' ' ' GLY . 0.0 OUTLIER -54.72 90.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.94 0.4 . . . . 0.0 110.924 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.08 35.19 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.504 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.528 HG23 HG13 ' A' ' 665' ' ' ILE . 0.8 OUTLIER -116.33 162.06 18.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.832 0.349 . . . . 0.0 111.127 179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.448 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.2 ttpt -139.52 138.88 36.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.555 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.05 143.37 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -71.3 140.31 50.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.206 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 694' ' ' VAL . 4.3 mt -108.28 127.37 53.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.783 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -106.67 149.94 26.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.772 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.478 ' HB2' HD12 ' A' ' 696' ' ' ILE . 6.0 t70 -47.66 106.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.038 0.447 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.99 36.3 4.52 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.602 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 7.6 t70 -92.13 113.33 25.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.305 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.592 ' HG3' HD21 ' A' ' 583' ' ' LEU . 0.5 OUTLIER -96.58 112.16 24.01 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.22 179.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.558 HG22 HD13 ' A' ' 659' ' ' LEU . 22.4 pt -105.41 128.84 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.96 0.41 . . . . 0.0 111.62 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 10.9 mmtp -87.27 116.54 25.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.988 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.773 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.1 OUTLIER -81.0 -36.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.377 -179.248 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 617' ' ' ARG . 4.7 tt -154.71 131.74 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 111.738 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -136.11 124.91 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.13 116.94 21.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.399 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -67.34 -46.66 72.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -74.06 -40.5 62.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.843 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -89.76 -8.65 51.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.548 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.26 19.11 7.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.721 0.296 . . . . 0.0 110.888 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.89 104.88 7.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.5 p -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.016 0.436 . . . . 0.0 111.858 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 681' ' ' ILE . 5.0 mt -128.18 152.49 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.358 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.435 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.58 140.93 3.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.281 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.555 ' CD2' HD11 ' A' ' 592' ' ' LEU . 3.0 m-30 -113.65 153.39 28.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 0.0 110.492 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -100.85 117.12 34.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 1.118 HG13 HD11 ' A' ' 578' ' ' LEU . 2.2 t -81.13 125.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.53 108.22 8.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.357 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 674' ' ' ASP . 18.9 mt -78.15 105.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -86.27 -46.95 9.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.893 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 27.5 t70 -110.85 140.45 45.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.434 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.444 -0.755 0 CA-C-O 121.292 0.568 . . . . 0.0 109.53 178.407 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.655 HG23 ' OD1' ' A' ' 662' ' ' ASN . 86.2 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.854 0.359 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.37 166.49 10.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.2 144.86 30.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -88.21 146.52 25.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.16 -176.88 3.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.612 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.17 -28.93 43.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.269 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -55.79 -52.81 62.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.649 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.78 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.7 mp0 -70.6 -48.15 56.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.641 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -57.36 -32.28 66.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.92 -40.85 83.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 723' ' ' GLU . 4.9 mt -56.88 -44.39 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.576 HG21 HG11 ' A' ' 621' ' ' VAL . 10.9 p -86.26 -15.32 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.605 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -52.85 -29.73 29.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.8 mttt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 179.815 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 40.0 ttp180 . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 120.757 0.313 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -103.6 -52.85 2.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.788 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.07 HD12 HD13 ' A' ' 647' ' ' ILE . 7.0 tt -113.45 140.08 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.719 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.1 m -118.49 114.93 23.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.861 HD21 HG23 ' A' ' 694' ' ' VAL . 6.4 mt -102.09 107.62 18.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.9 mtpt -113.44 99.43 49.42 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.8 Cg_exo -47.15 97.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.838 1.692 . . . . 0.0 109.541 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.68 158.37 84.94 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.58 -25.05 7.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.941 3.094 . . . . 0.0 113.389 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.39 -25.5 67.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 4.6 t -95.97 153.96 17.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.678 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -62.01 -8.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.872 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 90.1 mt -110.98 118.72 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -104.95 62.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.106 0.479 . . . . 0.0 110.256 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.601 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -124.91 171.45 10.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.207 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.33 128.85 45.36 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.085 0.469 . . . . 0.0 111.098 178.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.777 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.3 OUTLIER -112.25 142.62 44.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.74 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -124.51 113.7 18.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.913 HD12 HD22 ' A' ' 578' ' ' LEU . 87.3 mt -81.68 108.44 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 2.4 mm-40 -70.45 126.39 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.174 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.49 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.25 -32.12 2.88 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.488 0.661 . . . . 0.0 109.743 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -69.71 -23.85 76.56 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.992 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.523 HG11 ' CG ' ' A' ' 610' ' ' ASN . 99.5 t -99.34 117.36 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.084 0.942 . . . . 0.0 111.857 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.7 t30 -141.22 122.1 8.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.826 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.59 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.86 160.19 34.94 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 124.554 -1.019 . . . . 0.0 111.506 -0.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.601 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.3 t80 -92.25 115.67 28.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.55 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 42.3 m-85 -92.48 137.81 32.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.843 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.796 HG23 ' SG ' ' A' ' 611' ' ' CYS . 4.1 mp -124.7 144.89 33.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.3 -166.94 36.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.515 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.487 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -73.84 -54.87 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.88 0.371 . . . . 0.0 111.9 -179.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 132.66 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.374 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -56.21 -19.78 15.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -27.22 18.81 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.073 0.463 . . . . 0.0 110.432 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 10.5 m -79.03 132.91 36.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.582 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 19.7 m-80 -47.98 -28.64 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.511 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.796 ' SG ' HG23 ' A' ' 603' ' ' ILE . 25.7 t -110.17 141.23 43.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.58 104.6 12.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.637 HD11 HD21 ' A' ' 592' ' ' LEU . 24.6 mm -139.43 109.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.869 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.06 107.16 17.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.46 0.647 . . . . 0.0 112.601 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.608 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.2 t0 -129.47 107.59 9.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.624 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -39.81 -29.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -41.3 76.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.608 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.1 pp -89.22 158.7 17.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.463 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 t -78.57 167.37 21.37 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.385 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -48.64 -37.73 19.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.114 0.483 . . . . 0.0 110.37 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 727' ' ' VAL . 12.2 t -124.41 65.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.459 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.856 ' CD2' HG23 ' A' ' 680' ' ' ILE . 28.5 t60 -49.55 -42.12 43.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.809 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -168.98 159.2 9.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.472 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.2 p90 -143.23 147.92 35.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.498 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.728 HD11 HD11 ' A' ' 580' ' ' LEU . 4.7 mt -102.38 132.58 48.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.251 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -124.24 133.46 53.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.72 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 20.2 ttmt -98.59 136.5 38.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.557 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.33 158.11 41.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.324 -179.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.15 117.71 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.4 t60 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.83 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.1 mp . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -119.55 146.35 45.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.329 0.585 . . . . 0.0 112.444 -178.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.09 160.53 33.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.525 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.07 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -108.76 131.06 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.662 0.744 . . . . 0.0 112.689 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.911 ' CH2' HD22 ' A' ' 671' ' ' LEU . 92.5 m95 -115.29 126.9 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.504 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.662 ' CD2' HD13 ' A' ' 678' ' ' ILE . 3.7 t80 -90.52 117.63 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 35.3 m -103.32 133.12 48.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.398 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.422 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 64.7 t60 -110.57 130.61 55.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.3 p -130.27 10.74 5.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.461 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.0 178.91 53.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.276 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.1 t -102.06 -36.53 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.585 ' C ' HG13 ' A' ' 656' ' ' VAL . 3.0 m-80 -72.63 -0.16 12.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.942 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.585 HG13 ' C ' ' A' ' 655' ' ' ASN . 2.0 m 60.34 135.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 121.09 0.472 . . . . 0.0 111.577 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.422 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 4.3 t -97.63 165.65 11.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.672 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.488 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 5.6 m-85 -136.47 120.32 17.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.026 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.722 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -103.99 115.77 31.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.06 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.39 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.7 p-10 -136.31 6.29 3.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.471 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.651 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -103.15 141.01 36.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.825 0.345 . . . . 0.0 111.015 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.682 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -82.55 141.43 32.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.424 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 31.4 mmm -119.42 106.01 11.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.035 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.42 ' CG1' HG23 ' A' ' 668' ' ' THR . 49.9 pt -92.36 153.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.2 tt0 -47.07 99.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.37 41.05 1.29 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.42 HG23 ' CG1' ' A' ' 665' ' ' ILE . 1.3 p -121.43 162.28 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.619 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.474 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.4 ttpm? -133.02 146.6 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.579 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.481 ' CD2' ' CD1' ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.49 144.03 28.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.947 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.911 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.73 133.39 47.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.427 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -106.03 107.35 18.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 111.35 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -95.11 142.35 27.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.827 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 696' ' ' ILE . 20.2 t0 -45.15 114.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.758 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.08 36.75 5.63 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.435 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -96.92 119.13 34.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.407 -179.201 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -96.2 114.06 25.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.722 HG23 ' HG ' ' A' ' 659' ' ' LEU . 6.4 mt -105.59 128.54 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 23.8 mtpt -90.37 116.5 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.952 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.856 HG23 ' CD2' ' A' ' 622' ' ' HIS . 35.3 mt -84.84 -38.97 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.348 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.516 HG22 ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.54 133.0 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -136.4 128.01 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.744 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -122.82 116.56 23.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.583 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -46.83 71.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.942 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.91 -40.54 46.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -82.26 -16.81 48.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.271 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.66 11.44 8.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.963 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.413 ' CE1' HG13 ' A' ' 690' ' ' ILE . 29.0 t80 -81.19 104.39 11.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.7 p -117.73 133.38 64.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.467 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.516 ' HB ' HG22 ' A' ' 681' ' ' ILE . 4.7 mt -128.24 155.04 39.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.481 ' O ' HD22 ' A' ' 583' ' ' LEU . . . 179.43 132.77 1.83 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.578 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.577 ' HB2' HD22 ' A' ' 580' ' ' LEU . 9.7 m-30 -113.12 145.82 40.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.789 ' HB2' HD12 ' A' ' 583' ' ' LEU . 3.2 ttmt -101.2 117.66 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.991 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.861 HG23 HD21 ' A' ' 580' ' ' LEU . 2.3 t -80.1 117.95 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.321 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 579' ' ' THR . 7.0 tt0 -126.09 109.29 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 110.266 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.683 HD12 ' HB2' ' A' ' 674' ' ' ASP . 41.0 mt -80.37 105.88 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -91.06 -45.32 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.118 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 577' ' ' PHE . 9.4 t0 -110.37 141.08 43.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.445 0.641 . . . . 0.0 109.559 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.682 HG21 ' O ' ' A' ' 663' ' ' ARG . 48.4 t . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.811 0.339 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 166.37 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 135.28 45.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -85.1 160.0 20.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.57 -174.34 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -29.32 36.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.39 -52.09 67.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.692 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.742 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.4 OUTLIER -68.08 -42.37 80.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.587 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -33.46 72.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.85 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.47 -40.83 93.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.049 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.2 mt -57.73 -44.3 85.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.054 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.463 HG23 HG11 ' A' ' 621' ' ' VAL . 9.4 p -79.41 -27.34 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -57.78 -35.44 70.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.665 179.629 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.966 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -107.78 -52.54 2.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.226 -178.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 594' ' ' ILE . 9.3 tt -119.59 142.46 48.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.552 ' N ' HD23 ' A' ' 578' ' ' LEU . 6.1 m -119.85 114.42 22.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.669 ' HB3' HD12 ' A' ' 592' ' ' LEU . 0.4 OUTLIER -102.18 108.46 19.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.1 pttp -118.01 99.76 51.98 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -176.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.9 Cg_exo -46.0 102.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.815 1.677 . . . . 0.0 109.603 176.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -75.01 157.6 85.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.418 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.37 -24.75 9.09 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.866 3.044 . . . . 0.0 113.382 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.13 -24.11 66.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 1.5 t -95.95 152.01 18.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.93 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 587' ' ' ILE . 0.2 OUTLIER -56.33 -15.19 2.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.285 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.541 HG23 ' CB ' ' A' ' 582' ' ' PRO . 3.3 tt -112.58 124.88 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.849 0.357 . . . . 0.0 111.656 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.418 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -107.68 71.25 0.81 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.563 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 48.9 mt-10 -125.55 169.89 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.521 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.27 128.17 42.69 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.154 0.502 . . . . 0.0 110.917 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.909 HD21 HD11 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -112.48 140.09 47.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.637 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 20.4 mt-10 -124.06 113.81 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.884 HD12 HD22 ' A' ' 578' ' ' LEU . 83.6 mt -86.32 109.75 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.63 128.81 35.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.04 -30.24 2.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.367 0.603 . . . . 0.0 110.085 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.432 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -25.56 74.43 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.035 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.89 117.87 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.991 0.896 . . . . 0.0 111.924 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.25 122.13 9.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.861 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.58 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.6 Cg_endo -90.77 159.55 30.17 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.395 -1.085 . . . . 0.0 111.649 -0.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.25 115.83 28.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 42.9 m-85 -92.57 138.05 31.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.05 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.762 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.1 mp -126.47 145.15 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.511 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.99 -168.44 39.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.495 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.413 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 12.2 ttp85 -82.41 -19.22 39.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.614 0.245 . . . . 0.0 111.343 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.04 132.65 34.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -21.55 45.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.06 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.8 -29.36 64.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.908 0.385 . . . . 0.0 110.644 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.8 m -74.92 130.2 38.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.925 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 34.3 m120 -45.24 -31.86 1.7 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.26 0.552 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.776 ' SG ' HD13 ' A' ' 592' ' ' LEU . 43.8 t -107.87 142.74 37.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.618 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.97 116.29 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.909 HD11 HD21 ' A' ' 592' ' ' LEU . 26.7 mm -137.96 109.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.678 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.4 tt0 -92.43 103.49 15.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.881 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.712 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.6 t70 -132.22 117.06 17.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.021 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -46.16 -31.15 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.794 0.331 . . . . 0.0 111.194 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.482 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 1.7 mpt_? -77.73 -35.7 51.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.712 HD13 ' CB ' ' A' ' 615' ' ' ASP . 1.2 mp -66.38 159.69 26.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.3 m -108.61 167.09 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -48.93 22.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.239 0.542 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.651 HG11 HG23 ' A' ' 727' ' ' VAL . 10.3 t -119.74 61.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.279 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.548 ' NE2' HG23 ' A' ' 680' ' ' ILE . 28.2 t60 -49.13 -45.57 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.995 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -167.65 155.81 9.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.053 0.454 . . . . 0.0 111.339 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 603' ' ' ILE . 48.2 p90 -143.22 144.32 32.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.768 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -101.39 131.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.58 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.9 t80 -126.54 133.3 51.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.027 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.71 ' HB2' HG22 ' A' ' 647' ' ' ILE . 31.0 ttmt -98.44 133.6 42.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.91 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 159.62 40.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.771 -178.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.2 tpt180 -75.6 115.07 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.372 0.606 . . . . 0.0 110.533 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.309 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.553 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 4.0 m-20 -107.06 137.78 44.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' A' ' 671' ' ' LEU . 2.4 t0 -116.03 157.39 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.811 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.966 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 4.7 pt -109.4 117.08 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.502 0.668 . . . . 0.0 111.851 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.908 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 70.9 m95 -102.78 131.23 49.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.623 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.701 ' HB2' HD11 ' A' ' 672' ' ' LEU . 27.7 t80 -91.16 117.13 29.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 624' ' ' PHE . 23.6 m -103.95 123.98 48.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.298 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.456 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 68.8 t60 -102.25 134.51 45.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -134.38 8.65 3.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.33 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.92 151.35 26.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.63 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.6 t -73.67 -29.04 62.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.126 0.489 . . . . 0.0 111.464 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.608 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.1 m120 -72.66 -1.8 17.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.539 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 54.74 124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 111.877 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.451 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -98.02 166.41 11.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.257 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -134.21 126.21 29.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.076 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.764 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -93.74 99.45 11.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.298 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 61.92 -78.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.689 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 15.4 p-10 -129.08 -8.17 4.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.735 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.446 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 9.9 m120 -92.6 140.62 29.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -83.52 141.67 31.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.629 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.636 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 3.2 mtp -125.4 121.81 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.273 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.416 HG12 ' CG2' ' A' ' 668' ' ' THR . 33.7 pt -103.48 156.54 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.546 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -48.2 104.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.38 . . . . 0.0 111.343 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.4 35.73 2.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.4 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.416 ' CG2' HG12 ' A' ' 665' ' ' ILE . 2.8 p -117.63 162.03 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.741 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.515 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.0 OUTLIER -131.82 145.03 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.061 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.636 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 3.4 t80 -147.76 145.89 28.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.908 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.27 130.27 42.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.3 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.764 ' CD2' HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -109.76 129.58 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.143 0.497 . . . . 0.0 111.154 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.01 144.66 50.27 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.786 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.473 ' HB2' HD12 ' A' ' 696' ' ' ILE . 11.0 t70 -41.88 118.6 1.14 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.854 0.359 . . . . 0.0 110.91 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.02 33.83 7.55 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.25 109.89 21.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 111.126 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.501 ' HG3' HD11 ' A' ' 583' ' ' LEU . 15.2 tt0 -95.63 108.21 20.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.651 HG12 HD22 ' A' ' 659' ' ' LEU . 13.7 mt -105.46 122.63 59.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.581 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -78.91 115.9 18.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.71 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.734 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 1.1 mt -79.34 -32.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 690' ' ' ILE . 6.9 tt -154.98 131.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.63 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.56 126.7 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -126.23 117.39 22.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.226 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -46.58 73.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.105 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -73.57 -40.51 63.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.3 -14.24 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.603 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp 59.74 18.43 7.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.435 ' CE1' ' NH1' ' A' ' 617' ' ' ARG . 36.8 t80 -82.72 105.18 13.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.2 p -121.87 123.69 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.707 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 681' ' ' ILE . 3.9 tt -127.57 125.08 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.487 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.76 148.17 16.84 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.18 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.734 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 0.3 OUTLIER -116.14 151.94 34.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.666 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.47 117.39 34.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.788 HG22 HD21 ' A' ' 578' ' ' LEU . 2.5 t -75.16 128.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.347 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 579' ' ' THR . 5.6 tt0 -133.14 109.01 9.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 674' ' ' ASP . 39.9 mt -83.32 105.06 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.391 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.91 -45.88 11.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.492 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -110.24 140.77 44.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.331 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.446 -0.673 0 CA-C-O 121.338 0.59 . . . . 0.0 109.715 178.926 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 716' ' ' VAL . 5.1 p . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.931 0.396 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.1 OUTLIER -101.14 172.25 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.68 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 153.06 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.196 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.19 160.09 25.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -125.03 -178.66 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -28.82 37.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -66.11 -46.64 76.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 726' ' ' LEU . 8.3 mp0 -68.6 -43.17 77.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.812 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -55.97 -37.0 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -67.98 -36.6 80.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.003 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 723' ' ' GLU . 91.5 mt -55.63 -44.27 76.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.651 HG23 HG11 ' A' ' 621' ' ' VAL . 8.1 p -77.93 -29.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.758 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.9 mttp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.87 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -126.98 -54.38 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.055 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.049 HD12 HD13 ' A' ' 647' ' ' ILE . 7.1 tt -112.98 138.49 49.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.355 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.757 ' N ' HD23 ' A' ' 578' ' ' LEU . 6.4 m -118.29 114.2 22.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.992 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.769 HD12 HD11 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -104.09 108.04 19.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.6 OUTLIER -116.89 100.99 53.66 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.43 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.1 Cg_exo -45.61 100.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.824 1.682 . . . . 0.0 109.597 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.61 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.33 157.02 86.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.432 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 78.5 Cg_exo -50.31 -26.09 14.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.981 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.567 ' HB2' HD12 ' A' ' 583' ' ' LEU . 4.0 t0 -62.09 -27.22 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.423 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.4 t -95.62 154.2 17.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.704 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 31.2 pt -56.97 -11.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.729 0.299 . . . . 0.0 111.13 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.607 HD13 HG23 ' A' ' 613' ' ' ILE . 34.3 mt -108.72 122.33 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.744 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.63 57.04 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 110.404 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.533 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 mt-10 -124.62 171.06 10.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.194 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.06 129.32 46.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.073 0.463 . . . . 0.0 111.126 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.48 142.02 45.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.154 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.3 114.41 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.822 HD12 HD22 ' A' ' 578' ' ' LEU . 87.4 mt -83.84 108.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.7 125.49 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.315 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.01 -26.92 1.97 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.169 0.509 . . . . 0.0 110.413 179.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -76.65 -21.85 73.78 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.472 -0.785 . . . . 0.0 114.153 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.38 117.74 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 118.324 1.062 . . . . 0.0 111.534 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 15.0 t30 -140.72 122.29 9.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.23 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.578 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.9 Cg_endo -90.56 160.09 31.47 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.42 -1.075 . . . . 0.0 111.391 -0.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.627 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.29 114.96 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.561 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 43.5 m-85 -91.88 138.18 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.833 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.78 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.91 145.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.369 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.49 -172.94 36.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.416 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.469 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.6 OUTLIER -67.41 -52.05 44.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.339 . . . . 0.0 111.859 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.49 126.44 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.25 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.276 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -30.36 62.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.064 0.459 . . . . 0.0 110.299 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.642 ' SG ' HG22 ' A' ' 621' ' ' VAL . 8.3 m -71.32 134.69 46.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.485 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 21.0 m-80 -48.43 -26.59 2.18 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.539 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 35.7 t -113.83 142.45 46.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.537 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.07 105.2 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.785 HD11 HD21 ' A' ' 592' ' ' LEU . 25.9 mm -138.98 109.51 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.334 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -104.0 106.4 16.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 112.459 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.585 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -130.43 107.53 9.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.65 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.19 -29.37 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -41.46 85.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.601 0.238 . . . . 0.0 111.473 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.585 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.86 158.99 17.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 0.0 111.711 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 92.2 p -78.41 172.86 13.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.364 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.477 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 3.3 mpt_? -47.72 -46.41 29.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.117 0.484 . . . . 0.0 110.278 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.642 HG22 ' SG ' ' A' ' 609' ' ' CYS . 46.5 t -119.8 70.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.199 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 12.8 t60 -49.72 -45.98 49.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.769 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.1 p -164.23 158.7 19.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.602 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.503 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.1 p90 -143.4 147.73 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.561 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.3 mp -102.64 131.12 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.578 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.7 t80 -122.29 133.88 54.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.63 ' HD3' HG23 ' A' ' 647' ' ' ILE . 1.6 tppp? -97.85 136.58 37.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.043 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.6 OUTLIER -135.31 159.04 42.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.819 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.6 tpt180 -76.69 112.26 13.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.312 0.577 . . . . 0.0 110.334 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.3 mt . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.5 m-20 -116.47 147.34 41.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.242 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.3 156.93 44.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.877 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.049 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -104.18 125.02 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.636 . . . . 0.0 112.29 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.871 ' CH2' HD22 ' A' ' 671' ' ' LEU . 82.5 m95 -108.79 123.08 48.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.653 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.581 ' CD2' HD13 ' A' ' 678' ' ' ILE . 3.0 t80 -89.82 116.08 27.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 62.4 m -100.68 142.6 31.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.451 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.459 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 74.4 t60 -118.97 130.96 55.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.4 p -125.64 2.73 7.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.014 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 150.68 38.05 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.401 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.0 t -73.3 -32.55 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.495 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.588 ' O ' HG13 ' A' ' 656' ' ' VAL . 17.3 m-20 -75.56 2.24 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.764 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.07 125.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.767 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 37.3 p -88.78 166.15 14.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.609 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.48 120.42 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.73 99.9 10.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.806 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 59.5 -83.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -131.44 4.32 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.454 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -113.66 116.85 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -84.3 141.28 31.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.485 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.78 142.33 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.261 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.422 ' O ' ' OG1' ' A' ' 668' ' ' THR . 31.2 pt -96.56 163.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -52.77 91.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.46 39.91 0.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.754 HG22 ' HA ' ' A' ' 718' ' ' LYS . 0.8 OUTLIER -137.48 158.5 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 111.266 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.577 ' HE2' HD13 ' A' ' 717' ' ' LEU . 18.9 pttm -128.18 158.5 37.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.621 ' HB3' HD23 ' A' ' 659' ' ' LEU . 15.3 t80 -145.37 146.75 31.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.871 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.78 129.32 39.48 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.36 -179.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.774 HD13 HG21 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -103.82 130.8 51.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.242 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.94 150.37 42.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.5 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 696' ' ' ILE . 19.3 t0 -50.12 105.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.369 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.28 32.7 4.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.48 113.11 25.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.04 108.84 21.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.226 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.666 HG12 HD13 ' A' ' 659' ' ' LEU . 6.4 mt -105.91 136.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.795 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 116.5 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.864 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.518 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -79.72 -36.34 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.256 -179.17 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.714 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.2 tp -155.15 131.35 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 112.085 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -136.74 122.76 20.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.914 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -126.6 117.02 21.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.906 0.384 . . . . 0.0 110.687 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -46.37 73.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.867 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.74 -40.59 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.687 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.73 -9.61 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.519 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 15.8 tttt 60.61 17.56 7.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.951 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 7.5 t80 -77.5 104.97 8.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.5 p -121.71 121.77 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.168 0.509 . . . . 0.0 112.143 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' A' ' 681' ' ' ILE . 8.7 mt -128.72 153.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.423 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -179.76 137.14 2.97 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.148 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.487 ' CE2' HD11 ' A' ' 592' ' ' LEU . 9.0 m-30 -113.24 144.82 42.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.716 0.293 . . . . 0.0 110.422 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.61 ' HB2' HD22 ' A' ' 583' ' ' LEU . 13.3 tptm -101.07 116.85 33.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.996 0.427 . . . . 0.0 110.256 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 672' ' ' LEU . 3.8 t -79.68 125.37 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.636 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.1 109.16 9.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.548 HG23 ' CD1' ' A' ' 577' ' ' PHE . 17.4 mt -84.24 105.7 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.68 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -88.46 -46.02 9.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -110.96 139.53 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.812 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.423 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 7.4 p . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.747 0.308 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.577 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -97.05 166.99 11.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . 0.754 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.6 OUTLIER -103.23 154.81 18.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -87.35 154.69 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.746 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.22 -177.5 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.3 -30.51 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -47.47 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.695 ' HA ' HD12 ' A' ' 726' ' ' LEU . 57.7 mm-40 -66.97 -47.32 71.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -55.73 -32.99 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.95 -37.79 82.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.695 HD12 ' HA ' ' A' ' 723' ' ' GLU . 15.6 mt -57.55 -44.14 84.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.12 -15.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -45.19 83.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 110.616 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.21 179.845 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -89.7 -22.25 22.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 151.92 -46.15 0.6 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.53 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.51 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 8.7 ttm180 -113.53 143.7 44.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.642 0.258 . . . . 0.0 111.203 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.773 ' CE1' HG21 ' A' ' 647' ' ' ILE . 5.5 t80 -122.43 -57.07 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.026 HD11 HG13 ' A' ' 694' ' ' VAL . 20.3 tp -111.04 142.36 43.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.381 . . . . 0.0 111.176 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 695' ' ' GLU . 3.5 m -121.17 114.34 21.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.951 ' CD2' HG23 ' A' ' 694' ' ' VAL . 5.6 mt -103.37 108.38 19.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 7.7 mtmt -113.71 99.81 50.74 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -176.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.616 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.6 Cg_exo -47.02 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.692 1.595 . . . . 0.0 109.606 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.654 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.59 157.25 86.29 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.418 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 9.4 Cg_endo -51.53 -25.9 20.65 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.775 2.983 . . . . 0.0 112.841 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 583' ' ' LEU . 5.2 t0 -61.91 -27.46 68.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.408 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.9 t -95.68 154.11 17.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.797 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.719 HD11 HD11 ' A' ' 690' ' ' ILE . 12.6 pt -55.92 -11.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.704 0.288 . . . . 0.0 111.296 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.477 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.4 mt -109.58 124.88 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.853 0.359 . . . . 0.0 111.794 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -112.46 57.1 0.66 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.57 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.616 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 tt0 -124.87 171.53 10.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.012 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.64 128.83 46.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.012 0.434 . . . . 0.0 110.846 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.719 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -111.97 141.04 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.931 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.51 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -123.93 115.93 22.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.679 0.276 . . . . 0.0 111.611 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.922 HD11 HD12 ' A' ' 625' ' ' ILE . 80.2 mt -82.61 108.95 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.395 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.1 OUTLIER -66.91 118.2 10.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.994 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.648 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.36 -28.45 1.33 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.178 0.513 . . . . 0.0 110.674 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.44 -23.13 75.15 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.366 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.02 118.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.775 0.788 . . . . 0.0 111.502 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.5 t30 -139.5 122.58 10.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.929 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.8 Cg_endo -90.44 159.92 31.96 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.723 -0.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.667 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.95 115.28 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.553 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 32.2 m-85 -92.29 138.0 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.071 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.81 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.6 mp -124.73 145.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.625 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.09 -172.23 35.77 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.655 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -68.47 -52.31 33.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.975 0.417 . . . . 0.0 111.723 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -60.2 126.27 26.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.323 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.71 -20.13 2.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.133 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.87 -31.95 60.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.145 0.498 . . . . 0.0 110.201 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.673 ' SG ' HG22 ' A' ' 621' ' ' VAL . 11.4 m -70.74 130.19 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.8 m120 -44.52 -32.63 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.185 0.517 . . . . 0.0 110.39 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.81 ' SG ' HG23 ' A' ' 603' ' ' ILE . 25.9 t -107.35 142.3 37.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.041 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 104.55 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.59 HD11 HD21 ' A' ' 592' ' ' LEU . 24.1 mm -139.6 109.84 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.329 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -103.61 107.04 17.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.46 0.648 . . . . 0.0 112.42 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.574 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -129.16 107.49 9.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.602 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -40.46 -28.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.695 ' HG2' HD21 ' P' ' 606' ' ' LEU . 3.2 mpt_? -69.46 -41.28 76.42 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.574 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.22 159.11 17.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.75 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -78.18 173.29 12.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.222 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.522 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -46.7 -52.52 13.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.089 0.471 . . . . 0.0 110.187 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.673 HG22 ' SG ' ' A' ' 609' ' ' CYS . 41.6 t -114.44 70.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.291 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.536 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 11.4 t60 -48.06 -44.23 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.683 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 3.5 p -166.85 159.18 13.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 111.334 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.7 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.1 p90 -143.2 149.41 37.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.922 HD12 HD11 ' A' ' 594' ' ' ILE . 37.7 mt -102.14 135.16 40.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.001 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.3 t80 -128.68 134.48 48.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.3 ttmt -98.26 136.59 38.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.9 157.63 46.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.546 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.01 114.74 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.321 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 -73.89 125.06 27.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -138.87 128.05 24.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.078 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.07 176.35 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -73.86 -56.63 5.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.493 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.64 156.47 43.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 55.0 p -151.11 55.99 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.8 ttt -98.76 31.37 2.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.66 -66.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.416 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . 0.469 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 1.0 OUTLIER -75.83 144.48 41.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.316 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 2.3 m -102.11 101.35 18.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.146 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 6.0 Cg_exo -78.34 -155.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.891 2.394 . . . . 0.0 111.848 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -94.49 24.01 4.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.281 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.81 177.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 111.017 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.681 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -91.06 84.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.799 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.7 OUTLIER -103.59 -150.25 0.41 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.988 -0.124 . . . . 0.0 110.863 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.568 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 1.0 OUTLIER -112.94 148.9 34.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.309 0.576 . . . . 0.0 112.464 -178.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.568 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -135.19 129.6 34.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.787 179.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.788 HD12 ' HB2' ' A' ' 672' ' ' LEU . 2.1 pt -87.16 122.85 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.355 0.598 . . . . 0.0 111.918 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.599 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.8 m95 -105.83 148.98 26.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.159 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.588 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.0 t80 -108.16 116.61 32.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.7 m -102.07 137.66 40.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.315 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 62.4 t60 -118.4 131.59 56.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.43 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.9 p -129.04 5.79 5.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.303 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.8 151.6 32.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.637 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.477 HG23 ' N ' ' A' ' 655' ' ' ASN . 14.6 t -76.78 -44.33 33.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.016 0.436 . . . . 0.0 111.414 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.486 ' C ' HG23 ' A' ' 656' ' ' VAL . 2.1 m-20 -58.82 -18.09 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.795 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 664' ' ' MET . 4.4 t 78.55 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.142 0.496 . . . . 0.0 111.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 93.2 p -114.52 152.22 32.07 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -124.39 119.79 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.33 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.622 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -94.96 99.86 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.083 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 61.19 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.899 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.3 t30 -135.64 -0.44 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.481 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 1.7 m120 -101.0 135.41 42.49 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.927 0.394 . . . . 0.0 111.287 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 41.6 ttm-85 -75.59 141.17 42.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.573 ' O ' HG13 ' A' ' 656' ' ' VAL . 19.5 mmm -126.32 94.61 4.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.773 0.32 . . . . 0.0 111.086 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.411 HG12 ' CG2' ' A' ' 668' ' ' THR . 32.7 pt -87.67 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.578 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -48.8 110.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.201 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 100.96 30.78 5.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.287 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.411 ' CG2' HG12 ' A' ' 665' ' ' ILE . 13.8 p -112.78 162.28 15.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 111.348 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.9 ttpm? -143.81 133.95 24.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.57 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -139.88 143.48 36.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.812 0.339 . . . . 0.0 111.165 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.599 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.64 140.55 53.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.074 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.788 ' HB2' HD12 ' A' ' 647' ' ' ILE . 5.0 mt -109.43 125.98 52.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 706' ' ' GLY . 1.0 OUTLIER -107.68 147.16 31.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -48.53 103.7 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 110.465 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.67 33.62 3.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.81 118.8 30.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.533 -0.334 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -96.18 111.5 23.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.622 HG22 HD13 ' A' ' 659' ' ' LEU . 30.6 pt -105.71 137.4 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 112.064 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.42 116.54 30.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.894 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.536 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -84.96 -38.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 690' ' ' ILE . 3.1 tp -155.18 131.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 111.696 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -136.84 124.88 22.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.369 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.861 ' OD2' HD22 ' P' ' 606' ' ' LEU . 12.0 t0 -127.31 116.66 20.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.792 0.329 . . . . 0.0 110.306 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -67.36 -46.57 72.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.125 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -74.51 -40.49 61.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.917 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -87.64 -7.12 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.535 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tttt 59.13 18.18 6.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.732 0.301 . . . . 0.0 110.948 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -77.54 105.02 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.2 p -124.12 121.65 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 111.917 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.772 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.5 mt -128.79 150.34 34.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.179 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.61 138.68 3.54 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.626 ' HB2' HD22 ' A' ' 580' ' ' LEU . 7.8 m-30 -113.46 148.71 35.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.788 0.328 . . . . 0.0 110.449 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.452 ' HB2' HD22 ' A' ' 583' ' ' LEU . 3.6 tttm -101.33 116.95 33.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 1.026 HG13 HD11 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -81.55 123.1 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.407 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.6 OUTLIER -133.28 109.46 9.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.589 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.625 HG12 HD13 ' A' ' 578' ' ' LEU . 14.9 mt -78.39 105.53 7.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.703 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -47.95 11.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.22 139.83 46.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.875 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 701' ' ' GLY . 3.2 p -115.68 100.5 8.08 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.117 0.484 . . . . 0.0 109.727 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 700' ' ' THR . 5.1 t -67.25 71.13 0.11 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.669 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 53.82 53.55 35.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.687 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.799 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -93.08 153.57 18.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.144 0.497 . . . . 0.0 112.128 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.567 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -55.08 -24.84 27.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.22 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.66 HD21 HD13 ' A' ' 707' ' ' LEU . 4.0 t30 -165.54 -57.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.788 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.478 ' HA ' HD22 ' A' ' 702' ' ' LEU . 9.3 pt-20 164.82 -33.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.802 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 142.83 40.75 0.06 OUTLIER Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.147 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.66 HD13 HD21 ' A' ' 704' ' ' ASN . 1.0 OUTLIER -97.29 7.18 47.06 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.481 ' HA2' HD12 ' A' ' 671' ' ' LEU . . . 72.2 -103.64 1.35 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.884 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 8.6 mtm 65.98 71.68 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 0.0 110.712 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.54 ' H ' HD23 ' A' ' 710' ' ' LEU . 2.1 pt? -148.28 -160.39 1.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.698 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -46.99 -71.89 0.06 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.718 0.294 . . . . 0.0 111.205 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -76.76 139.2 40.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.772 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -88.84 100.81 13.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.123 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.45 ' HD3' ' NE2' ' A' ' 673' ' ' GLN . 8.4 mmm-85 47.75 81.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.56 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.65 142.74 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.641 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.4 p -84.57 114.79 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.16 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.31 172.2 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -100.64 150.54 22.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -75.27 153.22 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -119.36 -179.17 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.27 -29.53 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -65.96 -50.28 64.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -51.07 66.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.916 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -56.01 -32.86 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.63 -36.77 83.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.988 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.58 -44.16 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.6 p -76.48 -27.59 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -36.02 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -100.83 33.89 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 621' ' ' VAL . 4.7 tt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.768 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.834 0.349 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.68 72.22 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -107.79 84.86 2.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 51.9 tp -164.93 119.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.42 HG21 HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.95 78.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.34 125.49 26.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.861 HD22 ' OD2' ' A' ' 683' ' ' ASP . 30.2 mt -67.08 152.15 96.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.954 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.575 2.184 . . . . 0.0 112.382 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.589 -0.205 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -74.59 -22.43 58.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 111.004 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 140.38 -30.51 2.32 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.263 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.421 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 1.3 ttm-85 -106.38 136.07 46.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.558 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 7.8 t80 -122.66 -48.07 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.708 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.752 HD11 ' CG1' ' A' ' 694' ' ' VAL . 8.2 tp -119.55 141.98 48.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.419 . . . . 0.0 111.049 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 40.3 m -122.39 114.53 20.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.813 ' HG ' HG22 ' A' ' 694' ' ' VAL . 1.7 mp -105.63 108.57 20.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 8.4 ptpt -117.04 100.53 53.36 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 26.7 Cg_exo -44.77 104.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.739 1.626 . . . . 0.0 109.47 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.737 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.47 157.17 86.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.561 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 73.2 Cg_exo -49.18 -32.6 25.18 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.617 2.878 . . . . 0.0 112.891 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.737 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.5 OUTLIER -63.88 -21.76 66.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.88 0.371 . . . . 0.0 110.577 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.67 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 22.7 p -96.43 153.46 17.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.998 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.823 HG22 HG12 ' A' ' 690' ' ' ILE . 1.2 tt -52.49 -18.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.871 0.367 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 582' ' ' PRO . 10.8 mt -111.25 119.78 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.162 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.67 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -110.37 57.71 0.61 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.295 0.569 . . . . 0.0 110.758 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.553 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.0 mt-10 -125.13 172.08 9.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.578 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.54 128.31 46.66 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.144 0.497 . . . . 0.0 111.474 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.765 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -113.09 138.81 49.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.831 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.421 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 3.6 mp0 -123.92 115.76 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.973 HD11 HD12 ' A' ' 625' ' ' ILE . 46.3 mt -80.32 109.75 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.923 0.392 . . . . 0.0 111.033 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.2 mp0 -66.75 113.05 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.522 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.558 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.66 -30.68 0.97 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.456 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.05 -22.61 70.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.376 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.63 HG11 ' OD1' ' A' ' 610' ' ' ASN . 67.9 t -101.3 119.6 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 117.669 0.734 . . . . 0.0 111.538 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.3 t30 -138.66 122.73 11.41 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.59 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.38 160.47 32.53 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.618 -0.992 . . . . 0.0 111.994 0.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.705 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.6 115.68 28.25 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.562 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 51.0 m-85 -92.39 138.28 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.036 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.3 mp -127.15 145.42 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.588 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.09 -178.3 34.42 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.327 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -59.58 -52.68 64.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.88 0.372 . . . . 0.0 111.849 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.51 122.9 15.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.455 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -21.04 2.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.734 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -51.9 -30.52 24.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.177 0.513 . . . . 0.0 110.08 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.591 ' SG ' HG22 ' A' ' 621' ' ' VAL . 95.0 m -73.57 129.37 37.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.338 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 13.4 m-80 -45.55 -29.5 1.19 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.128 0.49 . . . . 0.0 110.621 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.765 ' SG ' HD13 ' A' ' 592' ' ' LEU . 53.4 t -109.22 142.91 39.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.47 106.93 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.462 HG13 ' CE2' ' A' ' 692' ' ' PHE . 30.9 mm -138.14 109.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.916 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.09 107.15 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.458 0.647 . . . . 0.0 112.369 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.579 ' OD2' HG21 ' A' ' 681' ' ' ILE . 10.9 t0 -129.1 107.55 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.123 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -41.74 -31.2 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.784 ' HG2' HD21 ' P' ' 606' ' ' LEU . 2.0 mtt180 -77.43 -38.15 50.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.303 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.774 ' O ' HD23 ' A' ' 618' ' ' LEU . 0.0 OUTLIER -89.67 147.25 23.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.831 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.45 162.73 12.04 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.841 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.1 OUTLIER -63.15 -17.69 62.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.504 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.841 HG23 ' HG2' ' A' ' 620' ' ' ARG . 29.4 t -137.38 55.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.617 ' CG ' HD12 ' A' ' 618' ' ' LEU . 6.8 t60 -47.66 -43.06 25.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.421 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.464 ' SG ' HD11 ' A' ' 680' ' ' ILE . 4.3 p -164.29 158.68 19.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 112.261 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.797 ' HA ' HD12 ' A' ' 603' ' ' ILE . 50.2 p90 -143.74 146.07 32.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.241 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.973 HD12 HD11 ' A' ' 594' ' ' ILE . 71.2 mt -102.18 128.62 54.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.522 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -119.49 134.68 55.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.504 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 35.4 ttmt -97.42 133.66 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.413 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.14 159.11 42.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.175 -178.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.3 tpt180 -77.07 112.43 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.282 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 -71.07 131.09 43.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.091 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -149.14 133.8 17.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.155 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.499 HG22 ' N ' ' A' ' 633' ' ' GLY . 4.6 p -107.49 159.06 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.036 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.499 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -100.45 123.29 7.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.558 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.3 124.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.864 0.364 . . . . 0.0 110.967 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 50.2 m -144.74 42.62 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 90.2 mtp -59.35 134.51 57.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.036 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.2 t80 75.84 -68.47 0.2 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.231 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -77.03 131.48 38.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.072 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.5 m -106.52 90.73 5.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.73 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.08 -164.56 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.489 2.126 . . . . 0.0 112.25 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.617 ' HB1' HD13 ' A' ' 644' ' ' LEU . . . -46.84 -28.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.628 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 18.9 mt-30 84.84 -70.73 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.451 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -177.86 95.65 0.1 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.322 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.769 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.4 mp -129.82 -157.57 0.83 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.831 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -114.3 146.44 40.47 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.214 0.531 . . . . 0.0 112.025 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.48 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.7 OUTLIER -136.61 157.65 46.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.137 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.718 HD13 HD13 ' A' ' 578' ' ' LEU . 2.7 pt -103.8 118.73 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.462 0.649 . . . . 0.0 111.835 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.969 ' CH2' HD22 ' A' ' 671' ' ' LEU . 89.0 m95 -100.47 127.97 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.206 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.572 ' CD2' HD13 ' A' ' 678' ' ' ILE . 2.6 t80 -90.21 116.69 28.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 14.3 m -103.36 142.12 34.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.374 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.468 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 29.5 t60 -121.15 133.06 55.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.981 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 5.6 p -131.26 9.81 4.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.422 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -82.15 151.13 29.69 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.832 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.423 HG22 HG21 ' P' ' 603' ' ' TPO . 3.9 t -76.39 -33.91 58.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.156 0.503 . . . . 0.0 111.365 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.86 3.09 7.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.33 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 664' ' ' MET . 1.5 p 50.7 142.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.731 0.777 . . . . 0.0 112.423 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.427 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 95.8 p -112.34 166.38 11.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.286 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -129.38 120.31 25.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 111.188 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -103.98 99.93 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.021 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.1 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 9.0 m120 -144.91 -0.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.601 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -103.54 141.28 36.27 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.95 0.405 . . . . 0.0 111.312 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -79.6 141.97 36.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.606 ' O ' HG23 ' A' ' 656' ' ' VAL . 23.1 mmm -118.04 97.86 6.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.2 pt -87.44 146.98 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -45.19 98.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.416 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.56 37.94 1.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.523 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 4.5 p -135.66 152.61 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.79 0.329 . . . . 0.0 111.336 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 15.1 pttm -123.68 158.03 32.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.282 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.527 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 0.2 OUTLIER -142.59 142.49 32.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.969 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -69.81 125.48 26.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.975 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.559 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.8 mt -101.33 136.14 41.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.383 0.611 . . . . 0.0 111.891 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.442 ' CD ' ' HA3' ' A' ' 708' ' ' GLY . 0.5 OUTLIER -124.22 137.33 54.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.251 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.601 ' HB3' HD12 ' A' ' 696' ' ' ILE . 1.8 p30 -39.8 118.81 0.91 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.955 0.407 . . . . 0.0 110.843 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.24 36.36 5.72 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.334 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.513 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -94.95 116.76 29.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.4 108.77 21.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.122 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 9.0 mt -107.95 130.19 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -93.79 116.07 28.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.828 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.464 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.0 OUTLIER -77.96 -35.69 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.462 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 617' ' ' ARG . 8.9 tt -154.8 134.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.854 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.33 123.31 21.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.47 ' OD1' HD13 ' P' ' 606' ' ' LEU . 1.6 t0 -120.92 117.0 26.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.552 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -67.55 -46.59 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.134 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -75.91 -40.68 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.862 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.33 -12.23 49.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.464 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.13 15.61 8.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.697 0.284 . . . . 0.0 110.873 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.566 ' CE1' HG21 ' A' ' 587' ' ' ILE . 2.3 t80 -76.86 105.12 7.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -121.46 122.43 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 112.122 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.823 HG12 HG22 ' A' ' 587' ' ' ILE . 7.6 mt -116.31 145.25 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.743 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -170.47 131.23 2.18 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.481 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.462 ' CE2' HG13 ' A' ' 613' ' ' ILE . 3.3 m-30 -113.81 147.03 39.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.343 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.601 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.1 tttt -101.2 116.91 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.491 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.813 HG22 ' HG ' ' A' ' 580' ' ' LEU . 3.5 t -81.74 127.34 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.603 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.28 108.71 8.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 0.0 111.146 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 674' ' ' ASP . 95.6 mt -73.28 105.42 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.504 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -81.16 -45.91 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 109.941 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.4 t0 -110.74 140.68 44.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.878 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 43.5 p -114.52 99.22 7.39 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.6 t -79.71 62.69 4.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.547 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.717 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 59.19 46.55 93.63 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.438 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.831 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -64.01 143.6 57.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.703 0.287 . . . . 0.0 111.157 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.769 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.8 p90 -40.92 -34.19 0.38 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.361 0.601 . . . . 0.0 110.839 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -138.24 -42.59 0.51 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.845 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.693 ' OE2' HD23 ' A' ' 707' ' ' LEU . 11.3 pt-20 137.29 -37.61 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.003 0.921 . . . . 0.0 109.11 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.585 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 126.6 14.14 2.94 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.405 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.693 HD23 ' OE2' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -82.82 -0.51 48.32 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.33 -0.512 . . . . 0.0 111.65 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.442 ' HA3' ' CD ' ' A' ' 673' ' ' GLN . . . 41.4 29.27 0.39 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.468 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.445 ' O ' ' CG ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER 45.68 62.3 2.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.733 0.301 . . . . 0.0 110.639 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 711' ' ' GLN . 0.2 OUTLIER 79.11 -177.8 0.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.601 -179.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . 0.74 ' N ' HD12 ' A' ' 710' ' ' LEU . 14.5 mt-30 -69.01 66.21 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.992 0.425 . . . . 0.0 110.933 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.55 139.8 38.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.227 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -84.21 136.17 34.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.556 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.435 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -90.95 -145.1 0.19 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.429 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 1.5 m -140.37 142.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.48 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.601 HG23 ' CG ' ' A' ' 662' ' ' ASN . 40.8 t -88.79 130.12 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.01 147.21 35.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.81 147.02 30.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -81.36 160.07 24.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.978 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 14.8 p -126.14 -175.75 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.62 -30.93 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.37 -47.29 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.732 ' HA ' HD12 ' A' ' 726' ' ' LEU . 29.9 mm-40 -64.42 -49.93 69.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -57.25 -32.79 66.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.43 -36.92 82.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' A' ' 723' ' ' GLU . 12.6 mt -59.76 -44.22 93.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.088 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.5 p -81.93 -29.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -55.75 -28.9 58.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -121.58 38.24 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.461 HD23 ' OXT' ' A' ' 730' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.818 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.735 0.302 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.23 149.21 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.045 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -170.4 100.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.99 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.07 105.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.423 HG21 HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -60.02 -36.54 77.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.741 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.64 108.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.082 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.784 HD21 ' HG2' ' A' ' 617' ' ' ARG . 11.4 mt -98.16 143.12 25.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.448 2.099 . . . . 0.0 112.397 -179.97 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -82.27 -16.28 50.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.725 0.298 . . . . 0.0 111.13 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -171.82 32.56 0.13 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.567 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.464 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.1 tmm_? -102.6 134.78 45.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.538 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -122.02 -64.98 1.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.346 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.009 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -106.31 125.64 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.843 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.725 HG22 ' HG3' ' A' ' 581' ' ' LYS . 24.3 m -104.68 117.2 33.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.637 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -105.96 108.08 19.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 177.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.725 ' HG3' HG22 ' A' ' 579' ' ' THR . 0.0 OUTLIER -112.66 99.12 46.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.3 Cg_exo -48.25 103.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.482 1.455 . . . . 0.0 109.009 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -73.51 157.26 88.04 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.47 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 10.3 Cg_endo -50.92 -29.16 26.11 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.613 2.876 . . . . 0.0 112.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.558 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -63.72 -15.23 57.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.913 0.387 . . . . 0.0 110.219 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.53 153.71 17.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.543 HG21 ' CZ ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -50.04 -24.44 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.908 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.5 tt -112.82 144.1 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.113 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.47 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.25 65.41 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 110.785 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 37.1 mt-10 -125.65 172.1 10.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.054 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.9 127.44 44.9 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.914 0.388 . . . . 0.0 110.99 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.94 143.58 43.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.966 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.464 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.39 118.08 25.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.738 HD12 HD22 ' A' ' 578' ' ' LEU . 55.1 mt -82.39 108.6 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.11 0.481 . . . . 0.0 110.156 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.0 mp0 -68.67 105.43 2.28 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.538 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -33.3 -54.23 0.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.209 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -47.39 -21.94 1.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.526 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.504 HG11 ' OD1' ' A' ' 610' ' ' ASN . 53.0 t -99.38 118.39 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.256 0.528 . . . . 0.0 111.293 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.5 t30 -140.13 123.21 10.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.127 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.561 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.4 Cg_endo -90.45 159.77 31.85 Favored 'Cis proline' 0 N--CA 1.461 -0.431 0 C-N-CA 124.411 -1.079 . . . . 0.0 111.832 0.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.698 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.61 115.88 28.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.525 ' CG ' HD12 ' A' ' 730' ' ' LEU . 26.7 m-85 -92.42 138.39 31.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.044 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.749 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mp -126.4 145.79 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.668 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.62 -171.83 38.54 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.134 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.484 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -69.57 -50.2 47.02 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.498 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -60.78 131.46 50.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -59.01 -18.04 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.654 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -55.33 -32.41 62.47 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 121.081 0.467 . . . . 0.0 110.241 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.509 ' SG ' HG22 ' A' ' 621' ' ' VAL . 34.5 m -71.53 132.46 44.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 2.4 m-80 -47.12 -27.09 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 0.0 110.681 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.768 ' SG ' HD13 ' A' ' 592' ' ' LEU . 40.4 t -112.75 142.51 45.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.293 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 105.62 13.87 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 592' ' ' LEU . 21.4 mm -138.21 109.28 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.43 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -105.12 106.24 16.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.556 0.693 . . . . 0.0 112.453 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.622 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.3 t0 -130.19 107.8 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.698 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -40.01 -29.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.625 ' O ' HG23 ' P' ' 603' ' ' TPO . 0.0 OUTLIER -68.93 -41.5 78.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.622 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.3 pp -90.12 158.8 17.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 12.8 t -76.91 162.98 27.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.049 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.6 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.7 OUTLIER -52.08 -26.68 11.65 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.441 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.6 HG23 ' HG2' ' A' ' 620' ' ' ARG . 37.6 t -130.71 62.7 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.838 ' CD2' HG23 ' A' ' 680' ' ' ILE . 25.1 t60 -51.8 -47.22 64.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.381 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 6.1 p -165.01 162.5 20.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.234 0.54 . . . . 0.0 112.138 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 603' ' ' ILE . 53.8 p90 -143.59 147.31 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.766 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.671 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.35 130.57 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.021 0.438 . . . . 0.0 109.981 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -122.12 133.62 54.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.607 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 30.9 ttmt -97.72 136.99 37.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.051 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.455 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.23 158.82 43.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.947 -178.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.2 tpt180 -76.64 112.34 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.1 t60 -66.79 132.38 47.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.384 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -179.73 148.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.041 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 5.7 m -115.92 -179.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -68.29 74.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.605 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.9 177.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.031 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 2.1 t -145.26 131.23 19.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.731 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 11.1 mtm -143.29 29.96 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 638' ' ' GLU . 10.8 p90 -178.39 -47.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.794 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . 0.444 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 1.7 tp10 -104.68 144.83 31.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.671 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.89 90.49 1.95 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 61.5 Cg_endo -71.49 -159.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.701 2.267 . . . . 0.0 112.183 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 703' ' ' PHE . . . -54.57 -20.36 7.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.973 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.424 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 1.7 mt-30 83.36 -66.53 0.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.368 0.267 . . . . 0.0 110.901 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.518 ' H ' HD12 ' A' ' 644' ' ' LEU . . . 172.9 65.2 0.05 OUTLIER Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.443 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.681 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.7 mp -118.85 -158.5 0.73 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.799 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.6 OUTLIER -118.48 146.62 44.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.15 0.5 . . . . 0.0 111.885 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.513 ' OD2' HD11 ' A' ' 671' ' ' LEU . 2.2 t0 -129.72 160.07 34.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.945 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.009 HD13 HD12 ' A' ' 578' ' ' LEU . 1.4 pt -108.66 120.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.479 0.657 . . . . 0.0 111.724 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.895 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 67.5 m95 -106.43 127.3 53.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.065 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.628 ' HB2' HD11 ' A' ' 672' ' ' LEU . 20.9 t80 -90.54 117.61 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.79 130.09 48.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.162 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.484 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 66.2 t60 -109.3 133.74 52.67 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -131.02 1.27 4.26 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.427 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.95 149.63 36.42 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.72 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.8 t -74.57 -32.37 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.451 . . . . 0.0 111.534 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.597 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.5 m-20 -73.13 1.86 8.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.461 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.82 126.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.28 0.562 . . . . 0.0 111.89 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.484 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 8.7 t -96.43 165.93 11.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.255 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -130.53 121.28 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.866 0.365 . . . . 0.0 111.265 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.673 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.51 99.47 11.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.9 m120 60.7 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -129.55 -0.27 4.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.488 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.472 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 10.8 m120 -100.89 141.99 32.99 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.888 0.375 . . . . 0.0 111.107 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.665 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -82.6 141.54 32.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 11.5 mmm -123.89 101.21 7.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.812 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.427 HG12 HG21 ' A' ' 668' ' ' THR . 50.7 pt -89.64 161.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.21 98.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.76 44.8 1.18 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.427 HG21 HG12 ' A' ' 665' ' ' ILE . 1.2 p -127.62 162.25 26.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.32 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -129.92 149.03 51.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.398 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.504 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 4.3 t80 -147.26 145.34 29.38 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.895 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 129.05 38.8 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.596 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.732 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.2 mt -108.74 119.94 41.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.291 0.567 . . . . 0.0 111.474 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.498 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 0.9 OUTLIER -110.15 144.0 39.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.24 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.742 ' HB2' HD12 ' A' ' 696' ' ' ILE . 68.3 t0 -43.06 123.93 3.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.772 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.15 7.39 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -95.23 112.85 24.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.372 . . . . 0.0 111.502 -179.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.75 108.66 21.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.053 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.641 HG12 HD13 ' A' ' 659' ' ' LEU . 11.2 mt -106.89 136.89 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.0 111.958 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -96.12 116.15 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.478 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.838 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.3 mt -83.71 -34.07 10.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.793 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.725 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.1 tp -154.86 131.58 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.102 0.477 . . . . 0.0 112.097 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.73 130.04 31.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.67 ' OD1' HD22 ' P' ' 606' ' ' LEU . 2.8 t0 -127.1 117.63 22.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.797 0.332 . . . . 0.0 110.735 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -66.97 -46.61 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.101 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -76.39 -40.52 50.72 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -88.8 -11.09 45.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.42 16.76 7.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.543 ' CZ ' HG21 ' A' ' 587' ' ' ILE . 15.5 t80 -76.9 105.44 7.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.31 125.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.908 0.385 . . . . 0.0 111.986 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.725 ' HB ' HG22 ' A' ' 681' ' ' ILE . 13.1 mt -123.8 153.16 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.178 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -176.59 138.2 3.93 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.278 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.786 ' CE2' HD12 ' A' ' 680' ' ' ILE . 1.8 m-30 -113.45 147.08 38.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.915 0.388 . . . . 0.0 110.541 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.537 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -101.27 117.23 34.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.477 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.812 HG22 HD21 ' A' ' 578' ' ' LEU . 3.9 t -80.29 123.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 579' ' ' THR . 24.3 tt0 -132.64 109.38 9.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.448 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 674' ' ' ASP . 54.6 mt -78.66 106.08 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.24 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.58 -45.26 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.37 140.93 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 37.7 p -114.58 100.14 8.06 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.184 0.516 . . . . 0.0 109.998 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 700' ' ' THR . 6.0 t -78.21 61.01 2.61 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.544 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.63 57.26 20.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.996 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -84.16 141.72 30.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.976 0.417 . . . . 0.0 111.523 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.681 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.7 p90 -37.79 -48.76 1.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.619 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 703' ' ' PHE . 0.1 OUTLIER -142.6 1.94 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.068 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 704' ' ' ASN . 1.4 pt-20 88.67 -45.06 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.028 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 127.46 28.6 0.89 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.565 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' A' ' 707' ' ' LEU . 0.1 OUTLIER -88.49 8.19 29.23 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 90.86 66.83 1.18 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.134 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.68 141.69 9.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 111.269 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.457 ' N ' HD23 ' A' ' 710' ' ' LEU . 1.2 pt? -31.97 133.38 0.1 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.809 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.13 52.66 12.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.2 0.524 . . . . 0.0 110.302 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.04 121.79 14.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.961 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.13 100.54 9.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.817 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -95.37 72.25 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.763 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.0 m -124.2 143.72 36.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.479 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 663' ' ' ARG . 27.7 t -77.74 120.26 28.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.923 0.392 . . . . 0.0 111.643 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.92 168.31 12.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.484 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.16 146.29 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.01 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -82.29 151.65 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 71.0 p -126.05 -179.19 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.28 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.86 -30.13 57.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.36 -51.1 70.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.678 ' HA ' HD12 ' A' ' 726' ' ' LEU . 5.3 mm-40 -65.65 -50.71 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.695 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 727' ' ' VAL . 2.4 ttpm? -55.86 -32.71 63.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -66.66 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.348 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.0 mt -58.34 -44.58 88.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 111.112 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 724' ' ' LYS . 13.3 p -73.6 -25.04 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -36.25 65.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.057 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -97.81 30.22 3.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.525 HD12 ' CG ' ' A' ' 602' ' ' PHE . 5.6 tt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.79 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.819 0.342 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . 0.474 ' O ' HG13 ' P' ' 600' ' ' VAL . 12.1 p -165.72 121.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -144.86 31.03 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.818 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.84 176.87 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.625 HG23 ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.77 74.9 9.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -59.59 125.89 25.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.772 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.67 HD22 ' OD1' ' A' ' 683' ' ' ASP . 9.9 mt -89.62 154.7 48.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 122.607 2.205 . . . . 0.0 112.271 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -69.94 -22.17 63.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.311 . . . . 0.0 111.057 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 178.01 47.95 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.827 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' CB ' ' A' ' 593' ' ' GLU . 5.1 tmm_? -94.45 124.9 38.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.924 0.392 . . . . 0.0 110.23 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.574 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -110.2 -61.89 1.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.247 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.864 HD21 HG22 ' A' ' 694' ' ' VAL . 9.3 tt -106.93 142.71 36.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.848 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.477 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.5 m -113.04 114.26 26.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.044 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.652 HD12 HD11 ' A' ' 594' ' ' ILE . 0.6 OUTLIER -106.75 108.6 20.2 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 10.9 ptpt -118.74 101.59 50.36 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.6 Cg_exo -45.34 105.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.842 1.695 . . . . 0.0 109.239 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.671 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.66 157.31 86.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.43 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.9 Cg_endo -53.65 -27.4 41.72 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.807 3.005 . . . . 0.0 112.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.671 ' HB2' HD12 ' A' ' 583' ' ' LEU . 7.4 m-20 -62.08 -24.28 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.487 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 1.8 t -96.02 153.96 17.49 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.207 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 690' ' ' ILE . 14.9 pt -55.29 -14.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.754 0.312 . . . . 0.0 111.022 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 35.4 mt -107.36 125.2 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.665 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.43 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.32 58.22 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.446 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.535 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.6 mp0 -125.28 168.76 13.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.613 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.23 121.59 25.06 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.381 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.3 mm? -113.34 150.73 32.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.423 ' CB ' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.72 117.09 23.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.688 HD12 HD22 ' A' ' 578' ' ' LEU . 66.2 mt -74.46 108.7 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -69.05 111.12 4.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.291 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.523 ' CD ' ' HG1' ' A' ' 700' ' ' THR . 0.0 OUTLIER -38.81 -52.12 1.72 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.281 0.563 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -46.94 -24.74 2.09 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.234 -0.893 . . . . 0.0 113.14 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.09 117.89 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.287 0.543 . . . . 0.0 110.916 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.7 t30 -140.18 122.33 9.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.058 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -89.76 159.93 35.32 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 124.407 -1.08 . . . . 0.0 111.54 -0.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.621 ' CG ' HG23 ' A' ' 594' ' ' ILE . 4.8 t80 -91.55 114.61 27.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.506 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 6.1 m-85 -92.2 138.08 31.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.75 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.5 mp -124.02 148.34 28.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.47 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.41 -171.54 36.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.347 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.486 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.58 -52.58 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 111.644 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.58 133.54 56.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.319 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -57.95 -19.25 28.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.772 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.51 -31.44 56.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.063 0.459 . . . . 0.0 110.258 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.621 ' SG ' HG22 ' A' ' 621' ' ' VAL . 8.6 m -73.56 128.47 35.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.447 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -43.36 -32.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.235 0.54 . . . . 0.0 110.408 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.75 ' SG ' HG23 ' A' ' 603' ' ' ILE . 34.8 t -106.48 142.01 36.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.007 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.85 104.71 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.412 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.3 mm -139.14 109.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.194 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.9 106.75 17.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.424 0.631 . . . . 0.0 112.432 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.59 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.5 t0 -129.46 107.59 9.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.55 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -40.68 -28.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 688' ' ' PHE . 9.3 mmt180 -69.38 -41.47 76.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.59 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -89.19 158.62 17.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.912 0.387 . . . . 0.0 111.527 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 73.1 m -78.97 170.58 16.46 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.367 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -46.93 -42.58 17.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.621 HG22 ' SG ' ' A' ' 609' ' ' CYS . 41.1 t -122.51 69.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.289 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.632 ' O ' ' N ' ' A' ' 653' ' ' GLY . 17.7 t60 -50.49 -47.05 57.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.745 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 6.2 p -164.6 163.35 21.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.119 0.485 . . . . 0.0 111.986 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.506 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 53.3 p90 -144.18 151.03 38.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.877 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.539 HD13 HD11 ' A' ' 594' ' ' ILE . 3.8 mp -102.71 132.89 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -124.17 132.54 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.872 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 29.9 ttmt -98.17 136.56 38.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.18 158.75 39.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.498 ' HE ' ' HB2' ' A' ' 631' ' ' ALA . 0.8 OUTLIER -76.61 114.49 15.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.235 0.54 . . . . 0.0 110.412 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.9 t60 -81.58 130.02 34.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.771 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.498 ' HB2' ' HE ' ' A' ' 629' ' ' ARG . . . -157.29 159.84 37.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.169 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 10.4 m -109.23 169.42 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.04 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -74.64 95.81 0.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.596 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 8.8 pttp 43.13 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.337 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.8 144.61 8.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.192 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.5 131.4 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.793 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 7.6 t80 69.35 -65.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.961 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -76.05 143.93 41.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.944 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 6.8 m -105.66 101.43 32.42 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -87.46 -163.14 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.84 2.36 . . . . 0.0 112.04 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -95.8 28.59 3.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.329 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 58.78 -168.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.019 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.591 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -89.88 91.04 1.66 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.542 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -105.18 -153.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 p-10 -122.15 147.62 45.93 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.013 0.435 . . . . 0.0 112.041 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.433 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -131.64 155.38 47.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.389 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.771 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -104.26 129.16 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.606 0.717 . . . . 0.0 112.702 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.917 ' CH2' HD22 ' A' ' 671' ' ' LEU . 96.1 m95 -113.49 128.57 56.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.215 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.476 ' HB2' HD21 ' A' ' 672' ' ' LEU . 4.7 t80 -90.32 117.29 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 63.2 m -102.78 130.24 49.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.873 0.368 . . . . 0.0 111.271 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.453 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -109.48 128.22 55.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.207 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.445 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.7 p -126.95 8.98 6.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.206 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.54 151.82 31.42 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.155 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.5 m -83.97 -17.17 41.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.578 0.227 . . . . 0.0 111.49 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.485 ' CB ' HD12 ' A' ' 681' ' ' ILE . 2.1 m120 -87.22 -5.51 58.93 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 664' ' ' MET . 6.6 t 74.8 145.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.122 0.486 . . . . 0.0 112.284 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.453 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 61.8 p -119.2 160.3 22.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 679' ' ' LYS . 21.8 m-85 -138.29 120.4 15.64 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.2 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -94.59 103.72 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.564 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 67.75 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -134.86 -3.68 2.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.595 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.8 OUTLIER -94.52 140.79 29.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.878 0.371 . . . . 0.0 111.099 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.658 ' O ' HG21 ' A' ' 716' ' ' VAL . 4.8 ttp180 -83.88 141.53 31.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 27.6 mtp -131.92 107.17 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.449 ' H ' HG21 ' A' ' 668' ' ' THR . 26.5 pt -86.72 164.73 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.124 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 652' ' ' THR . 36.1 tt0 -50.58 110.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.06 31.7 4.95 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.952 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 665' ' ' ILE . 9.4 p -112.7 162.57 15.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.594 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.45 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -137.37 144.35 42.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.608 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.26 144.14 28.63 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.632 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.917 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.23 136.02 51.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.67 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 694' ' ' VAL . 1.1 mt -107.48 106.72 17.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.117 0.484 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.504 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 16.4 mt-30 -93.48 141.08 28.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.492 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 706' ' ' GLY . 1.6 p30 -41.52 112.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 91.28 37.6 6.19 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 124.39 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.353 -0.424 . . . . 0.0 111.101 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -96.31 109.07 21.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.766 HG22 ' HG ' ' A' ' 659' ' ' LEU . 12.0 pt -105.41 132.83 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.076 0.465 . . . . 0.0 111.768 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 658' ' ' TYR . 12.3 mttp -93.72 115.88 28.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.633 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.482 HG23 HG22 ' A' ' 681' ' ' ILE . 1.3 tt -78.01 -34.79 19.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.125 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.521 HD11 HD21 ' P' ' 606' ' ' LEU . 0.9 OUTLIER -154.33 131.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.029 179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.619 ' CD1' ' CG1' ' A' ' 689' ' ' VAL . 11.7 t90 -136.02 113.25 10.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.768 ' HB2' HD22 ' P' ' 606' ' ' LEU . 16.3 t70 -128.57 114.07 16.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.834 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.59 -42.26 78.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -58.58 -40.16 82.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.258 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -76.08 -19.31 58.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.71 15.85 9.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.196 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 617' ' ' ARG . 0.2 OUTLIER -117.73 125.27 50.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.566 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.619 ' CG1' ' CD1' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -119.21 136.52 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.2 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 587' ' ' ILE . 7.2 mt -128.73 115.82 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.325 0.583 . . . . 0.0 110.464 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -139.75 147.01 18.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.883 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.453 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.08 145.01 41.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 10.8 tptm -101.59 116.91 33.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.864 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -82.36 114.99 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.957 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.24 108.99 12.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.995 0.426 . . . . 0.0 110.257 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.564 HD12 ' HB3' ' A' ' 674' ' ' ASP . 25.4 mt -79.4 122.01 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.294 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -105.1 -42.61 5.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.708 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.52 140.96 44.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.112 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.5 p -114.28 100.26 8.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.319 0.581 . . . . 0.0 110.025 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.523 ' HG1' ' CD ' ' A' ' 596' ' ' GLN . 3.3 m -72.29 65.42 0.61 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.798 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 66.15 32.83 83.48 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.142 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.772 HD22 ' HA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -79.06 134.31 36.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.746 0.308 . . . . 0.0 111.434 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 2.5 p90 -42.76 -33.38 0.73 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.411 0.624 . . . . 0.0 110.563 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.656 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 0.9 OUTLIER -153.6 -49.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.501 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.772 ' HA ' HD22 ' A' ' 702' ' ' LEU . 12.4 pt-20 137.5 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.124 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.656 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 141.8 86.76 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.3 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.501 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -104.93 -9.73 17.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.368 0.584 . . . . 0.0 111.738 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 81.48 47.55 6.34 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.481 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.28 114.38 28.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.361 . . . . 0.0 110.966 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.73 172.86 2.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.772 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -59.56 -65.04 0.74 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -66.9 140.03 57.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.747 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -90.72 100.18 13.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.144 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.623 ' NH2' HD22 ' A' ' 659' ' ' LEU . 6.1 mmm-85 39.57 86.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.801 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.78 142.92 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 663' ' ' ARG . 46.7 t -85.69 118.19 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.138 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.1 mp -91.8 172.28 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -103.25 148.31 25.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.04 157.71 22.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -178.47 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.51 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.93 -52.33 64.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -65.68 -46.65 78.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.44 -32.75 67.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.13 -36.92 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 9.2 mt -59.55 -44.54 93.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.033 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.9 p -81.64 -23.96 9.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -54.44 -34.93 62.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -100.18 31.16 3.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.801 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.476 HD12 ' CG ' ' A' ' 602' ' ' PHE . 3.7 tt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.673 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.884 0.373 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 23.3 t -153.96 93.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.0 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -127.17 32.66 5.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.998 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.76 166.48 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.48 82.75 2.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.764 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -57.35 137.44 56.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.026 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.768 HD22 ' HB2' ' A' ' 683' ' ' ASP . 0.5 OUTLIER -136.11 98.45 11.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.405 2.07 . . . . 0.0 112.222 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -74.3 -20.45 60.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.654 0.264 . . . . 0.0 111.05 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 118.23 -29.76 6.32 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.264 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.452 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.1 tmm_? -105.24 135.92 45.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.698 0.285 . . . . 0.0 111.14 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 647' ' ' ILE . 6.0 t80 -121.46 -52.98 2.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 647' ' ' ILE . 11.9 tp -112.22 142.32 44.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.023 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 695' ' ' GLU . 19.4 m -120.3 114.06 21.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.831 ' HG ' HG22 ' A' ' 694' ' ' VAL . 3.1 mp -107.18 108.94 20.62 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.9 pttt -114.45 100.76 53.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -44.9 102.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.787 1.658 . . . . 0.0 109.518 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.22 159.54 83.57 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.599 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 6.3 Cg_endo -48.69 -30.56 16.95 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.783 2.988 . . . . 0.0 112.989 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.672 ' HB2' HD12 ' A' ' 583' ' ' LEU . 8.2 m-20 -63.55 -17.72 63.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.063 0.459 . . . . 0.0 109.89 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.579 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 23.8 t -95.46 153.32 17.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.628 HD11 HD11 ' A' ' 690' ' ' ILE . 20.9 pt -59.24 -19.24 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 109.972 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.564 HD13 HG23 ' A' ' 613' ' ' ILE . 5.4 mt -112.55 118.54 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.784 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.599 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -106.04 66.0 0.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.374 0.607 . . . . 0.0 110.462 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.578 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.0 mt-10 -125.57 172.34 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.758 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.44 125.6 40.85 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.175 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.772 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.41 138.63 48.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.837 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.452 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.31 114.44 19.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.611 0.243 . . . . 0.0 111.398 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.086 HD11 HD12 ' A' ' 625' ' ' ILE . 46.1 mt -72.36 109.36 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.819 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.6 OUTLIER -64.14 110.13 2.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.45 -29.64 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.028 0.442 . . . . 0.0 111.022 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.78 -22.51 73.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.378 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.671 HG11 ' OD1' ' A' ' 610' ' ' ASN . 63.4 t -101.28 119.31 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 117.712 0.756 . . . . 0.0 111.465 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 15.5 t30 -138.94 123.37 11.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.884 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 46.0 Cg_endo -90.11 160.82 34.04 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 124.672 -0.97 . . . . 0.0 111.99 0.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.693 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.6 t80 -91.94 114.68 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.699 ' CG ' HD12 ' A' ' 730' ' ' LEU . 22.2 m-85 -92.29 138.21 31.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.702 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.7 mp -126.46 145.54 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 159.69 -175.03 36.6 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.43 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -65.45 -47.73 75.13 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 111.38 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.82 127.17 30.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.355 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -58.18 -17.35 18.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.92 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.36 -30.77 67.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.027 0.442 . . . . 0.0 110.186 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.723 ' SG ' HG22 ' A' ' 621' ' ' VAL . 62.3 m -70.61 133.44 46.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.63 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.671 ' OD1' HG11 ' A' ' 598' ' ' VAL . 0.7 OUTLIER -47.47 -28.32 2.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.767 ' SG ' HG23 ' A' ' 603' ' ' ILE . 43.1 t -111.96 142.16 44.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.514 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.28 105.27 13.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.772 HD11 HD21 ' A' ' 592' ' ' LEU . 25.0 mm -139.09 109.73 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.027 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -104.4 107.16 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.472 0.653 . . . . 0.0 112.548 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.616 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.4 t0 -129.38 107.56 9.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.766 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -40.0 -29.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.465 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.616 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.3 pp -89.66 158.85 17.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.549 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.8 164.94 25.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.621 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.911 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -53.06 -25.7 13.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.989 0.423 . . . . 0.0 110.369 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.911 HG23 ' HG2' ' A' ' 620' ' ' ARG . 47.1 t -131.67 64.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 8.0 t60 -49.0 -43.77 40.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.227 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.5 p -167.13 161.42 14.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.0 111.902 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.2 p90 -143.54 148.3 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.593 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.086 HD12 HD11 ' A' ' 594' ' ' ILE . 75.2 mt -102.25 136.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.6 t80 -127.25 135.08 50.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.588 ' CE ' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -97.16 136.82 37.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 158.73 43.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.753 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.8 OUTLIER -77.32 112.75 14.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.424 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.7 t-160 -82.87 122.84 28.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.828 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -142.77 160.69 39.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 5.8 m -119.88 165.25 15.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -97.64 107.01 3.4 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.327 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 6.4 tttp 63.24 140.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.9 p -126.68 106.33 9.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.2 mtp -94.38 117.07 29.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.74 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 67.25 -74.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.795 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.25 144.17 38.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 9.0 t -112.38 95.36 30.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.961 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 -154.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.574 2.183 . . . . 0.0 112.165 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -54.45 -23.09 14.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.524 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 71.97 -65.04 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.411 ' CA ' ' NE ' ' A' ' 629' ' ' ARG . . . -179.96 79.41 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.731 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.949 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.3 mt -121.87 -155.34 0.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 1.6 m-20 -112.43 147.96 35.36 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.444 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -138.03 131.78 31.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.662 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 578' ' ' LEU . 4.6 pt -87.4 123.82 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.876 ' CH2' HD22 ' A' ' 671' ' ' LEU . 88.0 m95 -104.84 144.09 32.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.871 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.717 ' CD2' HD13 ' A' ' 678' ' ' ILE . 7.4 t80 -104.38 117.15 33.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 25.4 m -105.47 130.02 53.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.482 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 60.4 t60 -108.78 133.08 53.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.22 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.6 p -130.08 6.32 4.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.249 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.43 150.69 31.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.692 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.429 HG22 HG21 ' P' ' 603' ' ' TPO . 3.9 t -73.64 -35.81 65.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 111.455 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.604 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.3 m-80 -70.7 -1.77 12.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.307 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 53.65 125.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.218 0.532 . . . . 0.0 111.786 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.3 p -90.65 165.71 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 89.4 m-85 -128.17 120.27 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.652 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -97.68 100.53 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.33 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 61.4 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -134.44 3.74 3.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.711 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.563 ' HB3' HG23 ' A' ' 716' ' ' VAL . 1.8 m-80 -107.12 141.23 38.7 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.658 ' O ' HG21 ' A' ' 716' ' ' VAL . 12.5 ttm180 -80.72 141.21 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.414 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 35.1 mmm -119.12 102.36 8.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.1 pt -87.86 150.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.276 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -44.31 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.445 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.6 43.35 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.655 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.04 162.13 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -131.41 146.28 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.588 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.72 144.88 28.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.876 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.06 134.8 49.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.206 179.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 694' ' ' VAL . 1.1 mt -109.96 98.11 7.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.155 0.502 . . . . 0.0 111.504 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 12.3 mt-30 -83.49 141.73 31.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.508 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 696' ' ' ILE . 19.5 t0 -46.54 111.42 0.38 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.972 0.415 . . . . 0.0 110.269 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 102.29 36.5 3.58 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.75 31.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 111.176 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.61 108.7 21.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.002 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.717 HD13 ' CD2' ' A' ' 649' ' ' TYR . 10.4 mt -105.97 133.92 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 111.938 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 7.8 mttt -96.65 116.14 28.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.72 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.543 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -80.3 -38.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.204 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.84 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.5 tp -155.37 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.408 . . . . 0.0 111.615 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -136.09 127.28 28.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.392 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.452 ' OD2' HD22 ' P' ' 606' ' ' LEU . 0.4 OUTLIER -127.18 117.25 21.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.458 179.102 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -66.73 -46.58 75.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.068 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -81.33 -40.22 23.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.821 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.69 -10.7 59.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.592 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.99 19.52 8.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.522 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 4.6 t80 -83.14 105.03 13.78 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.434 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -125.71 122.48 62.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.163 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.84 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.7 mt -128.78 119.32 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.37 137.19 7.42 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.801 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.46 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.4 m-30 -113.25 143.75 43.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.673 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.8 OUTLIER -101.07 116.7 33.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.753 179.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.831 HG22 ' HG ' ' A' ' 580' ' ' LEU . 2.7 t -84.87 125.79 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 25.7 tt0 -134.03 109.28 8.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.786 0.327 . . . . 0.0 111.404 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.592 HD12 ' HG3' ' A' ' 705' ' ' GLU . 84.5 mt -69.85 105.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.031 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -85.58 -48.78 8.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.475 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 11.3 t0 -111.9 142.11 44.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.871 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.557 HG22 ' HB2' ' A' ' 705' ' ' GLU . 66.9 p -113.82 101.29 9.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 24.3 m -65.81 61.75 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.257 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 49.73 42.13 36.23 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.704 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.618 ' CD1' ' HA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -99.21 -176.91 3.44 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.02 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.949 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -60.6 -143.24 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.729 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 707' ' ' LEU . 0.8 OUTLIER -56.49 2.57 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.618 ' HA ' ' CD1' ' A' ' 702' ' ' LEU . 0.5 OUTLIER 82.91 -54.63 0.18 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.841 0.353 . . . . 0.0 110.109 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 162.23 74.01 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.475 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.475 ' H ' ' ND2' ' A' ' 704' ' ' ASN . 3.3 mm? -105.49 -10.0 17.16 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.76 -0.259 . . . . 0.0 111.457 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.406 ' HA2' ' NE2' ' A' ' 673' ' ' GLN . . . 97.12 31.95 6.66 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.409 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.449 ' HE2' ' HB3' ' A' ' 709' ' ' MET . 0.6 OUTLIER -85.19 121.68 28.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.33 . . . . 0.0 110.895 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 178.91 166.09 0.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -68.17 -54.19 19.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.769 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 140.22 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.705 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -82.83 100.12 10.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.102 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.5 mmm-85 37.42 88.16 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.975 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.68 143.51 37.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.783 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 663' ' ' ARG . 61.3 t -84.38 129.09 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.206 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.6 mp -98.42 165.06 12.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.707 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.88 135.61 43.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -73.36 154.34 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 43.1 p -126.0 -174.62 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.198 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.8 62.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.8 -51.89 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.757 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.655 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.7 mp0 -65.26 -48.79 72.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.796 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -56.25 -32.8 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.84 -37.01 83.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.065 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 723' ' ' GLU . 11.9 mt -59.93 -44.12 94.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.998 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 1.6 t -77.02 -26.1 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.247 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -55.25 -33.75 63.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.849 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -99.4 30.83 3.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.804 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.699 HD12 ' CG ' ' A' ' 602' ' ' PHE . 5.5 tt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.787 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.776 0.322 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 17.1 t -117.31 77.72 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.981 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -175.82 37.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.986 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.21 120.7 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.429 HG21 HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -47.83 83.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.853 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 62.12 150.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.485 HD12 ' OD1' ' A' ' 655' ' ' ASN . 8.8 mt -123.02 80.79 50.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 C--O 1.249 1.061 0 C-N-CA 122.581 2.188 . . . . 0.0 112.259 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -87.38 -22.08 25.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.688 0.28 . . . . 0.0 111.108 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 174.89 40.12 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.993 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.46 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 45.5 ttp180 -111.99 124.24 51.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 647' ' ' ILE . 11.0 t80 -107.25 -55.64 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.611 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.756 HD11 ' CG1' ' A' ' 694' ' ' VAL . 10.2 tp -111.51 141.99 44.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.781 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 695' ' ' GLU . 18.5 m -124.78 113.97 18.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.705 HD21 HD11 ' A' ' 625' ' ' ILE . 1.6 mp -105.54 108.81 20.52 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -112.7 99.62 48.28 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.101 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.6 Cg_exo -44.6 99.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.864 1.709 . . . . 0.0 109.612 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.753 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.77 157.45 85.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.52 -25.66 11.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.832 3.021 . . . . 0.0 113.166 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -28.12 69.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.0 OUTLIER -95.98 154.0 17.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.624 178.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.46 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 5.4 pt -58.57 -10.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.732 0.301 . . . . 0.0 110.91 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.485 HD13 HG23 ' A' ' 613' ' ' ILE . 41.1 mt -106.96 118.81 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -109.08 57.44 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.213 0.53 . . . . 0.0 110.106 179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.606 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.2 mm-40 -124.49 171.91 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.162 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.26 122.99 33.02 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.041 0.448 . . . . 0.0 111.233 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.987 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.67 132.68 55.07 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.46 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -123.95 121.8 36.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.106 HD11 HD12 ' A' ' 625' ' ' ILE . 86.9 mt -74.09 108.96 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.137 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.5 ' O ' ' C ' ' A' ' 596' ' ' GLN . 1.1 mp0 -70.54 81.5 0.58 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -7.53 -62.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.583 0.753 . . . . 0.0 112.788 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . -44.69 -21.2 0.27 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.838 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.412 HG11 ' CG ' ' A' ' 610' ' ' ASN . 37.6 t -96.61 118.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 117.432 0.616 . . . . 0.0 111.067 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -139.62 123.63 10.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.265 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.581 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 49.3 Cg_endo -90.66 159.85 30.86 Favored 'Cis proline' 0 N--CA 1.46 -0.495 0 C-N-CA 124.454 -1.061 . . . . 0.0 111.798 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.7 t80 -92.08 114.72 27.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.733 ' CG ' HD12 ' A' ' 730' ' ' LEU . 49.8 m-85 -92.31 138.02 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.733 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.802 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.7 mp -125.88 144.54 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.739 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.09 -169.44 36.68 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.42 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.511 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -69.81 -52.86 21.44 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.819 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.28 130.0 44.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -56.7 -18.63 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.949 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.96 -31.91 61.01 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.15 0.5 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 73.1 m -71.82 132.72 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.583 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 14.0 m-80 -47.95 -28.43 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.46 . . . . 0.0 110.558 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.8 t -111.07 142.79 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.48 105.23 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.987 HD11 HD21 ' A' ' 592' ' ' LEU . 34.1 mm -139.39 109.62 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.961 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.48 106.57 17.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.445 0.641 . . . . 0.0 112.652 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.628 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.2 t0 -130.35 107.91 9.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.721 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -39.28 -30.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.678 ' CD ' HD21 ' P' ' 606' ' ' LEU . 0.7 OUTLIER -68.6 -41.01 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.628 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.22 159.05 17.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.802 0.334 . . . . 0.0 111.428 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.3 t -80.57 166.05 21.5 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.376 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.481 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 2.9 mpt_? -47.23 -37.14 9.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.175 0.512 . . . . 0.0 110.374 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.453 HG11 HG23 ' A' ' 727' ' ' VAL . 13.1 t -122.95 63.59 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.558 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 9.4 t60 -48.74 -42.97 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.833 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.6 p -167.79 157.73 10.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.802 ' HA ' HD12 ' A' ' 603' ' ' ILE . 50.1 p90 -143.14 146.0 33.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.687 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.106 HD12 HD11 ' A' ' 594' ' ' ILE . 60.5 mt -102.14 129.27 53.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.323 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.5 t80 -120.83 135.1 55.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.398 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 25.1 ttmt -97.66 134.34 40.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.961 0.41 . . . . 0.0 110.394 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.46 158.37 44.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.759 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -77.43 111.9 13.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.935 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.2 t60 -67.96 125.73 27.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.107 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . 179.92 114.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.933 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 29.0 m -55.21 156.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.214 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -53.59 -27.91 35.89 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.666 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -169.29 115.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 110.784 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.82 134.47 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.0 tpt -90.01 84.3 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 61.73 -84.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.767 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -114.38 103.47 11.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 5.9 p -138.64 156.09 73.22 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.026 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 45.9 Cg_endo -67.86 -162.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.588 2.192 . . . . 0.0 111.839 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 78.76 -56.55 0.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.508 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 69.3 -69.19 0.17 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.883 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.571 ' H ' HD12 ' A' ' 644' ' ' LEU . . . 153.96 61.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.794 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.1 mp -115.15 -165.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.874 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.4 OUTLIER -113.14 147.0 38.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.433 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -133.54 153.0 51.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.714 HD13 HD13 ' A' ' 578' ' ' LEU . 2.9 pt -100.64 119.02 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.304 0.573 . . . . 0.0 111.524 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.918 ' CH2' HD22 ' A' ' 671' ' ' LEU . 84.8 m95 -100.63 127.84 46.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.453 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.462 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.2 t80 -90.29 117.59 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' A' ' 624' ' ' PHE . 7.9 m -104.13 136.98 42.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.444 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -115.88 127.52 55.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.206 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.8 p -125.86 10.96 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.198 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.29 159.61 41.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.261 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.0 m -88.09 -19.17 27.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.677 0.275 . . . . 0.0 111.46 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.584 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.4 m-80 -87.01 2.7 48.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.8 128.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.35 0.595 . . . . 0.0 112.083 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.444 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 87.5 p -100.28 165.74 11.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.341 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -129.79 120.65 25.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.28 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.644 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.42 102.59 14.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 61.57 -81.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -131.56 -5.65 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.537 ' ND2' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -97.84 141.37 30.91 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 111.095 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.675 ' O ' HG21 ' A' ' 716' ' ' VAL . 29.1 ttp180 -81.86 141.0 33.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.773 ' HE1' HG13 ' A' ' 716' ' ' VAL . 13.3 mmm -120.89 99.64 6.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.431 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 42.3 pt -87.59 154.28 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -45.62 107.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.313 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.12 35.88 3.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.61 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.43 ' CG2' HG12 ' A' ' 665' ' ' ILE . 3.4 p -119.89 162.28 19.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.184 0.516 . . . . 0.0 111.686 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.48 ' HE2' HD13 ' A' ' 717' ' ' LEU . 5.4 ttpm? -130.4 148.79 52.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.007 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.625 ' CZ ' ' HG2' ' A' ' 714' ' ' ARG . 2.4 t80 -147.25 143.94 28.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.918 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -74.05 130.57 40.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.193 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.696 HD13 HG21 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -97.07 139.64 32.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.28 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.717 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 7.6 mt-30 -124.9 131.5 53.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.075 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.852 ' HB2' HD12 ' A' ' 696' ' ' ILE . 40.3 t0 -42.93 104.0 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 110.581 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 106.19 33.77 3.35 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.506 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -94.51 113.86 25.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.382 . . . . 0.0 111.324 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -95.66 111.91 23.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.642 HG12 HD13 ' A' ' 659' ' ' LEU . 4.3 mt -104.92 137.04 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.062 0.458 . . . . 0.0 111.855 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -93.14 115.98 28.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.803 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.549 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -85.47 -35.48 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.744 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.7 tp -154.97 131.33 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.072 0.463 . . . . 0.0 111.826 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -137.11 125.35 23.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.843 ' OD2' HD22 ' P' ' 606' ' ' LEU . 7.9 t0 -127.15 116.81 21.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.884 0.373 . . . . 0.0 110.266 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -46.84 71.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.21 -40.68 62.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.84 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -87.24 -8.7 56.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? 60.71 17.94 8.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.46 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 6.7 t80 -77.08 104.59 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.4 p -124.51 122.17 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 111.813 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.744 ' HB ' HG22 ' A' ' 681' ' ' ILE . 7.0 mt -128.18 151.43 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.517 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.428 ' O ' HD22 ' A' ' 583' ' ' LEU . . . 178.26 137.83 2.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.091 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.579 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 1.8 m-30 -114.5 150.33 35.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.732 0.301 . . . . 0.0 110.738 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.753 ' HB2' HD12 ' A' ' 583' ' ' LEU . 6.5 tttt -101.16 116.62 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 110.633 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.756 ' CG1' HD11 ' A' ' 578' ' ' LEU . 3.6 t -79.56 124.72 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.686 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -134.05 108.75 8.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.852 HD12 ' HB2' ' A' ' 674' ' ' ASP . 58.1 mt -69.67 105.6 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.04 -47.06 16.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.697 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.468 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 80.6 m-20 -111.08 140.98 45.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.637 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 82.8 p -114.32 99.9 7.94 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.7 t -80.32 59.05 3.28 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.97 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.56 60.78 7.92 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.068 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.874 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -80.8 144.91 31.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.594 0.235 . . . . 0.0 110.949 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.709 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.1 p90 -39.13 -44.58 1.19 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.254 0.55 . . . . 0.0 111.346 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -120.57 -28.08 5.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.844 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 15.8 pt-20 140.63 -17.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.421 1.088 . . . . 0.0 108.618 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.717 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 110.46 12.28 17.52 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.591 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' A' ' 674' ' ' ASP . 0.4 OUTLIER -103.28 8.11 38.34 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.453 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 89.84 -113.05 4.12 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.562 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.41 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 2.4 ptp -173.57 110.42 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.941 0.4 . . . . 0.0 111.22 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 709' ' ' MET . 0.5 OUTLIER 42.0 50.05 4.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.139 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 49.63 27.95 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.445 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -74.12 141.32 45.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.957 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.23 135.96 35.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.402 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.625 ' HG2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -96.13 -150.65 0.33 Allowed 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 120.954 0.406 . . . . 0.0 110.237 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.47 166.92 3.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.692 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.773 HG13 ' HE1' ' A' ' 664' ' ' MET . 12.0 t -98.44 114.19 35.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.267 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.48 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.8 OUTLIER -89.86 168.37 12.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.84 146.6 27.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -80.66 154.87 27.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -123.77 -177.26 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.26 -30.76 62.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -64.83 -49.9 68.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.722 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -64.34 -50.62 67.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.498 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.6 OUTLIER -59.0 -32.55 69.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.049 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -62.8 -39.93 95.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.003 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 723' ' ' GLU . 3.2 mt -61.04 -44.56 97.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 724' ' ' LYS . 10.5 p -72.56 -25.51 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -65.11 -34.33 78.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 110.266 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -79.83 -16.86 54.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.946 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.733 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.2 tt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.068 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.93 0.395 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . 0.547 HG22 ' O ' ' P' ' 600' ' ' VAL . 12.3 p -120.01 51.43 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.091 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.3 64.75 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 1.7 pp -159.63 163.7 34.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.764 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.511 HG22 ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -41.23 98.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.939 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 53.75 106.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.023 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.843 HD22 ' OD2' ' A' ' 683' ' ' ASP . 14.8 mt -76.29 -45.5 3.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.454 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' P' ' 606' ' ' LEU . 77.9 Cg_exo . . . . . 0 C--O 1.248 0.988 0 C-N-CA 122.291 1.994 . . . . 0.0 112.331 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -89.39 9.41 26.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.536 0.208 . . . . 0.0 111.379 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.49 ' C ' ' HG2' ' A' ' 596' ' ' GLN . . . 166.74 36.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.15 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 577' ' ' PHE . 3.1 tmm_? -115.1 129.77 56.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.765 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.761 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -115.31 -57.42 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.371 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.976 HD23 HD12 ' A' ' 594' ' ' ILE . 24.0 tp -106.59 142.21 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.656 0.265 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.896 HG23 ' HG3' ' A' ' 593' ' ' GLU . 8.3 m -123.57 113.03 18.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 1.11 HD22 HG22 ' A' ' 694' ' ' VAL . 0.0 OUTLIER -107.9 107.84 18.74 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.5 mtpt -109.57 99.59 38.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -175.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.3 Cg_exo -46.67 108.92 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.56 1.507 . . . . 0.0 108.722 176.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.71 156.77 88.19 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.49 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 13.9 Cg_endo -56.24 -25.89 58.29 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.639 2.893 . . . . 0.0 112.825 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -63.31 -20.51 65.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.191 0.52 . . . . 0.0 109.653 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.439 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.4 t -97.38 153.84 17.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.759 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 690' ' ' ILE . 5.2 pt -52.68 -21.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 109.908 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.837 HD13 HG23 ' A' ' 613' ' ' ILE . 48.1 mt -106.71 118.74 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.845 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -114.38 63.67 0.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.572 0.701 . . . . 0.0 109.773 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 17.6 mt-10 -125.24 173.25 8.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.455 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.15 116.52 21.48 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.691 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.43 128.03 56.31 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.896 ' HG3' HG23 ' A' ' 579' ' ' THR . 2.8 mp0 -124.98 131.21 53.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.976 HD12 HD23 ' A' ' 578' ' ' LEU . 67.0 mt -71.44 109.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 598' ' ' VAL . 0.6 OUTLIER -51.17 105.16 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.417 0.627 . . . . 0.0 111.645 -178.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.761 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 1.3 mm-40 41.63 -125.76 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.908 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -96.95 41.04 2.41 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.972 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 595' ' ' GLN . 4.7 t -73.05 118.73 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -135.26 127.69 18.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.222 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.618 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 19.9 Cg_endo -92.77 153.23 17.6 Favored 'Cis proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.957 -1.268 . . . . 0.0 112.508 0.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.749 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.1 t80 -96.1 112.2 24.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.667 ' CG ' HD12 ' A' ' 730' ' ' LEU . 72.8 m-85 -93.01 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.46 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.772 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mt -126.57 145.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.478 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.51 -168.38 35.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.383 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.497 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -69.08 -54.84 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.48 56.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.0 111.592 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -57.58 -19.47 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.815 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -53.34 -31.27 43.58 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.175 0.512 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 87.0 m -73.18 131.19 41.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.493 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 7.1 m-80 -46.31 -29.87 1.83 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.223 0.535 . . . . 0.0 110.404 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.82 ' SG ' HD13 ' A' ' 592' ' ' LEU . 41.4 t -110.76 143.13 41.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.028 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.24 105.44 13.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 592' ' ' LEU . 32.9 mm -138.99 109.61 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.027 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -104.06 106.96 17.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.627 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.3 t0 -130.0 107.7 9.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.604 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . 0.402 ' ND2' ' HD2' ' A' ' 617' ' ' ARG . 0.3 OUTLIER -38.73 -30.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.499 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -68.86 -41.6 78.18 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.627 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -88.65 159.13 17.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.953 0.406 . . . . 0.0 111.938 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 60.1 p -77.55 173.08 12.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -49.55 -32.95 13.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.516 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 621' ' ' VAL . 8.9 p -134.99 66.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.606 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 13.7 t60 -44.65 -39.53 5.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.96 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.454 ' SG ' HD11 ' A' ' 680' ' ' ILE . 4.3 p -165.39 158.86 16.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.47 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 36.3 p90 -143.77 147.74 34.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.972 HD12 HD11 ' A' ' 594' ' ' ILE . 55.7 mt -101.92 134.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.019 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 135.76 51.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.422 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -97.15 137.84 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.127 0.489 . . . . 0.0 110.879 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.71 158.92 43.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.877 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -77.17 112.47 13.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.307 0.575 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.5 t60 -80.71 129.8 34.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.885 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -141.02 167.39 22.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 4.5 m -114.83 128.43 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -65.23 -34.41 89.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.637 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -140.99 128.07 20.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.883 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 5.7 p -127.11 132.92 50.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.2 mtt -95.53 75.44 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.828 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.6 -68.0 0.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -112.28 105.08 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.34 144.37 50.86 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.806 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 58.1 Cg_endo -71.85 178.55 5.71 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.455 2.103 . . . . 0.0 112.228 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.788 ' O ' HD12 ' A' ' 644' ' ' LEU . . . 70.35 -64.49 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.47 -68.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.022 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 179.05 67.56 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.439 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.947 HD13 ' HA ' ' A' ' 703' ' ' PHE . 1.2 mt -115.28 -154.53 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.61 ' O ' HD12 ' A' ' 702' ' ' LEU . 1.1 m-20 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.343 0.592 . . . . 0.0 112.526 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.435 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.8 OUTLIER -132.13 137.31 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.605 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.859 HD13 HD22 ' A' ' 578' ' ' LEU . 2.5 pt -88.96 120.65 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.334 0.587 . . . . 0.0 112.145 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.923 ' CH2' HD22 ' A' ' 671' ' ' LEU . 87.4 m95 -101.74 143.82 31.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.726 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.585 ' HB2' HD11 ' A' ' 672' ' ' LEU . 16.7 t80 -104.24 117.34 33.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -105.29 138.47 41.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.162 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.44 ' CE1' ' N ' ' A' ' 657' ' ' SER . 49.2 t60 -118.44 130.98 56.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.43 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -127.36 8.76 6.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.139 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.37 148.51 28.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.282 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.61 HG21 ' HB3' ' P' ' 605' ' ' GLU . 2.3 t -75.78 -31.17 59.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.1 0.476 . . . . 0.0 111.197 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.616 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.2 m120 -71.95 -1.17 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.024 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.6 126.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.346 0.593 . . . . 0.0 111.57 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 91.8 p -95.54 165.92 12.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.304 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -128.09 120.03 26.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 111.403 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -96.56 99.87 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.679 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.94 -81.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -135.11 3.1 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.806 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.469 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 3.2 m-80 -103.68 141.65 35.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.826 0.345 . . . . 0.0 111.111 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -77.85 141.56 39.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.021 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.425 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 31.3 mmm -125.93 97.9 5.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.6 pt -87.83 153.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' A' ' 652' ' ' THR . 52.0 tt0 -48.05 100.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.82 37.25 1.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.37 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.9 p -125.48 158.71 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 111.445 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.458 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.6 ttpm? -130.26 148.56 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.529 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.458 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.9 145.35 28.61 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.923 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.64 135.21 51.05 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.419 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.5 mt -111.63 104.99 13.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.549 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 15.5 mt-30 -92.05 143.58 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.219 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.616 ' HB2' HD12 ' A' ' 696' ' ' ILE . 40.5 t0 -45.5 113.91 0.67 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 110.877 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 99.52 35.51 4.64 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 116.32 28.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.993 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.05 108.76 21.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.22 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.68 HG12 HD13 ' A' ' 659' ' ' LEU . 11.4 mt -107.69 135.0 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.999 0.428 . . . . 0.0 111.894 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.439 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 4.5 mttm -96.79 116.2 28.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.848 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.561 HG23 HD23 ' A' ' 618' ' ' LEU . 0.0 OUTLIER -76.33 -34.6 25.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.303 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.779 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.2 tp -154.27 131.02 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.67 122.08 19.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.548 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.07 116.32 20.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 110.4 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -46.63 71.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.148 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -69.09 -40.51 78.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.058 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.72 -2.44 53.81 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt 58.11 19.23 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 0.0 110.829 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.502 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 2.6 t80 -76.84 104.46 7.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.431 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -126.19 120.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.17 0.51 . . . . 0.0 111.808 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 587' ' ' ILE . 13.6 mt -129.64 124.68 59.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -150.04 141.49 8.85 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.716 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.616 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 3.1 m-30 -113.92 141.85 46.86 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 580' ' ' LEU . 2.7 tttt -101.23 115.75 31.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.938 0.399 . . . . 0.0 110.299 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 1.11 HG22 HD22 ' A' ' 580' ' ' LEU . 1.9 t -80.5 127.02 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.857 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.2 OUTLIER -134.21 109.03 8.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.677 HD12 ' HG3' ' A' ' 705' ' ' GLU . 60.1 mt -71.45 105.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.099 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.36 -46.85 8.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.288 0.566 . . . . 0.0 109.565 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.536 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.0 t0 -111.32 142.68 43.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.341 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.697 ' HB ' HD23 ' A' ' 702' ' ' LEU . 34.5 p -113.48 100.75 8.76 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.69 62.06 0.07 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.945 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 51.83 47.21 53.87 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.481 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.78 HD21 ' HA ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -105.39 177.67 4.78 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.704 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.947 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -58.24 -141.8 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.953 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.503 ' N ' ' CG ' ' A' ' 703' ' ' PHE . 0.7 OUTLIER -59.24 9.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.78 ' HA ' HD21 ' A' ' 702' ' ' LEU . 0.4 OUTLIER 77.95 -56.89 0.49 Allowed 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.962 0.41 . . . . 0.0 110.105 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 160.06 58.94 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.078 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 707' ' ' LEU . 1.0 OUTLIER -104.54 7.21 35.14 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.779 -0.247 . . . . 0.0 111.567 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 86.91 56.28 2.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.008 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.98 135.64 1.28 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.046 0.451 . . . . 0.0 111.677 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.1 mp 73.71 -172.76 0.13 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.8 -97.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.129 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -114.76 101.25 8.89 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.698 0.285 . . . . 0.0 111.378 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 7.2 mp0 -115.12 100.32 8.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.491 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.468 ' HD3' ' NE2' ' A' ' 673' ' ' GLN . 8.4 mmm-85 -160.55 76.06 0.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.438 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 4.6 m -123.99 141.42 44.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.289 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.1 t -81.64 130.04 36.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.253 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.477 HD11 ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -106.19 162.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.618 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.89 145.06 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.853 0.358 . . . . 0.0 111.005 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -79.98 156.61 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 33.9 p -126.06 -174.21 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.71 -29.39 53.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.199 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.65 -50.37 65.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.668 ' HA ' HD12 ' A' ' 726' ' ' LEU . 41.1 mp0 -64.0 -45.29 89.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -57.73 -32.94 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.42 -37.02 82.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 723' ' ' GLU . 12.2 mt -59.43 -44.84 92.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.015 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 14.2 p -84.75 -24.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.347 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -56.6 -30.27 63.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -112.45 28.39 8.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.667 HD12 ' CG ' ' A' ' 602' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.635 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.781 0.324 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 14.8 t -146.26 58.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 64.77 39.33 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.46 168.02 3.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.706 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.402 ' CG2' ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.54 80.45 4.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.742 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . 0.61 ' HB3' HG21 ' A' ' 654' ' ' THR . 1.4 pt-20 -59.86 107.79 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.052 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.417 HD21 ' CZ ' ' A' ' 617' ' ' ARG . 93.0 mt -60.43 110.68 3.09 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.415 2.077 . . . . 0.0 112.372 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -83.55 -10.99 57.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.536 0.207 . . . . 0.0 111.427 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.4 ' HA2' ' OE1' ' A' ' 596' ' ' GLN . . . 141.15 -8.47 2.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.508 -0.854 . . . . 0.0 113.078 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.451 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.8 OUTLIER -106.58 141.21 38.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.856 0.36 . . . . 0.0 111.068 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.752 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -128.06 -49.17 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.927 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 694' ' ' VAL . 7.3 tp -118.23 142.51 47.39 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.996 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 24.0 m -115.83 117.19 29.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.782 HD11 HD11 ' A' ' 625' ' ' ILE . 9.6 mt -105.56 109.11 20.96 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.73 99.55 52.26 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 38.2 Cg_exo -46.03 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.884 1.722 . . . . 0.0 109.628 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.798 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.3 OUTLIER -74.87 157.78 85.29 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.409 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 74.4 Cg_exo -49.39 -24.93 9.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.633 2.889 . . . . 0.0 112.785 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.798 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.5 t0 -61.62 -27.38 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.466 ' OG ' HD13 ' A' ' 690' ' ' ILE . 4.7 t -95.56 154.0 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.721 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 690' ' ' ILE . 1.4 pt -56.5 -13.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.43 ' CD1' HG23 ' A' ' 613' ' ' ILE . 60.8 mt -108.08 130.92 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -117.32 60.12 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 110.728 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.592 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.7 mt-10 -124.9 169.58 11.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.103 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.56 121.49 25.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.66 0.267 . . . . 0.0 111.559 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.2 mm? -112.93 149.38 33.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.451 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.95 118.69 26.83 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.946 HD11 HD12 ' A' ' 625' ' ' ILE . 63.7 mt -73.97 109.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.321 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -64.55 113.55 3.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.661 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.24 -30.89 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.226 0.536 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.57 -20.43 73.84 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.052 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.488 HG11 ' CG ' ' A' ' 610' ' ' ASN . 48.1 t -99.86 118.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.561 0.681 . . . . 0.0 111.287 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.5 t30 -139.54 121.87 10.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.993 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.6 Cg_endo -90.21 160.13 33.22 Favored 'Cis proline' 0 N--CA 1.462 -0.367 0 C-N-CA 124.499 -1.042 . . . . 0.0 111.811 -0.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.631 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.4 t80 -91.27 114.76 27.37 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 33.6 m-85 -91.89 138.04 31.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.294 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.783 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -125.39 143.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.229 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.38 -163.57 35.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.454 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -77.13 -51.15 11.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.37 127.02 29.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.293 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -53.88 -19.78 5.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.004 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.93 -30.32 61.47 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.002 0.43 . . . . 0.0 110.224 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 38.0 m -70.59 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.589 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 15.3 m-80 -47.34 -29.0 2.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.036 0.446 . . . . 0.0 110.482 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.783 ' SG ' HG23 ' A' ' 603' ' ' ILE . 37.1 t -110.87 137.0 49.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.16 104.76 14.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.43 HG23 ' CD1' ' A' ' 588' ' ' ILE . 15.5 mm -139.53 109.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.299 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -104.98 107.17 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.594 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -129.17 107.4 9.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.466 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -39.86 -27.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 681' ' ' ILE . 0.3 OUTLIER -73.51 -39.81 64.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.594 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -88.78 158.73 18.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 111.403 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.8 m -76.82 169.07 18.99 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.791 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.439 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -51.15 -35.27 35.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.28 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.67 63.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.52 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.613 ' HD2' HG23 ' A' ' 680' ' ' ILE . 26.3 t60 -47.83 -40.38 21.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.825 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.7 p -168.69 156.72 8.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.037 0.446 . . . . 0.0 111.631 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.718 ' HA ' HD12 ' A' ' 603' ' ' ILE . 27.3 p90 -143.34 148.47 36.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.55 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.946 HD12 HD11 ' A' ' 594' ' ' ILE . 61.4 mt -102.15 135.25 39.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.891 0.377 . . . . 0.0 110.133 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -126.87 134.13 50.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.647 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 7.8 ttpt -98.08 134.97 40.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.506 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.71 158.24 44.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.761 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -77.39 115.93 17.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.473 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.3 t60 -74.66 128.15 34.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.961 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -135.77 153.41 51.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.035 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 633' ' ' GLY . 6.7 p -127.74 159.99 37.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -56.63 -71.68 0.7 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.523 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -171.12 98.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.35 . . . . 0.0 110.846 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 2.3 m -67.08 153.95 42.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -133.79 142.89 48.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 71.38 -65.42 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -82.86 142.22 31.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.017 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 52.1 m -102.69 105.75 46.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.722 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.23 -161.21 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.628 2.218 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.765 ' HB1' ' HG ' ' A' ' 644' ' ' LEU . . . -74.95 -3.93 35.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.822 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 74.72 -68.9 0.2 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.644 0.259 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.645 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -172.98 87.1 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.788 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.809 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.5 OUTLIER -103.7 -153.15 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.805 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -116.5 147.42 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.146 0.498 . . . . 0.0 111.876 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.423 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -133.48 147.01 51.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.234 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.802 HD13 HD13 ' A' ' 578' ' ' LEU . 9.3 pt -96.74 126.93 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 CA-C-O 121.231 0.538 . . . . 0.0 111.617 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.923 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.7 m95 -110.68 131.65 54.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.202 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.601 ' CD2' HD13 ' A' ' 678' ' ' ILE . 6.9 t80 -92.48 117.64 30.15 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.428 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 36.6 m -104.2 137.16 42.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.991 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.454 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 31.6 t60 -115.86 131.3 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.086 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 3.1 p -131.86 15.75 4.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.415 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.51 153.42 27.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.212 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 89.8 m -82.13 -25.81 34.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.619 ' OD1' HD12 ' P' ' 606' ' ' LEU . 1.0 OUTLIER -81.81 3.41 26.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.021 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.38 134.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 112.181 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.441 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 73.8 m -106.22 166.27 10.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.406 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 679' ' ' LYS . 6.1 m-85 -127.74 120.31 27.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.821 0.343 . . . . 0.0 111.006 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.603 HD22 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -102.09 99.53 9.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.4 m120 58.68 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.143 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.2 OUTLIER -130.98 3.19 4.38 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.472 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 4.9 m-80 -109.08 138.01 46.09 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -75.71 141.32 42.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 656' ' ' VAL . 49.7 mmm -119.82 87.83 2.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.711 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 42.1 pt -87.48 156.1 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.035 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -48.9 94.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.243 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.77 41.71 0.77 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.579 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.1 p -127.9 162.16 27.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.931 0.396 . . . . 0.0 111.381 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpm? -137.76 141.69 40.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.752 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.58 144.94 28.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.768 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.923 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.56 140.65 55.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.018 0.437 . . . . 0.0 111.192 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.815 HD13 HG21 ' A' ' 694' ' ' VAL . 2.0 mt -112.15 124.04 51.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.899 ' HB3' HD22 ' A' ' 707' ' ' LEU . 2.6 mt-30 -109.97 161.84 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.761 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.489 ' N ' HD12 ' A' ' 696' ' ' ILE . 35.9 t0 -59.19 100.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.368 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.22 30.27 3.95 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.55 114.19 23.08 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.514 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -96.09 108.6 21.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.093 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.603 HG12 HD22 ' A' ' 659' ' ' LEU . 5.4 mt -105.67 120.9 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.637 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 658' ' ' TYR . 4.1 mttp -82.28 115.48 21.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.358 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.613 HG23 ' HD2' ' A' ' 622' ' ' HIS . 1.6 mt -75.44 -39.05 40.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.569 HG22 ' CG1' ' A' ' 690' ' ' ILE . 5.4 tt -155.78 131.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.916 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -136.58 121.44 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.07 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.798 ' OD2' HD22 ' P' ' 606' ' ' LEU . 4.8 t0 -127.13 116.82 21.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 110.544 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -67.46 -46.5 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.919 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -66.05 -40.34 90.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.927 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -93.85 -8.46 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.621 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 62.04 16.52 8.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.63 0.253 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.9 t80 -77.06 105.46 8.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.3 p -119.58 124.62 73.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.1 0.476 . . . . 0.0 111.922 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.569 ' CG1' HG22 ' A' ' 681' ' ' ILE . 27.3 mm -128.1 154.97 39.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.397 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 174.05 134.18 1.81 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.448 ' CZ ' ' HG3' ' A' ' 582' ' ' PRO . 9.6 m-30 -112.89 147.28 37.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 110.331 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -101.37 116.52 32.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.198 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.862 HG13 HD11 ' A' ' 578' ' ' LEU . 2.1 t -80.86 129.7 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.464 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -133.47 109.43 9.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.926 0.394 . . . . 0.0 111.16 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.821 HD13 ' HB2' ' A' ' 705' ' ' GLU . 26.7 mt -78.19 105.69 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.238 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . 0.42 ' HB2' ' NH1' ' A' ' 576' ' ' ARG . 20.2 m120 -93.25 -45.93 7.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.05 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.492 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 2.8 t70 -110.78 139.84 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.464 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -115.71 100.56 8.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.291 0.567 . . . . 0.0 109.74 178.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 24.7 m -69.01 69.2 0.18 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.566 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.19 51.6 56.49 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.612 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.809 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -93.46 153.11 18.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.201 0.524 . . . . 0.0 111.911 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.491 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -56.91 -23.19 43.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.878 178.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.732 HD21 HD23 ' A' ' 707' ' ' LEU . 3.9 t30 -164.73 -54.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.564 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.821 ' HB2' HD13 ' A' ' 696' ' ' ILE . 6.5 pt-20 160.99 -31.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.725 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 140.38 44.38 0.07 OUTLIER Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.591 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.899 HD22 ' HB3' ' A' ' 673' ' ' GLN . 0.6 OUTLIER -83.22 7.52 15.99 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.423 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 109.87 -121.93 6.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.946 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 10.8 ptp -178.32 121.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.845 0.355 . . . . 0.0 110.503 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.784 HD22 ' HB2' ' A' ' 711' ' ' GLN . 0.0 OUTLIER -39.92 162.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.508 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . 0.784 ' HB2' HD22 ' A' ' 710' ' ' LEU . 18.4 tt0 75.24 -62.85 0.44 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.178 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.41 103.45 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.283 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -82.58 100.55 10.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.275 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.8 mmm-85 38.91 88.27 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.24 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.53 141.8 43.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.147 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.5 p -95.95 118.65 42.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.853 0.359 . . . . 0.0 111.356 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.08 172.46 8.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 157.37 16.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -87.32 155.19 20.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.81 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -126.17 -175.25 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.87 -30.74 64.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.087 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.49 -52.03 66.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -66.14 -46.0 79.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.795 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -55.68 -33.68 64.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.693 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.2 -36.94 80.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 22.8 mt -56.91 -44.41 82.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.909 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 730' ' ' LEU . 8.3 p -80.45 -22.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -37.47 78.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -79.15 -18.55 52.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 730' ' ' LEU . 8.7 tt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.118 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . 0.425 ' O ' HG23 ' P' ' 600' ' ' VAL . 5.3 m -141.36 99.89 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.019 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -110.29 40.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.91 123.24 18.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.28 150.47 30.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.36 90.35 3.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.798 HD22 ' OD2' ' A' ' 683' ' ' ASP . 8.3 mt -59.64 148.01 76.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.836 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.519 2.146 . . . . 0.0 112.277 180.0 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -78.85 -22.24 46.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.736 0.303 . . . . 0.0 111.083 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 171.87 60.78 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.021 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.425 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 5.4 tmm_? -110.18 107.49 17.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.668 ' HE1' HD13 ' A' ' 647' ' ' ILE . 6.3 t80 -95.33 -54.0 3.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.864 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.931 HD13 HD13 ' A' ' 647' ' ' ILE . 10.8 tp -108.79 143.31 38.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.989 0.423 . . . . 0.0 111.773 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.47 HG22 ' CG ' ' A' ' 581' ' ' LYS . 25.3 m -121.94 115.12 22.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.608 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.7 OUTLIER -105.21 109.13 21.0 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.485 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 18.1 mtmt -115.17 99.41 52.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.623 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 33.2 Cg_exo -46.27 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.711 1.607 . . . . 0.0 109.126 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.727 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -75.1 157.61 85.06 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.437 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 76.1 Cg_exo -49.84 -25.59 12.19 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.438 2.759 . . . . 0.0 112.644 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.5 t70 -62.23 -28.82 69.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.504 ' HB2' HD13 ' A' ' 690' ' ' ILE . 0.8 OUTLIER -96.05 153.84 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.753 178.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.684 HD13 ' CE1' ' A' ' 688' ' ' PHE . 13.9 pt -54.99 -11.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.672 0.273 . . . . 0.0 111.34 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 42.0 mt -107.16 128.73 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.411 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.437 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -116.09 54.88 0.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.797 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.623 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 51.3 mm-40 -124.62 169.84 11.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.033 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.36 124.07 31.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.661 0.267 . . . . 0.0 111.659 178.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.2 mm? -112.87 148.96 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.425 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.68 122.44 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.007 HD11 HD12 ' A' ' 625' ' ' ILE . 33.0 mt -78.9 108.68 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 0.5 OUTLIER -65.15 111.52 2.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.47 -34.26 1.29 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.41 0.624 . . . . 0.0 109.972 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -62.9 -24.45 66.74 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.329 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.489 HG11 ' ND2' ' A' ' 610' ' ' ASN . 97.7 t -101.29 119.26 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.659 0.73 . . . . 0.0 111.414 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.1 t30 -138.91 122.91 11.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.704 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 48.0 Cg_endo -90.17 160.32 33.48 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 124.56 -1.017 . . . . 0.0 112.0 0.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.2 t80 -91.97 115.9 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.821 ' CG ' HD12 ' A' ' 730' ' ' LEU . 30.7 m-85 -92.38 138.0 31.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.144 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.819 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -125.03 145.76 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.742 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 160.63 -171.43 36.78 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.374 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.442 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -70.72 -46.91 62.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 111.372 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.16 130.56 46.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.381 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -18.32 29.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.783 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.05 -30.9 66.53 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 121.205 0.526 . . . . 0.0 110.301 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 94.7 m -70.54 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.1 m120 -44.52 -33.21 1.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 0.0 110.186 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.819 ' SG ' HG23 ' A' ' 603' ' ' ILE . 35.1 t -106.93 138.67 42.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.815 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.97 104.59 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.466 HG13 ' CE2' ' A' ' 692' ' ' PHE . 16.6 mm -139.47 109.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.409 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -104.07 106.09 16.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.436 0.636 . . . . 0.0 111.994 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.55 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 3.1 t70 -129.68 108.85 10.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.894 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . 0.419 ' ND2' ' HG2' ' A' ' 617' ' ' ARG . 0.9 OUTLIER -40.2 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.762 ' HD3' HD21 ' P' ' 606' ' ' LEU . 0.0 OUTLIER -70.65 -42.69 70.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 680' ' ' ILE . 1.5 pp -89.44 158.21 17.82 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.679 0.276 . . . . 0.0 111.013 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.82 165.82 20.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.0 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.879 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -54.22 -25.21 21.75 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.075 0.464 . . . . 0.0 110.435 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.879 HG23 ' HG2' ' A' ' 620' ' ' ARG . 57.6 t -130.75 57.44 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.997 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.855 ' CD2' HG23 ' A' ' 680' ' ' ILE . 37.0 t60 -48.4 -45.69 36.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.6 p -168.37 161.35 11.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 111.543 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.73 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.9 p90 -143.44 147.53 34.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.509 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.007 HD12 HD11 ' A' ' 594' ' ' ILE . 62.1 mt -102.02 134.52 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -125.87 134.36 51.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.737 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.529 ' HE2' HG23 ' A' ' 647' ' ' ILE . 1.9 ttmm -97.59 136.73 37.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.122 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.469 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.15 159.35 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.764 -178.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.82 113.62 14.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.409 0.623 . . . . 0.0 110.502 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 -65.88 130.88 44.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.33 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 630' ' ' HIS . . . 170.97 123.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.02 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.25 155.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -55.58 104.48 0.31 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.646 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 13.6 tptt 60.02 159.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 75.3 p -109.59 58.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.87 113.72 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 69.4 -66.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.07 143.76 35.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.4 108.38 54.62 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.49 -153.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.636 2.224 . . . . 0.0 111.798 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.697 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -97.33 34.0 1.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.388 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 66.89 -72.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 176.29 76.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.843 HD13 ' HA ' ' A' ' 703' ' ' PHE . 1.1 mt -118.16 -147.64 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 48.1 m-20 -122.23 148.25 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.792 ' OD2' HD11 ' A' ' 671' ' ' LEU . 3.3 t0 -133.62 151.21 51.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.701 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.931 HD13 HD13 ' A' ' 578' ' ' LEU . 8.9 pt -100.25 122.45 52.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 111.487 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.55 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 77.6 m95 -108.05 134.01 51.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.308 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.636 ' CE2' HD12 ' A' ' 678' ' ' ILE . 7.9 t80 -95.68 117.53 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 26.1 m -101.0 133.49 45.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 54.5 t60 -112.87 131.64 55.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.4 p -129.67 0.95 4.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.449 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 148.36 34.8 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.712 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.492 HG22 HG21 ' P' ' 603' ' ' TPO . 5.8 t -75.91 -34.49 59.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.114 0.483 . . . . 0.0 111.311 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.586 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.1 m120 -70.16 2.0 4.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.379 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.17 133.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.435 0.636 . . . . 0.0 112.32 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 98.2 p -103.86 165.69 10.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.482 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.68 120.24 30.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.225 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.788 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -105.24 109.38 21.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.903 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.591 ' N ' HD12 ' A' ' 659' ' ' LEU . 1.3 m-80 55.43 -82.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.975 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 659' ' ' LEU . 18.5 m-20 -137.49 5.87 2.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.814 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.504 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 3.2 t-20 -108.81 135.57 49.81 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.943 0.402 . . . . 0.0 111.253 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 17.0 ttp-105 -73.65 141.43 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.504 ' O ' HG23 ' A' ' 656' ' ' VAL . 39.5 mmm -117.07 98.17 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.053 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.434 HG12 HG21 ' A' ' 668' ' ' THR . 41.1 pt -88.19 149.13 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.114 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.59 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.433 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.26 42.31 1.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.617 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.434 HG21 HG12 ' A' ' 665' ' ' ILE . 1.1 p -127.14 162.28 26.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.45 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.451 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -134.07 135.93 43.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.467 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.648 ' CZ ' ' HG2' ' A' ' 714' ' ' ARG . 0.3 OUTLIER -140.03 144.19 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.46 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.792 HD11 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.78 141.05 53.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.127 0.489 . . . . 0.0 111.345 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.779 HD13 HG21 ' A' ' 694' ' ' VAL . 2.9 mt -112.27 98.16 7.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.427 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.457 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 30.6 mt-30 -82.72 131.01 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.946 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 706' ' ' GLY . 5.7 t70 -36.01 107.32 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.099 0.476 . . . . 0.0 110.96 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.92 33.94 3.62 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.537 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -94.04 118.37 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.003 -179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -96.2 108.87 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.757 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.788 HG22 HD13 ' A' ' 659' ' ' LEU . 25.8 pt -105.61 136.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.99 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.8 OUTLIER -99.05 115.96 30.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.752 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.855 HG23 ' CD2' ' A' ' 622' ' ' HIS . 4.3 mt -84.24 -35.67 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.478 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.744 HD11 HD11 ' P' ' 606' ' ' LEU . 4.2 tp -154.33 129.05 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.328 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -137.96 123.44 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.302 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.471 ' CG ' HD22 ' P' ' 606' ' ' LEU . 11.1 t0 -127.51 116.08 19.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.925 0.393 . . . . 0.0 110.607 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -46.57 70.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.956 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.78 -40.83 97.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.135 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -98.06 4.01 49.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.9 mttm 54.24 22.07 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.776 0.322 . . . . 0.0 110.93 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.684 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.5 t80 -76.4 104.36 6.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.7 p -117.45 124.22 72.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.054 0.454 . . . . 0.0 111.867 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.626 HD11 HG12 ' A' ' 587' ' ' ILE . 4.9 mm -128.06 154.89 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.331 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . 175.68 134.11 1.87 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.52 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.486 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.9 m-30 -113.27 142.89 45.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.727 ' HB2' HD22 ' A' ' 583' ' ' LEU . 7.2 tttp -100.87 116.34 32.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 109.88 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.779 HG21 HD13 ' A' ' 672' ' ' LEU . 2.7 t -85.12 123.24 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.569 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 110.02 9.51 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.082 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 705' ' ' GLU . 66.3 mt -65.3 105.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.24 -48.08 12.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.934 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.445 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 38.7 t0 -111.69 139.38 47.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.173 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p -115.94 100.09 7.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.3 t -75.46 58.08 0.98 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.307 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.452 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 48.97 48.08 31.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.984 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.643 HD21 ' HA ' ' A' ' 705' ' ' GLU . 1.8 pt? -91.45 -175.91 4.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.771 0.32 . . . . 0.0 111.117 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.843 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -55.92 -149.91 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.981 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.568 ' N ' ' CG ' ' A' ' 703' ' ' PHE . 1.1 t30 -31.52 -34.42 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.125 0.57 . . . . 0.0 111.709 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.665 ' CD ' HD22 ' A' ' 707' ' ' LEU . 4.0 pt-20 105.04 6.14 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.964 0.905 . . . . 0.0 111.32 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.673 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 85.32 18.13 61.2 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.63 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.665 HD22 ' CD ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -81.65 7.65 11.81 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.314 -0.521 . . . . 0.0 111.859 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 712' ' ' GLU . . . 62.6 11.0 33.25 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.267 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.694 ' C ' HD23 ' A' ' 710' ' ' LEU . 2.9 mtm 46.8 86.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.924 0.362 . . . . 0.0 111.281 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.694 HD23 ' C ' ' A' ' 709' ' ' MET . 1.0 OUTLIER 45.42 48.79 10.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.69 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.16 75.5 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 708' ' ' GLY . 20.7 tt0 -114.49 140.52 48.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.062 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -82.49 135.88 35.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.471 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.648 ' HG2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -100.31 -157.54 0.61 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.161 0.505 . . . . 0.0 109.936 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.511 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 0.6 OUTLIER -148.62 142.2 18.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.614 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 12.7 p -88.85 127.67 41.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.35 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.19 172.33 7.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -99.67 156.97 16.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.958 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.26 148.49 22.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 22.0 p -126.14 -173.44 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.218 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.47 -29.03 33.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.54 -51.61 67.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.36 -44.72 90.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.617 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -57.59 -32.72 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.74 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.15 -37.23 83.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 40.7 mt -59.48 -44.15 93.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.63 -24.93 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -32.14 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -87.76 -12.07 46.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.394 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.821 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.3 tt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.799 0.333 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.05 49.68 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 60.17 70.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -166.61 130.46 2.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.807 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.492 HG21 HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -84.91 -26.9 26.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 64.33 156.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.762 HD21 ' HD3' ' A' ' 617' ' ' ARG . 2.2 mt -104.72 150.6 38.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.641 2.227 . . . . 0.0 112.296 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.608 -0.197 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.99 -20.74 63.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.984 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -176.87 44.57 0.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.081 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.9 tmm_? -108.1 112.12 24.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.594 0.235 . . . . 0.0 110.919 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.608 ' CZ ' HD22 ' A' ' 702' ' ' LEU . 3.1 t80 -99.83 -45.18 5.81 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.696 HD22 ' CD1' ' A' ' 647' ' ' ILE . 10.3 tp -118.59 142.84 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 30.3 m -120.49 115.84 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.837 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 1.024 HD22 HG22 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -105.5 109.32 21.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 19.3 pttt -116.87 98.77 52.38 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 23.4 Cg_exo -46.03 98.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.923 1.748 . . . . 0.0 109.823 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.3 OUTLIER -74.71 157.86 85.45 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.49 -29.74 19.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.508 2.806 . . . . 0.0 112.876 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.71 ' HB2' HD12 ' A' ' 583' ' ' LEU . 23.2 m-20 -62.33 -24.9 67.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 5.6 t -95.51 153.27 17.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.644 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 10.6 tt -56.34 -14.48 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.185 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 613' ' ' ILE . 21.0 mt -111.51 128.14 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 111.626 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.7 OUTLIER -112.64 55.98 0.68 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.625 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.7 mt-10 -124.79 170.28 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.908 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.677 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -130.35 119.7 23.17 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.74 0.305 . . . . 0.0 111.621 178.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.677 HD13 ' C ' ' A' ' 591' ' ' SER . 0.2 OUTLIER -113.03 146.33 39.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.5 OUTLIER -123.97 121.47 35.37 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.027 HD11 HD12 ' A' ' 625' ' ' ILE . 70.4 mt -75.86 109.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.148 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.9 mm-40 -66.12 114.65 5.41 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.91 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -42.49 -34.73 0.89 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.353 0.597 . . . . 0.0 110.111 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.496 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.0 -20.24 68.61 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.702 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.625 HG11 ' OD1' ' A' ' 610' ' ' ASN . 99.3 t -101.07 118.79 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 117.912 0.856 . . . . 0.0 111.67 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 8.8 t30 -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.908 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.591 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.7 Cg_endo -90.39 160.45 32.47 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.621 -0.991 . . . . 0.0 111.632 -0.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.622 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.5 t80 -91.26 114.88 27.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.548 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 46.4 m-85 -91.84 138.16 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.098 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.79 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -126.76 145.03 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.787 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.31 -165.48 34.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.46 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.427 ' HG2' ' CD2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -71.33 -54.59 10.29 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.34 130.81 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.483 -178.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -19.33 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.63 -30.35 42.39 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.119 0.485 . . . . 0.0 110.056 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 95.8 m -73.41 131.21 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.297 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.625 ' OD1' HG11 ' A' ' 598' ' ' VAL . 0.7 OUTLIER -46.51 -28.65 1.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.79 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.2 t -111.44 141.58 44.81 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.19 107.53 16.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.611 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.6 mm -138.37 110.05 5.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.313 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.58 106.09 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.739 ' CB ' HD22 ' A' ' 618' ' ' LEU . 31.0 t0 -130.25 108.24 9.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.898 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.25 -32.74 0.2 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.821 0.343 . . . . 0.0 111.601 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.705 ' HB3' HD11 ' A' ' 681' ' ' ILE . 2.5 mtm-85 -78.19 -38.03 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.03 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.739 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -88.91 120.03 29.96 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.13 167.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.529 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.3 mpt_? -56.25 -35.92 67.95 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.12 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.611 HG11 HG23 ' A' ' 727' ' ' VAL . 17.3 t -124.01 57.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.736 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.775 ' CD2' HG23 ' A' ' 680' ' ' ILE . 31.9 t60 -50.28 -48.45 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.931 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.3 p -159.33 156.0 27.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.029 0.442 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.773 ' HA ' HD12 ' A' ' 603' ' ' ILE . 48.5 p90 -143.66 149.31 37.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.461 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.027 HD12 HD11 ' A' ' 594' ' ' ILE . 79.7 mt -102.61 130.34 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.927 0.394 . . . . 0.0 109.981 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.591 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.8 t80 -122.65 133.55 54.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 647' ' ' ILE . 35.4 ttmt -98.28 136.98 37.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.26 158.74 42.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.288 -179.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.637 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -76.44 112.74 13.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.329 0.585 . . . . 0.0 110.299 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.447 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.9 t60 -80.73 125.32 29.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.823 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.637 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -130.45 160.77 33.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 1.9 m -131.81 179.27 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -83.82 -106.99 0.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.374 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.4 142.94 39.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 94.1 p -120.69 150.42 40.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 14.0 tpt -132.78 118.85 19.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.71 -65.98 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -75.94 139.55 41.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.85 101.11 14.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 -165.11 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.498 2.132 . . . . 0.0 112.267 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.549 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -50.04 -31.38 12.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.468 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 62.55 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.937 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -159.07 61.72 0.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.577 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.896 HD13 ' HA ' ' A' ' 703' ' ' PHE . 2.4 mt -104.15 -152.92 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.69 ' HB2' HD12 ' A' ' 702' ' ' LEU . 2.1 m-20 -118.78 148.09 43.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.309 0.576 . . . . 0.0 112.378 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.677 ' OD2' HD11 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -132.3 138.51 47.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.778 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.696 ' CD1' HD22 ' A' ' 578' ' ' LEU . 5.0 pt -96.03 119.06 43.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.572 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 85.8 m95 -103.7 132.63 49.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.972 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.561 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.9 t80 -90.73 116.23 28.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 624' ' ' PHE . 1.3 m -98.13 143.22 28.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.111 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 60.8 t60 -124.58 129.28 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 16.9 p -128.6 4.88 5.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.325 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.95 149.01 33.92 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.692 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.2 t -75.81 -28.27 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.523 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.634 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.7 OUTLIER -73.93 0.01 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.272 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 56.77 133.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.345 0.593 . . . . 0.0 111.896 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.44 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 14.8 t -105.11 165.58 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.004 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.408 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 10.4 m-85 -134.6 120.19 19.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.711 ' HA ' HG23 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -99.35 100.49 11.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.9 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 31.0 t30 -132.17 -0.7 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.62 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.405 ' OD1' ' CZ ' ' A' ' 670' ' ' PHE . 21.3 m120 -104.04 122.39 45.16 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.991 0.424 . . . . 0.0 111.245 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -66.63 141.77 57.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.968 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 37.6 mmm -114.8 102.49 10.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.9 pt -88.16 147.33 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.802 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.91 95.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.435 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.2 39.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.841 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 718' ' ' LYS . 1.3 p -138.16 161.99 35.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.405 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 19.3 pttm -135.62 135.66 40.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.562 ' HB3' HD23 ' A' ' 659' ' ' LEU . 18.8 t80 -127.15 143.55 51.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.51 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.677 HD11 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.95 136.53 50.63 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.03 0.443 . . . . 0.0 111.597 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 1.011 HD13 HG21 ' A' ' 694' ' ' VAL . 2.7 mt -98.57 143.52 28.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.307 0.575 . . . . 0.0 111.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.691 ' HB3' ' HA ' ' A' ' 707' ' ' LEU . 26.0 mt-30 -119.09 141.85 48.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.529 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 696' ' ' ILE . 26.8 t70 -48.07 96.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.22 0.533 . . . . 0.0 110.213 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 107.49 32.6 3.36 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.415 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -86.63 114.35 23.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 110.98 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -96.12 108.73 21.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.711 HG23 ' HA ' ' A' ' 659' ' ' LEU . 1.4 mt -105.2 137.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 111.745 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.24 115.87 28.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.623 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.775 HG23 ' CD2' ' A' ' 622' ' ' HIS . 8.1 mt -82.97 -35.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.236 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 617' ' ' ARG . 1.2 tt -154.9 132.67 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 111.586 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -136.33 124.22 22.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.227 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.77 117.0 27.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.314 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -67.16 -47.08 72.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.803 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.5 p-10 -83.44 -40.33 19.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.533 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.408 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 0.7 OUTLIER -77.75 -15.6 59.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.383 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.83 9.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 0.0 110.952 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.644 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 1.8 t80 -85.37 105.1 15.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.9 OUTLIER -122.87 121.75 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.287 0.565 . . . . 0.0 112.144 -178.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.667 ' CG1' HG22 ' A' ' 681' ' ' ILE . 2.5 mm -109.77 144.41 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.38 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -169.58 127.35 1.48 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.753 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 9.3 m-30 -113.95 146.13 40.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.784 0.326 . . . . 0.0 110.42 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.736 ' HB2' HD22 ' A' ' 583' ' ' LEU . 26.7 tttt -101.36 116.59 33.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 1.024 HG22 HD22 ' A' ' 580' ' ' LEU . 2.5 t -82.5 124.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.436 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.3 tp10 -133.69 109.23 9.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.898 0.38 . . . . 0.0 111.05 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.683 HD12 ' HB2' ' A' ' 674' ' ' ASP . 24.0 mt -72.17 104.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.268 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -88.32 -49.97 6.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 5.5 t70 -112.18 139.52 47.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.032 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.5 OUTLIER -115.94 99.66 7.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.4 t -69.67 72.39 0.36 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.457 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 56.78 36.8 73.98 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.381 -0.914 . . . . 0.0 110.901 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.695 HD23 ' HA ' ' A' ' 705' ' ' GLU . 0.6 OUTLIER -85.37 156.59 20.81 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.783 0.325 . . . . 0.0 111.532 -178.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.896 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -61.2 -142.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 7.0 t30 -35.81 -36.63 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.549 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.695 ' HA ' HD23 ' A' ' 702' ' ' LEU . 6.0 pt-20 125.42 -22.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.736 1.215 . . . . 0.0 109.278 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 129.11 -8.21 6.34 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.866 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.823 ' O ' HD13 ' A' ' 707' ' ' LEU . 1.7 tm? -81.63 8.45 9.78 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.423 ' N ' ' ND2' ' A' ' 704' ' ' ASN . . . -137.44 173.66 22.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.423 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.438 ' CE ' HD23 ' A' ' 710' ' ' LEU . 0.0 OUTLIER -143.93 132.97 22.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.941 0.401 . . . . 0.0 110.979 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.438 HD23 ' CE ' ' A' ' 709' ' ' MET . 0.5 OUTLIER -60.23 -154.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.717 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -36.4 -40.86 0.26 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.814 0.34 . . . . 0.0 111.66 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.69 137.27 42.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.405 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -105.17 100.12 9.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.137 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.442 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 8.1 mmm-85 35.26 77.96 0.04 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.079 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.33 142.65 40.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.295 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 8.3 p -82.7 129.74 36.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.798 0.333 . . . . 0.0 111.28 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.557 HD12 ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -98.38 163.21 12.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . 0.532 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.1 OUTLIER -102.62 145.61 29.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.44 151.89 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.2 p -126.0 -173.95 2.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.97 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.99 -28.97 55.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -49.21 64.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -63.78 -50.95 67.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -57.41 -32.83 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.85 -37.25 86.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 600' ' ' PRO . 14.4 mt -62.79 -44.5 96.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.961 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.611 HG23 HG11 ' A' ' 621' ' ' VAL . 8.4 p -76.17 -28.57 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -58.08 -33.84 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -98.0 24.57 6.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.448 HD12 ' CG ' ' A' ' 602' ' ' PHE . 4.2 tt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.774 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.818 0.342 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 24.5 t -132.78 96.9 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.071 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.03 171.16 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.83 138.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.608 ' H ' ' P ' ' P' ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.74 98.71 11.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.92 154.44 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.842 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.586 HD21 ' HG2' ' A' ' 617' ' ' ARG . 6.2 mt -137.77 97.64 10.04 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.46 2.107 . . . . 0.0 112.353 -179.967 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -76.85 -7.6 55.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.565 0.222 . . . . 0.0 111.407 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 131.25 -0.19 5.16 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.102 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 19.9 ttp-105 -92.35 114.69 27.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.819 0.309 . . . . 0.0 110.582 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -99.44 -58.98 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.447 . . . . 0.0 110.504 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.886 HD12 HD13 ' A' ' 647' ' ' ILE . 9.4 tt -107.84 141.98 38.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.633 HG22 ' HG2' ' A' ' 581' ' ' LYS . 16.0 m -117.58 115.24 24.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.587 ' CD1' HD11 ' A' ' 594' ' ' ILE . 0.4 OUTLIER -104.4 108.64 20.15 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.633 ' HG2' HG22 ' A' ' 579' ' ' THR . 11.6 mtmt -114.86 99.13 51.58 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -47.26 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.761 1.641 . . . . 0.0 109.394 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.481 HD21 ' HG3' ' A' ' 677' ' ' GLU . 0.2 OUTLIER -74.68 157.91 85.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.11 -25.27 8.97 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.688 2.925 . . . . 0.0 112.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.65 -28.16 69.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.447 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 2.0 t -95.94 153.8 17.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.631 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.672 HD13 ' CE1' ' A' ' 688' ' ' PHE . 16.0 pt -57.14 -13.68 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 110.973 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 613' ' ' ILE . 23.4 mt -105.48 120.26 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.685 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -108.41 56.79 0.62 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.063 0.459 . . . . 0.0 110.343 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.652 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.0 mt-10 -124.72 170.36 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.215 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.576 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -130.19 120.54 24.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.359 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 591' ' ' SER . 0.4 OUTLIER -113.15 148.43 35.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.81 125.51 44.12 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.817 HD12 HD22 ' A' ' 578' ' ' LEU . 94.0 mt -83.73 109.05 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -67.05 124.38 22.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.696 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.52 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.66 -29.7 3.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.244 0.545 . . . . 0.0 109.817 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.93 -24.04 77.46 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.86 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.24 117.86 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 118.018 0.909 . . . . 0.0 111.66 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.5 t30 -140.37 121.7 9.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.596 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -89.84 160.49 35.22 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.296 -0.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.587 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.4 t80 -91.69 115.62 28.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.496 ' CG ' HD12 ' A' ' 730' ' ' LEU . 23.6 m-85 -92.35 137.91 31.97 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.952 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.777 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.1 mp -126.45 146.03 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.436 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.19 -166.53 37.09 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.887 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.522 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.4 OUTLIER -71.49 -54.15 11.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 111.611 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.48 131.32 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.391 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -56.57 -19.07 14.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.982 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.08 -31.66 52.45 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.85 132.88 46.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.66 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 28.8 m120 -46.03 -31.05 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.236 0.541 . . . . 0.0 110.378 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.777 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.5 t -110.16 142.06 42.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.318 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.46 109.04 18.4 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.554 HG23 ' CD1' ' A' ' 588' ' ' ILE . 19.7 mm -138.05 109.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.084 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.522 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 1.0 OUTLIER -95.03 104.32 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.919 -178.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.666 ' HB2' HD21 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.67 113.96 14.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.19 177.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.5 -21.12 3.43 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.689 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.68 ' HD3' HD21 ' P' ' 606' ' ' LEU . 0.2 OUTLIER -74.33 -41.65 60.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -88.53 158.9 18.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 112.268 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 67.6 p -80.77 177.95 8.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.2 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.452 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -47.36 -45.76 25.15 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.121 0.486 . . . . 0.0 110.197 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 621' ' ' VAL . 7.4 p -125.68 71.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.568 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 9.3 t60 -45.7 -47.93 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.537 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 2.1 p -161.2 160.62 30.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.614 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 603' ' ' ILE . 1.7 p90 -143.68 148.7 36.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.666 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.469 HD13 HD11 ' A' ' 603' ' ' ILE . 3.5 mp -101.96 130.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.086 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.0 t80 -121.3 132.47 54.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.519 ' HE3' HG23 ' A' ' 647' ' ' ILE . 5.3 ttmt -97.97 137.16 37.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.439 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.492 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.59 159.25 41.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.54 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.7 OUTLIER -76.25 112.72 13.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.1 t60 -80.68 127.01 31.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.577 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -150.91 150.31 30.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.21 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.626 HG21 ' HG3' ' A' ' 640' ' ' PRO . 8.5 m -99.38 171.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -63.35 -68.61 1.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.541 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -148.83 122.51 9.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 110.83 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 84.6 p -79.69 61.29 3.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -119.94 33.97 5.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.75 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -176.74 -43.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.594 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . 0.41 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 42.1 mm-40 -110.99 144.56 39.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.636 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 82.5 p -107.92 95.73 15.66 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.626 ' HG3' HG21 ' A' ' 632' ' ' VAL . 69.0 Cg_endo -88.84 -161.53 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.93 2.42 . . . . 0.0 112.15 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -96.48 34.66 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.242 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.64 -174.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.021 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -89.22 96.24 2.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 630' ' ' HIS . 25.0 mt -119.89 -149.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.58 ' O ' HD12 ' A' ' 702' ' ' LEU . 3.3 m-20 -116.95 147.61 42.1 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.436 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -130.48 160.17 34.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.518 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.886 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -110.36 127.58 67.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.568 0.699 . . . . 0.0 112.776 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.879 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 81.9 m95 -110.93 125.89 54.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.411 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 11.7 t80 -90.01 116.1 27.8 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 20.1 m -101.65 142.57 32.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.432 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 60.6 t60 -125.88 130.23 50.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.082 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 25.1 p -126.69 5.18 6.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.168 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.76 153.17 36.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.582 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.8 t -73.64 -34.8 65.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.159 0.504 . . . . 0.0 111.486 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.609 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.3 m120 -68.26 -4.89 15.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.434 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.83 123.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 111.67 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.413 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 57.9 p -88.68 166.26 14.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.354 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -131.22 120.39 23.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.868 0.366 . . . . 0.0 111.409 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.905 HD22 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -94.99 99.84 11.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.383 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 61.2 -81.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -134.45 3.4 3.32 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.682 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -104.95 123.6 48.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 111.171 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.35 141.38 57.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.92 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 21.7 mmm -118.14 111.93 19.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.9 pt -91.03 150.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.102 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.402 ' CG ' ' O ' ' A' ' 652' ' ' THR . 2.9 tt0 -51.87 100.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.471 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.87 37.26 1.16 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.002 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 718' ' ' LYS . 1.8 p -139.35 159.19 42.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.602 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.0 pttm -123.96 158.19 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.58 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 716' ' ' VAL . 10.6 t80 -144.27 146.46 32.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.879 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.53 128.17 35.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.696 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.816 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -105.76 121.85 44.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.43 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 56.2 mt-30 -109.33 162.83 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.39 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.574 ' HB3' HD12 ' A' ' 696' ' ' ILE . 11.7 p30 -58.62 110.47 1.0 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.42 . . . . 0.0 110.686 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 95.51 36.92 5.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.214 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -91.63 115.35 27.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.323 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 583' ' ' LEU . 0.7 OUTLIER -96.28 110.35 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.053 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.905 HG22 HD22 ' A' ' 659' ' ' LEU . 26.9 pt -105.62 132.58 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.98 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -91.03 116.62 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.004 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.418 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -81.22 -34.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.45 -179.245 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.651 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.1 tp -154.43 131.34 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 111.718 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.402 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 10.2 t90 -136.47 126.32 25.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.516 ' OD2' HD13 ' P' ' 606' ' ' LEU . 1.9 m-20 -126.22 116.77 21.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -67.4 -46.77 72.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.989 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -77.74 -40.41 41.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.769 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -7.79 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.602 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp 59.66 17.95 6.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.672 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.3 t80 -76.55 104.82 7.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.1 p -120.68 121.98 66.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 112.134 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.651 ' HB ' HG22 ' A' ' 681' ' ' ILE . 4.2 mt -128.72 155.26 40.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.436 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.447 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.98 135.9 2.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.231 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.478 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 5.0 m-30 -113.08 149.73 33.06 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.16 117.47 35.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.008 0.433 . . . . 0.0 110.704 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.774 HG22 HD21 ' A' ' 578' ' ' LEU . 2.6 t -80.48 114.75 21.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.659 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.1 108.96 12.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 0.0 110.123 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.851 HG21 ' HB2' ' A' ' 705' ' ' GLU . 8.9 mt -80.45 111.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.334 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -96.15 -45.85 6.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.981 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 4.1 t70 -111.13 140.34 45.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.014 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.2 OUTLIER -115.0 101.35 8.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 700' ' ' THR . 9.9 t -66.62 65.3 0.05 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.881 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 56.41 40.07 85.03 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.574 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -112.25 159.08 18.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.728 0.299 . . . . 0.0 110.842 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.745 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -56.29 119.64 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.628 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 7.0 t30 49.7 -74.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.418 0.627 . . . . 0.0 110.552 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.851 ' HB2' HG21 ' A' ' 696' ' ' ILE . 19.4 pt-20 161.82 -36.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.265 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.628 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 156.13 84.97 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.004 -1.453 . . . . 0.0 111.317 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.445 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -104.65 -9.56 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.226 -0.573 . . . . 0.0 111.572 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 117.85 -35.73 3.95 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.239 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 703' ' ' PHE . 0.0 OUTLIER 60.31 109.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.691 0.282 . . . . 0.0 110.988 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.57 110.99 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.063 0.458 . . . . 0.0 111.176 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 178.1 -57.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.752 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -114.25 130.04 56.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.856 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.527 ' O ' HG13 ' A' ' 715' ' ' VAL . 2.4 mm-40 -81.98 99.84 9.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.716 0.293 . . . . 0.0 111.027 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 713' ' ' GLN . 4.4 mmm-85 17.94 84.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.742 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 713' ' ' GLN . 3.4 m -124.57 142.48 41.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.632 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 716' ' ' VAL . 10.0 p -86.49 119.82 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.048 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 169.59 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.985 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . 0.691 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.5 OUTLIER -102.9 157.94 16.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.855 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -88.6 158.3 18.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.985 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -178.83 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.12 54.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.01 -52.07 52.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -43.34 96.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.783 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -57.32 -33.82 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.22 -36.78 80.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.483 HD13 ' HG3' ' A' ' 600' ' ' PRO . 23.2 mt -58.18 -44.32 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.75 -27.82 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -57.38 -32.71 67.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.813 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -101.58 27.56 6.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.496 HD12 ' CG ' ' A' ' 602' ' ' PHE . 3.0 tt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.796 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.913 0.387 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . 0.439 HG22 ' N ' ' P' ' 601' ' ' GLU . 10.0 p -58.76 155.76 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.071 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . 0.439 ' N ' HG22 ' P' ' 600' ' ' VAL . 49.0 tt0 -129.28 88.2 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 5.6 tt -149.58 136.12 19.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.401 HG22 ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 88.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.79 145.47 52.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.68 HD21 ' HD3' ' A' ' 617' ' ' ARG . 8.7 mt -116.36 87.38 20.06 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.85 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.602 2.201 . . . . 0.0 112.353 -179.983 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.5 10.16 26.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.655 0.264 . . . . 0.0 111.421 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -166.87 40.54 0.25 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.401 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.441 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 51.5 ttp85 -99.55 112.18 24.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.686 0.279 . . . . 0.0 110.803 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.935 ' CE2' HD13 ' A' ' 702' ' ' LEU . 0.5 OUTLIER -101.1 -50.94 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.909 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.011 HD11 HG13 ' A' ' 694' ' ' VAL . 44.6 tp -114.55 142.3 46.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.102 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 32.9 m -118.97 121.8 40.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.531 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.914 ' CD2' HG23 ' A' ' 694' ' ' VAL . 6.6 mt -109.03 108.57 19.33 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.23 100.24 50.22 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -176.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 27.1 Cg_exo -47.84 105.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.694 1.596 . . . . 0.0 109.271 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.535 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.17 156.73 87.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -176.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.464 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 77.2 Cg_exo -50.4 -25.83 14.81 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.741 2.961 . . . . 0.0 113.357 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.86 -20.62 65.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.056 0.455 . . . . 0.0 110.039 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.48 ' HB2' ' H ' ' A' ' 691' ' ' GLY . 3.7 t -97.24 154.34 17.46 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.969 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.767 HD13 ' CE1' ' A' ' 688' ' ' PHE . 4.1 pt -55.11 -19.68 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.115 0.483 . . . . 0.0 109.84 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.13 119.01 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.87 63.7 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.124 0.487 . . . . 0.0 110.701 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.57 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.8 mt-10 -124.97 170.81 10.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.48 121.6 27.58 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.681 0.277 . . . . 0.0 111.427 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.3 mm? -113.21 150.8 31.81 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.441 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.3 mt-10 -125.18 131.26 53.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.826 HD12 HD23 ' A' ' 578' ' ' LEU . 73.7 mt -90.13 108.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.8 mt-30 -69.14 124.64 24.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.9 -32.37 3.75 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.506 0.669 . . . . 0.0 109.505 179.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.81 -22.55 75.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.664 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.88 HG11 ' OD1' ' A' ' 610' ' ' ASN . 81.9 t -98.36 117.94 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.929 0.864 . . . . 0.0 111.545 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 4.5 t30 -140.38 121.33 9.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.023 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.606 ' HD3' HD22 ' A' ' 726' ' ' LEU . 43.7 Cg_endo -90.96 159.72 29.3 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.475 -1.052 . . . . 0.0 111.415 -0.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.666 ' CG ' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -92.11 113.27 25.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.53 ' CG ' HD12 ' A' ' 730' ' ' LEU . 5.8 m-85 -91.9 138.28 31.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.083 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.814 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -123.7 145.49 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.481 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.55 -167.55 35.77 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.427 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.456 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -73.62 -52.22 14.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 128.99 39.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.387 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -54.46 -19.9 6.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.965 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -28.26 51.78 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.018 0.437 . . . . 0.0 110.382 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 81.1 m -75.26 131.33 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.589 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.88 ' OD1' HG11 ' A' ' 598' ' ' VAL . 1.5 m-80 -46.44 -29.68 1.84 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.066 0.46 . . . . 0.0 110.464 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.814 ' SG ' HG23 ' A' ' 603' ' ' ILE . 31.0 t -109.59 137.46 47.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.68 104.94 14.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.442 HG13 ' CE2' ' A' ' 692' ' ' PHE . 14.2 mm -139.32 109.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.322 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.66 106.05 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.436 0.636 . . . . 0.0 111.998 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.508 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.8 OUTLIER -129.99 108.69 10.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.733 177.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -39.44 -27.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.554 ' HB3' HD11 ' A' ' 681' ' ' ILE . 32.3 mmt180 -71.4 -42.09 68.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.508 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -88.47 158.63 18.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.261 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.7 t -83.9 171.28 13.19 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.619 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.473 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -49.72 -41.83 44.49 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.143 0.497 . . . . 0.0 110.369 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 727' ' ' VAL . 11.7 t -121.4 61.52 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.6 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.82 ' CD2' HG23 ' A' ' 680' ' ' ILE . 38.5 t60 -46.21 -45.22 16.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.59 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.4 p -167.34 159.29 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.597 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.633 ' HA ' HD12 ' A' ' 603' ' ' ILE . 51.7 p90 -143.48 146.52 33.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.817 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 580' ' ' LEU . 16.6 mt -102.1 130.22 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 109.919 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -121.7 135.56 54.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.692 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HE2' HD12 ' A' ' 702' ' ' LEU . 6.0 tttt -97.77 133.46 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.111 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.8 OUTLIER -136.07 159.79 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.95 -178.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 6.4 tpt85 -75.79 112.31 12.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.359 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.9 t60 -63.28 134.33 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.336 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -73.15 -163.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.777 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.3 p -163.29 160.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.053 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -145.25 -143.42 3.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 128.94 39.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . 0.405 ' HB3' ' CD ' ' A' ' 640' ' ' PRO . 4.9 p -128.15 79.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.6 116.1 28.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.649 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 70.97 -63.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.898 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.34 144.33 32.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.78 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.86 105.39 37.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.05 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.405 ' CD ' ' HB3' ' A' ' 635' ' ' SER . 21.0 Cg_exo -65.54 -155.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.593 2.195 . . . . 0.0 112.08 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.742 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -59.09 -22.31 60.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.417 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 70.11 -67.73 0.23 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.003 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.412 ' HA3' ' NH2' ' A' ' 629' ' ' ARG . . . 169.55 56.06 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.722 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 703' ' ' PHE . 2.8 mp -111.17 -171.76 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.595 0.236 . . . . 0.0 110.748 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.538 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 0.6 OUTLIER -97.05 147.98 23.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 111.434 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.457 ' OD2' ' CD2' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -129.82 160.03 34.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.049 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.767 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.2 pt -107.32 119.09 56.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.552 0.691 . . . . 0.0 111.854 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 86.8 m95 -104.68 130.87 52.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.152 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.424 ' CB ' HD21 ' A' ' 672' ' ' LEU . 39.0 t80 -90.99 117.24 29.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 624' ' ' PHE . 10.9 m -103.77 138.07 40.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.829 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.469 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 27.0 t60 -120.84 130.53 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.238 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 15.1 p -128.14 7.33 6.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.213 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.13 151.44 36.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.837 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.6 t -75.37 -36.27 60.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 111.405 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m-20 -72.74 2.09 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.601 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.587 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 49.12 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.587 0.708 . . . . 0.0 112.153 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.406 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 39.2 m -105.63 165.6 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.398 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 5.1 m-85 -124.7 120.18 31.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 111.266 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -98.86 100.02 11.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.673 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 61.83 -80.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.859 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.0 m120 -135.83 0.76 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.641 ' HB3' HG23 ' A' ' 716' ' ' VAL . 2.1 m120 -106.77 141.12 38.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.174 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.486 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.1 ttm180 -75.07 141.76 43.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.615 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 12.0 mmm -124.08 85.85 2.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.469 HG12 HG21 ' A' ' 668' ' ' THR . 29.2 pt -87.53 165.3 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 111.071 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.7 118.39 3.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.366 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.53 27.66 12.69 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.469 HG21 HG12 ' A' ' 665' ' ' ILE . 32.9 p -112.96 162.0 16.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 0.0 111.435 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpm? -141.98 140.62 32.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.615 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 0.3 OUTLIER -145.22 142.64 29.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.224 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.55 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -70.21 140.02 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 110.699 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 694' ' ' VAL . 2.0 mt -109.43 119.09 38.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 111.062 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 2.8 mt-30 -105.24 138.03 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.813 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 706' ' ' GLY . 35.7 t0 -42.38 107.15 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.089 0.471 . . . . 0.0 110.807 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 105.93 32.65 3.75 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.17 119.99 32.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.371 . . . . 0.0 110.731 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.498 ' OE2' HD21 ' A' ' 583' ' ' LEU . 3.4 tm-20 -96.1 111.33 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.093 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.54 HG22 HD13 ' A' ' 659' ' ' LEU . 33.2 pt -105.59 135.42 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 112.016 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 116.74 33.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.607 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.82 HG23 ' CD2' ' A' ' 622' ' ' HIS . 5.6 mt -91.36 -30.76 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.968 HG22 ' HB ' ' A' ' 690' ' ' ILE . 4.0 tp -153.8 130.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 111.674 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -137.46 126.83 24.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -126.88 117.05 21.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.874 0.369 . . . . 0.0 110.363 178.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.77 -46.81 74.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.804 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -83.36 -40.37 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.565 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.35 -11.1 59.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.446 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 57.75 22.11 8.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.695 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.767 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -81.57 104.38 11.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 689' ' ' VAL . 0.5 OUTLIER -126.98 120.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.968 ' HB ' HG22 ' A' ' 681' ' ' ILE . 30.2 mt -129.83 120.53 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.511 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 586' ' ' SER . . . -143.03 140.93 10.11 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.516 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.488 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 8.6 m-30 -112.66 146.06 39.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.809 0.338 . . . . 0.0 110.368 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.535 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.1 tptt -101.04 116.15 32.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.07 0.462 . . . . 0.0 109.846 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -82.69 122.34 37.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.306 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -133.09 109.84 9.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.971 0.415 . . . . 0.0 111.033 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.628 HD13 ' O ' ' A' ' 705' ' ' GLU . 16.3 mt -78.89 106.05 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.728 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.75 -45.04 10.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 9.4 t0 -110.3 140.14 44.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.483 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.0 OUTLIER -115.32 100.17 7.92 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.297 0.57 . . . . 0.0 109.891 178.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.3 71.68 4.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.015 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.453 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 63.32 36.61 93.64 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.033 -178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.935 HD13 ' CE2' ' A' ' 577' ' ' PHE . 1.7 tp -80.98 154.04 27.14 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 111.444 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.766 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -60.28 -142.57 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.478 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.598 ' N ' ' CG ' ' A' ' 703' ' ' PHE . 0.6 OUTLIER -29.89 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.791 0.436 . . . . 0.0 111.085 178.172 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.713 ' HA ' HD23 ' A' ' 702' ' ' LEU . 13.2 pt-20 117.55 -37.07 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.458 1.103 . . . . 0.0 109.929 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 127.52 21.52 1.6 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.525 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.41 ' N ' HD21 ' A' ' 704' ' ' ASN . 0.1 OUTLIER -85.01 8.07 19.11 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.497 -0.414 . . . . 0.0 111.659 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 96.05 60.12 1.03 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.286 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 47.1 ttp -57.78 141.31 49.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.917 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.63 44.84 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.471 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -105.01 -75.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.319 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -88.85 135.37 33.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.921 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.763 ' O ' HG13 ' A' ' 715' ' ' VAL . 11.0 mt-30 -82.87 99.53 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.319 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 713' ' ' GLN . 9.1 mmm-85 -10.63 78.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.794 0.838 . . . . 0.0 112.757 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 713' ' ' GLN . 3.0 m -123.67 142.73 39.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.475 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.641 HG23 ' HB3' ' A' ' 662' ' ' ASN . 96.5 t -77.8 130.22 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.38 171.37 7.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.597 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -103.09 142.57 33.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.965 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -77.4 154.44 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 -179.51 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.236 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.88 -31.97 51.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -61.83 -48.84 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.733 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.707 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.6 mp0 -65.76 -49.34 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -61.08 -32.74 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.181 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -38.68 92.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.273 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 723' ' ' GLU . 2.7 mt -63.18 -44.36 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 621' ' ' VAL . 9.1 p -81.21 -27.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -56.34 -30.93 63.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 110.787 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -84.03 -22.44 31.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.914 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.68 ' O ' HD23 ' A' ' 730' ' ' LEU . 8.3 tt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.96 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.842 0.353 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.01 145.36 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . 0.449 ' C ' HD12 ' P' ' 602' ' ' LEU . 0.0 OUTLIER -165.42 52.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.999 0.428 . . . . 0.0 110.891 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . 0.449 HD12 ' C ' ' P' ' 601' ' ' GLU . 6.8 mp -131.24 152.37 50.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.99 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -101.5 85.22 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.855 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -63.13 108.27 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 19.5 mt -74.89 147.8 84.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.543 2.162 . . . . 0.0 112.276 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -69.86 -22.32 63.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.606 0.241 . . . . 0.0 111.236 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.449 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . 145.09 -41.32 1.07 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.523 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.436 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.2 ttm105 -112.22 143.82 42.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.734 0.302 . . . . 0.0 111.112 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.933 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -124.01 -63.25 1.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.221 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.834 HD21 HG22 ' A' ' 694' ' ' VAL . 10.1 tt -108.98 142.69 39.27 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.202 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.587 HG21 ' CE ' ' A' ' 581' ' ' LYS . 2.1 m -120.97 113.88 20.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.748 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.627 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -101.52 107.92 19.35 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.587 ' CE ' HG21 ' A' ' 579' ' ' THR . 69.1 mttt -113.16 99.18 48.3 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -176.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.6 Cg_exo -47.28 99.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.767 1.645 . . . . 0.0 109.416 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -74.5 157.47 86.2 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.64 -25.36 11.02 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.809 3.006 . . . . 0.0 112.961 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -27.84 68.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.452 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.0 OUTLIER -95.73 153.87 17.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.554 178.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 690' ' ' ILE . 6.5 pt -58.17 -11.46 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.629 HD13 HG23 ' A' ' 613' ' ' ILE . 49.6 mt -107.16 119.01 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.76 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.424 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -107.68 58.13 0.62 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.134 0.493 . . . . 0.0 110.252 179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.611 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 30.7 mm-40 -124.62 171.58 9.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.351 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.03 128.3 44.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.775 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.51 141.1 46.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.017 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.436 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.0 mt-10 -124.52 115.78 21.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.801 HD12 HD22 ' A' ' 578' ' ' LEU . 77.0 mt -83.24 109.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.294 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 0.3 OUTLIER -66.94 120.23 13.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.057 179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.549 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.67 -29.84 2.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.176 0.513 . . . . 0.0 110.696 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -18.44 78.63 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.765 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.74 HG11 ' OD1' ' A' ' 610' ' ' ASN . 46.5 t -101.2 117.98 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 117.902 0.851 . . . . 0.0 111.983 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.412 ' ND2' ' HG3' ' A' ' 627' ' ' LYS . 27.9 t30 -140.27 122.77 9.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.873 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.1 Cg_endo -90.52 159.81 31.53 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.286 -1.131 . . . . 0.0 111.775 -0.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.638 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.31 115.62 28.24 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.765 ' CG ' HD12 ' A' ' 730' ' ' LEU . 43.3 m-85 -92.33 137.95 31.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.838 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.4 143.31 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.438 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.16 -170.3 38.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.297 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.466 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.5 OUTLIER -70.75 -49.45 46.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 111.614 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.71 130.64 47.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.479 -179.058 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -18.14 23.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.3 -28.65 63.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.086 0.47 . . . . 0.0 110.455 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.62 ' SG ' HG22 ' A' ' 621' ' ' VAL . 84.4 m -74.11 132.5 42.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.632 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.74 ' OD1' HG11 ' A' ' 598' ' ' VAL . 14.2 m-80 -47.44 -29.37 2.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.179 0.514 . . . . 0.0 110.254 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.775 ' SG ' HD13 ' A' ' 592' ' ' LEU . 42.5 t -109.93 142.07 41.79 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 105.38 13.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.77 HD11 HD21 ' A' ' 592' ' ' LEU . 20.5 mm -139.09 109.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.13 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.65 106.57 17.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.463 0.649 . . . . 0.0 112.255 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.577 ' H ' HD11 ' A' ' 618' ' ' LEU . 2.2 t0 -129.68 107.53 9.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.633 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.39 -27.24 0.08 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.551 ' O ' HG23 ' P' ' 603' ' ' TPO . 2.3 mmt-85 -69.95 -42.05 73.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.684 0.278 . . . . 0.0 111.382 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.577 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.2 pp -90.08 158.75 17.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.73 164.15 26.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.014 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.552 ' HG2' HG23 ' A' ' 621' ' ' VAL . 1.0 OUTLIER -50.38 -28.33 7.89 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.068 0.461 . . . . 0.0 110.449 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.62 HG22 ' SG ' ' A' ' 609' ' ' CYS . 45.0 t -130.8 64.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.694 ' CD2' HG23 ' A' ' 680' ' ' ILE . 20.8 t60 -50.57 -46.94 57.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.119 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.6 p -165.36 161.5 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.511 . . . . 0.0 111.93 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.529 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.8 p90 -143.6 147.67 34.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.664 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.7 mp -102.15 130.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -124.4 134.16 53.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -99.56 136.93 38.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.619 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.4 OUTLIER -135.88 158.94 43.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.584 -178.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.6 tpt180 -75.99 112.44 12.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.356 0.598 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -65.19 134.79 54.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.233 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -107.12 144.55 33.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.112 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 641' ' ' ALA . 2.9 m -131.26 166.16 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -103.43 -95.73 2.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.386 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -105.32 -174.86 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.799 0.333 . . . . 0.0 110.742 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 27.5 p -153.43 116.0 4.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.095 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.27 113.48 26.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 67.81 -72.24 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -89.8 144.44 25.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.726 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 69.0 m -89.58 112.07 49.54 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.36 -150.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.628 2.219 . . . . 0.0 112.164 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.553 ' HB3' ' CG1' ' A' ' 632' ' ' VAL . . . -47.52 -27.16 1.66 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.567 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 77.37 -74.76 0.07 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.987 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.435 ' H ' HD12 ' A' ' 644' ' ' LEU . . . 160.34 76.53 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.074 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 703' ' ' PHE . 0.8 OUTLIER -134.2 -156.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.543 ' O ' HD13 ' A' ' 702' ' ' LEU . 3.4 m-20 -100.68 146.27 27.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.37 0.605 . . . . 0.0 112.398 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 4.9 t0 -126.69 160.53 30.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.29 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.933 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 3.3 pt -114.88 115.37 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.386 0.612 . . . . 0.0 112.026 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.929 ' CH2' HD22 ' A' ' 671' ' ' LEU . 63.9 m95 -102.73 136.86 41.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.151 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.667 ' HB2' HD11 ' A' ' 672' ' ' LEU . 17.0 t80 -93.05 117.52 30.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.013 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 14.8 m -101.87 130.67 48.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.087 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.475 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 45.0 t60 -111.19 132.88 53.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.483 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 13.4 p -129.27 2.47 5.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.416 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.86 148.1 32.96 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.4 t -73.28 -33.0 64.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.068 0.461 . . . . 0.0 111.244 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.584 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.9 m-20 -72.27 -0.18 11.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.362 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.31 130.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 0.0 112.081 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.447 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 46.7 m -100.94 166.3 10.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.1 121.39 29.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.538 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.717 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.75 99.95 11.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.608 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 60.26 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.0 m-80 -130.02 -1.7 4.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.614 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.471 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.5 m-80 -101.6 142.02 33.59 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.239 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.585 ' O ' HG21 ' A' ' 716' ' ' VAL . 46.8 ttp180 -81.55 141.27 33.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.272 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.503 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 15.3 mmm -121.16 96.92 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.693 HG13 HG23 ' A' ' 668' ' ' THR . 6.7 pt -87.75 164.55 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.86 100.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.57 37.78 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.693 HG23 HG13 ' A' ' 665' ' ' ILE . 1.9 p -119.81 162.44 19.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.099 0.476 . . . . 0.0 111.535 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.637 ' O ' HD12 ' A' ' 717' ' ' LEU . 1.6 ttpm? -131.3 147.27 52.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.523 ' CD1' HG22 ' A' ' 716' ' ' VAL . 2.4 t80 -147.44 144.93 28.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.929 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.22 133.34 47.83 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.607 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.717 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.5 mt -114.8 124.84 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.677 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 0.6 OUTLIER -114.91 151.53 33.87 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.464 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 706' ' ' GLY . 8.2 t70 -49.07 119.41 3.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 110.405 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.29 36.4 5.95 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.46 110.09 22.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.737 0.303 . . . . 0.0 111.336 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.75 108.82 21.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.06 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.658 HG12 HD13 ' A' ' 659' ' ' LEU . 8.9 mt -105.61 136.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.897 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.15 116.48 28.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.679 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.694 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -84.72 -34.05 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.581 -178.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.843 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.5 tp -154.58 131.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.135 0.493 . . . . 0.0 111.866 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.407 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 13.0 t90 -136.26 126.81 26.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.046 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.595 ' OD2' HD22 ' P' ' 606' ' ' LEU . 0.4 OUTLIER -127.03 116.9 21.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.416 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -67.36 -46.71 72.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.873 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.11 -40.42 27.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.622 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -85.07 -10.55 56.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.427 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.9 mttt 59.82 19.2 8.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 682' ' ' TRP . 1.5 t80 -77.38 104.76 8.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.7 p -125.64 123.82 65.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 112.195 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.843 ' HB ' HG22 ' A' ' 681' ' ' ILE . 19.0 mt -128.32 154.87 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.424 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.452 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.24 135.75 2.76 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.113 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.607 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 5.9 m-30 -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.289 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -100.95 117.06 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.721 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.834 HG22 HD21 ' A' ' 578' ' ' LEU . 2.6 t -78.84 126.45 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.373 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.7 tt0 -133.29 109.33 9.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 110.59 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 674' ' ' ASP . 47.0 mt -82.89 105.68 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.102 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -87.86 -45.98 9.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.826 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.6 140.95 44.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.407 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.8 p -113.77 99.49 7.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.325 0.583 . . . . 0.0 109.669 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 700' ' ' THR . 8.6 t -81.67 60.15 4.49 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.198 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 69.09 59.01 6.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.613 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 645' ' ' ASP . 1.2 mm? -79.39 143.64 34.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.735 0.302 . . . . 0.0 111.119 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.492 ' HA ' ' HB2' ' A' ' 644' ' ' LEU . 3.5 p90 -44.54 -33.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.495 0.665 . . . . 0.0 110.369 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -141.13 -42.24 0.38 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.557 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 16.0 pt-20 135.17 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.242 1.017 . . . . 0.0 109.388 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 115.92 15.35 7.37 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.708 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 707' ' ' LEU . 1.0 OUTLIER -85.99 7.5 24.17 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.519 -0.4 . . . . 0.0 111.968 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 107.65 -50.34 0.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.761 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.421 ' O ' ' C ' ' A' ' 710' ' ' LEU . 9.9 ttp 68.79 117.47 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.751 0.31 . . . . 0.0 110.285 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 710' ' ' LEU . 0.2 OUTLIER -28.64 144.82 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.082 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 49.13 44.68 23.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.046 0.45 . . . . 0.0 110.244 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -62.97 109.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.907 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -82.24 102.04 10.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.707 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -96.24 76.57 3.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.53 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.3 143.17 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.421 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.585 HG21 ' O ' ' A' ' 663' ' ' ARG . 12.7 t -80.55 125.09 39.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.629 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.637 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -102.55 168.68 9.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.482 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 144.91 30.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -82.61 158.52 23.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -175.01 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.171 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.79 60.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.37 -46.56 88.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.694 ' HA ' HD12 ' A' ' 726' ' ' LEU . 3.7 mp0 -66.69 -47.8 71.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.767 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -59.99 -33.11 71.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -63.14 -39.58 95.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.694 HD12 ' HA ' ' A' ' 723' ' ' GLU . 4.7 mt -60.53 -44.02 96.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.0 p -80.62 -27.9 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -54.2 -34.4 60.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.09 -24.1 40.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.765 HD12 ' CG ' ' A' ' 602' ' ' PHE . 10.2 tt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.834 0.349 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . 0.48 ' O ' HG23 ' P' ' 600' ' ' VAL . 13.1 m -96.05 80.94 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.08 83.85 0.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.957 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . 0.428 ' O ' HD12 ' P' ' 602' ' ' LEU . 1.3 pp -155.72 169.37 24.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.551 HG23 ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.57 92.41 4.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.797 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.52 133.15 55.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.598 HD11 HD11 ' A' ' 681' ' ' ILE . 6.8 mt -109.3 149.89 40.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.581 2.188 . . . . 0.0 112.228 179.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -89.55 10.05 24.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.625 0.25 . . . . 0.0 111.316 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 160.6 -26.86 0.3 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.382 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.436 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? -106.63 140.28 39.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.005 0.431 . . . . 0.0 111.241 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -126.9 -62.86 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.087 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -106.42 142.23 36.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.841 ' N ' HD23 ' A' ' 578' ' ' LEU . 7.1 m -124.55 114.62 19.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.713 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.8 OUTLIER -104.25 108.42 19.81 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -117.0 100.22 53.28 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 24.5 Cg_exo -45.43 104.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.565 1.51 . . . . 0.0 109.105 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.39 156.98 86.92 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.001 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.56 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -49.88 -31.6 27.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.663 2.909 . . . . 0.0 112.908 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.686 ' HB2' HD12 ' A' ' 583' ' ' LEU . 4.7 m-20 -63.82 -21.49 66.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.927 0.394 . . . . 0.0 110.465 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.663 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 24.7 p -96.46 153.23 17.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.201 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.655 HG23 HG13 ' A' ' 588' ' ' ILE . 3.9 tt -52.46 -19.47 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.633 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.72 HD13 HG23 ' A' ' 613' ' ' ILE . 40.4 mt -110.62 118.54 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.299 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -109.7 60.81 0.6 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.298 0.571 . . . . 0.0 110.841 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.54 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 29.3 mt-10 -125.48 171.91 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.668 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.24 127.7 44.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 178.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.772 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.6 137.72 50.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.616 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.436 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.9 OUTLIER -124.12 119.53 29.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.587 HD11 HD13 ' A' ' 625' ' ' ILE . 80.3 mt -86.68 109.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.113 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -68.99 122.5 18.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.996 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.6 -29.56 1.88 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.69 -25.2 74.08 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.823 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.13 118.12 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.002 0.901 . . . . 0.0 111.661 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -140.09 122.63 10.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.844 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.1 Cg_endo -89.93 159.66 34.36 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 124.352 -1.104 . . . . 0.0 111.695 -0.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.4 t80 -91.93 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.86 ' CG ' HD12 ' A' ' 730' ' ' LEU . 58.9 m-85 -92.77 138.16 31.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.665 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.738 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.1 mp -128.12 144.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.66 -173.21 40.56 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.68 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -75.88 -18.39 59.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.324 0.249 . . . . 0.0 111.372 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.16 129.96 35.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -55.36 -23.0 21.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -55.07 -30.37 59.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.085 0.469 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 34.8 m -73.44 127.99 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.829 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 32.8 m120 -44.31 -33.93 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.306 0.574 . . . . 0.0 110.298 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.772 ' SG ' HD13 ' A' ' 592' ' ' LEU . 54.1 t -104.36 143.04 33.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.172 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.429 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -119.79 113.53 20.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.72 HG23 HD13 ' A' ' 588' ' ' ILE . 26.5 mm -137.95 109.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.447 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -97.28 105.23 17.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.513 0.673 . . . . 0.0 112.291 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.666 ' CB ' HD13 ' A' ' 618' ' ' LEU . 38.3 t0 -131.43 123.05 27.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.062 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -47.63 -29.23 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.75 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.616 ' HB3' HD13 ' A' ' 681' ' ' ILE . 3.2 mpt_? -77.76 -39.35 44.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.666 HD13 ' CB ' ' A' ' 615' ' ' ASP . 2.2 mp -65.88 159.22 26.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.786 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.0 m -110.61 172.08 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.433 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -47.84 31.76 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 110.174 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.938 HG11 HG23 ' A' ' 727' ' ' VAL . 4.1 t -121.45 56.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.482 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.572 ' CD2' HG23 ' A' ' 680' ' ' ILE . 49.3 t60 -43.67 -47.63 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.598 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 2.7 p -165.6 151.65 9.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.969 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.0 p90 -143.29 146.9 33.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.829 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.721 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.4 mp -101.86 127.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.586 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -120.37 134.33 55.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 27.2 ttmt -97.82 136.5 38.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.075 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.59 158.29 44.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.833 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.4 113.98 15.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.334 0.588 . . . . 0.0 110.572 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.9 t60 -70.86 131.05 43.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.132 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -174.7 168.34 3.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 633' ' ' GLY . 6.4 p -147.05 159.59 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.059 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -75.05 110.72 3.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.505 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 2.0 mttm 63.3 142.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.836 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.08 48.09 1.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -59.29 123.48 16.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 11.7 t80 68.34 -68.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -78.02 127.7 32.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.817 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 29.1 t -110.92 99.68 43.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.49 -150.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.65 2.233 . . . . 0.0 111.748 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.608 ' HB1' HD13 ' A' ' 644' ' ' LEU . . . -89.35 9.89 24.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.665 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 641' ' ' ALA . 19.6 mt-30 81.23 -72.12 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.285 0.234 . . . . 0.0 111.104 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -179.19 90.88 0.08 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.411 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.697 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.6 mp -122.7 -155.3 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.0 m-20 -122.05 146.43 47.19 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.239 0.543 . . . . 0.0 112.033 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.437 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -132.17 160.56 35.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.042 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.087 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -107.9 121.94 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.482 0.658 . . . . 0.0 112.274 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.933 ' CH2' HD22 ' A' ' 671' ' ' LEU . 79.4 m95 -106.0 124.65 49.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.168 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CD2' HD13 ' A' ' 678' ' ' ILE . 7.3 t80 -90.39 116.92 28.71 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 26.6 m -102.11 144.08 31.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.254 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 18.3 t60 -131.03 124.28 30.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.404 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 1.4 p -121.13 6.69 10.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.06 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.48 148.11 35.11 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.278 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.466 HG21 ' HG3' ' P' ' 605' ' ' GLU . 3.5 t -69.84 -34.7 73.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.795 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.585 ' O ' HG13 ' A' ' 656' ' ' VAL . 51.5 m-80 -70.56 -2.51 14.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.608 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.72 133.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.434 0.635 . . . . 0.0 111.893 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 81.8 p -103.06 165.59 10.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.816 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.5 120.26 30.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.775 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.84 101.33 12.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 59.78 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 65.1 t30 -133.47 -2.2 3.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.521 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 1.3 t-20 -104.98 141.41 36.61 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.197 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.89 141.2 33.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.573 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -109.24 100.11 9.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.691 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.7 pt -87.12 134.9 26.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.963 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' A' ' 652' ' ' THR . 1.2 tt0 -38.49 98.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.988 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 37.38 1.17 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 718' ' ' LYS . 2.1 p -139.21 158.37 44.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.703 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.491 ' HE2' HD13 ' A' ' 717' ' ' LEU . 12.6 pttm -123.61 158.2 32.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.72 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.3 OUTLIER -145.08 146.3 31.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.933 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.95 130.92 44.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.86 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.763 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -109.81 118.65 37.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 111.625 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 3.0 mt-30 -108.52 138.31 45.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.438 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 706' ' ' GLY . 8.7 t70 -38.88 116.95 0.62 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.84 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 93.8 35.28 6.19 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.43 114.89 27.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.86 108.52 20.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 13.0 mt -107.91 131.79 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.898 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 115.65 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.567 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.62 HD12 ' CE2' ' A' ' 692' ' ' PHE . 1.1 mt -78.01 -36.05 21.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.364 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.701 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -155.14 131.91 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 0.0 111.73 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -136.21 125.75 25.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.54 ' OD2' HD22 ' P' ' 606' ' ' LEU . 4.0 t70 -127.11 116.9 21.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.924 0.393 . . . . 0.0 110.318 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -67.22 -46.55 73.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.895 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -74.46 -40.29 61.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.77 -11.97 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.451 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt 61.61 16.94 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.727 0.298 . . . . 0.0 111.019 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 2.3 t80 -82.27 105.49 13.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.613 ' O ' HG22 ' A' ' 587' ' ' ILE . 0.9 OUTLIER -125.95 121.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.214 0.531 . . . . 0.0 111.997 -178.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 681' ' ' ILE . 31.5 mt -117.73 130.82 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.63 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -154.91 130.85 2.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.421 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.62 ' CE2' HD12 ' A' ' 680' ' ' ILE . 3.4 m-30 -113.33 143.91 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.863 0.363 . . . . 0.0 110.38 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.627 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -101.47 117.35 34.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.03 0.443 . . . . 0.0 110.682 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.777 HG22 HD21 ' A' ' 578' ' ' LEU . 3.0 t -79.97 127.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.515 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -133.39 109.53 9.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 674' ' ' ASP . 52.2 mt -83.19 105.14 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.36 -46.58 12.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.279 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.08 140.68 45.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.122 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 7.2 p -114.24 99.4 7.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.316 0.579 . . . . 0.0 109.568 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 700' ' ' THR . 88.3 m -76.75 67.91 2.9 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.238 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 61.25 55.63 28.2 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.452 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.683 HD23 ' C ' ' A' ' 705' ' ' GLU . 1.6 tp -81.51 141.42 33.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.121 0.486 . . . . 0.0 111.595 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.697 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.9 p90 -44.42 -33.87 1.83 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.07 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -140.42 -47.22 0.42 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.001 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.683 ' C ' HD23 ' A' ' 702' ' ' LEU . 17.0 pt-20 136.28 -35.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.964 0.906 . . . . 0.0 109.179 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 120.64 18.18 4.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.968 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.62 1.87 36.13 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.473 -0.428 . . . . 0.0 111.684 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 48.69 95.48 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.985 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.65 138.07 47.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 0.0 110.821 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.7 -166.42 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.717 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.85 -106.42 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.661 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -114.94 98.91 7.09 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.83 0.347 . . . . 0.0 110.994 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.1 102.53 9.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.72 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER 167.39 130.37 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.298 0.57 . . . . 0.0 110.526 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.79 146.28 28.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.537 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 669' ' ' LYS . 7.2 p -77.11 130.2 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.808 -178.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.491 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.6 OUTLIER -109.07 172.43 6.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.787 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . 0.53 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.0 OUTLIER -95.23 158.05 15.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 723' ' ' GLU . 15.1 mt-30 -95.88 160.27 14.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.864 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.1 p -120.2 -174.44 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.91 58.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -60.78 -48.17 82.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 726' ' ' LEU . 5.6 tm-20 -64.12 -48.86 74.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -53.1 -33.47 52.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.96 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.21 -36.91 80.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 723' ' ' GLU . 38.4 mt -56.65 -44.31 81.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.938 HG23 HG11 ' A' ' 621' ' ' VAL . 10.2 p -80.86 -21.25 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -67.82 -39.2 83.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.752 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -79.02 -11.69 60.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.198 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.86 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.2 tt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.052 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.787 0.327 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.14 73.96 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.17 74.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.942 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.06 159.28 41.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.779 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.548 HG22 ' O3P' ' P' ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -36.14 70.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.859 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . 0.466 ' HG3' HG21 ' A' ' 654' ' ' THR . 0.7 OUTLIER 59.92 90.29 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.638 ' CD1' HD11 ' A' ' 681' ' ' ILE . 43.8 mt -59.72 139.3 89.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.465 2.11 . . . . 0.0 112.317 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -83.65 0.18 48.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.549 0.214 . . . . 0.0 111.521 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 131.05 -1.87 5.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.998 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.464 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.9 OUTLIER -100.93 131.71 46.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.762 0.281 . . . . 0.0 110.487 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -121.69 -62.41 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 111.476 -179.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.028 HD12 HD13 ' A' ' 647' ' ' ILE . 5.7 tt -105.93 125.99 51.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.66 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.4 m -102.46 119.19 38.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.268 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.862 HD12 HD11 ' A' ' 594' ' ' ILE . 4.7 mt -105.64 108.54 20.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -117.97 100.72 52.09 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.125 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.59 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.7 Cg_exo -46.14 101.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.778 1.652 . . . . 0.0 109.451 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -75.09 157.97 84.72 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -50.06 -25.75 13.33 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.461 2.774 . . . . 0.0 112.244 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.564 ' CB ' HD12 ' A' ' 583' ' ' LEU . 10.2 t70 -62.36 -26.47 68.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.44 ' HA ' HG13 ' A' ' 689' ' ' VAL . 54.5 p -95.4 153.47 17.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.711 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.801 HD13 ' CE1' ' A' ' 688' ' ' PHE . 1.0 OUTLIER -58.7 -14.16 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.856 0.36 . . . . 0.0 110.56 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.458 ' CD1' HG23 ' A' ' 613' ' ' ILE . 73.0 mt -106.49 118.67 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.315 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.35 57.58 0.68 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 110.524 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.59 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.5 mt-10 -124.76 169.39 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.79 122.28 26.89 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.573 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.52 HD13 ' C ' ' A' ' 591' ' ' SER . 0.7 OUTLIER -113.17 150.31 32.43 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.392 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.464 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -124.44 125.34 44.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.862 HD11 HD12 ' A' ' 580' ' ' LEU . 93.9 mt -83.51 108.97 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.608 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.4 mp0 -64.16 122.84 17.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.63 -30.06 3.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.258 0.551 . . . . 0.0 110.021 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.476 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -73.42 -20.94 79.97 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.926 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.685 HG11 ' ND2' ' A' ' 610' ' ' ASN . 61.0 t -98.62 118.04 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 118.108 0.954 . . . . 0.0 111.642 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.0 t30 -140.18 121.6 9.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.002 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.591 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.0 Cg_endo -90.56 159.34 31.11 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.442 -1.066 . . . . 0.0 111.511 -0.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.62 ' CD2' HG23 ' A' ' 594' ' ' ILE . 4.3 t80 -91.78 115.6 28.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.566 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.6 m-85 -92.54 137.94 31.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.349 -177.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.785 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.2 mp -123.97 145.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.438 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 157.67 -169.85 34.58 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.317 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -69.83 -48.74 57.82 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.21 124.28 19.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.343 -178.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -19.44 5.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.665 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.48 -30.15 66.77 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 98.0 m -68.8 133.04 47.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.446 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.685 ' ND2' HG11 ' A' ' 598' ' ' VAL . 32.6 m120 -45.54 -30.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.19 0.519 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.785 ' SG ' HG23 ' A' ' 603' ' ' ILE . 32.8 t -113.1 142.34 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.373 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 105.92 15.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 588' ' ' ILE . 24.8 mm -138.39 109.71 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.441 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.22 106.89 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.584 0.707 . . . . 0.0 112.657 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.699 ' CB ' HD22 ' A' ' 618' ' ' LEU . 27.1 t0 -129.42 107.11 9.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.724 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.48 -30.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.456 ' HG2' HD21 ' P' ' 606' ' ' LEU . 0.0 OUTLIER -77.98 -37.56 47.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.498 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.699 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -89.63 134.09 34.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.66 165.52 0.41 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -59.45 -21.64 60.35 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 621' ' ' VAL . 14.9 p -140.27 56.58 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.54 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 14.1 t60 -41.86 -37.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.39 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 9.0 p -170.09 160.05 7.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.248 0.547 . . . . 0.0 112.03 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.575 ' HA ' HD12 ' A' ' 603' ' ' ILE . 40.6 p90 -143.37 147.59 34.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.172 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 580' ' ' LEU . 3.8 mp -101.55 130.83 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.591 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.0 t80 -122.96 133.8 54.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.891 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.576 ' HD3' HG23 ' A' ' 647' ' ' ILE . 3.0 tppp? -98.07 136.66 37.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.477 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.65 159.14 41.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.737 -178.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -76.41 112.45 12.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.355 0.598 . . . . 0.0 110.705 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.4 t60 -75.1 124.49 27.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.698 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -164.22 98.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.077 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 7.4 m -60.65 162.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.153 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -59.73 89.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.54 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 59.48 -177.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.23 103.75 4.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.042 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.77 123.19 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.719 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.87 -65.46 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.839 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -75.91 144.3 41.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.675 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 74.6 m -105.01 102.46 36.01 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.096 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.81 -150.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.676 2.251 . . . . 0.0 111.81 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 703' ' ' PHE . . . -93.61 32.51 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 0.0 111.339 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.29 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 172.27 84.88 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.656 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.9 mp -120.03 -153.23 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.556 ' O ' HD23 ' A' ' 702' ' ' LEU . 9.9 m-20 -112.63 146.93 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.404 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -129.59 160.09 34.35 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.275 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.028 HD13 HD12 ' A' ' 578' ' ' LEU . 1.9 pt -106.53 126.86 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.6 0.714 . . . . 0.0 112.892 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.874 ' CH2' HD22 ' A' ' 671' ' ' LEU . 82.7 m95 -111.22 128.55 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.687 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.734 ' CE1' HD12 ' A' ' 678' ' ' ILE . 20.2 t80 -90.76 117.8 29.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 38.4 m -102.8 131.87 49.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.484 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 47.4 t60 -111.91 130.85 55.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 6.6 p -131.47 12.42 4.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.342 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.32 154.27 32.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.295 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.415 HG22 ' HG2' ' P' ' 605' ' ' GLU . 55.3 m -83.61 -24.15 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.741 0.305 . . . . 0.0 111.381 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.61 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.9 OUTLIER -82.6 4.14 25.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 53.27 133.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.504 0.668 . . . . 0.0 111.981 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.457 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 60.0 m -102.0 166.17 10.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.376 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.407 ' O ' ' N ' ' A' ' 679' ' ' LYS . 34.9 m-85 -130.61 120.01 23.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.974 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -100.15 103.54 15.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.872 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.468 ' N ' HD12 ' A' ' 659' ' ' LEU . 16.9 t-20 60.56 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.768 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 659' ' ' LEU . 2.8 m120 -136.43 6.03 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.508 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.878 ' OD1' HG23 ' A' ' 716' ' ' VAL . 1.0 OUTLIER -107.37 142.0 37.86 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.804 0.335 . . . . 0.0 111.001 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.441 ' NH1' HG22 ' A' ' 665' ' ' ILE . 24.8 ttt-85 -78.02 141.39 38.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.402 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.438 ' O ' HG23 ' A' ' 656' ' ' VAL . 42.7 mmm -121.9 93.02 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.542 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.441 HG22 ' NH1' ' A' ' 663' ' ' ARG . 36.1 pt -87.71 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -47.25 96.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.115 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 115.26 41.47 0.81 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.0 p -128.94 162.15 28.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.056 0.455 . . . . 0.0 111.86 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.468 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -134.73 146.71 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.299 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.468 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.54 145.5 29.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.874 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.84 133.22 47.98 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.705 179.341 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.75 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -108.59 119.15 38.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.153 0.501 . . . . 0.0 111.443 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.554 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 9.6 mt-30 -106.67 139.73 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.828 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' A' ' 696' ' ' ILE . 41.1 t0 -40.8 114.8 0.51 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 110.732 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.78 36.69 5.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.65 115.38 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.056 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -96.55 108.68 21.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.238 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.974 HG22 HD13 ' A' ' 659' ' ' LEU . 23.4 pt -108.27 129.1 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.206 0.527 . . . . 0.0 111.946 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -89.22 116.03 27.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.307 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.498 HG23 ' CD2' ' A' ' 622' ' ' HIS . 3.0 mt -78.31 -36.0 20.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.566 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.646 HG22 ' CG1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -154.92 131.87 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.35 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -136.1 128.34 30.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 111.501 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.524 ' OD2' HD22 ' P' ' 606' ' ' LEU . 12.4 t0 -127.14 116.37 20.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.14 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.48 -46.47 72.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.16 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.83 -40.37 65.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -90.55 -10.33 43.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 15.97 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.663 0.268 . . . . 0.0 111.064 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.801 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.7 t80 -76.48 104.78 7.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 586' ' ' SER . 2.2 p -118.95 125.96 74.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.839 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.646 ' CG1' HG22 ' A' ' 681' ' ' ILE . 33.1 mm -127.93 125.62 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.36 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -160.7 136.74 4.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.136 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 8.1 m-30 -112.99 148.76 34.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.607 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.348 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.843 HG22 HD21 ' A' ' 578' ' ' LEU . 3.3 t -79.2 121.17 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.702 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.97 109.37 11.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.867 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' A' ' 674' ' ' ASP . 64.1 mt -78.31 110.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.33 -45.45 6.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.426 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 7.5 t70 -111.04 140.64 45.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.4 OUTLIER -114.46 100.39 8.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.398 0.618 . . . . 0.0 109.845 178.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 700' ' ' THR . 10.0 t -77.07 63.71 2.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.743 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 72.69 37.35 57.7 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.044 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -81.81 136.99 35.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.657 0.265 . . . . 0.0 111.209 -179.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.796 ' HB2' ' HB1' ' A' ' 641' ' ' ALA . 5.5 p90 -47.0 -34.85 6.0 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.452 0.644 . . . . 0.0 110.481 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.671 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 0.7 OUTLIER -148.37 -53.4 0.19 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.383 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.539 ' O ' HD13 ' A' ' 696' ' ' ILE . 8.5 pt-20 144.23 -50.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.096 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.671 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 159.69 79.87 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.766 -1.107 . . . . 0.0 112.127 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.465 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.14 -9.88 17.48 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.532 -0.393 . . . . 0.0 111.43 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.43 ' CA ' ' NE2' ' A' ' 673' ' ' GLN . . . 103.23 28.62 6.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.837 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.454 ' CE ' ' CE1' ' A' ' 630' ' ' HIS . 18.3 mmm 60.39 -143.26 0.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.704 0.287 . . . . 0.0 110.506 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 710' ' ' LEU . 1.4 tp -56.92 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.221 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -41.16 -86.13 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.515 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -114.69 98.46 6.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.89 0.376 . . . . 0.0 111.175 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 100.95 8.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.682 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.468 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 14.3 mmm-85 -154.94 77.27 1.02 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.007 0.432 . . . . 0.0 111.737 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.454 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.5 m -123.77 140.99 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.717 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.878 HG23 ' OD1' ' A' ' 662' ' ' ASN . 92.1 t -82.69 121.87 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.439 . . . . 0.0 111.482 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.72 167.52 11.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.377 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.09 150.42 23.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.209 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.77 149.02 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.432 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 31.7 p -126.15 -173.62 2.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.405 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -61.86 -28.69 69.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.159 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.13 -53.2 58.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.7 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.5 pp20? -70.6 -37.74 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -58.53 -34.93 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.544 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 728' ' ' LYS . 10.2 t70 -68.14 -39.35 82.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.7 HD12 ' HA ' ' A' ' 723' ' ' GLU . 17.0 mt -58.27 -44.17 88.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.03 -23.78 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.576 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 725' ' ' ASP . 0.0 OUTLIER -50.49 -48.82 56.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.066 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -27.31 67.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.919 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.7 ' O ' HD23 ' A' ' 730' ' ' LEU . 1.6 tt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.806 0.336 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . 0.401 ' O ' HG23 ' P' ' 600' ' ' VAL . 16.5 m -143.82 120.72 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 60.38 31.79 20.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' P' ' 602' ' ' LEU . 10.6 tp -142.36 157.59 44.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . 0.41 ' CG ' ' HG3' ' A' ' 617' ' ' ARG . 0.4 OUTLIER -105.23 83.0 1.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.794 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . 0.415 ' HG2' HG22 ' A' ' 654' ' ' THR . 1.0 OUTLIER -50.25 126.6 15.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.129 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.524 HD22 ' OD2' ' A' ' 683' ' ' ASP . 9.6 mt -90.0 143.03 29.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.838 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.472 2.115 . . . . 0.0 112.3 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -74.56 -22.13 59.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.675 0.274 . . . . 0.0 111.13 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 143.32 -15.8 2.29 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.748 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 6.4 tmm_? -107.7 134.85 50.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 111.314 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.801 ' CE1' HG21 ' A' ' 647' ' ' ILE . 0.2 OUTLIER -122.3 -52.79 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.425 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.059 HD21 HG13 ' A' ' 694' ' ' VAL . 1.4 tt -107.04 140.42 39.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.112 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.732 ' N ' HD23 ' A' ' 578' ' ' LEU . 23.8 m -118.52 113.55 21.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.755 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.848 HD23 HD11 ' A' ' 678' ' ' ILE . 0.7 OUTLIER -105.7 108.85 20.57 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.1 ptpt -117.01 99.86 53.11 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.1 Cg_exo -45.98 104.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.893 1.729 . . . . 0.0 109.503 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.18 157.39 85.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -176.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.1 Cg_endo -50.72 -27.73 20.78 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.603 2.869 . . . . 0.0 112.53 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.578 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.1 t70 -62.54 -26.72 68.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.64 153.57 17.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.157 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 690' ' ' ILE . 8.1 pt -57.14 -12.88 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.977 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.505 ' CD1' HG23 ' A' ' 613' ' ' ILE . 38.9 mt -108.87 118.82 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.637 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -107.65 59.33 0.62 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.146 179.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.645 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mm-40 -125.57 170.04 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.264 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.2 116.73 18.06 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.304 178.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.771 HD22 ' SG ' ' A' ' 611' ' ' CYS . 0.8 OUTLIER -113.53 143.56 44.32 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.418 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.7 OUTLIER -125.17 123.92 40.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.252 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.623 HG23 ' CD1' ' A' ' 601' ' ' PHE . 78.7 mt -75.23 108.84 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.511 ' CB ' HG23 ' A' ' 598' ' ' VAL . 1.6 mp0 -59.44 116.78 4.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.939 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -30.44 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.273 0.559 . . . . 0.0 110.118 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.447 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.88 -16.12 79.54 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.671 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.511 HG23 ' CB ' ' A' ' 595' ' ' GLN . 42.0 t -96.77 117.77 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 118.009 0.905 . . . . 0.0 111.212 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.9 OUTLIER -140.46 123.91 10.31 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.166 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.525 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 34.6 Cg_endo -91.38 158.85 27.27 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.349 -1.105 . . . . 0.0 112.052 -0.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.0 t80 -93.1 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.135 0.493 . . . . 0.0 109.752 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 1.1 m-85 -93.44 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.492 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.78 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -127.21 143.99 38.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.3 -163.61 31.6 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.504 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.558 ' CG ' HD12 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -73.57 -41.7 62.59 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 28.6 t -60.69 119.9 9.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.551 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.15 -18.65 10.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -62.45 -30.05 70.96 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.235 0.54 . . . . 0.0 109.614 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 61.5 m -67.1 128.05 34.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.378 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.8 m120 -44.1 -31.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.558 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.2 t -108.62 135.53 49.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.03 109.08 20.03 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 588' ' ' ILE . 24.0 mm -138.2 109.46 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.97 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -103.26 105.17 15.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.591 0.71 . . . . 0.0 112.22 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.674 ' HB2' HD21 ' A' ' 618' ' ' LEU . 1.0 OUTLIER -130.92 108.3 9.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.422 177.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -39.34 -29.75 0.05 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.744 ' HG2' HD21 ' P' ' 606' ' ' LEU . 8.3 mpt_? -70.62 -41.12 72.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -86.64 158.69 19.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 111.443 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 45.8 t -86.36 176.45 7.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.432 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -52.17 -51.75 56.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.479 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 621' ' ' VAL . 38.5 t -109.22 57.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.766 ' CD2' HG23 ' A' ' 680' ' ' ILE . 50.4 t60 -46.26 -38.09 8.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.937 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.12 174.9 10.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.531 0.681 . . . . 0.0 111.773 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.46 136.22 25.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.963 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.643 HD12 HD11 ' A' ' 603' ' ' ILE . 62.9 mt -132.37 117.05 30.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -134.4 147.49 50.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 111.552 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 16.3 ttmt -101.23 137.55 39.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.562 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 157.19 44.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.118 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.529 ' NH1' ' HB3' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -78.05 118.07 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.5 t60 -81.41 132.53 35.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.824 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.529 ' HB3' ' NH1' ' A' ' 629' ' ' ARG . . . -165.42 103.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.217 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 28.7 m -67.76 173.88 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.035 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -57.87 -101.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.539 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -119.55 143.84 47.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.339 . . . . 0.0 110.735 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.29 142.77 51.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.961 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 21.1 ttp -121.3 129.99 53.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.81 -64.11 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.055 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -75.57 141.56 42.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.778 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.31 91.6 5.9 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.118 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.3 -161.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.523 2.149 . . . . 0.0 112.086 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -45.03 -30.45 1.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.535 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 63.27 -78.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.41 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -160.14 51.35 0.37 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.73 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.666 HD12 ' N ' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -93.08 -157.36 0.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.841 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.7 OUTLIER -123.0 147.34 46.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.088 0.47 . . . . 0.0 111.932 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.408 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -135.76 137.97 42.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.175 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.801 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -90.26 124.87 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.288 0 CA-C-O 121.331 0.586 . . . . 0.0 111.67 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.901 ' CH2' HD22 ' A' ' 671' ' ' LEU . 92.7 m95 -110.08 131.22 55.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.651 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.52 ' CB ' HD21 ' A' ' 672' ' ' LEU . 1.6 t80 -100.34 117.3 34.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.592 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.3 m -111.66 145.12 39.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.549 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 664' ' ' MET . 23.5 t60 -119.55 125.2 48.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.935 0.398 . . . . 0.0 111.463 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.483 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 4.2 p -120.27 9.13 10.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.929 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.96 -178.99 47.85 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.74 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.471 HG23 ' N ' ' A' ' 655' ' ' ASN . 11.7 t -105.55 -45.07 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 111.642 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.497 ' C ' HG23 ' A' ' 656' ' ' VAL . 5.8 m-80 -60.04 -16.08 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.854 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 664' ' ' MET . 4.2 t 79.06 143.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.786 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 664' ' ' MET . 37.9 m -115.39 165.9 12.47 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 679' ' ' LYS . 27.8 m-85 -137.58 119.61 15.44 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.119 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.779 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -101.61 107.14 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.308 -179.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.543 ' N ' HD12 ' A' ' 659' ' ' LEU . 44.4 m-20 56.12 -82.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 659' ' ' LEU . 30.3 m-80 -133.92 4.46 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.644 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 9.5 m120 -106.84 125.85 51.54 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.915 0.388 . . . . 0.0 111.306 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.0 ttm105 -65.95 141.24 58.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.509 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.54 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -114.7 85.71 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 110.584 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.424 HG12 HG21 ' A' ' 668' ' ' THR . 38.3 pt -87.05 149.42 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 652' ' ' THR . 17.1 tt0 -45.62 100.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.542 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 111.81 37.7 1.52 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.603 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.424 HG21 HG12 ' A' ' 665' ' ' ILE . 3.0 p -128.9 162.58 27.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.482 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 717' ' ' LEU . 3.5 ttpm? -138.31 144.93 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.123 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.505 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.8 OUTLIER -147.02 145.53 29.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.109 0.48 . . . . 0.0 111.862 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.901 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.8 140.63 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.646 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.901 HD13 HG21 ' A' ' 694' ' ' VAL . 1.2 mt -106.87 123.88 48.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.154 0.502 . . . . 0.0 110.852 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.74 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 10.0 mt-30 -102.28 133.02 47.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.123 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.755 ' HB2' HD12 ' A' ' 696' ' ' ILE . 12.5 t0 -44.5 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 109.931 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.48 36.29 3.34 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.87 122.63 33.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.045 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.15 108.16 20.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.848 HD11 HD23 ' A' ' 580' ' ' LEU . 0.1 OUTLIER -105.51 137.52 34.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.867 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 658' ' ' TYR . 7.9 mmtt -101.74 116.44 32.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.988 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.766 HG23 ' CD2' ' A' ' 622' ' ' HIS . 6.3 mt -82.8 -35.91 12.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.133 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.616 HG22 ' HB ' ' A' ' 690' ' ' ILE . 1.3 tt -154.7 131.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.714 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -136.37 119.84 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.173 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.22 116.57 20.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 0.0 110.678 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -46.6 71.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.877 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.68 -40.72 93.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.181 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -105.19 2.93 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.94 22.59 3.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.725 0.298 . . . . 0.0 110.973 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.3 OUTLIER -76.82 104.88 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.6 p -122.8 122.79 66.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 111.768 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 587' ' ' ILE . 3.0 mt -127.9 126.07 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.478 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.91 139.98 6.59 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.78 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.55 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 3.2 m-30 -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 0.0 110.483 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -101.01 116.89 33.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.128 0.489 . . . . 0.0 110.312 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 1.059 HG13 HD21 ' A' ' 578' ' ' LEU . 2.2 t -81.79 120.0 32.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.0 OUTLIER -133.5 109.22 9.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 179.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 674' ' ' ASP . 13.8 mt -77.82 104.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.04 -45.02 21.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.24 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.44 141.63 43.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.63 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 8.1 p -114.1 99.72 7.85 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.262 0.553 . . . . 0.0 109.632 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 35.1 m -75.07 66.84 1.68 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.409 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 60.19 57.01 21.4 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.645 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.841 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -86.87 125.39 33.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.641 0.258 . . . . 0.0 111.441 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.666 ' N ' HD12 ' A' ' 644' ' ' LEU . 8.2 p90 -36.48 -43.74 0.41 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.419 0.628 . . . . 0.0 111.05 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 1.2 t30 -118.33 -43.35 2.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.409 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 9.8 pt-20 146.6 -19.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.208 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.74 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 109.03 24.79 5.87 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.094 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.0 OUTLIER -104.3 7.48 35.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.864 0.466 . . . . 0.0 112.092 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 131.04 179.98 16.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.007 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -143.88 130.32 19.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 110.778 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.75 -166.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.077 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 69.79 -65.64 0.3 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.741 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.92 122.32 42.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.365 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -82.69 99.42 9.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.082 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.488 ' NH1' ' O ' ' A' ' 671' ' ' LEU . 0.0 OUTLIER 32.2 94.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.718 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.58 140.68 47.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.049 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 716' ' ' VAL . 14.5 p -95.68 124.19 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.164 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 669' ' ' LYS . 3.2 mt -90.13 172.63 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.844 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.92 156.61 17.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.043 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.4 144.3 25.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.752 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 70.9 p -126.36 -176.81 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.8 37.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.269 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -55.97 -51.51 67.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.598 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.731 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.1 OUTLIER -70.18 -49.8 46.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.631 179.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -58.77 -32.12 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.97 -43.48 92.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.49 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.4 mt -57.51 -44.49 85.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.112 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.4 p -78.45 -14.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.461 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -25.83 19.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.327 . . . . 0.0 111.179 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -116.05 29.59 7.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.045 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.605 HD12 ' CD2' ' A' ' 602' ' ' PHE . 3.4 tt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.706 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . 0.599 ' O ' HG13 ' P' ' 600' ' ' VAL . 9.6 p -149.08 68.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -122.93 71.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 25.1 tp -172.22 135.34 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.755 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.626 HG22 ' O1P' ' P' ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -60.12 -37.25 79.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.563 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . 0.423 ' HG3' HG21 ' A' ' 654' ' ' THR . 13.4 mt-10 59.87 155.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.033 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.744 HD21 ' HG2' ' A' ' 617' ' ' ARG . 4.0 mt -140.95 87.53 10.92 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.501 2.134 . . . . 0.0 112.324 179.944 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.163 -0.375 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -84.8 -16.25 42.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 161.55 -22.57 0.22 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.768 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.7 tmm_? -106.08 139.38 40.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.739 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.3 t80 -127.94 -52.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.998 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.118 HD11 HG13 ' A' ' 694' ' ' VAL . 5.3 tp -115.45 125.6 53.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.444 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.58 ' N ' HD12 ' A' ' 578' ' ' LEU . 11.5 m -105.2 114.12 28.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.689 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.8 OUTLIER -106.09 108.83 20.54 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.0 mtmm -113.84 100.04 51.44 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_exo -45.01 100.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.923 1.749 . . . . 0.0 109.724 177.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 677' ' ' GLU . 0.2 OUTLIER -74.99 157.33 85.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.02 -25.28 12.26 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.698 2.932 . . . . 0.0 113.075 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -28.23 69.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.436 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.5 t -96.12 154.03 17.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.622 178.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.454 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 8.6 pt -58.55 -10.21 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.733 0.301 . . . . 0.0 111.121 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.726 HD13 HG23 ' A' ' 613' ' ' ILE . 54.6 mt -108.55 118.85 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.736 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.436 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.1 OUTLIER -108.75 60.27 0.6 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.22 0.533 . . . . 0.0 110.33 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.613 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.8 mt-10 -124.73 171.64 9.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.108 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.5 123.7 34.21 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -112.75 139.89 47.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 579' ' ' THR . 9.4 mt-10 -124.65 111.45 15.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.895 HD11 HD12 ' A' ' 625' ' ' ILE . 30.8 mt -72.21 108.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.947 0.403 . . . . 0.0 110.071 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.2 mp0 -68.03 116.56 8.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.871 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.29 -30.44 2.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.228 0.537 . . . . 0.0 110.475 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.46 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.22 -21.59 77.23 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.348 -0.842 . . . . 0.0 113.557 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.432 HG11 ' ND2' ' A' ' 610' ' ' ASN . 52.4 t -101.07 118.42 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -140.14 124.18 10.75 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.919 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 42.8 Cg_endo -90.63 159.22 30.73 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.232 0.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 1.9 t80 -92.67 114.27 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.562 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 0.4 OUTLIER -93.38 139.09 31.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.127 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.792 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.7 mp -127.07 143.79 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.894 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 156.52 -165.72 33.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.477 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.468 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -70.19 -42.61 72.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.92 -179.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 11.3 t -60.42 121.79 12.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.633 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.55 -18.18 18.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.335 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -64.2 -29.18 70.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.142 0.496 . . . . 0.0 109.665 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.0 m -66.96 128.87 37.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.199 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -44.05 -31.21 0.87 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.079 0.466 . . . . 0.0 110.501 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.792 ' SG ' HG23 ' A' ' 603' ' ' ILE . 43.1 t -110.53 142.06 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 107.5 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.8 HD11 HD21 ' A' ' 592' ' ' LEU . 24.5 mm -138.61 109.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.811 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -104.08 106.22 16.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.536 0.684 . . . . 0.0 112.723 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.643 ' H ' HD11 ' A' ' 618' ' ' LEU . 2.0 t0 -130.85 107.73 9.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.685 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -39.25 -28.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.579 ' HB3' HD11 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -73.7 -38.6 64.81 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.643 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -88.41 158.98 18.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.528 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.446 ' HB3' ' P ' ' P' ' 603' ' ' TPO . 1.6 p -83.56 168.76 16.1 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.504 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 4.4 ptp180 -51.24 -46.13 62.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.017 0.437 . . . . 0.0 110.322 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 727' ' ' VAL . 47.7 t -108.55 60.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.641 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 13.9 t60 -52.92 -39.71 63.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.926 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.773 ' SG ' HD11 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -144.99 175.26 10.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.595 0.712 . . . . 0.0 111.872 -178.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -144.92 142.21 29.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.183 -178.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.895 HD12 HD11 ' A' ' 594' ' ' ILE . 61.4 mt -133.26 116.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 3.0 t80 -132.88 138.7 47.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.586 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 32.7 ttmt -98.45 136.71 38.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.529 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.36 158.52 44.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.661 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.1 tpt180 -76.76 116.12 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.178 0.513 . . . . 0.0 110.627 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.1 t60 -82.33 129.56 34.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.602 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.427 ' HB2' ' HE ' ' A' ' 629' ' ' ARG . . . -158.71 149.61 20.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.241 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 21.0 m -112.82 -177.5 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -51.87 -85.23 0.02 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.705 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -148.5 40.48 0.93 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.828 0.346 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 25.3 p 49.63 86.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.5 ttp -65.95 100.61 0.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.39 -69.07 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.994 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -81.71 141.45 33.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.31 107.12 52.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.98 -149.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.55 2.167 . . . . 0.0 111.884 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.606 ' HB3' ' HB2' ' A' ' 703' ' ' PHE . . . -92.29 38.27 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.531 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 54.89 -167.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 111.046 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.639 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -89.07 93.97 1.95 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -105.5 -155.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.86 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -116.13 147.74 41.04 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.548 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -134.83 142.88 46.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.848 HD13 HD22 ' A' ' 578' ' ' LEU . 5.1 pt -94.76 120.63 44.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.374 0.607 . . . . 0.0 111.593 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.537 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.2 m95 -104.97 125.89 51.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.867 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.644 ' CB ' HD21 ' A' ' 672' ' ' LEU . 21.4 t80 -90.93 117.44 29.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.94 144.87 36.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.621 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 77.6 t60 -115.0 129.98 56.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.427 ' OG1' HG12 ' A' ' 621' ' ' VAL . 3.3 p -127.53 10.45 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.47 152.17 26.21 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.558 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.509 HG21 ' HB3' ' P' ' 605' ' ' GLU . 1.2 t -76.07 -30.82 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 111.72 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.587 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -75.08 2.05 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.027 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.08 122.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.464 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 80.2 p -93.15 165.94 12.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.173 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 57.1 m-85 -131.96 119.64 21.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 0.0 110.697 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -95.06 100.53 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.606 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.9 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 22.7 m120 -132.05 -0.3 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.342 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.655 ' OD1' HG23 ' A' ' 716' ' ' VAL . 1.8 m-80 -95.36 141.62 28.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.825 0.345 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 3.5 ttm105 -81.96 141.05 33.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.227 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.416 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 31.6 mmm -129.35 108.93 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 111.047 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.528 HG13 HG23 ' A' ' 668' ' ' THR . 3.1 pt -98.95 165.06 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.71 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 653' ' ' GLY . 0.0 OUTLIER -54.72 90.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.94 0.4 . . . . 0.0 110.924 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.08 35.19 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.504 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.528 HG23 HG13 ' A' ' 665' ' ' ILE . 0.8 OUTLIER -116.33 162.06 18.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.832 0.349 . . . . 0.0 111.127 179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.448 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.2 ttpt -139.52 138.88 36.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.555 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.05 143.37 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -71.3 140.31 50.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.206 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 694' ' ' VAL . 4.3 mt -108.28 127.37 53.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.783 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.787 ' OE1' HD23 ' A' ' 707' ' ' LEU . 1.3 mt-30 -106.67 149.94 26.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.772 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.478 ' HB2' HD12 ' A' ' 696' ' ' ILE . 6.0 t70 -47.66 106.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.038 0.447 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.99 36.3 4.52 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.602 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 7.6 t70 -92.13 113.33 25.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.305 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.592 ' HG3' HD21 ' A' ' 583' ' ' LEU . 0.5 OUTLIER -96.58 112.16 24.01 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.22 179.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.558 HG22 HD13 ' A' ' 659' ' ' LEU . 22.4 pt -105.41 128.84 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.96 0.41 . . . . 0.0 111.62 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 10.9 mmtp -87.27 116.54 25.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.988 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.773 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.1 OUTLIER -81.0 -36.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.377 -179.248 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 617' ' ' ARG . 4.7 tt -154.71 131.74 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 111.738 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -136.11 124.91 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.537 ' OD2' HD22 ' P' ' 606' ' ' LEU . 1.7 t0 -127.13 116.94 21.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.399 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -67.34 -46.66 72.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.991 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -74.06 -40.5 62.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.843 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -89.76 -8.65 51.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.548 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.26 19.11 7.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.721 0.296 . . . . 0.0 110.888 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.89 104.88 7.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.5 p -121.98 124.28 70.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.016 0.436 . . . . 0.0 111.858 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 681' ' ' ILE . 5.0 mt -128.18 152.49 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.358 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.435 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.58 140.93 3.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.281 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.555 ' CD2' HD11 ' A' ' 592' ' ' LEU . 3.0 m-30 -113.65 153.39 28.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 0.0 110.492 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -100.85 117.12 34.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 1.118 HG13 HD11 ' A' ' 578' ' ' LEU . 2.2 t -81.13 125.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.53 108.22 8.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.357 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 705' ' ' GLU . 18.9 mt -78.15 105.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -86.27 -46.95 9.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.893 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 27.5 t70 -110.85 140.45 45.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.434 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p -114.63 99.63 7.67 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.292 0.568 . . . . 0.0 109.53 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 74.7 p -70.15 73.87 0.48 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.459 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 55.08 48.43 67.88 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.605 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.86 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -86.55 140.12 30.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.899 0.381 . . . . 0.0 111.621 -179.076 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.606 ' HB2' ' HB3' ' A' ' 641' ' ' ALA . 0.3 OUTLIER -50.19 -27.38 5.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.328 0.585 . . . . 0.0 109.902 178.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.675 HD21 HD12 ' A' ' 707' ' ' LEU . 2.5 t30 -158.08 -57.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.946 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.577 ' O ' HD13 ' A' ' 696' ' ' ILE . 4.9 pt-20 164.4 -30.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.118 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 141.18 30.7 0.16 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.639 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.787 HD23 ' OE1' ' A' ' 673' ' ' GLN . 10.0 mt -90.97 7.54 39.77 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.125 0.463 . . . . 0.0 111.887 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 671' ' ' LEU . . . 67.88 -76.34 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.71 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 708' ' ' GLY . 0.0 OUTLIER 41.34 33.3 0.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.605 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.43 -164.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.693 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -51.72 -71.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.92 0.39 . . . . 0.0 110.898 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -71.8 131.75 43.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.654 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.82 100.67 10.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.962 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.412 ' HD3' ' NE2' ' A' ' 673' ' ' GLN . 10.2 mmm-85 46.93 87.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.445 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.62 148.71 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.762 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.655 HG23 ' OD1' ' A' ' 662' ' ' ASN . 86.2 t -80.9 130.44 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.251 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.37 166.49 10.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.611 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.2 144.86 30.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -88.21 146.52 25.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.16 -176.88 3.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.612 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.17 -28.93 43.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.269 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -55.79 -52.81 62.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.649 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.78 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.7 mp0 -70.6 -48.15 56.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.641 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -57.36 -32.28 66.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.92 -40.85 83.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 723' ' ' GLU . 4.9 mt -56.88 -44.39 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.744 0.307 . . . . 0.0 111.287 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.576 HG21 HG11 ' A' ' 621' ' ' VAL . 10.9 p -86.26 -15.32 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.605 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -52.85 -29.73 29.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -110.86 31.34 6.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.435 HD12 ' CD2' ' A' ' 602' ' ' PHE . 3.0 tt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.788 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.81 0.338 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.17 63.8 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 54.41 45.52 26.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.105 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.0 110.24 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.446 ' P ' ' HB3' ' A' ' 619' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.08 77.32 9.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.708 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 654' ' ' THR . 8.3 pt-20 -69.77 119.99 14.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.032 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.537 HD22 ' OD2' ' A' ' 683' ' ' ASP . 1.1 mt -85.18 146.81 46.02 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.571 2.181 . . . . 0.0 112.39 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -69.97 -22.22 63.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.726 0.298 . . . . 0.0 111.092 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 158.91 49.19 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.407 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 40.0 ttp180 -93.34 115.71 28.28 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.757 0.313 . . . . 0.0 110.226 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -103.6 -52.85 2.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.788 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.07 HD12 HD13 ' A' ' 647' ' ' ILE . 7.0 tt -113.45 140.08 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.719 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.1 m -118.49 114.93 23.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.861 HD21 HG23 ' A' ' 694' ' ' VAL . 6.4 mt -102.09 107.62 18.78 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.9 mtpt -113.44 99.43 49.42 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.8 Cg_exo -47.15 97.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.838 1.692 . . . . 0.0 109.541 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.68 158.37 84.94 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.58 -25.05 7.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.941 3.094 . . . . 0.0 113.389 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.39 -25.5 67.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 4.6 t -95.97 153.96 17.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.678 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -62.01 -8.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.872 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 90.1 mt -110.98 118.72 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -104.95 62.3 0.7 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.106 0.479 . . . . 0.0 110.256 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.601 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -124.91 171.45 10.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.207 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.33 128.85 45.36 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.085 0.469 . . . . 0.0 111.098 178.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.777 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.3 OUTLIER -112.25 142.62 44.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.74 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -124.51 113.7 18.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.913 HD12 HD22 ' A' ' 578' ' ' LEU . 87.3 mt -81.68 108.44 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.4 mm-40 -70.45 126.39 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.174 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.49 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.25 -32.12 2.88 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.488 0.661 . . . . 0.0 109.743 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -69.71 -23.85 76.56 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.992 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.523 HG11 ' CG ' ' A' ' 610' ' ' ASN . 99.5 t -99.34 117.36 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.084 0.942 . . . . 0.0 111.857 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.7 t30 -141.22 122.1 8.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.826 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.59 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.86 160.19 34.94 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 124.554 -1.019 . . . . 0.0 111.506 -0.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.601 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.3 t80 -92.25 115.67 28.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.55 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 42.3 m-85 -92.48 137.81 32.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.843 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.796 HG23 ' SG ' ' A' ' 611' ' ' CYS . 4.1 mp -124.7 144.89 33.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 162.3 -166.94 36.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.515 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.487 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -73.84 -54.87 7.03 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.88 0.371 . . . . 0.0 111.9 -179.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.52 132.66 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.374 -178.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -56.21 -19.78 15.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . 0.514 ' HB3' HD21 ' A' ' 730' ' ' LEU . 0.2 OUTLIER -53.05 -27.22 18.81 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.073 0.463 . . . . 0.0 110.432 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 10.5 m -79.03 132.91 36.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.582 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 19.7 m-80 -47.98 -28.64 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.511 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.796 ' SG ' HG23 ' A' ' 603' ' ' ILE . 25.7 t -110.17 141.23 43.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.58 104.6 12.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.637 HD11 HD21 ' A' ' 592' ' ' LEU . 24.6 mm -139.43 109.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.869 177.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.06 107.16 17.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.46 0.647 . . . . 0.0 112.601 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.608 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.2 t0 -129.47 107.59 9.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.624 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -39.81 -29.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.525 ' HG2' HD21 ' P' ' 606' ' ' LEU . 0.0 OUTLIER -69.58 -41.3 76.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.608 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.1 pp -89.22 158.7 17.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.463 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 t -78.57 167.37 21.37 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.385 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 3.3 mpt_? -48.64 -37.73 19.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.114 0.483 . . . . 0.0 110.37 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 727' ' ' VAL . 12.2 t -124.41 65.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.459 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.856 ' CD2' HG23 ' A' ' 680' ' ' ILE . 28.5 t60 -49.55 -42.12 43.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.809 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -168.98 159.2 9.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.472 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 603' ' ' ILE . 2.2 p90 -143.23 147.92 35.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.498 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.728 HD11 HD11 ' A' ' 580' ' ' LEU . 4.7 mt -102.38 132.58 48.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.251 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -124.24 133.46 53.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.72 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 20.2 ttmt -98.59 136.5 38.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.557 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.33 158.11 41.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.324 -179.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.15 117.71 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.442 ' CE1' ' CE ' ' A' ' 709' ' ' MET . 4.4 t60 -80.37 130.58 35.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.83 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -160.1 117.53 2.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.221 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 11.4 m -75.55 175.28 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -113.92 -18.25 6.97 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.652 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -89.51 63.26 6.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.972 0.415 . . . . 0.0 110.922 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 80.0 p -150.38 105.33 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 13.1 mtt -110.74 29.24 7.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.078 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 637' ' ' TYR . 0.0 OUTLIER 177.75 -99.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.33 105.82 13.59 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.722 0.296 . . . . 0.0 110.891 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 640' ' ' PRO . 62.9 m -135.39 143.61 46.08 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.445 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 52.7 Cg_exo -54.98 -168.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.535 2.156 . . . . 0.0 112.194 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 69.96 -63.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.204 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.574 ' HB3' HD12 ' A' ' 644' ' ' LEU . 0.2 OUTLIER 66.17 -175.68 0.19 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -94.23 67.82 1.43 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.604 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 642' ' ' GLN . 4.1 mp -100.69 -160.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.815 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -119.55 146.35 45.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.329 0.585 . . . . 0.0 112.444 -178.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.444 ' OD2' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -130.09 160.53 33.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.525 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.07 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -108.76 131.06 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.662 0.744 . . . . 0.0 112.689 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.911 ' CH2' HD22 ' A' ' 671' ' ' LEU . 92.5 m95 -115.29 126.9 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.504 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.662 ' CD2' HD13 ' A' ' 678' ' ' ILE . 3.7 t80 -90.52 117.63 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 35.3 m -103.32 133.12 48.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.398 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.422 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 64.7 t60 -110.57 130.61 55.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.3 p -130.27 10.74 5.36 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.461 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.0 178.91 53.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.276 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.1 t -102.06 -36.53 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.585 ' C ' HG13 ' A' ' 656' ' ' VAL . 3.0 m-80 -72.63 -0.16 12.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.942 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.585 HG13 ' C ' ' A' ' 655' ' ' ASN . 2.0 m 60.34 135.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 121.09 0.472 . . . . 0.0 111.577 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.422 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 4.3 t -97.63 165.65 11.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.672 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.488 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 5.6 m-85 -136.47 120.32 17.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.026 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.744 HD22 HH21 ' A' ' 714' ' ' ARG . 0.3 OUTLIER -103.99 115.77 31.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.06 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.39 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.7 p-10 -136.31 6.29 3.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.471 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.651 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -103.15 141.01 36.58 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.825 0.345 . . . . 0.0 111.015 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.682 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -82.55 141.43 32.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.424 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 31.4 mmm -119.42 106.01 11.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.035 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.42 ' CG1' HG23 ' A' ' 668' ' ' THR . 49.9 pt -92.36 153.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.2 tt0 -47.07 99.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 111.232 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.37 41.05 1.29 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.42 HG23 ' CG1' ' A' ' 665' ' ' ILE . 1.3 p -121.43 162.28 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.619 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.474 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.4 ttpm? -133.02 146.6 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.579 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.499 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -147.49 144.03 28.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.947 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.911 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.73 133.39 47.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.427 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -106.03 107.35 18.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 111.35 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 11.7 mt-30 -95.11 142.35 27.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.827 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 696' ' ' ILE . 20.2 t0 -45.15 114.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.758 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 94.08 36.75 5.63 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.435 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.4 OUTLIER -96.92 119.13 34.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.407 -179.201 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -96.2 114.06 25.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.722 HG23 ' HG ' ' A' ' 659' ' ' LEU . 6.4 mt -105.59 128.54 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 23.8 mtpt -90.37 116.5 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.952 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.856 HG23 ' CD2' ' A' ' 622' ' ' HIS . 35.3 mt -84.84 -38.97 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.348 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.516 HG22 ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.54 133.0 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -136.4 128.01 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.744 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.594 ' CG ' HD13 ' P' ' 606' ' ' LEU . 4.1 t0 -122.82 116.56 23.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.583 179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -46.83 71.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.942 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.91 -40.54 46.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -82.26 -16.81 48.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.271 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.66 11.44 8.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.963 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.413 ' CE1' HG13 ' A' ' 690' ' ' ILE . 29.0 t80 -81.19 104.39 11.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.7 p -117.73 133.38 64.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.467 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.516 ' HB ' HG22 ' A' ' 681' ' ' ILE . 4.7 mt -128.24 155.04 39.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.802 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.481 ' O ' HD22 ' A' ' 583' ' ' LEU . . . 179.43 132.77 1.83 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.578 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.577 ' HB2' HD22 ' A' ' 580' ' ' LEU . 9.7 m-30 -113.12 145.82 40.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.789 ' HB2' HD12 ' A' ' 583' ' ' LEU . 3.2 ttmt -101.2 117.66 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.02 0.438 . . . . 0.0 110.991 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.861 HG23 HD21 ' A' ' 580' ' ' LEU . 2.3 t -80.1 117.95 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.321 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 579' ' ' THR . 7.0 tt0 -126.09 109.29 12.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 110.266 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 705' ' ' GLU . 41.0 mt -80.37 105.88 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.902 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -91.06 -45.32 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.118 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 577' ' ' PHE . 9.4 t0 -110.37 141.08 43.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.29 100.11 8.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.445 0.641 . . . . 0.0 109.559 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 700' ' ' THR . 31.0 m -84.23 57.23 4.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.966 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 85.28 37.37 9.89 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -78.02 129.75 35.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.654 0.227 . . . . 0.0 110.433 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.569 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.8 p90 -42.04 -33.99 0.65 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.627 0.727 . . . . 0.0 110.104 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 0.1 OUTLIER -146.57 -63.27 0.3 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.857 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.687 ' O ' HD12 ' A' ' 696' ' ' ILE . 8.3 pt-20 145.52 32.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.891 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 67.22 77.07 0.33 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.484 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.498 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.08 -9.82 17.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.989 0.394 . . . . 0.0 111.687 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.411 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 79.76 38.16 20.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.521 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.442 ' CE ' ' CE1' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -96.69 116.84 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 0.0 111.099 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -176.89 164.96 2.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.937 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -58.02 -42.52 85.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -88.52 139.27 30.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.49 100.33 13.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.1 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.744 HH21 HD22 ' A' ' 659' ' ' LEU . 4.5 mmm-85 41.06 86.48 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.785 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.9 m -124.63 142.85 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.604 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.682 HG21 ' O ' ' A' ' 663' ' ' ARG . 48.4 t -79.63 123.77 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.167 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 166.37 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 135.28 45.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -85.1 160.0 20.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.57 -174.34 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -29.32 36.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.39 -52.09 67.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.692 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.742 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.4 OUTLIER -68.08 -42.37 80.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.587 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -33.46 72.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.85 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.47 -40.83 93.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.049 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.2 mt -57.73 -44.3 85.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.054 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.463 HG23 HG11 ' A' ' 621' ' ' VAL . 9.4 p -79.41 -27.34 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -57.78 -35.44 70.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -97.54 25.85 5.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.665 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.656 ' O ' HD23 ' A' ' 730' ' ' LEU . 5.6 tt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.826 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.775 0.321 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 17.9 t -71.38 70.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.001 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -122.45 -165.35 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.891 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 64.55 116.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.822 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 72.27 3.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.741 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -60.56 119.46 8.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.594 HD13 ' CG ' ' A' ' 683' ' ' ASP . 9.3 mt -83.51 -46.05 0.81 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.308 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' P' ' 606' ' ' LEU . 78.5 Cg_exo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 122.326 2.017 . . . . 0.0 112.456 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.71 1.71 57.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.561 0.22 . . . . 0.0 111.439 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.425 ' O ' ' CG ' ' A' ' 595' ' ' GLN . . . 122.76 -27.36 5.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.471 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.0 OUTLIER -78.36 121.14 24.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.966 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -107.78 -52.54 2.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.226 -178.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 594' ' ' ILE . 9.3 tt -119.59 142.46 48.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.552 ' N ' HD23 ' A' ' 578' ' ' LEU . 6.1 m -119.85 114.42 22.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.669 ' HB3' HD12 ' A' ' 592' ' ' LEU . 0.4 OUTLIER -102.18 108.46 19.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 5.1 pttp -118.01 99.76 51.98 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -176.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.9 Cg_exo -46.0 102.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.815 1.677 . . . . 0.0 109.603 176.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -75.01 157.6 85.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.418 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.4 Cg_exo -49.37 -24.75 9.09 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.866 3.044 . . . . 0.0 113.382 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.13 -24.11 66.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 1.5 t -95.95 152.01 18.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.93 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.478 HD13 ' N ' ' A' ' 587' ' ' ILE . 0.2 OUTLIER -56.33 -15.19 2.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.285 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.541 HG23 ' CB ' ' A' ' 582' ' ' PRO . 3.3 tt -112.58 124.88 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.849 0.357 . . . . 0.0 111.656 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.418 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -107.68 71.25 0.81 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.563 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 48.9 mt-10 -125.55 169.89 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.521 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.27 128.17 42.69 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.154 0.502 . . . . 0.0 110.917 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.909 HD21 HD11 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -112.48 140.09 47.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.637 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 20.4 mt-10 -124.06 113.81 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.884 HD12 HD22 ' A' ' 578' ' ' LEU . 83.6 mt -86.32 109.75 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -76.63 128.81 35.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.04 -30.24 2.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.367 0.603 . . . . 0.0 110.085 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.432 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -25.56 74.43 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.035 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.89 117.87 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 117.991 0.896 . . . . 0.0 111.924 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.25 122.13 9.66 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.861 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.58 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.6 Cg_endo -90.77 159.55 30.17 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.395 -1.085 . . . . 0.0 111.649 -0.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -92.25 115.83 28.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.795 ' CG ' HD12 ' A' ' 730' ' ' LEU . 42.9 m-85 -92.57 138.05 31.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.05 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.762 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.1 mp -126.47 145.15 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.511 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.99 -168.44 39.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.495 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.413 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 12.2 ttp85 -82.41 -19.22 39.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.614 0.245 . . . . 0.0 111.343 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.04 132.65 34.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -21.55 45.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.06 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.8 -29.36 64.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.908 0.385 . . . . 0.0 110.644 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.8 m -74.92 130.2 38.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.925 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 34.3 m120 -45.24 -31.86 1.7 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.26 0.552 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.776 ' SG ' HD13 ' A' ' 592' ' ' LEU . 43.8 t -107.87 142.74 37.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.618 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.97 116.29 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.909 HD11 HD21 ' A' ' 592' ' ' LEU . 26.7 mm -137.96 109.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.678 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.4 tt0 -92.43 103.49 15.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.881 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.712 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.6 t70 -132.22 117.06 17.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.021 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -46.16 -31.15 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.794 0.331 . . . . 0.0 111.194 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.58 ' HG2' HD11 ' P' ' 606' ' ' LEU . 1.7 mpt_? -77.73 -35.7 51.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.712 HD13 ' CB ' ' A' ' 615' ' ' ASP . 1.2 mp -66.38 159.69 26.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.3 m -108.61 167.09 10.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -48.93 22.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.239 0.542 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.651 HG11 HG23 ' A' ' 727' ' ' VAL . 10.3 t -119.74 61.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.279 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.548 ' NE2' HG23 ' A' ' 680' ' ' ILE . 28.2 t60 -49.13 -45.57 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.995 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -167.65 155.81 9.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.053 0.454 . . . . 0.0 111.339 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 603' ' ' ILE . 48.2 p90 -143.22 144.32 32.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.768 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -101.39 131.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.58 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.9 t80 -126.54 133.3 51.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.027 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.71 ' HB2' HG22 ' A' ' 647' ' ' ILE . 31.0 ttmt -98.44 133.6 42.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.91 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 159.62 40.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.771 -178.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.2 tpt180 -75.6 115.07 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.372 0.606 . . . . 0.0 110.533 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 -61.53 135.18 57.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.309 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -70.12 -162.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.869 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 633' ' ' GLY . 6.8 p -169.11 159.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.962 0.411 . . . . 0.0 111.109 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.518 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -145.95 90.2 0.15 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.478 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt 59.65 175.19 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.713 0.292 . . . . 0.0 110.806 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 1.8 p -163.97 36.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.018 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 25.3 ttp -60.47 113.28 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 2.7 t80 71.94 -62.55 0.46 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -75.86 144.28 41.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.0 89.85 21.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -62.14 -154.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.739 2.293 . . . . 0.0 112.311 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -63.63 -14.17 49.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.61 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 78.44 -66.51 0.2 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.713 0.292 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.539 ' C ' HD23 ' A' ' 644' ' ' LEU . . . 154.01 68.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.808 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.933 HD12 ' O ' ' A' ' 702' ' ' LEU . 0.1 OUTLIER -108.8 -154.23 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 702' ' ' LEU . 4.0 m-20 -107.06 137.78 44.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' A' ' 671' ' ' LEU . 2.4 t0 -116.03 157.39 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.811 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.966 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 4.7 pt -109.4 117.08 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.502 0.668 . . . . 0.0 111.851 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.908 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 70.9 m95 -102.78 131.23 49.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.623 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.701 ' HB2' HD11 ' A' ' 672' ' ' LEU . 27.7 t80 -91.16 117.13 29.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 624' ' ' PHE . 23.6 m -103.95 123.98 48.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.298 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.456 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 68.8 t60 -102.25 134.51 45.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -134.38 8.65 3.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.33 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.92 151.35 26.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.63 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 1.6 t -73.67 -29.04 62.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.126 0.489 . . . . 0.0 111.464 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.608 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.1 m120 -72.66 -1.8 17.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.539 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 54.74 124.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 111.877 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.451 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -98.02 166.41 11.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.257 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -134.21 126.21 29.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.076 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.764 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -93.74 99.45 11.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.298 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 61.92 -78.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.689 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 659' ' ' LEU . 15.4 p-10 -129.08 -8.17 4.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.735 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.446 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 9.9 m120 -92.6 140.62 29.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -83.52 141.67 31.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.629 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.636 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 3.2 mtp -125.4 121.81 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.273 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.416 HG12 ' CG2' ' A' ' 668' ' ' THR . 33.7 pt -103.48 156.54 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.546 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -48.2 104.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.38 . . . . 0.0 111.343 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.4 35.73 2.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.4 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.416 ' CG2' HG12 ' A' ' 665' ' ' ILE . 2.8 p -117.63 162.03 18.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.741 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.515 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.0 OUTLIER -131.82 145.03 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.061 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.636 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 3.4 t80 -147.76 145.89 28.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.908 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.27 130.27 42.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.3 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.764 ' CD2' HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -109.76 129.58 55.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.143 0.497 . . . . 0.0 111.154 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.434 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 1.0 OUTLIER -125.01 144.66 50.27 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.786 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.509 ' H ' ' HA3' ' A' ' 706' ' ' GLY . 11.0 t70 -41.88 118.6 1.14 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.854 0.359 . . . . 0.0 110.91 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.02 33.83 7.55 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.25 109.89 21.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 111.126 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.501 ' HG3' HD11 ' A' ' 583' ' ' LEU . 15.2 tt0 -95.63 108.21 20.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.651 HG12 HD22 ' A' ' 659' ' ' LEU . 13.7 mt -105.46 122.63 59.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.581 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -78.91 115.9 18.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.71 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.734 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 1.1 mt -79.34 -32.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 690' ' ' ILE . 6.9 tt -154.98 131.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.63 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.56 126.7 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.136 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.567 ' OD1' HD13 ' P' ' 606' ' ' LEU . 65.0 m-20 -126.23 117.39 22.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.226 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -46.58 73.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.105 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -73.57 -40.51 63.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.3 -14.24 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.603 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp 59.74 18.43 7.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.435 ' CE1' ' NH1' ' A' ' 617' ' ' ARG . 36.8 t80 -82.72 105.18 13.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.2 p -121.87 123.69 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.707 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 681' ' ' ILE . 3.9 tt -127.57 125.08 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.487 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.76 148.17 16.84 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.18 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.734 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 0.3 OUTLIER -116.14 151.94 34.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.666 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.47 117.39 34.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.788 HG22 HD21 ' A' ' 578' ' ' LEU . 2.5 t -75.16 128.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.347 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 579' ' ' THR . 5.6 tt0 -133.14 109.01 9.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 674' ' ' ASP . 39.9 mt -83.32 105.06 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.391 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.91 -45.88 11.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.492 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -110.24 140.77 44.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.331 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.8 p -114.03 99.32 7.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.338 0.59 . . . . 0.0 109.715 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 26.3 m -82.36 69.77 9.18 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.147 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 65.79 40.53 95.69 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.388 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.933 ' O ' HD12 ' A' ' 644' ' ' LEU . 1.8 mm? -62.58 129.82 42.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.455 0.169 . . . . 0.0 110.997 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 704' ' ' ASN . 3.4 p90 -37.32 -33.65 0.07 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.252 0.549 . . . . 0.0 111.162 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 703' ' ' PHE . 0.1 OUTLIER -141.29 -43.14 0.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.717 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 16.5 pt-20 137.89 -32.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.189 0.931 . . . . 0.0 109.342 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.509 ' HA3' ' H ' ' A' ' 674' ' ' ASP . . . 119.37 15.74 5.39 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.08 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.413 ' N ' HD21 ' A' ' 704' ' ' ASN . 0.1 OUTLIER -94.29 8.96 39.99 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 90.83 -141.58 15.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.874 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.65 ' C ' HD23 ' A' ' 710' ' ' LEU . 0.0 OUTLIER 172.57 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.691 0.245 . . . . 0.0 111.212 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.65 HD23 ' C ' ' A' ' 709' ' ' MET . 0.7 OUTLIER 36.92 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.802 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 77.08 121.16 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.919 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.54 98.89 0.13 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.039 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.54 118.83 34.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.316 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.446 ' HG3' ' CZ ' ' A' ' 670' ' ' PHE . 10.1 ptt180 -176.48 125.29 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.325 0.583 . . . . 0.0 110.788 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.417 ' O ' HD23 ' A' ' 717' ' ' LEU . 3.2 m -122.97 146.89 27.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.722 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 716' ' ' VAL . 5.1 p -76.83 121.01 28.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.931 0.396 . . . . 0.0 111.353 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.1 OUTLIER -101.14 172.25 7.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.68 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 153.06 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.196 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.19 160.09 25.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -125.03 -178.66 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -28.82 37.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -66.11 -46.64 76.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 726' ' ' LEU . 8.3 mp0 -68.6 -43.17 77.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.812 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -55.97 -37.0 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -67.98 -36.6 80.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.003 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 723' ' ' GLU . 91.5 mt -55.63 -44.27 76.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.225 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.651 HG23 HG11 ' A' ' 621' ' ' VAL . 8.1 p -77.93 -29.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.758 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -57.85 -32.13 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -101.52 27.26 6.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.866 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.795 HD12 ' CG ' ' A' ' 602' ' ' PHE . 2.5 tt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.666 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.752 0.311 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . 0.639 ' O ' HG13 ' P' ' 600' ' ' VAL . 7.9 p -153.83 96.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.077 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -117.36 83.77 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 3.9 pp -168.66 157.98 8.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.521 HG22 ' O1P' ' P' ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.11 -30.63 19.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 60.86 96.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.924 HD12 HD11 ' A' ' 681' ' ' ILE . 3.7 mt -111.09 153.41 43.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.947 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.59 2.193 . . . . 0.0 112.393 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.95 -21.76 63.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.735 0.302 . . . . 0.0 111.095 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 147.1 -52.22 0.56 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.162 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -112.19 143.15 43.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.966 0.413 . . . . 0.0 111.451 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -126.98 -54.38 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.055 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.049 HD12 HD13 ' A' ' 647' ' ' ILE . 7.1 tt -112.98 138.49 49.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.355 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.757 ' N ' HD23 ' A' ' 578' ' ' LEU . 6.4 m -118.29 114.2 22.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.992 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.769 HD12 HD11 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -104.09 108.04 19.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.6 OUTLIER -116.89 100.99 53.66 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -176.43 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 37.1 Cg_exo -45.61 100.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.824 1.682 . . . . 0.0 109.597 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.61 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.33 157.02 86.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.432 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 78.5 Cg_exo -50.31 -26.09 14.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.981 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.567 ' HB2' HD12 ' A' ' 583' ' ' LEU . 4.0 t0 -62.09 -27.22 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.423 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.4 t -95.62 154.2 17.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.704 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 31.2 pt -56.97 -11.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.729 0.299 . . . . 0.0 111.13 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.607 HD13 HG23 ' A' ' 613' ' ' ILE . 34.3 mt -108.72 122.33 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.744 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.63 57.04 0.61 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 110.404 179.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.533 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 23.3 mt-10 -124.62 171.06 10.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.194 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.06 129.32 46.46 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.073 0.463 . . . . 0.0 111.126 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.48 142.02 45.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.154 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.3 114.41 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.822 HD12 HD22 ' A' ' 578' ' ' LEU . 87.4 mt -83.84 108.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.5 mp0 -65.7 125.49 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.315 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.01 -26.92 1.97 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.169 0.509 . . . . 0.0 110.413 179.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -76.65 -21.85 73.78 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.472 -0.785 . . . . 0.0 114.153 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.38 117.74 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 118.324 1.062 . . . . 0.0 111.534 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 15.0 t30 -140.72 122.29 9.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.23 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.578 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.9 Cg_endo -90.56 160.09 31.47 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.42 -1.075 . . . . 0.0 111.391 -0.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.627 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.8 t80 -92.29 114.96 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.561 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 43.5 m-85 -91.88 138.18 31.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.833 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.78 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.91 145.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.369 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.49 -172.94 36.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.416 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.469 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.6 OUTLIER -67.41 -52.05 44.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.339 . . . . 0.0 111.859 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.49 126.44 27.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.25 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.276 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -30.36 62.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.064 0.459 . . . . 0.0 110.299 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.642 ' SG ' HG22 ' A' ' 621' ' ' VAL . 8.3 m -71.32 134.69 46.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.485 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 21.0 m-80 -48.43 -26.59 2.18 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 110.539 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.78 ' SG ' HG23 ' A' ' 603' ' ' ILE . 35.7 t -113.83 142.45 46.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.537 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.07 105.2 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.785 HD11 HD21 ' A' ' 592' ' ' LEU . 25.9 mm -138.98 109.51 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.334 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -104.0 106.4 16.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 112.459 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.585 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.9 t0 -130.43 107.53 9.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.65 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.19 -29.37 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.674 ' CD ' HD21 ' P' ' 606' ' ' LEU . 0.3 OUTLIER -67.2 -41.46 85.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.601 0.238 . . . . 0.0 111.473 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.585 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -89.86 158.99 17.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 0.0 111.711 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 92.2 p -78.41 172.86 13.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.364 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.477 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 3.3 mpt_? -47.72 -46.41 29.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.117 0.484 . . . . 0.0 110.278 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.642 HG22 ' SG ' ' A' ' 609' ' ' CYS . 46.5 t -119.8 70.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.199 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 12.8 t60 -49.72 -45.98 49.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.769 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.1 p -164.23 158.7 19.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.602 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.503 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 2.1 p90 -143.4 147.73 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.561 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.3 mp -102.64 131.12 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.578 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.7 t80 -122.29 133.88 54.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.63 ' HD3' HG23 ' A' ' 647' ' ' ILE . 1.6 tppp? -97.85 136.58 37.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.043 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.6 OUTLIER -135.31 159.04 42.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.819 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.6 tpt180 -76.69 112.26 13.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.312 0.577 . . . . 0.0 110.334 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.53 ' CE1' ' HE3' ' A' ' 709' ' ' MET . 4.0 t60 -80.57 123.96 28.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.745 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -142.74 131.73 23.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.299 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 5.4 m -108.13 119.95 58.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.02 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -87.64 57.05 4.44 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.603 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -176.25 81.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.98 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.66 52.35 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.757 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 22.4 ttt -62.5 120.34 10.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.956 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.4 -62.88 0.42 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.27 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.66 144.3 41.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.128 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 10.6 p -114.63 91.85 26.78 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.704 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.16 -148.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.668 2.245 . . . . 0.0 112.098 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.868 ' HB1' HD12 ' A' ' 644' ' ' LEU . . . -78.25 4.44 12.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.935 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 69.06 -77.89 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.715 0.293 . . . . 0.0 110.989 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -170.82 97.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.865 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.868 HD12 ' HB1' ' A' ' 641' ' ' ALA . 5.3 mt -115.45 -155.26 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 2.5 m-20 -116.47 147.34 41.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.242 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.405 ' OD1' ' CE2' ' A' ' 703' ' ' PHE . 2.1 m-20 -131.3 156.93 44.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.877 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.049 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -104.18 125.02 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.636 . . . . 0.0 112.29 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.871 ' CH2' HD22 ' A' ' 671' ' ' LEU . 82.5 m95 -108.79 123.08 48.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.653 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.581 ' CD2' HD13 ' A' ' 678' ' ' ILE . 3.0 t80 -89.82 116.08 27.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 62.4 m -100.68 142.6 31.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.451 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.459 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 74.4 t60 -118.97 130.96 55.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.4 p -125.64 2.73 7.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.014 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.88 150.68 38.05 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.401 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.408 HG21 ' CG ' ' P' ' 605' ' ' GLU . 2.0 t -73.3 -32.55 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.495 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.588 ' O ' HG13 ' A' ' 656' ' ' VAL . 17.3 m-20 -75.56 2.24 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.764 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.07 125.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.767 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 37.3 p -88.78 166.15 14.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.609 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.48 120.42 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.73 99.9 10.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.806 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 59.5 -83.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -131.44 4.32 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.454 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -113.66 116.85 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -84.3 141.28 31.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.57 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.485 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.78 142.33 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 111.261 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.422 ' O ' ' OG1' ' A' ' 668' ' ' THR . 31.2 pt -96.56 163.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -52.77 91.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.46 39.91 0.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.754 HG22 ' HA ' ' A' ' 718' ' ' LYS . 0.8 OUTLIER -137.48 158.5 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 111.266 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.577 ' HE2' HD13 ' A' ' 717' ' ' LEU . 18.9 pttm -128.18 158.5 37.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.621 ' HB3' HD23 ' A' ' 659' ' ' LEU . 15.3 t80 -145.37 146.75 31.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.871 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.78 129.32 39.48 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.36 -179.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.774 HD13 HG21 ' A' ' 694' ' ' VAL . 0.7 OUTLIER -103.82 130.8 51.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.242 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.939 ' HB3' HD12 ' A' ' 707' ' ' LEU . 0.7 OUTLIER -121.94 150.37 42.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.5 -179.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 696' ' ' ILE . 19.3 t0 -50.12 105.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.369 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 104.28 32.7 4.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.48 113.11 25.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.04 108.84 21.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.226 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.666 HG12 HD13 ' A' ' 659' ' ' LEU . 6.4 mt -105.91 136.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.795 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 116.5 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.864 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.518 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -79.72 -36.34 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.256 -179.17 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.714 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.2 tp -155.15 131.35 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 112.085 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -136.74 122.76 20.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.914 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.783 ' OD2' HD22 ' P' ' 606' ' ' LEU . 7.7 t0 -126.6 117.02 21.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.906 0.384 . . . . 0.0 110.687 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -46.37 73.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.867 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.74 -40.59 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.687 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.73 -9.61 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.519 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 15.8 tttt 60.61 17.56 7.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.951 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 7.5 t80 -77.5 104.97 8.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.5 p -121.71 121.77 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.168 0.509 . . . . 0.0 112.143 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' A' ' 681' ' ' ILE . 8.7 mt -128.72 153.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.423 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -179.76 137.14 2.97 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.148 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.487 ' CE2' HD11 ' A' ' 592' ' ' LEU . 9.0 m-30 -113.24 144.82 42.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.716 0.293 . . . . 0.0 110.422 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.61 ' HB2' HD22 ' A' ' 583' ' ' LEU . 13.3 tptm -101.07 116.85 33.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.996 0.427 . . . . 0.0 110.256 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 672' ' ' LEU . 3.8 t -79.68 125.37 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.636 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.1 109.16 9.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.548 HG23 ' CD1' ' A' ' 577' ' ' PHE . 17.4 mt -84.24 105.7 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.68 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -88.46 -46.02 9.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -110.96 139.53 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.812 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.3 OUTLIER -115.21 101.64 9.15 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.9 t -66.08 64.13 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.403 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 51.33 48.71 47.16 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.998 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.826 HD11 ' CA ' ' A' ' 705' ' ' GLU . 1.0 OUTLIER -111.62 163.47 14.07 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.818 0.342 . . . . 0.0 111.122 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.746 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -58.08 110.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.381 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.715 HD21 HD13 ' A' ' 707' ' ' LEU . 12.6 t30 55.12 -76.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 0.0 110.674 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.826 ' CA ' HD11 ' A' ' 702' ' ' LEU . 6.7 pt-20 179.82 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.305 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 148.08 39.67 0.04 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.792 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.939 HD12 ' HB3' ' A' ' 673' ' ' GLN . 1.9 mp -85.75 7.89 21.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.474 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 83.5 -90.32 1.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.411 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.53 ' HE3' ' CE1' ' A' ' 630' ' ' HIS . 0.6 OUTLIER 60.16 91.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.368 . . . . 0.0 110.443 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.522 ' N ' HD23 ' A' ' 710' ' ' LEU . 2.5 pt? -171.32 -167.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.877 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -69.46 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.853 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -76.6 139.34 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.609 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -95.92 110.71 22.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.223 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.416 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 2.8 mmm-85 53.39 76.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.74 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.77 142.87 41.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.193 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.423 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 7.4 p -85.38 128.94 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 111.378 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.577 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -97.05 166.99 11.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . 0.754 ' HA ' HG22 ' A' ' 668' ' ' THR . 0.6 OUTLIER -103.23 154.81 18.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -87.35 154.69 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.746 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.22 -177.5 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.3 -30.51 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -47.47 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.695 ' HA ' HD12 ' A' ' 726' ' ' LEU . 57.7 mm-40 -66.97 -47.32 71.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -55.73 -32.99 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.95 -37.79 82.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.695 HD12 ' HA ' ' A' ' 723' ' ' GLU . 15.6 mt -57.55 -44.14 84.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.12 -15.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -45.19 83.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 110.616 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -72.45 -14.43 61.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.21 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.463 HD13 HG21 ' A' ' 621' ' ' VAL . 8.7 tt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.053 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.798 0.332 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . 0.57 HG12 ' O ' ' P' ' 600' ' ' VAL . 25.6 t -94.3 47.18 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.098 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -79.5 65.17 4.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.807 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.8 -173.7 4.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . 0.665 HG23 ' O ' ' A' ' 617' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 88.2 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . 0.408 ' CG ' HG21 ' A' ' 654' ' ' THR . 17.6 mt-10 -65.67 100.59 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.763 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.783 HD22 ' OD2' ' A' ' 683' ' ' ASP . 25.4 mt -64.89 149.85 95.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.558 2.172 . . . . 0.0 112.362 179.914 . . . . . . . . 0 0 . 1 stop_ save_